000005|N05AX0801|Risperdal|töflur|0,5|mg|20|stk|1|ţpakki||N05AX08|01.04.2000||R|1|0|0|0|0|0|JAS|0|0|0|100|SEK|1632|3280|lyfalmen|V0045|1657|1|20|0|2,0000|Vistor hf|Janssen-Cilag AB|Risperídón||1632||1632|3280||1 000018|G01AF0501|Pevaryl|krem/sti|||15|g|1|sett|krem+3 stílar|G01AF05|01.05.1978||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|15|0|4,5000|Vistor hf|McNeil Sweden AB|Ekónazól|||||||1 000054|B03XA0103|NeoRecormon|stl|4000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|33035|43341|lyfsjukr|||1|1,8|0|24,0000|Icepharma hf|Roche|Epóetín||33035||33035|43341||2 000145|B03XA0103|NeoRecormon|stl|6000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|49629|64167|lyfsjukr|||1|1,8|0|36,0000|Icepharma hf|Roche|Epóetín||49629||49629|64167||2 000153|A02BC0102|Losec|sh-tfl|20|mg|7|stk|1|ţpakki||A02BC01|01.09.2009||L|1|0|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||0|7|0|7,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||||1 000159|N05AH0302|Zyprexa Velotab|munndr.t|5|mg|28|stk|1|ţpakki||N05AH03|01.06.2002||R|0|0|0|0|0|0|ELD|0|0|0|100|XEU|10495|15405|lyfalmen|V0457|7915|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||10495||10495|15405||2 000184|N05AH0302|Zyprexa Velotab|munndr.t|15|mg|28|stk|1|ţpakki||N05AH03|01.06.2002||R|0|0|0|0|0|0|ELD|0|0|0|100|XEU|30588|41111|lyfalmen|V0475|13537|1|28|0|42,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||30588||30588|41111||2 000193|N05AH0302|Zyprexa Velotab|munnltfl|20|mg|28|stk|1|ţpakki||N05AH03|01.12.2003||R|0|0|0|0|0|0|ELD|0|0|0|100|XEU|39780|52647|lyfalmen|V0540|30736|1|28|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||39780||39780|52647||2 000198|N05AH0302|Zyprexa Velotab|munndr.t|10|mg|28|stk|1|ţpakki||N05AH03|01.06.2002||R|0|0|0|0|0|0|ELD|0|0|0|100|XEU|21398|29578|lyfalmen|V0456|15904|1|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||21398||21398|29578||2 000223|G02CX0101|Tractocile|stl|7,5|mg/ml|0,9|ml|1|hgl|lausn|G02CX01|01.12.2006||R|0|0|0|1|0|1|FER|0|0|0|100|DKK|4970|7173|lyfsjukr|||1|0,9|0|0,0400|Vistor hf|Ferring|Atosíban||4970||4970|7173||1 000225|QM01AC0601|Metacam|mixtúra|1,5|mg/ml|100|ml|1|fl||QM01AC06|01.05.2004||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|7518|14608|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|||7518||7518|14608||1 000237|G02CX0101|Tractocile|irţ|7,5|mg/ml|5|ml|1|hgl|lausn|G02CX01|01.12.2006||R|0|0|0|1|0|1|FER|0|0|0|100|DKK|13313|18590|lyfsjukr|||1|5|0|0,2300|Vistor hf|Ferring|Atosíban||13313||13313|18590||1 000290|G03GA0601|Puregon|stl|300|ae/rörly|0,36|ml|1|pakki||G03GA06|01.02.2002||R|0|0|0|1|G|0|ORG|0|0|0|100|DKK|19335|26989|lyfalmen|||1|0,36|0|4,0000|Vistor hf|N.V. Organon|Follitrópín beta||19335||19335|26989||1 000316|G03GA0601|Puregon|stl|600|ae/rörly|0,72|ml|1|pakki||G03GA06|01.02.2002||R|0|0|0|1|G|0|ORG|0|0|0|100|DKK|38865|51499|lyfalmen|||1|0,72|0|8,0000|Vistor hf|N.V. Organon|Follitrópín beta||38865||38865|51499||1 000373|N02CC0402|Maxalt Smelt|munnltfl|10|mg|6|stk|1|ţpakki||N02CC04|01.03.1999||R|0|0|0|0|G|0|MSD|0|0|0|100|DKK|4526|7239|lyfalmen|||1|6|0|6,0000|Vistor hf|M.S.D.|Rizatriptan||4526||4526|7239||1 000390|J01CR0202|Augmentin|sts|600|mg/hgl|10|hgl|1|pakki|500+100 mg|J01CR02|01.01.2000||R|0|0|0|0|0|1|GSK|0|0|0|100|IKR|2534|3657|lyfsjukr|||1|10|0|1,6700|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||2534||2534|3657||1 000402|J01CR0202|Augmentin|sts|1200|mg/hgl|5|hgl|1|pakki|1000+200 mg|J01CR02|01.01.2000||R|0|0|0|0|0|1|GSK|0|0|0|100|IKR|2175|3139|lyfsjukr|||1|5|0|1,6700|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||2175||2175|3139||1 000448|D07AC1301|Elocon|húđlausn|0,1|%|100|ml|1|glas||D07AC13|01.03.2009||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|2658|4684|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||||2658|4684||1 000530|J07BF0301|Imovax Polio|bóluefni|||0,5|ml|20|áf.spr|án nála|J07BF03|01.06.2005||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|27714|37504|lyfalmen|||1|10|0||Icepharma hf|Sanofi Pasteur MSD|Mćnusótt, dauđ veira||27714||27714|37504||2 000548|S01GX0801|Zaditen|augndr|0,25|mg/ml|5|ml|1|glas||S01GX08|01.07.2001||R|0|0|0|0|G|0|LTH|0|0|0|100|SEK|1837|3561|lyfalmen|V0075|3561|1|5|0||Vistor hf|Laboratoires THEA|Ketotifen||1837||1837|3561||1 000552|G04BE0105|Caverject Dual|sts|20|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|4830|7655|lyfalmen|||1|2|0|2,0000|Icepharma hf|Pfizer ApS|Alprostadíl||4830||4830|7655||1 000555|N03AX1101|Topimax|hylki|15|mg|60|stk|1|plglas||N03AX11|01.05.2001||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|3741|6165|lyfalmen|||1|60|0|3,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||3741||3741|6165||1 000565|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|20|sk-hyl||S01GX08|01.07.2001||L|0|0|0|0|0|0|LTH|0|0|0|100|IKR|||lyflausa|||0|8|0||Vistor hf|Laboratoires THEA|Ketotifen|||||||1 000573|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|60|sk-hyl||S01GX08|01.07.2001|30.06.2013|R|0|0|0|0|G|0|LTH|0|0|0|100|SEK|5304|8304|lyfalmen|||1|24|0||Vistor hf|Laboratoires THEA|Ketotifen||5304||5304|8304||1 000641|B05BA0202|Intralipid 200 mg/ml|irl|200|mg/ml|100|ml|10|fl||B05BA02|01.04.2004||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|15462|21287|lyfsjukr|||1|1000|0||Icepharma hf|Fresenius Kabi|Fitusambönd||15462||15462|21287||2 000646|C08CA0101|Norvasc|töflur|10|mg|30|stk|1|ţpakki||C08CA01|01.01.1992||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|3045|5213|lyfalmen|||1|30|0|60,0000|Icepharma hf|Pfizer ApS|Amlódipín||3045||3045|5213||1 000784|G04BE0105|Caverject Dual|sts|10|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|3749|6176|lyfalmen|||1|2|0|1,0000|Icepharma hf|Pfizer ApS|Alprostadíl||3749||3749|6176||1 000801|R06AA0201|Benylan|mixtúra|2,8|mg/ml|125|ml|1|glas||R06AA02|01.05.1999||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|125|0|1,7500|Vistor hf|McNeil Denmark ApS|Dífenhýdramín|||||||1 000815|R06AA0201|Benylan|mixtúra|1,4|mg/ml|125|ml|1|glas||R06AA02|01.06.2001||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|125|0|0,8750|Vistor hf|McNeil Denmark ApS|Dífenhýdramín|||||||1 000879|L03AB0702|Rebif|stl|44|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.01.2001||R|0|0|0|1|0|1|MSE|0|1|0|100|SEK|172305|218125|lyfsjukr|||1|6|0|122,7907|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||172305||172305|218125||2 000957|H01AC0101|Genotropin|sts|5|mg|1|rörlyk|1|pakki|tvíhólfa|H01AC01|01.05.2001||R|0|0|0|1|0|1|PER|0|1|0|100|DKK|22211|29757|lyfsjukr|||1|1|0|7,5000|Icepharma hf|Pfizer ApS|Sómatrópín||22211||22211|29757||1 001167|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|1|spr||H01CC01|01.05.2001||R|0|0|0|1|0|1|ORG|0|0|0|100|DKK|5668|8180|lyfsjukr|||1|0,5|0|1,0000|Vistor hf|N.V. Organon|Ganirelix||5668||5668|8180||1 001194|M01AH0101|Celebra|hylki|200|mg|10|stk|1|ţpakki||M01AH01|01.03.2003||R|1|0|0|0|G|0|PER|0|0|1|100|DKK|1446|3026|lyfalmen|V0037|2137|1|10|0|10,0000|Icepharma hf|Pfizer ApS|Celekoxíb||1446||1446|3026||1 001225|C10AA0501|Zarator|töflur|80|mg|30|stk|1|ţpakki||C10AA05|01.06.2002||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|6318|9691|lyfalmen|||1|30|0|120,0000|Icepharma hf|Pfizer ApS|Atorvastatín||6318||6318|9691||1 001239|C10AA0501|Zarator|töflur|80|mg|100|stk|1|ţpakki||C10AA05|01.06.2002||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|16751|23746|lyfalmen|V0115|13359|1|100|0|400,0000|Icepharma hf|Pfizer ApS|Atorvastatín||16751||16751|23746||1 001291|C07AB0206|Seloken ZOC|forđatfl|23,75|mg|100|stk|1|plglas||C07AB02|01.05.2006||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|2282|4170|lyfalmen|V0050|2917|1|100|0|15,8300|Vistor hf|AstraZeneca A/S DK|Metóprólól||2282||2282|4170||1 001399|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|5|spr||H01CC01|01.05.2001||R|0|0|0|1|0|1|ORG|0|0|0|100|DKK|28340|37449|lyfsjukr|||1|2,5|0|5,0000|Vistor hf|N.V. Organon|Ganirelix||28340||28340|37449||1 001437|N05AH0308|Lazapix|filmhtfl|2,5|mg|28|stk|1|ţpakki||N05AH03|01.10.2011||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|2547|1709|lyfalmen|V0278|1709|2|28|0|7,0000|Portfarma ehf|Portfarma|Olanzapín||483||483|1709||2 001490|A10AD0502|NovoMix 30 Penfill|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.08.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|6068|9349|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulín aspart||6068||6068|9349||1 001512|C04AD0301|Trental|forđatfl|400|mg|100|stk|1|ţpakki||C04AD03|01.05.2002||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|4238|6845|lyfalmen|||1|100|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Pentoxífýllín||4238||4238|6845||1 001517|N06AB0308|Fluoxetin Actavis|hylki|20|mg|30|stk|1|ţpakki||N06AB03|01.03.2000||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|883|1869|lyfalmen|V0038|1867|2|30|0|30,0000|Actavis Group hf|Actavis hf|Flúoxetín||600||600|1869||1 001528|N06AB0308|Fluoxetin Actavis|hylki|20|mg|100|stk|1|ţpakki||N06AB03|01.03.2000||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|2456|3100|lyfalmen|V0039|3098|2|100|0|100,0000|Actavis Group hf|Actavis hf|Flúoxetín||1500||1500|3100||1 001588|B05BA1014|Kabiven|irl|900|kcal|1026|ml|4|pokar||B05BA10|01.08.2003||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|21841|29293|lyfsjukr|||1|4104|0||Icepharma hf|Fresenius Kabi|Blöndur||21841||21841|29293||2 001599|B03AC0201|Venofer|stl|20|mg/ml|5|ml|5|lykjur||B03AC02|01.07.2005||R|0|0|0|0|G|0|VIF|0|0|1|100|CHF|14758|21245|lyfalmen|V0034|18874|1|25|0|5,0000|Vistor hf|Vifor France SA|Járnoxíđ (sykurflétta)||14758||14758|21245||1 001605|B05BA1014|Kabiven|irl|1400|kcal|1540|ml|4|pokar||B05BA10|01.08.2003||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|31825|41823|lyfsjukr|||1|6160|0||Icepharma hf|Fresenius Kabi|Blöndur||31825||31825|41823||2 001874|G02AB0101|Methergin|stl|0,2|mg/ml|1|ml|10|lykjur||G02AB01|01.11.2001||R|0|0|0|0|0|1|NOH|0|0|0|100|DKK|2408|3475|lyfsjukr|||1|10|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Metýlergómetrín||2408||2408|3475||1 001878|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|3|glös||S01EC04|01.11.2001||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|4112|6673|lyfalmen|V0444|6673|0|15|0|75,0000|Vistor hf|Alcon Laboratories Ltd.|Brinzólamíđ||4112||4112|6673||1 001889|A02BC0501|Nexium|sh-tfl|20|mg|7|stk|1|ţpakki||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|858|2222|lyfalmen|V0004|534|1|7|0|4,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||858||858|2222||1 001954|N05AX0802|Rison|töflur|1|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1946|3442|lyfalmen|V0291|3442|2|60|0|12,0000|Actavis Group hf|Actavis hf|Risperídón||1750||1750|3442||1 001957|N05AX0802|Rison|töflur|4|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|6936|10536|lyfalmen|V0294|10536|2|60|0|48,0000|Actavis Group hf|Actavis hf|Risperídón||6936||6936|10536||1 001962|N01BX0401|Capsina|krem|0,75|mg/g|45|g|1|túpa||N01BX04|01.06.1998||R|0|0|0|0|0|0|BIG|0|0|1|100|SEK|4399|7066|lyfalmen|||1|45|0||Icepharma hf|Bioglan AB|Capsaicin||4399||4399|7066||2 001965|N05AX0802|Rison|töflur|2|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|3353|5635|lyfalmen|V0292|5635|2|60|0|24,0000|Actavis Group hf|Actavis hf|Risperídón||3353||3353|5635||1 001980|A02BC0501|Nexium|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|4472|7165|lyfalmen|V0004|2135|1|28|0|18,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||4472||4472|7165||1 001986|N05AX0802|Rison|töflur|3|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|5263|8247|lyfalmen|V0293|8247|2|60|0|36,0000|Actavis Group hf|Actavis hf|Risperídón||5263||5263|8247||1 001991|A02BC0501|Nexium|sh-tfl|20|mg|56|stk|1|veski||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|8878|13193|lyfalmen|V0011|2897|1|56|0|37,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||8878||8878|13193||1 002011|A02BC0501|Nexium|sh-tfl|40|mg|7|stk|1|ţpakki||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|1410|2977|lyfalmen|V0005|546|1|7|0|9,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||1410||1410|2977||1 002033|A02BC0501|Nexium|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|6257|9607|lyfalmen|V0005|2183|1|28|0|37,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||6257||6257|9607||1 002071|A07EC0204|Asacol|sh-tfl|400|mg|100|stk|1|ţpakki||A07EC02|01.01.2000||R|1|0|0|0|G|0|TIL|0|0|0|100|SEK|5017|7911|lyfalmen|||1|100|0|26,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||||5017|7911||2 002180|A02BC0501|Nexium|sh-tfl|20|mg|50|stk|1|ţpakki|stakskammtar|A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|5479|8543|lyfalmen|V0011|2587|1|50|0|33,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||5479||5479|8543||1 002194|B05BA1010|Kabiven Peripheral|irl|1000|kcal|1440|ml|4|pokar|fleyti|B05BA10|01.02.2002||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|25711|34150|lyfsjukr|||1|5760|0||Icepharma hf|Fresenius Kabi|Blöndur||25711||25711|34150||2 002197|A02BC0501|Nexium|sh-tfl|20|mg|100|stk|1|glas||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|12529|7403|lyfalmen|V0011|5173|1|100|0|66,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||4646||4646|7403||1 002205|A02BC0501|Nexium|sh-tfl|40|mg|50|stk|1|ţpakki|stakskammtar|A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|9980|14700|lyfalmen|V0012|2587|1|50|0|66,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||9980||9980|14700||1 002208|A10AB0504|NovoRapid|stl|100|ae/ml|10|ml|1|hgl||A10AB05|01.04.2006||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|3108|5300|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||3108||3108|5300||1 002219|A02BC0501|Nexium|sh-tfl|40|mg|100|stk|1|glas||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|15275|21893|lyfalmen|V0012|5173|1|100|0|133,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||15275||15275|21893||1 002328|R03DC0301|Singulair|tuggutfl|4|mg|98|stk|1|ţpakki||R03DC03|01.08.2002||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|17049|24120|lyfalmen|V0492|12515|1|98|0|39,2000|Vistor hf|M.S.D.|Montelúkast||17049||17049|24120||1 002342|B02BD0204|Helixate NexGen|sts|1000|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|0|0|0|0|0|1|BAY|0|1|0|100|SEK|102939|131071|lyfsjukr|||1|1|0|2,0000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuţáttur VIII||||102939|131071||2 002356|B02BD0204|Helixate NexGen|sts|500|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|0|0|0|0|0|1|BAY|0|1|0|100|SEK|52469|67731|lyfsjukr|||1|1|0|1,0000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuţáttur VIII||||52469|67731||2 002367|B02BD0204|Helixate NexGen|sts|250|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|0|0|0|0|0|1|BAY|0|1|0|100|SEK|27164|35973|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuţáttur VIII||||27164|35973||2 002391|G03AA1201|Yasmin|töflur|||63|stk|1|ţpakki|3+0,03 mg|G03AA12|01.02.2001||R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|3361|5646|lyfalmen|||1|63|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og ethinylestradíól||||3361|5646||2 002413|G03AA1204|Yasmin 28|töflur|||84|stk|1|ţpakki|3+0,03 mg|G03AA12|01.10.2007||R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|3361|5646|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og ethinylestradíól||3361||3361|5646||2 002487|R06AX1304|Loritin|töflur|10|mg|10|stk|1|ţpakki||R06AX13|01.10.2000||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Actavis Group hf|Actavis hf|Lóratadín|||||||1 002499|R06AX1304|Loritin|töflur|10|mg|30|stk|1|ţpakki||R06AX13|01.10.2000||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Actavis Group hf|Actavis hf|Lóratadín|||||||1 002510|R06AX1304|Loritin|töflur|10|mg|100|stk|1|ţpakki||R06AX13|01.10.2000||L|1|0|0|0|G|0|ACA|0|0|1|100|IKR|||lyfalmen|V0362|2090|2|100|0|100,0000|Actavis Group hf|Actavis hf|Lóratadín|||||2271||1 002659|QP52AA0101|Droncit vet.|sts|57|mg/ml|10|ml|1|hgl|lausn|QP52AA01|01.03.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|SEK|3550|6193|vetorma|||0|10|0||Icepharma hf|Bayer Animal Health GmbH|||3550||3550|6193||2 002754|N07BA0107|Nicotinell Mint|munnstfl|1|mg|204|stk|1|pakki||N07BA01|01.06.2002||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|6,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 002830|S01ED0106|Timosan Depot|augngel|1|mg/g|5|g|1|glas||S01ED01|01.08.2000||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|1254|2763|lyfalmen|||1|5|0|28,0000|Icepharma hf|Santen Oy|Tímólól||1254||1254|2763||2 002853|M03AX0101|Botox|sts|100|ae/hgl|1|hgl|1|pakki||M03AX01|01.07.1994||R|0|0|0|1|0|1|ALL|0|1|0|100|SEK|31186|41021|lyfsjukr|||1|1|0||Vistor hf|Allergan|Clostridium botulinum toxín-A||31186||31186|41021||1 003023|C09DA0104|Cozaar Comp Forte|filmhtfl|125|mg|98|stk|1|ţpakki|100+25 mg|C09DA01|01.06.2007||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|14091|15366|lyfalmen|V0089|1938|1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og ţvagrćsilyf||10467||10467|15366||1 003078|N03AX1401|Keppra|filmhtfl|250|mg|100|stk|1|ţpakki||N03AX14|01.10.2005||R|1|0|0|0|0|0|UCB|0|0|0|100|DKK|10415|15295|lyfalmen|V0515|3525|1|100|0|16,6700|Vistor hf|U.C.B|Levetíracetam||10415||10415|15295||1 003099|L01DB0104|Myocet|irţ|50|mg|2|sett|1|pakki|ördreifa|L01DB01|01.07.2006||R|0|0|0|1|0|1|TBV|0|0|0|100|DKK|244997|309354|lyfsjukr|||1|2|0||Vistor hf|Teva Pharma B.V.|Doxórúbicín||244997||244997|309354||2 003112|N03AX1401|Keppra|filmhtfl|500|mg|100|stk|1|ţpakki||N03AX14|01.10.2005||R|1|0|0|0|0|0|UCB|0|0|0|100|DKK|17716|24957|lyfalmen|V0253|5436|1|100|0|33,3300|Vistor hf|U.C.B|Levetíracetam||17716||17716|24957||1 003158|N03AX1401|Keppra|filmhtfl|1000|mg|100|stk|1|ţpakki||N03AX14|01.10.2005||R|1|0|0|0|0|0|UCB|0|0|0|100|DKK|34380|45870|lyfalmen|V0516|11666|1|100|0|66,6700|Vistor hf|U.C.B|Levetíracetam||34380||34380|45870||1 003164|L01CA0401|Navelbine|hylki|20|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|0|0|0|1|G|0|PFP|0|0|0|100|SEK|10564|15499|lyfalmen|||1|1|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||10564||10564|15499||1 003175|L01CA0401|Navelbine|hylki|30|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|0|0|0|1|G|0|PFP|0|0|0|100|SEK|15704|22432|lyfalmen|||1|1|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||15704||15704|22432||1 003298|V08CA0901|Gadovist|stl|1|mmol/ml|15|ml|10|hgl|lausn|V08CA09|01.04.2007||R|0|0|0|0|0|1|BGB|0|0|0|100|DKK|199787|252615|lyfsjukr|||1|150|0||Icepharma hf|Bayer Pharma AG|Gadóbútról||199787||199787|252615||2 003310|R03AK0701|Symbicort Turbuhaler|innönddu|164,5|mcg/sk|120|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|9082|13472|lyfalmen|V0356|12306|1|120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||9082||9082|13472||1 003325|R03AK0702|Symbicort mite Turbuhaler|innönddu|84,5|mcg/sk|120|skammtar|1|pakki|80+4,5 mcg/sk|R03AK07|01.08.2002||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|8138|12180|lyfalmen|||1|120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||8138||8138|12180||1 003455|A02BB0101|Cytotec|töflur|0,2|mg|60|stk|1|ţpakki||A02BB01|01.08.2002||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|3221|5454|lyfalmen|||1|60|0|15,0000|Icepharma hf|Pfizer ApS|Mísóprostól||3221||3221|5454||1 003800|A10BG0301|Actos|töflur|15|mg|98|stk|1|ţpakki||A10BG03|01.12.2000||R|1|1|0|0|G|0|TPA|0|0|0|100|SEK|15561|11662|lyfalmen|V0572|8410|1|98|0|49,0000|Vistor hf|Takeda Pharma A/S|Píóglítazón||7759||7759|11662||1 003831|A10BG0301|Actos|töflur|30|mg|98|stk|1|ţpakki||A10BG03|01.12.2000||R|1|1|0|0|G|0|TPA|0|0|0|100|SEK|22797|25251|lyfalmen|V0573|24168|1|98|0|98,0000|Vistor hf|Takeda Pharma A/S|Píóglítazón||17950||17950|25251||1 003869|R01BA5202|Clarinase|forđatfl|10|mg|10|stk|1|pakki|ţp 10+240 mg|R01BA52|01.09.1998||R|1|0|0|0|G|0|MBV|0|0|1|100|DKK|873|2242|lyfalmen|||1|10|0|10,0000|Vistor hf|Merck Sharp & Dohme B.V.|Pseudóefedrín í blöndum||873||873|2242||1 003927|N06AB0602|Sertral|töflur|50|mg|28|stk|1|ţpakki||N06AB06|01.11.2000||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1017|1655|lyfalmen|V0151|1545|2|28|0|28,0000|Actavis Group hf|Actavis hf|Sertralín||444||444|1655||1 003939|M01AB0505|Voltaren|sh-tfl|50|mg|20|stk|1|ţpakki||M01AB05|01.03.1984||R|1|0|0|0|G|0|NOH|0|0|1|100|DKK|588|1852|lyfalmen|||1|20|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||588||588|1852||1 003950|N06AB0602|Sertral|töflur|50|mg|98|stk|1|ţpakki||N06AB06|01.11.2000||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|2389|2772|lyfalmen|V0322|2717|2|98|0|98,0000|Actavis Group hf|Actavis hf|Sertralín||1260||1260|2772||1 003974|J05AR1001|Kaletra|mixtúra|100|mg/ml|60|ml|5|glös|80 + 20 mg/ml|J05AR10|01.08.2003||R|0|0|0|1|0|1|ABL|0|0|0|100|DKK|72774|93214|lyfsjukr|||1|300|0|30,0000|Vistor hf|Abbott Laboratories A/S|Lopínavír og ritónavír||72774||72774|93214||1 003988|M01AB0505|Voltaren|sh-tfl|50|mg|100|stk|1|ţpakki||M01AB05|01.03.1984||R|1|0|0|0|G|0|NOH|0|0|1|100|DKK|2130|3962|lyfalmen|V0469|2014|1|100|0|50,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||2130||2130|3962||1 004002|L04AD0101|Sandimmun|irţ|50|mg/ml|5|ml|10|lykjur||L04AD01|01.10.1985||R|0|0|0|0|0|1|NOH|0|0|0|100|DKK|21832|29282|lyfsjukr|||1|50|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||21832||21832|29282||1 004014|N03AF0201|Trileptal|mixtúra|60|mg/ml|250|ml|1|fl||N03AF02|01.01.2002||R|0|0|0|0|G|0|NOH|0|0|0|100|DKK|7925|11889|lyfalmen|||1|250|0|15,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||7925||7925|11889||1 004028|A07DA0301|Imodium|mixtúra|0,2|mg/ml|100|ml|1|fl||A07DA03|01.01.1990||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|100|0|2,0000|Vistor hf|McNeil Sweden AB|Lóperamíđ|||||||1 004050|R03AK0601|Seretide|innúđal|75|mcg/sk|120|skammtar|1|pakki|25+50 mcg/sk|R03AK06|01.10.2002||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|4052|6591|lyfalmen|||1|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||4052||4052|6591||1 004086|N06AB0601|Zoloft|töflur|25|mg|7|stk|1|ţpakki||N06AB06|01.05.2003||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|593|1859|lyfalmen|||1|7|0|3,5000|Icepharma hf|Pfizer ApS|Sertralín||593||593|1859||1 004111|N05CD0102|Dalmadorm medium|hylki|15|mg|30|stk|1|ţpakki||N05CD01|01.12.2000||R|1|0|0|0|0|0|MAB|0|0|1|100|SEK|1230|2731|lyfalmen|||1|30|0|15,0000|Vistor hf|Meda AB|Flúrazepam||1230||1230|2731||1 004259|N05AE0401|Zeldox|hylki|40|mg|14|stk|1|ţpakki|hart hylki|N05AE04|01.03.2003||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|5480|8544|lyfalmen|||1|14|0|7,0000|Icepharma hf|Pfizer ApS|Ziprasidon||5480||5480|8544||1 004282|R03AK0601|Seretide|innúđal|150|mcg/sk|120|skammtar|1|pakki|25+125 mcg/sk|R03AK06|01.10.2002||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|6851|10420|lyfalmen|||1|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||6851||6851|10420||1 004293|R03AK0601|Seretide|innúđal|275|mcg/sk|120|skammtar|1|pakki|25+250 mcg/sk|R03AK06|01.10.2002||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|9742|14374|lyfalmen|||1|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||9742||9742|14374||1 004298|R06AX2701|Aerius|töflur|5|mg|10|stk|1|ţpakki||R06AX27|01.05.2001||R|1|0|0|0|G|0|SCP|0|0|1|100|DKK|635|1917|lyfalmen|V0366|853|1|10|0|10,0000|Vistor hf|Schering-Plough|Deslóratadín||635||635|1917||1 004301|N06AX1101|Remeron|mixtúra|15|mg/ml|66|ml|1|fl|lausn|N06AX11|01.01.2003||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|5935|9167|lyfalmen|||1|66|0|33,0000|Vistor hf|N.V. Organon|Mirtazapín||5935||5935|9167||1 004352|J02AC0301|Vfend|irs|200|mg|1|hgl|1|pakki||J02AC03|01.11.2002||R|0|0|0|0|0|1|IPI|0|0|0|100|DKK|21093|28354|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Pfizer Limited|Voricónazól||21093||21093|28354||1 004370|R06AX2701|Aerius|töflur|5|mg|30|stk|1|ţpakki||R06AX27|01.05.2001||R|1|0|0|0|G|0|SCP|0|0|1|100|DKK|1656|3313|lyfalmen|V0366|2558|1|30|0|30,0000|Vistor hf|Schering-Plough|Deslóratadín||1656||1656|3313||1 004374|A04AA0101|Zofran|töflur|4|mg|10|stk|1|ţpakki||A04AA01|01.01.2009||R|1|0|0|0|G|0|GSK|0|0|0|100|GBP|5367|4849|lyfalmen|V0381|4587|1|10|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||2779||2779|4849||1 004378|R06AX2701|Aerius|töflur|5|mg|100|stk|1|ţpakki||R06AX27|01.05.2001||R|1|0|0|0|G|0|SCP|0|0|1|100|DKK|4274|6895|lyfalmen|V0458|4291|1|100|0|100,0000|Vistor hf|Schering-Plough|Deslóratadín||4274||4274|6895||1 004388|QJ51RC2501|Benestermycin, vet.|spenalyf|||5|ml|20|spr||QJ51RC25|01.12.1978||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|4802|9393|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|||4802||4802|9393||1 004455|N02AX0208|Zytram|forđatfl|75|mg|56|stk|1|glas||N02AX02|01.01.2001||R|1|0|1|0|G|0|NOP|0|0|1|100|DKK|3251|5495|lyfalmen|||1|56|0|14,0000|Icepharma hf|Norpharma |Tramadól||3251||3251|5495||2 004465|C01DA0801|Sorbangil|töflur|5|mg|100|stk|1|ţpakki||C01DA08|01.06.1980||R|1|0|0|0|G|0|REP|0|0|0|100|SEK|658|1948|lyfalmen|||1|100|0|8,3333|Vistor hf|Recip AB|Ísósorbíđ dínítrat||658||658|1948||1 004478|N02AX0208|Zytram|forđatfl|100|mg|56|stk|1|glas||N02AX02|01.01.2001||R|1|0|1|0|G|0|NOP|0|0|1|100|DKK|4336|6979|lyfalmen|V0226|2798|1|56|0|18,6667|Icepharma hf|Norpharma |Tramadól||4336||4336|6979||2 004489|N02AX0208|Zytram|forđatfl|150|mg|56|stk|1|glas||N02AX02|01.01.2001||R|1|0|1|0|G|0|NOP|0|0|1|100|DKK|6125|9427|lyfalmen|V0227|4100|1|56|0|28,0000|Icepharma hf|Norpharma |Tramadól||6125||6125|9427||2 004500|N02AX0208|Zytram|forđatfl|200|mg|56|stk|1|glas||N02AX02|01.01.2001||R|1|0|1|0|G|0|NOP|0|0|1|100|DKK|8152|12199|lyfalmen|V0228|5074|1|56|0|37,3333|Icepharma hf|Norpharma |Tramadól||8152||8152|12199||2 004502|J07BC0101|Engerix-B|bóluefni|20|mcg/ml|0,5|ml|1|dćla|einnota dćla|J07BC01|01.01.1990||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|2148|3986|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-B, hreinsađir mótefnavakar||2148||2148|3986||1 004586|A10BB1201|Amaryl|töflur|4|mg|90|stk|1|ţpakki||A10BB12|01.06.2005||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|3563|2926|lyfalmen|V0494|2926|1|90|0|180,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríđ||1373||1373|2926||1 004589|N06AB0402|Oropram|töflur|20|mg|100|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|2556|2211|lyfalmen|V0318|2204|2|100|0|100,0000|Actavis Group hf|Actavis hf|Cítalópram||850||850|2211||1 004611|H01AC0104|Saizen|sts|8|mg/hgl|1|hgl|1|pakki|+ leysir f.click easy|H01AC01|01.05.2002||R|0|0|0|1|0|1|EMA|0|1|0|100|SEK|36939|48241|lyfsjukr|||1|1|0|12,0000|Icepharma hf|E. Merck AB|Sómatrópín||36939||36939|48241||2 004612|D06BX0105|Metronidazol Actavis|krem|10|mg/g|25|g|1|túpa||D06BX01|01.07.1987||R|0|0|0|0|0|0|AGT|0|0|1|100|DKK|1420|2990|lyfalmen|||2|25|0||Actavis Group hf|Actavis Group hf|Metrónídazól||1420||1420|2990||1 004613|J07BC0101|Engerix-B|bóluefni|20|mcg/ml|1|ml|1|áfspr||J07BC01|01.01.1990||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|3170|5384|lyfalmen|||1|1|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-B, hreinsađir mótefnavakar||3170||3170|5384||1 004625|N06AB0402|Oropram|töflur|40|mg|28|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|0|0|ACA|0|0|0|100|IKR|1836|2233|lyfalmen|V0071|2233|2|28|0|56,0000|Actavis Group hf|Actavis hf|Cítalópram||866||866|2233||1 004645|N06AB0402|Oropram|töflur|40|mg|100|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|4843|4194|lyfalmen|V0320|4187|2|100|0|200,0000|Actavis Group hf|Actavis hf|Cítalópram||2300||2300|4194||1 004656|N06AB0402|Oropram|töflur|10|mg|28|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|776|1520|lyfalmen|V0062|1234|2|28|0|14,0000|Actavis Group hf|Actavis hf|Cítalópram||345||345|1520||1 004667|N06AB0402|Oropram|töflur|10|mg|100|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1921|2074|lyfalmen|V0317|2067|2|100|0|50,0000|Actavis Group hf|Actavis hf|Cítalópram||750||750|2074||1 004678|N06AB0402|Oropram|töflur|20|mg|28|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|926|1520|lyfalmen|V0067|1234|2|28|0|28,0000|Actavis Group hf|Actavis hf|Cítalópram||345||345|1520||1 004687|A02AA0403|Magnesia "medic"|filmhtfl|500|mg|100|stk|1|glas||A02AA04|01.02.2006||L|1|0|0|0|0|0|MET|0|0|0|100|DKK|||lyfalmen|||0|100|0|16,6700|Vistor hf|Medic Team|Magnesíum hýdroxíđ|||||1832||1 004688|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|7|spr||L04AC03|01.07.2002||R|0|0|0|1|0|1|BIA|0|0|0|100|DKK|38160|49773|lyfsjukr|||1|4,69|0|7,0000|Vistor hf|Biovitrum AB (publ)|Anakinra||38160||38160|49773||1 004691|N06AB0402|Oropram|töflur|20|mg|56|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1778|3480|lyfalmen|V0318|1234|2|56|0|56,0000|Actavis Group hf|Actavis hf|Cítalópram||1778||1778|3480||1 004696|R05DA0901|Dexomet|mixtúra|3|mg/ml|150|ml|1|glas||R05DA09|01.06.2001||L|0|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|150|0|5,0000|Actavis Group hf|Actavis hf|Dextrómetorfan|||||||1 004733|H01AC0104|Saizen|sts|8|mg/hgl|5|hgl|1|pakki|+ leysir f.click easy|H01AC01|01.05.2002||R|0|0|0|1|0|1|EMA|0|1|0|100|SEK|184694|233673|lyfsjukr|||1|5|0|60,0000|Icepharma hf|E. Merck AB|Sómatrópín||184694||184694|233673||2 004746|A10AE0405|Lantus [Clikstar]|stl|100|ein/ml|3|ml|5|rörlyk|rörlykjur fyrir Clikstar penna|A10AE04|01.06.2004||R|0|0|0|0|G|0|SDE|0|0|0|100|NOK|10571|15509|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||10571||10571|15509||1 004834|N03AX1201|Neurontin|hylki|300|mg|100|stk|1|ţpakki||N03AX12|01.03.2009||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|5236|7522|lyfalmen|V0250|4885|1|100|0|16,6667|Icepharma hf|Pfizer ApS|Gabapentín||4733||4733|7522||1 004855|P01AB0105|Metronidazol Actavis|töflur|250|mg|24|stk|1|ţpakki||P01AB01|01.12.1972||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|650|1937|lyfalmen|||2|24|0|3,0000|Actavis Group hf|Actavis Group hf|Metrónídazól||650||650|1937||1 004874|N05AH0308|Lazapix|filmhtfl|10|mg|56|stk|1|ţpakki||N05AH03|01.09.2011||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|14905|4052|lyfalmen|V0282|4052|2|56|0|56,0000|Portfarma ehf|Portfarma|Olanzapín||2196||2196|4052||2 004880|J01FA1001|Zitromax|irs|500|mg|10|ml|1|hgl||J01FA10|01.05.2003||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|5423|7827|lyfsjukr|||1|10|0|1,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||5423||5423|7827||1 004888|P01AB0105|Metronidazol Actavis|töflur|500|mg|8|stk|1|glas||P01AB01|01.03.1981||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|374|1560|lyfalmen|||2|8|0|2,0000|Actavis Group hf|Actavis Group hf|Metrónídazól||374||374|1560||1 004921|P01AB0105|Metronidazol Actavis|töflur|500|mg|14|stk|1|glas||P01AB01|01.01.1988||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|657|1947|lyfalmen|||2|14|0|3,5000|Actavis Group hf|Actavis Group hf|Metrónídazól||657||657|1947||1 004976|P01AB0105|Metronidazol Actavis|töflur|500|mg|30|stk|1|glas||P01AB01|01.01.1988||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|1243|2748|lyfalmen|||2|30|0|7,5000|Actavis Group hf|Actavis Group hf|Metrónídazól||1243||1243|2748||1 005048|N07BA0107|Nicotinell Mint|munnstfl|2|mg|36|stk|1|pakki||N07BA01|01.04.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|36|0|2,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 005059|N07BA0107|Nicotinell Mint|munnstfl|2|mg|96|stk|1|pakki||N07BA01|01.04.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 005070|N07BA0107|Nicotinell Mint|munnstfl|2|mg|204|stk|1|pakki||N07BA01|01.04.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 005085|J07AJ5205|Boostrix|stl|||0,5|ml|1|spr|áfyllt, dreifa|J07AJ52|01.01.2007||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|1740|3428|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Kíghósti, í blöndum međ öđrum toxóíđum||1740||1740|3428||1 005089|J07AL0103|Pneumovax|stl|||0,5|ml|1|hgl|lausn|J07AL01|01.11.2008||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|2322|4224|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Hreinsuđ pneumococca poly­sakkaríđ mótefnavakar||||2322|4224||2 005108|G04CA0201|Omnic|forđahlk|0,4|mg|90|stk|1|ţpakki||G04CA02|01.08.1998||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|8791|7170|lyfalmen|V0148|2282|1|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||4475||4475|7170||1 005178|J01CF0102|Staklox|hylki|250|mg|30|stk|1|ţpakki||J01CF01|01.05.2001||R|0|0|0|0|0|0|ACA|0|0|1|100|DKK|2219|4083|lyfalmen|||2|30|0|3,7500|Actavis Group hf|Actavis hf|Díkloxacillín||2219||2219|4083||1 005189|J01CF0102|Staklox|hylki|500|mg|20|stk|1|ţpakki||J01CF01|01.05.2001||R|0|0|0|0|0|0|ACA|0|0|1|100|DKK|2556|4544|lyfalmen|||2|20|0|5,0000|Actavis Group hf|Actavis hf|Díkloxacillín||2556||2556|4544||1 005200|J01CF0102|Staklox|hylki|500|mg|30|stk|1|ţpakki||J01CF01|01.05.2001||R|0|0|0|0|0|0|ACA|0|0|1|100|DKK|3172|5387|lyfalmen|||2|30|0|7,5000|Actavis Group hf|Actavis hf|Díkloxacillín||3172||3172|5387||1 005241|R03AK0701|Symbicort Turbuhaler|innönddu|164,5|mcg/sk|360|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|27247|36918|lyfalmen|V0356|36917|1|360|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||27247||27247|36918||1 005296|N05AH0401|Seroquel|filmhtfl|300|mg|100|stk|1|ţpakki||N05AH04|01.12.2002||R|1|0|0|0|0|0|AZA|0|0|0|100|SEK|52634|68779|lyfalmen|V0287|44908|1|100|0|75,0000|Vistor hf|AstraZeneca AB|Quetíapín||52634||52634|68779||1 005303|N02CC0303|Zomig Nasal|nefúđi|5|mg/sk|5|mg|2|stauk||N02CC03|01.02.2003||R|0|0|0|0|G|0|ASZ|0|0|0|100|SEK|3452|5770|lyfalmen|||1|10|0|4,0000|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||3452||3452|5770||1 005330|D08AG0201|Betadine|húđlausn|100|mg/ml|500|ml|1|fl|sprittlausn|D08AG02|01.09.1982||L|0|0|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Norpharma a/s|Jođ/pólývídón|||||||2 005336|R01AA0704|Otrivin ukonserveret|nefúđi|0,5|mg/ml|10|ml|1|glas|sk-úđari|R01AA07|01.07.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|6,2500|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||||1 005355|S01AA1301|Fucithalmic|augndr|10|mg/g|0,2|g|12|sk-hyl|2 mg/sk|S01AA13|01.04.1992||R|0|0|0|0|G|0|LEP|0|0|1|100|DKK|1127|2590|lyfalmen|||1|2,4|0||Vistor hf|LEO Pharma A/S|Fúsidínsýra||1127||1127|2590||1 005363|L02AE0301|Zoladex|vefjalyf|10,8|mg|1|áf.spr|1|pakki||L02AE03|01.04.1996||R|0|0|0|1|G|0|AZA|0|0|0|100|SEK|61363|79734|lyfalmen|V0451|78345|1|1|0|83,7209|Vistor hf|AstraZeneca AB|Góserelín||61363||61363|79734||1 005390|R03BB0101|Atrovent|innúđal|20|mcg/sk|200|skammtar|1|stauk||R03BB01|01.08.2004||R|0|0|0|0|G|0|BOI|0|0|0|100|DKK|1488|3083|lyfalmen|||1|200|0|33,3300|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíđ||1488||1488|3083||1 005503|N05AH0301|Zyprexa|húđuđtfl|15|mg|28|stk|1|ţpakki||N05AH03|01.06.2002||R|1|0|0|0|G|0|ELD|0|0|0|100|XEU|29634|18634|lyfalmen|V0283|3268|1|28|0|42,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||12678||12678|18634||2 005526|N05AH0301|Zyprexa|húđuđtfl|20|mg|28|stk|1|ţpakki||N05AH03|01.12.2003||R|1|0|0|0|0|0|ELD|0|0|0|100|XEU|35264|46980|lyfalmen|V0281|21963|1|28|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||35264||35264|46980||2 005538|G03AA0702|Microgyn|töflur|||63|stk|1|ţpakki||G03AA07|01.06.1977||R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|1305|2833|lyfalmen|V0545|2800|1|63|0|84,0000|Icepharma hf|Bayer Pharma AG|Levónorgestrel og ethinylestradíól||1305||1305|2833||2 005576|R05CA0301|Tussol|mixtúra|||150|ml|1|glas||R05CA03|01.10.2001||L|0|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|150|0||Actavis Group hf|Actavis hf|Slímlosandi lyf nema slímţynnir (mucolytica)- guaifenesin|||||||1 005588|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki|R03BB04|01.01.2003||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|6102|9395|lyfalmen|||1|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíđ||6102||6102|9395||1 005600|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki + Handihaler|R03BB04|01.01.2003||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|6413|9821|lyfalmen|||1|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíđ||6413||6413|9821||1 005606|J07AH0703|NeisVac-C|bóluefni|||0,5|ml|1|spr|áfyllt sprauta|J07AH07|01.09.2001||R|0|0|0|0|0|0|BAX|0|0|0|100|USD|4133|6702|lyfalmen|||1|0,5|0||Icepharma hf|Baxter|Hreinsuđ meningókokka C, poly­sakkaríđ mótefnavakar||4133||4133|6702||2 005624|A10BB0902|Diamicron Uno|töflur|30|mg|30|stk|1|ţpakki||A10BB09|01.04.2002||R|1|0|0|0|G|0|LLS|0|0|0|100|DKK|1599|3235|lyfalmen|||1|30|0|15,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíđ||1599||1599|3235||2 005641|A10BB0902|Diamicron Uno|töflur|30|mg|60|stk|1|ţpakki||A10BB09|01.04.2002||R|1|0|0|0|G|0|LLS|0|0|0|100|DKK|2788|4862|lyfalmen|V0020|3724|1|60|0|30,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíđ||2788||2788|4862||2 005672|A10BB0902|Diamicron Uno|töflur|30|mg|180|stk|1|ţpakki||A10BB09|01.04.2002||R|1|0|0|0|G|0|LLS|0|0|0|100|DKK|7401|11172|lyfalmen|V0020|11172|1|180|0|90,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíđ||7401||7401|11172||2 005674|A10BB0902|Diamicron Uno|töflur|30|mg|90|stk|1|ţpakki||A10BB09|01.04.2002||R|1|0|0|0|G|0|LLS|0|0|0|100|DKK|4067|6611|lyfalmen|V0020|5586|1|90|0|45,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíđ||4067||4067|6611||2 005757|N06AB1001|Cipralex|töflur|5|mg|28|stk|1|ţpakki||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|1789|3495|lyfalmen|||1|28|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||1789||1789|3495||1 005790|N06AB1001|Cipralex|töflur|5|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|6652|9157|lyfalmen|V0324|2884|1|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||5928||5928|9157||1 005812|N06AB1001|Cipralex|töflur|10|mg|28|stk|1|ţpakki||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|3154|5031|lyfalmen|V0035|3717|1|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||2912||2912|5031||1 005822|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|5|l|1|fl||QP54AA01|01.08.2001||R|0|0|0|0|0|0|MEF|0|0|0|100|XEU|17994|31390|vetorma|||0|5|0||Vistor hf|Merial (MSD)|Ivermectinum||17994||17994|31390||1 005823|N06AB1001|Cipralex|töflur|10|mg|56|stk|1|ţpakki||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|6270|9625|lyfalmen|V0325|1688|1|56|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||6270||6270|9625||1 005845|N06AB1001|Cipralex|töflur|10|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|10577|14287|lyfalmen|V0325|3015|1|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||9678||9678|14287||1 005867|N06AB1001|Cipralex|töflur|15|mg|28|stk|1|ţpakki||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|5066|7555|lyfalmen|||1|28|0|42,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||4757||4757|7555||1 005884|P01BC0201|Lariam|töflur|250|mg|8|stk|1|ţpakki||P01BC02|01.01.1993||R|1|0|0|1|0|0|ROC|0|0|0|100|DKK|3498|5833|lyfalmen|||1|8|0|2,0000|Icepharma hf|Roche|Meflókvín||3498||3498|5833||2 005885|N05AH0301|Zyprexa|sts|10|mg|1|hgl|1|pakki||N05AH03|01.02.2004||R|0|0|0|0|G|0|ELD|0|0|0|100|XEU|885|2259|lyfalmen|||1|1|0|1,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||885||885|2259||2 005902|N06AB1001|Cipralex|töflur|15|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|16376|21063|lyfalmen|V0326|3875|1|100|0|150,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||14613||14613|21063||1 005910|C09CA0301|Diovan|filmhtfl|80|mg|28|stk|1|ţpakki||C09CA03|01.01.2001||R|1|0|0|0|0|0|NOH|0|0|0|100|DKK|3573|5936|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||3573||3573|5936||1 005922|N06AB1001|Cipralex|töflur|20|mg|28|stk|1|ţpakki||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|6471|8841|lyfalmen|V0246|4590|1|28|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||5697||5697|8841||1 005933|N06AB1001|Cipralex|töflur|20|mg|56|stk|1|ţpakki||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|12679|18635|lyfalmen|V0327|1651|1|56|0|112,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||12679||12679|18635||1 005963|J01CR0204|Amoxin comp|filmhtfl|875|mg|14|stk|1|ţpakki|875+125 mg|J01CR02|01.02.2013||R|0|0|0|0|0|0|ROY|0|0|1|100|XEU|1952|2167|lyfalmen|V0169|2167|2|14|0|12,2500|Medical ehf|ratiopharm Oy|Amoxicillín og ensímblokkar||818||818|2167||2 006000|R07AA0201|Curosurf|innö.guf|80|mg/ml|1,5|ml|1|hgl||R07AA02|01.01.1995||R|0|0|0|1|0|1|NYC|0|0|0|100|DKK|84239|107602|lyfsjukr|||1|1,5|0|0,7500|Vistor hf|Nycomed Danmark A/S|Náttúrulegir fosfólípíđar||84239||84239|107602||1 006024|A10AD0501|NovoMix 30 FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.07.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|5787|8964|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulín aspart||5787||5787|8964||1 006079|J02AX0403|Cancidas|irţ|70|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|0|0|0|1|0|1|MSD|0|0|0|100|DKK|104475|132999|lyfsjukr|||1|1|0|1,4000|Vistor hf|M.S.D.|Caspofungin||104475||104475|132999||1 006102|A10AB0501|NovoRapid FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|einnota pennar|A10AB05|01.12.2001||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|5614|8728|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||5614||5614|8728||1 006111|R07AA0201|Curosurf|innö.guf|80|mg/ml|3|ml|1|hgl||R07AA02|01.01.1995||R|0|0|0|1|0|1|NYC|0|0|0|100|DKK|156867|198751|lyfsjukr|||1|3|0|1,5000|Vistor hf|Nycomed Danmark A/S|Náttúrulegir fosfólípíđar||156867||156867|198751||1 006115|J02AX0403|Cancidas|irţ|50|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|0|0|0|1|0|1|MSD|0|0|0|100|DKK|79787|102015|lyfsjukr|||1|1|0|1,0000|Vistor hf|M.S.D.|Caspofungin||79787||79787|102015||1 006239|J01CF0501|Heracillin|töflur|500|mg|30|stk|1|glas||J01CF05|01.10.1995||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|2641|4661|lyfalmen|||1|30|0|7,5000|Vistor hf|Recip AB|Flúkloxacillín||2641||2641|4661||1 006443|QM01AC0601|Metacam|stl|20|mg/ml|50|ml|1|hgl||QM01AC06|01.05.2004||R|0|0|0|0|0|0|BOI|1|0|0|100|DKK|7877|15298|vetalmen|||0|50|0||Vistor hf|Boehringer Ingelheim|||||7877|15298||1 006547|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|10|spr|áfyllt sprauta|B01AX05|01.07.2012||R|0|0|0|0|G|0|GGL|0|0|0|100|GBP|6421|9832|lyfalmen|||1|5|0|10,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||6421||6421|9832||1 006637|D05AX5201|Daivobet|smyrsli|||120|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.04.2013||R|0|0|0|0|G|0|LEP|0|0|0|100|DKK|14331|20709|lyfalmen|||1|120|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||14331||14331|20709||1 006681|N02BE0109|Panodil Hot|skammtar|500|mg|10|skammtar|1|pakki||N02BE01|01.05.2003||L|0|0|0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa|||0|10|0|1,6700|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1 006732|A16AB0401|Fabrazyme|irţ|5|mg/ml|35|mg|1|hgl|lausn|A16AB04|01.05.2012||R|0|1|0|1|0|1|GZE|0|1|0|100|XEU|542483|682699|lyfsjukr|||1|35|0|7,0000|Vistor hf|Genzyme Europe B.V.|Agalsidase beta||542483||542483|682699||1 006785|G03AD0101|NorLevo|töflur|750|mcg|2|stk|1|ţpakki||G03AD01|01.01.2005||L|0|0|0|0|0|0|LAR|0|0|0|100|IKR|||lyflausa|||0|2|0|1,0000|Vistor hf|Laboratoire HRA Pharma|Levonorgestrel|||||||1 006928|C09CA0101|Cozaar|töflur|100|mg|98|stk|1|ţpakki||C09CA01|01.05.2002||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|14658|21119|lyfalmen|||1|98|0|196,0000|Vistor hf|M.S.D.|Lósartan||14658||14658|21119||1 007099|C10AA0701|Crestor|filmhtfl|10|mg|28|stk|1|ţpakki||C10AA07|01.06.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|4667|7432|lyfalmen|||1|28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||4667||4667|7432||1 007126|QJ01CE9002|Mamyzin vet.|sts|10|millj ae|20|hgl|1|pakki|+ leysir|QJ01CE90|01.12.2002||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|25433|49008|vetalmen|||0|20|0||Vistor hf|Boehringer Ingelheim Danmark|||25433||25433|49008||1 007133|C10AA0701|Crestor|filmhtfl|10|mg|98|stk|1|ţpakki||C10AA07|01.07.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|14109|20430|lyfalmen|V0117|10740|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||14109||14109|20430||1 007144|C10AA0701|Crestor|filmhtfl|20|mg|28|stk|1|ţpakki||C10AA07|01.06.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|7037|10674|lyfalmen|||1|28|0|56,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||7037||7037|10674||1 007155|C10AA0701|Crestor|filmhtfl|20|mg|98|stk|1|ţpakki||C10AA07|01.06.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|20836|28873|lyfalmen|V0118|15771|1|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||20836||20836|28873||1 007161|N05AA0201|Nozinan|töflur|100|mg|100|stk|1|glas||N05AA02|01.10.1995||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|5330|8339|lyfalmen|||1|100|0|33,3333|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||5330||5330|8339||1 007165|C09AA0105|Captopril Actavis|töflur|50|mg|100|stk|1|ţpakki||C09AA01|01.05.2013||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|1934|3694|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis hf|Kaptópríl||1934||1934|3694||1 007166|C10AA0701|Crestor|filmhtfl|40|mg|28|stk|1|ţpakki||C10AA07|01.07.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|8844|13146|lyfalmen|||1|28|0|112,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||8844||8844|13146||1 007186|C10AA0701|Crestor|filmhtfl|40|mg|98|stk|1|ţpakki||C10AA07|01.07.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|26122|35506|lyfalmen|||1|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||26122||26122|35506||1 007223|B01AD1201|Ceprotin|sts|500|ae/hgl|1|hgl|1|pakki|+ 5 ml leysir|B01AD12|01.02.2002||R|0|0|0|1|0|1|BAX|0|0|0|100|SEK|172657|218567|lyfsjukr|||1|1|0||Icepharma hf|Baxter|Prótein C||172657||172657|218567||2 007268|B01AD1201|Ceprotin|sts|1000|ae/hgl|1|hgl|1|pakki|+ 10 ml leysir|B01AD12|01.02.2002||R|0|0|0|1|0|1|BAX|0|0|0|100|SEK|329483|415384|lyfsjukr|||1|1|0||Icepharma hf|Baxter|Prótein C||329483||329483|415384||2 007292|S01EE0301|Lumigan|augndr|0,3|mg/ml|3|ml|1|glös||S01EE03|01.04.2005||R|0|0|0|0|G|0|ALL|0|0|0|100|SEK|3086|5269|lyfalmen|V0377|4492|1|3|0|30,0000|Vistor hf|Allergan|Bimatóprost||3086||3086|5269||1 007297|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.04.2002||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 007375|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.04.2002||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 007378|J01XX0801|Zyvoxid|irl|2|mg/ml|300|ml|10|pokar||J01XX08|01.12.2001||R|0|0|0|1|0|1|PER|0|1|0|100|DKK|98360|125324|lyfsjukr|||1|3000|0|5,0000|Icepharma hf|Pfizer ApS|Linezolíd||98360||98360|125324||1 007385|A02BA0205|Zantac|töflur|150|mg|20|stk|1|ţpakki||A02BA02|01.09.1983||L|1|0|0|0|0|0|GSK|0|0|0|100|IKR|||lyflausa|||0|20|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ranitidín|||||||1 007424|J01XX0801|Zyvoxid|töflur|600|mg|30|stk|1|ţpakki||J01XX08|01.12.2001||R|0|0|0|1|0|1|PER|0|1|0|100|DKK|281201|354790|lyfsjukr|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Linezolíd||281201||281201|354790||1 007434|S01ED5106|Xalcom|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml |S01ED51|01.12.2001||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|3233|5471|lyfalmen|V0374|4395|1|2,5|0|25,0000|Icepharma hf|Pfizer ApS|Tímólól í blöndum||3233||3233|5471||1 007448|B05XC04|Cernevit|sts|||5|ml|10|hgl||B05XC|01.05.2002||R|0|0|0|0|0|1|CPS|0|0|0|100|SEK|8870|12802|lyfsjukr|||1|50|0||Icepharma hf|Clintec parenteral SA|Vítamín||8870||8870|12802||2 007449|V03AB3401|Fomepizole OPi|irţ|5|mg/ml|20|ml|5|hgl||V03AB34|01.09.2003||R|0|0|0|0|0|1|OPO|0|0|0|100|XEU|118610|150738|lyfsjukr|||1|100|0||Swedish Orphan International AB|OPi Orphan Pharma international (S)|Fómepízól||118610||118610|150738||3 007462|N01AB0801|Sevorane|innönd.l|||250|ml|1|plastf||N01AB08|01.03.2002||R|0|0|0|0|0|1|ABV|0|0|0|100|DKK|23399|31248|lyfsjukr|||1|250|0||Vistor hf|AbbVie Ltd.|Sevóflúran||23399||23399|31248||1 007494|QP52AA0101|Droncit vet.|hlaup|9|%|6,67|g|1|dćla|til inntöku|QP52AA01|01.04.2002||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1970|3437|vetorma|||0|6,67|0||Icepharma hf|Bayer Animal Health GmbH|||1970||1970|3437||2 007505|G04BD0702|Detrusitol Retard|forđahlk|2|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|6251|9599|lyfalmen|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Tólteródín||6251||6251|9599||1 007538|R03BA0701|Asmanex Twisthaler|innönddu|400|mcg|30|skammtar|1|pakki||R03BA07|01.04.2003||R|0|0|0|0|G|0|MBV|0|0|0|100|DKK|4962|7836|lyfalmen|||1|30|0|30,0000|Vistor hf|Merck Sharp & Dohme B.V.|Mometasón||4962||4962|7836||1 007540|N02BE0111|Perfalgan|irl|10|mg/ml|100|ml|12|hgl||N02BE01|01.08.2003||R|0|0|0|0|0|1|BRS|0|0|0|100|DKK|4497|6490|lyfsjukr|||1|1200|0|4,0000|Vistor hf|Bristol-Myers Squibb|Paracetamól||4497||4497|6490||1 007549|R03BA0701|Asmanex Twisthaler|innönddu|400|mcg|60|skammtar|1|pakki||R03BA07|01.03.2003||R|0|0|0|0|G|0|MBV|0|0|0|100|DKK|5542|8629|lyfalmen|||1|60|0|60,0000|Vistor hf|Merck Sharp & Dohme B.V.|Mometasón||5542||5542|8629||1 007760|G04BD0702|Detrusitol Retard|forđahlk|4|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|6418|9827|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Tólteródín||6418||6418|9827||1 007769|G04BD0702|Detrusitol Retard|forđahlk|4|mg|100|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|21789|30069|lyfalmen|V0589|26287|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Tólteródín||21789||21789|30069||1 007778|N05AX0802|Rison|töflur|0,5|mg|60|stk|1|glas||N05AX08|01.10.2001||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1691|3168|lyfalmen|V0290|3168|2|60|0|6,0000|Actavis Group hf|Actavis hf|Risperídón||1550||1550|3168||1 007852|G02BB0101|NuvaRing|sk-hring|||3|stk|1|pakki|međ forđaverkun|G02BB01|01.11.2002||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|4005|6527|lyfalmen|||1|3|0|84,0000|Vistor hf|N.V. Organon|Skeiđarinnleg međ progestógeni og östrógeni||4005||4005|6527||1 007878|V07AB0001|Sterilt vatten Baxter Viaflo|leysir|||50|ml|50|pokar|leysir f.stungulyf|V07AB|01.08.2005||L|0|0|0|0|0|0|BAM|0|0|0|100|IKR|||lyflausa|||0|2500|0||Icepharma hf|Baxter Medical AB|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||2 007889|V07AB0002|Sterilt Vand "Baxter" Viaflo|leysir|||100|ml|50|pokar|leysir f.stungulyf|V07AB|01.02.2006||L|0|0|0|0|0|0|BAX|0|0|0|100|IKR|||lyflausa|||0|5000|0||Icepharma hf|Baxter|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||2 007921|S01GX0901|Opatanol|augndr|1|mg/ml|5|ml|1|glas||S01GX09|01.05.2004||R|0|0|0|0|0|0|ALA|0|0|0|100|USD|1313|2844|lyfalmen|||0|5|0||Vistor hf|Alcon Laboratories Ltd.|Ólópatadín||1313||1313|2844||1 007986|D07AA0208|Mildison Lipid|krem|10|mg/g|15|g|1|túpa|feitt|D07AA02|01.01.1990||L|0|0|0|0|0|0|ASP|0|0|1|100|IKR|||lyflausa|||0|15|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón|||||||1 007995|R07AX0101|INOmax|innö.gas|400|ppm|10|l|1|gashyl||R07AX01|01.01.2004||R|0|1|0|1|0|1|AGA|0|0|0|100|XEU|20571|27699|lyfsjukr|||1|10|0||Ísaga ehf|AGA AB|Nituroxíđ||20571||20571|27699||5 007997|H02AB0104|Betapred|lausnart|0,5|mg|30|stk|1|ţpakki||H02AB01|01.09.1998||R|0|0|0|0|0|0|LOL|0|0|1|100|IKR|729|2045|lyfalmen|||0|30|1|10,0000|Lyfjaver ehf|Lyfjaver- óskráđ|Betametasón||729||729|2045||3 008023|A10BA0201|Glucophage|töflur|1000|mg|30|stk|1|ţpakki||A10BA02|01.01.2002||R|1|0|0|0|G|0|MCK|0|0|0|100|SEK|410|1609|lyfalmen|V0502|1133|1|30|0|15,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||410||410|1609||2 008058|B05BA1011|Oliclinomel N4 550E|irl|||1500|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|24461|32581|lyfsjukr|||1|6000|0||Icepharma hf|Baxter Medical AB|Blöndur||24461||24461|32581||2 008069|B05BA1011|Oliclinomel N4 550E|irl|||2000|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|30349|39970|lyfsjukr|||1|8000|0||Icepharma hf|Baxter Medical AB|Blöndur||30349||30349|39970||2 008097|N02CC0402|Maxalt Smelt|munnltfl|5|mg|6|stk|1|ţpakki||N02CC04|01.03.2003||R|0|0|0|0|G|0|MSD|0|0|0|100|DKK|5512|8588|lyfalmen|||1|6|0|3,0000|Vistor hf|M.S.D.|Rizatriptan||5512||5512|8588||1 008101|L03AB1001|PegIntron|sts|50|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|0|0|0|1|0|1|DSM|0|0|0|100|DKK|55268|71244|lyfsjukr|||1|4|0|26,6700|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||55268||55268|71244||1 008108|L03AB1001|PegIntron|sts|100|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|0|0|0|1|0|1|DSM|0|0|0|100|DKK|110538|140608|lyfsjukr|||1|4|0|53,3300|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||110538||110538|140608||1 008131|L03AB1001|PegIntron|sts|80|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.08.2003||R|0|0|0|1|0|1|DSM|0|0|0|100|DKK|88086|112430|lyfsjukr|||1|4|0|42,6700|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||88086||88086|112430||1 008134|L03AB1001|PegIntron|sts|120|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.08.2003||R|0|0|0|1|0|1|DSM|0|0|0|100|DKK|130307|165418|lyfsjukr|||1|4|0|64,0000|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||130307||130307|165418||1 008145|L03AB1001|PegIntron|sts|150|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|0|0|0|1|0|1|DSM|0|0|0|100|DKK|153073|193989|lyfsjukr|||1|4|0|80,0000|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||153073||153073|193989||1 008194|D07AA0208|Mildison Lipid|krem|10|mg/g|30|g|1|túpa|feitt|D07AA02|01.01.1990||L|0|0|0|0|0|0|ASP|0|0|1|100|IKR|||lyflausa|||0|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón|||||||1 008196|D07AA0208|Mildison Lipid|krem|10|mg/g|100|g|1|túpa|feitt|D07AA02|01.01.1990||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|1530|3141|lyfalmen|||1|100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón||1530||1530|3141||1 008219|D07AC0101|Betnovat|húđfl|1|mg/ml|20|ml|1|plglas||D07AC01|01.12.1980||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|282|1434|lyfalmen|||1|20|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||282||282|1434||1 008223|B05BA1013|Oliclinomel N6 900E|irl|||1000|ml|6|plpok|fleyti|B05BA10|01.06.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|37846|49379|lyfsjukr|||1|6000|0||Icepharma hf|Baxter Medical AB|Blöndur||37846||37846|49379||2 008234|B05BA1013|Oliclinomel N6 900E|irl|||1500|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|29635|39074|lyfsjukr|||1|6000|0||Icepharma hf|Baxter Medical AB|Blöndur||29635||29635|39074||2 008243|D07AC0101|Betnovat|húđlausn|1|mg/g|30|ml|1|plglas|í hársvörđ|D07AC01|01.01.1985||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|551|1802|lyfalmen|||1|30|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||551||551|1802||1 008245|B05BA1013|Oliclinomel N6 900E|irl|||2000|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|34626|45338|lyfsjukr|||1|8000|0||Icepharma hf|Baxter Medical AB|Blöndur||34626||34626|45338||2 008301|N02AX0209|Tramol-L|forđatfl|100|mg|20|stk|1|ţpakki||N02AX02|01.04.2002||R|1|0|1|0|G|0|ACA|0|0|1|100|XEU|894|2119|lyfalmen|||2|20|0|6,6700|Actavis Group hf|Actavis hf|Tramadól||783||783|2119||1 008326|D07AC0101|Betnovat|húđlausn|1|mg/g|100|ml|1|plglas|í hársvörđ|D07AC01|01.07.1988||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|1244|2750|lyfalmen|||1|100|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||1244||1244|2750||1 008338|N02AX0209|Tramol-L|forđatfl|100|mg|100|stk|1|ţpakki||N02AX02|01.04.2002||R|1|0|1|0|G|0|ACA|0|0|1|100|XEU|2887|4997|lyfalmen|V0226|4997|2|100|0|33,3300|Actavis Group hf|Actavis hf|Tramadól||2887||2887|4997||1 008360|N02AX0209|Tramol-L|forđatfl|150|mg|100|stk|1|ţpakki||N02AX02|01.04.2002||R|1|0|1|0|G|0|ACA|0|0|1|100|XEU|4586|7321|lyfalmen|V0227|7321|2|100|0|50,0000|Actavis Group hf|Actavis hf|Tramadól||4586||4586|7321||1 008368|N02AX0209|Tramol-L|forđatfl|200|mg|100|stk|1|ţpakki||N02AX02|01.04.2002||R|1|0|1|0|G|0|ACA|0|0|1|100|XEU|6458|9060|lyfalmen|V0228|9060|2|100|0|66,6700|Actavis Group hf|Actavis hf|Tramadól||5857||5857|9060||1 008370|V04CJ0101|Thyrogen|sts|0,9|mg/hgl|2|hgl|1|pakki|lausn|V04CJ01|01.01.2006||R|0|0|0|1|0|1|GEZ|0|1|0|100|XEU|154180|195378|lyfsjukr|||1|2|0||Vistor hf|Genzyme BV|Thýrótrópín||154180||154180|195378||1 008396|H03AA0104|Euthyrox|töflur|50|mcg|100|stk|1|ţpakki||H03AA01|01.05.2002||R|1|0|0|0|G|0|MKA|0|0|0|100|SEK|561|1815|lyfalmen|V0153|1815|1|100|0|33,3300|Icepharma hf|Merck KgaA|Levótýroxínnatríum||561||561|1815||2 008435|H03AA0104|Euthyrox|töflur|100|mcg|100|stk|1|ţpakki||H03AA01|01.05.2002||R|1|0|0|0|G|0|MKA|0|0|0|100|SEK|736|2055|lyfalmen|V0154|2021|1|100|0|66,6700|Icepharma hf|Merck KgaA|Levótýroxínnatríum||736||736|2055||2 008484|QP52AC1303|Zerofen, vet.|mixtúra|10|%|1000|ml|1|plbrús||QP52AC13|01.11.2001||R|0|0|0|0|0|0|CHP|0|0|0|100|USD|5064|8834|vetorma|||0|1000|0||Icepharma hf|Chanelle Pharmaceuticals |||5064||5064|8834||2 008497|QN05CM9203|Chanazine, vet.|stl|10|%|50|ml|1|hgl||QN05CM92|01.11.2001||R|0|0|0|0|0|0|CHP|1|0|0|100|XEU|12732|24620|vetalmen|||0|50|0||Icepharma hf|Chanelle Pharmaceuticals |||12732||12732|24620||2 008498|R06AX2201|Kestine|töflur|10|mg|10|stk|1|ţpakki||R06AX22|01.04.1998||L|1|0|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||||1 008519|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|100|stk|1|ţpakki||R06AE07|01.09.2012||L|1|0|0|0|G|0|RGM|0|0|1|100|XEU|||lyfalmen|V0575|3804|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Cetirizín|||||3804||2 008534|R06AX2201|Kestine|töflur|10|mg|30|stk|1|ţpakki||R06AX22|01.04.1998||L|1|0|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||||1 008545|G03FB0506|NovoFem|filmhtfl|||84|stk|1|skífup|1+1mg|G03FB05|01.06.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2892|5004|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2892||2892|5004||1 008673|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|10|stk|1|ţpakki||R06AE07|01.09.2012||L|1|0|0|0|0|0|RGM|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Medical ehf|ratiopharm GmbH|Cetirizín|||||||2 008745|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 008767|L03AB1101|Pegasys|stl|135|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|109241|138980|lyfsjukr|||1|2|0|20,7700|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||109241||109241|138980||2 008768|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 008782|L03AB1101|Pegasys|stl|180|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|115237|146505|lyfsjukr|||1|2|0|27,6900|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||115237||115237|146505||2 008904|D10AF0101|Dalacin|lausn|10|mg/ml|60|ml|1|glas|Áburđur, lausn|D10AF01|01.01.1994||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|1938|3699|lyfalmen|||1|60|0||Icepharma hf|Pfizer ApS|Klindamýcín||1938||1938|3699||1 008927|G04BE0801|Cialis|filmhtfl|20|mg|4|stk|1|ţpakki||G04BE08|01.02.2003||R|0|0|0|0|0|0|LIL|0|0|0|100|XEU|6057|9334|lyfalmen|V0145|8686|1|4|0|8,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||6057|9334||2 008950|G04BE0801|Cialis|filmhtfl|20|mg|8|stk|1|ţpakki||G04BE08|01.02.2003||R|0|0|0|0|0|0|LIL|0|0|0|100|XEU|11933|17372|lyfalmen|V0145|17372|1|8|0|16,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||11933|17372||2 008959|R01AA0706|Naso-ratiopharm|nefúđi|0,5|mg/ml|10|ml|1|glas|lausn|R01AA07|01.12.2012||L|0|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||0|10|0|6,2500|LYFIS ehf|ratiopharm GmbH|Xýlómetazólín|||||||2 009078|N06AG0202|Moclobemid ratiopharm|filmhtfl|300|mg|30|stk|1|ţpakki||N06AG02|01.02.2013||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|1757|3182|lyfalmen|V0064|3182|2|30|0|30,0000|Medical ehf|ratiopharm GmbH|Móklóbemíđ||1560||1560|3182||2 009113|B05DB0005|Balance|kviđ.sk|1,5|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|8788|12683|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||8788||8788|12683||2 009117|N06AG0202|Moclobemid ratiopharm|filmhtfl|150|mg|100|stk|1|ţpakki||N06AG02|01.02.2013||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|4325|6449|lyfalmen|V0063|6449|2|100|0|50,0000|Medical ehf|ratiopharm GmbH|Móklóbemíđ||3948||3948|6449||2 009213|B05DB0005|Balance|kviđ.sk|2,3|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|8788|12683|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||8788||8788|12683||2 009214|M01AH0401|Dynastat|sts|40|mg/hgl|10|hgl|1|pakki||M01AH04|01.06.2002||R|0|0|0|0|0|0|IPI|0|0|1|100|DKK|14309|20681|lyfalmen|||1|10|0|10,0000|Icepharma hf|Pfizer Limited|Parekoxíb||14309||14309|20681||1 009216|B05DB0005|Balance|kviđ.sk|4,25|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|8788|12683|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||8788||8788|12683||2 009270|R01AA0706|Naso-ratiopharm|nefúđi|1|mg/ml|10|ml|1|glas|lausn|R01AA07|01.12.2012||L|0|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|LYFIS ehf|ratiopharm GmbH|Xýlómetazólín|||||||2 009278|J02AC0301|Vfend|töflur|50|mg|30|stk|1|ţpakki||J02AC03|01.11.2002||R|1|0|0|0|0|1|IPI|0|0|0|100|DKK|52198|67391|lyfsjukr|||1|30|0|3,7500|Icepharma hf|Pfizer Limited|Voricónazól||52198||52198|67391||1 009282|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|20|lykjur|fyrir stl|V07AB|01.07.1995||L|0|0|0|0|0|0|FRP|0|0|0|100|DKK|||lyfalmen|||0|400|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||1881||2 009285|D11AH0101|Protopic|smyrsli|0,03|%|30|g|1|túpa||D11AH01|01.07.2003||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|5461|8518|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Takrólímus||5461||5461|8518||1 009340|V07AB0013|Sterilt vatten/vann/vand Fresenius Kabi|leysir|||20|ml|20|plastl|fyrir stungulyf|V07AB|01.10.1994||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|400|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||2 009409|G03CA0316|Vivelle Dot|forđapl|37,5|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|G|0|NOH|0|0|0|100|DKK|1142|2610|lyfalmen|||1|8|0|21,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1142||1142|2610||1 009443|G03CA0316|Vivelle Dot|forđapl|50|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|G|0|NOH|0|0|0|100|DKK|1259|2770|lyfalmen|V0130|1666|1|8|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1259||1259|2770||1 009465|G03CA0316|Vivelle Dot|forđapl|75|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|G|0|NOH|0|0|0|100|DKK|1456|3040|lyfalmen|V0131|2510|1|8|0|42,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1456||1456|3040||1 009489|G03CA0316|Vivelle Dot|forđapl|100|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|G|0|NOH|0|0|0|100|DKK|1824|3543|lyfalmen|V0132|2785|1|8|0|56,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1824||1824|3543||1 009525|B05DB0005|Balance|kviđ.sk|1,5|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|7432|10726|lyfsjukr|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||7432||7432|10726||2 009560|B05DB0005|Balance|kviđ.sk|4,25|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|7432|10726|lyfsjukr|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||7432||7432|10726||2 009591|B05DB0005|Balance|kviđ.sk|2,3|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|7432|10726|lyfsjukr|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||7432||7432|10726||2 009609|J02AC0301|Vfend|töflur|200|mg|30|stk|1|ţpakki||J02AC03|01.11.2002||R|1|0|0|0|0|1|IPI|0|0|0|100|DKK|199257|251950|lyfsjukr|||1|30|0|15,0000|Icepharma hf|Pfizer Limited|Voricónazól||199257||199257|251950||1 009649|D11AH0101|Protopic|smyrsli|0,1|%|30|g|1|túpa||D11AH01|01.07.2003||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|5276|8265|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Takrólímus||5276||5276|8265||1 009679|J05AF0701|Viread|filmhtfl|245|mg|30|stk|1|glas||J05AF07|01.04.2003||R|1|0|0|1|0|1|GIS|0|0|0|100|DKK|59626|76713|lyfsjukr|||1|30|0|30,0000|Gilead Sience Sweden AB|Gilead Science International ltd.|Tenófóvír dísóproxíl||59626||59626|76713||3 009900|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk|sjálfs|N01BB03|01.03.1984||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|9562|14128|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Mepívakaín||9562||9562|14128||1 009905|N01BB5402|Citanest Dental Octapressin|stl|||1,8|ml|100|rörlyk||N01BB54|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|8731|12991|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Prílókaín í blöndum||8731||8731|12991||1 009911|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml|N01BB52|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|8065|12080|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Lídókaín í blöndum||8065||8065|12080||1 009942|N01BB5402|Citanest Dental Octapressin|stl|||1,8|ml|100|rörlyk|sjálfsog|N01BB54|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|10041|14784|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Prílókaín í blöndum||10041||10041|14784||1 009945|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml-sjálfsog|N01BB52|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|8233|12310|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Lídókaín í blöndum||8233||8233|12310||1 009947|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk||N01BB03|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|8886|13204|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Mepívakaín||8886||8886|13204||1 009993|QP52AF0201|Banminth, vet.|pasta|115,3|mg/g|3|g|1|spr||QP52AF02|01.01.2013||R|0|0|0|0|0|0|PAL|0|0|0|100|DKK|1240|2163|vetorma|||0|3|0||Icepharma hf|Pfizer Oy Animal Health|||1240||1240|2163||2 010002|N06AX1102|Remeron Smelt|munndr.t|15|mg|30|stk|1|ţpakki||N06AX11|01.05.2003||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|2174|4022|lyfalmen|V0329|2546|1|30|0|15,0000|Vistor hf|N.V. Organon|Mirtazapín||2174||2174|4022||1 010035|N06AX1102|Remeron Smelt|munndr.t|30|mg|30|stk|1|ţpakki||N06AX11|01.05.2003||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|4139|6710|lyfalmen|V0330|2919|1|30|0|30,0000|Vistor hf|N.V. Organon|Mirtazapín||4139||4139|6710||1 010057|N06AX1102|Remeron Smelt|munndr.t|45|mg|30|stk|1|ţpakki||N06AX11|01.05.2003||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|5915|9139|lyfalmen|||1|30|0|45,0000|Vistor hf|N.V. Organon|Mirtazapín||5915||5915|9139||1 010182|J05AB1401|Valcyte|filmhtfl|450|mg|60|stk|1|plglas||J05AB14|01.11.2002||R|1|0|0|0|0|1|ROA|0|0|0|100|DKK|226699|286390|lyfsjukr|||1|60|0|30,0000|Icepharma hf|Roche A.S.|Valgancíklóvír||226699||226699|286390||2 010234|J01DH0301|Invanz|irs|1|g/hgl|1|hgl|1|pakki||J01DH03|01.08.2002||R|0|0|0|1|0|1|MSD|0|0|0|100|DKK|7270|10492|lyfsjukr|||1|1|0|1,0000|Vistor hf|M.S.D.|Ertapenem||7270||7270|10492||1 010240|N06AX1102|Remeron Smelt|munndr.t|30|mg|96|stk|1|ţpakki||N06AX11|01.05.2003||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|12849|18849|lyfalmen|V0331|4892|1|96|0|96,0000|Vistor hf|N.V. Organon|Mirtazapín||12849||12849|18849||1 010254|N06AX1102|Remeron Smelt|munndr.t|45|mg|96|stk|1|ţpakki||N06AX11|01.05.2003||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|18116|25459|lyfalmen|V0332|8672|1|96|0|144,0000|Vistor hf|N.V. Organon|Mirtazapín||18116||18116|25459||1 010290|N06DX0101|Ebixa|mixtúra|5|mg/sk|50|g|1|fl|dćluskammtur|N06DX01|01.08.2010||R|0|0|0|0|G|0|LBK|0|0|0|100|DKK|14320|20695|lyfalmen|||1|50|0|25,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||14320|20695||1 010334|N06DX0101|Ebixa|töflur|10|mg|100|stk|1|ţpakki||N06DX01|01.10.2002||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|23214|31857|lyfalmen|V0605|26030|1|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||23214||23214|31857||1 010348|J07BB0203|Vaxigrip|bóluefni|||0,5|ml|10|áf.spr||J07BB02|01.10.1995||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|7395|11164|lyfalmen|||1|5|0||Icepharma hf|Sanofi Pasteur MSD|Inflúensa, hreinsađir mótefnavakar||7395||7395|11164||2 010361|C09DA0701|MicardisPlus|töflur|92,5|mg|98|stk|1|ţpakki|80 + 12,5 mg|C09DA07|01.02.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|12559|18485|lyfalmen|||1|98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og ţvagrćsilyf||12559||12559|18485||1 010437|QI09AB1301|Stellamune One|stl|||100|ml|10|glös|Fleyti|QI09AB13|01.09.2008||R|0|0|0|0|0|0|ELA|0|0|0|100|DKK|74109|129279|vetorma|||0|1000|0||Icepharma hf|Elanco Animal Health A/S|Óvirkar bakteríur í bóluefnum||74109||74109|129279||2 010446|A07EC0204|Asacol|sh-tfl|800|mg|60|stk|1|ţpakki||A07EC02|01.01.2003||R|1|0|0|0|G|0|TIL|0|0|0|100|SEK|6776|10317|lyfalmen|||1|60|0|32,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||||6776|10317||2 010464|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|50|ml|50|pokar|lausn|B05BB01|01.11.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|7475|10788|lyfsjukr|||1|2500|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||7475||7475|10788||2 010534|B05BA0108|Vaminolac|irl|||100|ml|10|fl||B05BA01|01.03.2004||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|9222|13310|lyfsjukr|||1|1000|0||Icepharma hf|Fresenius Kabi|Amínósýrur||9222||9222|13310||2 010573|S01AE0501|Oftaquix|augndr|5|mg/ml|5|ml|1|glas||S01AE05|01.08.2002||R|0|0|0|0|0|0|SAO|0|0|1|100|XEU|1191|2677|lyfalmen|||1|5|0||Icepharma hf|Santen Oy|Levófloxacín||1191||1191|2677||2 010669|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|250|ml|30|pokar|lausn|B05BA03|01.11.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|6134|8853|lyfsjukr|||1|7500|0||Icepharma hf|Baxter Medical AB|Kolvetni||6134||6134|8853||2 010672|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|100|ml|50|pokar|lausn|B05BA03|01.11.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|9434|13616|lyfsjukr|||1|5000|0||Icepharma hf|Baxter Medical AB|Kolvetni||9434||9434|13616||2 010683|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|500|ml|20|pokar|lausn|B05BA03|01.11.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|4173|6023|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||4173||4173|6023||2 010691|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|1000|ml|10|pokar|lausn|B05BA03|01.11.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|2392|3452|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||2392||2392|3452||2 010705|A02BC0110|Omeprazol ratiopharm|sţ-hylki|20|mg|28|stk|1|glas|hart|A02BC01|01.02.2012||L|1|0|0|0|0|0|RAT|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól|||||||2 010706|S01EE0301|Lumigan|augndr|0,3|mg/ml|3|ml|3|glös||S01EE03|01.04.2005||R|0|0|0|0|G|0|ALL|0|0|0|100|SEK|9085|13476|lyfalmen|V0377|13476|1|9|0|90,0000|Vistor hf|Allergan|Bimatóprost||9085||9085|13476||1 010707|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|100|ml|50|pokar|lausn|B05BB01|01.11.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|9422|13598|lyfsjukr|||1|5000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||9422||9422|13598||2 010716|A02BC0110|Omeprazol ratiopharm|sţ-hylki|20|mg|56|stk|1|glas|hart|A02BC01|01.02.2012||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|2373|2672|lyfalmen|V0006|2078|2|56|0|56,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól||1187||1187|2672||2 010729|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|250|ml|30|pokar|lausn|B05BB01|01.11.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|6764|9762|lyfsjukr|||1|7500|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||6764||6764|9762||2 010740|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|500|ml|20|pokar|lausn|B05BB01|01.11.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|4106|5926|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||4106||4106|5926||2 010746|M05BA0702|Optinate Septimum|filmhtfl|35|mg|12|stk|1|ţpakki||M05BA07|01.12.2002||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|14610|5971|lyfalmen|V0207|1664|1|12|0|84,0000|Vistor hf|Sanofi-aventis Norge AS|Rísedrónsýru||3599||3599|5971||1 010760|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|1000|ml|10|pokar|lausn|B05BB01|01.11.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|2210|3190|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||2210||2210|3190||2 010804|C02KX0101|Tracleer|filmhtfl|62,5|mg|56|stk|1|ţpakki||C02KX01|01.11.2003||R|1|1|0|1|0|1|ACT|0|1|0|100|DKK|353986|446135|lyfsjukr|||1|56|0|14,0000|Lyfjaver ehf|Actelion Registration Ltd.|Bósentan||353986||353986|446135||3 010826|C02KX0101|Tracleer|filmhtfl|125|mg|56|stk|1|ţpakki||C02KX01|01.11.2003||R|1|1|0|1|0|1|ACL|0|1|0|100|DKK|353986|446135|lyfsjukr|||1|56|0|28,0000|Actelion Registration Ltd|Actelion Registration Ltd.|Bósentan||353986||353986|446135||3 010890|A02BC0107|Lomex-T|sh-tfl|20|mg|28|stk|1|glas||A02BC01|01.06.2002||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1269|1539|lyfalmen|||2|28|0|28,0000|Actavis Group hf|Actavis hf|Ómeprazól||359||359|1539|30.6.2013|1 010900|A01AB0301|Corsodyl|munnh.l|2|mg/ml|300|ml|1|fl||A01AB03|01.07.1986||L|0|0|0|0|0|0|SMB|0|0|1|100|IKR|||lyflausa|||0|300|0|20,0000|GlaxoSmithKline ehf|SmithKline Beecham Ltd|Klórhexidín|||||||1 010912|A02BC0107|Lomex-T|sh-tfl|20|mg|100|stk|1|glas||A02BC01|01.06.2002||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|4614|4454|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis hf|Ómeprazól||2490||2490|4454|30.6.2013|1 010923|A02BC0107|Lomex-T|sh-tfl|20|mg|56|stk|1|glas||A02BC01|01.06.2002||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|2975|2911|lyfalmen|||2|56|0|56,0000|Actavis Group hf|Actavis hf|Ómeprazól||1362||1362|2911|30.6.2013|1 010924|L01DC0103|Bleomycin Baxter|sts|15000|ae|10|hgl|1|pakki||L01DC01|01.04.1998||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|50394|65127|lyfsjukr|||2|10|0||Icepharma hf|Baxter Medical AB|Bleómýcín||50394||50394|65127||2 010935|J01CF0201|Ekvacillin|sts/irs|1|g|10|hgl|1|pakki||J01CF02|01.10.2003||R|0|0|0|0|0|1|REP|0|0|0|100|SEK|3263|4709|lyfsjukr|||1|10|0|5,0000|Vistor hf|Recip AB|Kloxacillín||3263||3263|4709||1 010951|N05AX1201|Abilify|töflur|10|mg|28|stk|1|ţpakki||N05AX12|01.01.2005||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|20272|28165|lyfalmen|||1|28|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||20272||20272|28165||1 010953|N05AX1201|Abilify|töflur|15|mg|28|stk|1|ţpakki||N05AX12|01.01.2005||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|20036|27869|lyfalmen|||1|28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||20036||20036|27869||1 010959|A01AB0301|Corsodyl|munnh.hl|10|mg/g|50|g|1|túpa||A01AB03|01.09.1982|30.06.2013|L|0|0|0|0|0|0|SMB|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6667|GlaxoSmithKline ehf|SmithKline Beecham Ltd|Klórhexidín|||||||1 011008|N05AX1201|Abilify|töflur|10|mg|56|stk|1|ţpakki||N05AX12|01.01.2005||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|34516|46041|lyfalmen|||1|56|0|37,3330|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||34516||34516|46041||1 011019|N05AX1201|Abilify|töflur|15|mg|56|stk|1|ţpakki||N05AX12|01.01.2005||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|34281|45746|lyfalmen|||1|56|0|56,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||34281||34281|45746||1 011163|A07EA0601|Entocort|forđahlk|3|mg|100|stk|1|glas||A07EA06|01.10.1996||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|19081|26670|lyfalmen|||1|100|0|33,3300|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||19081||19081|26670||1 011207|M01AH0501|Arcoxia|filmhtfl|60|mg|28|stk|1|ţpakki||M01AH05|01.10.2002||R|1|0|0|0|G|0|MSD|0|0|1|100|DKK|4528|7242|lyfalmen|||1|28|0|28,0000|Vistor hf|M.S.D.|Etoríkoxíb||4528||4528|7242||1 011271|M01AH0501|Arcoxia|filmhtfl|90|mg|28|stk|1|ţpakki||M01AH05|01.10.2002||R|1|0|0|0|G|0|MSD|0|0|1|100|DKK|4705|7484|lyfalmen|||1|28|0|42,0000|Vistor hf|M.S.D.|Etoríkoxíb||4705||4705|7484||1 011314|N06AB1001|Cipralex|töflur|20|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|20371|26711|lyfalmen|V0327|2949|1|100|0|200,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||19114||19114|26711||1 011326|M01AH0501|Arcoxia|filmhtfl|120|mg|7|stk|1|ţpakki||M01AH05|01.01.2010||R|1|0|0|0|G|0|MSD|0|0|1|100|DKK|1201|2691|lyfalmen|||1|7|0|14,0000|Vistor hf|M.S.D.|Etoríkoxíb||1201||1201|2691||1 011336|N05AH0309|Kozylex|munndr.t|5|mg|28|stk|1|ţpakki||N05AH03|01.10.2011||R|0|0|0|0|G|0|POF|0|0|0|100|IKR|7436|3414|lyfalmen|||2|28|0|14,0000|Portfarma ehf|Portfarma|Olanzapín||1680||1730|3414|30.6.2013|2 011353|N05AF0502|Cisordinol Depot|stl|500|mg/ml|1|ml|5|lykjur||N05AF05|01.10.1988||R|0|0|0|0|G|0|LBK|0|0|0|100|DKK|12219|18058|lyfalmen|||1|5|0|166,6667|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||12219||12219|18058||1 011369|C09CA0102|Lopress|töflur|50|mg|28|stk|1|glas||C09CA01|01.11.2002||R|1|0|0|0|0|0|ACA|0|0|0|100|XEU|1068|2509|lyfalmen|||2|28|0|28,0000|Actavis Group hf|Actavis hf|Lósartan||1068||1068|2509||1 011380|C09CA0102|Lopress|töflur|50|mg|98|stk|1|glas||C09CA01|01.11.2002||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|2945|1759|lyfalmen|V0069|1759|2|98|0|98,0000|Actavis Group hf|Actavis hf|Lósartan||520||520|1759||1 011409|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|60|skammtar|1|pakki|320+9 mcg/sk|R03AK07|01.05.2003||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|9125|13530|lyfalmen|V0357|12926|1|60|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||9125||9125|13530||1 011489|N06BA0402|Concerta|forđatfl|18|mg|30|stk|1|glas||N06BA04|01.01.2003||R|1|0|1|0|0|0|JAS|0|0|0|100|SEK|6975|10589|lyfalmen|||1|30|0|18,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||6975||6975|10589||1 011540|N01AX1401|S-Ketamin "Pfizer"|stl|5|mg/ml|5|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|0|0|1|0|0|1|PER|0|0|0|100|DKK|2440|3522|lyfsjukr|||1|50|0||Icepharma hf|Pfizer ApS|Esketamín||2440||2440|3522||1 011555|N06BA0402|Concerta|forđatfl|36|mg|30|stk|1|glas||N06BA04|01.01.2003||R|1|0|1|0|0|0|JAS|0|0|0|100|SEK|9130|13537|lyfalmen|||1|30|0|36,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||9130||9130|13537||1 011561|QN05CM9203|Chanazine, vet.|stl|2|%|25|ml|1|hgl||QN05CM92|01.09.2002||R|0|0|0|0|0|0|CHP|1|0|0|100|XEU|1938|3855|vetalmen|||0|25|0||Icepharma hf|Chanelle Pharmaceuticals |||1938||1938|3855||2 011609|N01AX1401|S-Ketamin "Pfizer"|stl|25|mg/ml|2|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|0|0|1|0|0|1|PER|0|0|0|100|DKK|4974|7179|lyfsjukr|||1|20|0||Icepharma hf|Pfizer ApS|Esketamín||4974||4974|7179||1 011620|G03CA0311|Estrogel|hlaup|0,6|mg/g|64|skammtar|1|fl|međ skammtadćlu|G03CA03|01.03.2000||R|0|0|0|0|G|0|OYL|0|0|0|100|DKK|1226|2725|lyfalmen|||2|64|0||Vistor hf|Oy Leiras Finland Ab|Estradíól||1226||1226|2725||1 011690|J05AB0402|Copegus|töflur|200|mg|168|stk|1|plglas||J05AB04|01.03.2003||R|0|0|0|1|0|1|ROA|0|0|0|100|DKK|88656|113146|lyfsjukr|||1|168|0|33,6000|Icepharma hf|Roche A.S.|Ribavirin||88656||88656|113146||2 011718|QJ01CE0101|Geepenil, vet.|sts|24|g|1|hgl|1|pakki|+ leysir, lausn|QJ01CE01|01.09.2012||R|0|0|0|0|0|0|OCO|0|0|0|100|SEK|2909|5758|vetalmen|||0|1|0||Icepharma hf|Orion Corporation (I)|Benzylpenicillín sodíum||2909||2909|5758||2 011863|N06AB0602|Sertral|töflur|100|mg|28|stk|1|ţpakki||N06AB06|01.10.2005||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1796|2041|lyfalmen|V0152|2041|2|28|0|56,0000|Actavis Group hf|Actavis hf|Sertralín||726||726|2041||1 011880|N06AB0602|Sertral|töflur|100|mg|98|stk|1|ţpakki||N06AB06|01.10.2005||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|4738|4239|lyfalmen|V0323|4154|2|98|0|196,0000|Actavis Group hf|Actavis hf|Sertralín||2333||2333|4239||1 011953|N01BB0103|Marcain spinal|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|4560|6581|lyfsjukr|||1|20|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||4560||4560|6581||1 011969|N01BB0105|Marcain spinal tung|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|2638|3807|lyfsjukr|||1|20|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||2638||2638|3807||1 011985|N06DX0101|Ebixa|filmhtfl|10|mg|28|stk|1|ţpakki||N06DX01|01.06.2009||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|8020|12019|lyfalmen|V0604|8376|1|28|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||8020|12019||1 012030|J05AG0301|Stocrin|töflur|600|mg|30|stk|1|glas||J05AG03|01.01.2003||R|1|0|0|1|0|1|MSD|0|0|0|100|DKK|40768|53046|lyfsjukr|||1|30|0|30,0000|Vistor hf|M.S.D.|Efavirenz||40768||40768|53046||1 012113|J02AC0104|Fluconazol ratiopharm|hylki|50|mg|7|stk|1|ţpakki||J02AC01|01.10.2012||R|1|0|0|0|0|0|RGM|0|0|1|100|XEU|1319|1644|lyfalmen|V0551|1595|2|7|0|1,7500|Medical ehf|ratiopharm GmbH|Flúkónazól||436||436|1644||2 012243|G04CB0201|Avodart|hylki|0,5|mg|30|stk|1|ţpakki|hylki mjúk|G04CB02|01.03.2012||R|1|0|0|0|G|0|GSK|0|0|0|100|GBP|3865|6335|lyfalmen|||1|30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Dútasteríđ||3865||3865|6335||1 012273|G04BE0801|Cialis|filmhtfl|10|mg|4|stk|1|ţpakki||G04BE08|01.02.2003||R|0|0|0|0|0|0|LIL|0|0|0|100|XEU|6037|9306|lyfalmen|||1|4|0|4,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||6037||6037|9306||2 012278|N07BA0106|Nicotinell|forđapl|7|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|7|0|3,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 012290|J02AC0104|Fluconazol ratiopharm|hylki|150|mg|4|stk|1|ţpakki||J02AC01|01.10.2012||R|1|0|0|0|0|0|RGM|0|0|1|100|XEU|1877|2107|lyfalmen|V0556|1595|2|4|0|3,0000|Medical ehf|ratiopharm GmbH|Flúkónazól||774||774|2107||2 012326|N06BA0402|Concerta|forđatfl|54|mg|30|stk|1|glas||N06BA04|01.08.2005||R|1|0|1|0|0|0|JAS|0|0|0|100|SEK|11465|16731|lyfalmen|||1|30|0|54,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||11465||11465|16731||1 012347|J02AC0104|Fluconazol ratiopharm|hylki|50|mg|28|stk|1|ţpakki||J02AC01|01.10.2012||R|1|0|0|0|0|0|RGM|0|0|1|100|XEU|3956|3829|lyfalmen|V0552|3167|2|28|0|7,0000|Medical ehf|ratiopharm GmbH|Flúkónazól||2033||2033|3829||2 012461|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 012504|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 012508|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 012577|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 012716|N07BA0106|Nicotinell|forđapl|14|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|7|0|7,0000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 012738|M05BC0101|InductOs|ígr.sett|12|mg|1|stk|1|pakki||M05BC01|01.09.2003||R|0|0|0|1|0|1|WTE|0|0|0|100|DKK|448907|565261|lyfsjukr|||1|1|0||Icepharma hf|Wyeth Europe|Díbótermín alfa||448907||448907|565261||2 012799|N07BA0106|Nicotinell|forđapl|21|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|7|0|10,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 012880|J01CR0202|Augmentin|mixtduft|62,5|mg/ml|80|ml|1|glas|50+12.5 mg|J01CR02|01.10.1989||R|0|0|0|0|0|0|GSK|0|0|1|100|IKR|718|2030|lyfalmen|||1|80|0|4,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||718||718|2030||1 012921|G03AA1301|Evra|forđapl|||9|stk|1|pakki|6 mg+600 mcg|G03AA13|01.11.2003||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|4838|7666|lyfalmen|||1|9|0||Vistor hf|Janssen-Cilag International N.V.|Norelgestromín og ethinylestradíól||4838||4838|7666||1 012953|G03BA0306|Testogel|hlaup|50|mg|30|sk-pokar|1|pakki||G03BA03|01.12.2003||R|0|0|0|0|G|0|LBI|0|0|0|100|DKK|6578|10046|lyfalmen|||1|30|0|30,0000|Icepharma hf|Laboratoires Besins International|Testósterón||6578||6578|10046||2 012966|N03AX1208|Gabapentin ratiopharm|hylki|300|mg|100|stk|1|ţpakki||N03AX12|01.03.2012||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|2805|4885|lyfalmen|V0250|4885|2|100|0|16,6667|Medical ehf|ratiopharm GmbH|Gabapentín||2805||2805|4885||2 012988|N03AX1208|Gabapentin ratiopharm|hylki|400|mg|100|stk|1|ţpakki||N03AX12|01.03.2012||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|3673|5160|lyfalmen|V0251|5160|2|100|0|22,2200|Medical ehf|ratiopharm GmbH|Gabapentín||3006||3006|5160||2 013068|N06BA0403|Ritalin Uno|hylki|20|mg|30|stk|1|glas||N06BA04|01.02.2004||R|1|0|1|0|0|0|NOH|0|0|0|100|DKK|5929|9159|lyfalmen|||1|30|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||5929||5929|9159||1 013070|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|0|0|0|0|0|0|PAL|0|0|0|100|DKK|6995|13604|vetalmen|||0|100|0||Icepharma hf|Pfizer Oy Animal Health|||6995||6995|13604||2 013079|N06BA0403|Ritalin Uno|hylki|40|mg|30|stk|1|glas||N06BA04|01.02.2004||R|1|0|1|0|0|0|NOH|0|0|0|100|DKK|9350|13838|lyfalmen|||1|30|0|40,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||9350||9350|13838||1 013082|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|20|stk|1|pakki||QM01AE91|01.08.2005||R|0|0|0|0|0|0|PAL|0|0|0|100|DKK|1761|3503|vetalmen|||0|20|0||Icepharma hf|Pfizer Oy Animal Health|||1761||1761|3503||2 013100|R07AX0101|INOmax|innö.gas|400|ppm|2|l|1|gashyl||R07AX01|01.01.2004||R|0|1|0|1|0|1|AGA|0|0|0|100|XEU|22293|29860|lyfsjukr|||1|2|0||Ísaga ehf|AGA AB|Nituroxíđ||22293||22293|29860||5 013172|J06BB0101|Rhophylac|stl|1500|ae|2|ml|1|spr||J06BB01|01.02.2004||R|0|0|0|0|0|1|ZLB|0|0|0|100|SEK|7252|10466|lyfsjukr|||1|2|0||Icepharma hf|ZLB GmbH|And-D(rh) immúnóglóbúlín||7252||7252|10466||2 013259|B02BD0901|BeneFIX|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD09|01.02.2004||R|0|0|0|1|0|1|WTE|0|1|0|100|DKK|29675|39125|lyfsjukr|||1|1|0|0,5600|Icepharma hf|Wyeth Europe|Storkuţáttur IX||29675||29675|39125||2 013270|B02BD0901|BeneFIX|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD09|01.02.2004||R|0|0|0|1|0|1|WTE|0|1|0|100|DKK|50228|64919|lyfsjukr|||1|1|0|1,1100|Icepharma hf|Wyeth Europe|Storkuţáttur IX||50228||50228|64919||2 013302|C02CA0405|Cardosin Retard|forđatfl|4|mg|100|stk|1|ţpakki||C02CA04|01.09.2009||R|1|0|0|0|G|0|ANO|0|0|0|100|XEU|3380|4781|lyfalmen|V0042|4781|2|100|0|100,0000|Actavis Group PTC hf|Actavis Nordic A/S|Doxazósín||2729||2729|4781||1 013308|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|0|0|0|0|0|0|PAL|0|0|0|100|DKK|4594|8994|vetalmen|||0|100|0||Icepharma hf|Pfizer Oy Animal Health|||4594||4594|8994||2 013317|QM01AE9101|Rimadyl vet.|tuggutfl|100|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|0|0|0|0|0|0|PAL|0|0|0|100|DKK|10719|20755|vetalmen|||0|100|0||Icepharma hf|Pfizer Oy Animal Health|||10719||10719|20755||2 013328|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|20|stk|1|pakki||QM01AE91|01.08.2005||R|0|0|0|0|0|0|PAL|0|0|0|100|DKK|1125|2238|vetalmen|||0|20|0||Icepharma hf|Pfizer Oy Animal Health|||1125||1125|2238||2 013341|B02BD0206|Advate|sts|1500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|0|0|0|0|0|1|BAL|0|1|0|100|SEK|154408|195665|lyfsjukr|||1|1|0|3,0000|Lyfjaver ehf|Baxter Medical AB (L)|Storkuţáttur VIII||||154408|195665||3 013347|L01XE0201|Iressa|töflur|250|mg|30|stk|1|ţpakki||L01XE02|01.03.2010||R|0|0|0|1|0|1|AZD|0|0|0|100|SEK|420934|468081|lyfsjukr|||1|30|0||Vistor hf|AstraZeneca A/S DK|Gefitiníb||371473||371473|468081||1 013362|B02BD0206|Advate|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|0|0|0|0|0|1|BER|0|1|0|100|SEK|27159|35967|lyfsjukr|||1|1|0|0,5000|Lyfjaver ehf|Baxter AG (L)|Storkuţáttur VIII||||27159|35967||3 013365|B02BD0206|Advate|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|0|0|0|0|0|1|BER|0|1|0|100|SEK|102938|131070|lyfsjukr|||1|1|0|2,0000|Lyfjaver ehf|Baxter AG (L)|Storkuţáttur VIII||||102938|131070||3 013373|B02BD0206|Advate|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|0|0|0|0|0|1|BER|0|1|0|100|SEK|52469|67731|lyfsjukr|||1|1|0|1,0000|Lyfjaver ehf|Baxter AG (L)|Storkuţáttur VIII||||52469|67731||3 013386|C10AX0901|Ezetrol|töflur|10|mg|28|stk|1|ţpakki||C10AX09|01.01.2010||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|5443|8494|lyfalmen|V0612|8494|1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb||5443||5443|8494||1 013485|C10AX0901|Ezetrol|töflur|10|mg|98|stk|1|ţpakki||C10AX09|01.05.2003||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|18532|25981|lyfalmen|V0613|25981|1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb||18532||18532|25981||1 013551|N02AA0503|Oxynorm|stl|10|mg/ml|1|ml|5|lykjur||N02AA05|01.08.2009||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|1321|2855|lyfalmen|||1|5|0|1,6700|Icepharma hf|Norpharma|Oxýcódon||1321||1321|2855||2 013593|A01AA3001|Xerodent|munnstfl|||90|stk|1|plglas|28,6 mg /0,25 mg|A01AA30|01.01.2008||L|0|0|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||0|90|0||Actavis Group hf|Actavis Group hf|Blöndur|||||1579||1 013615|M01AE0113|Ibuxin|filmhtfl|400|mg|100|stk|1|ţpakki||M01AE01|01.01.2013||R|1|0|0|0|G|0|ROY|0|0|1|100|XEU|766|1815|lyfalmen|V0562|1815|2|100|0|33,3300|Medical ehf|ratiopharm Oy|Íbúprófen||561||561|1815||2 013628|N02AA0503|Oxynorm|stl|10|mg/ml|2|ml|5|lykjur||N02AA05|01.08.2009||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|2525|4502|lyfalmen|||1|10|0|3,3300|Icepharma hf|Norpharma|Oxýcódon||2525||2525|4502||2 013707|N01BB0203|Xylocain|hlaup|20|mg/ml|30|g|1|túpa||N01BB02|01.10.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|422|1625|lyfalmen|||1|30|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||422||422|1625||1 013718|M05BA0801|Zometa|irţ|4|mg/hgl|5|ml|1|hgl|lausn|M05BA08|01.05.2004||R|0|0|0|1|0|1|NOE|0|1|0|100|DKK|37562|49023|lyfsjukr|||1|5|0|1,0000|Vistor hf|Novartis Europharm Ltd|Zoledronsýra||37562||37562|49023||1 013756|C09DA0307|Diovan Comp 160/25 mg|filmhtfl|185|mg|28|stk|1|ţpakki||C09DA03|01.04.2005||R|1|0|0|0|0|0|NOH|0|0|0|100|DKK|4714|7496|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og ţvagrćsilyf||4714||4714|7496||1 013802|H02AB0103|Diprospan|stl|7|mg/ml|1|ml|1|lykja||H02AB01|01.08.2009||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|969|2373|lyfalmen|||1|1|0|4,6700|Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||||969|2373||1 013861|J01CR0202|Augmentin|töflur|625|mg|20|stk|1|ţpakki|500+125 mg|J01CR02|01.01.2003||R|0|0|0|0|0|0|GSK|0|0|1|100|IKR|1215|2710|lyfalmen|||1|20|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||1215||1215|2710||1 013901|A10AC0108|Insulatard InnoLet|stl|100|ae/ml|3|ml|5|spr|áfylltar spr.|A10AC01|01.02.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|6229|9569|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||6229||6229|9569||1 013950|A10AB0101|Actrapid|stl|100|ae/ml|10|ml|1|hgl||A10AB01|01.03.2004||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2595|4598|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||2595||2595|4598||1 013957|A10AC0109|Insulatard FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AC01|01.02.2004||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|4653|7413|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||4653||4653|7413||1 013971|L01XE0101|Glivec|filmhtfl|100|mg|60|stk|1|ţpakki||L01XE01|01.06.2012||R|0|0|0|1|0|1|NOE|0|1|0|100|DKK|178361|225726|lyfsjukr|||1|60|0||Vistor hf|Novartis Europharm Ltd|Imatiníb||178361||178361|225726||1 013982|L01XE0101|Glivec|filmhtfl|400|mg|30|stk|1|ţpakki||L01XE01|01.05.2004||R|0|0|0|1|0|1|NOE|0|1|0|100|DKK|379147|477712|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Imatiníb||379147||379147|477712||1 014010|A10AC0103|Insulatard|stl|100|ae/ml|10|ml|1|hgl||A10AC01|01.04.1986||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2511|4483|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||2511||2511|4483||1 014031|A02BC0501|Nexium|sts|40|mg|5|ml|10|hgl|lausn|A02BC05|01.04.2004||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|9328|13463|lyfsjukr|||1|50|0|13,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||9328||9328|13463||1 014081|N03AX1401|Keppra|mixtúra|100|mg/ml|300|ml|1|glas||N03AX14|01.12.2006||R|0|0|0|0|0|0|UCB|0|0|0|100|DKK|18217|25586|lyfalmen|||1|300|0|20,0000|Vistor hf|U.C.B|Levetíracetam||18217||18217|25586||1 014094|H05AA0202|Forsteo|stl|250|mcg/ml|2,4|ml|1|penni|20 mcg/80 mcl|H05AA02|01.11.2003||R|0|0|0|0|0|0|ELD|0|0|0|100|XEU|57517|74907|lyfalmen|||1|2,4|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Teriparatíđ||57517||57517|74907||2 014138|B05BA1020|StructoKabiven elektrolyfri|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|29905|39413|lyfsjukr|||1|5908|0||Icepharma hf|Fresenius Kabi|Blöndur||29905||29905|39413||2 014185|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|180|skammtar|1|pakki|320+9 mcg/sk|R03AK07|01.08.2009||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|28728|38777|lyfalmen|V0357|38777|1|180|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||28728||28728|38777||1 014261|D10AX0302|Finacea|hlaup|15|%|30|g|1|túpa||D10AX03|01.04.2005||R|0|0|0|0|0|0|IGB|0|0|0|100|DKK|1634|3283|lyfalmen|||1|30|0||Icepharma hf|Intendis GmbH Berlin|Azelainsýra||1634||1634|3283||2 014290|S01GX0201|Livostin|augndr|0,5|mg/ml|4|ml|1|glas||S01GX02|01.10.1991||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|4|0||Vistor hf|McNeil Sweden AB|Levókabastín|||||||1 014352|B05BA1015|StructoKabiven|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|19864|26812|lyfsjukr|||1|3944|0||Icepharma hf|Fresenius Kabi|Blöndur||19864||19864|26812||2 014361|B05BA1015|StructoKabiven|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|26004|34518|lyfsjukr|||1|5908|0||Icepharma hf|Fresenius Kabi|Blöndur||26004||26004|34518||2 014365|M01AE0113|Ibuxin|filmhtfl|600|mg|30|stk|1|ţpakki||M01AE01|01.01.2013||R|1|0|0|0|G|0|ROY|0|0|1|100|XEU|368|1551|lyfalmen|V0563|1551|2|30|0|15,0000|Medical ehf|ratiopharm Oy|Íbúprófen||368||368|1551||2 014415|P01AB0106|Flagyl|mixtúra|40|mg/ml|100|ml|1|fl||P01AB01|01.08.2009||R|0|0|0|0|0|0|PCO|0|0|1|100|NOK|2614|4624|lyfalmen|||0|100|1||Distica|Distica - óskráđ lyf|Metrónídazól||2614||2614|4624||1 014435|QM01AE03|Dolovet vet.|duft|2,4|g|15|g|3|pokar||QM01AE03|01.06.2009||R|0|0|0|0|0|0|VET|0|0|0|100|XEU|2304|4583|vetalmen|||0|45|0||Dýraheilsa ehf|Vetcare Ltd.|||||2304|4583||2 014453|G02BA0302|Mirena|leginnle|20|mcg/sólh|1|stk|1|pakki||G02BA03|01.04.1994||R|0|0|0|0|0|0|BOY|0|0|0|100|DKK|18503|25945|lyfalmen|||1|1|0||Icepharma hf|Bayer OY|Plast lyfjalykkja (IUD) međ prógestógen||18503||18503|25945||2 014510|J05AF0801|Hepsera|töflur|10|mg|30|stk|1|glas||J05AF08|01.03.2009||R|0|0|0|1|0|1|GIS|0|0|0|100|DKK|83070|106135|lyfsjukr|||1|30|0|30,0000|Gilead Sience Sweden AB|Gilead Science International ltd.|Adefovír||||83070|106135||3 014541|QA02BX1202|Orbesealer vet.|spenalyf|2,6|g/dćlu|24|dćlur|1|pakki||QA02BX12|01.04.2005||R|0|0|0|0|0|0|PAL|0|0|0|100|XEU|5726|11167|vetalmen|||0|24|0||Icepharma hf|Pfizer Oy Animal Health|||5726||5726|11167||2 014583|J05AX0701|Fuzeon|sts|90|mg/ml|60|hgl|1|pakki|+ leysir|J05AX07|01.12.2003||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|242063|305672|lyfsjukr|||1|60|0|36,0000|Icepharma hf|Roche Registration Limited|Enfúvirtíđ||242063||242063|305672||2 014597|M01AE0113|Ibuxin|filmhtfl|600|mg|100|stk|1|ţpakki||M01AE01|01.01.2013||R|1|0|0|0|G|0|ROY|0|0|1|100|XEU|929|2038|lyfalmen|V0564|2038|2|100|0|50,0000|Medical ehf|ratiopharm Oy|Íbúprófen||724||724|2038||2 014679|N02AA0501|Oxycontin|forđatfl|5|mg|28|stk|1|ţpakki||N02AA05|01.12.2005||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|2307|4204|lyfalmen|V0596|3572|1|28|0|1,8600|Icepharma hf|Norpharma |Oxýcódon||2307||2307|4204||2 014696|C03EA0111|Miloride|töflur|55|mg|100|stk|1|glas|5+50 mg|C03EA01|01.02.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1151|2622|lyfalmen|V0558|2386|2|100|0|100,0000|Icepharma hf|Mylan AB|Hýdróklórtíazíđ og kalíumsparandi lyf||1151||1151|2622||2 014728|L03AA0201|Neupogen|stl|0,6|mg/ml|0,5|ml|5|spr|áfyllt sprauta, lausn|L03AA02|01.12.2003||R|0|0|0|1|0|1|AEU|0|0|0|100|DKK|63268|81284|lyfsjukr|||1|2,5|0|4,2900|Vistor hf|Amgen Europe B.V.|Fílgrastím||63268||63268|81284||1 014739|L03AA0201|Neupogen|stl|0,96|mg/ml|0,5|ml|5|spr|áfyllt sprauta, lausn|L03AA02|01.12.2003||R|0|0|0|1|0|1|AEU|0|0|0|100|DKK|101226|128921|lyfsjukr|||1|2,5|0|6,8600|Vistor hf|Amgen Europe B.V.|Fílgrastím||101226||101226|128921||1 014795|C03EA0112|Miloride mite|töflur|27,5|mg|100|stk|1|glas|2,5+25 mg|C03EA01|01.11.2009||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1192|2679|lyfalmen|V0559|2520|2|100|0|100,0000|Icepharma hf|Mylan AB|Hýdróklórtíazíđ og kalíumsparandi lyf||||1192|2679||2 014847|L04AA1801|Certican|töflur|0,25|mg|60|stk|1|ţpakki||L04AA18|01.04.2007||R|0|0|0|1|G|0|NOH|0|0|0|100|DKK|19386|27053|lyfalmen|||1|60|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Everolímus||19386||19386|27053||1 014852|A06AD6502|Movicol|mixtduft|13,8|g|20|pokar|1|pakki|lausn|A06AD65|01.09.2011||L|0|0|0|0|0|0|NOI|0|0|0|100|IKR|||lyflausa|||0|20|0|10,0000|Artasan ehf|Norgine A/S|Makrógól 3350|||||||1 014853|L04AA1801|Certican|töflur|0,75|mg|60|stk|1|ţpakki||L04AA18|01.04.2007||R|0|0|0|1|G|0|NOH|0|0|0|100|DKK|58497|76137|lyfalmen|||1|60|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Everolímus||58497||58497|76137||1 014859|L04AA1801|Certican|töflur|0,5|mg|60|stk|1|ţpakki||L04AA18|01.04.2007||R|0|0|0|1|G|0|NOH|0|0|0|100|DKK|38938|51591|lyfalmen|||1|60|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Everolímus||38938||38938|51591||1 015037|M01AX0502|Glucosamin Pharma Nord|hylki|400|mg|90|stk|1|glas||M01AX05|01.10.2006||L|1|0|0|0|0|0|PNA|0|0|1|100|IKR|||lyflausa|||0|90|0|30,5400|Icepharma hf|Pharma Nord ApS|Glúkósamín|||||||2 015230|R01AC0301|Lastin|nefúđi|1|mg/ml|10|ml|1|glas||R01AC03|01.06.1998||R|0|0|0|0|G|0|MAB|0|0|1|100|SEK|794|2134|lyfalmen|||1|10|0|17,8571|Vistor hf|Meda AB|Azelastínum||794||794|2134||1 015301|M01AX0502|Glucosamin Pharma Nord|hylki|400|mg|270|stk|1|glas||M01AX05|01.10.2006||L|1|0|0|0|0|0|PNA|0|0|1|100|IKR|||lyflausa|||0|270|0|91,6200|Icepharma hf|Pharma Nord ApS|Glúkósamín|||||||2 015316|N06AX1103|Miron|filmhtfl|30|mg|100|stk|1|plglas||N06AX11|01.07.2003||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|2743|4800|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis hf|Mirtazapín||2743||2743|4800||1 015343|A10AE0501|Levemir FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AE05|01.12.2005||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|8637|12863|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín detemír||8637||8637|12863||1 015344|N06AX1103|Miron|filmhtfl|30|mg|30|stk|1|ţpakki||N06AX11|01.07.2003||R|1|0|0|0|0|0|ACA|0|0|0|100|XEU|1111|2546|lyfalmen|||2|30|0|30,0000|Actavis Group hf|Actavis hf|Mirtazapín||1095||1095|2546||1 015381|H02AB0104|Betapred|lausnart|0,5|mg|100|stk|1|glas||H02AB01|01.01.1998||R|0|0|0|0|0|0|LOL|0|0|1|100|IKR|2760|4823|lyfalmen|||0|100|1|33,3333|Lyfjaver ehf|Lyfjaver- óskráđ|Betametasón||2760||2760|4823||3 015419|G03CA0316|Vivelle Dot|forđapl|25|mcg/sólh|8|stk|1|pakki||G03CA03|01.02.2006||R|0|0|0|0|G|0|NOH|0|0|0|100|DKK|1095|2546|lyfalmen|V0129|1738|1|8|0|14,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1095||1095|2546||1 015442|N02CC0103|Imigran Radis|filmhtfl|100|mg|6|stk|1|ţpakki||N02CC01|01.10.2005||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|1894|2520|lyfalmen|V0234|2520|1|6|0|12,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||1076||1076|2520||1 015443|N02CC0103|Imigran Radis|filmhtfl|50|mg|12|stk|1|ţpakki||N02CC01|01.10.2005||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|2705|2520|lyfalmen|V0233|2371|1|12|0|12,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||1076||1076|2520||1 015448|A10AE0502|Levemir Penfill|stl|100|ae/ml|3|ml|5|rörlyk||A10AE05|01.03.2007||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|10291|15125|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín detemír||10291||10291|15125||1 015532|L01CX0101|Yondelis|irţ|1|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|0|0|0|1|0|1|PAM|0|0|0|100|DKK|347132|437533|lyfsjukr|||1|1|0||Lyfjaver ehf|Pharma Mar S.A.|Trabecetedín||347132||347132|437533||3 015598|L01CX0101|Yondelis|irţ|0,25|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|0|0|0|1|0|1|PAM|0|0|0|100|DKK|92266|117676|lyfsjukr|||1|1|0||Lyfjaver ehf|Pharma Mar S.A.|Trabecetedín||92266||92266|117676||3 015605|N04BA0301|Stalevo|filmhtfl|262,5|mg|30|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|5336|8347|lyfalmen|||1|30|0|3,3300|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||5336||5336|8347||1 015652|N04BA0301|Stalevo|filmhtfl|262,5|mg|100|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|13566|19749|lyfalmen|||1|100|0|11,1100|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||13566||13566|19749||1 015655|N04BA0301|Stalevo|filmhtfl|387,5|mg|30|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|5336|8347|lyfalmen|||1|30|0|10,0000|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||5336||5336|8347||1 015663|N04BA0301|Stalevo|filmhtfl|387,5|mg|100|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|14665|21128|lyfalmen|||1|100|0|33,3300|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||14665||14665|21128||1 015695|J05AE0801|Reyataz|hylki|150|mg|60|stk|1|ţpakki||J05AE08|01.04.2005||R|1|0|0|1|0|1|BRS|0|0|0|100|DKK|70776|90706|lyfsjukr|||1|60|0|30,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||70776||70776|90706||1 015707|N04BA0301|Stalevo|filmhtfl|325|mg|30|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|5336|8347|lyfalmen|||1|30|0|6,6700|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||5336||5336|8347||1 015718|N04BA0301|Stalevo|filmhtfl|325|mg|100|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|13423|19569|lyfalmen|||1|100|0|22,2200|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||13423||13423|19569||1 015723|J05AE0801|Reyataz|hylki|200|mg|60|stk|1|plglas||J05AE08|01.06.2008||R|1|0|0|1|0|1|BRS|0|0|0|100|DKK|70776|90706|lyfsjukr|||1|60|0|40,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||70776||70776|90706||1 015733|L04AA0602|Myfortic|sh-tfl|180|mg|120|stk|1|ţpakki||L04AA06|01.11.2004||R|0|0|0|1|G|0|NOH|0|0|0|100|DKK|22695|31206|lyfalmen|||1|120|0|10,8000|Vistor hf|Novartis Healthcare A/S-|Mýcófenólsýra||22695||22695|31206||1 015755|L04AA0602|Myfortic|sh-tfl|360|mg|120|stk|1|ţpakki||L04AA06|01.11.2004||R|0|0|0|1|G|0|NOH|0|0|0|100|DKK|47272|62050|lyfalmen|||1|120|0|21,6000|Vistor hf|Novartis Healthcare A/S-|Mýcófenólsýra||47272||47272|62050||1 015823|QP54AB5205|Advocate stórir kettir|bl.lausn|110|mg|0,8|ml|3|pípett|100+10 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|4061|7084|vetorma|||0|2,4|0||Icepharma hf|Bayer Animal Health GmbH|||4061||4061|7084||2 015855|QP54AB5206|Advocate yfirstćrđar hundar|bl.lausn|125|mg|4|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|5286|9221|vetorma|||0|12|0||Icepharma hf|Bayer Animal Health GmbH|||5286||5286|9221||2 015873|QP54AB5202|Advocate litlir kettir|bl.lausn|110|mg|0,4|ml|3|pípett|100+10 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|3397|5926|vetorma|||0|1,2|0||Icepharma hf|Bayer Animal Health GmbH|||3397||3397|5926||2 015882|QP54AB5203|Advocate millistórir hundar|bl.lausn|125|mg|1|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|4599|8023|vetorma|||0|3|0||Icepharma hf|Bayer Animal Health GmbH|||4599||4599|8023||2 015883|M01CC0101|Atamir|hylki|250|mg|50|stk|1|ţpakki||M01CC01|01.05.1978||R|1|0|0|0|G|0|SGM|0|0|0|100|DKK|4562|7289|lyfalmen|V0200|5556|1|50|0|25,0000|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||4562||4562|7289||3 015904|QP54AB5204|Advocate stórir hundar|bl.lausn|125|mg|2,5|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|5058|8823|vetorma|||0|7,5|0||Icepharma hf|Bayer Animal Health GmbH|||5058||5058|8823||2 015910|D01AC0804|Ketoconazol ratiopharm|hársápa|20|mg/ml|100|ml|1|fl||D01AC08|01.04.2012||L|0|0|0|0|0|0|RPO|0|0|1|100|IKR|||lyflausa|||0|100|0||LYFIS ehf|ratiopharm Oy|Ketókónazól|||||||2 015912|D11AH0101|Protopic|smyrsli|0,03|%|10|g|1|túpa||D11AH01|01.03.2009||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|2019|3810|lyfalmen|||1|10|0||Vistor hf|Astellas Pharma A/S|Takrólímus||||2019|3810||1 015923|D11AH0101|Protopic|smyrsli|0,1|%|10|g|1|túpa||D11AH01|01.10.2007||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|2267|4149|lyfalmen|||1|10|0||Vistor hf|Astellas Pharma A/S|Takrólímus||2267||2267|4149||1 015929|N02AA0110|Morphine Sulphate BP|stl|10|mg/ml|1|ml|10|lykjur||N02AA01|01.07.2003||R|0|0|1|0|0|0|MAP|0|0|0|100|GBP|1535|3148|lyfalmen|||2|10|0|3,3300|Icepharma hf|Martindale Pharmaceuticals|Morfín||1535||1535|3148||2 015944|QP54AB5201|Advocate litlir hundar|bl.lausn|125|mg|0,4|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|4024|7020|vetorma|||0|1,2|0||Icepharma hf|Bayer Animal Health GmbH|||4024||4024|7020||2 015956|D01AC0804|Ketoconazol ratiopharm|hársápa|20|mg/ml|60|ml|1|fl||D01AC08|01.04.2012||L|0|0|0|0|0|0|RPO|0|0|1|100|IKR|||lyflausa|||0|60|0||LYFIS ehf|ratiopharm Oy|Ketókónazól|||||||2 015964|N06AB0501|Seroxat|töflur|10|mg|28|stk|1|ţpakki||N06AB05|01.12.2006||R|1|0|0|0|0|0|GSK|0|0|0|100|GBP|1959|3728|lyfalmen|||1|28|0|14,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||1959||1959|3728||1 016017|C10AA0701|Crestor|filmhtfl|10|mg|100|stk|1|ţpakki||C10AA07|01.03.2004||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|15302|21927|lyfalmen|V0117|10959|1|100|0|100,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||15302||15302|21927||1 016021|N02AB0203|Pethidine BP|stl|50|mg/ml|1|ml|10|lykjur||N02AB02|01.07.2003||R|0|0|1|0|0|0|MAP|0|0|0|100|GBP|1140|2607|lyfalmen|||2|10|0|1,2500|Icepharma hf|Martindale Pharmaceuticals|Petidín||1140||1140|2607||2 016028|C10AA0701|Crestor|filmhtfl|20|mg|100|stk|1|ţpakki||C10AA07|01.03.2004||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|22913|31479|lyfalmen|V0118|16093|1|100|0|200,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||22913||22913|31479||1 016032|N02AB0203|Pethidine BP|stl|50|mg/ml|2|ml|10|lykjur||N02AB02|01.01.2004||R|0|0|1|0|0|0|MAP|0|0|0|100|GBP|1209|2702|lyfalmen|||2|20|0|2,5000|Icepharma hf|Martindale Pharmaceuticals|Petidín||1209||1209|2702||2 016038|N02CC0501|Almogran|filmhtfl|12,5|mg|3|stk|1|ţpakki||N02CC05|01.05.2001||R|1|0|0|0|G|0|ALM|0|0|0|100|SEK|2617|4628|lyfalmen|V0236|3949|1|3|0|3,0000|Vistor hf|Almirall S.A.|Almótriptan||2617||2617|4628||1 016285|N03AX1601|Lyrica|hylki|150|mg|14|stk|1|ţpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|2748|4807|lyfalmen|||1|14|0|7,0000|Icepharma hf|Pfizer ApS|Pregabalín||2748||2748|4807||1 016294|N03AX1601|Lyrica|hylki|75|mg|56|stk|1|ţpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|7162|10845|lyfalmen|||1|56|0|14,0000|Icepharma hf|Pfizer ApS|Pregabalín||7162||7162|10845||1 016296|G03GA0801|Ovitrelle|stl|250|mcg/spr|0,5|ml|1|spr|lausn|G03GA08|01.03.2004||R|0|0|0|1|G|0|MSE|0|0|0|100|SEK|5228|8200|lyfalmen|||1|0,5|0|1,0000|Icepharma hf|Merck Serono Europe Ltd|Chóríógónadótrópín alfa||||5228|8200||2 016315|N03AX1601|Lyrica|hylki|150|mg|56|stk|1|ţpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|10858|15901|lyfalmen|||1|56|0|28,0000|Icepharma hf|Pfizer ApS|Pregabalín||10858||10858|15901||1 016318|N03AX1601|Lyrica|hylki|75|mg|14|stk|1|ţpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|1814|3529|lyfalmen|||1|14|0|3,5000|Icepharma hf|Pfizer ApS|Pregabalín||1814||1814|3529||1 016323|N03AX1601|Lyrica|hylki|300|mg|56|stk|1|ţpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|15781|22529|lyfalmen|||1|56|0|56,0000|Icepharma hf|Pfizer ApS|Pregabalín||15781||15781|22529||1 016337|C08CA0302|Lomir Retard|forđahlk|5|mg|100|stk|1|ţpakki||C08CA03|01.04.1992||R|1|0|0|0|G|0|NOH|0|0|0|100|DKK|8890|13209|lyfalmen|||1|100|0|100,0000|Vistor hf|Novartis Healthcare A/S-|Ísradipín||8890||8890|13209||1 016382|J02AC0301|Vfend|mixtúra|40|mg/ml|70|ml|1|fl||J02AC03|01.03.2005||R|0|0|0|0|0|1|IPI|0|0|0|100|DKK|96734|123284|lyfsjukr|||1|70|0|7,0000|Icepharma hf|Pfizer Limited|Voricónazól||96734||96734|123284||1 016385|L01BC0108|Cytarabine Pfizer|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.10.1995||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|4283|6181|lyfsjukr|||1|10|0||Icepharma hf|Pfizer ApS|Cýtarabín||4283||4283|6181||1 016395|N03AX1601|Lyrica|hylki|25|mg|56|stk|1|ţpakki||N03AX16|01.01.2007||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|2825|4912|lyfalmen|||1|56|0|4,6667|Icepharma hf|Pfizer ApS|Pregabalín||2825||2825|4912||1 016502|N07BA0111|Nicorette Classic|tyggigúm|2|mg|30|stk|1|ţpakki||N07BA01|01.03.2004||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016524|N07BA0111|Nicorette Classic|tyggigúm|2|mg|210|stk|1|ţpakki||N07BA01|01.03.2004||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016528|N07BA0111|Nicorette Classic|tyggigúm|4|mg|210|stk|1|ţpakki||N07BA01|01.03.2004||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016572|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|210|stk|1|ţpakki||N07BA01|01.09.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016589|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|30|stk|1|ţpakki||N07BA01|01.01.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016590|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|30|stk|1|ţpakki||N07BA01|01.01.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016596|N05AX1201|Abilify|töflur|5|mg|28|stk|1|ţpakki||N05AX12|01.02.2006||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|17669|24898|lyfalmen|||1|28|0|9,3330|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||17669||17669|24898||1 016611|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|210|stk|1|ţpakki||N07BA01|01.09.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016622|A06AG1101|Microlax|innhl|||5|ml|50|túpa||A06AG11|01.09.2005||L|0|0|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||0|250|0|50,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, ţ.m.t. í blöndum|||||7899||1 016635|N05AX1201|Abilify|töflur|5|mg|56|stk|1|ţpakki||N05AX12|01.02.2006||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|34516|46041|lyfalmen|||1|56|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||34516||34516|46041||1 016637|J01CR0201|Amoksiklav|töflur|1000|mg|12|stk|1|pakki|875+125 mg|J01CR02|01.08.2003||R|0|0|0|0|0|0|LPM|0|0|1|100|IKR|1026|1974|lyfalmen|V0169|1857|2|12|0|10,5000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||677||677|1974||1 016640|B03XA0103|NeoRecormon|stl|30000|ae/spr|0,6|ml|4|spr||B03XA01|01.05.2007||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|186085|235419|lyfsjukr|||1|2,4|0|120,0000|Icepharma hf|Roche|Epóetín||186085||186085|235419||2 016727|N06BA0403|Ritalin Uno|hylki|30|mg|30|stk|1|glas||N06BA04|01.02.2004||R|1|0|1|0|0|0|NOH|0|0|0|100|DKK|7599|11443|lyfalmen|||1|30|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||7599||7599|11443||1 016736|N03AF0107|Tegretol Retard (Lyfjaver)|forđatfl|200|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|1|0|0|0|G|0|LVR|0|0|0|100|DKK|3084|5267|lyfalmen|V0240|5267|3|200|0|40,0000|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||3084||3084|5267||3 016772|N03AF0107|Tegretol Retard (Lyfjaver)|forđatfl|400|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|1|0|0|0|G|0|LVR|0|0|0|100|DKK|5692|8834|lyfalmen|V0433|8834|3|200|0|80,0000|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||5692||5692|8834||3 016791|H05BX0101|Mimpara|filmhtfl|60|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|0|AEU|0|0|0|100|DKK|61573|79997|lyfalmen|||1|28|0|28,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||61573||61573|79997||1 016802|H05BX0101|Mimpara|filmhtfl|90|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|0|AEU|0|0|0|100|DKK|90728|116587|lyfalmen|||1|28|0|42,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||90728||90728|116587||1 016868|H05BX0101|Mimpara|filmhtfl|30|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|0|AEU|0|0|0|100|DKK|29320|39520|lyfalmen|||1|28|0|14,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||29320||29320|39520||1 016930|A16AB0401|Fabrazyme|irţ|5|mg/ml|5|mg|1|hgl|lausn|A16AB04|01.05.2012||R|0|1|0|1|0|1|GZE|0|1|0|100|XEU|79321|101430|lyfsjukr|||1|5|0|1,0000|Vistor hf|Genzyme Europe B.V.|Agalsidase beta||79321||79321|101430||1 016946|A02BC0301|Lanzo|munndr.t|15|mg|56|stk|1|ţpakki||A02BC03|01.11.2009||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|3578|5942|lyfalmen|||1|56|0|28,0000|Icepharma hf|Pfizer ApS|Lansóprazól||||3578|5942||1 016973|J05AF0901|Emtriva|hylki|200|mg|30|stk|1|glas||J05AF09|01.04.2004||R|1|0|0|1|0|1|GIS|0|0|0|100|XEU|40084|52188|lyfsjukr|||1|30|0|30,0000|Gilead Sience Sweden AB|Gilead Science International ltd.|Emtrícítabín||40084||40084|52188||3 016979|N02AE0103|Norspan|forđapl|5|mcg/klst|4|stk|1|ţpakki||N02AE01|01.01.2006||R|0|0|1|0|G|0|NOP|0|0|0|100|DKK|3170|5384|lyfalmen|||1|4|0|16,6700|Icepharma hf|Norpharma |Búprenorfín||3170||3170|5384||2 016981|QA02BX1202|Orbesealer vet.|spenalyf|2,6|g/dćlu|60|dćlur|1|pakki||QA02BX12|01.12.2006||R|0|0|0|0|0|0|PAL|0|0|0|100|DKK|18937|36534|vetalmen|||0|60|0||Icepharma hf|Pfizer Oy Animal Health|||18937||18937|36534||2 017006|B05BA1019|StructoKabiven Perifer|irl|830|kcal|1206|ml|4|pokar|fleyti|B05BA10|01.06.2005||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|25711|34150|lyfsjukr|||1|4824|0||Icepharma hf|Fresenius Kabi|Blöndur||25711||25711|34150||2 017020|G03DA0201|Depo-Provera|stl|50|mg/ml|3|ml|1|hgl||G03DA02|01.12.1972||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|1542|3157|lyfalmen|||1|3|0|21,4286|Icepharma hf|Pfizer ApS|Medroxýprógesterón||1542||1542|3157||1 017111|A09AA0201|Combizym|töflur|||100|stk|1|ţpakki||A09AA02|01.07.1988||R|1|0|0|0|G|0|DSG|0|0|0|100|XEU|1448|3029|lyfalmen|||1|100|0|25,0000|Icepharma hf|Daiichi Sankyo Europe GmbH|Hvatablöndur (lípasi, próteasi o.s.frv.)||1448||1448|3029||2 017130|L01BC0109|DepoCyte|stl|50|mg/hgl|5|ml|1|hgl||L01BC01|01.07.2005||R|0|0|0|1|0|1|SKY|0|1|0|100|DKK|266218|335986|lyfsjukr|||1|5|0||Icepharma hf|SkyPharma PLC|Cýtarabín||266218||266218|335986||2 017145|C08DB0102|Cardizem Retard|forđatfl|180|mg|60|stk|1|glas||C08DB01|01.04.1990||R|1|0|0|0|G|0|FRO|0|0|0|100|DKK|7702|11584|lyfalmen|||1|60|0|45,0000|Vistor hf|Ferrosan A/S|Diltíazem||7702||7702|11584|30.6.2013|1 017182|N05CF0106|Zopiclone Actavis|filmhtfl|5|mg|500|stk|1|plglas||N05CF01|01.10.2012||R|2|0|0|0|0|0|AGT|0|0|0|100|XEU|6093|9383|lyfalmen|||2|500|0|333,0000|Actavis Group hf|Actavis Group hf|Zópíklón||6093||6093|9383||1 017193|N05CF0106|Zopiclone Actavis|filmhtfl|7,5|mg|500|stk|1|glas||N05CF01|01.05.2013||R|2|0|0|0|0|0|AGT|0|0|0|100|SEK|6396|9797|lyfalmen|V0316|8202|2|500|0|500,0000|Actavis Group hf|Actavis Group hf|Zópíklón||6396||6396|9797||1 017195|L01XX3201|Velcade|sts|3,5|mg/hgl|1|hgl|1|pakki|lausn|L01XX32|01.09.2004||R|0|1|0|1|0|1|JCI|0|1|0|100|SEK|185219|234332|lyfsjukr|||1|1|0||Vistor hf|Janssen-Cilag International N.V.|Bortezomíb||185219||185219|234332||1 017203|M05BA0601|Bondronat|irţ|1|mg/ml|6|ml|1|hgl||M05BA06|01.09.2004||R|0|0|0|1|0|1|ROC|0|1|0|100|DKK|40632|52876|lyfsjukr|||1|6|0|1,0000|Icepharma hf|Roche|Íbandrónsýra||40632||40632|52876||2 017210|C03DA0102|Spirix|töflur|25|mg|100|stk|1|glas||C03DA01|01.02.2003||R|1|0|0|0|G|0|NYC|0|0|0|100|DKK|1061|2499|lyfalmen|V0046|2326|2|100|0|33,3333|Vistor hf|Nycomed Danmark A/S|Spírónólaktón||1061||1061|2499||1 017234|L03AB0701|Avonex|stl|30|mcg/spr|0,5|ml|4|spr|lausn, áfylltar sprautur|L03AB07|01.12.2003||R|0|0|0|1|0|1|BIB|0|1|0|100|XEU|129223|164057|lyfsjukr|||1|2|0|27,9100|Icepharma hf|Biogen Idec Ltd|Interferón beta-1a||129223||129223|164057||2 017238|M05BA0601|Bondronat|filmhtfl|50|mg|28|stk|1|ţpakki||M05BA06|01.08.2004||R|1|0|0|1|0|0|ROC|0|0|0|100|DKK|48290|63327|lyfalmen|||1|28|0|280,0000|Icepharma hf|Roche|Íbandrónsýra||48290||48290|63327||2 017247|M05BA0601|Bondronat|filmhtfl|50|mg|84|stk|1|ţpakki||M05BA06|01.08.2004||R|1|0|0|1|0|0|ROC|0|0|0|100|DKK|149960|190923|lyfalmen|||1|84|0|840,0000|Icepharma hf|Roche|Íbandrónsýra||149960||149960|190923||2 017266|N02AE0103|Norspan|forđapl|10|mcg/klst|4|stk|1|ţpakki||N02AE01|01.01.2006||R|0|0|1|0|G|0|NOP|0|0|0|100|DKK|5503|8576|lyfalmen|||1|4|0|33,3300|Icepharma hf|Norpharma |Búprenorfín||5503||5503|8576||2 017326|N02AE0103|Norspan|forđapl|20|mcg/klst|4|stk|1|ţpakki||N02AE01|01.01.2006||R|0|0|1|0|G|0|NOP|0|0|0|100|DKK|10478|15381|lyfalmen|||1|4|0|66,6600|Icepharma hf|Norpharma |Búprenorfín||10478||10478|15381||2 017327|C03DA0102|Spirix|töflur|50|mg|100|stk|1|glas||C03DA01|01.02.2003||R|1|0|0|0|G|0|NYC|0|0|0|100|DKK|2720|4769|lyfalmen|||2|100|0|66,6667|Vistor hf|Nycomed Danmark A/S|Spírónólaktón||2720||2720|4769||1 017331|A04AD1201|Emend|hylki|||3|stk|1|ţpakki|samsett pakkning|A04AD12|01.04.2004||R|1|0|0|0|0|1|MSD|0|0|0|100|DKK|9105|13141|lyfsjukr|||1|3|0|3,0000|Vistor hf|M.S.D.|Aprepitant||9105||9105|13141||1 017365|J01CR0201|Amoksiklav|töflur|375|mg|20|stk|1|glas|250+125 mg|J01CR02|01.12.2003||R|0|0|0|0|0|0|LPM|0|0|1|100|XEU|896|2274|lyfalmen|||2|20|0|5,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||896||896|2274||1 017384|H02AB0701|Deltison|töflur|50|mg|30|stk|1|glas||H02AB07|01.08.2005||R|1|0|0|0|G|0|REP|0|0|1|100|SEK|3099|5287|lyfalmen|||1|30|0|150,0000|Vistor hf|Recip AB|Prednisón||3099||3099|5287||1 017556|J01CR0201|Amoksiklav|töflur|625|mg|20|stk|1|glas|500+125 mg|J01CR02|01.12.2003||R|0|0|0|0|0|0|LPM|0|0|1|100|IKR|1459|2710|lyfalmen|||2|20|0|10,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1215||1215|2710|30.6.2013|1 017564|QM01AC0601|Metacam|mixtúra|15|mg/ml|100|ml|1|fl||QM01AC06|01.09.2004||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|6758|13149|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|||6758||6758|13149||1 017792|C03DA0401|Inspra|filmhtfl|50|mg|30|stk|1|ţpakki||C03DA04|01.08.2005||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|10520|15439|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Eplerenón||10520||10520|15439||1 017809|N06DA0401|Reminyl|forđahlk|24|mg|84|stk|1|ţpakki||N06DA04|01.08.2005||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|44918|59095|lyfalmen|||1|84|0|126,0000|Vistor hf|Janssen-Cilag AB|Galantamín||44918||44918|59095||1 017963|C03DA0401|Inspra|filmhtfl|25|mg|30|stk|1|ţpakki||C03DA04|01.08.2005||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|9607|14190|lyfalmen|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Eplerenón||9607||9607|14190||1 018514|J07BA0101|FSME-Immun Junior|stl|1,2|mcg/sk|0,25|ml|1|spr|bóluefni|J07BA01|01.06.2004||R|0|0|0|0|0|0|BAA|0|0|0|100|SEK|3999|6518|lyfalmen|||1|0,25|0||Icepharma hf|Baxter AG|Heilabólguveira óvirk, borin međ blóđmaur||3999||3999|6518||2 018527|J07BA0102|FSME-Immun Vuxen|stl|2,4|mcg/sk|0,5|ml|1|spr|bóluefni|J07BA01|01.06.2004||R|0|0|0|0|0|0|BAA|0|0|0|100|SEK|4367|7022|lyfalmen|||1|0,5|0||Icepharma hf|Baxter AG|Heilabólguveira óvirk, borin međ blóđmaur||4367||4367|7022||2 018535|N03AX0901|Lamictal|dreifit.|25|mg|42|stk|1|ţpakki||N03AX09|01.11.2004||R|1|0|0|0|G|0|GSK|0|0|0|100|IKR|1030|1674|lyfalmen|V0243|1499|1|42|0|3,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||458||458|1674||1 018594|G04BD0801|Vesicare|filmhtfl|10|mg|30|stk|1|ţpakki||G04BD08|01.11.2004||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|8346|12465|lyfalmen|||1|30|0|60,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||8346||8346|12465||1 018663|J01DD0401|Rocephalin|sts|1|g|1|stk|5|hgl|+ leysir, lausn|J01DD04|01.10.1985||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|13802|19204|lyfsjukr|||1|5|0|2,5000|Icepharma hf|Roche|Ceftríaxón||13802||13802|19204||2 018677|G04BD0801|Vesicare|filmhtfl|10|mg|90|stk|1|ţpakki||G04BD08|01.11.2004||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|20462|28403|lyfalmen|V0441|22950|1|90|0|180,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||20462||20462|28403||1 018681|C09CA0301|Diovan|filmhtfl|40|mg|28|stk|1|ţpakki||C09CA03|01.07.2005||R|1|0|0|0|0|0|NOH|0|0|0|100|DKK|2848|4944|lyfalmen|||1|28|0|14,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||2848||2848|4944|30.6.2013|1 018682|H02AB0604|Decortin H|töflur|5|mg|100|stk|1|ţpakki||H02AB06|11.06.2004||R|1|0|0|0|G|0|MKA|0|0|1|100|SEK|1001|2417|lyfalmen|V0414|2040|1|100|0|50,0000|Icepharma hf|Merck KgaA|Prednisólón||1001||1001|2417||2 018685|G04BD0801|Vesicare|filmhtfl|5|mg|30|stk|1|ţpakki||G04BD08|01.11.2004||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|5910|9133|lyfalmen|V0438|7416|1|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||5910||5910|9133||1 018694|G04BD0801|Vesicare|filmhtfl|5|mg|90|stk|1|ţpakki||G04BD08|01.11.2004||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|16660|23632|lyfalmen|V0440|19181|1|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||16660||16660|23632||1 018714|C03DA0401|Inspra|filmhtfl|50|mg|100|stk|1|ţpakki||C03DA04|01.08.2005||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|34724|46302|lyfalmen|||1|100|0|100,0000|Icepharma hf|Pfizer ApS|Eplerenón||34724||34724|46302||1 018779|L03AX1301|Copaxone|stl|20|mg/spr|28|spr|1|pakki|+ leysir|L03AX13|01.08.2004||R|0|0|0|1|0|1|TEP|0|1|0|100|NOK|123892|157367|lyfsjukr|||1|28|0|28,0000|Vistor hf|Teva Pharmaceuticals Limited UK|Glatíramer acetat||123892||123892|157367||1 018975|J05AE0701|Telzir|filmhtfl|700|mg|60|stk|1|glas||J05AE07|01.12.2004||R|1|0|0|1|0|1|VII|0|0|0|100|GBP|58776|75646|lyfsjukr|||1|60|0|30,0000|GlaxoSmithKline ehf|Viiv Healthcare UK Ltd|Fosamprenavír||58776||58776|75646||1 018978|C03CA0101|Furix|töflur|20|mg|100|stk|1|glas||C03CA01|01.03.2003||R|1|0|0|0|G|0|NYC|0|0|0|100|DKK|426|1631|lyfalmen|||2|100|0|50,0000|Vistor hf|Nycomed Danmark A/S|Fúrósemíđ||426||426|1631||1 018980|QN01BB5202|Lidokel Adrenalin vet. Kela|stl|20|mg/ml|100|ml|1|hgl|20mg/ml+36mcg/ml|QN01BB52|01.02.2004||R|0|0|0|0|0|0|KEL|1|0|0|100|NOK|1324|2634|vetalmen|||0|100|0||Icepharma hf|Kela Laboratoria NV|||1324||1324|2634||2 018995|N02AB0301|Durogesic|forđapl|75|mcg/klst|5|stk|1|ţpakki||N02AB03|01.01.1996||R|0|0|1|0|G|0|JAS|0|0|0|100|SEK|10570|15507|lyfalmen|V0221|7714|1|5|0|22,5000|Vistor hf|Janssen-Cilag AB|Fentanýl||10570||10570|15507||1 019066|V08AB0201|Omnipaque|stl|140|mg J/ml|50|ml|10|plastf||V08AB02|01.04.2011||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|21561|28942|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jóhexól||21561||21561|28942||2 019094|N02AB0301|Durogesic|forđapl|50|mcg/klst|5|stk|1|ţpakki||N02AB03|01.01.1996||R|0|0|1|0|G|0|JAS|0|0|0|100|SEK|7555|11383|lyfalmen|V0220|5978|1|5|0|15,0000|Vistor hf|Janssen-Cilag AB|Fentanýl||7555||7555|11383||1 019099|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|24334|32422|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jóhexól||24334||24334|32422||2 019108|N02AB0301|Durogesic|forđapl|25|mcg/klst|5|stk|1|ţpakki||N02AB03|01.01.1996||R|0|0|1|0|G|0|JAS|0|0|0|100|SEK|4189|6778|lyfalmen|V0219|3505|1|5|0|7,5000|Vistor hf|Janssen-Cilag AB|Fentanýl||4189||4189|6778||1 019112|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|33783|44280|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jóhexól||33783||33783|44280||2 019121|V08AB0901|Visipaque|stl|270|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|34640|45356|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jódixanól||34640||34640|45356||2 019132|V08AB0901|Visipaque|stl|320|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|42325|55000|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jódixanól||42325||42325|55000||2 019167|N02AB0301|Durogesic|forđapl|100|mcg/klst|5|stk|1|ţpakki||N02AB03|01.01.1996||R|0|0|1|0|G|0|JAS|0|0|0|100|SEK|8266|12355|lyfalmen|V0223|8387|1|5|0|30,0000|Vistor hf|Janssen-Cilag AB|Fentanýl||8266||8266|12355||1 019175|C09CA0601|Atacand|töflur|32|mg|98|stk|1|ţpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|14568|21006|lyfalmen|||1|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||14568||14568|21006||1 019194|C09CA0601|Atacand|töflur|32|mg|28|stk|1|ţpakki||C09CA06|01.02.2010|31.05.2013|R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|5056|7964|lyfalmen|||1|28|0|112,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||5056||5056|7964||1 019293|B02BC3001|TachoSil|svampur|5,5|mg|1|stk|1|pakki|+ 2,0 IU - 9,5x4,8 cm|B02BC30|01.05.2005||R|0|0|0|1|0|1|NYC|0|0|0|100|DKK|52353|67586|lyfsjukr|||2|1|0||Vistor hf|Nycomed Danmark A/S|Fíbrínógen og Mannatromnín manna||52353||52353|67586||1 019295|B01AE0601|Angiox|sts/irs|250|mg|10|hgl|1|pakki|ţykkni, lausn|B01AE06|01.05.2005||R|0|0|0|1|0|1|THE|0|0|0|100|XEU|749467|942464|lyfsjukr|||1|10|0|10,0000|The Medicines Company UK Ltd.|The Medicines Company UK Ltd.|Bívalirúdín||749467||749467|942464||1 019308|QG03XB9001|Alizin, vet|stl|30|mg/ml|10|ml|1|hgl|fyrir hunda (tíkur)|QG03XB90|01.05.2012||R|0|0|0|0|0|0|VIR|1|0|0|100|IKR|4877|9537|vetalmen|||0|10|0||Vistor hf|Virbac S.A|Aglepristonum||4877||4877|9537||1 019339|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 019403|QJ51CE0901|Carepen vet.|spenalyf|600|mg|10|g|100|dćlur||QJ51CE09|01.04.2010||R|0|0|0|0|0|0|VET|0|0|0|100|DKK|21314|41099|vetalmen|||0|1000|0||Dýraheilsa ehf|Vetcare Ltd.|Benzylpenicillínprokaín||||21314|41099||2 019421|N06AX2102|Yentreve|hylki|20|mg|56|stk|1|ţpakki|sýruţ.hylki, hörđ|N06AX21|01.10.2004||R|1|0|0|0|0|0|ELD|0|0|0|100|XEU|6893|10477|lyfalmen|||1|56|0|18,6700|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||6893||6893|10477||2 019445|L01XC0701|Avastin|irţ|25|mg/ml|4|ml|1|hgl|lausn|L01XC07|01.05.2005||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|52765|68103|lyfsjukr|||1|4|0||Icepharma hf|Roche Registration Limited|Bevacizúmab||52765||52765|68103||2 019469|N06AX2102|Yentreve|hylki|40|mg|56|stk|1|ţpakki|sýruţ.hylki, hörđ|N06AX21|01.10.2004||R|1|0|0|0|0|0|ELD|0|0|0|100|XEU|6893|10477|lyfalmen|||1|56|0|37,3300|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||6893||6893|10477||2 019513|C03CA0101|Furix|töflur|40|mg|100|stk|1|glas||C03CA01|01.03.2003||R|1|0|0|0|G|0|NYC|0|0|0|100|DKK|486|1713|lyfalmen|||2|100|0|100,0000|Vistor hf|Nycomed Danmark A/S|Fúrósemíđ||486||486|1713||1 019659|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 019670|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 019672|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 019711|L01BC0501|Gemzar|irs|200|mg|1|hgl|1|pakki||L01BC05|01.03.1999||R|0|0|0|1|0|1|ELI|0|0|0|100|XEU|3774|5447|lyfsjukr|||1|1|0||Icepharma hf|Eli Lilly Danmark A/S|Gemcitabín||3774||3774|5447||2 019713|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.01.2005||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 019745|C03CA0101|Furix|töflur|40|mg|250|stk|1|glas|til vélskömmtunar|C03CA01|01.04.2005||R|1|0|0|0|G|0|NYC|0|0|0|100|DKK|620|1896|lyfalmen|||2|250|0|250,0000|Vistor hf|Nycomed Danmark A/S|Fúrósemíđ||620||620|1896|31.5.2013|1 019760|L01BC0501|Gemzar|irs|1|g|1|hgl|1|pakki||L01BC05|01.03.1999||R|0|0|0|1|0|1|ELI|0|0|0|100|XEU|16581|22692|lyfsjukr|||1|1|0||Icepharma hf|Eli Lilly Danmark A/S|Gemcitabín||16581||16581|22692||2 019781|L01XC0701|Avastin|irţ|25|mg/ml|16|ml|1|hgl|lausn|L01XC07|01.05.2005||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|195942|247790|lyfsjukr|||1|16|0||Icepharma hf|Roche Registration Limited|Bevacizúmab||195942||195942|247790||2 019782|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 019786|J01CA0411|Amoxicillin Mylan|hylki|500|mg|20|stk|1|glas||J01CA04|01.04.1993||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|1151|2250|lyfalmen|V0159|2215|2|20|0|10,0000|Icepharma hf|Mylan AB|Amoxicillín||879||879|2250||2 019793|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|96|stk|1|pakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 019797|L01BA0401|Alimta|irţ|500|mg/hgl|1|hgl|1|pakki||L01BA04|01.03.2005||R|0|0|0|1|0|1|ELD|0|1|0|100|XEU|199877|252728|lyfsjukr|||1|1|0||Icepharma hf|Eli Lilly Nederland B.V.|Pemetrexed||199877||199877|252728||2 019811|N06BA0901|Strattera|hylki|10|mg|28|stk|1|ţpakki|hart|N06BA09|01.08.2006||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|12997|19035|lyfalmen|||1|28|0|3,5000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12997||12997|19035||2 019833|N06BA0901|Strattera|hylki|18|mg|28|stk|1|ţpakki|hart|N06BA09|01.08.2006||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|12997|19035|lyfalmen|||1|28|0|6,3000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12997||12997|19035||2 019837|G03GA0601|Puregon|stl|900|ae/rörly|1,08|ml|1|lykja||G03GA06|01.10.2005||R|0|0|0|1|G|0|ORG|0|0|0|100|DKK|56073|73095|lyfalmen|||1|1,08|0|12,0000|Vistor hf|N.V. Organon|Follitrópín beta||56073||56073|73095||1 019857|N06BA0901|Strattera|hylki|25|mg|28|stk|1|ţpakki|hart|N06BA09|01.08.2006||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|12997|19035|lyfalmen|||1|28|0|8,7500|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12997||12997|19035||2 019882|N06BA0901|Strattera|hylki|40|mg|28|stk|1|ţpakki|hart|N06BA09|01.08.2006||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|12997|19035|lyfalmen|||1|28|0|14,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12997||12997|19035||2 019904|N06BA0901|Strattera|hylki|60|mg|28|stk|1|ţpakki|hart|N06BA09|01.08.2006||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|12997|19035|lyfalmen|||1|28|0|21,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12997||12997|19035||2 019916|V03AF0801|Kepivance|sts|6,25|mg/hgl|6|hgl|1|pakki|lausn|V03AF08|01.07.2006||R|0|0|0|1|0|1|BIA|0|0|0|100|DKK|791547|995274|lyfsjukr|||1|6|0|8,9300|Vistor hf|Biovitrum AB (publ)|Palifermín||791547||791547|995274||1 019931|N04BC0403|Adartrel|filmhtfl|0,25|mg|12|stk|1|ţpakki||N04BC04|01.12.2006||R|1|0|0|0|G|0|GSK|0|0|0|100|GBP|388|1579|lyfalmen|||1|12|0|0,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||||388|1579||1 019938|J05AR0201|Kivexa|filmhtfl|900|mg|30|stk|1|ţpakki|600+300 mg|J05AR02|01.05.2004||R|1|0|0|1|0|1|GGL|0|0|0|100|GBP|66604|85471|lyfsjukr|||1|30|0|30,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Lamívúdín og abacavír||66604||66604|85471||1 019968|J01CA0411|Amoxicillin Mylan|hylki|500|mg|30|stk|1|glas||J01CA04|01.04.1995||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|1703|2815|lyfalmen|V0160|2766|2|30|0|15,0000|Icepharma hf|Mylan AB|Amoxicillín||1292||1292|2815||2 020016|B03AA0704|Duroferon|forđatfl|100|mg|100|stk|1|glas||B03AA07|01.03.1979||L|1|0|0|0|0|0|AHN|0|0|1|100|IKR|||lyflausa|||0|100|0|50,0000|Aco Hud Nordic AB|Aco Hud Nordic AB|Ferrósúlfat|||||||1 020048|M02AA1502|Voltaren|hlaup|11,6|mg/g|100|g|1|túpa||M02AA15|01.03.2009||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|100|0||Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||||1 020238|G04CA0203|Omnic Ocas|forđatfl|0,4|mg|30|stk|1|ţpakki||G04CA02|01.04.2006||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|2939|5068|lyfalmen|||1|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||2939||2939|5068||1 020244|J07CA0204|Boostrix Polio|stl|||0,5|ml|10|áf.spr|dreifa|J07CA02|01.09.2007||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|25969|35314|lyfalmen|||1|5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, kíghósti, mćnusótt, stífkrampi||25969||25969|35314||1 020276|A06AB0203|Dulcolax (Lyfjaver)|eţ-stíll|10|mg|50|stk|1|ţpakki||A06AB02|01.07.2005||R|0|0|0|0|0|0|LVR|0|0|0|100|NOK|2817|4901|lyfalmen|||3|50|0|50,0000|Lyfjaver ehf|Lyfjaver ehf|Bisakódýl||2817||2817|4901||3 020277|N06AX1602|Efexor Depot|forđahlk|37,5|mg|7|stk|1|ţpakki||N06AX16|01.02.2007||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|582|1844|lyfalmen|V0333|1669|1|7|0|2,6300|Icepharma hf|Pfizer ApS|Venlafaxín||582||582|1844||1 020292|M02AA1502|Voltaren|hlaup|11,6|mg/g|50|g|1|túpa||M02AA15|01.06.2010||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|50|0||Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||||1 020338|G04CA0203|Omnic Ocas|forđatfl|0,4|mg|90|stk|1|ţpakki||G04CA02|01.04.2006||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|6863|10436|lyfalmen|||1|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||6863||6863|10436||1 020355|L02AE0203|Eligard|sts|22,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|53564|69946|lyfalmen|||1|2|0|155,7500|Vistor hf|Astellas Pharma A/S|Leuprórelín||53564||53564|69946||1 020364|N04BC0403|Adartrel|filmhtfl|0,5|mg|84|stk|1|ţpakki||N04BC04|01.06.2006||R|1|0|0|0|G|0|GSK|0|0|0|100|GBP|4728|4347|lyfalmen|V0530|3784|1|84|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||2412||2412|4347||1 020417|N04BC0403|Adartrel|filmhtfl|2|mg|84|stk|1|ţpakki||N04BC04|01.12.2006||R|1|0|0|0|G|0|GSK|0|0|0|100|GBP|10733|5049|lyfalmen|V0531|4486|1|84|0|28,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||2925||2925|5049||1 020427|L02AE0203|Eligard|sts|7,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|24172|33059|lyfalmen|||1|2|0|51,9400|Vistor hf|Astellas Pharma A/S|Leuprórelín||24172||24172|33059||1 020444|D07AB0201|Locoid|krem|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|608|1880|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||608||608|1880||1 020456|M05BX0301|Protelos|mixt.kyr|2|g|28|sk-pokar|1|pakki|dreifa|M05BX03|01.08.2005||R|0|0|0|0|0|0|SEV|0|0|0|100|DKK|5733|8890|lyfalmen|||1|28|0|28,0000|Icepharma hf|Servier|Strontíum ranelat||5733||5733|8890||2 020457|D07AB0201|Locoid|krem|1|mg/g|100|g|1|túpa||D07AB02|01.03.1977||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|1853|3583|lyfalmen|||1|100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1853||1853|3583||1 020533|M05BX0301|Protelos|mixt.kyr|2|g|84|sk-pokar|1|pakki|dreifa|M05BX03|01.08.2005||R|0|0|0|0|0|0|SEV|0|0|0|100|DKK|16696|23677|lyfalmen|||1|84|0|84,0000|Icepharma hf|Servier|Strontíum ranelat||16696||16696|23677||2 020648|R06AX2201|Kestine|töflur|20|mg|10|stk|1|ţpakki||R06AX22|01.10.2005||L|1|0|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||0|10|0|20,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||||1 020711|G03AD0102|Postinor|töflur|1500|mcg|1|stk|1|ţpakki||G03AD01|01.01.2007||L|0|0|0|0|0|0|MEI|0|0|0|100|IKR|||lyflausa|||0|1|0|1,0000|Icepharma hf|Medimpex UK Limited|Levonorgestrel|||||||2 020770|QP54AA5101|Eqvalan Duo|pasta|||7,74|g|1|sk-dćl||QP54AA51|01.10.2006||R|0|0|0|0|0|0|MES|0|0|0|100|XEU|2240|3908|vetorma|||0|7,74|0||Vistor hf|Merial SAS|Ivermectinum í blöndum||2240||2240|3908||1 020774|L04AB0101|Enbrel|sts|50|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.10.2005||R|0|0|0|1|0|1|WTE|0|1|0|100|DKK|157228|199204|lyfsjukr|||1|4|0|28,5700|Icepharma hf|Wyeth Europe|Etanercept||157228||157228|199204||2 020861|QP52AF0202|Twinhip Vet.|pasta|439|mg/g|52|g|1|spr||QP52AF02|01.08.2011||R|0|0|0|0|0|0|VEB|0|0|0|100|XEU|2620|4570|vetorma|||0|52|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||2620||2620|4570||2 020924|J01FA1003|Zithromax (D.A.C.)|töflur|500|mg|3|stk|1|ţpakki||J01FA10|01.09.2007||R|1|0|0|0|0|0|DAC|0|0|1|100|DKK|2032|3416|lyfalmen|V0174|3063|3|3|0|5,0000|D.A.C. ehf|D.A.C. ehf|Azitrómýcín||1731||1731|3416||2 020992|C09AA0402|Coversyl Novum|filmhtfl|5|mg|30|stk|1|glas||C09AA04|01.08.2011||R|1|0|0|0|0|0|LLS|0|0|0|100|DKK|3030|5193|lyfalmen|||1|30|0|37,5000|Icepharma hf|Les Laboratoires Servier|Perindópríl||3030||3030|5193||2 021053|D10AD0301|Differin|hlaup|0,1|%|60|g|1|túpa||D10AD03|01.12.2007||R|0|0|0|0|0|0|GAN|0|0|0|100|SEK|2570|4564|lyfalmen|||1|60|0||Icepharma hf|Galderma Nordic AB|Adapalen||2570||2570|4564||2 021057|J01CR0203|Augmentine (D.A.C.)|töflur|625|mg|12|stk|1|ţpakki|500+125 mg|J01CR02|01.05.2005||R|0|0|0|0|0|0|DAC|0|0|1|100|IKR|827|2025|lyfalmen|||3|12|0|6,0000|D.A.C. ehf|D.A.C. ehf|Amoxicillín og ensímblokkar||714||714|2025||2 021149|J01CR0203|Augmentine (D.A.C.)|töflur|1000|mg|12|stk|1|ţpakki|875+125 mg|J01CR02|01.05.2005||R|0|0|0|0|0|0|DAC|0|0|1|100|IKR|1025|2413|lyfalmen|V0169|1857|3|12|0|10,5000|D.A.C. ehf|D.A.C. ehf|Amoxicillín og ensímblokkar||998||998|2413||2 021161|M01AB0513|Vostar-S|filmhtfl|50|mg|30|stk|1|ţpakki||M01AB05|01.03.2005||R|1|0|0|0|G|0|ACA|0|0|1|100|IKR|453|1560|lyfalmen|V0188|1560|2|30|0|15,0000|Actavis Group hf|Actavis hf|Díklófenak||374||374|1560||1 021169|S01XA1201|Corneregel|augnhl|50|mg/g|10|g|1|túpa||S01XA12|01.08.2005||R|0|0|0|0|G|0|GEM|0|0|0|100|XEU|1281|2800|lyfalmen|||1|10|0||Actavis Group hf|Gerhard Mann|Dexpantenól||1281||1281|2800||1 021227|M01AB0513|Vostar-S|filmhtfl|50|mg|100|stk|1|ţpakki||M01AB05|01.03.2005||R|1|0|0|0|G|0|ACA|0|0|1|100|IKR|1187|2391|lyfalmen|V0189|2391|2|100|0|50,0000|Actavis Group hf|Actavis hf|Díklófenak||982||982|2391||1 021341|R03AK0603|Seretide Diskus (Lyfjaver)|innönddu|550|mcg/sk|60|skammtar|1|pakki|50+500 mcg, discus|R03AK06|01.05.2012||R|0|0|0|0|G|0|LVR|0|0|0|100|GBP|8715|12970|lyfalmen|V0437|12970|3|60|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||8715||8715|12970||3 021345|R03DC0301|Singulair|filmhtfl|10|mg|98|stk|1|ţpakki||R03DC03|01.09.1998||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|17248|24370|lyfalmen|V0490|5579|1|98|0|98,0000|Vistor hf|M.S.D.|Montelúkast||17248||17248|24370||1 021365|R03AK0603|Seretide Diskus (Lyfjaver)|innönddu|300|mcg/sk|60|skammtar|1|pakki|50+250 mcg, discus|R03AK06|01.05.2012||R|0|0|0|0|G|0|LVR|0|0|0|100|GBP|6551|10009|lyfalmen|||3|60|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||6551||6551|10009|31.5.2013|3 021375|M01AB0512|Voltaren Dolo|töflur|12,5|mg|20|stk|1|ţpakki||M01AB05|01.10.2004||L|1|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|20|0|2,5000|Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||||1 021417|R01AD0504|Rhinocort (D.A.C.)|nefúđi|64|mcg/sk|120|skammtar|1|fl||R01AD05|01.11.2004||R|0|0|0|0|G|0|DAC|0|0|1|100|SEK|1691|3361|lyfalmen|V0443|3361|3|120|0|38,4000|D.A.C. ehf|D.A.C. ehf|Búdesóníđ||1691||1691|3361||2 021428|A06AB0201|Dulcolax|eţ-stíll|10|mg|6|stk|1|pakki||A06AB02|01.01.1995||L|0|0|0|0|0|0|BOI|0|0|0|100|IKR|||lyflausa|||0|6|0|6,0000|Vistor hf|Boehringer Ingelheim|Bisakódýl|||||||1 021469|R03DC0301|Singulair|tuggutfl|5|mg|98|stk|1|ţpakki||R03DC03|01.09.1998||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|17522|24713|lyfalmen|V0491|11100|1|98|0|49,0000|Vistor hf|M.S.D.|Montelúkast||17522||17522|24713||1 021494|N01AX1003|Propolipid|stl|10|mg/ml|20|ml|5|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|1591|2296|lyfsjukr|||2|100|0||Icepharma hf|Fresenius Kabi|Própófól||1591||1591|2296||2 021593|H01BA0201|Minirin|frţ.tfl|60|mcg|30|stk|1|ţpakki||H01BA02|01.10.2005||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|4421|7096|lyfalmen|||1|30|0|4,5000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||4421||4421|7096||1 021604|H01BA0201|Minirin|frţ.tfl|60|mcg|100|stk|1|ţpakki||H01BA02|01.10.2005||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|13533|19707|lyfalmen|||1|100|0|15,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||13533||13533|19707||1 021613|C10AA0701|Crestor|filmhtfl|5|mg|98|stk|1|ţpakki||C10AA07|01.01.2006||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|14960|21498|lyfalmen|||1|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||14960||14960|21498||1 021614|H01BA0201|Minirin|frţ.tfl|120|mcg|30|stk|1|ţpakki||H01BA02|01.10.2005||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|7152|10832|lyfalmen|||1|30|0|9,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||7152||7152|10832||1 021625|A07EC0203|Pentasa Sachets|forđakyr|2|g|60|pokar|1|pakki||A07EC02|01.05.2011||R|0|0|0|0|G|0|FER|0|0|0|100|DKK|15196|21794|lyfalmen|||1|60|0|80,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||15196||15196|21794||1 021636|N01AX1003|Propolipid|stl|10|mg/ml|100|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|15909|21848|lyfsjukr|||2|1000|0||Icepharma hf|Fresenius Kabi|Própófól||15909||15909|21848||2 021641|H01BA0201|Minirin|frţ.tfl|120|mcg|100|stk|1|ţpakki||H01BA02|01.10.2005||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|22781|31314|lyfalmen|||1|100|0|30,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||22781||22781|31314||1 021647|N01AX1003|Propolipid|stl|20|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|15909|21848|lyfsjukr|||2|500|0||Icepharma hf|Fresenius Kabi|Própófól||15909||15909|21848||2 021659|V01AA0304|Alutard SQ, derm. pter.|stl|||5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|24487|33455|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|rykmaurar||24487||24487|33455||1 021674|C10AA0701|Crestor|filmhtfl|5|mg|28|stk|1|ţpakki||C10AA07|01.01.2006||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|4663|7427|lyfalmen|||1|28|0|14,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||4663||4663|7427||1 021676|N01AX1003|Propolipid|stl|10|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|9148|13203|lyfsjukr|||2|500|0||Icepharma hf|Fresenius Kabi|Própófól||9148||9148|13203||2 021677|B02AA0202|Tranexamsyre "Pfizer"|stl|100|mg/ml|5|ml|10|lykjur||B02AA02|01.11.2005||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|4617|6663|lyfsjukr|||1|50|0|2,5000|Icepharma hf|Pfizer ApS|Tranexamsýra||4617||4617|6663||1 021709|V01AA0304|Alutard SQ, derm. pter.|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|19604|27326|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|rykmaurar||19604||19604|27326||1 021721|N06AX2101|Cymbalta|sh-hylki|30|mg|28|stk|1|ţpakki||N06AX21|01.04.2005||R|1|0|0|0|0|0|ELD|0|0|0|100|XEU|3860|6328|lyfalmen|||1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||3860||3860|6328||2 021950|B05AA0705|HyperHAES|irl|||250|ml|10|pokar||B05AA07|01.07.2005||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|21716|29136|lyfsjukr|||1|2500|0||Icepharma hf|Fresenius Kabi|Hýdróxyetýl sterkja||21716||21716|29136||2 021967|N06AX2101|Cymbalta|sh-hylki|60|mg|28|stk|1|ţpakki||N06AX21|01.04.2005||R|1|0|0|0|0|0|ELD|0|0|0|100|XEU|5335|8346|lyfalmen|||1|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||5335||5335|8346||2 021975|N06AX2101|Cymbalta|sh-hylki|60|mg|98|stk|1|ţpakki||N06AX21|01.04.2005||R|1|0|0|0|0|0|ELD|0|0|0|100|XEU|18383|25794|lyfalmen|||1|98|0|98,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||18383||18383|25794||2 021999|L01XX3501|Xagrid|hylki|0,5|mg|100|stk|1|glas|hart|L01XX35|01.10.2012||R|0|0|0|1|0|1|SHI|0|0|0|100|DKK|82240|105094|lyfsjukr|||1|100|0||Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Anagrelidum||82240||82240|105094||3 022020|V01AA0304|Alutard SQ, derm. pter.|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|19604|27326|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|rykmaurar||19604||19604|27326||1 022045|L01XE0301|Tarceva|filmhtfl|25|mg|30|stk|1|ţpakki||L01XE03|01.01.2006||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|84418|107827|lyfsjukr|||1|30|0||Icepharma hf|Roche Registration Limited|Erlótiníb||84418||84418|107827||2 022112|B05AA0112|Flexbumin|irl|200|g/líter|100|ml|12|pokar|lausn|B05AA01|01.06.2010||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|127919|162421|lyfsjukr|||1|1200|0||Icepharma hf|Baxter Medical AB|Albúmín||127919||127919|162421||2 022128|A01AA0117|Fludent Banan|munnstfl|0,25|mg|200|stk|1|plglas||A01AA01|01.01.2008||L|0|0|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||0|200|0|45,4500|Actavis Group hf|Actavis Group hf|Natríumflúoríđ|||||||1 022135|C10BA0201|Inegy|töflur|30|mg|28|stk|1|ţpakki|10 mg + 20 mg|C10BA02|01.01.2010||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|6189|9514|lyfalmen|V0617|9514|1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb og simvastatín||6189||6189|9514||1 022157|C10BA0201|Inegy|töflur|50|mg|28|stk|1|ţpakki|10 mg + 40 mg|C10BA02|01.01.2010||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|8491|12663|lyfalmen|V0616|12663|1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb og simvastatín||8491||8491|12663||1 022159|C10BA0201|Inegy|töflur|50|mg|98|stk|1|ţpakki|10 mg + 40 mg|C10BA02|01.09.2005||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|22303|30714|lyfalmen|V0615|30714|1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb og simvastatín||22303||22303|30714||1 022165|A10AB0606|Apidra [Clikstar]|stl|100|ein/ml|3|ml|5|lykjur|rörlykjur fyrir Clikstar penna|A10AB06|01.07.2010||R|0|0|0|0|G|0|SAA|0|0|0|100|NOK|5498|8569|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - Aventis|Insúlín glúlisín||5498||5498|8569||1 022174|C10BA0201|Inegy|töflur|90|mg|28|stk|1|ţpakki|10 mg + 80 mg|C10BA02|01.01.2010||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|9054|13433|lyfalmen|V0614|13433|1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb og simvastatín||9054||9054|13433||1 022191|L01XE0301|Tarceva|filmhtfl|100|mg|30|stk|1|ţpakki||L01XE03|01.01.2006||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|295430|372647|lyfsjukr|||1|30|0||Icepharma hf|Roche Registration Limited|Erlótiníb||295430||295430|372647||2 022205|L01XE0301|Tarceva|filmhtfl|150|mg|30|stk|1|ţpakki||L01XE03|01.01.2006||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|326030|411050|lyfsjukr|||1|30|0||Icepharma hf|Roche Registration Limited|Erlótiníb||326030||326030|411050||2 022218|QP52AA5102|Drontal Comp.vet.|töflur|||24|stk|1|ţpakki||QP52AA51|01.01.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|12727|22202|vetorma|||0|24|0||Icepharma hf|Bayer Animal Health GmbH|||12727||12727|22202||2 022250|M03AX0103|Vistabel|sts|50|ein/hgl|1|hgl|1|pakki|4 Allerg.ein/0,1ml|M03AX01|01.02.2008||R|0|0|0|1|0|0|ALL|0|0|0|100|SEK|25490|34713|lyfalmen|||1|1|0||Vistor hf|Allergan|Clostridium botulinum toxín-A||25490||25490|34713||1 022261|QP52AA5107|Profender fyrir kisur 5-8 kg|bl.lausn|1,12|ml/sk|1,12|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2284|3984|vetorma|||0|2,24|0||Icepharma hf|Bayer Animal Health GmbH|||2284||2284|3984||2 022269|C08CA0101|Norvasc|töflur|5|mg|30|stk|1|ţpakki||C08CA01|01.01.1992||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|1306|2834|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Amlódipín||1306||1306|2834||1 022281|QP52AA5102|Drontal Comp.vet.|töflur|||2|stk|1|ţpakki||QP52AA51|01.10.1991||L|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1443|2517|vetorma|||0|2|0||Icepharma hf|Bayer Animal Health GmbH|||||1443|2517||2 022293|C08CA0101|Norvasc|töflur|5|mg|100|stk|1|ţpakki||C08CA01|01.01.1992||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|3859|2795|lyfalmen|V0056|1702|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Amlódipín||1277||1277|2795||1 022368|C08CA0101|Norvasc|töflur|10|mg|100|stk|1|ţpakki||C08CA01|01.01.1992||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|6783|3819|lyfalmen|V0057|1606|1|100|0|200,0000|Icepharma hf|Pfizer ApS|Amlódipín||2026||2026|3819||1 022407|QP52AA5106|Profender fyrir kisur 2,5-5 kg|bl.lausn|0,7|ml/sk|0,7|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2163|3773|vetorma|||0|1,4|0||Icepharma hf|Bayer Animal Health GmbH|||2163||2163|3773||2 022440|D07AB0203|Locoid Lipid|krem|1|mg/g|30|g|1|túpa|feitt|D07AB02|01.07.1986||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|634|1915|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||634||634|1915||1 022451|D07AB0203|Locoid Lipid|krem|1|mg/g|100|g|1|túpa|feitt|D07AB02|01.04.1987||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|1902|3650|lyfalmen|||1|100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1902||1902|3650||1 022465|QP52AA5105|Profender fyrir kisur 0,5-2,5 kg|bl.lausn|0,35|ml/sk|0,35|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1401|2444|vetorma|||0|0,7|0||Icepharma hf|Bayer Animal Health GmbH|||1401||1401|2444||2 022532|C09DA0303|Diovan Comp 160/12,5 mg|filmhtfl|172,5|mg|28|stk|1|ţpakki||C09DA03|01.11.2003||R|1|0|0|0|0|0|NOH|0|0|0|100|DKK|4713|7495|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og ţvagrćsilyf||4713||4713|7495||1 022537|N06AB0504|Paxetin|töflur|20|mg|100|stk|1|glas||N06AB05|01.01.2005||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|2129|3062|lyfalmen|V0321|3062|2|100|0|100,0000|Actavis Group hf|Actavis hf|Paroxetín||1472||1472|3062||1 022577|N06AB0504|Paxetin|töflur|20|mg|60|stk|1|ţpakki||N06AB05|01.01.2005||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1554|2115|lyfalmen|V0321|1837|2|60|0|60,0000|Actavis Group hf|Actavis hf|Paroxetín||780||780|2115||1 022757|S01XA2019|Oftagel|augnhl|2,5|mg/g|0,5|g|60|sk-hyl||S01XA20|01.07.2012||L|0|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|30|0||Icepharma hf|Santen Oy|Gervitár og ađrar óvirkar samsetningar|||||4873||2 022783|B01AX0501|Arixtra|stl|10|mg/spr|0,8|ml|10|spr|áfyllt sprauta|B01AX05|01.10.2011||R|0|0|0|0|G|0|GGL|0|0|0|100|GBP|25550|34789|lyfalmen|||1|8|0|40,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||25550||25550|34789||1 022815|B01AX0501|Arixtra|stl|5|mg/spr|0,4|ml|10|spr|áfyllt sprauta|B01AX05|01.10.2011||R|0|0|0|0|G|0|GGL|0|0|0|100|GBP|12775|18756|lyfalmen|||1|4|0|20,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||12775||12775|18756||1 022831|B01AX0501|Arixtra|stl|7,5|mg/spr|0,6|ml|10|spr|áfyllt sprauta|B01AX05|01.04.2012||R|0|0|0|0|G|0|GGL|0|0|0|100|GBP|19183|26798|lyfalmen|||1|6|0|30,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||19183||19183|26798||1 022845|S01XA2019|Oftagel|augnhl|2,5|mg/g|0,5|g|30|sk-hyl||S01XA20|01.05.2007||L|0|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|15|0||Icepharma hf|Santen Oy|Gervitár og ađrar óvirkar samsetningar|||||2960||2 022904|D10BA0102|Decutan|hylki|10|mg|30|stk|1|ţpakki||D10BA01|01.02.2006||R|0|1|0|1|G|0|ACA|0|0|0|30|IKR|1407|2896|lyfalmen|||2|30|0|10,0000|Actavis Group hf|Actavis hf|Ísótretínóín||1351||1351|2896||1 022915|D10BA0102|Decutan|hylki|20|mg|30|stk|1|ţpakki||D10BA01|01.02.2006||R|0|1|0|1|G|0|ACA|0|0|0|30|IKR|2450|4265|lyfalmen|||2|30|0|20,0000|Actavis Group hf|Actavis hf|Ísótretínóín||2352||2352|4265||1 023063|J05AR0301|Truvada|filmhtfl|445|mg|30|stk|1|glas|200+245 mg|J05AR03|01.03.2006||R|0|0|0|1|0|1|GIS|0|0|0|100|DKK|84411|107818|lyfsjukr|||1|30|0|30,0000|Gilead Sience Sweden AB|Gilead Science International ltd.|Tenófóvír dísóproxíl og emtrícítabín||84411||84411|107818||3 023066|V03AE0301|Fosrenol|tuggutfl|500|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|1|0|0|1|0|0|SHI|0|0|0|100|DKK|25916|35248|lyfalmen|||1|90|0|20,0000|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Lanthanum karbónat||25916||25916|35248||3 023080|V03AE0301|Fosrenol|tuggutfl|750|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|1|0|0|1|0|0|SHI|0|0|0|100|DKK|40461|53502|lyfalmen|||1|90|0|30,0000|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Lanthanum karbónat||40461||40461|53502||3 023124|G04BD1001|Emselex|forđatfl|7,5|mg|98|stk|1|ţpakki||G04BD10|01.07.2005||R|1|0|0|0|G|0|NOE|0|0|0|100|DKK|20490|28438|lyfalmen|||1|98|0|98,0000|Vistor hf|Novartis Europharm Ltd|Darífenacín||20490||20490|28438||1 023193|G04BD1001|Emselex|forđatfl|15|mg|98|stk|1|ţpakki||G04BD10|01.07.2005||R|1|0|0|0|G|0|NOE|0|0|0|100|DKK|20698|28699|lyfalmen|||1|98|0|196,0000|Vistor hf|Novartis Europharm Ltd|Darífenacín||20698||20698|28699||1 023329|N03AX1206|Gabapentin Mylan|hylki|300|mg|100|stk|1|glas||N03AX12|01.01.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|2849|4320|lyfalmen|||2|100|0|16,6667|Actavis Group PTC ehf|Mylan AB|Gabapentín||2392||2392|4320|31.5.2013|2 023376|N03AX1206|Gabapentin Mylan|hylki|400|mg|100|stk|1|glas||N03AX12|01.01.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|3766|5443|lyfalmen|V0251|5160|2|100|0|22,2200|Icepharma hf|Mylan AB|Gabapentín||3213||3213|5443||2 023409|N01BB2004|Oraqix|thhlaup|5|%|1,7|g|20|rörlyk||N01BB20|01.09.2006||R|0|0|0|0|0|0|DED|0|0|1|100|XEU|19809|27584|lyfalmen|||1|34|0||Vistor hf|Dentsply DeTrey GmbH|Blöndur||19809||19809|27584||1 023414|B03XA0201|Aranesp|stl|20|mcg/pen|0,5|ml|1|penni|áfylltur penni|B03XA02|01.01.2006|30.04.2013|R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|7697|11109|lyfsjukr|||1|0,5|0|4,4400|Vistor hf|Amgen|Darbepóetín alfa||7697||7697|11109||1 023419|B03XA0201|Aranesp|stl|80|mcg/pen|0,4|ml|1|penni|áfylltur penni|B03XA02|01.01.2006|30.04.2013|R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|29597|39027|lyfsjukr|||1|0,4|0|17,7800|Vistor hf|Amgen|Darbepóetín alfa||29597||29597|39027||1 023425|B03XA0201|Aranesp|stl|60|mcg/pen|0,3|ml|1|penni|áfylltur penni|B03XA02|01.01.2006|30.04.2013|R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|22412|30010|lyfsjukr|||1|0,3|0|13,3300|Vistor hf|Amgen|Darbepóetín alfa||22412||22412|30010||1 023441|B03XA0201|Aranesp|stl|150|mcg/pen|0,3|ml|1|penni|áfylltur penni|B03XA02|01.01.2006|30.04.2013|R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|53376|68869|lyfsjukr|||1|0,3|0|33,3300|Vistor hf|Amgen|Darbepóetín alfa||53376||53376|68869||1 023447|B03XA0201|Aranesp|stl|100|mcg/pen|0,5|ml|1|penni|áfylltur penni|B03XA02|01.01.2006|30.04.2013|R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|36068|47148|lyfsjukr|||1|0,5|0|22,2200|Vistor hf|Amgen|Darbepóetín alfa||36068||36068|47148||1 023448|J06BA0207|Kiovig|irl|100|mg/ml|10|ml|1|glerfl||J06BA02|01.09.2007||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|8787|12682|lyfsjukr|||1|10|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||8787||8787|12682||2 023452|B03XA0201|Aranesp|stl|300|mcg/pen|0,6|ml|1|penni|áfylltur penni|B03XA02|01.01.2006|30.04.2013|R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|107503|136799|lyfsjukr|||1|0,6|0|66,6700|Vistor hf|Amgen|Darbepóetín alfa||107503||107503|136799||1 023459|J06BA0207|Kiovig|irl|100|mg/ml|25|ml|1|glerfl||J06BA02|01.09.2007||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|21969|29454|lyfsjukr|||1|25|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||21969||21969|29454||2 023463|B03XA0201|Aranesp|stl|40|mcg/pen|0,4|ml|1|penni|áfylltur penni|B03XA02|01.01.2006|30.04.2013|R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|15471|21299|lyfsjukr|||1|0,4|0|8,8900|Vistor hf|Amgen|Darbepóetín alfa||15471||15471|21299||1 023470|J06BA0207|Kiovig|irl|100|mg/ml|50|ml|1|glerfl||J06BA02|01.09.2007||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|40810|53099|lyfsjukr|||1|50|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||40810||40810|53099||2 023476|J06BA0207|Kiovig|irl|100|mg/ml|100|ml|1|glerfl||J06BA02|01.09.2007||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|81618|104313|lyfsjukr|||1|100|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||81618||81618|104313||2 023480|B03XA0201|Aranesp|stl|500|mcg/pen|1|ml|1|penni|áfyllur penni|B03XA02|01.07.2007|30.04.2013|R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|187347|237003|lyfsjukr|||1|1|0|111,1100|Vistor hf|Amgen|Darbepóetín alfa||187347||187347|237003||1 023487|J06BA0207|Kiovig|irl|100|mg/ml|200|ml|1|glerfl||J06BA02|01.09.2007||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|163237|206745|lyfsjukr|||1|200|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||163237||163237|206745||2 023506|J05AE0901|Aptivus|hylki|250|mg|120|stk|1|glas||J05AE09|01.03.2007||R|0|0|0|1|0|1|BII|0|0|0|100|DKK|136141|172739|lyfsjukr|||1|120|0|30,0000|Vistor hf|Boehringer Ingelheim International |Tipranavír||136141||136141|172739||1 023509|B01AC0401|Plavix|töflur|75|mg|100|stk|1|ţpakki||B01AC04|01.07.2007||R|1|0|0|0|G|0|SBM|0|0|0|100|NOK|27070|31661|lyfalmen|V0029|7030|1|100|0|100,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||23058||23058|31661||1 023590|S01ED0106|Timosan Depot|augnhl|1|mg/g|0,4|g|30|sk-hyl||S01ED01|01.07.2007||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|3145|5350|lyfalmen|||1|12|0|30,0000|Icepharma hf|Santen Oy|Tímólól||3145||3145|5350||2 023608|N01AB0802|Sevofluran Baxter|innönd.l|100|%|250|ml|6|fl||N01AB08|01.04.2012||R|0|0|0|0|0|1|BAX|0|0|0|100|SEK|161087|204047|lyfsjukr|||2|1500|0||Icepharma hf|Baxter|Sevóflúran||161087||161087|204047||2 023708|J05AE0101|Invirase|filmhtfl|500|mg|120|stk|1|glas||J05AE01|01.01.2006||R|1|0|0|1|0|1|ROC|0|0|0|100|DKK|57087|73527|lyfsjukr|||1|120|0|33,3300|Icepharma hf|Roche|Saquínavír||57087||57087|73527||2 023968|G04BE0302|Revatio|filmhtfl|20|mg|90|stk|1|ţpakki||G04BE03|01.08.2006||R|0|1|0|1|0|1|IPI|0|0|0|100|DKK|77288|98879|lyfsjukr|||1|90|0|36,0000|Icepharma hf|Pfizer Limited|Síldenafíl||77288||77288|98879||1 024018|N04BA0204|Sinemet 25/100|töflur|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.10.1985||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|2955|5090|lyfalmen|||1|100|0|16,6667|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||2955||2955|5090||1 024056|N02AB0301|Durogesic|forđapl|12|mcg/klst|5|stk|1|ţpakki||N02AB03|01.02.2006||R|0|0|1|0|G|0|JAS|0|0|0|100|SEK|2552|4539|lyfalmen|V0222|3897|1|5|0|3,6000|Vistor hf|Janssen-Cilag AB|Fentanýl||2552||2552|4539||1 024090|N04BD0201|Azilect|töflur|1|mg|30|stk|1|glas||N04BD02|01.10.2005||R|1|0|0|0|G|0|TPG|0|0|0|100|DKK|19527|27230|lyfalmen|||1|30|0|30,0000|Lundbeck Export A/S|Teva Pharma GmbH|Rasagilín||19527||19527|27230||1 024135|B05BB0119|Ringer-Acetat Baxter Viaflo|irl|||1000|ml|10|pokar|lausn|B05BB01|01.10.2005||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|1882|2716|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||1882||1882|2716||2 024151|B05BA1020|StructoKabiven elektrolyfri|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.03.2010||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|22844|30552|lyfsjukr|||1|3944|0||Icepharma hf|Fresenius Kabi|Blöndur||22844||22844|30552||2 024185|N05AH0309|Kozylex|munndr.t|10|mg|28|stk|1|ţpakki||N05AH03|01.09.2011||R|0|0|0|0|G|0|POF|0|0|0|100|IKR|14561|7030|lyfalmen|||2|28|0|28,0000|Portfarma ehf|Portfarma|Olanzapín||4245||4373|7030|30.6.2013|2 024200|N04BD0201|Azilect|töflur|1|mg|100|stk|1|ţpakki||N04BD02|01.10.2005||R|1|0|0|0|G|0|TPG|0|0|0|100|DKK|64405|83552|lyfalmen|||1|100|0|100,0000|Lundbeck Export A/S|Teva Pharma GmbH|Rasagilín||64405||64405|83552||1 024307|V01AA1105|Alutard SQ, hundahar|stl|||5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|24487|33455|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|dýr||24487||24487|33455||1 024478|V04CL0016|Soluprick SQ ALK553 - hundahár|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|7709|11593|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7709||7709|11593||1 024481|R03CC0301|Bricanyl|mixtúra|0,3|mg/ml|100|ml|1|fl||R03CC03|01.03.2006||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|450|1664|lyfalmen|||1|100|0|2,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||450||450|1664||1 024482|V04CL0017|Soluprick SQ ALK555 - kattahár|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|7709|11593|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7709||7709|11593||1 024504|V04CL0003|Soluprick SQ ALK106 - Rauđölur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|12989|19025|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||12989||12989|19025||1 024526|V04CL0006|Soluprick SQ ALK113 - Hesliviđur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|13011|19052|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||13011||13011|19052||1 024565|V04CL0009|Soluprick SQ ALK218 - Hávingull|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|13144|19219|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||13144||13144|19219||1 024583|V04CL0011|Soluprick SQ ALK225 - Vallarfoxgras|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|5558|8651|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||5558||5558|8651||1 024590|M05BA0802|Aclasta|irl|5|mg|100|ml|1|fl|lausn|M05BA08|01.07.2005||R|0|1|0|1|0|0|NOE|0|0|0|100|DKK|70619|91350|lyfalmen|||1|100|0|1,2500|Vistor hf|Novartis Europharm Ltd|Zoledronsýra||70619||70619|91350||1 024600|V04CL0013|Soluprick SQ ALK231 - Rúgur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|13144|19219|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||13144||13144|19219||1 024603|V04CL0001|Soluprick Negativ Kontrol|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|1583|3213|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||1583||1583|3213||1 024622|V04CL0005|Soluprick SQ ALK108 - Birkifrjó|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|5558|8651|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||5558||5558|8651||1 024644|V04CL0015|Soluprick SQ ALK552 - Hrossavćrur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|7709|11593|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7709||7709|11593||1 024670|V04CL0014|Soluprick SQ ALK504 - Rykmaur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|7709|11593|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7709||7709|11593||1 024681|V04CL0002|Soluprick Positiv Kontrol|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|1583|3213|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||1583||1583|3213||1 024991|M01AE0111|Burana|filmhtfl|600|mg|30|stk|1|ţpakki||M01AE01|01.06.2012||R|1|0|0|0|G|0|OPF|0|0|1|100|XEU|381|1569|lyfalmen|V0563|1551|2|30|0|15,0000|Portfarma ehf|Orion Corporation|Íbúprófen||381||381|1569||2 025009|M01AE0111|Burana|filmhtfl|400|mg|30|stk|1|ţpakki||M01AE01|01.07.2012||L|1|0|0|0|0|0|OPF|0|0|1|100|IKR|||lyflausa|||0|30|0|10,0000|Portfarma ehf|Orion Corporation|Íbúprófen|||||||2 025020|M01AE0111|Burana|filmhtfl|400|mg|100|stk|1|glas||M01AE01|01.06.2012||R|1|0|0|0|G|0|OPF|0|0|1|100|XEU|764|2068|lyfalmen|V0562|1815|2|100|0|33,3300|Portfarma ehf|Orion Corporation|Íbúprófen||746||746|2068||2 025053|M01AE0111|Burana|filmhtfl|600|mg|100|stk|1|glas||M01AE01|01.06.2012||R|1|0|0|0|G|0|OPF|0|0|1|100|XEU|917|2293|lyfalmen|V0564|2038|2|100|0|50,0000|Portfarma ehf|Orion Corporation|Íbúprófen||910||910|2293||2 025142|D07AB0202|Locoid Crelo|lausn|1|mg/g|30|g|1|glas|á húđ|D07AB02|01.04.1994||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|643|1928|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||643||643|1928||1 025155|V01AA1105|Alutard SQ, hundahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|19604|27326|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|dýr||19604||19604|27326||1 025262|V01AA1105|Alutard SQ, hundahar|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|19604|27326|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|dýr||19604||19604|27326||1 025306|M05BB0301|Fosavance|töflur|||12|stk|1|ţpakki|70mg+70mcg|M05BB03|01.10.2006||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|13921|20194|lyfalmen|||1|12|0|84,0000|Vistor hf|M.S.D.|Alendrónsýra og kólekalsíferól||13921||13921|20194||1 025317|J05AF1001|Baraclude|filmhtfl|1|mg|30|stk|1|ţpakki||J05AF10|01.09.2007||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|84759|108255|lyfsjukr|||1|30|0|60,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||84759||84759|108255||1 025323|J05AF1001|Baraclude|filmhtfl|0,5|mg|30|stk|1|ţpakki||J05AF10|01.09.2007||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|79168|101238|lyfsjukr|||1|30|0|30,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||79168||79168|101238||1 025388|QM01AC0601|Metacam|stl|5|mg/ml|20|ml|1|hgl||QM01AC06|01.10.2006||R|0|0|0|0|0|0|BOI|1|0|0|100|DKK|9714|18825|vetalmen|||0|20|0||Vistor hf|Boehringer Ingelheim|||9714||9714|18825||1 025425|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|30|stk|1|ţpakki|frostţurrkađar|V01AA02|01.02.2008||R|0|0|0|1|0|0|ALK|0|0|0|100|DKK|16816|23827|lyfalmen|||1|30|0||Vistor hf|ALK-Abello A/S|grasfrjó||16816||16816|23827||1 025444|C09CA0301|Diovan|filmhtfl|320|mg|98|stk|1|ţpakki||C09CA03|01.04.2007|31.05.2013|R|1|0|0|0|0|0|NOH|0|0|0|100|DKK|19628|27356|lyfalmen|||1|98|0|392,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||19628||19628|27356||1 025458|A10BX0203|Repaglinide Portfarma|töflur|0,5|mg|90|stk|1|ţpakki||A10BX02|01.01.2012||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|2515|2808|lyfalmen|V0462|2808|2|90|0|11,2500|Portfarma ehf|Portfarma|Repaglíníđ||1287||1287|2808||2 025469|A10BX0203|Repaglinide Portfarma|töflur|1|mg|90|stk|1|ţpakki||A10BX02|01.01.2012||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|2737|2951|lyfalmen|V0471|2951|2|90|0|22,5000|Portfarma ehf|Portfarma|Repaglíníđ||1391||1391|2951||2 025588|M05BA0602|Bonviva|filmhtfl|150|mg|1|stk|1|ţpakki||M05BA06|01.01.2006||R|1|0|0|0|0|0|RRL|0|0|0|100|DKK|5320|8325|lyfalmen|V0205|1242|1|1|0|30,0000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||5320||5320|8325||2 025599|M05BA0602|Bonviva|filmhtfl|150|mg|3|stk|1|ţpakki||M05BA06|01.01.2006||R|1|0|0|0|0|0|RRL|0|0|0|100|DKK|14256|20615|lyfalmen|V0205|3725|1|3|0|90,0000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||14256||14256|20615||2 025632|A10BX0203|Repaglinide Portfarma|töflur|2|mg|90|stk|1|ţpakki||A10BX02|01.01.2012||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|2942|3075|lyfalmen|V0472|3075|2|90|0|45,0000|Portfarma ehf|Portfarma|Repaglíníđ||1482||1482|3075||2 025736|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|100|stk|1|ţpakki|frostţurrkađar|V01AA02|01.02.2008||R|0|0|0|1|0|0|ALK|0|0|0|100|DKK|54016|70513|lyfalmen|||1|100|0||Vistor hf|ALK-Abello A/S|grasfrjó||54016||54016|70513||1 025747|C01BB0101|Xylocard 100 mg/ 5 ml|stl|20|mg/ml|5|ml|5|gl-lyk||C01BB01|01.12.2006||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|7672|11073|lyfsjukr|||1|25|0|0,1667|Vistor hf|AstraZeneca A/S DK|Lídókaín||7672||7672|11073||1 025841|V01AA1106|Alutard SQ, kattahar|stl|||5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|24487|33455|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|dýr||24487||24487|33455||1 025895|N02AA0505|Oxycodone ratiopharm|forđatfl|10|mg|28|stk|1|ţpakki||N02AA05|01.04.2013||R|1|0|1|0|G|0|RGM|0|0|0|100|XEU|1916|3669|lyfalmen|V0597|3669|2|28|0|3,7300|Medical ehf|ratiopharm GmbH|Oxýcódon||1916||1916|3669||2 025906|N02AA0505|Oxycodone ratiopharm|forđatfl|10|mg|98|stk|1|ţpakki||N02AA05|01.04.2013||R|1|0|1|0|G|0|RGM|0|0|0|100|XEU|5635|7165|lyfalmen|V0598|7165|2|98|0|13,0700|Medical ehf|ratiopharm GmbH|Oxýcódon||4472||4472|7165||2 025917|L04AX0201|Thalidomide Celgene|hylki|50|mg|28|stk|1|ţpakki|hart|L04AX02|01.09.2011||R|0|1|0|1|0|1|CEE|0|0|0|100|XEU|58428|75210|lyfsjukr|||1|28|0|14,0000|Celgene Europe ltd|Celgene Europe ltd|Thalidómíde||||58428|75210||2 025941|R03DC0302|Montelukast Portfarma|tuggutfl|4|mg|98|stk|1|ţpakki||R03DC03|01.01.2012||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|13547|13011|lyfalmen|V0492|12515|2|98|0|39,2000|Portfarma ehf|Portfarma|Montelúkast||8745||8745|13011||2 025963|R03DC0302|Montelukast Portfarma|tuggutfl|5|mg|98|stk|1|ţpakki||R03DC03|01.01.2012||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|16431|11807|lyfalmen|V0491|11100|2|98|0|49,0000|Portfarma ehf|Portfarma|Montelúkast||7865||7865|11807||2 025965|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|1|l|1|fl||QP54AA01|01.04.1992||R|0|0|0|0|0|0|MEF|0|0|0|100|XEU|4775|8330|vetorma|||0|1|0||Vistor hf|Merial (MSD)|Ivermectinum||4775||4775|8330||1 025986|R03DC0302|Montelukast Portfarma|filmhtfl|10|mg|98|stk|1|ţpakki||R03DC03|01.11.2011||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|13857|6038|lyfalmen|V0490|5579|2|98|0|98,0000|Portfarma ehf|Portfarma|Montelúkast||3648||3648|6038||2 025997|A07DA0302|Loperamid Portfarma|töflur|2|mg|20|stk|1|ţpakki||A07DA03|01.05.2011||L|1|0|0|0|0|0|POF|0|0|0|100|IKR|||lyflausa|||0|20|0|4,0000|Portfarma ehf|Portfarma|Lóperamíđ|||||||2 026000|QS02CA0301|Easotic|eyrnadr|||10|ml|1|fl|dreifa|QS02CA03|01.04.2012||R|0|0|0|0|0|0|VIR|0|0|0|100|SEK|2760|5472|vetalmen|||0|10|0||Vistor hf|Virbac S.A|Hýdrókortisón,miconazol,gentamicin||2760||2760|5472||1 026019|A07DA0302|Loperamid Portfarma|töflur|2|mg|100|stk|1|ţpakki||A07DA03|01.07.2011||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|820|2170|lyfalmen|V0447|2170|2|100|0|20,0000|Portfarma ehf|Portfarma|Lóperamíđ||820||820|2170|| 026021|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA01|01.04.1992||R|0|0|0|0|0|0|MEF|0|0|0|100|XEU|9408|16412|vetorma|||0|2,5|0||Vistor hf|Merial (MSD)|Ivermectinum||9408||9408|16412||1 026086|N05AH0309|Kozylex|munndr.t|15|mg|28|stk|1|ţpakki||N05AH03|01.11.2011||R|0|0|0|0|G|0|POF|0|0|0|100|IKR|23430|13537|lyfalmen|V0475|13537|2|28|0|42,0000|Portfarma ehf|Portfarma|Olanzapín||9130||9130|13537||2 026096|V01AA1106|Alutard SQ, kattahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|19604|27326|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|dýr||19604||19604|27326||1 026101|L01CA0501|Javlor|irţ|25|mg/ml|2|ml|1|hgl|lausn|L01CA05|01.12.2010||R|0|0|0|1|0|1|PFM|0|0|0|100|DKK|43240|56149|lyfsjukr|||1|2|0||Vistor hf|Pierre Fabre Médicament|Vínflúnín||43240||43240|56149||1 026114|L01CA0501|Javlor|irţ|25|mg/ml|10|ml|1|hgl|lausn|L01CA05|01.12.2010||R|0|0|0|1|0|1|PFM|0|0|0|100|DKK|216227|273247|lyfsjukr|||1|10|0||Vistor hf|Pierre Fabre Médicament|Vínflúnín||216227||216227|273247||1 026569|R02AA0305|Strepsils Cool|sogtfl|||24|stk|1|ţpakki||R02AA03|01.09.2010||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 026571|N03AX1801|Vimpat|filmhtfl|50|mg|14|stk|1|ţpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|1842|3568|lyfalmen|||1|14|0|2,3300|Vistor hf|U.C.B|Lacosamíđ||||1842|3568||1 026582|N03AX1801|Vimpat|filmhtfl|50|mg|56|stk|1|ţpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|6980|10596|lyfalmen|||1|56|0|9,3300|Vistor hf|U.C.B|Lacosamíđ||||6980|10596||1 026593|N03AX1801|Vimpat|filmhtfl|100|mg|14|stk|1|ţpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|3639|6026|lyfalmen|||1|14|0|4,6700|Vistor hf|U.C.B|Lacosamíđ||||3639|6026||1 026605|N03AX1801|Vimpat|filmhtfl|100|mg|56|stk|1|ţpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|14415|20814|lyfalmen|||1|56|0|18,6700|Vistor hf|U.C.B|Lacosamíđ||||14415|20814||1 026627|N03AX1801|Vimpat|filmhtfl|150|mg|56|stk|1|ţpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|21601|29833|lyfalmen|||1|56|0|28,0000|Vistor hf|U.C.B|Lacosamíđ||||21601|29833||1 026638|N03AX1801|Vimpat|filmhtfl|200|mg|56|stk|1|ţpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|28787|38851|lyfalmen|||1|56|0|37,3300|Vistor hf|U.C.B|Lacosamíđ||||28787|38851||1 026682|J01XE0101|Furadantin|töflur|50|mg|100|stk|1|glas||J01XE01|01.03.2004||R|1|0|0|0|0|0|REP|0|0|1|100|SEK|1508|3111|lyfalmen|||2|100|0|25,0000|Vistor hf|Recip AB|Nítrófúrantóín||1508||1508|3111||1 026698|A02BC0110|Omeprazol ratiopharm|sţ-hylki|20|mg|14|stk|1|glas|hart|A02BC01|01.02.2012||L|1|0|0|0|0|0|RAT|0|0|0|100|IKR|||lyflausa|||0|14|0|14,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól|||||||2 026702|C10AA0505|Atorvastatin Bluefish|filmhtfl|40|mg|100|stk|1|ţpakki||C10AA05|01.10.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|4560|3196|lyfalmen|V0114|3196|2|100|0|200,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Atorvastatín||1570||1570|3196||2 026946|J01CA0412|Amoxicillin Mylan (D.A.C.)|hylki|500|mg|30|stk|1|glas||J01CA04|01.07.2011||R|0|0|0|0|0|0|DAC|0|0|1|100|SEK|1683|2814|lyfalmen|V0160|2766|3|30|0|15,0000|D.A.C. ehf|D.A.C. ehf|Amoxicillín||1291||1291|2814||2 026957|J01CA0412|Amoxicillin Mylan (D.A.C.)|hylki|500|mg|20|stk|1|glas||J01CA04|01.05.2011||R|0|0|0|0|0|0|DAC|0|0|1|100|SEK|1196|2249|lyfalmen|V0159|2215|3|20|0|10,0000|D.A.C. ehf|D.A.C. ehf|Amoxicillín||878||878|2249||2 027094|J01XE0101|Furadantin|töflur|5|mg|50|stk|1|glas||J01XE01|01.03.2004||R|1|0|0|0|0|0|REP|0|0|1|100|SEK|448|1661|lyfalmen|||2|50|0|1,2500|Vistor hf|Recip AB|Nítrófúrantóín||448||448|1661||1 027144|M01CC0101|Atamir|hylki|150|mg|50|stk|1|ţpakki||M01CC01|01.06.1982||R|1|0|0|0|G|0|SGM|0|0|0|100|DKK|2737|4792|lyfalmen|V0199|3542|1|50|0|15,0000|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||2737||2737|4792||3 027202|S01ED5111|Azarga|augndr|15|mg/ml|5|ml|1|glas|10+5 mg/ml|S01ED51|01.10.2009||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|2334|4241|lyfalmen|||1|5|0|25,0000|Vistor hf|Alcon Laboratories Ltd.|Tímólól í blöndum||2334||2334|4241||1 027235|G03HA0104|Cyproteron Mylan|töflur|50|mg|50|stk|1|glas||G03HA01|01.04.1997||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|7373|11134|lyfalmen|||2|50|0|25,0000|Icepharma hf|Mylan AB|Cýpróterón||7373||7373|11134||2 027281|N06DA0204|Donepezil Actavis|filmhtfl|5|mg|100|stk|1|ţpakki||N06DA02|01.05.2009||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|16853|10029|lyfalmen|V0341|9593|2|100|0|66,6600|Actavis Group hf|Actavis hf|Dónepezíl||6565||6565|10029||1 027305|N06DA0204|Donepezil Actavis|filmhtfl|10|mg|100|stk|1|ţpakki||N06DA02|01.05.2009||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|19347|10029|lyfalmen|V0342|9593|2|100|0|133,3300|Actavis Group hf|Actavis hf|Dónepezíl||6565||6565|10029||1 027586|N03AX1501|Zonegran|hylki|25|mg|56|stk|1|ţpakki||N03AX15|01.03.2007||R|1|0|0|0|G|0|EIS|0|0|0|100|SEK|7616|11466|lyfalmen|||1|56|0|7,0000|Vistor hf|Eisai Ltd|Zonisamíđ||7616||7616|11466||1 027595|N03AX1501|Zonegran|hylki|50|mg|56|stk|1|ţpakki||N03AX15|01.03.2007||R|1|0|0|0|G|0|EIS|0|0|0|100|SEK|9735|14365|lyfalmen|||1|56|0|14,0000|Vistor hf|Eisai Ltd|Zonisamíđ||9735||9735|14365||1 027649|H03AA0105|Levaxin|töflur|0,05|mg|100|stk|1|glas||H03AA01|01.04.2004||R|1|0|0|0|G|0|NYC|0|0|0|100|DKK|612|1885|lyfalmen|V0153|1815|2|100|0|33,3300|Vistor hf|Nycomed Danmark A/S|Levótýroxínnatríum||612||612|1885||1 027656|H03AA0105|Levaxin|töflur|0,1|mg|100|stk|1|glas||H03AA01|01.03.2003||R|1|0|0|0|G|0|NYC|0|0|0|100|DKK|711|2021|lyfalmen|V0154|2021|2|100|0|66,6667|Vistor hf|Nycomed Danmark A/S|Levótýroxínnatríum||711||711|2021||1 027733|N05AH0409|Quetiapin Orion|filmhtfl|25|mg|100|stk|1|ţpakki||N05AH04|01.10.2012||R|1|0|0|0|G|0|OPF|0|0|0|100|IKR|2109|2642|lyfalmen|V0284|2642|2|100|0|6,2500|Portfarma ehf|Orion Corporation|Quetíapín||1165||1165|2642||2 027795|J02AC0401|Noxafil|mixtúra|40|mg/ml|105|ml|1|fl||J02AC04|01.08.2006||R|0|0|0|1|0|1|SPE|0|0|0|100|DKK|101890|129754|lyfsjukr|||1|105|0|5,2500|Vistor hf|SP Europe|Posacónazól||101890||101890|129754||1 027968|N05AX1201|Abilify|munndr.t|10|mg|28|stk|1|ţpakki||N05AX12|01.01.2007||R|0|0|0|0|0|0|OTS|0|0|0|100|DKK|20790|28815|lyfalmen|||1|28|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||20790||20790|28815||1 027976|N05AH0307|Zypadhera|sts|210|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|0|1|ELD|0|0|0|100|XEU|32412|42560|lyfsjukr|||1|1|0|21,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||||32412|42560||2 027977|N05AX1201|Abilify|munndr.t|15|mg|28|stk|1|ţpakki||N05AX12|01.01.2007||R|0|0|0|0|0|0|OTS|0|0|0|100|DKK|24028|32878|lyfalmen|||1|28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||24028||24028|32878||1 027988|N05AH0307|Zypadhera|sts|300|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|0|1|ELD|0|0|0|100|XEU|47759|61820|lyfsjukr|||1|1|0|30,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||47759||47759|61820||2 027999|N05AH0307|Zypadhera|sts|405|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|0|1|ELD|0|0|0|100|XEU|60162|77386|lyfsjukr|||1|1|0|40,5000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||||60162|77386||2 028045|G03AB0801|Qlaira|töflur|||84|stk|1|ţpakki|3x28 stk|G03AB08|01.11.2009||R|0|0|0|0|0|0|BAP|0|0|0|100|DKK|5385|8414|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Kaflaskipt lyf, prógestógen og östrógen||5385||5385|8414||2 028110|A10BD0701|Janumet|filmhtfl|900|mg|196|stk|1|ţpakki|50/850 mg|A10BD07|01.03.2013||R|1|0|0|0|G|0|MLD|0|0|0|100|DKK|23025|31620|lyfalmen|V0387|31620|1|196|0|98,0000|Vistor hf|Merck Sharp & Dohme Limited|Metforminum og sitagliptinum||23025||23025|31620||1 028112|R06AX2602|Nefoxef|filmhtfl|120|mg|30|stk|1|ţpakki||R06AX26|01.07.2008||L|1|0|0|0|0|0|MUN|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Icepharma hf|Mundipharma|Fexófenadín|||||||2 028121|A10BD0701|Janumet|filmhtfl|1050|mg|196|stk|1|ţpakki|50/1000mg|A10BD07|01.01.2010||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|23365|32046|lyfalmen|V0386|32046|1|196|0|98,0000|Vistor hf|M.S.D.|Metforminum og sitagliptinum||23365||23365|32046||1 028124|R06AX2602|Nefoxef|filmhtfl|120|mg|100|stk|1|ţpakki||R06AX26|01.07.2008||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|3804|5001|lyfalmen|||2|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Fexófenadín||2102||2890|5001|31.5.2013|2 028268|R03DX0501|Xolair|stl|150|mg|1|áf.spr|1|pakki||R03DX05|01.04.2011||R|0|0|0|1|0|1|NOE|0|1|0|100|DKK|57475|74014|lyfsjukr|||1|1|0|9,3800|Vistor hf|Novartis Europharm Ltd|Omalizúmab||57475||57475|74014||1 028314|J07AP0301|Typhim Vi|stl|25|mcg/spr|0,5|ml|1|áf.spr|m/ ađsk. nál|J07AP03|01.05.2008||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|2566|4558|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Taugaveiki, hreinsađir mótefnavakar||2566||2566|4558||2 028333|J07CA0602|Pentavac|sts|||0,5|ml|10|hgl|+ 10 áf. spr.|J07CA06|01.02.2013||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|45796|60197|lyfalmen|||1|5|0||Icepharma hf|Sanofi Pasteur MSD|Barnaveiki, haemophilus influenza B, kíghósti, mćnusótt, stí||45796||45796|60197||2 028351|J07BL0101|Stamaril|sts|||0,5|ml|10|hgl|+ 10 áf.spr. međ leysi|J07BL01|01.01.1996||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|21542|29759|lyfalmen|||1|5|0||Icepharma hf|Sanofi Pasteur MSD|Gulusótt, veikluđ veira||21542||21542|29759||2 028360|J07BG0101|Rabies - Imovax|bóluefni|||1|ml|1|hgl||J07BG01|01.01.1996||R|0|0|0|0|0|0|SPM|0|0|0|100|SEK|10794|15814|lyfalmen|||1|1|0||Icepharma hf|Sanofi Pasteur MSD|Hundaćđi, dauđ veira||10794||10794|15814||2 028387|M03BX0105|Baklofen Mylan|töflur|25|mg|50|stk|1|glas||M03BX01|01.10.2008||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|1967|3739|lyfalmen|V0202|3739|2|50|0|25,0000|Icepharma hf|Mylan AB|Baklófen||1967||1967|3739||2 028405|M01AE0217|Naproxen-E Mylan|sh-tfl|500|mg|50|stk|1|plglas||M01AE02|01.07.1993||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|2205|4064|lyfalmen|V0428|3513|2|50|0|50,0000|Icepharma hf|Mylan AB|Naproxen||2205||2205|4064||2 028498|C08DB0102|Cardizem Retard|forđatfl|120|mg|60|stk|1|glas||C08DB01|01.04.1987||R|1|0|0|0|G|0|FRO|0|0|0|100|DKK|4690|7464|lyfalmen|||1|60|0|30,0000|Vistor hf|Ferrosan A/S|Diltíazem||4690||4690|7464|30.6.2013|1 028575|N03AX0901|Lamictal|dreifit.|5|mg|56|stk|1|ţpakki||N03AX09|01.05.2009||R|1|0|0|0|G|0|GSK|0|0|0|100|IKR|1278|2796|lyfalmen|||1|56|0|0,9334|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||||1278|2796||1 028586|N03AX0901|Lamictal|dreifit.|100|mg|98|stk|1|ţpakki||N03AX09|01.05.2009||R|1|0|0|0|G|0|GSK|0|0|0|100|IKR|5812|4057|lyfalmen|V0245|3753|1|98|0|32,6667|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||2200||2200|4057||1 028598|N03AX0901|Lamictal|dreifit.|200|mg|98|stk|1|ţpakki||N03AX09|01.05.2009||R|1|0|0|0|G|0|GSK|0|0|0|100|IKR|10358|8654|lyfalmen|V0232|8165|1|98|0|65,3333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||5560||5560|8654||1 028599|N04BC0503|Pramipexole Portfarma|töflur|0,088|mg|30|stk|1|ţpakki||N04BC05|01.02.2010||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|809|1475|lyfalmen|V0266|1372|2|30|0|1,0600|Portfarma ehf|Portfarma|Pramipexól||312||312|1475||2 028606|QN05CM1801|Dexdomitor|stl|0,5|mg/ml|10|ml|1|hgl||QN05CM18|01.11.2007||R|0|0|0|0|0|0|OCO|1|0|0|100|DKK|8062|15653|vetalmen|||0|10|0||Icepharma hf|Orion Corporation (I)|||8062||8062|15653||2 028609|R03DC0302|Montelukast Portfarma|filmhtfl|10|mg|28|stk|1|ţpakki||R03DC03|01.10.2011||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|4657|5513|lyfalmen|||2|28|0|28,0000|Portfarma ehf|Portfarma|Montelúkast||3264||3264|5513||2 028610|N04BC0503|Pramipexole Portfarma|töflur|0,18|mg|100|stk|1|ţpakki||N04BC05|01.02.2010||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|3918|2644|lyfalmen|V0267|2465|2|100|0|7,2000|Portfarma ehf|Portfarma|Pramipexól||1167||1167|2644||2 028739|C08CA0502|Adalat Oros|forđatfl|30|mg|28|stk|1|ţpakki||C08CA05|01.03.2013||R|1|0|0|0|G|0|BGB|0|0|0|100|DKK|2467|4423|lyfalmen|V0085|4423|1|28|0|28,0000|Icepharma hf|Bayer Pharma AG|Nífedipín||||2467|4423||2 028907|J02AC0103|Fluconazole Portfarma|hylki|50|mg|7|stk|1|ţpakki||J02AC01|01.05.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|1362|1595|lyfalmen|V0551|1595|2|7|0|1,7500|Portfarma ehf|Portfarma|Flúkónazól||400||400|1595||2 028918|J02AC0103|Fluconazole Portfarma|hylki|50|mg|30|stk|1|ţpakki||J02AC01|01.05.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|4998|3393|lyfalmen|V0552|3393|2|30|0|7,5000|Portfarma ehf|Portfarma|Flúkónazól||1714||1714|3393||2 028929|J02AC0103|Fluconazole Portfarma|hylki|150|mg|1|stk|1|ţpakki||J02AC01|01.05.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|577|1837|lyfalmen|V0554|1837|2|1|0|0,7500|Portfarma ehf|Portfarma|Flúkónazól||577||577|1837||2 028940|J02AC0103|Fluconazole Portfarma|hylki|150|mg|2|stk|1|ţpakki||J02AC01|01.05.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|563|1818|lyfalmen|V0555|1818|2|2|0|1,5000|Portfarma ehf|Portfarma|Flúkónazól||563||563|1818||2 028953|J02AC0103|Fluconazole Portfarma|hylki|150|mg|4|stk|1|ţpakki||J02AC01|01.05.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|2031|1595|lyfalmen|V0556|1595|2|4|0|3,0000|Portfarma ehf|Portfarma|Flúkónazól||400||400|1595||2 029066|R01AD0801|Flixonase|nefúđi|50|mcg/sk|16|ml|1|stauk|120 sk|R01AD08|01.04.1992||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|1081|2527|lyfalmen|||1|16|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||||1081|2527||1 029078|N06AX2201|Valdoxan|filmhtfl|25|mg|28|stk|1|ţpakki||N06AX22|01.01.2010||R|1|1|0|0|0|0|SEV|0|0|0|100|DKK|7696|11576|lyfalmen|||1|28|0|28,0000|Icepharma hf|Servier|Agómelatín||7696||7696|11576||2 029100|N06AX2201|Valdoxan|filmhtfl|25|mg|84|stk|1|ţpakki||N06AX22|01.01.2010||R|1|1|0|0|0|0|SEV|0|0|0|100|DKK|19259|26893|lyfalmen|||1|84|0|84,0000|Icepharma hf|Servier|Agómelatín||19259||19259|26893||2 029198|R06AX2201|Kestine|filmhtfl|20|mg|30|stk|1|ţpakki||R06AX22|01.06.2012||R|1|0|0|0|G|0|APS|0|0|1|100|DKK|2937|5066|lyfalmen|||1|30|0|60,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||2937||2937|5066||1 029276|J04BA0202|Dapsone|töflur|50|mg|28|stk|1|ţpakki||J04BA02|01.04.2013||R|0|0|0|1|G|0|AUK|0|0|0|100|XEU|1122|2583|lyfalmen|||0|28|0|28,0000|Actavis Group hf|Actavis UK Ltd.|Dapsón||1122||1122|2583||1 029287|C03DB0105|Amiloride|töflur|5|mg|28|stk|1|ţpakki||C03DB01|01.04.2009||R|0|0|0|0|G|0|AUK|0|0|0|100|GBP|253|1394|lyfalmen|||2|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Amiloridhýdróklóríđ||||253|1394||1 029307|A07EA0603|Entocort enema (D.A.C.)|endaţ.dr|0,02|mg/ml|7|stk|1|ţpakki|samsett pk|A07EA06|01.01.2007||R|||0|0|G|0|DAC|0|0|0|100|SEK|8012|12008|lyfalmen||||7|0|7,0000|D.A.C. ehf|D.A.C. ehf|Búdesóníđ||7272||8012|12008|31.5.2013| 029429|L01XX4101|Halaven|stl|0,44|mg/ml|2|ml|1|hgl|lausn|L01XX41|01.11.2011||R|0|0|0|1|0|1|EIS|0|0|0|100|SEK|67618|86743|lyfsjukr|||1|2|0||Vistor hf|Eisai Ltd|Eribulin||67618||67618|86743||1 029517|L01BB0503|Fludarabin Actavis|sts/irs|25|mg/ml|50|mg|1|hgl||L01BB05|01.04.2009||R|0|0|0|1|0|1|AGP|0|0|0|100|XEU|22890|30609|lyfsjukr|||2|50|0||Actavis Group hf|Actavis Group PTC ehf|Flúdarabín||22890||22890|30609||1 029528|L01CA0402 |Vinorelbin Actavis|irţ|10|mg/ml|5|ml|1|hgl||L01CA04|01.04.2009||R|0|0|0|1|0|1|AGP|0|0|0|100|XEU|5918|8541|lyfsjukr|||2|5|0||Actavis Group hf|Actavis Group PTC ehf|Vínorelbín||5918||5918|8541||1 029574|L01XX1904|Irinotecan Actavis|irţ|20|mg/ml|5|ml|1|hgl|lausn|L01XX19|01.04.2009||R|0|0|0|1|0|1|AGT|0|0|0|100|XEU|4546|6561|lyfsjukr|||2|5|0||Actavis Group hf|Actavis Group hf|Írinótekan||4546||4546|6561||1 029695|C09DA0601|Atacand Plus|töflur|44,5|mg|28|stk|1|ţpakki|32+12,5 mg|C09DA06|01.02.2010|31.05.2013|R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|5406|8443|lyfalmen|||1|28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||||5406|8443||1 029706|C09DA0601|Atacand Plus|töflur|44,5|mg|98|stk|1|ţpakki|32+12,5 mg|C09DA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|16778|23780|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||||16778|23780||1 029729|C09DA0601|Atacand Plus|töflur|57|mg|98|stk|1|ţpakki|32+25 mg|C09DA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|16778|23780|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||||16778|23780||1 029800|J01AA0208|Oracea|hylki|40|mg|56|stk|1|ţpakki|međ br.losunarhrađa|J01AA02|01.12.2011||R|1|0|0|0|0|0|GAN|0|0|1|100|SEK|6796|10345|lyfalmen|||1|56|0|22,4000|Icepharma hf|Galderma Nordic AB|Doxýcýklín||6796||6796|10345||2 029811|B02BX0401|Nplate|sts|250|mcg|1|hgl|1|pakki||B02BX04|01.04.2010||R|0|1|0|1|0|1|AEU|0|1|0|100|DKK|101800|129642|lyfsjukr|||1|1|0|8,3300|Vistor hf|Amgen Europe B.V.|Romiplóstím||101800||101800|129642||1 029822|B02BX0401|Nplate|sts|500|mcg|1|hgl|1|pakki||B02BX04|01.04.2010||R|0|1|0|1|0|1|AEU|0|1|0|100|DKK|203598|257398|lyfsjukr|||1|1|0|16,6600|Vistor hf|Amgen Europe B.V.|Romiplóstím||203598||203598|257398||1 029860|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|30|stk|1|ţpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 029869|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|105|stk|1|ţpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|105|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 029878|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|210|stk|1|ţpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 029887|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|30|stk|1|ţpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 029896|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|105|stk|1|ţpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|105|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 029905|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|210|stk|1|ţpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 030108|R06AX2701|Aerius|filmhtfl|5|mg|10|stk|1|ţpakki||R06AX27|01.11.2012||R|1|0|0|0|G|0|MLD|0|0|1|100|DKK|635|1917|lyfalmen|V0366|853|1|10|0|10,0000|Vistor hf|Merck Sharp & Dohme Limited|Deslóratadín||635||635|1917||1 030313|G04CA0206|Tamsulosin Portfarma|forđahlk|0,4|mg|90|stk|1|ţpakki||G04CA02|01.05.2011||R|1|0|0|0|G|0|POF|0|0|0|100|SEK|5056|3137|lyfalmen|V0148|2282|2|90|0|90,0000|Portfarma ehf|Portfarma|Tamsúlósín||1527||1527|3137||2 030315|N03AX1501|Zonegran|hylki|100|mg|98|stk|1|ţpakki||N03AX15|01.03.2007||R|1|0|0|0|G|0|EIS|0|0|0|100|SEK|22831|31376|lyfalmen|||1|98|0|49,0000|Vistor hf|Eisai Ltd|Zonisamíđ||22831||22831|31376||1 030627|N05AH0201|Leponex|töflur|100|mg|100|stk|1|glas||N05AH02|01.04.1993||R|1|0|0|0|G|0|NOH|0|0|0|100|DKK|9370|13866|lyfalmen|V0277|13864|1|100|0|33,3333|Vistor hf|Novartis Healthcare A/S-|Klózapín||9370||9370|13866||1 030635|N05AH0201|Leponex|töflur|25|mg|100|stk|1|glas||N05AH02|01.04.1993||R|1|0|0|0|G|0|NOH|0|0|0|100|IKR|2884|4993|lyfalmen|||1|100|0|8,3333|Vistor hf|Novartis Healthcare A/S-|Klózapín||2884||2884|4993||1 030822|QI02AB0001|Startvac|stl|||2|ml|20|glös|fleyti|QI02AB|01.05.2010||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|16384|28581|vetorma|||0|40|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||||16384|28581||2 030940|C07AB0210|Metoprolol Mylan|töflur|50|mg|100|stk|1|glas||C07AB02|01.10.1995||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1457|3041|lyfalmen|V0051|3041|2|100|0|33,3333|Icepharma hf|Mylan AB|Metóprólól||1457||1457|3041||2 031039|C07AB0210|Metoprolol Mylan|töflur|100|mg|100|stk|1|glas||C07AB02|01.10.1995||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|2303|4198|lyfalmen|||2|100|0|66,6667|Icepharma hf|Mylan AB|Metóprólól||2303||2303|4198||2 031070|A04AD0101|Scopoderm|forđapl|1|mg/72kls|2|stk|1|pakki||A04AD01|01.07.1985||L|0|0|0|0|0|0|NEH|0|0|1|100|DKK|||lyfalmen|||0|2|0|2,0000|Artasan ehf|Novartis Healthcare A/S|Skópólamín|||||2758||1 031088|A10AB0401|Humalog|stl|100|ae/ml|10|ml|1|hgl||A10AB04|01.01.1997||R|0|0|0|0|G|0|ELD|0|0|0|100|XEU|3067|5243|lyfalmen|||1|10|0|25,0000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||3067||3067|5243||2 031201|L01BA0109|Metoject|stl|50|mg/ml|0,25|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|3131|5331|lyfalmen|||1|0,25|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||3131||3131|5331||2 031314|L01AX0301|Temodal|hylki|20|mg|20|sk-pokar|1|pakki||L01AX03|01.01.2010||R|0|0|0|1|0|1|SCP|0|1|0|100|DKK|66547|85399|lyfsjukr|||1|20|0||Vistor hf|Schering-Plough|Temozolomid||66547||66547|85399||1 031325|L01AX0301|Temodal|hylki|100|mg|5|sk-pokar|1|pakki||L01AX03|01.01.2010||R|0|0|0|1|0|1|SCP|0|1|0|100|DKK|81077|103634|lyfsjukr|||1|5|0||Vistor hf|Schering-Plough|Temozolomid||81077||81077|103634||1 031394|L01AX0301|Temodal|hylki|250|mg|5|sk-pokar|1|pakki||L01AX03|01.01.2010||R|0|0|0|1|0|1|SCP|0|1|0|100|DKK|178751|226215|lyfsjukr|||1|5|0||Vistor hf|Schering-Plough|Temozolomid||178751||178751|226215||1 031773|C01DA0801|Sorbangil|töflur|20|mg|100|stk|1|glas||C01DA08|01.01.1985||R|1|0|0|0|G|0|REP|0|0|0|100|SEK|2212|4074|lyfalmen|||1|100|0|33,3333|Vistor hf|Recip AB|Ísósorbíđ dínítrat||2212||2212|4074||1 031849|A10AB0503|NovoRapid Penfill|stl|100|ein/ml|3|ml|5|rörlyk||A10AB05|01.07.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|6030|9297|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||6030||6030|9297||1 031942|H01BA0401|Glypressin|sts|1|mg/hgl|1|mg|5|hgl|og leysir|H01BA04|01.01.1998||R|0|0|0|0|0|1|FEL|0|0|0|100|DKK|23616|31521|lyfsjukr|||1|5|0|0,4200|Vistor hf|Ferring Lćgemidler A/S|Terlípressín||23616||23616|31521||1 031971|C07AA0705|Sotalol Mylan|töflur|160|mg|100|stk|1|plglas||C07AA07|01.01.1994||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|2110|3934|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Sótalól||2110||2110|3934||2 032523|N05AX1201|Abilify|mixtúra|1|mg/ml|150|ml|1|fl||N05AX12|01.02.2007||R|0|0|0|0|G|0|OTS|0|0|0|100|DKK|21435|29624|lyfalmen|||1|150|0|10,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||21435||21435|29624||1 032649|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|50|ml|1|hgl|plast|QP54AA01|01.01.1985||R|0|0|0|0|0|0|MEF|1|0|0|100|XEU|3864|6741|vetorma|||0|50|0||Vistor hf|Merial (MSD)|Ivermectinum||3864||3864|6741||1 032664|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|200|ml|1|fl||QP54AA01|01.01.1985||R|0|0|0|0|0|0|MEF|1|0|0|100|XEU|15080|26306|vetorma|||0|200|0||Vistor hf|Merial (MSD)|Ivermectinum||15080||15080|26306||1 032706|C03EA0113|Diuramin|töflur|55|mg|100|stk|1|ţpakki|5+50 mg|C03EA01|01.05.2013||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|1256|2386|lyfalmen|V0558|2386|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Hýdróklórtíazíđ og kalíumsparandi lyf||978||978|2386||2 033124|L02BX0201|Firmagon|sts|80|mg|1|hgl|1|pakki|leysir|L02BX02|01.11.2010||R|0|1|0|1|G|0|FER|0|0|0|100|DKK|21726|29989|lyfalmen|||1|1|0|29,6300|Vistor hf|Ferring|Degarelix||||21726|29989||1 033135|L02BX0201|Firmagon|sts|120|mg|2|hgl|1|pakki|leysir|L02BX02|01.11.2010||R|0|1|0|1|G|0|FER|0|0|0|100|DKK|43332|57105|lyfalmen|||1|2|0|88,8900|Vistor hf|Ferring|Degarelix||||43332|57105||1 033193|QP54AA0105|Noromectin|pasta|18,7|mg/g|7,49|g|1|áf.spr|Fyrir hesta|QP54AA01|01.11.2011||R|0|0|0|0|0|0|NOB|1|0|0|100|XEU|1245|2172|vetorma|||0|7,49|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||1245||1245|2172||2 033195|N02AA5501|Targin|forđatfl|15|mg|28|stk|1|ţpakki|10+5 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|3131|5331|lyfalmen|||1|28|0|3,7400|Icepharma hf|Norpharma|Oxycodonum í blöndum||3131||3131|5331||2 033201|QJ01DD9001|Eficur vet.|stl|50|mg/ml|100|ml|1|hgl||QJ01DD90|01.02.2010||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|9324|18076|vetalmen|||0|100|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Ceftiofurhydróklóríđ||||9324|18076||2 033206|N02AA5501|Targin|forđatfl|15|mg|98|stk|1|ţpakki|10+5 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|10669|15643|lyfalmen|||1|98|0|13,0700|Icepharma hf|Norpharma|Oxycodonum í blöndum||10669||10669|15643||2 033218|N02AA5501|Targin|forđatfl|30|mg|28|stk|1|ţpakki|20+10 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|6266|9619|lyfalmen|||1|28|0|7,4700|Icepharma hf|Norpharma|Oxycodonum í blöndum||6266||6266|9619||2 033229|N02AA5501|Targin|forđatfl|30|mg|98|stk|1|ţpakki|20+10 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|18495|25935|lyfalmen|||1|98|0|26,1400|Icepharma hf|Norpharma|Oxycodonum í blöndum||18495||18495|25935||2 033251|S01CA0102|Tobradex|augndr|||5|ml|1|glas|3+1 mg/ml|S01CA01|01.06.2007||R|0|0|0|0|G|0|ACK|0|0|1|100|USD|1269|2784|lyfalmen|||0|5|0||Vistor hf|Alcon Denmark A/S|Dexametasón||1269||1269|2784||1 033777|L02BG0404|Letromal|filmhtfl|2,5|mg|100|stk|1|ţpakki||L02BG04|01.04.2011||R|0|0|0|0|G|0|WIH|0|0|0|100|XEU|19099|20258|lyfalmen|V0185|20258|2|100|0|100,0000|Portfarma ehf|Williams & Halls|Letrózól||13972||13972|20258||2 033884|J05AE1001|Prezista|filmhtfl|400|mg|60|stk|1|plglas||J05AE10|01.11.2009||R|1|0|0|1|0|1|JCI|0|0|0|100|SEK|84872|108397|lyfsjukr|||1|60|0|20,0000|Vistor hf|Janssen-Cilag International N.V.|Darunavír||84872||84872|108397||1 033895|J05AE1001|Prezista|filmhtfl|600|mg|60|stk|1|plglas||J05AE10|01.11.2009||R|1|0|0|1|0|1|JCI|0|0|0|100|SEK|110703|140815|lyfsjukr|||1|60|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Darunavír||110703||110703|140815||1 034033|QJ01MA9001|Baytril vet.|töflur|50|mg|10|stk|1|ţpakki||QJ01MA90|01.03.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2521|5013|vetalmen|||0|10|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||||2521|5013||2 034157|J07AM5104|Diftavax|bóluefni|||0,5|ml|1|spr|einnota sprauta|J07AM51|01.01.2000||R|0|0|0|0|0|0|SPM|0|0|1|100|XEU|760|2088|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Stífkrampatoxóíđ í blöndum međ barnaveikistoxóíđum||760||760|2088||2 034401|J06BA0208|Privigen|irl|100|mg/ml|25|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|24420|32530|lyfsjukr|||1|25|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í ćđ||24420||24420|32530||2 034423|J07BA0201|Ixiaro|stl|6|mcg|0,5|ml|1|spr|dreifa|J07BA02|01.01.2012||R|0|0|0|0|0|0|IAG|0|0|0|100|SEK|15804|22557|lyfalmen|||1|0,5|0||Intercell AG|Intercell AG|Japönsk heilabólguveira óvirk||15804||15804|22557||2 034468|B01AC2201|Efient|filmhtfl|5|mg|28|stk|1|ţpakki||B01AC22|01.12.2009||R|0|1|0|0|G|0|ELD|0|0|0|100|XEU|8276|12369|lyfalmen|||1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Prasugrel||||8276|12369||2 034479|B01AC2201|Efient|filmhtfl|10|mg|28|stk|1|ţpakki||B01AC22|01.12.2009||R|0|1|0|0|G|0|ELD|0|0|0|100|XEU|8276|12369|lyfalmen|||1|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Prasugrel||||8276|12369||2 034494|N05CM1801|Dexdor|irţ|100|mcg/ml|10|ml|4|hgl|lausn|N05CM18|01.03.2012||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|78022|99800|lyfsjukr|||1|40|0|4,0000|Vistor hf|Orion Corporation|Dexmedetómid||78022||78022|99800||1 034934|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|20|sk-hyl||S01BC03|01.04.1996||R|0|0|0|0|G|0|NOL|0|0|1|100|SEK|1858|3590|lyfalmen|V0367|3590|1|6|0||Vistor hf|Novartis Healthcare A/S|Díklófenak||1858||1858|3590||1 034983|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|40|sk-hyl||S01BC03|01.04.1996||R|0|0|0|0|G|0|NOL|0|0|1|100|SEK|3108|5300|lyfalmen|||1|12|0||Vistor hf|Novartis Healthcare A/S|Díklófenak||3108||3108|5300||1 034988|L03AB0702|Rebif|stl|44|mcg/lykj|0,5|ml|4|rörlyk||L03AB07|01.03.2010||R|0|0|0|1|0|1|MSE|0|1|0|100|SEK|182663|231125|lyfsjukr|||1|2|0|40,9300|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||182663||182663|231125||2 035024|V03AB1402|Protaminsulfat Leo Pharma|stl|10|mg/ml|5|ml|5|hgl||V03AB14|01.06.2007||R|0|0|0|0|0|1|LEP|0|0|0|100|DKK|7589|10953|lyfsjukr|||1|25|0||Vistor hf|LEO Pharma A/S|Prótamín||7589||7589|10953||1 035113|B05XA0501|Addex-Magnesium|irţ|1|mmol/ml|10|ml|10|plhgl||B05XA05|01.03.2010||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2305|3327|lyfsjukr|||1|100|0||Icepharma hf|Fresenius Kabi|Magnesíum súlfat||2305||2305|3327||2 035212|A07EC0202|Pentasa|forđatfl|500|mg|300|stk|1|ţpakki||A07EC02|01.04.1992||R|1|0|0|0|G|0|FER|0|0|0|100|DKK|16266|23137|lyfalmen|||1|300|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||16266||16266|23137||1 035444|C09CA0601|Atacand|töflur|16|mg|28|stk|1|ţpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|3753|6182|lyfalmen|||1|28|0|56,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||||3753|6182||1 035494|C07AB0211|Metoprolol ratiopharm|forđatfl|23,75|mg|100|stk|1|ţpakki||C07AB02|01.05.2012||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|1366|2917|lyfalmen|V0050|2917|2|100|0|15,8300|Medical ehf|ratiopharm GmbH|Metóprólól||1366||1366|2917||2 035515|N03AX0903|Lamotrin|dreifit.|50|mg|56|stk|1|ţpakki||N03AX09|01.11.2005||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1844|2274|lyfalmen|V0244|2274|2|56|0|9,3300|Actavis Group hf|Actavis hf|Lamótrigín||896||896|2274||1 035528|C07AB0211|Metoprolol ratiopharm|forđatfl|47,5|mg|100|stk|1|ţpakki||C07AB02|01.06.2012||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|1358|2906|lyfalmen|V0048|2906|2|100|0|31,6600|Medical ehf|ratiopharm GmbH|Metóprólól||1358||1358|2906||2 035563|C07AB0211|Metoprolol ratiopharm|forđatfl|95|mg|100|stk|1|ţpakki||C07AB02|01.05.2012||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|2425|4365|lyfalmen|V0049|4365|2|100|0|63,3300|Medical ehf|ratiopharm GmbH|Metóprólól||2425||2425|4365||2 035568|C09CA0601|Atacand|töflur|16|mg|98|stk|1|ţpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|10205|15008|lyfalmen|V0080|12711|1|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||10205||10205|15008||1 035597|C07AB0211|Metoprolol ratiopharm|forđatfl|190|mg|100|stk|1|ţpakki||C07AB02|01.06.2012||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|5299|7895|lyfalmen|V0054|7895|2|100|0|126,6600|Medical ehf|ratiopharm GmbH|Metóprólól||5005||5005|7895||2 036062|V03AE0202|Renvela|filmhtfl|800|mg|180|stk|1|pakki||V03AE02|01.04.2010||R|1|1|0|0|0|0|GZE|0|0|0|100|XEU|30634|38024|lyfalmen|||1|180|0|22,5000|Vistor hf|Genzyme Europe B.V.|Sevelamer||28128||28128|38024||1 036108|L03AB0702|Rebif|stl|22|mcg/lykj|0,5|ml|4|rörlyk||L03AB07|01.03.2010||R|0|0|0|1|0|1|MSE|0|1|0|100|SEK|149773|189848|lyfsjukr|||1|2|0|20,4700|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||149773||149773|189848||2 036145|M01AC0202|Tilcotil|töflur|20|mg|60|stk|1|glas||M01AC02|01.04.1988||R|1|0|0|0|G|0|MAS|0|0|1|100|SEK|6258|9609|lyfalmen|||1|60|0|60,0000|Vistor hf|Meda AS|Tenoxíkam||6258||6258|9609||1 036152|C09CA0601|Atacand|töflur|8|mg|28|stk|1|ţpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|2986|5133|lyfalmen|||1|28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||2986||2986|5133|30.6.2013|1 036228|C09CA0601|Atacand|töflur|8|mg|98|stk|1|ţpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|8547|12740|lyfalmen|V0081|10738|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||8547||8547|12740||1 036290|J05AE0301|Norvir|filmhtfl|100|mg|30|stk|1|glas||J05AE03|01.10.2010||R|1|0|0|1|0|1|ABV|0|0|0|100|DKK|6176|8914|lyfsjukr|||1|30|0|2,5000|Vistor hf|AbbVie Ltd.|Ritonavír||6176||6176|8914||1 036332|L01XE0401|Sutent|hylki|12,5|mg|30|stk|1|glas||L01XE04|01.10.2006||R|1|0|0|1|0|1|IPI|0|1|0|100|DKK|200304|253264|lyfsjukr|||1|30|0||Icepharma hf|Pfizer Limited|Sunitíníb||200304||200304|253264||1 036341|L01XE0401|Sutent|hylki|25|mg|30|stk|1|glas||L01XE04|01.10.2006||R|1|0|0|1|0|1|IPI|0|1|0|100|DKK|399524|503285|lyfsjukr|||1|30|0||Icepharma hf|Pfizer Limited|Sunitíníb||399524||399524|503285||1 036351|L01XE0401|Sutent|hylki|50|mg|30|stk|1|glas||L01XE04|01.10.2006||R|1|0|0|1|0|1|IPI|0|1|0|100|DKK|797369|1002581|lyfsjukr|||1|30|0||Icepharma hf|Pfizer Limited|Sunitíníb||797369||797369|1002581||1 036442|J01CE0204|Kaavepenin|töflur|800|mg|20|stk|1|ţpakki||J01CE02|01.01.1988||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|856|2219|lyfalmen|||1|20|0|8,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||856||856|2219||1 036517|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|60|ml|1|glas||J01CE02|01.07.1992||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|1505|3107|lyfalmen|||1|60|0|3,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1505||1505|3107||1 036541|A03AX1301|Minifom|dropar|||30|ml|1|glas|+drteljari|A03AX13|01.12.1975||L|0|0|0|0|0|0|AHN|0|0|0|100|IKR|||lyflausa|||0|30|0|6,0000|Aco Hud Nordic AB|Aco Hud Nordic AB|Silíkonsambönd|||||||1 036616|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|125|ml|1|glas||J01CE02|01.07.1992||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|2970|5111|lyfalmen|||1|125|0|6,2500|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||2970||2970|5111||1 036665|J01CE0204|Kaavepenin|töflur|800|mg|30|stk|1|ţpakki||J01CE02|01.01.1988||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|901|2280|lyfalmen|||1|30|0|12,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||901||901|2280||1 037287|N04BC0404|Requip Depot|forđatfl|2|mg|84|stk|1|ţpakki||N04BC04|01.09.2008||R|1|0|0|0|G|0|GSK|0|0|0|100|GBP|9267|8949|lyfalmen|V0532|8561|1|84|0|28,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||5776||5776|8949||1 037305|N04BC0404|Requip Depot|forđatfl|4|mg|84|stk|1|ţpakki||N04BC04|01.09.2008||R|1|0|0|0|G|0|GSK|0|0|0|100|GBP|18827|15362|lyfalmen|V0533|14820|1|84|0|56,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||10464||10464|15362||1 037323|N04BC0404|Requip Depot|forđatfl|8|mg|84|stk|1|ţpakki||N04BC04|01.09.2008||R|1|0|0|0|G|0|GSK|0|0|0|100|GBP|33438|28601|lyfalmen|V0534|28123|1|84|0|112,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||20620||20620|28601||1 037358|N04BA0201|Madopar|töflur|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.07.1990||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|2558|4547|lyfalmen|V0434|4547|1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2558||2558|4547||2 037531|D07AC1301|Elocon|húđlausn|0,1|%|30|ml|1|glas||D07AC13|01.01.2009||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1170|2648|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||1170||1170|2648||1 037584|N06AB0604|Sertralin Bluefish|filmhtfl|50|mg|30|stk|1|ţpakki||N06AB06|01.02.2013||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|967|1655|lyfalmen|V0151|1655|2|30|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Sertralín||444||444|1655||2 037595|N06AB0604|Sertralin Bluefish|filmhtfl|50|mg|100|stk|1|ţpakki||N06AB06|01.02.2013||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|2311|2772|lyfalmen|V0322|2772|2|100|0|100,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Sertralín||1260||1260|2772||2 037607|N06AB0604|Sertralin Bluefish|filmhtfl|100|mg|100|stk|1|ţpakki||N06AB06|01.02.2013||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|4353|4239|lyfalmen|V0323|4239|2|100|0|200,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Sertralín||2333||2333|4239||2 037846|A12BA0101|Kaleorid|forđatfl|750|mg|100|stk|1|glas||A12BA01|01.12.1972||L|1|0|0|0|G|0|LEP|0|0|0|100|DKK|||lyfalmen|||0|100|0|25,0000|Vistor hf|LEO Pharma A/S|Kalíumklóríđ|||||2343||1 037853|A12BA0101|Kaleorid|forđatfl|750|mg|250|stk|1|glas||A12BA01|01.12.1972||L|1|0|0|0|G|0|LEP|0|0|0|100|DKK|||lyfalmen|||0|250|0|62,5000|Vistor hf|LEO Pharma A/S|Kalíumklóríđ|||||3765||1 037895|C09CA0601|Atacand|töflur|4|mg|98|stk|1|ţpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|8813|13104|lyfalmen|||1|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||||8813|13104||1 038174|N06AB0501|Seroxat|töflur|20|mg|20|stk|1|ţpakki||N06AB05|01.04.1993||R|1|0|0|0|0|0|GSK|0|0|0|100|IKR|664|1568|lyfalmen|||1|20|0|20,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||380||380|1568||1 038448|N06AB0501|Seroxat|töflur|20|mg|100|stk|1|ţpakki||N06AB05|01.04.1993||R|1|0|0|0|G|0|GSK|0|0|0|100|IKR|2667|3224|lyfalmen|V0321|3062|1|100|0|100,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||1591||1591|3224||1 038513|D06BA0101|Flamazine|krem|10|mg/g|50|g|1|túpa||D06BA01|01.10.1988||R|0|0|0|0|0|0|SON|0|0|1|100|DKK|1059|2497|lyfalmen|||1|50|0||Icepharma hf|Smith & Nephew|Silfursúlfadíazín||1059||1059|2497||2 038554|C09CA0601|Atacand|töflur|4|mg|28|stk|1|ţpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|2706|4750|lyfalmen|||1|28|0|14,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||2706||2706|4750||1 038607|L03AA1301|Neulasta|stl|6|mg/penna|0,6|ml|1|penni|áfylltur penni, lausn|L03AA13|01.07.2006||R|0|0|0|1|0|1|AEU|0|0|0|100|DKK|177697|224892|lyfsjukr|||1|0,6|0|20,0000|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||177697||177697|224892||1 038689|L04AB0101|Enbrel|sts|25|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.04.2010|30.04.2013|R|0|0|0|1|0|1|WTE|0|1|0|100|DKK|79284|101384|lyfsjukr|||1|4|0|14,2900|Icepharma hf|Wyeth Europe|Etanercept||79284||79284|101384||2 039005|L01XA0301|Eloxatin|irţ|5|mg/ml|10|ml|1|hgl||L01XA03|01.03.2007||R|0|0|0|1|0|1|SNO|0|0|0|100|NOK|42054|54660|lyfsjukr|||1|10|0||Vistor hf|Sanofi-aventis Norge AS|Oxalíplatín||42054||42054|54660||1 039014|L01XA0301|Eloxatin|irţ|5|mg/ml|20|ml|1|hgl||L01XA03|01.03.2007||R|0|0|0|1|0|1|SNO|0|0|0|100|NOK|70299|90108|lyfsjukr|||1|20|0||Vistor hf|Sanofi-aventis Norge AS|Oxalíplatín||70299||70299|90108||1 039141|B01AF0101|Xarelto|filmhtfl|15|mg|42|stk|1|ţpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|16758|23755|lyfalmen|||1|42|0|63,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||16758|23755||2 039147|N04BC0701|Apomorfin PharmSwed|irl|5|mg/ml|20|ml|5|hgl|lausn|N04BC07|01.03.2013||R|0|0|0|1|0|1|PSS|0|0|0|100|SEK|42949|55783|lyfsjukr|||1|100|0|25,0000|Williams & Halls efh|PharmSwed|Apómorfín||42949||42949|55783||2 039430|J07AL5201|Synflorix|stl|||0,5|ml|1|áf.spr|m.nál, dreifa|J07AL52|01.04.2012||R|0|0|0|0|0|0|GLB|0|0|0|100|GBP|6852|10421|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Lungnabólga a.v.pneumok.Hreins pneumok polysakk móte.v Hae||6852||6852|10421||1 039631|C01BD0701|Multaq|filmhtfl|400|mg|20|stk|1|ţpakki||C01BD07|01.08.2010||R|1|1|0|1|0|0|SAA|0|0|0|100|NOK|4678|7447|lyfalmen|||1|20|0|10,0000|Vistor hf|Sanofi - Aventis|Dronedarón||||4678|7447||1 039643|C01BD0701|Multaq|filmhtfl|400|mg|100|stk|1|ţpakki||C01BD07|01.08.2010||R|1|1|0|1|0|0|SAA|0|0|0|100|NOK|21632|29872|lyfalmen|||1|100|0|50,0000|Vistor hf|Sanofi - Aventis|Dronedarón||||21632|29872||1 039676|N06AX0307|Mianserin Mylan|filmhtfl|30|mg|100|stk|1|ţpakki||N06AX03|01.06.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|3763|6196|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Míanserín||3763||3763|6196||2 039698|C07AB0311|Atenolol Mylan|töflur|25|mg|98|stk|1|ţpakki||C07AB03|01.04.1992||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|502|1669|lyfalmen|V0541|1621|2|98|0|32,6667|Icepharma hf|Mylan AB|Atenólól||454||454|1669||2 039709|C07AB0311|Atenolol Mylan|töflur|50|mg|98|stk|1|ţpakki||C07AB03|01.01.1991||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|676|1721|lyfalmen|V0542|1665|2|98|0|65,3333|Icepharma hf|Mylan AB|Atenólól||492||492|1721||2 039776|J01FA1001|Zitromax|mixtúrud|40|mg/ml|15|ml|1|glas||J01FA10|01.07.1994||R|0|0|0|0|0|0|PER|0|0|1|100|DKK|1313|2844|lyfalmen|||1|15|0|2,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1313||1313|2844||1 039784|J01FA1001|Zitromax|mixtúrud|40|mg/ml|22,5|ml|1|glas||J01FA10|01.01.1995||R|0|0|0|0|0|0|PER|0|0|1|100|DKK|1892|3636|lyfalmen|||1|22,5|0|3,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1892||1892|3636||1 039837|N02BE0107|Paratabs|filmhtfl|500|mg|30|stk|1|ţpakki||N02BE01|01.03.2013||L|1|0|0|0|0|0|APC|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||||1 039909|L01AA0101|Sendoxan|sts|200|mg|1|stk|1|hgl||L01AA01|01.07.1992||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|1395|2013|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíđ||1395||1395|2013||2 039935|C10AA0105|Simvastatin Actavis|filmhtfl|40|mg|98|stk|1|ţpakki||C10AA01|01.06.2009||R|1|0|0|0|G|0|AGP|0|0|0|100|IKR|1630|2014|lyfalmen|V0110|1971|2|98|0|130,6700|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||706||706|2014||1 039957|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|42|stk|1|ţpakki||J05AB11|01.01.2010||R|1|0|0|0|G|0|AGP|0|0|1|100|GBP|7634|8732|lyfalmen|V0182|8732|2|42|0|7,0000|Actavis Group hf|Actavis Group PTC ehf|Valacíklóvír||5617||5617|8732||1 039958|L01AA0101|Sendoxan|sts|500|mg|1|stk|1|hgl||L01AA01|01.01.1988||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|3495|5044|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíđ||3495||3495|5044||2 039968|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|10|stk|1|ţpakki||J05AB11|01.01.2010||R|1|0|0|0|G|0|AGP|0|0|1|100|GBP|1823|2122|lyfalmen|V0033|2122|2|10|0|1,6667|Actavis Group hf|Actavis Group PTC ehf|Valacíklóvír||785||785|2122||1 040089|L01AA0101|Sendoxan|sts|1|g|1|stk|1|hgl||L01AA01|01.07.1994||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|6973|10064|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíđ||6973||6973|10064||2 040426|R06AX2703|Desloratadine Actavis|filmhtfl|5|mg|30|stk|1|ţpakki||R06AX27|01.05.2012||R|1|0|0|0|G|0|APC|0|0|1|100|XEU|1327|2558|lyfalmen|V0366|2558|2|30|0|30,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Deslóratadín||1104||1104|2558||1 040543|S01XA2012|Dacriosol|augndr|3|mg/ml|15|ml|1|glas||S01XA20|01.03.2000||L|0|0|0|0|G|0|SAL|0|0|0|100|IKR|||lyfalmen|||0|15|0||Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Gervitár og ađrar óvirkar samsetningar|||||1792||1 040735|J01FA1005|Azithromycin Actavis|filmhtfl|500|mg|3|stk|1|ţpakki||J01FA10|01.12.2012||R|1|0|0|0|0|0|APC|0|0|1|100|XEU|1597|3063|lyfalmen|V0174|3063|2|3|0|5,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Azitrómýcín||1473||1473|3063||1 041423|G03AA1203|Yasminelle|töflur|||63|stk|1|ţpakki|3+0,02 mg|G03AA12|01.12.2006||R|0|0|0|0|0|0|BYP|0|0|0|100|DKK|3558|5915|lyfalmen|V0593|5915|1|63|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og ethinylestradíól||3558||3558|5915||2 041490|N06AB0404|Citalopram Bluefish|filmhtfl|20|mg|100|stk|1|ţpakki||N06AB04|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|2521|2204|lyfalmen|V0318|2204|2|100|0|100,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Cítalópram||845||845|2204||2 041704|QG03XA9101|Improvac|stl|300|mcg|20|ml|12|fl||QG03XA91|01.08.2010||R|0|0|0|0|0|0|ZBE|1|0|0|100|DKK|28437|49607|vetorma|||0|240|0||Icepharma hf|Zoetis Belgium S.A.|gonadotropin releasing factor analogue, conjugated||||28437|49607||2 041749|QI04AB0101|Lambivac, vet.|stl|126|Lf/ml|100|ml|1|fl|dreifa|QI04AB01|01.04.2007||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|4453|7768|vetorma|||0|100|0||Vistor hf|Intervet International BV|||4453||4453|7768||1 041898|N06AX0307|Mianserin Mylan|filmhtfl|10|mg|90|stk|1|ţpakki||N06AX03|01.06.2008||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1243|2748|lyfalmen|||2|90|0|15,0000|Icepharma hf|Mylan AB|Míanserín||||1243|2748||2 041938|A02BC0508|Esomeprazol Actavis|sţ-hylki|40|mg|28|stk|1|ţpakki|hart|A02BC05|01.03.2012||R|1|0|0|0|0|0|APC|0|0|0|100|IKR|2903|2183|lyfalmen|V0005|2183|2|28|0|37,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||830||830|2183||1 041996|A06AG1101|Microlax|innhl|||5|ml|4|túpa||A06AG11|01.12.1972||L|0|0|0|0|0|0|MCN|0|0|0|100|IKR|||lyflausa|||0|20|0|4,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, ţ.m.t. í blöndum|||||||1 042036|C07AB0205|Seloken|stl|1|mg/ml|5|ml|5|lykjur||C07AB02|01.01.1985||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|1598|3234|lyfalmen|||1|25|0|0,1667|Vistor hf|AstraZeneca A/S DK|Metóprólól||1598||1598|3234||1 042101|N01BB0902|Naropin|irl|2|mg/ml|100|ml|5|plpok||N01BB09|01.05.1998||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|13451|18764|lyfsjukr|||1|500|0||Vistor hf|AstraZeneca A/S DK|Rópívakaín||13451||13451|18764||1 042305|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|10|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2571|3711|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||2571||2571|3711||2 042314|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3108|4486|lyfsjukr|||2|7500|0||Icepharma hf|Fresenius Kabi|Kolvetni||3108||3108|4486||2 042323|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|1000|ml|10|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|4400|6350|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||4400||4400|6350||2 042332|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|4510|6509|lyfsjukr|||2|7500|0||Icepharma hf|Fresenius Kabi|Kolvetni||4510||4510|6509||2 042360|B05BA0311|Glucos Fresenius Kabi|irl|500|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|5745|8291|lyfsjukr|||2|7500|0||Icepharma hf|Fresenius Kabi|Kolvetni||5745||5745|8291||2 042369|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|40|plpok|Excel umbúđir|B05BA03|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|7090|10233|lyfsjukr|||2|4000|0||Icepharma hf|Fresenius Kabi|Kolvetni||7090||7090|10233||2 042378|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|20|plpok|Freeflex umbúđir|B05BA03|01.03.2010||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3842|5545|lyfsjukr|||2|5000|0||Icepharma hf|Fresenius Kabi|Kolvetni||3842||3842|5545||2 042387|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2941|4245|lyfsjukr|||2|7500|0||Icepharma hf|Fresenius Kabi|Kolvetni||2941||2941|4245||2 042396|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|1000|ml|10|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2248|3244|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||2248||2248|3244||2 042405|B05BB0213|Kalium-Natrium-Glucose "Fresenius Kabi"|irl|||1000|ml|10|plpok|Freeflex umbúđir|B05BB02|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2813|4060|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ kol­vetnum||2813||2813|4060||2 042451|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|20|plpok|Freeflex umbúđir|B05BB01|01.03.2010||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3692|5328|lyfsjukr|||2|5000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||3692||3692|5328||2 042460|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BB01|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2522|3640|lyfsjukr|||2|7500|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||2522||2522|3640||2 042469|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|10|plpok|Freeflex umbúđir|B05BB01|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|1817|2622|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||1817||1817|2622||2 042478|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|40|plpok|Excel umbúđir|B05BB01|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|6165|8898|lyfsjukr|||2|4000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||6165||6165|8898||2 042524|B05BB0115|Ringer-acetat Fresenius Kabi|irl|||1000|ml|10|plpok|Freeflex umbúđir|B05BB01|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2057|2969|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||2057||2057|2969||2 042549|J07BF0301|Imovax Polio|bóluefni|||0,5|ml|1|áf.spr|međ nál|J07BF03|01.01.1996||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|2399|4330|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Mćnusótt, dauđ veira||2399||2399|4330||2 042551|B05BB0209|Glucos 100 mg/ml med Na40 + K20 Fres|irl|||1000|ml|10|plpok||B05BB02|01.04.2009||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3329|4805|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ kol­vetnum||3329||3329|4805||2 042556|J07BF0301|Imovax Polio|bóluefni|||0,5|ml|20|áf.spr|međ nál|J07BF03|01.01.1996||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|14986|21531|lyfalmen|||1|10|0||Icepharma hf|Sanofi Pasteur MSD|Mćnusótt, dauđ veira||14986||14986|21531||2 042561|QM01AH9201|Trocoxil|tuggutfl|6|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|0|0|0|0|0|0|IPF|0|0|0|100|DKK|1359|2703|vetalmen|||0|2|0||Icepharma hf|Pfizer Limited|Mavakoxíb||1359||1359|2703||2 042573|QM01AH9201|Trocoxil|tuggutfl|20|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|0|0|0|0|0|0|IPF|0|0|0|100|DKK|2026|4030|vetalmen|||0|2|0||Icepharma hf|Pfizer Limited|Mavakoxíb||2026||2026|4030||2 042584|QM01AH9201|Trocoxil|tuggutfl|30|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|0|0|0|0|0|0|IPF|0|0|0|100|DKK|2716|5388|vetalmen|||0|2|0||Icepharma hf|Pfizer Limited|Mavakoxíb||2716||2716|5388||2 042595|QM01AH9201|Trocoxil|tuggutfl|75|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|0|0|0|0|0|0|IPF|0|0|0|100|DKK|5433|10605|vetalmen|||0|2|0||Icepharma hf|Pfizer Limited|Mavakoxíb||5433||5433|10605||2 042607|QM01AH9201|Trocoxil|tuggutfl|95|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|0|0|0|0|0|0|IPF|0|0|0|100|DKK|6247|12168|vetalmen|||0|2|0||Icepharma hf|Pfizer Limited|Mavakoxíb||6247||6247|12168||2 042615|B05BB0210|Rehydrex m. gl. 25 mg/ml Fresenius Kabi|irl|||1000|ml|10|plpok|Freeflex umbúđir|B05BB02|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2452|3539|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ kol­vetnum||2452||2452|3539||2 042669|V07AB0013|Sterilt vatten/vann/vand Fresenius Kabi|leysir|||100|ml|40|plastl|fyrir stungulyf|V07AB|01.04.2008||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|4000|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||2 042775|A06AB0603|Senokot (Icepharma)|töflur|7,5|mg|500|stk|1|glas||A06AB06|01.10.2012||R|1|0|0|0|0|0|ICE|0|0|0|100|GBP|2242|4115|lyfalmen|||3|500|0||Icepharma hf|Icepharma hf|Senna||2242||2242|4115||2 043232|N05CD0306|Flunitrazepam Mylan|töflur|1|mg|30|stk|1|ţpakki||N05CD03|01.10.1992||R|1|0|1|0|0|0|MYL|0|0|0|100|SEK|600|1869|lyfalmen|||2|30|0|30,0000|Icepharma hf|Mylan AB|Flúnítrazepam||600||600|1869||2 043257|N01BB0902|Naropin|stl/irl|2|mg/ml|20|ml|5|plastl||N01BB09|01.05.1998||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|3332|4809|lyfsjukr|||1|100|0||Vistor hf|AstraZeneca A/S DK|Rópívakaín||3332||3332|4809||1 043345|N03AX1405|Matever|filmhtfl|1000|mg|100|stk|1|ţpakki||N03AX14|01.02.2012||R|1|0|0|0|0|0|PSA|0|0|0|100|XEU|19123|12282|lyfalmen|V0516|11666|2|100|0|66,6700|Portfarma ehf|Pharmathen S.A.|Levetíracetam||8212||8212|12282||2 043379|R03AC1201|Serevent|innúđal|25|mcg/sk|120|skammtar|1|stauk|HFA 134a|R03AC12|01.04.2007||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|4027|6557|lyfalmen|||1|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról||4027||4027|6557||1 043547|N01BB0902|Naropin|stl|7,5|mg/ml|20|ml|5|plastl||N01BB09|01.05.1998||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|6160|8890|lyfsjukr|||1|100|0||Vistor hf|AstraZeneca A/S DK|Rópívakaín||6160||6160|8890||1 043729|N05CD0503|Halcion|töflur|0,125|mg|30|stk|1|ţpakki||N05CD05|01.12.1983||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|571|1829|lyfalmen|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Tríazólam||571||571|1829||1 043745|G03CA0401|Ovestin|töflur|2|mg|30|stk|1|ţpakki||G03CA04|01.07.1989||R|0|0|0|0|G|0|ORG|0|0|0|100|DKK|1241|2746|lyfalmen|||1|30|0|30,0000|Vistor hf|N.V. Organon|Estríól||1241||1241|2746||1 043919|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|10|ml|20|lykjur|fyrir stl|V07AB|01.07.1995||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|200|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||2 043935|V07AB0013|Sterilt vatten/vann/vand Fresenius Kabi|leysir|||10|ml|20|plastl|fyrir stungulyf|V07AB|01.10.1994||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|200|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||2 043988|B03AA0705|Ferrous Sulphate|töflur|200|mg|100|stk|1|glas|sykurhúđađar|B03AA07|01.09.2009||L|1|0|0|0|0|0|AUK|0|0|1|100|IKR|||lyflausa|||0|100|0|32,5000|Actavis Group hf|Actavis UK Ltd.|Ferrósúlfat|||||||1 044360|B03AC0203|Venofer (Lyfjaver)|stl|20|mg/ml|5|ml|5|lykjur||B03AC02|01.05.2006||R|0|0|0|0|G|0|LVR|0|0|1|100|CHF|12869|18874|lyfalmen|V0034|18874|3|25|0|5,0000|Lyfjaver ehf|Lyfjaver ehf|Járnoxíđ (sykurflétta)||12869||12869|18874||3 044580|L01XE1001|Afinitor|töflur|5|mg|30|stk|1|ţpakki||L01XE10|01.09.2011||R|0|0|0|1|0|1|NOE|0|1|0|100|DKK|385974|486280|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Everolímus||||385974|486280||1 044591|L01XE1001|Afinitor|töflur|10|mg|30|stk|1|ţpakki||L01XE10|01.09.2011||R|0|0|0|1|0|1|NOE|0|1|0|100|DKK|544678|685453|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Everolímus||||544678|685453||1 044739|N04BC0502|Sifrol|forđatfl|0,52|mg|100|stk|1|pakki||N04BC05|01.02.2010||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|17357|24506|lyfalmen|||1|100|0|20,8000|Vistor hf|Boehringer Ingelheim International|Pramipexól||17357||17357|24506||1 044752|N04BC0502|Sifrol|forđatfl|2,1|mg|100|stk|1|pakki||N04BC05|01.02.2010||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|50634|66269|lyfalmen|||1|100|0|84,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||50634||50634|66269||1 044763|N04BC0502|Sifrol|forđatfl|0,52|mg|10|stk|1|pakki||N04BC05|01.02.2010||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|2712|4758|lyfalmen|||1|10|0|2,0800|Vistor hf|Boehringer Ingelheim International|Pramipexól||2712||2712|4758||1 044888|QN05CM9001|Domosedan, vet.|munnh.hl|7,6|mg/ml|3|ml|1|áf.spr|munnsk.dćla|QN05CM90|01.01.2012||R|0|0|0|0|0|0|OCO|0|0|0|100|DKK|2113|4203|vetalmen|||0|3|0||Icepharma hf|Orion Corporation (I)|||2113||2113|4203||2 045385|J07BF0301|Imovax Polio|bóluefni|||0,5|ml|10|áf.spr|međ nál|J07BF03|01.01.1996||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|7492|11297|lyfalmen|||1|5|0||Icepharma hf|Sanofi Pasteur MSD|Mćnusótt, dauđ veira||7492||7492|11297||2 045510|C10AA0105|Simvastatin Actavis|filmhtfl|20|mg|98|stk|1|ţpakki||C10AA01|01.06.2009||R|1|0|0|0|G|0|AGP|0|0|0|100|IKR|1050|1665|lyfalmen|V0109|1629|2|98|0|65,3400|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||451||451|1665||1 045533|C10AA0105|Simvastatin Actavis|filmhtfl|10|mg|98|stk|1|ţpakki||C10AA01|01.06.2009||R|1|0|0|0|G|0|AGP|0|0|0|100|IKR|868|1531|lyfalmen|V0108|1497|2|98|0|32,6700|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||353||353|1531||1 045588|J01DC0204 |Cefuroxim Villerton|sts|750|mg/hgl|10|hgl|1|pakki||J01DC02|01.05.2009||R|0|0|0|0|0|1|VIL|0|0|0|100|NOK|2944|4249|lyfsjukr|||1|10|0|2,5000|Lyfjaver ehf|Villerton Invest AS|Cefúroxím||2944||2944|4249||3 045599|J01DC0204 |Cefuroxim Villerton|sts|1500|mg/hgl|10|hgl|1|pakki||J01DC02|01.05.2009||R|0|0|0|0|0|1|VIL|0|0|0|100|NOK|5887|8496|lyfsjukr|||1|10|0|5,0000|Lyfjaver ehf|Villerton Invest AS|Cefúroxím||5887||5887|8496||3 045634|N02AA5907|Pinex Comp Forte|eţ-stíll|530|mg|10|stk|1|pakki|30+500 mg|N02AA59|01.01.2011||R|0|0|0|0|0|0|AGT|0|0|1|100|XEU|402|1598|lyfalmen|||2|10|0|3,3333|Actavis Group hf|Actavis Group hf|Kódein í blöndum nema međ geđlyfjum||402||402|1598||1 045765|C03CA0110|Impugan|dropar|10|mg/ml|30|ml|1|glas||C03CA01|01.06.2013||R|0|0|0|0|G|0|AGT|0|0|0|100|SEK|1709|3386|lyfalmen|||2|30|0|7,5000|Actavis Group hf|Actavis Group hf|Fúrósemíđ||1709||1709|3386||1 046077|QJ01DD9101|Convenia|sts|80|mg/ml|10|ml|1|hgl|+leysir, lausn|QJ01DD91|01.01.2008||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|21421|41304|vetalmen|||0|10|0||Icepharma hf|Zoetis Belgium S.A.|||21421||21421|41304||2 046248|S01EE0105|Monoprost|augndr|50|mcg/ml|0,2|ml|30|sk-hyl|30 (6x5)|S01EE01|01.03.2013||R|0|0|0|0|G|0|THA|0|0|0|100|SEK|1720|3401|lyfalmen|||1|6|0|30,0000|Vistor hf|Laboratories THEA|Latanóprost||1720||1720|3401||1 046269|C09AA0502|Ramil|töflur|2,5|mg|100|stk|1|ţpakki||C09AA05|01.03.2006||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|1042|2473|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis hf|Ramipríl||1042||1042|2473||1 046396|A04AA0102|Ondansetron Vian|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.02.2008||R|0|0|0|0|G|0|VIS|0|0|0|100|DKK|3983|6496|lyfalmen|V0382|6399|1|10|0|1,2500|Icepharma hf|Vian SA|Ondansetrón||3983||3983|6496||2 046405|A10BB1202|Glimeryl|töflur|1|mg|90|stk|1|ţpakki||A10BB12|01.05.2006||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|687|1876|lyfalmen|V0021|1876|2|90|0|45,0000|Actavis Group hf|Actavis hf|Glímepíríđ||605||605|1876||1 046414|A10BB1202|Glimeryl|töflur|2|mg|90|stk|1|ţpakki||A10BB12|01.05.2006||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|812|2159|lyfalmen|V0022|2159|2|90|0|90,0000|Actavis Group hf|Actavis hf|Glímepíríđ||812||812|2159||1 046423|A10BB1202|Glimeryl|töflur|3|mg|90|stk|1|ţpakki||A10BB12|01.05.2006||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|1040|2471|lyfalmen|V0023|2471|2|90|0|135,0000|Actavis Group hf|Actavis hf|Glímepíríđ||1040||1040|2471||1 046687|A04AA0102|Ondansetron Vian|stl|2|mg/ml|4|ml|5|lykjur||A04AA01|01.02.2008||R|0|0|0|0|G|0|VIS|0|0|0|100|DKK|6633|10122|lyfalmen|||1|20|0|2,5000|Icepharma hf|Vian SA|Ondansetrón||6633||6633|10122||2 046745|N04BC0405|Ropinirol Portfarma|filmhtfl|0,5|mg|84|stk|1|ţpakki||N04BC04|01.02.2012||R|0|0|0|0|G|0|POF|0|0|0|100|GBP|4986|3784|lyfalmen|V0530|3784|2|84|0|7,0000|Portfarma ehf|Portfarma|Rópíníról||2000||2000|3784||2 046767|N04BC0405|Ropinirol Portfarma|filmhtfl|2|mg|84|stk|1|ţpakki||N04BC04|01.02.2012||R|0|0|0|0|G|0|POF|0|0|0|100|GBP|6254|4486|lyfalmen|V0531|4486|2|84|0|28,0000|Portfarma ehf|Portfarma|Rópíníról||2513||2513|4486||2 046779|N05AH0308|Lazapix|filmhtfl|15|mg|28|stk|1|ţpakki||N05AH03|01.09.2011||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|10558|3268|lyfalmen|V0283|3268|2|28|0|42,0000|Portfarma ehf|Portfarma|Olanzapín||1623||1623|3268||2 046812|M05BA0603|Ibandronic acid Portfarma|filmhtfl|150|mg|3|stk|1|ţpakki||M05BA06|01.02.2012||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|5525|3725|lyfalmen|V0205|3725|2|3|0|90,0000|Portfarma ehf|Portfarma|Íbandrónsýra||1957||1957|3725||2 046823|N05AH0308|Lazapix|filmhtfl|5|mg|28|stk|1|ţpakki||N05AH03|01.09.2011||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|3407|1969|lyfalmen|V0279|1969|2|28|0|14,0000|Portfarma ehf|Portfarma|Olanzapín||673||673|1969||2 047159|C07AA0705|Sotalol Mylan|töflur|40|mg|100|stk|1|glas||C07AA07|01.01.1994||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1066|2506|lyfalmen|||2|100|0|25,0000|Icepharma hf|Mylan AB|Sótalól||1066||1066|2506||2 047442|N01AX1301|Niontix|lyfjagas|100|%|10|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|13388|18684|lyfsjukr|||1|10|0||Ísaga ehf|AGA AB|di-Nitrogen oxíđ||13388||13388|18684||5 047460|N01AX1301|Niontix|lyfjagas|100|%|50|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|47555|61564|lyfsjukr|||1|50|0||Ísaga ehf|AGA AB|di-Nitrogen oxíđ||47555||47555|61564||5 047560|L04AB0101|Enbrel|stl|50|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.05.2008||R|0|0|0|1|0|1|WTE|0|1|0|100|DKK|148882|188729|lyfsjukr|||1|4|0|28,5800|Icepharma hf|Wyeth Europe|Etanercept||148882||148882|188729||2 047941|N03AX2101|Trobalt|filmhtfl|300|mg|84|stk|1|ţpakki||N03AX21|01.12.2011|30.06.2013|R|1|1|0|0|G|0|GGL|0|0|0|100|GBP|24728|33757|lyfalmen|||1|84|0|28,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||24728||24728|33757||1 047986|L02BB0305|Bicalutamide Portfarma|filmhtfl|50|mg|30|stk|1|ţpakki||L02BB03|01.02.2011||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|12787|5436|lyfalmen|V0420|5436|2|30|0|30,0000|Portfarma ehf|Portfarma|Bíkalútamíđ||3208||3208|5436||2 047998|L02BB0305|Bicalutamide Portfarma|filmhtfl|150|mg|30|stk|1|ţpakki||L02BB03|01.02.2011||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|15355|15064|lyfalmen|V0421|15064|2|30|0|90,0000|Portfarma ehf|Portfarma|Bíkalútamíđ||10246||10246|15064||2 048015|B05AA0111|Albumin Baxter|irl|50|g/líter|250|ml|1|hgl||B05AA01|01.06.2007||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|5537|7991|lyfsjukr|||1|250|0||Icepharma hf|Baxter Medical AB|Albúmín||5537||5537|7991||2 048028|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|50|pokar|Freeflex umbúđir|B05BB01|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|8862|12790|lyfsjukr|||2|5000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||8862||8862|12790||2 048043|B05AA0111|Albumin Baxter|irl|200|g/líter|100|ml|1|hgl||B05AA01|01.06.2007||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|8739|12613|lyfsjukr|||1|100|0||Icepharma hf|Baxter Medical AB|Albúmín||8739||8739|12613||2 048100|N06AB1004|Esopram|töflur|5|mg|100|stk|1|ţpakki||N06AB10|01.04.2010||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|2739|2948|lyfalmen|V0324|2884|2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||1389||1389|2948||1 048111|N06AB1004|Esopram|töflur|10|mg|28|stk|1|ţpakki||N06AB10|01.04.2010||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|2544|3717|lyfalmen|V0035|3717|2|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||1951||1951|3717||1 048122|N06AB1004|Esopram|töflur|10|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|7897|3083|lyfalmen|V0325|3015|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||1488||1488|3083||1 048144|N06AB1004|Esopram|töflur|15|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|7758|3974|lyfalmen|V0326|3875|2|100|0|150,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||2139||2139|3974||1 048155|N06AB1004|Esopram|töflur|20|mg|28|stk|1|ţpakki||N06AB10|01.04.2010||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|3979|4590|lyfalmen|V0246|4590|2|28|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||2589||2589|4590||1 048166|N06AB1004|Esopram|töflur|20|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|15513|3684|lyfalmen|V0327|2949|2|100|0|200,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||1927||1927|3684||1 048199|A03CA0201|Librax|töflur|||100|stk|1|glas||A03CA02|01.12.1972||R|1|0|0|0|G|0|MAB|0|0|0|100|SEK|1310|2840|lyfalmen|||1|100|0||Vistor hf|Meda AB|Klídín og geđlyf||1310||1310|2840||1 048297|C09DA0101|Cozaar Comp|filmhtfl|112,5|mg|98|stk|1|ţpakki|100+12,5 mg|C09DA01|01.06.2007||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|14091|20408|lyfalmen|||1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og ţvagrćsilyf||14091||14091|20408||1 048355|C01DA0801|Sorbangil|töflur|40|mg|100|stk|1|glas||C01DA08|01.10.1988||R|1|0|0|0|G|0|REP|0|0|0|100|SEK|4318|6955|lyfalmen|||1|100|0|66,6667|Vistor hf|Recip AB|Ísósorbíđ dínítrat||4318||4318|6955||1 048447|G03AA0901|Marvelon|töflur|||63|stk|1|ţpakki|150/30 mcg|G03AA09|01.07.1986||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|1818|3535|lyfalmen|||1|63|0|84,0000|Vistor hf|N.V. Organon|Desógestrel og ethinylestradíól||1818||1818|3535||1 048488|L04AA0601|Cellcept|töflur|500|mg|150|stk|1|ţpakki||L04AA06|01.03.1999||R|0|0|0|1|G|0|ROC|0|0|0|100|DKK|62481|77701|lyfalmen|V0187|13761|1|150|0|37,5000|Icepharma hf|Roche|Mýcófenólsýra||59743||59743|77701||2 048505|L03AX1601|Mozobil|stl|20|mg/ml|1,2|ml|1|hgl|lausn|L03AX16|01.07.2010||R|0|0|0|1|0|1|GZE|0|1|0|100|XEU|1001385|1258621|lyfsjukr|||1|1,2|0|1,4300|Vistor hf|Genzyme Europe B.V.|Plerixaforum||1001385||1001385|1258621||1 048744|N02BE0101|Panodil|töflur|500|mg|100|stk|1|glas||N02BE01|01.03.1984||R|1|0|0|0|0|0|GSH|0|0|1|100|DKK|488|1715|lyfalmen|V0230|1625|1|100|0|16,6667|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól||488||488|1715||1 048770|B05ZB0001|Hemosol BO|blóđ.sk|||5000|ml|2|pokar||B05ZB|01.04.2013||R|0|0|0|1|0|1|GBL|0|0|0|100|SEK|5062|7306|lyfsjukr|||1|10000|0||Vistor hf|Gambro Lundia AB|Blóđsölt og stuđpúđalausn||5062||5062|7306||1 049015|A02BA0201|Asyran|töflur|300|mg|100|stk|1|ţpakki||A02BA02|01.10.1987||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|2481|4442|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis hf|Ranitidín||2481||2481|4442||1 049033|C08DB0108|Cardil|forđatfl|120|mg|60|stk|1|glas||C08DB01|01.05.2013||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|4856|7691|lyfalmen|||2|60|0|30,0000|Vistor hf|Orion Corporation|Diltíazem||4856||4856|7691||1 049169|M05BA0602|Bonviva|stl|1|mg/ml|3|ml|1|spr||M05BA06|01.10.2006||R|0|0|0|0|0|0|RRL|0|0|0|100|DKK|16875|23901|lyfalmen|||1|3|0|0,5000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||16875||16875|23901||2 049395|B01AC0701|Persantin|töflur|100|mg|100|stk|1|glas||B01AC07|01.10.1985||R|1|0|0|0|G|0|BOI|0|0|0|100|DKK|2429|4371|lyfalmen|||1|100|0|25,0000|Vistor hf|Boehringer Ingelheim|Dípýrídamól||2429||2429|4371||1 049549|N03AX2201|Fycompa|filmhtfl|2|mg|7|stk|1|ţpakki||N03AX22|01.07.2013||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|6441|9859|lyfalmen|||1|7|0||Vistor hf|Eisai Europe Ltd.|Perampanel||6441||6441|9859||1 049551|D01AE1601|Loceryl|lakk|50|mg/ml|5|ml|1|glas||D01AE16|01.10.1992||R|0|0|0|0|0|0|GAN|0|0|1|100|CHF|6569|10034|lyfalmen|||1|5|0||Icepharma hf|Galderma Nordic AB|Amorolfín||6569||6569|10034||2 049561|C10AA0104|Simvastatin (Portfarma)|filmhtfl|10|mg|98|stk|1|ţpakki||C10AA01|01.07.2006||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|1059|2211|lyfalmen|V0108|1497|2|98|0|32,6667|Portfarma ehf|Portfarma|Simvastatín||850||850|2211||2 049579|C10AA0104|Simvastatin (Portfarma)|filmhtfl|20|mg|98|stk|1|ţpakki||C10AA01|01.07.2006||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|1154|1937|lyfalmen|V0109|1629|2|98|0|65,3400|Portfarma ehf|Portfarma|Simvastatín||650||650|1937||2 049597|C10AA0104|Simvastatin (Portfarma)|filmhtfl|40|mg|100|stk|1|ţpakki||C10AA01|01.07.2006||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|1827|2347|lyfalmen|V0110|2011|2|100|0|133,3333|Portfarma ehf|Portfarma|Simvastatín||950||950|2347||2 049650|D01BA0201|Lamisil|töflur|250|mg|28|stk|1|ţpakki||D01BA02|01.04.1993||R|1|0|0|0|0|0|NOH|0|0|0|100|IKR|8006|5068|lyfalmen|V0123|3062|1|28|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Terbínafín||2939||2939|5068||1 049678|C09AA0502|Ramil|töflur|5|mg|100|stk|1|ţpakki||C09AA05|01.04.2006||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|1213|2694|lyfalmen|||2|100|0|200,0000|Actavis Group hf|Actavis hf|Ramipríl||1203||1203|2694||1 049684|D01AE1501|Lamisil|krem|10|mg/g|30|g|1|túpa||D01AE15|01.04.1993||L|0|0|0|0|0|0|NHE|0|0|1|100|DKK|||lyflausa|||0|30|0||Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||||1 049687|C09AA0502|Ramil|töflur|10|mg|100|stk|1|ţpakki||C09AA05|01.08.2005||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|2499|3747|lyfalmen|||2|100|0|400,0000|Actavis Group hf|Actavis hf|Ramipríl||1973||1973|3747||1 049834|N02BE0113|Pinex Junior|eţ-stíll|125|mg|10|stk|1|ţpakki||N02BE01|01.12.2011||L|0|0|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||0|10|0|0,4167|Actavis Group hf|Actavis Group hf|Paracetamól|||||||1 049845|N02BE0113|Pinex Junior|eţ-stíll|250|mg|10|stk|1|ţpakki||N02BE01|01.12.2011||L|0|0|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||0|10|0|0,8333|Actavis Group hf|Actavis Group hf|Paracetamól|||||||1 049856|N02BE0114|Pinex|eţ-stíll|500|mg|10|stk|1|pakki||N02BE01|01.01.2012||L|0|0|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||0|10|0|1,6667|Actavis Group hf|Actavis Group hf|Paracetamól|||||1486||1 049894|N02BG1001|Sativex|munnhúđi|52|mg|10|ml|3|úđagl|27 mg + 25 mg|N02BG10|01.07.2013||R|0|0|1|1|0|0|GWP|0|0|0|100|DKK|82545|106317|lyfalmen|||1|30|0|37,1400|Vistor hf|GW Pharma Ltd.|Nabiximols||82545||82545|106317||1 049902|J06BA0207|Kiovig|irl|100|mg/ml|200|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|0|0|100|SEK|163237|206745|lyfsjukr|||1|200|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||163237||163237|206745||2 049908|L04AA0601|Cellcept|hylki|250|mg|300|stk|1|ţpakki||L04AA06|01.03.1999||R|0|0|0|1|G|0|ROC|0|0|0|100|DKK|62481|81137|lyfalmen|V0470|77043|1|300|0|37,5000|Icepharma hf|Roche|Mýcófenólsýra||62481||62481|81137||2 049913|J06BA0207|Kiovig|irl|100|mg/ml|10|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|0|0|100|SEK|8787|12682|lyfsjukr|||1|10|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||8787||8787|12682||2 049925|J06BA0207|Kiovig|irl|100|mg/ml|25|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|0|0|100|SEK|21969|29454|lyfsjukr|||1|25|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||21969||21969|29454||2 049936|J06BA0207|Kiovig|irl|100|mg/ml|50|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|0|0|100|SEK|40810|53099|lyfsjukr|||1|50|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||40810||40810|53099||2 049947|J06BA0207|Kiovig|irl|100|mg/ml|100|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|0|0|100|SEK|81618|104313|lyfsjukr|||1|100|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||81618||81618|104313||2 050010|G04CB0104|Finasterid LYFIS|filmhtfl|5|mg|98|stk|1|ţpakki||G04CB01|01.12.2012||R|1|0|0|0|G|0|LYF|0|0|0|100|XEU|3344|3033|lyfalmen|V0445|3033|2|98|0|98,0000|LYFIS ehf|LYFIS ehf|Fínasteríđ||1451||1451|3033||2 050306|G04CA0104|Alfuzosin hydrochlorid ratiopharm|forđatfl|10|mg|90|stk|1|ţpakki||G04CA01|01.12.2012||R|1|0|0|0|G|0|RAT|0|0|0|100|XEU|4355|5777|lyfalmen|V0550|5635|2|90|0|120,0000|LYFIS ehf|ratiopharm GmbH|Alfúzósín||3457||3457|5777||2 050342|L01XE0501|Nexavar|filmhtfl|200|mg|112|stk|1|ţpakki||L01XE05|01.12.2006||R|0|0|0|1|0|1|BAP|0|1|0|100|DKK|607104|763798|lyfsjukr|||1|112|0||Icepharma hf|Bayer Schering Pharma AG|Sorafeníb||607104||607104|763798||2 050438|L04AA2701|Gilenya|hylki|0,5|mg|7|stk|1|ţpakki||L04AA27|01.09.2011||R|0|1|0|1|0|1|NOE|0|1|0|100|DKK|72750|93184|lyfsjukr|||1|7|0|7,0000|Vistor hf|Novartis Europharm Ltd|Fingolimod||||72750|93184||1 050483|A02BC0507|Esomeprazole Portfarma|sţ-tfl|40|mg|56|stk|1|ţpakki||A02BC05|01.11.2011||R|1|0|0|0|0|0|POF|0|0|0|100|IKR|7624|3740|lyfalmen|V0012|2897|2|56|0|74,6700|Portfarma ehf|Portfarma|Esómeprazól||1968||1968|3740||2 050510|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|28|stk|1|ţpakki||A02BC01|01.05.2010||L|1|0|0|0|0|0|AGT|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|Actavis Group hf|Actavis Group hf|Ómeprazól|||||||1 050605|N03AX1601|Lyrica|hylki|225|mg|14|stk|1|ţpakki||N03AX16|01.04.2007||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|3198|5423|lyfalmen|||1|14|0|10,5000|Icepharma hf|Pfizer ApS|Pregabalín||3198||3198|5423||1 050614|N03AX1601|Lyrica|hylki|225|mg|56|stk|1|ţpakki||N03AX16|01.04.2007||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|13485|19647|lyfalmen|||1|56|0|42,0000|Icepharma hf|Pfizer ApS|Pregabalín||13485||13485|19647||1 050660|C02CA0402|Carduran Retard|forđatfl|4|mg|100|stk|1|ţpakki||C02CA04|01.01.2007||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|5579|5286|lyfalmen|V0042|4781|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Doxazósín||3098||3098|5286||1 050679|A02BC0108|Omeprazol Actavis|sh-hylki|10|mg|100|stk|1|glas||A02BC01|01.09.2010||R|1|0|0|0|G|0|AGT|0|0|0|100|IKR|4615|5316|lyfalmen|V0002|5316|2|100|0|50,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||3120||3120|5316||1 050691|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|100|stk|1|glas||A02BC01|01.09.2010||R|1|0|0|0|G|0|AGT|0|0|0|100|IKR|4435|3715|lyfalmen|V0006|3711|2|100|0|100,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||1950||1950|3715||1 050702|A02BC0108|Omeprazol Actavis|sh-hylki|40|mg|100|stk|1|plglas||A02BC01|01.08.2010||R|1|0|0|0|G|0|AGT|0|0|0|100|IKR|10567|5146|lyfalmen|||2|100|0|200,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||2996||2996|5146||1 051029|N03AG0102|Orfiril|sh-tfl|150|mg|100|stk|1|glas||N03AG01|01.10.1995||R|1|0|0|0|G|0|DEA|0|0|0|100|XEU|1727|3410|lyfalmen|||1|100|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||1727||1727|3410||1 051110|N03AG0102|Orfiril|sh-tfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|1|0|0|0|G|0|DEA|0|0|0|100|XEU|1759|3454|lyfalmen|||1|100|0|20,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||1759||1759|3454||1 051349|R06AX2602|Nefoxef|filmhtfl|180|mg|30|stk|1|ţpakki||R06AX26|01.07.2008||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|1510|2741|lyfalmen|||2|30|0|45,0000|Actavis Group PTC ehf|Mylan AB|Fexófenadín||1238||1238|2741|31.5.2013|2 051358|R06AX2602|Nefoxef|töflur|180|mg|100|stk|1|ţpakki||R06AX26|01.07.2008||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|4105|5782|lyfalmen|||2|100|0|150,0000|Actavis Group PTC ehf|Mylan AB|Fexófenadín||3461||3461|5782|31.5.2013|2 051550|N03AX1401|Keppra|irţ|100|mg/ml|5|ml|10|hgl||N03AX14|01.02.2007||R|0|0|0|0|0|1|UCB|0|0|0|100|DKK|30752|40476|lyfsjukr|||1|50|0|3,3300|Vistor hf|U.C.B|Levetíracetam||30752||30752|40476||1 051686|N05AE0402|Zeldox (DAC)|hylki|80|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.06.2011||R|1|0|0|0|G|0|DAC|0|0|0|100|DKK|27474|27333|lyfalmen|V0611|27333||56|0|56,0000|D.A.C. ehf|D.A.C. ehf|Ziprasidon||19609||19609|27333|| 051732|C08CA0104|Amlódipín Portfarma|töflur|5|mg|100|stk|1|ţpakki||C08CA01|01.12.2006||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|1598|2037|lyfalmen|V0056|1702|2|100|0|100,0000|Portfarma ehf|Portfarma|Amlódipín||723||723|2037||2 051750|C08CA0104|Amlódipín Portfarma|töflur|10|mg|100|stk|1|ţpakki||C08CA01|01.12.2006||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|2683|2510|lyfalmen|V0057|1606|2|100|0|200,0000|Portfarma ehf|Portfarma|Amlódipín||1069||1069|2510||2 051761|R03AC0302|Bricanyl Turbuhaler|innönddu|0,5|mg/sk|100|skammtar|1|stauk||R03AC03|01.07.2012||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|995|2409|lyfalmen|||1|100|0|25,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||995||995|2409||1 052286|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|20|stk|1|ţpakki||N05BA12|01.10.2009||R|1|0|0|0|0|0|MYL|0|0|1|100|SEK|224|1354|lyfalmen|V0047|1354|2|20|0|5,0000|Icepharma hf|Mylan AB|Alprazólam||224||224|1354||2 052297|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|50|stk|1|ţpakki||N05BA12|01.10.2009||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|527|1769|lyfalmen|V0305|1050|2|50|0|12,5000|Icepharma hf|Mylan AB|Alprazólam||527||527|1769||2 052305|L01XE0601|Sprycel|filmhtfl|20|mg|60|stk|1|glas||L01XE06|01.09.2007||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|348005|438629|lyfsjukr|||1|60|0||Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||348005||348005|438629||1 052309|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|20|stk|1|ţpakki||N05BA12|01.07.2009||R|1|0|0|0|0|0|MYL|0|0|1|100|SEK|374|1560|lyfalmen|V0439|1560|2|20|0|10,0000|Icepharma hf|Mylan AB|Alprazólam||||374|1560||2 052320|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|50|stk|1|ţpakki||N05BA12|01.10.2009||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|920|2306|lyfalmen|||2|50|0|25,0000|Icepharma hf|Mylan AB|Alprazólam||920||920|2306||2 052331|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|100|stk|1|glas||N05BA12|01.08.2009||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|768|2099|lyfalmen|V0305|2099|2|100|0|25,0000|Icepharma hf|Mylan AB|Alprazólam||768||768|2099||2 052333|L01XE0601|Sprycel|filmhtfl|50|mg|60|stk|1|glas||L01XE06|01.09.2007||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|726982|914245|lyfsjukr|||1|60|0||Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||726982||726982|914245||1 052360|L01XE0601|Sprycel|filmhtfl|70|mg|60|stk|1|glas||L01XE06|01.09.2007||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|644336|810524|lyfsjukr|||1|60|0||Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||644336||644336|810524||1 052405|S01ED5112|Ganfort|augndr|5,3|mg/ml|3|ml|1|glas||S01ED51|01.01.2010||R|0|0|0|0|G|0|ALL|0|0|0|100|SEK|3948|6449|lyfalmen|||1|3|0|30,0000|Vistor hf|Allergan|Tímólól í blöndum||3948||3948|6449||1 052478|D06BB0305|Zovirax (D.A.C.)|krem|50|mg/g|2|g|1|túpa|+sk.dćla|D06BB03|01.03.2007||L|0|0|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||0|2|0||D.A.C. ehf|D.A.C. ehf|Acíklóvír|||||||2 052505|B05BA1014|Kabiven|irl|1900|kcal|2053|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|37637|49117|lyfsjukr|||1|8212|0||Icepharma hf|Fresenius Kabi|Blöndur||37637||37637|49117||2 052515|B05BA1014|Kabiven|irl|2300|kcal|2566|ml|3|pokar||B05BA10|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|30597|40282|lyfsjukr|||1|7698|0||Icepharma hf|Fresenius Kabi|Blöndur||30597||30597|40282||2 052524|B05BA1010|Kabiven Peripheral|irl|1400|kcal|1920|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|32300|42419|lyfsjukr|||1|7680|0||Icepharma hf|Fresenius Kabi|Blöndur||32300||32300|42419||2 052533|B05BA1010|Kabiven Peripheral|irl|1700|kcal|2400|ml|3|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|27024|35798|lyfsjukr|||1|7200|0||Icepharma hf|Fresenius Kabi|Blöndur||27024||27024|35798||2 052542|B05BA1015|StructoKabiven|irl|2100|kcal|1970|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|36343|47493|lyfsjukr|||1|7880|0||Icepharma hf|Fresenius Kabi|Blöndur||36343||36343|47493||2 052560|B05BA1019|StructoKabiven Perifer|irl|1300|kcal|1904|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|33747|44235|lyfsjukr|||1|7616|0||Icepharma hf|Fresenius Kabi|Blöndur||33747||33747|44235||2 052838|A10BX0701|Victoza|stl|6|mg/ml|3|ml|2|lyfjap|lausn,áfylltur lyfjapenni|A10BX07|01.01.2012||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|15710|22439|lyfalmen|||1|6|0|30,0000|Vistor hf|Novo-Nordisk A/S|Liraglútíđ||15710||15710|22439||1 053006|N05CF0204|Zolpidem Mylan|filmhtfl|10|mg|100|stk|1|ţpakki||N05CF02|01.11.2006||R|2|0|0|0|0|0|MYL|0|0|0|100|SEK|2492|4063|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Zolpidem||2204||2204|4063||2 053025|G03HB0102|Diane mite|töflur|||63|stk|1|ţpakki||G03HB01|01.07.1989||R|0|0|0|0|0|0|BAP|0|0|0|100|DKK|2221|4086|lyfalmen|V0134|3554|1|63|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Cýpróterón og östrógen||2221||2221|4086||2 053043|J05AR1001|Kaletra|filmhtfl|250|mg|120|stk|1|glös|200+50 mg|J05AR10|01.11.2006||R|1|0|0|1|0|1|ABT|0|0|0|100|DKK|63281|81300|lyfsjukr|||1|120|0|30,0000|Vistor hf|Abbott Laboratories Ltd|Lopínavír og ritónavír||63281||63281|81300||1 053055|C01BA0302|Durbis Retard|forđatfl|250|mg|100|stk|1|ţpakki||C01BA03|01.05.1983||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|5656|8785|lyfalmen|||1|100|0|62,5000|Vistor hf|Sanofi-aventis Norge AS|Dísópýramíđ||5656||5656|8785||1 053155|N02AA5501|Targin|forđatfl|60|mg|28|stk|1|ţpakki|40+20 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|12309|18171|lyfalmen|||1|28|0|14,9400|Icepharma hf|Norpharma|Oxycodonum í blöndum||12309||12309|18171||2 053166|N02AA5501|Targin|forđatfl|60|mg|98|stk|1|ţpakki|40+20 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|36660|48732|lyfalmen|||1|98|0|52,2700|Icepharma hf|Norpharma|Oxycodonum í blöndum||36660||36660|48732||2 053200|N02AA5501|Targin|forđatfl|7,5|mg|98|stk|1|ţpakki|5+2,5 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|6137|9443|lyfalmen|||1|98|0|6,5400|Icepharma hf|Norpharma|Oxycodonum í blöndum||6137||6137|9443||2 053211|N02AA5501|Targin|forđatfl|7,5|mg|28|stk|1|ţpakki|5+2,5 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|1799|3502|lyfalmen|||1|28|0|1,8700|Icepharma hf|Norpharma|Oxycodonum í blöndum||1794||1794|3502||2 053231|J07BB0201|Fluarix|bóluefni|||0,5|ml|10|áf.spr||J07BB02|01.10.1994||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|6077|9361|lyfalmen|||1|5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Inflúensa, hreinsađir mótefnavakar||6077||6077|9361||1 053371|L04AA1301|Arava|töflur|10|mg|100|stk|1|glas||L04AA13|01.11.2000||R|0|1|0|1|G|0|SDE|0|0|0|100|NOK|39916|52818|lyfalmen|V0453|44299|1|100|0|50,0000|Vistor hf|Sanofi - aventis Deutschland GmbH|Leflúnómíđ||39916||39916|52818||1 053413|L04AA1301|Arava|töflur|20|mg|100|stk|1|glas||L04AA13|01.11.2000|30.04.2013|R|0|1|0|1|G|0|SDE|0|0|0|100|NOK|35220|46924|lyfalmen|||1|100|0|100,0000|Vistor hf|Sanofi - aventis Deutschland GmbH|Leflúnómíđ||35220||35220|46924||1 053689|N05CF0204|Zolpidem Mylan|filmhtfl|10|mg|20|stk|1|ţpakki||N05CF02|01.11.2006||R|1|0|0|0|0|0|MYL|0|0|1|100|SEK|664|1446|lyfalmen|V0060|1100|2|20|0|20,0000|Icepharma hf|Mylan AB|Zolpidem||291||291|1446||2 053905|N02AA0305|Hydromorphone Hydrochloride Inj. USP|stl|20|mg/ml|1|ml|10|lykjur||N02AA03|01.05.2006||R|0|0|1|0|0|0|MAP|0|0|0|100|GBP|15527|22210|lyfalmen|||2|10|0|50,0000|Icepharma hf|Martindale Pharmaceuticals|Hýdrómorphón||15527||15527|22210||2 053932|N05AX1201|Abilify|stl|7,5|mg/ml|1,33|ml|1|hgl||N05AX12|01.01.2010||R|0|0|0|0|0|0|OTS|0|0|0|100|DKK|1574|3201|lyfalmen|||1|1,33|0|0,6650|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||1574||1574|3201||1 053991|D10AF0101|Dalacin|lausn|10|mg/ml|30|ml|1|glas|Áburđur, lausn|D10AF01|01.07.1985||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|1174|2654|lyfalmen|||1|30|0||Icepharma hf|Pfizer ApS|Klindamýcín||1174||1174|2654||1 054054|R03DC0303|Montelukast Actavis|filmhtfl|10|mg|100|stk|1|ţpakki||R03DC03|01.11.2011||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|7952|6141|lyfalmen|V0490|5693|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Montelúkast||3723||3723|6141||1 054213|J07AG0101|Act-Hib|bóluefni|34|mcg/hgl|0,5|ml|1|hgl|+ leysir (10+24 mcg)|J07AG01|01.07.1994||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|4270|6889|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Haemophilus influenzae B||4270||4270|6889||2 054247|R01AA0503|Nezeril|nefdr|0,25|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|0|0|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||0|2|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||||1 054278|D01AE1502|Lamisil Once|húđlausn|1|%|4|g|1|túpa||D01AE15|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|4|0||Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||||1 054321|J01CA0801|Selexid|filmhtfl|400|mg|15|stk|1|ţpakki||J01CA08|01.04.2012||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|2774|4843|lyfalmen|||1|15|0|10,0000|Vistor hf|LEO Pharma A/S|Pívmecillínam||2774||2774|4843||1 054332|J01CA0801|Selexid|filmhtfl|400|mg|20|stk|1|ţpakki||J01CA08|01.04.2012||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|3826|6282|lyfalmen|||1|20|0|13,3300|Vistor hf|LEO Pharma A/S|Pívmecillínam||3826||3826|6282||1 054369|J05AB0402|Copegus|filmhtfl|400|mg|56|stk|1|plglas||J05AB04|01.05.2007||R|0|0|0|1|0|1|ROA|0|0|0|100|DKK|65695|84330|lyfsjukr|||1|56|0|22,4000|Icepharma hf|Roche A.S.|Ribavirin||65695||65695|84330||2 054403|R01AA0503|Nezeril|nefdr|0,5|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|0|0|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||0|2|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||||1 054533|N05BB0101|Atarax|mixtúra|2|mg/ml|200|ml|1|glas||N05BB01|01.10.1994||R|0|0|0|0|0|0|UCN|0|0|1|100|SEK|1145|2614|lyfalmen|||1|200|0|5,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||1145||1145|2614||1 054552|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|30|stk|1|ţpakki||N06AB03|01.10.2006||R|1|0|0|0|0|0|ACA|0|0|0|100|XEU|1731|3416|lyfalmen|V0061|3416|2|30|0|30,0000|Actavis Group hf|Actavis hf|Flúoxetín||1731||1731|3416||1 054594|QN02AE0101|Vetergesic vet.|stl|300|mcg/ml|10|ml|1|hgl|lausn|QN02AE01|01.10.2010||R|0|0|1|0|0|0|ALS|0|0|0|100|DKK|4881|9545|vetalmen|||0|10|0||Icepharma hf|Alstoe Limited|Buprenorphinhýdróklóríđ||||4881|9545||2 054650|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|20|stk||QG03DA02|01.12.1978||R|0|0|0|0|0|0|PAL|1|0|0|100|DKK|7905|13790|vetorma|||0|20|0||Icepharma hf|Pfizer Oy Animal Health|Medroxyprogesteronum||7905||7905|13790||2 054974|R03BB0501|Eklira Genuair|innönddu|322|mcg|60|skammtar|1|innö.t||R03BB05|01.01.2013||R|0|0|0|0|G|0|ALM|0|0|0|100|XEU|5649|8775|lyfalmen|||1|60|0||Vistor hf|Almirall S.A.|Aclídínumbrómíđ||5649||5649|8775||1 055164|S01AE0701|Vigamox|augndr|5|mg/ml|5|ml|1|glas|án rotvarnar|S01AE07|01.08.2010||R|0|0|0|0|0|0|ALA|0|0|1|100|USD|1756|3450|lyfalmen|||1|5|0||Vistor hf|Alcon Laboratories Ltd.|Moxífloxacín||||1756|3450||1 055186|J01FA0103|Ery-Max|sh-hylki|250|mg|20|stk|1|glas||J01FA01|01.01.1986||R|1|0|0|0|0|0|REP|0|0|1|100|SEK|817|2166|lyfalmen|||1|20|0|5,0000|Vistor hf|Recip AB|Erýtrómýcín||817||817|2166||1 055257|G03AA0903|Benidette|töflur|||63|stk|1|ţpakki|150/20 mcg|G03AA09|01.04.2013||R|0|0|0|0|0|0|AVB|0|0|0|100|XEU|1365|2915|lyfalmen|V0065|2915|2|63|0|84,0000|Actavis Group PTC ehf|Actavis BV|Desógestrel og ethinylestradíól||1365||1365|2915||1 055277|N02AA0101|Contalgin|forđatfl|60|mg|100|stk|1|ţpakki||N02AA01|01.10.1995||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|9469|14001|lyfalmen|||1|100|0|60,0000|Icepharma hf|Pfizer ApS|Morfín||9469||9469|14001||1 055481|A02BC0402|Rabeprazol Actavis|sh-tfl|10|mg|56|stk|1|ţpakki||A02BC04|01.06.2011||R|1|0|0|0|G|0|APC|0|0|0|100|IKR|2064|3008|lyfalmen|V0467|2882|2|56|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||1433||1433|3008||1 055749|N07BA0107|Nicotinell Mint|munnstfl|1|mg|36|stk|1|pakki||N07BA01|01.06.2000||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|36|0|1,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 055939|N07BA0107|Nicotinell Mint|munnstfl|1|mg|96|stk|1|pakki||N07BA01|01.06.2000||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 056015|C10AA0503|Atacor|filmhtfl|10|mg|100|stk|1|ţpakki||C10AA05|01.06.2006||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|4539|2636|lyfalmen|V0112|2636|2|100|0|50,0000|Actavis Group hf|Actavis hf|Atorvastatín||1161||1161|2636||1 056024|C10AA0503|Atacor|filmhtfl|20|mg|100|stk|1|ţpakki||C10AA05|01.06.2006||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|6185|1759|lyfalmen|V0113|1746|2|100|0|100,0000|Actavis Group hf|Actavis hf|Atorvastatín||520||520|1759||1 056033|C10AA0503|Atacor|filmhtfl|40|mg|100|stk|1|ţpakki||C10AA05|01.06.2006||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|7867|3209|lyfalmen|V0114|3196|2|100|0|200,0000|Actavis Group hf|Actavis hf|Atorvastatín||1580||1580|3209||1 056183|B01AC2401|Brilique|filmhtfl|90|mg|100|stk|1|ţpakki||B01AC24|01.06.2011|30.06.2013|R|1|0|0|0|G|0|AZA|0|0|0|100|SEK|18650|26129|lyfalmen|||1|100|0|50,0000|Vistor hf|AstraZeneca AB|Ticagrelor||18650||18650|26129||1 056308|N07XX0701|Fampyra|forđatfl|10|mg|28|stk|1|ţpakki||N07XX07|01.03.2013||R|0|0|0|1|0|0|BIB|0|0|0|100|XEU|32977|44109|lyfalmen|V0016|44109|1|28|0|14,0000|Icepharma hf|Biogen Idec Ltd|Fampridine||32977||32977|44109||2 056442|QG03DA0401|Prid alpha|sk-innl|1,55|g|10|stk|1|pakki||QG03DA04|01.04.2011||R|0|0|0|0|0|0|CES|1|0|0|100|XEU|27741|48393|vetorma|||0|10|0||Icepharma hf|Ceva Sante Animale|Prógesterón||27741||27741|48393||2 056523|J01FA0103|Ery-Max|sh-hylki|250|mg|40|stk|1|glas||J01FA01|01.01.1986||R|1|0|0|0|0|0|REP|0|0|1|100|SEK|1330|2867|lyfalmen|||1|40|0|10,0000|Vistor hf|Recip AB|Erýtrómýcín||1330||1330|2867||1 056664|N06AX1608|Venlafaxin Actavis|forđahlk|75|mg|100|stk|1|glas|Til skömmtunar|N06AX16|01.10.2011||R|2|0|0|0|G|0|AGP|0|0|0|100|XEU|3825|6280|lyfalmen|||2|100|0|75,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||||3825|6280||1 056675|N06AX1608|Venlafaxin Actavis|forđahlk|150|mg|100|stk|1|glas|til skömmtunar|N06AX16|01.10.2011||R|2|0|0|0|G|0|AGP|0|0|0|100|XEU|3825|6280|lyfalmen|||2|100|0|150,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||||3825|6280||1 056763|D11AH0201|Elidel|krem|1|%|15|g|1|túpa||D11AH02|01.09.2012||R|0|0|0|0|G|0|MAB|0|0|1|100|DKK|3080|5261|lyfalmen|||1|15|0||Vistor hf|Meda AB|Pímekrólímus||3080||3080|5261||1 056915|L04AA2301|Tysabri|irţ|300|mg/hgl|15|ml|1|hgl|lausn|L04AA23|01.09.2007||R|0|1|0|1|0|1|EPI|0|1|0|100|XEU|239272|302169|lyfsjukr|||1|15|0|30,0000|Icepharma hf|Elan Pharma International|Natalizumab||239272||239272|302169||2 057026|C09DA0601|Atacand Plus|töflur|28,5|mg|28|stk|1|ţpakki|16 + 12,5 mg|C09DA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|3753|6182|lyfalmen|||1|28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||3753||3753|6182||1 057042|C09DA0601|Atacand Plus|töflur|28,5|mg|98|stk|1|ţpakki|16 + 12,5 mg|C09DA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|11359|16586|lyfalmen|V0095|13990|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||11359||11359|16586||1 057307|H01CB0201|Sandostatin|stl|200|mcg/ml|5|ml|1|hgl||H01CB02|01.01.1991||R|0|0|0|1|0|1|NOH|0|0|0|100|DKK|12073|17034|lyfsjukr|||1|5|0|1,4300|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||12073||12073|17034||1 057335|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|500|ml|20|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|4173|6023|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||4173||4173|6023||2 057349|H01CB0201|Sandostatin|stl|100|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|0|0|0|1|0|1|NOH|0|0|0|100|DKK|6942|10019|lyfsjukr|||1|5|0|0,7100|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||6942||6942|10019||1 057367|J06BA0207|Kiovig|irl|100|mg/ml|300|ml|1|hgl|lausn|J06BA02|01.10.2011||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|254966|321865|lyfsjukr|||1|300|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||254966||254966|321865||2 057401|N06DA0404|Galantamine Portfarma|forđahlk|16|mg|84|stk|1|ţpakki||N06DA04|01.12.2011||R|1|0|0|0|G|0|POF|0|0|0|100|SEK|24405|33352|lyfalmen|||2|84|0|84,0000|Portfarma ehf|Portfarma|Galantamín||24405||24405|33352||2 057422|B05XA3102|Tracel|irţ|||10|ml|20|plastl||B05XA31|01.01.1987||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|5023|7249|lyfsjukr|||1|200|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ öđrum efnum||5023||5023|7249||2 057455|H01CB0201|Sandostatin|stl|50|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|0|0|0|1|0|1|NOH|0|0|0|100|DKK|3828|5525|lyfsjukr|||1|5|0|0,3600|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||3828||3828|5525||1 057492|L01XC1001|Arzerra|irţ|20|mg/ml|50|ml|1|hgl|1000 mg pr. hgl.|L01XC10|01.03.2012||R|0|0|0|1|0|1|GGL|0|1|0|100|GBP|354110|446291|lyfsjukr|||1|50|0||GlaxoSmithKline ehf|Glaxo Group Limited|Ofatúmúmabi||354110||354110|446291||1 057556|L02BX0301|Zytiga|töflur|250|mg|120|stk|1|glas||L02BX03|01.12.2011||R|0|0|0|1|0|1|JAS|0|1|0|100|SEK|571650|719303|lyfsjukr|||1|120|0|30,0000|Vistor hf|Janssen-Cilag AB|Abírateron||571650||571650|719303||1 058014|N07BA0301|Champix|filmhtfl|1|mg|112|stk|1|ţpakki||N07BA03|01.03.2009||R|1|0|0|0|0|0|IPI|0|0|1|100|DKK|20715|28721|lyfalmen|||1|112|0|56,0000|Icepharma hf|Pfizer Limited|Vareniclin||||20715|28721||1 058164|A03BB0101|Buscopan|stl|20|mg/ml|1|ml|5|lykjur||A03BB01|01.10.1995||R|0|0|0|0|G|0|BOI|0|0|0|100|DKK|438|1647|lyfalmen|||1|5|0|1,6667|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||438||438|1647||1 058272|L01XE1101|Votrient|filmhtfl|200|mg|30|stk|1|glas||L01XE11|01.02.2011||R|1|0|0|1|0|1|GGL|0|1|0|100|GBP|128105|162654|lyfsjukr|||1|30|0||GlaxoSmithKline ehf|Glaxo Group Limited|Pazópaníb||128105||128105|162654||1 058283|QI01AD040|Avipro Thymovac|frţlyf|||500|skammtar|10|pakkar||QI01AD04|01.07.2009||R|0|0|0|0|0|0|LOH|0|0|0|100|XEU|166668|290744|vetorma|||0|5000|0||Icepharma hf|Lohmann Animal Health|||||166668|290744||2 058294|QI01AD040|Avipro Thymovac|frţlyf|||1000|skammtar|10|pakkar||QI01AD04|01.07.2009||R|0|0|0|0|0|0|LOH|0|0|0|100|XEU|253184|441667|vetorma|||0|10000|0||Icepharma hf|Lohmann Animal Health|||||253184|441667||2 058397|J07BM0101|Gardasil|stl|||0,5|ml|1|áf.spr|dreifa|J07BM01|01.01.2007||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|16739|23731|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Papillomavírus (manna gerđ 6, 11, 16, 18)||16739||16739|23731||2 058503|J01EA0107|Trimetoprim Meda|mixtúra|10|mg/ml|100|ml|1|fl|dreifa|J01EA01|01.01.2004||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|1076|2520|lyfalmen|||1|100|0|2,5000|Vistor hf|Recip AB|Trímetóprím||1076||1076|2520||1 058506|J05AF1001|Baraclude|mixtúra|0,05|mg/ml|210|ml|1|fl||J05AF10|01.09.2007||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|103014|131165|lyfsjukr|||1|210|0|21,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||103014||103014|131165||1 058609|N05AX1302|Xeplion|stl|50|mg|1|stk|1|áf.spr|forđadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|43669|57528|lyfalmen|||1|1|0|20,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||43669||43669|57528||1 058622|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|250|ml|30|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|6134|8853|lyfsjukr|||1|7500|0||Icepharma hf|Baxter Medical AB|Kolvetni||6134||6134|8853||2 058735|C03CA0105|Lasix Retard|forđahlk|30|mg|100|stk|1|ţpakki||C03CA01|01.10.1995||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|1278|2796|lyfalmen|||1|100|0|75,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíđ||1278||1278|2796||1 058768|C03CA0105|Lasix Retard|forđahlk|60|mg|100|stk|1|ţpakki||C03CA01|01.10.1995||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|2382|4306|lyfalmen|||1|100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíđ||2382||2382|4306||1 059070|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|56|stk|1|ţpakki||A02BC01|01.05.2011||R|1|0|0|0|G|0|AGT|0|0|0|100|IKR|2374|2676|lyfalmen|V0006|2078|2|56|0|56,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||1190||1190|2676||1 059204|C01DA0801|Sorbangil|töflur|5|mg|250|stk|1|plglas||C01DA08|01.04.2004||R|1|0|0|0|G|0|REP|0|0|0|100|SEK|1584|3215|lyfalmen|||1|250|0|20,8300|Vistor hf|Recip AB|Ísósorbíđ dínítrat||1584||1584|3215||1 059224|A04AA0501|Aloxi|stl|250|mcg|5|ml|1|hgl|lausn|A04AA05|01.04.2013||R|0|0|0|0|0|0|HBP|0|0|0|100|DKK|12146|17967|lyfalmen|||1|5|0|1,0000|Swedish Orphan Biovitrum AB|Helsinn Birex Pharmaceuticals Ltd.|Palonosetrón||12146||12146|17967||3 059295|S01AA0104|Kloramfenikol - Lyfjaver|augnsm|1|%|5|g|1|túpa||S01AA01|01.06.2012||R|0|0|0|0|G|0|LOL|0|0|1|100|IKR|2297|4190|lyfalmen|||0|5|1||Lyfjaver ehf|Lyfjaver- óskráđ|Klóramfeníkól||2297||2297|4190||3 059569|L02AE0203|Eligard|sts|45|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.05.2008||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|101782|130460|lyfalmen|||1|2|0|311,1900|Vistor hf|Astellas Pharma A/S|Leuprórelín||101782||101782|130460||1 059659|J07CA0601|Infanrix-Polio + Hib|bóluefni|||0,5|ml|10|spr||J07CA06|01.01.2007||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|32821|43914|lyfalmen|||1|5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, haemophilus influenza B, kíghósti, mćnusótt, stí||32821||32821|43914||1 059767|N03AF0401|Zebinix|töflur|800|mg|30|stk|1|ţpakki||N03AF04|01.03.2010||R|1|0|0|0|G|0|BPC|0|0|0|100|SEK|42649|49268|lyfalmen|||1|30|0|30,0000|Vistor hf|Bial-Portela & C.S.A.|Eslícarbazepín||37087||37087|49268||1 059803|C08CA0502|Adalat Oros|forđatfl|30|mg|98|stk|1|ţpakki||C08CA05|01.04.2013||R|1|0|0|0|G|0|BAP|0|0|0|100|DKK|5815|9003|lyfalmen|V0087|9003|1|98|0|98,0000|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||||5815|9003||2 060114|N02AB0305|Fentanyl ratiopharm|forđapl|25|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RGM|0|0|0|100|XEU|2789|3505|lyfalmen|V0219|3505|2|5|0|7,5000|Medical ehf|ratiopharm GmbH|Fentanýl||1796||1796|3505||2 060123|N02AB0305|Fentanyl ratiopharm|forđapl|50|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RGM|0|0|0|100|XEU|4429|5978|lyfalmen|V0220|5978|2|5|0|15,0000|Medical ehf|ratiopharm GmbH|Fentanýl||3604||3604|5978||2 060132|N02AB0305|Fentanyl ratiopharm|forđapl|75|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RGM|0|0|0|100|XEU|5742|7714|lyfalmen|V0221|7714|2|5|0|22,5000|Medical ehf|ratiopharm GmbH|Fentanýl||4873||4873|7714||2 060141|N02AB0305|Fentanyl ratiopharm|forđapl|100|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RGM|0|0|0|100|XEU|6695|8387|lyfalmen|V0223|8387|2|5|0|30,0000|Medical ehf|ratiopharm GmbH|Fentanýl||5365||5365|8387||2 060560|V03AC0301|Exjade|dreifit.|500|mg|84|stk|1|ţpakki||V03AC03|01.03.2007||R|0|1|0|1|0|0|NOE|0|0|0|100|DKK|349377|441191|lyfalmen|||1|84|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||349377||349377|441191||1 060569|V03AC0301|Exjade|dreifit.|250|mg|84|stk|1|ţpakki||V03AC03|01.03.2007||R|0|1|0|1|0|0|NOE|0|0|0|100|DKK|193476|245536|lyfalmen|||1|84|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||193476||193476|245536||1 060848|N06AA0402|Anafranil Retard|forđatfl|75|mg|100|stk|1|ţpakki||N06AA04|01.10.1989||R|1|0|0|0|G|0|NOH|0|0|0|100|DKK|5789|8967|lyfalmen|||1|100|0|75,0000|Vistor hf|Novartis Healthcare A/S-|Klómípramín||5789||5789|8967||1 061414|QA04AD901|Cerenia|töflur|60|mg|4|stk|1|ţpakki||QA04AD90|01.02.2009||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|2821|5589|vetalmen|||0|4|0||Icepharma hf|Zoetis Belgium S.A.|||||2821|5589||2 061442|QA04AD901|Cerenia|töflur|24|mg|4|stk|1|ţpakki||QA04AD90|01.02.2009||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|1478|2940|vetalmen|||0|4|0||Icepharma hf|Zoetis Belgium S.A.|||||1478|2940||2 061451|QA04AD901|Cerenia|stl|10|mg/ml|20|ml|1|hgl|lausn|QA04AD90|01.02.2009||R|0|0|0|0|0|0|ZBE|1|0|0|100|DKK|8732|16939|vetalmen|||0|20|0||Icepharma hf|Zoetis Belgium S.A.|||||8732|16939||2 061460|G03CX0102|Livial (D.A.C.)|töflur|2,5|mg|84|stk|1|ţpakki||G03CX01|01.04.2010||R|0|0|0|0|G|0|DAC|0|0|0|100|DKK|7172|10859|lyfalmen|V0133|10859|3|84|0|84,0000|D.A.C. ehf|D.A.C. ehf|Tíbólón||7172||7172|10859||2 061465|M02AA0701|Felden gel|hlaup|5|mg/g|50|g|1|túpa||M02AA07|01.04.1996||L|0|0|0|0|0|0|PER|0|0|1|100|IKR|||lyflausa|||0|50|0||Icepharma hf|Pfizer ApS|Píroxíkam|||||||1 061481|G03CX0101|Livial|töflur|2,5|mg|84|stk|1|ţpakki||G03CX01|01.07.1998||R|0|0|0|0|G|0|ORG|0|0|0|100|DKK|7173|10860|lyfalmen|V0133|10859|1|84|0|84,0000|Vistor hf|N.V. Organon|Tíbólón||7173||7173|10860||1 061580|QP52AF0201|Banminth, vet.|pasta|439|mg/g|26|g|1|spr||QP52AF02|01.04.1992||R|0|0|0|0|0|0|PAL|0|0|0|100|DKK|1747|3048|vetorma|||0|26|0||Icepharma hf|Pfizer Oy Animal Health|||1747||1747|3048||2 061937|L04AD0101|Sandimmun|irţ|50|mg/ml|1|ml|10|lykjur||L04AD01|01.10.1985||R|0|0|0|0|0|1|NOH|0|0|0|100|DKK|4558|6578|lyfsjukr|||1|10|0|2,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||4558||4558|6578||1 061961|J01XX0901|Cubicin|sts/irs|350|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|0|0|0|1|0|1|NOE|0|0|0|100|DKK|16275|22308|lyfsjukr|||1|1|0|1,2500|Vistor hf|Novartis Europharm Ltd|Daptomýcín||16275||16275|22308||1 061970|J01XX0901|Cubicin|sts/irs|500|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|0|0|0|1|0|1|NOE|0|0|0|100|DKK|22913|30638|lyfsjukr|||1|1|0|1,7900|Vistor hf|Novartis Europharm Ltd|Daptomýcín||22913||22913|30638||1 062117|N05BA1204|Tafil Retard|forđatfl|0,5|mg|30|stk|1|ţpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|471|1692|lyfalmen|V0307|1550|1|30|0|15,0000|Icepharma hf|Pfizer ApS|Alprazólam||471||471|1692||1 062202|N06DX0102|Memantine Merz|filmhtfl|10|mg|30|stk|1|ţpakki||N06DX01|01.07.2013||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|6874|10451|lyfalmen|V0604|8974|2|30|0|15,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||6874||6874|10451||1 062341|L04AA0604|Mykofenolatmofetil Actavis|filmhtfl|500|mg|150|stk|1|ţpakki||L04AA06|01.08.2010||R|0|0|0|1|G|0|AGP|0|0|0|100|XEU|9714|14336|lyfalmen|V0187|13761|2|150|0|37,5000|Actavis Group hf|Actavis Group PTC ehf|Mýcófenólsýra||9714||9714|14336||1 062387|N04BC0502|Sifrol|forđatfl|0,26|mg|10|stk|1|pakki||N04BC05|01.02.2010||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|1693|3364|lyfalmen|||1|10|0|1,0400|Vistor hf|Boehringer Ingelheim International|Pramipexól||1693||1693|3364||1 062704|R02AA0305|Strepsils Cool|sogtfl|||36|stk|1|ţpakki||R02AA03|01.09.2010||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|36|0|6,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 062729|N05BA1204|Tafil Retard|forđatfl|0,5|mg|60|stk|1|ţpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|951|2349|lyfalmen|V0308|2063|1|60|0|30,0000|Icepharma hf|Pfizer ApS|Alprazólam||951||951|2349||1 062737|B03BA0102|Betolvex|töflur|1|mg|100|stk|1|glas||B03BA01|01.03.2008||R|1|0|0|0|G|0|AGT|0|0|1|100|XEU|1456|3040|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis Group hf|Cyanocobalamin||1456||1456|3040||1 062745|QP53AF0102|Sebacil vet.|húđlausn|500|mg/ml|1000|ml|1|fl||QP53AF01|01.05.2005||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|18481|32239|vetorma|||0|1000|0||Icepharma hf|Bayer Animal Health GmbH|||18481||18481|32239||2 062761|L03AA0202|Zarzio|stl/irl|30|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.04.2011||R|0|0|0|1|0|1|SAR|0|0|0|100|DKK|42424|55125|lyfsjukr|||1|2,5|0|4,2900|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||42424||42424|55125||1 062772|L03AA0202|Zarzio|stl/irl|48|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.04.2011||R|0|0|0|1|0|1|SAR|0|0|0|100|DKK|51797|66888|lyfsjukr|||1|2,5|0|6,8600|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||51797||51797|66888||1 062987|J07BM0201|Cervarix|stl|||0,5|ml|1|áf.spr|dreifa|J07BM02|01.11.2007||R|0|0|0|0|0|0|GLB|0|0|0|100|GBP|14537|16179|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Papillomavírus (manna gerđ 16, 18)||11061||11061|16179||1 063057|J05AB0901|Famvir|töflur|125|mg|10|stk|1|ţpakki||J05AB09|01.10.1995||R|1|0|0|0|G|0|NOH|0|0|1|100|DKK|4321|6959|lyfalmen|||1|10|0|1,6667|Vistor hf|Novartis Healthcare A/S-|Famcíclóvír||4321||4321|6959||1 063661|A06AD1107|Medilax|mixtúra|667|mg/ml|500|ml|1|plastf||A06AD11|01.06.2007||L|0|0|0|0|0|0|MET|0|0|0|100|DKK|||lyfalmen|||0|500|0|49,7761|Vistor hf|Medic Team|Laktúlósa|||||3068||1 063697|D01BA0203|Terbinafin Actavis|töflur|250|mg|28|stk|1|ţpakki||D01BA02|01.11.2006||R|1|0|0|0|0|0|ACA|0|0|0|100|XEU|2606|3062|lyfalmen|V0123|3062|2|28|0|28,0000|Actavis Group hf|Actavis hf|Terbínafín||1472||1472|3062||1 063715|R06AX2702|Aerius (D.A.C.)|töflur|5|mg|100|stk|1|ţpakki||R06AX27|01.07.2011||R|1|0|0|0|G|0|DAC|0|0|1|100|XEU|4270|6450|lyfalmen|V0458|4291|3|100|0|100,0000|D.A.C. ehf|D.A.C. ehf|Deslóratadín||3949||3949|6450||2 063818|J06BB0102|Rhesonativ|stl|625|ae/ml|2|ml|1|lykja||J06BB01|01.05.2008||R|0|0|0|0|0|1|OCT|0|0|0|100|DKK|7986|11526|lyfsjukr|||1|2|0||Vistor hf|Octapharma AB|And-D(rh) immúnóglóbúlín||7986||7986|11526||1 063923|QP54AB5207|Equest Pramox vet|hlaup|||11,8|g|1|sk-dćl|19,5mg/g+121,7mg/g|QP54AB52|01.12.2006||R|0|0|0|0|0|0|PAS|0|0|0|100|XEU|2604|4543|vetorma|||0|11,8|0||Vistor hf|Pfizer Oy Animal Health|||2604||2604|4543||1 063941|N05BA1204|Tafil Retard|forđatfl|1|mg|30|stk|1|ţpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|998|2413|lyfalmen|V0309|2130|1|30|0|30,0000|Icepharma hf|Pfizer ApS|Alprazólam||998||998|2413||1 063958|N05BA1204|Tafil Retard|forđatfl|1|mg|60|stk|1|ţpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|2092|3910|lyfalmen|V0310|3021|1|60|0|60,0000|Icepharma hf|Pfizer ApS|Alprazólam||2092||2092|3910||1 064069|B01AC2101|Remodulin|irl|2,5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|0|0|1|0|1|UTE|0|0|0|100|XEU|1114501|1400581|lyfsjukr|||1|20|0|11,6300|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||1114501|1400581||2 064106|B01AC2101|Remodulin|irl|1|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|0|0|1|0|1|UTE|0|0|0|100|XEU|445800|561362|lyfsjukr|||1|20|0|4,6500|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||445800|561362||2 064170|N05BA1204|Tafil Retard|forđatfl|2|mg|30|stk|1|ţpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|2196|4052|lyfalmen|V0311|3021|1|30|0|60,0000|Icepharma hf|Pfizer ApS|Alprazólam||2196||2196|4052||1 064224|B01AC2101|Remodulin|irl|10|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|0|0|1|0|1|UTE|0|0|0|100|XEU|4458005|5596679|lyfsjukr|||1|20|0|46,5100|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||4458005|5596679||2 064233|B01AC2101|Remodulin|irl|5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|0|0|1|0|1|UTE|0|0|0|100|XEU|2229003|2799281|lyfsjukr|||1|20|0|23,2600|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||2229003|2799281||2 064270|B01AC0404|Clopidogrel Krka (Lyfis)|filmhtfl|75|mg|28|stk|1|ţpakki||B01AC04|01.07.2013||R|1|0|0|0|G|0|LYF|0|0|0|100|XEU|3558|3830|lyfalmen|V0009|1803|3|28|0|28,0000|LYFIS ehf|LYFIS ehf|Klópídógrel||2034||2034|3830||2 064281|B01AC0404|Clopidogrel Krka (Lyfis)|filmhtfl|75|mg|100|stk|1|ţpakki||B01AC04|01.07.2013||R|1|0|0|0|G|0|LYF|0|0|0|100|XEU|8442|7030|lyfalmen|V0029|7030|3|100|0|100,0000|LYFIS ehf|LYFIS ehf|Klópídógrel||4373||4373|7030||2 064402|QJ01AA0603|Engemycin, vet.|stl|100|mg/ml|100|ml|1|hgl||QJ01AA06|01.06.2013||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|1214|2415|vetalmen|||0|100|0||Vistor hf|Intervet International BV|||1214||1214|2415||1 064732|A03BB0101|Buscopan|húđuđtfl|10|mg|100|stk|1|ţpakki||A03BB01|01.03.2012||R|1|0|0|0|G|0|BOI|0|0|0|100|DKK|2156|3997|lyfalmen|||1|100|0|16,6700|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||2156||2156|3997||1 064733|J07BB0203|Vaxigrip|bóluefni|||0,5|ml|1|áfspr||J07BB02|01.10.1985||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|846|2205|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Inflúensa, hreinsađir mótefnavakar||846||846|2205||2 064742|B02BD0101|Octaplex|irs|500|ae|1|hgl|1|pakki|+leysir,lausn|B02BD01|01.12.2011||R|0|0|0|0|0|1|OCT|0|0|0|100|DKK|60077|77279|lyfsjukr|||1|1|0|1,4300|Vistor hf|Octapharma AB|Storkuţćttir lX,ll,Vll,X||60077||60077|77279||1 064840|A03FA0102|Afipran|töflur|10|mg|50|stk|1|glas||A03FA01|01.03.2013||R|1|0|0|0|G|0|NPA|0|0|1|100|DKK|853|2215|lyfalmen|||2|50|0|6,6700|Vistor hf|Nycomed Pharma AS|Metóklópramíđ||853||853|2215||1 064956|A03FA0102|Afipran|stl|5|mg/ml|2|ml|10|lykjur|lausn|A03FA01|01.03.2013||R|0|0|0|0|G|0|NPA|0|0|1|100|DKK|490|1718|lyfalmen|||2|20|0|3,3300|Vistor hf|Nycomed Pharma AS|Metóklópramíđ||490||490|1718||1 065029|A03FA0102|Afipran|eţ-stíll|20|mg|5|stk|1|ţpakki||A03FA01|01.03.2013||R|0|0|0|0|G|0|NPA|0|0|1|100|DKK|251|1391|lyfalmen|||2|5|0|3,3300|Vistor hf|Nycomed Pharma AS|Metóklópramíđ||251||251|1391||1 065032|D10AF5101|Duac|hlaup|||25|g|1|túpa|50 mg/g + 10 mg/g|D10AF51|01.01.2007||R|0|0|0|0|0|0|SLL|0|0|0|100|DKK|2004|3789|lyfalmen|||1|25|0||Vistor hf|Stiefel Laboratories (Ireland) Ltd.|Klindamýcín í blöndum||2004||2004|3789||1 065314|G01AF0201|Canesten|sk-tfl|100|mg|6|stk|1|pakki|+stjaka|G01AF02|01.12.1982||L|0|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|6|0|6,0000|Icepharma hf|Bayer AB|Klótrímazól|||||||2 065332|G01AF0201|Canesten|sk-tfl|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.04.1985||L|0|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|1|0|5,0000|Icepharma hf|Bayer AB|Klótrímazól|||||||2 065441|V08AB0901|Visipaque|stl|320|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|15691|21575|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Jódixanól||15691||15691|21575||2 065706|S01EE0101|Xalatan|augndr|50|mcg/sk|2,5|ml|1|glas||S01EE01|01.10.1999||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|2569|3865|lyfalmen|V0376|1727|1|2,5|0|25,0000|Icepharma hf|Pfizer ApS|Latanóprost||2059||2059|3865||1 065711|L02AE0306|Zoladex (Lyfjaver)|vefjalyf|10,8|mg|1|áf.spr|1|pakki||L02AE03|01.06.2011||R|0|0|0|1|G|0|LVR|0|0|0|100|SEK|61362|78345|lyfalmen|V0451|78345|3|1|0|83,7209|Lyfjaver ehf|Lyfjaver ehf|Góserelín||60256||60256|78345||3 065722|S01EE0101|Xalatan|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.05.2009||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|6303|9670|lyfalmen|V0376|5181|1|7,5|0|75,0000|Icepharma hf|Pfizer ApS|Latanóprost||6303||6303|9670||1 065729|N07BA0142|Nicorette Invisi|forđapl|15|mg/16kls|14|stk|1|ţpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|15,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 065740|N07BA0142|Nicorette Invisi|forđapl|15|mg/16kls|7|stk|1|ţpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|7|0|7,5000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 065751|J01CR0204|Amoxin comp|mixtduft|80|mg/ml|70|ml|1|glas|80+11,4 mg|J01CR02|01.02.2013||R|0|0|0|0|0|0|RGM|0|0|1|100|XEU|1025|2130|lyfalmen|V0163|2130|2|70|0|5,6000|Medical ehf|ratiopharm GmbH|Amoxicillín og ensímblokkar||791||791|2130||2 065752|N07BA0142|Nicorette Invisi|forđapl|10|mg/16kls|14|stk|1|ţpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|10,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 065775|N07BA0142|Nicorette Invisi|forđapl|25|mg/16kls|14|stk|1|ţpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|25,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 065786|N07BA0142|Nicorette Invisi|forđapl|25|mg/16kls|7|stk|1|ţpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|7|0|12,5000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 065870|V08AB0201|Omnipaque|stl|180|mg J/ml|10|ml|10|glhgl||V08AB02|01.12.2009||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|4866|7023|lyfsjukr|||1|100|0||Icepharma hf|GE Healthcare AS|Jóhexól||4866||4866|7023||2 066195|QM01AC0605|Melovem|stl|5|mg/ml|100|ml|1|hgl||QM01AC06|01.08.2011||R|0|0|0|0|0|0|DOR|1|0|0|100|DKK|4192|8222|vetalmen|||0|100|0||Icepharma hf|Dopharma Reserch B.V|||4192||4192|8222||2 066278|R03BB0403|Spiriva Respimat|innöndl|2,5|mcg/sk|60|skammtar|1|pakki|lausn|R03BB04|01.04.2008||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|6413|9821|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Tíótrópíumbrómíđ||6413||6413|9821||1 066287|B05AA0704|Voluven|irl|60|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05AA07|01.05.2008||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|33991|44541|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Kabi|Hýdróxyetýl sterkja||33991||33991|44541||2 066399|N07BA0106|Nicotinell|forđapl|7|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|21|0|10,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 066407|N07BA0106|Nicotinell|forđapl|14|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|21|0|21,0000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 066411|A01AA0101|Duraphat|tannpast|5|mg/ml|51|g|1|túpa||A01AA01|01.04.2011||R|0|0|0|0|0|0|GOG|0|0|1|100|DKK|869|2237|lyfalmen|||1|51|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríđ||869||869|2237||2 066423|N07BA0106|Nicotinell|forđapl|21|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|21|0|31,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 066593|A02BC0111|Omeprazol Pensa|sţ-hylki|20|mg|100|stk|1|glas|2x50 stk|A02BC01|01.12.2012||R|1|0|0|0|G|0|PEN|0|0|0|100|IKR|2100|3715|lyfalmen|V0006|3711|2|100|0|100,0000|Lyfjaver ehf|Pensa Pharma AB|Ómeprazól||1950||1950|3715||3 066688|V08AB0201|Omnipaque|stl|240|mg J/ml|20|ml|6|glerfl||V08AB02|01.12.1983||R|0|0|0|0|0|1|GEH|0|0|0|100|IKR|4575|6603|lyfsjukr|||1|120|0||Icepharma hf|GE Healthcare AS|Jóhexól||4575||4575|6603||2 066751|C01BD0103|Cordarone (D.A.C.)|töflur|100|mg|30|stk|1|ţpakki||C01BD01|01.11.2006||R|1|0|0|0|G|0|DAC|0|0|0|100|NOK|1226|2725|lyfalmen|V0036|2725|3|30|0|15,0000|D.A.C. ehf|D.A.C. ehf|Amíódarón||1226||1226|2725||2 066862|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|14|stk|1|ţpakki||A02BC01|01.05.2010||L|1|0|0|0|0|0|AGT|0|0|0|100|IKR|||lyflausa|||0|14|0|14,0000|Actavis Group hf|Actavis Group hf|Ómeprazól|||||||1 066897|L01CD0104|Paclitaxel Actavis|irţ|6|mg/ml|50|ml|1|hgl|lausn|L01CD01|01.06.2010||R|0|0|0|1|0|1|AGP|0|0|0|100|XEU|15708|21596|lyfsjukr|||2|50|0||Actavis Group hf|Actavis Group PTC ehf|Paklítaxel||15708||15708|21596||1 067001|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|50|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|8863|12792|lyfsjukr|||2|5000|0||Icepharma hf|Fresenius Kabi|Kolvetni||8863||8863|12792||2 067587|N05BB0101|Atarax|töflur|25|mg|100|stk|1|ţpakki||N05BB01|01.07.1994||R|1|0|0|0|0|0|UCN|0|0|0|100|DKK|1529|3140|lyfalmen|||1|100|0|33,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||1529||1529|3140||1 067748|S01EE0104|Latanoprost Actavis|augndr|50|mcg/ml|2,5|ml|1|glas||S01EE01|01.09.2010||R|0|0|0|0|G|0|APC|0|0|0|100|DKK|1049|2483|lyfalmen|V0376|1727|2|2,5|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Latanóprost||1049||1049|2483||1 067751|J02AC0102|Candizol|hylki|50|mg|7|stk|1|glas||J02AC01|01.12.1998||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|1567|1635|lyfalmen|V0551|1595|2|7|0|1,7500|Actavis Group hf|Actavis hf|Flúkónazól||429||429|1635||1 067769|J02AC0102|Candizol|hylki|50|mg|30|stk|1|glas||J02AC01|01.12.1998||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|5748|3926|lyfalmen|V0552|3393|2|30|0|7,5000|Actavis Group hf|Actavis hf|Flúkónazól||2104||2104|3926||1 067785|J02AC0102|Candizol|hylki|150|mg|1|stk|1|glas||J02AC01|01.12.1998||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|664|1837|lyfalmen|V0554|1837|2|1|0|0,7500|Actavis Group hf|Actavis hf|Flúkónazól||577||577|1837||1 067793|J02AC0102|Candizol|hylki|150|mg|2|stk|1|glas||J02AC01|01.12.1998||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|612|1818|lyfalmen|V0555|1818|2|2|0|1,5000|Actavis Group hf|Actavis hf|Flúkónazól||563||563|1818||1 067801|J02AC0102|Candizol|hylki|150|mg|4|stk|1|glas||J02AC01|01.12.1998||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|2031|2071|lyfalmen|V0556|1595|2|4|0|3,0000|Actavis Group hf|Actavis hf|Flúkónazól||748||748|2071||1 067827|J02AC0102|Candizol|hylki|200|mg|30|stk|1|glas||J02AC01|01.12.1998||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|14199|13506|lyfalmen|V0419|13506|2|30|0|30,0000|Actavis Group hf|Actavis hf|Flúkónazól||9107||9107|13506||1 068312|QN01AX0302|Narketan, vet.|stl|100|mg/ml|50|ml|1|hgl||QN01AX03|01.01.1991||R|0|0|1|0|0|0|VEQ|1|0|0|100|XEU|6267|12206|vetalmen|||0|50|0||Icepharma hf|Vétoquinol AG|||6267||6267|12206||2 068358|L01XC1001|Arzerra|irţ|20|mg/ml|5|ml|3|hgl|100 mg pr. hgl.|L01XC10|01.03.2012||R|0|0|0|1|0|1|GGL|0|1|0|100|GBP|106233|135205|lyfsjukr|||1|15|0||GlaxoSmithKline ehf|Glaxo Group Limited|Ofatúmúmabi||106233||106233|135205||1 068381|B02BX0501|Revolade|filmhtfl|25|mg|14|stk|1|ţpakki||B02BX05|01.04.2011||R|1|1|0|1|0|1|GTS|0|0|0|100|GBP|78146|99956|lyfsjukr|||1|14|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline Trading Services Ltd.|Eltrombópag||78146||78146|99956||1 068437|C01BC0401|Tambocor|töflur|100|mg|20|stk|1|ţpakki||C01BC04|01.04.1987||R|1|0|0|1|G|0|MEB|0|0|0|100|SEK|1869|3605|lyfalmen|||1|20|0|10,0000|Vistor hf|Meda AB (V)|Flekaíníđ||1869||1869|3605||1 068445|C01BC0401|Tambocor|töflur|100|mg|100|stk|1|ţpakki||C01BC04|01.04.1987||R|1|0|0|1|G|0|MEB|0|0|0|100|SEK|5884|9097|lyfalmen|||1|100|0|50,0000|Vistor hf|Meda AB (V)|Flekaíníđ||5884||5884|9097||1 068698|N06DA0206|Donepezil Medical|filmhtfl|10|mg|98|stk|1|ţpakki||N06DA02|01.04.2012||R|1|0|0|0|G|0|MED|0|0|0|100|XEU|18960|10788|lyfalmen|V0342|9401|2|98|0|130,6700|Medical ehf|Medical ehf|Dónepezíl||7120||7120|10788||2 068811|L01BA0109|Metoject|stl|50|mg/ml|0,55|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|3791|6234|lyfalmen|||1|0,55|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||3791||3791|6234||2 068896|B05XA0303|Natriumklorid B.Braun|irţ|1|mmol/ml|20|ml|20|plastl||B05XA03|01.09.2010||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|2582|3726|lyfsjukr|||2|400|0||Actavis Group hf|Braun|Natríumklóríđ||2582||2582|3726||1 068905|B05XA0103|Kaliumklorid B.Braun|irţ|1|mmol/ml|20|ml|20|plastl||B05XA01|01.09.2010||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|3213|4637|lyfsjukr|||2|400|0||Actavis Group hf|Braun|Kalíumklóríđ||3213||3213|4637||1 068923|V07AB0004|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|10|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|200|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||1 068933|V07AB0004|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|20|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|400|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||1 068951|V07AB0009|Sterilt Vann B. Braun|leysir|||10|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|200|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||1 068960|V07AB0009|Sterilt Vann B. Braun|leysir|||20|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|400|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||1 069106|H01BA0201|Minirin|frţ.tfl|240|mcg|30|stk|1|ţpakki||H01BA02|01.08.2012||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|14521|20947|lyfalmen|||1|30|0|18,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||14521||14521|20947||1 069115|H01BA0201|Minirin|frţ.tfl|240|mcg|100|stk|1|ţpakki||H01BA02|01.08.2012||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|45834|60245|lyfalmen|||1|100|0|60,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||45834||45834|60245||1 069799|D01AE1501|Lamisil|krem|10|mg/g|15|g|1|túpa||D01AE15|01.04.1993||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|15|0||Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||||1 069850|C09AA0210|Enalapril LYFIS|töflur|5|mg|100|stk|1|ţpakki||C09AA02|01.06.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|XEU|441|1609|lyfalmen|V0448|1609|2|100|0|50,0000|LYFIS ehf|LYFIS ehf|Enalapríl||410||410|1609||2 070020|N05AX0803|Risperdal Consta|sts|25|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.04.2010||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|18031|25352|lyfalmen|||1|1|0|9,2600|Vistor hf|Janssen-Cilag AB|Risperídón||||18031|25352||1 070031|N05AX0803|Risperdal Consta|sts|37,5|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.04.2010||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|26002|35356|lyfalmen|||1|1|0|13,8900|Vistor hf|Janssen-Cilag AB|Risperídón||||26002|35356||1 070042|N05AX0803|Risperdal Consta|sts|50|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.04.2010||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|33463|44719|lyfalmen|||1|1|0|18,5200|Vistor hf|Janssen-Cilag AB|Risperídón||||33463|44719||1 070113|B01AC0601|Hjartamagnyl|sţ-tfl|75|mg|500|stk|1|glas||B01AC06|01.10.2012||L|1|0|0|0|0|0|AGT|0|0|0|100|IKR|||lyflausa|||0|500|0|500,0000|Actavis Group hf|Actavis Group hf|Asetýlsalicýlsýra|||||||1 070142|G04BD0704|Tolterodin Actavis|forđahlk|4|mg|100|stk|1|ţpakki||G04BD07|01.01.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|19223|26287|lyfalmen|V0589|26287|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Tólteródín||18776||18776|26287||1 070342|V08AB0201|Omnipaque|stl|350|mg J/ml|100|ml|10|glerfl||V08AB02|01.12.1983||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|47543|61549|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Jóhexól||47543||47543|61549||2 070797|N05AX0801|Risperdal|mixtúra|1|mg/ml|100|ml|1|fl|međ skammtasprautu|N05AX08|01.01.1997||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|13098|19161|lyfalmen|||1|100|0|20,0000|Vistor hf|Janssen-Cilag AB|Risperídón||13098||13098|19161||1 071223|N02BG0801|Prialt|irl|100|mcg/ml|1|ml|1|hgl||N02BG08|01.06.2007||R|0|0|0|1|0|1|EIS|0|0|0|100|SEK|69497|89101|lyfsjukr|||1|1|0|8,3300|Vistor hf|Eisai Ltd|Ziconotíđ||69497||69497|89101||1 071232|N02BG0801|Prialt|irl|100|mcg/ml|5|ml|1|hgl||N02BG08|01.06.2007||R|0|0|0|1|0|1|EIS|0|0|0|100|SEK|347489|437981|lyfsjukr|||1|5|0|41,6500|Vistor hf|Eisai Ltd|Ziconotíđ||347489||347489|437981||1 071591|N05AH0405|Seroquel Prolong|forđatfl|150|mg|30|stk|1|ţpakki||N05AH04|01.10.2011||R|1|0|0|0|0|0|ASA|0|0|0|100|SEK|9034|13406|lyfalmen|||1|30|0|11,2500|Vistor hf|Astra Zeneca A/S|Quetíapín||||9034|13406||1 071611|G04BE0305|Vizarsin (Lyfis)|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|11161|9641|lyfalmen|V0144|9146|3|12|0|24,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||6282||6282|9641||2 071844|M01AE0109|Ibuprofen Portfarma|filmhtfl|400|mg|50|stk|1|ţpakki||M01AE01|01.03.2013||L|1|0|0|0|0|0|POF|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6600|Portfarma ehf|Portfarma|Íbúprófen|||||||2 071975|L01BB0501|Fludara|filmhtfl|10|mg|20|stk|1|ţpakki||L01BB05|01.09.2011||R|0|0|0|1|0|1|GZE|0|0|0|100|XEU|95935|122281|lyfsjukr|||1|20|0||Vistor hf|Genzyme Europe B.V.|Flúdarabín||95935||95935|122281||1 072044|B01AC0402|Grepid|töflur|75|mg|30|stk|1|ţpakki||B01AC04|01.01.2010||R|1|0|0|0|G|0|PSA|0|0|0|100|XEU|3236|1932|lyfalmen|V0009|1932|2|30|0|30,0000|Portfarma ehf|Pharmathen S.A.|Klópídógrel||646||646|1932||2 072132|QN05CM9001|Domosedan, vet.|stl|10|mg/ml|5|ml|1|hgl||QN05CM90|01.01.1991||R|0|0|0|0|0|0|ORF|1|0|0|100|DKK|7203|14003|vetalmen|||0|5|0||Vistor hf|Orion-Farmos|||7203||7203|14003||1 072233|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|300|stk|1|ţpakki||N07BA01|01.02.2010||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|300|0|20,0000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 072380|B01AC0402|Grepid|töflur|75|mg|100|stk|1|ţpakki||B01AC04|01.12.2009||R|1|0|0|0|G|0|PSA|0|0|0|100|XEU|8443|7030|lyfalmen|V0029|7030|2|100|0|100,0000|Portfarma ehf|Pharmathen S.A.|Klópídógrel||4373||4373|7030||2 072641|V04CX0001|Lung test gas CO (HE) Aga|lyfjagas|0,28|%|20|l|1|hylki|undir ţrýstingi|V04CX|01.05.2012||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|143477|181946|lyfsjukr|||1|20|0||Ísaga ehf|AGA AB|Carbon monoxide||143477||143477|181946||5 072654|V04CX0002|Lung test gas CO (C2H2/CH4) Aga|lyfjagas|0,3|%|20|l|1|hylki|undir ţrýstingi|V04CX|01.05.2012||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|143477|181946|lyfsjukr|||1|20|0||Ísaga ehf|AGA AB|Carbon monoxide||143477||143477|181946||5 072751|N01AH0301|Sufenta|stl|5|mcg/ml|2|ml|5|lykjur||N01AH03|01.06.2000||R|0|0|1|0|0|1|JAS|0|0|0|100|SEK|681|983|lyfsjukr|||1|10|0||Vistor hf|Janssen-Cilag AB|Súfentaníl||681||681|983||1 072770|L04AB0401|Humira|stl|40|mg/penna|0,8|ml|2|pennar||L04AB04|01.06.2007||R|0|1|0|1|0|1|ABV|0|1|0|100|DKK|152022|192670|lyfsjukr|||1|1,6|0|27,5900|Vistor hf|AbbVie Ltd.|Adalimumab||152022||152022|192670||1 072978|A10BX0401|Byetta|stl|5|mcg/sk|1,2|ml|1|penni|lausn|A10BX04|01.05.2007||R|0|0|0|0|G|0|EEI|0|0|0|100|XEU|16958|24006|lyfalmen|||1|1,2|0|20,0000|Vistor hf|Bristol-Myers Squibb/AstraZeneca EEIG|Exenatíđ||16958||16958|24006||2 072996|A10BX0401|Byetta|stl|10|mcg/sk|2,4|ml|1|penni|lausn|A10BX04|01.05.2007||R|0|0|0|0|G|0|EEI|0|0|0|100|XEU|16958|24006|lyfalmen|||1|2,4|0|40,0000|Vistor hf|Bristol-Myers Squibb/AstraZeneca EEIG|Exenatíđ||16958||16958|24006||2 073027|J05AG0401|Intelence|töflur|200|mg|60|stk|1|glas||J05AG04|01.04.2012||R|0|0|0|1|0|1|JCI|0|0|0|100|SEK|78093|99889|lyfsjukr|||1|60|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Etravírín||78093||78093|99889||1 073205|N05AF0103|Fluanxol Mite|filmhtfl|0,5|mg|100|stk|1|glas||N05AF01|01.12.1972|30.06.2013|R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|1045|2477|lyfalmen|||1|100|0|8,3333|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1045||1045|2477||1 073313|L01XE1601|Xalkori|hylki|200|mg|60|stk|1|ţpakki||L01XE16|01.05.2013||R|1|1|0|1|0|1|IPI|0|0|0|100|SEK|809117|1017324|lyfsjukr|||1|60|0||Icepharma hf|Pfizer Limited|Crizotiníb||809117||809117|1017324||2 073559|G04CA5201|Duodart|hylki|0,9|mg|30|stk|1|glas|0,5 mg + 0,4 mg|G04CA52|01.12.2010||R|1|0|0|0|G|0|GSK|0|0|0|100|GBP|3753|6182|lyfalmen|||1|30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Dútasteríđ og tamsúlósínhýdroklóríđ||3753||3753|6182||1 073684|N05AF0103|Fluanxol Mite|filmhtfl|1|mg|100|stk|1|glas||N05AF01|01.12.1972|30.06.2013|R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|1655|3312|lyfalmen|||1|100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1655||1655|3312||1 073708|L02BG0405|Letrozol Actavis|filmhtfl|2,5|mg|100|stk|1|ţpakki||L02BG04|01.09.2011||R|0|0|0|0|G|0|AGP|0|0|0|100|XEU|19099|21110|lyfalmen|V0185|20258|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Letrózól||14651||14651|21110||1 073776|C09AA0210|Enalapril LYFIS|töflur|10|mg|100|stk|1|ţpakki||C09AA02|01.06.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|XEU|735|2011|lyfalmen|V0066|2011|2|100|0|100,0000|LYFIS ehf|LYFIS ehf|Enalapríl||704||704|2011||2 073825|N05BA1203|Tafil|töflur|0,25|mg|20|stk|1|ţpakki||N05BA12|01.04.1987||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|313|1476|lyfalmen|V0047|1354|1|20|0|5,0000|Icepharma hf|Pfizer ApS|Alprazólam||313||313|1476||1 073833|N05BA1203|Tafil|töflur|0,25|mg|50|stk|1|ţpakki||N05BA12|01.04.1987||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|770|2101|lyfalmen|V0305|1050|1|50|0|12,5000|Icepharma hf|Pfizer ApS|Alprazólam||770||770|2101||1 073841|N05BA1203|Tafil|töflur|0,25|mg|100|stk|1|ţpakki||N05BA12|01.04.1987||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|983|2393|lyfalmen|V0305|2099|1|100|0|25,0000|Icepharma hf|Pfizer ApS|Alprazólam||983||983|2393||1 073858|N05BA1203|Tafil|töflur|0,5|mg|20|stk|1|ţpakki||N05BA12|01.04.1987||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|529|1772|lyfalmen|V0439|1560|1|20|0|10,0000|Icepharma hf|Pfizer ApS|Alprazólam||529||529|1772||1 073874|N05BA1203|Tafil|töflur|0,5|mg|100|stk|1|ţpakki||N05BA12|01.04.1987||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|1437|3014|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Alprazólam||1437||1437|3014||1 073935|QP54AA0107|Noromectin Drench|mixtúra|0,8|mg/ml|1|l|1|fl|lausn|QP54AA01|01.11.2011||R|0|0|0|0|0|0|NOB|1|0|0|100|XEU|3820|6664|vetorma|||0|1|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||3820||3820|6664||2 073947|L04AX0102|Imurel|töflur|25|mg|50|stk|1|ţpakki||L04AX01|01.12.2010||R|0|0|0|0|G|0|APT|0|0|0|100|GBP|1334|2873|lyfalmen|||1|50|0|8,3333|GlaxoSmithKline ehf|Aspen Pharma Trading Limited|Azatíóprín||1334||1334|2873||1 074016|G04BE0303|Viagra (D.A.C.)|filmhtfl|25|mg|4|stk|1|ţpakki||G04BE03|01.12.2009||R|1|0|0|0|0|0|DAC|0|0|0|100|DKK|4760|7559|lyfalmen|V0142|7559|3|4|0|2,0000|D.A.C. ehf|D.A.C. ehf|Síldenafíl||4760||4760|7559||2 074042|C09DB0101|Exforge|filmhtfl|85|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|1|0|0|0|0|0|NOE|0|0|0|100|DKK|3681|6083|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||3681||3681|6083||1 074083|B03BB0106|Folic Acid (D.A.C.)|töflur|5|mg|28|stk|1|ţpakki||B03BB01|01.03.2011||R|1|0|0|0|G|0|DAC|0|0|1|100|GBP|402|1592|lyfalmen|V0391|1592|3|28|0|350,0000|D.A.C. ehf|D.A.C. ehf|Fólínsýra||398||398|1592||2 074348|N03AX2201|Fycompa|filmhtfl|8|mg|28|stk|1|ţpakki||N03AX22|01.07.2013||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|25764|35057|lyfalmen|||1|28|0||Vistor hf|Eisai Europe Ltd.|Perampanel||25764||25764|35057||1 074443|V08CA0301|Omniscan|stl|0,5|mmol/ml|5|ml|10|hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|17965|24429|lyfsjukr|||1|50|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||17965||17965|24429||2 074468|N05BA0105|Stesolid|töflur|5|mg|25|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|491|1720|lyfalmen|||2|25|0|12,5000|Actavis Group hf|Actavis Group hf|Díazepam||491||491|1720||1 074484|N05BA0105|Stesolid|töflur|5|mg|50|stk|1|glas||N05BA01|01.12.1980||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|680|1978|lyfalmen|||2|50|0|25,0000|Actavis Group hf|Actavis Group hf|Díazepam||680||680|1978||1 074492|N05BA0105|Stesolid|töflur|5|mg|100|stk|1|glas||N05BA01|01.08.2011||R|1|0|0|0|0|0|AGT|0|0|0|100|DKK|1105|2560|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group hf|Díazepam||1105||1105|2560||1 074617|QI06AA0402|Fel-O-Vax PCT vet.|bóluefni|||1|ml|25|spr|áfyllt sprauta|QI06AA04|01.06.2000||R|0|0|0|0|0|0|PAL|1|0|0|100|DKK|21227|37029|vetorma|||0|25|0||Icepharma hf|Pfizer Oy Animal Health|||21227||21227|37029||1 074667|N06AA0905|Amitriptyline|filmhtfl|10|mg|98|stk|1|ţpakki||N06AA09|01.03.2011||R|1|0|0|0|G|0|AUK|0|0|0|100|GBP|408|1588|lyfalmen|V0510|1588|2|98|0|13,0700|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||395||395|1588||1 074679|N06AA0905|Amitriptyline|filmhtfl|25|mg|98|stk|1|ţpakki||N06AA09|01.02.2011||R|1|0|0|0|G|0|AUK|0|0|0|100|GBP|706|2014|lyfalmen|V0512|2014|2|98|0|32,6600|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||706||706|2014||1 074758|C01AA0503|Lanoxin|mixtúra|50|mcg/ml|60|ml|1|glas||C01AA05|01.12.2010||R|0|0|0|0|G|0|AEG|0|0|0|100|GBP|951|2349|lyfalmen|||1|60|0|12,0000|GlaxoSmithKline ehf|Aspen Europe GmbH|Digoxín||951||951|2349||1 074782|C01AA0503|Lanoxin|töflur|0,25|mg|100|stk|1|glas||C01AA05|01.09.2010||R|1|0|0|0|G|0|APT|0|0|0|100|GBP|507|1741|lyfalmen|||1|100|0|100,0000|GlaxoSmithKline ehf|Aspen Pharma Trading Limited|Digoxín||507||507|1741||1 075009|L04AX0102|Imurel|töflur|50|mg|100|stk|1|ţpakki||L04AX01|01.08.2011||R|0|0|0|0|G|0|APT|0|0|0|100|GBP|2345|4256|lyfalmen|||1|100|0|33,3333|GlaxoSmithKline ehf|Aspen Pharma Trading Limited|Azatíóprín||2345||2345|4256||1 075031|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|0|1|0|0|G|0|NOE|0|0|1|100|DKK|5012|7904|lyfalmen|||1|30|0|30,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||5012||5012|7904||1 075042|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|0|1|0|0|G|0|NOE|0|0|1|100|DKK|15036|21594|lyfalmen|||1|90|0|90,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||15036||15036|21594||1 075044|J02AB0201|Fungoral|töflur|200|mg|10|stk|1|ţpakki||J02AB02|01.01.1985||R|1|0|0|0|0|0|JAS|0|0|1|100|SEK|1853|3583|lyfalmen|||1|10|0|10,0000|Vistor hf|Janssen-Cilag AB|Ketókónazól||1853||1853|3583||1 075064|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|0|1|0|0|G|0|NOE|0|0|1|100|DKK|5012|7904|lyfalmen|||1|30|0|60,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||5012||5012|7904||1 075069|R06AX2601|Telfast|töflur|180|mg|30|stk|1|ţpakki||R06AX26|01.11.1999||R|1|0|0|0|G|0|SNO|0|0|1|100|NOK|1918|2878|lyfalmen|||1|30|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||1338||1338|2878||1 075075|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|0|1|0|0|G|0|NOE|0|0|1|100|DKK|15036|21594|lyfalmen|||1|90|0|180,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||15036||15036|21594||1 075078|N07BA0131|Nicorette Microtab Classic|tungur.t|2|mg|90|stk|1|ţpakki||N07BA01|01.10.2008||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|90|0|6,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 075087|N02BE5102|Parkodin|töflur|510|mg|300|stk|1|plglas|10+500 mg|N02BE51|01.07.2007||R|2|0|1|0|0|0|ACA|0|0|1|100|XEU|3237|5476|lyfalmen|||2|300|0|50,0000|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema međ geđlyfjum (psycholeptica)||3237||3237|5476||1 075096|N02AA5902|Parkodin forte|töflur|530|mg|300|stk|1|plglas|30+500 mg|N02AA59|01.07.2007||R|2|0|1|0|0|0|ACA|0|0|1|100|NOK|5063|7974|lyfalmen|||2|300|0|100,0000|Actavis Group hf|Actavis hf|Kódein í blöndum nema međ geđlyfjum||5063||5063|7974||1 075187|A06AD0001|Moviprep|mixtduft|||4|pokar|1|pakki||A06AD|01.09.2011||R|0|0|0|0|0|0|NBV|0|0|0|100|XEU|2673|4704|lyfalmen|||1|4|0||Norgine BV|Norgine BV|Hćgđalyf međ osmótíska verkun||||2673|4704||1 075310|M01AH0103|Celebra (Lyfjaver)|hylki|200|mg|100|stk|1|ţpakki||M01AH01|01.12.2009||R|1|0|0|0|G|0|LVR|0|0|1|100|DKK|13614|19809|lyfalmen|V0196|16790|3|100|0|100,0000|Lyfjaver ehf|Lyfjaver ehf|Celekoxíb||13614||13614|19809||3 075356|G04BD0703|Detrusitol SR (Lyfjaver)|forđahlk|4|mg|84|stk|1|ţpakki||G04BD07|01.07.2011||R|1|0|0|0|G|0|LVR|0|0|0|100|XEU|18292|22517|lyfalmen|V0589|22081|3|84|0|84,0000|Lyfjaver ehf|Lyfjaver ehf|Tólteródín||15772||15772|22517||3 075413|G04BD0802|Vesicare (Lyfjaver)|filmhtfl|10|mg|90|stk|1|ţpakki||G04BD08|01.05.2012||R|1|0|0|0|G|0|LVR|0|0|0|100|XEU|20462|28403|lyfalmen|V0441|22950|3|90|0|180,0000|Lyfjaver ehf|Lyfjaver ehf|Sólífenacín||20462||20462|28403||3 075425|G04BD0802|Vesicare (Lyfjaver)|filmhtfl|5|mg|90|stk|1|ţpakki||G04BD08|01.05.2012||R|1|0|0|0|G|0|LVR|0|0|0|100|XEU|16660|23632|lyfalmen|V0440|19181|3|90|0|90,0000|Lyfjaver ehf|Lyfjaver ehf|Sólífenacín||16660||16660|23632||3 075451|G04CB0103|Finasteride Portfarma|filmhtfl|5|mg|98|stk|1|ţpakki||G04CB01|01.05.2011||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|4210|3469|lyfalmen|V0445|3033|2|98|0|98,0000|Portfarma ehf|Portfarma|Fínasteríđ||1770||1770|3469||2 075470|L01CD0201|Taxotere|irţ|20|mg|1|ml|1|hgl|lausn|L01CD02|01.06.2010||R|0|0|0|1|0|1|AVS|0|0|0|100|NOK|31789|41778|lyfsjukr|||1|1|0||Vistor hf|Aventis Pharma SA|Docetaxel||31789||31789|41778||1 075482|L01CD0201|Taxotere|irţ|80|mg|4|ml|1|hgl|lausn|L01CD02|01.06.2010||R|0|0|0|1|0|1|AVS|0|0|0|100|NOK|119316|151624|lyfsjukr|||1|4|0||Vistor hf|Aventis Pharma SA|Docetaxel||119316||119316|151624||1 075777|QG03DA0201|Perlutex, vet.|töflur|5|mg|20|stk|1|ţpakki||QG03DA02|01.03.2011||R|0|0|0|0|0|0|DEC|0|0|0|100|DKK|981|1951|vetalmen|||0|20|0||Vistor hf|Dechra Veterinary Products A/S|Medroxyprogesteronum||981||981|1951||1 075865|G04BD0803|Solifenacin Portfarma|filmhtfl|5|mg|90|stk|1|ţpakki||G04BD08|01.06.2013||R|1|0|0|0|G|0|PEH|0|0|0|100|XEU|13114|19181|lyfalmen|V0440|19181|2|90|0|90,0000|Portfarma ehf|Portfarma ehf|Sólífenacín||13114||13114|19181||2 075869|B05DB0005|Balance|kviđ.sk|1,5|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|6218|8974|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6218||6218|8974||2 075888|B05DB0005|Balance|kviđ.sk|2,3|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|6218|8974|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6218||6218|8974||2 075906|B05DB0005|Balance|kviđ.sk|4,25|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|6218|8974|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6218||6218|8974||2 075936|P01BC0104|Quinine Sulphate Actavis|filmhtfl|200|mg|28|stk|1|ţpakki||P01BC01|01.07.2010||R|1|0|0|0|0|0|AUK|0|0|0|100|GBP|440|1650|lyfalmen|||2|28|0|3,7300|Actavis Group hf|Actavis UK Ltd.|Kínín||440||440|1650||1 075947|J01EE0107|Trimezol|töflur|480|mg|20|stk|1|ţpakki|80+400 mg|J01EE01|01.12.2009||R|0|0|0|0|0|0|AEA|0|0|1|100|XEU|462|1680|lyfalmen|||2|20|0|5,0000|Actavis hf|Actavis EAD|Súlfametoxazól og trímetóprím||462||462|1680||1 075991|C09AA0210|Enalapril LYFIS|töflur|20|mg|100|stk|1|ţpakki||C09AA02|01.06.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|XEU|916|2256|lyfalmen|V0449|2256|2|100|0|200,0000|LYFIS ehf|LYFIS ehf|Enalapríl||883||883|2256||2 076024|A10BH0101|Januvia|filmhtfl|100|mg|28|stk|1|ţpakki||A10BH01|01.01.2010||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|6717|10236|lyfalmen|||1|28|0|28,0000|Vistor hf|M.S.D.|Sítagliptín||6717||6717|10236||1 076033|A10BH0101|Januvia|filmhtfl|100|mg|98|stk|1|ţpakki||A10BH01|01.11.2007||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|22406|30843|lyfalmen|||1|98|0|98,0000|Vistor hf|M.S.D.|Sítagliptín||||22406|30843||1 076043|A10BH0101|Januvia|filmhtfl|25|mg|98|stk|1|ţpakki||A10BH01|01.02.2013||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|23401|32092|lyfalmen|||1|98|0|24,5000|Vistor hf|M.S.D.|Sítagliptín||23401||23401|32092||1 076052|A10BH0101|Januvia|filmhtfl|50|mg|98|stk|1|ţpakki||A10BH01|01.10.2012||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|23415|32109|lyfalmen|||1|98|0|49,0000|Vistor hf|M.S.D.|Sítagliptín||23415||23415|32109||1 076361|V03AN0101|Conoxia|lyfjagas|100|%|2|l|1|hylki|undir ţrýstingi/LIV|V03AN01|01.12.2009||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|2|0||Ísaga ehf|AGA AB|Súrefni|||||||5 076369|N05AX0805|Risperidon Portfarma|filmhtfl|0,5|mg|20|stk|1|ţpakki||N05AX08|01.07.2007||R|1|0|0|0|0|0|POF|0|0|0|100|IKR|445|1657|lyfalmen|V0045|1657|2|20|0|2,0000|Portfarma ehf|Portfarma|Risperídón||445||445|1657||2 076378|N05AX0805|Risperidon Portfarma|filmhtfl|0,5|mg|60|stk|1|ţpakki||N05AX08|01.07.2007||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|1691|3168|lyfalmen|V0290|3168|2|60|0|6,0000|Portfarma ehf|Portfarma|Risperídón||1550||1550|3168||2 076387|N05AX0805|Risperidon Portfarma|filmhtfl|1|mg|60|stk|1|ţpakki||N05AX08|01.07.2007||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|1946|3442|lyfalmen|V0291|3442|2|60|0|12,0000|Portfarma ehf|Portfarma|Risperídón||1750||1750|3442||2 076403|S01GX0801|Zaditen|augndr|0,25|mg/ml|5|ml|1|glas||S01GX08|01.06.2013||R|0|0|0|0|G|0|LTH|0|0|0|100|SEK|1837|3561|lyfalmen|V0075|3561|1|5|0||Vistor hf|Laboratoires THEA|Ketotifen||1837||1837|3561||1 076551|N05AB0301|Trilafon|filmhtfl|8|mg|100|stk|1|ţpakki||N05AB03|01.04.2009||R|1|0|0|0|G|0|SPL|0|0|0|100|DKK|1801|3512|lyfalmen|V0027|3512|1|100|0|26,6667|Vistor hf|Schering-Plough Europe|Perfenazín||||1801|3512||1 076752|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|100|ml|1|hgl|plast|QP54AA01|01.01.1985||R|0|0|0|0|0|0|MEF|1|0|0|100|XEU|7315|12761|vetorma|||0|100|0||Vistor hf|Merial (MSD)|Ivermectinum||7315||7315|12761||1 076871|G01AF0202|Canesten (D.A.C.)|sk-tfl|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.12.2009||L|0|0|0|0|0|0|DAC|0|0|0|100|IKR|||lyflausa|||0|1|0|5,0000|D.A.C. ehf|D.A.C. ehf|Klótrímazól|||||||2 077420|N02BE5102|Parkodin|töflur|510|mg|30|stk|1|pakki|ţp 10+500 mg|N02BE51|01.01.1985||R|1|0|0|0|0|0|ACA|0|0|1|100|XEU|378|1565|lyfalmen|||2|30|0|5,0000|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema međ geđlyfjum (psycholeptica)||378||378|1565||1 077446|N02BE5102|Parkodin|töflur|510|mg|100|stk|1|pakki|ţp 10+500 mg|N02BE51|01.01.1985||R|1|0|0|0|0|0|ACA|0|0|1|100|XEU|1072|2514|lyfalmen|||2|100|0|16,6667|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema međ geđlyfjum (psycholeptica)||1072||1072|2514||1 077821|B01AC0403|Clopidogrel Actavis|filmhtfl|75|mg|100|stk|1|ţpakki||B01AC04|01.07.2010||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|8443|7444|lyfalmen|V0029|7030|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Klópídógrel||4676||4676|7444||1 077875|A02BA0205|Zantac|stl|25|mg/ml|2|ml|5|lykjur||A02BA02|01.10.1987||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|786|2123|lyfalmen|||1|10|0|0,8333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ranitidín||786||786|2123||1 078193|D01AC0102|Canesten (D.A.C.)|krem|1|%|20|g|1|túpa||D01AC01|01.12.2009||L|0|0|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||0|20|0||D.A.C. ehf|D.A.C. ehf|Klótrímazól|||||||2 078307|J02AC0103|Fluconazole Portfarma|hylki|200|mg|28|stk|1|ţpakki||J02AC01|01.12.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|11524|12676|lyfalmen|V0419|12606|2|28|0|28,0000|Portfarma ehf|Portfarma|Flúkónazól||8500||8500|12676||2 078568|J01CE0204|Kaavepenin|töflur|250|mg|20|stk|1|ţpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|555|1807|lyfalmen|||1|20|0|2,5000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||555||555|1807||1 078576|J01CE0204|Kaavepenin|töflur|250|mg|40|stk|1|ţpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|845|2204|lyfalmen|||1|40|0|5,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||845||845|2204||1 078688|N01BB0204|Lidokain FarmaPlus|stl|10|mg/ml|20|ml|5|hgl|međ rotvörn|N01BB02|01.04.2012||R|0|0|0|0|0|0|FPL|0|0|1|100|XEU|1429|3003|lyfalmen|V0560|3003|2|100|0||FarmaPlus AS|FarmaPlus AS|Lídókaín||1429||1429|3003||2 078699|N01BB0204|Lidokain FarmaPlus|stl|20|mg/ml|20|ml|5|hgl|međ rotvörn|N01BB02|01.04.2012||R|0|0|0|0|0|0|FPL|0|0|1|100|XEU|2044|3844|lyfalmen|V0561|3844|2|100|0||FarmaPlus AS|FarmaPlus AS|Lídókaín||2044||2044|3844||2 078933|L03AB0801|Betaferon|sts|8|mi.ae/ml|15|spr|1|pakki|+leysir|L03AB08|01.01.2002||R|0|0|0|1|0|1|SAG|0|1|0|100|DKK|132107|167677|lyfsjukr|||1|15|0|30,0000|Icepharma hf|Schering AG|Interferón beta-1b||132107||132107|167677||2 079061|C09CA0101|Cozaar|töflur|50|mg|98|stk|1|ţpakki||C09CA01|01.01.1995||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|9109|6276|lyfalmen|V0069|1759|1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan||3822||3822|6276||1 079103|L01AA0601|Holoxan|sts/irs|500|mg|1|stk|1|hgl||L01AA06|01.07.1998||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|3207|4629|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíđ||3207||3207|4629||2 079111|L01AA0601|Holoxan|sts/irs|1|g|1|stk|1|hgl||L01AA06|01.07.1998||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|6414|9257|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíđ||6414||6414|9257||2 079129|L01AA0601|Holoxan|sts/irs|2|g|1|stk|1|hgl||L01AA06|01.07.1998||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|12868|18032|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíđ||12868||12868|18032||2 079202|J05AH0201|Tamiflu|hylki|75|mg|10|stk|1|ţpakki||J05AH02|01.11.2002||R|1|0|0|0|0|0|RRL|0|0|0|100|DKK|3733|6154|lyfalmen|||1|10|0|5,0000|Icepharma hf|Roche Registration Limited|Oseltamivír||3733||3733|6154||2 079269|N05AB0302|Trilafon decanoat|stl|108,2|mg/ml|1|ml|10|lykjur||N05AB03|01.01.1988||R|0|0|0|0|G|0|MBV|0|0|0|100|DKK|18857|26389|lyfalmen|||1|10|0|154,5714|Vistor hf|Merck Sharp & Dohme B.V.|Perfenazín||18857||18857|26389||1 079358|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.05.2010||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 079381|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.05.2010||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 079495|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|100|stk|1|ţpakki||N06AB03|01.05.2010||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|3575|5938|lyfalmen|V0315|5938|2|100|0|100,0000|Actavis Group hf|Actavis hf|Flúoxetín||3575||3575|5938||1 079749|J01CF0101|Diclocil|sts/irs|1|g|1|stk|5|hgl||J01CF01|01.04.1987||R|0|0|0|0|0|1|BRS|0|0|0|100|DKK|2117|3055|lyfsjukr|||1|5|0|2,5000|Vistor hf|Bristol-Myers Squibb|Díkloxacillín||2117||2117|3055||1 080106|J01MA0203|Siprox|töflur|250|mg|10|stk|1|ţpakki||J01MA02|01.10.1992||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|393|1586|lyfalmen|V0176|1586|2|10|0|2,5000|Actavis Group hf|Actavis hf|Cíprófloxacín||393||393|1586||1 080115|J01MA0203|Siprox|töflur|250|mg|20|stk|1|ţpakki||J01MA02|01.10.1992||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|638|1921|lyfalmen|V0418|1921|2|20|0|5,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||638||638|1921||1 080124|J01MA0203|Siprox|töflur|500|mg|10|stk|1|ţpakki||J01MA02|01.05.2008||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|647|1933|lyfalmen|V0177|1933|2|10|0|5,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||647||647|1933||1 080133|J01MA0203|Siprox|töflur|500|mg|20|stk|1|ţpakki||J01MA02|01.01.1994||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|1168|2646|lyfalmen|V0411|2646|2|20|0|10,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||1168||1168|2646||1 080145|QG02AD9002|Genestran|stl|75|mcg/ml|20|ml|1|hgl|lausn|QG02AD90|01.11.2011||R|0|0|0|0|0|0|ANI|1|0|0|100|IKR|4985|9745|vetalmen|||0|20|0||Dýraheilsa ehf|aniMedica GmbH|||4985||4985|9745||2 080156|QN02AF0101|Morphasol handa hundum og köttum|stl|4|mg/ml|10|ml|1|hgl||QN02AF01|01.06.2010||R|0|0|0|0|0|0|ANI|1|0|0|100|XEU|4102|8049|vetalmen|||0|10|0||Dýraheilsa ehf|aniMedica GmbH|Bútorfanóltartrat||||4102|8049||2 080331|L02BB0306|Bicalutamid LYFIS|filmhtfl|150|mg|30|stk|1|ţpakki||L02BB03|01.06.2012||R|0|0|0|0|G|0|LYF|0|0|0|100|XEU|15355|15236|lyfalmen|V0421|15064|2|30|0|90,0000|LYFIS ehf|LYFIS ehf|Bíkalútamíđ||10372||10372|15236||2 080424|G01AF0502|Pevaryl Depot|sk-stíll|150|mg|1|stk|1|still||G01AF05|01.04.1989||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|1|0|1,5000|Vistor hf|McNeil Sweden AB|Ekónazól|||||||1 080447|QP52AA5103|Drontal Vet.|filmhtfl|250|mg|24|stk|1|ţpakki|230+20 mg|QP52AA51|01.11.2011||R|0|0|0|0|0|0|BAN|1|0|0|100|DKK|10432|18198|vetorma|||0|24|0||Icepharma hf|Bayer Animal Health GmbH|||10432||10432|18198||2 080470|L02BG0406|Letrozole Bluefish|filmhtfl|2,5|mg|30|stk|1|ţpakki||L02BG04|01.03.2012||R|0|0|0|0|G|0|RAT|0|0|0|100|XEU|16957|10179|lyfalmen|V0170|10179|2|30|0|30,0000|LYFIS ehf|ratiopharm GmbH|Letrózól||6675||6675|10179||2 080482|L02BG0406|Letrozole Bluefish|filmhtfl|2,5|mg|100|stk|1|ţpakki||L02BG04|01.03.2012||R|0|0|0|0|G|0|RAT|0|0|0|100|XEU|19099|20981|lyfalmen|V0185|20258|2|100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Letrózól||14548||14548|20981||2 080507|N06AA1001|Noritren|töflur|50|mg|100|stk|1|glas||N06AA10|01.04.1986||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|2297|4190|lyfalmen|||1|100|0|66,6667|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||2297||2297|4190||1 080524|N06AX1202|Wellbutrin Retard|töflur|300|mg|30|stk|1|glas|m/br. losunarhrađa|N06AX12|01.07.2007||R|1|0|0|0|0|0|GSK|0|0|0|100|GBP|5899|9117|lyfalmen|||1|30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Bupropionum||5899||5899|9117||1 080538|G04BE0306|Sildenafil Actavis|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|2713|3654|lyfalmen|V0143|2467|2|4|0|4,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||1905||1905|3654||1 080542|N06AX1202|Wellbutrin Retard|töflur|150|mg|30|stk|1|glas|m/br. losunarhrađa|N06AX12|01.07.2007||R|1|0|0|0|0|0|GSK|0|0|0|100|GBP|3063|5238|lyfalmen|||1|30|0|15,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Bupropionum||3063||3063|5238||1 080549|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|500|ml|1|fl||QP54AA01|01.01.1985||R|0|0|0|0|0|0|MEF|1|0|0|100|XEU|34912|60902|vetorma|||0|500|0||Vistor hf|Merial (MSD)|Ivermectinum||34912||34912|60902||1 080550|G04BE0306|Sildenafil Actavis|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|7668|7532|lyfalmen|V0143|7400|2|12|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||4740||4740|7532||1 080561|G04BE0306|Sildenafil Actavis|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|2995|3750|lyfalmen|V0144|3049|2|4|0|8,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||1975||1975|3750||1 080564|L01DB0601|Zavedos|sts|5|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|15284|21064|lyfsjukr|||1|1|0||Icepharma hf|Pfizer ApS|Ídarúbicín||15284||15284|21064||1 080573|G04BE0306|Sildenafil Actavis|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|11162|9650|lyfalmen|V0144|9146|2|12|0|24,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||6288||6288|9650||1 080820|L01DB0601|Zavedos|sts|10|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|30131|39697|lyfsjukr|||1|1|0||Icepharma hf|Pfizer ApS|Ídarúbicín||30131||30131|39697||1 081305|L01XE1601|Xalkori|hylki|250|mg|60|stk|1|ţpakki||L01XE16|01.05.2013||R|1|1|0|1|0|1|IPI|0|0|0|100|SEK|809117|1017324|lyfsjukr|||1|60|0||Icepharma hf|Pfizer Limited|Crizotiníb||809117||809117|1017324||2 081490|A01AB0301|Corsodyl|munnh.hl|10|mg/g|50|g|1|túpa||A01AB03|01.07.2013||L|0|0|0|0|0|0|SMB|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6667|GlaxoSmithKline ehf|SmithKline Beecham Ltd|Klórhexidín|||||||1 081525|V03AN0101|Conoxia|lyfjagas|100|%|10|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|10|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081534|V03AN0101|Conoxia|lyfjagas|100|%|20|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|20|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081543|V03AN0101|Conoxia|lyfjagas|100|%|50|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|50|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081552|V03AN0101|Conoxia|lyfjagas|100|%|5|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|5|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081561|V03AN0101|Conoxia|lyfjagas|100|%|50|l|12|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|600|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081589|V03AN0101|Conoxia|lyfjagas|100|%|1|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|1|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081613|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.05.2010||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 081625|V03AN0101|Conoxia|lyfjagas|100|%|2|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|2|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081634|V03AN0101|Conoxia|lyfjagas|100|%|4|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|4|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081635|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.05.2010||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 081645|N03AX1405|Matever|filmhtfl|250|mg|100|stk|1|ţpakki||N03AX14|01.02.2012||R|1|0|0|0|0|0|PSA|0|0|0|100|XEU|8218|3837|lyfalmen|V0515|3525|2|100|0|16,6700|Portfarma ehf|Pharmathen S.A.|Levetíracetam||2039||2039|3837||2 081669|G03DA0404|Lutinus|sk-tafla|100|mg|21|stk|1|ţpakki||G03DA04|01.04.2011||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|4709|7490|lyfalmen|||1|21|0|23,3300|Vistor hf|Ferring Lćgemidler A/S|Prógesterón||4709||4709|7490||1 081671|V03AN0101|Conoxia|lyfjagas|100|%|4|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|4|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081745|N05CD0801|Dormicum|stl|5|mg/ml|1|ml|10|lykjur||N05CD08|01.07.1985||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|1865|2692|lyfsjukr|||1|10|0|3,3333|Icepharma hf|Roche|Mídazólam||1865||1865|2692||2 081897|N05AH0305|Zyprexa Velotab (D.A.C.)|munndr.t|10|mg|28|stk|1|ţpakki||N05AH03|01.04.2010||R|0|0|0|0|G|0|DAC|0|0|0|100|XEU|20012|15904|lyfalmen|V0456|15904|3|28|0|28,0000|D.A.C. ehf|D.A.C. ehf|Olanzapín||10860||10860|15904||2 081987|A10AB0602|Apidra [Solostar]|stl|100|ein/ml|3|ml|5|lyfjap|áfylltir lyfjapennar|A10AB06|01.01.2008||R|0|0|0|0|G|0|SAA|0|0|0|100|NOK|5977|9224|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - Aventis|Insúlín glúlisín||5977||5977|9224||1 081996|A10AE0403|Lantus [SoloStar]|stl|100|ein/ml|3|ml|5|lyfjap|áfylltir lyfjapennar|A10AE04|01.01.2008||R|0|0|0|0|G|0|SDE|0|0|0|100|NOK|8418|12563|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||8418||8418|12563||1 082021|L02BG0302|Anastrozol Actavis|filmhtfl|1|mg|98|stk|1|ţpakki||L02BG03|01.03.2011||R|0|0|0|0|G|0|AGP|0|0|0|100|XEU|17433|12555|lyfalmen|V0184|11981|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Anastrózól||8412||8412|12555||1 082040|D07XC0101|Diprosalic|áburđur|||100|ml|1|glas||D07XC01|01.01.1987||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|2291|4182|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||2291||2291|4182||1 082233|V03AN0101|Conoxia|lyfjagas|100|%|36|l|1|hylki|kćlt|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|36|0||Ísaga ehf|AGA AB|Súrefni|||||||5 082685|R03BA0502|Flixotide Diskus|innönddu|250|mcg/sk|60|skammtar|1|pakki|í diskus-t|R03BA05|01.07.1995||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|3052|5223|lyfalmen|||1|60|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||3052||3052|5223||1 082719|R03BA0502|Flixotide Diskus|innönddu|500|mcg/sk|60|skammtar|1|pakki|í diskus-t|R03BA05|01.07.1995||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|5501|8573|lyfalmen|||1|60|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||5501||5501|8573||1 082792|J01CA0411|Amoxicillin Mylan|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CA04|01.07.1998||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|942|2337|lyfalmen|||2|125|0|6,2500|Icepharma hf|Mylan AB|Amoxicillín||942||942|2337|30.6.2013|2 082797|N02BE0117|Panodil Zapp|filmhtfl|500|mg|20|stk|1|ţpakki||N02BE01|01.02.2012||L|0|0|0|0|0|0|GGK|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|GlaxoSmithKline ehf|GlaxoSmithKline Consumer Healthcare A/S|Paracetamól|||||||1 082883|R03BA0201|Pulmicort|innúđal|0,125|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|4127|6693|lyfalmen|||1|40|0|3,3400|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||4127||4127|6693||1 082933|R03BA0201|Pulmicort|innúđal|0,25|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|4493|7194|lyfalmen|||1|40|0|6,6700|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||4493||4493|7194||1 082940|C09CA0602|Candpress|töflur|16|mg|100|stk|1|ţpakki||C09CA06|01.01.2012||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|9179|12970|lyfalmen|V0080|12970|2|100|0|200,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan||8715||8715|12970||1 082958|N06DA0301|Exelon|hylki|1,5|mg|56|stk|1|ţpakki||N06DA03|01.10.2008||R|1|0|0|0|G|0|NOH|0|0|0|100|DKK|13387|19524|lyfalmen|V0354|16254|1|56|0|9,3350|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||13387||13387|19524||1 083113|L02BG0301|Arimidex|filmhtfl|1|mg|28|stk|1|ţpakki||L02BG03|01.03.1998||R|0|0|0|0|G|0|AZA|0|0|0|100|SEK|19740|27497|lyfalmen|V0186|7572|1|28|0|28,0000|Vistor hf|AstraZeneca AB|Anastrózól||19740||19740|27497||1 083121|N06DA0301|Exelon|hylki|3|mg|56|stk|1|ţpakki||N06DA03|01.10.2008||R|1|0|0|0|G|0|NOH|0|0|0|100|DKK|13981|20270|lyfalmen|V0344|15437|1|56|0|18,6700|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||13981||13981|20270||1 083154|R03BA0201|Pulmicort|innúđal|0,5|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|6098|9390|lyfalmen|||1|40|0|13,3400|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||6098||6098|9390||1 083413|QN05CM9102|Narcostart|stl|1|mg/ml|10|mg|1|hgl|fyrir hunda og ketti|QN05CM91|01.07.2013||R|0|0|0|0|0|0|BVL|1|0|0|100|XEU|6301|12271|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet B.V.|Metetomidinum||6301||6301|12271||2 083592|J05AE0301|Norvir|mixtúra|80|mg/ml|90|ml|5|glös||J05AE03|01.08.2003||R|0|0|0|1|0|1|ABV|0|0|0|100|DKK|78131|99937|lyfsjukr|||1|450|0|30,0000|Vistor hf|AbbVie Ltd.|Ritonavír||78131||78131|99937||1 083634|N06DA0301|Exelon|hylki|6|mg|112|stk|1|ţpakki||N06DA03|01.01.1999||R|1|0|0|0|G|0|NOH|0|0|0|100|DKK|30339|40799|lyfalmen|V0346|32953|1|112|0|74,6667|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||30339||30339|40799||1 083644|N02BE0101|Panodil|filmhtfl|500|mg|300|stk|1|glas||N02BE01|01.02.2013||R|1|0|0|0|0|0|GSH|0|0|1|100|DKK|1334|2873|lyfalmen|||1|300|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól||1334||1334|2873||1 083980|L02AE0101|Suprefact|stl|1|mg/ml|5,5|ml|2|hgl||L02AE01|01.10.1987||R|0|0|0|1|0|1|SNO|0|0|0|100|NOK|8555|12347|lyfsjukr|||1|11|0|7,3333|Vistor hf|Sanofi-aventis Norge AS|Búserelín||8555||8555|12347||1 084097|C09CA0105|Losartan LYFIS|filmhtfl|50|mg|98|stk|1|ţpakki||C09CA01|01.05.2012||R|1|0|0|0|G|0|LYF|0|0|0|100|XEU|2156|3714|lyfalmen|V0069|1759|2|98|0|98,0000|LYFIS ehf|LYFIS ehf|Lósartan||1949||1949|3714||2 084160|C03CA0101|Furix|stl|10|mg/ml|2|ml|5|lykjur||C03CA01|01.03.2003||R|0|0|0|0|G|0|NYC|0|0|0|100|DKK|273|1421|lyfalmen|||2|10|0|2,5000|Vistor hf|Nycomed Danmark A/S|Fúrósemíđ||273||273|1421||1 084192|N05BA1206|Alprazolam Krka|forđatfl|2|mg|30|stk|1|ţpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|1|100|XEU|2071|3021|lyfalmen|V0311|3021|2|30|0|60,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||1442||1442|3021||2 084376|C03CA0101|Furix|stl|10|mg/ml|4|ml|5|lykjur||C03CA01|01.03.2003||R|0|0|0|0|G|0|NYC|0|0|0|100|DKK|528|1770|lyfalmen|||2|20|0|5,0000|Vistor hf|Nycomed Danmark A/S|Fúrósemíđ||528||528|1770||1 084591|L04AB0101|Enbrel|stl|25|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.04.2012||R|0|0|0|1|0|1|IPI|0|1|0|100|DKK|74451|95319|lyfsjukr|||1|4|0|14,2900|Icepharma hf|Pfizer Limited|Etanercept||74451||74451|95319||1 084669|B03XA0301|Mircera|stl|150|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|62281|80045|lyfsjukr|||1|0,3|0|37,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||62281||62281|80045||2 084678|B03XA0301|Mircera|stl|200|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|81191|103777|lyfsjukr|||1|0,3|0|50,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||81191||81191|103777||2 084687|B03XA0301|Mircera|stl|250|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|100445|127941|lyfsjukr|||1|0,3|0|62,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||100445||100445|127941||2 084696|B03XA0301|Mircera|stl|50|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|20761|27938|lyfsjukr|||1|0,3|0|12,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||20761||20761|27938||2 084705|B03XA0301|Mircera|stl|75|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|32425|42576|lyfsjukr|||1|0,3|0|18,7500|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||32425||32425|42576||2 084714|B03XA0301|Mircera|stl|100|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|41520|53990|lyfsjukr|||1|0,3|0|25,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||41520||41520|53990||2 084751|B03XA0301|Mircera|stl|30|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.05.2009||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|12858|18019|lyfsjukr|||1|0,3|0|7,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||12858|18019||2 084778|B03XA0301|Mircera|stl|120|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.05.2009||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|49016|63398|lyfsjukr|||1|0,3|0|30,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||49016|63398||2 084787|B03XA0301|Mircera|stl|360|mcg/spr|0,6|ml|1|áf.spr||B03XA03|01.05.2009||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|150965|191344|lyfsjukr|||1|0,6|0|90,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||150965|191344||2 084878|N03AF0301|Inovelon|filmhtfl|100|mg|10|stk|1|ţpakki||N03AF03|01.09.2007||R|0|0|0|1|G|0|EIS|0|0|0|100|SEK|984|2394|lyfalmen|||1|10|0|0,7100|Vistor hf|Eisai Ltd|Rúfínamíđ||984||984|2394||1 084887|N03AF0301|Inovelon|filmhtfl|200|mg|60|stk|1|ţpakki||N03AF03|01.09.2007||R|0|0|0|1|G|0|EIS|0|0|0|100|SEK|11674|17017|lyfalmen|||1|60|0|8,5700|Vistor hf|Eisai Ltd|Rúfínamíđ||11674||11674|17017||1 084896|N03AF0301|Inovelon|filmhtfl|400|mg|100|stk|1|ţpakki||N03AF03|01.09.2007||R|0|0|0|1|G|0|EIS|0|0|0|100|SEK|37992|50403|lyfalmen|||1|100|0|28,5700|Vistor hf|Eisai Ltd|Rúfínamíđ||37992||37992|50403||1 084936|L03AB1001|PegIntron|sts|150|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.04.2013||R|0|0|0|1|0|1|DSM|0|0|0|100|DKK|153073|193989|lyfsjukr|||1|4|0|80,0000|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||153073||153073|193989||1 085068|N02AA0101|Contalgin|forđatfl|100|mg|100|stk|1|ţpakki||N02AA01|01.10.1985||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|12950|18976|lyfalmen|||1|100|0|100,0000|Icepharma hf|Pfizer ApS|Morfín||12950||12950|18976||1 085184|L01XD0301|Metvix|krem|160|mg/g|2|g|1|túpa||L01XD03|01.09.2010||R|0|0|0|1|G|0|GAN|0|0|0|100|NOK|44372|58410|lyfalmen|||1|2|0||Icepharma hf|Galderma Nordic AB|Metýlamínólevúlínat||44372||44372|58410||2 085205|S01AE0501|Oftaquix|augndr|5|mg/ml|0,5|ml|30|sk-hyl||S01AE05|01.03.2008||R|0|0|0|0|0|0|SAO|0|0|1|100|XEU|2670|4700|lyfalmen|||1|15|0||Icepharma hf|Santen Oy|Levófloxacín||2670||2670|4700||2 085316|N06DA0301|Exelon|hylki|4,5|mg|112|stk|1|ţpakki||N06DA03|01.01.1999||R|1|0|0|0|G|0|NOH|0|0|0|100|DKK|30339|40799|lyfalmen|V0345|32953|1|112|0|56,0000|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||30339||30339|40799||1 085407|R03AC0206|Ventoline|lausn|1|mg/ml|20|lykjur|1|pakki|f. vél|R03AC02|01.04.1992||R|0|0|0|0|G|0|GSK|0|0|1|100|IKR|756|2082|lyfalmen|||1|20|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||756||756|2082||1 085488|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|250|ml|30|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|6764|9762|lyfsjukr|||1|7500|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||6764||6764|9762||2 085542|G03GA0202|Menopur|sts|||75|ae|5|hgl|+ leysir|G03GA02|01.03.2001||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|20646|28634|lyfalmen|V0412|23823|1|375|0|12,5000|Vistor hf|Ferring Lćgemidler A/S|Menótrópín||20646||20646|28634||1 085551|G03GA0202|Menopur|sts|||75|ae|10|hgl|+ leysir|G03GA02|01.03.2001||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|35795|47646|lyfalmen|V0412|47646|1|750|0|25,0000|Vistor hf|Ferring Lćgemidler A/S|Menótrópín||35795||35795|47646||1 085770|G04BE0804|Adcirca|filmhtfl|20|mg|56|stk|1|ţpakki||G04BE08|01.12.2010||R|0|0|0|1|0|1|ELD|0|0|0|100|XEU|95787|122095|lyfsjukr|||1|56|0|112,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||95787||95787|122095||2 085771|N07XX0202|Riluzol Actavis|filmhtfl|50|mg|56|stk|1|ţpakki||N07XX02|01.11.2012||R|1|0|0|0|G|0|AGP|0|0|0|100|SEK|43759|54044|lyfalmen|V0579|54044|2|56|0|28,0000|Actavis Group hf|Actavis Group PTC ehf|Rílúzól||40893||40893|54044||1 085804|M05BX0401|Prolia|stl|60|mg/ml|1|ml|1|áf.spr|lausn|M05BX04|01.10.2010||R|0|0|0|0|0|0|AEU|0|0|0|100|DKK|40531|53590|lyfalmen|||1|1|0|181,8100|Vistor hf|Amgen Europe B.V.|Denosúmab||40531||40531|53590||1 085830|L01XA0211|Carboplatin Actavis|irţ|10|mg/ml|60|ml|1|hgl||L01XA02|01.05.2013||R|0|0|0|1|0|1|APC|0|0|0|100|XEU|5521|7968|lyfsjukr|||2|60|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Karbóplatín||5521||5521|7968||1 085838|S01EE0301|Lumigan|augndr|0,1|mg/ml|3|ml|1|glös|lausn|S01EE03|01.10.2011||R|0|0|0|0|G|0|API|0|0|0|100|SEK|3079|5260|lyfalmen|V0465|4498|1|3|0|30,0000|Vistor hf|Allergan Pharmaceuticals Ireland|Bimatóprost||3079||3079|5260||1 085849|S01EE0301|Lumigan|augndr|0,1|mg/ml|3|ml|3|glös|lausn|S01EE03|01.10.2011||R|0|0|0|0|G|0|API|0|0|0|100|SEK|9099|13495|lyfalmen|V0465|13495|1|9|0|90,0000|Vistor hf|Allergan Pharmaceuticals Ireland|Bimatóprost||9099||9099|13495||1 085969|R06AX2601|Telfast|töflur|120|mg|100|stk|1|ţpakki||R06AX26|01.11.1999||R|1|0|0|0|G|0|SNO|0|0|1|100|NOK|2221|4086|lyfalmen|||1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||2221||2221|4086||1 086108|R06AX2601|Telfast|töflur|180|mg|100|stk|1|ţpakki||R06AX26|01.11.1999||R|1|0|0|0|G|0|SNO|0|0|1|100|NOK|5645|6161|lyfalmen|||1|100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||3738||3738|6161||1 086142|N07XX0701|Fampyra|forđatfl|10|mg|56|stk|1|ţpakki||N07XX07|01.03.2013||R|0|0|0|1|0|0|BIB|0|0|0|100|XEU|65953|85494|lyfalmen|V0019|85494|1|56|0|28,0000|Icepharma hf|Biogen Idec Ltd|Fampridine||65953||65953|85494||2 086207|J01DD0202|Fortum|sts|1|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|0|0|0|0|0|1|GSK|0|0|0|100|GBP|8181|11807|lyfsjukr|||1|5|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ceftazidím||8181||8181|11807||1 086231|J01DD0202|Fortum|sts|2|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|0|0|0|0|0|1|GSK|0|0|0|100|GBP|14222|19731|lyfsjukr|||1|5|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ceftazidím||14222||14222|19731||1 086368|G03GA0202|Menopur|sts|||600|ae|1|hgl|+ leysir|G03GA02|01.04.2011||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|30680|41227|lyfalmen|||1|600|0|20,0000|Vistor hf|Ferring Lćgemidler A/S|Menótrópín||30680||30680|41227||1 086380|G03GA0202|Menopur|sts|||1200|ae|1|hgl|+ leysir|G03GA02|01.04.2011||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|61361|79731|lyfalmen|||1|1200|0|40,0000|Vistor hf|Ferring Lćgemidler A/S|Menótrópín||61361||61361|79731||1 086434|L04AA2401|Orencia|stl/irţ|250|mg/hgl|1|hgl|1|hgl|+ sprauta|L04AA24|01.02.2008||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|54443|70208|lyfsjukr|||1|1|0|9,2600|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Abatacept||54443||54443|70208||1 086530|G02BA0302|Mirena|leginnle|20|mcg/sólh|1|stk|1|pakki||G02BA03|01.08.2012||R|0|0|0|0|0|0|BOY|0|0|0|100|DKK|18503|25945|lyfalmen|||1|1|0||Icepharma hf|Bayer OY|Plast lyfjalykkja (IUD) međ prógestógen||||18503|25945||2 086969|J05AB1401|Valcyte|mixtúrud|50|mg/ml|100|ml|1|glerfl|lausn|J05AB14|01.09.2009||R|0|0|0|0|0|1|ROA|0|0|0|100|DKK|51060|65963|lyfsjukr|||1|100|0|5,5000|Icepharma hf|Roche A.S.|Valgancíklóvír||51060||51060|65963||2 087114|G03CX0101|Livial|töflur|2,5|mg|28|stk|1|ţpakki||G03CX01|01.07.1998||R|0|0|0|0|G|0|ORG|0|0|0|100|DKK|3029|5191|lyfalmen|||1|28|0|28,0000|Vistor hf|N.V. Organon|Tíbólón||3029||3029|5191||1 087215|A03AX1335|Imogaze|hylki|240|mg|30|stk|1|ţpakki|mjúk hylki|A03AX13|01.12.2008||L|1|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|30|0|14,4000|Vistor hf|McNeil Sweden AB|Silíkonsambönd|||||||1 087233|N05CF0201|Stilnoct|töflur|10|mg|30|stk|1|ţpakki||N05CF02|01.08.2012||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|440|1650|lyfalmen|V0060|1650|1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||440||440|1650||1 087260|J05AX0901|Celsentri|filmhtfl|150|mg|60|stk|1|ţpakki||J05AX09|01.04.2008||R|1|0|0|1|0|1|VII|0|0|0|100|DKK|163463|207029|lyfsjukr|||1|60|0|15,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Maravíroc||163463||163463|207029||1 087304|N05CF0101|Imovane|töflur|7,5|mg|10|stk|1|ţpakki||N05CF01|01.10.1995||R|1|0|0|0|0|0|SNO|0|0|1|100|NOK|298|1456|lyfalmen|V0312|469|1|10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||298||298|1456||1 087312|N05CF0101|Imovane|töflur|7,5|mg|30|stk|1|ţpakki||N05CF01|01.10.1995||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|262|1406|lyfalmen|V0312|1406|1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||262||262|1406||1 087320|N05CF0101|Imovane|töflur|7,5|mg|100|stk|1|ţpakki||N05CF01|01.10.1995||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|2209|4070|lyfalmen|||1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||2209||2209|4070||1 087445|A02BX1301|Gaviscon|mixtúra|||500|ml|1|glas||A02BX13|01.08.1984||L|0|0|0|0|0|0|NDR|0|0|0|100|IKR|||lyfalmen|||0|500|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||3655||1 087759|G03GB0202|Pergotime|töflur|50|mg|5|stk|1|ţpakki||G03GB02|01.07.1986||R|0|0|0|0|G|0|MEC|0|0|0|100|SEK|916|2301|lyfalmen|||1|5|0|27,7778|Icepharma hf|Merck AB|Klómífen||916||916|2301||2 087788|B01AC0403|Clopidogrel Actavis|filmhtfl|75|mg|28|stk|1|ţpakki||B01AC04|01.11.2010||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|3558|1874|lyfalmen|V0009|1803|2|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Klópídógrel||604||604|1874||1 087832|L02BB0304|Bicalutamid Actavis|filmhtfl|50|mg|30|stk|1|ţpakki||L02BB03|01.09.2007||R|0|0|0|0|G|0|AGP|0|0|0|100|XEU|6821|6272|lyfalmen|V0420|5436|2|30|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Bíkalútamíđ||3819||3819|6272||1 087867|QP52AA5108|Prazitel Plus|töflur|||104|stk|1|ţpakki|50/144/150|QP52AA51|01.07.2010||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|31979|55786|vetorma|||0|104|0||Icepharma hf|Chanelle Pharmaceuticals|||31979||31979|55786||2 087932|A02BX1301|Gaviscon|tuggutfl|||20|stk|1|ţpakki||A02BX13|01.10.1993||L|1|0|0|0|0|0|NDR|0|0|0|100|IKR|||lyflausa|||0|20|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||||1 087969|QD07AC0001|Cortavance|húđúđi|0,584|mg/ml|76|ml|1|fl|lausn|QD07AC|01.04.2012||R|0|0|0|0|0|0|VIR|0|0|0|100|DKK|4514|8840|vetalmen|||0|76|0||Vistor hf|Virbac S.A|Hýdrókortisón aceponat||4514||4514|8840||1 088026|QG03DA0402|Prid delta|sk-innl|1,55|g|10|stk|1|pakki||QG03DA04|01.02.2012||R|0|0|0|0|0|0|CES|1|0|0|100|SEK|29275|51069|vetorma|||0|10|0||Icepharma hf|Ceva Sante Animale|Prógesterón||29275||29275|51069||2 088261|R01AD1201|Avamys|nefúđi|27,5|mcg/sk|120|skammtar|1|glas||R01AD12|01.04.2008||R|0|0|0|0|G|0|GGL|0|0|1|100|GBP|1240|2744|lyfalmen|||1|120|0|30,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Flútíkasón fúróat||1240||1240|2744||1 088310|M01AX0101|Relifex|lausnart|1|g|20|stk|1|ţpakki||M01AX01|01.04.1995||R|0|0|0|0|G|0|MAB|0|0|1|100|SEK|1596|3231|lyfalmen|||1|20|0|20,0000|Vistor hf|Meda AB|Nabúmeton||1596||1596|3231||1 088328|M01AX0101|Relifex|lausnart|1|g|100|stk|1|ţpakki||M01AX01|01.04.1995||R|0|0|0|0|G|0|MAB|0|0|1|100|SEK|6160|9474|lyfalmen|||1|100|0|100,0000|Vistor hf|Meda AB|Nabúmeton||6160||6160|9474||1 088612|N06DA0207|Donepezil Bluefish|filmhtfl|10|mg|98|stk|1|ţpakki||N06DA02|01.04.2013||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|13192|9848|lyfalmen|V0342|9401|2|98|0|130,6700|LYFIS ehf|Bluefish Pharmaceuticals AB|Dónepezíl||6433||6433|9848||2 088696|D05AX5201|Daivobet|hlaup|||30|g|1|fl|50 mcg/g+0,5 mg/g|D05AX52|01.04.2012||R|0|0|0|0|G|0|LEP|0|0|0|100|DKK|5145|8086|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||5145||5145|8086||1 088705|D05AX5201|Daivobet|hlaup|||60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.02.2011||R|0|0|0|0|G|0|LEP|0|0|0|100|DKK|9939|14644|lyfalmen|||1|60|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||9939||9939|14644||1 088714|D05AX5201|Daivobet|hlaup|||60|g|2|fl|50 mcg/g+0,5 mg/g|D05AX52|01.04.2012||R|0|0|0|0|G|0|LEP|0|0|0|100|DKK|15248|21860|lyfalmen|||1|120|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||15248||15248|21860||1 088814|L02BB0304|Bicalutamid Actavis|filmhtfl|150|mg|30|stk|1|ţpakki||L02BB03|01.12.2008||R|0|0|0|0|G|0|AGP|0|0|0|100|XEU|15355|15519|lyfalmen|V0421|15064|2|30|0|90,0000|Actavis Group hf|Actavis Group PTC ehf|Bíkalútamíđ||10579||10579|15519||1 088964|S01EE0103|Latanoprost Portfarma|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.08.2010||R|0|0|0|0|G|0|POF|0|0|0|100|DKK|3021|5181|lyfalmen|V0376|5181|2|7,5|0|75,0000|Portfarma ehf|Portfarma|Latanóprost||3021||3021|5181||2 088975|G03AA1005|Harmonet|töflur|||63|stk|1|ţpakki|20+75 mcg|G03AA10|01.10.2011||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|1500|3100|lyfalmen|||1|63|0|84,0000|Icepharma hf|Pfizer ApS|Gestóden og ethinylestradíól||1500||1500|3100||1 089077|J07BD5204|M-M-RVAXPRO|sts|||10|hgl|1|pakki|+ lausn í áf.sp|J07BD52|01.02.2013||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|23806|32600|lyfalmen|||1|10|0||Icepharma hf|Sanofi Pasteur MSD|Mislingar í blöndum međ hettusótt og rauđum hundum (veiklađa||23806||23806|32600||2 089094|A02BX1301|Gaviscon|tuggutfl|||120|stk|1|ţpakki||A02BX13|01.01.1989||L|1|0|0|0|0|0|NDR|0|0|0|100|IKR|||lyfalmen|||0|120|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||5743||1 089114|J05AX0901|Celsentri|filmhtfl|300|mg|60|stk|1|ţpakki||J05AX09|01.04.2008||R|1|0|0|1|0|1|VII|0|0|0|100|DKK|163463|207029|lyfsjukr|||1|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Maravíroc||163463||163463|207029||1 089156|A03AA0406|Mebeverin Dura|filmhtfl|135|mg|100|stk|1|ţpakki||A03AA04|01.07.2010||R|1|0|0|0|G|0|MYD|0|0|0|100|SEK|4186|6774|lyfalmen|||2|100|0|45,0000|Icepharma hf|Mylan dura GmbH|Mebeverín||4186||4186|6774||2 089281|R06AX1305|Loratadin LYFIS|töflur|10|mg|10|stk|1|ţpakki||R06AX13|01.05.2012||L|1|0|0|0|0|0|LYF|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|LYFIS ehf|LYFIS ehf|Lóratadín|||||||2 089293|R06AX1305|Loratadin LYFIS|töflur|10|mg|30|stk|1|ţpakki||R06AX13|01.05.2012||L|1|0|0|0|0|0|LYF|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|LYFIS ehf|LYFIS ehf|Lóratadín|||||||2 089304|R06AX1305|Loratadin LYFIS|töflur|10|mg|100|stk|1|ţpakki||R06AX13|01.05.2012||L|1|0|0|0|G|0|LYF|0|0|1|100|XEU|||lyfalmen|V0362|2090|2|100|0|100,0000|LYFIS ehf|LYFIS ehf|Lóratadín|||||2090||2 089533|V03AE0401|OsvaRen|filmhtfl|||180|stk|1|glas|435 mg / 235 mg|V03AE04|01.10.2012||R|1|0|0|0|0|0|FMC|0|0|0|100|XEU|6783|10327|lyfalmen|||1|180|0|30,0000|Icepharma hf|Fresenius Medical Care Deutschland GmbH|Kalsíum asetat og ţungt magnesíum karbón||6783||6783|10327||2 089801|B03AC0601|Monofer|irl|100|mg/ml|1|ml|5|hgl||B03AC06|01.10.2012||R|0|0|0|0|G|0|PAC|0|0|1|100|DKK|25139|34273|lyfalmen|||1|5|0|5,0000|Vistor hf|Pharmacosmos A/S|Ferrii oxidum- dextran komplex||25139||25139|34273||1 089913|B03AC0601|Monofer|irl|100|mg/ml|5|ml|5|hgl||B03AC06|01.10.2012||R|0|0|0|0|G|0|PAC|0|0|1|100|DKK|135687|160468|lyfalmen|||1|25|0|25,0000|Vistor hf|Pharmacosmos A/S|Ferrii oxidum- dextran komplex||125693||125693|160468||1 089936|B03AC0601|Monofer|irl|100|mg/ml|10|ml|2|hgl||B03AC06|01.10.2012||R|0|0|0|0|G|0|PAC|0|0|1|100|DKK|100555|128920|lyfalmen|||1|20|0|20,0000|Vistor hf|Pharmacosmos A/S|Ferrii oxidum- dextran komplex||100555||100555|128920||1 090229|J01DB0101|Keflex|töflur|500|mg|20|stk|1|ţpakki||J01DB01|01.07.2011||R|0|0|0|0|0|0|PAD|0|0|1|100|DKK|1613|3254|lyfalmen|||1|20|0|5,0000|Icepharma hf|PharmaCoDane ApS|Cefalexín||1613||1613|3254||2 090240|J01DB0101|Keflex|töflur|500|mg|40|stk|1|ţpakki||J01DB01|01.05.2011||R|0|0|0|0|0|0|PAD|0|0|1|100|DKK|3203|5429|lyfalmen|||1|40|0|10,0000|Icepharma hf|PharmaCoDane ApS|Cefalexín||3203||3203|5429||2 090320|J01DB0101|Keflex|mixt.kyr|50|mg/ml|100|ml|1|fl|dreifa|J01DB01|01.03.2012||R|0|0|0|0|0|0|PAD|0|0|1|100|DKK|962|2364|lyfalmen|||1|100|0|2,5000|Icepharma hf|PharmaCoDane ApS|Cefalexín||962||962|2364||2 090354|J01DB0401|Kefzol|sts|1|g|10|stk|1|hgl||J01DB04|01.06.2011||R|0|0|0|0|0|1|NOM|0|0|0|100|DKK|5896|8509|lyfsjukr|||1|10|0|3,3333|Icepharma hf|NordMedica ApS|Cefazólín||5896||5896|8509||2 090662|R01AD1101|Nasacort|nefúđi|55|mcg/sk|16,5|ml|1|stauk|120 sk|R01AD11|01.11.1998||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|1818|3535|lyfalmen|||1|16,5|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Tríamcínólón||1818||1818|3535||1 090979|S01JA0101|Anatera|stl|100|mg/ml|5|ml|12|hgl|lausn|S01JA01|01.10.2011||R|0|0|0|1|0|1|ACK|0|0|0|100|USD|16530|22628|lyfsjukr|||1|60|0||Vistor hf|Alcon Denmark A/S|Flúorescein||||16530|22628||1 091266|V03AF0401|Isovorin|stl|10|mg/ml|2,5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|2893|4175|lyfsjukr|||1|2,5|0|0,8333|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||2893||2893|4175||1 091277|V03AF0401|Isovorin|stl|10|mg/ml|5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|5001|7218|lyfsjukr|||1|5|0|1,6667|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||5001||5001|7218||1 091289|V03AF0401|Isovorin|stl|10|mg/ml|17,5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|14673|20297|lyfsjukr|||1|17,5|0|5,8333|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||14673||14673|20297||1 091345|N06BA0403|Ritalin Uno|hylki|10|mg|30|stk|1|glas||N06BA04|01.03.2011||R|1|0|1|0|0|0|NOH|0|0|0|100|DKK|3406|5707|lyfalmen|||1|30|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||3406||3406|5707||1 091493|A10BH0501|Trajenta|filmhtfl|5|mg|30|stk|1|ţpakki||A10BH05|01.12.2012||R|1|0|0|0|G|0|BII|0|0|0|100|DKK|6650|10145|lyfalmen|||1|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Línaglíptín||6650||6650|10145||1 091649|L01DB0105|Doxorubicin Actavis|sts|10|mg|1|stk|1|hgl|lausn|L01DB01|01.12.2011||R|0|0|0|1|0|1|APC|0|0|0|100|XEU|1821|2628|lyfsjukr|||2|1|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Doxórúbicín||||1821|2628||1 091662|L01DB0105|Doxorubicin Actavis|sts|50|mg|1|stk|1|hgl|lausn|L01DB01|01.12.2011||R|0|0|0|1|0|1|APC|0|0|0|100|XEU|7452|10755|lyfsjukr|||2|1|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Doxórúbicín||||7452|10755||1 091736|S01BA0102|Opnol|augndr|1|mg/ml|30|sk-hyl|1|pakki|lausn|S01BA01|01.05.2011||R|0|0|0|0|G|0|CHA|0|0|1|100|DKK|4019|6546|lyfalmen|||1|30|0||Vistor hf|CCS Healthcare AB|Dexametasón||4019||4019|6546||1 091751|A10BB1201|Amaryl|töflur|1|mg|90|stk|1|ţpakki||A10BB12|01.09.1997||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|1288|1876|lyfalmen|V0021|1876|1|90|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríđ||605||605|1876||1 091769|A10BB1201|Amaryl|töflur|2|mg|90|stk|1|ţpakki||A10BB12|01.09.1997||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|2226|2300|lyfalmen|V0022|2159|1|90|0|90,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríđ||915||915|2300||1 091872|C07AA0512|Pranolol|töflur|80|mg|100|stk|1|glas||C07AA05|01.12.2011||R|1|0|0|0|G|0|AGT|0|0|0|100|XEU|633|1914|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group hf|Própranólól||633||633|1914||1 092005|N06AB1001|Cipralex|dropar|20|mg/ml|15|ml|1|glerfl||N06AB10|01.04.2009||R|0|0|0|0|0|0|LBK|0|0|0|100|DKK|3915|6403|lyfalmen|||1|15|0|30,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||||3915|6403||1 092130|QJ01CA0401|Clamoxyl, vet.|töflur|200|mg|100|stk|1|ţpakki||QJ01CA04|01.10.1987||R|0|0|0|0|0|0|PAL|1|0|0|100|DKK|9280|17992|vetalmen|||0|100|0||Icepharma hf|Pfizer Oy Animal Health|||9280||9280|17992||2 092361|B01AC0401|Plavix|töflur|75|mg|28|stk|1|ţpakki||B01AC04|01.12.1999||R|1|0|0|0|G|0|SBM|0|0|0|100|NOK|8096|11064|lyfalmen|V0009|1803|1|28|0|28,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||7322||7322|11064||1 092553|N07BA0144|Nicorette Whitemint|tyggigúm|2|mg|30|stk|1|ţpakki||N07BA01|01.08.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 092575|N07BA0144|Nicorette Whitemint|tyggigúm|2|mg|210|stk|1|ţpakki||N07BA01|01.08.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 092586|N07BA0144|Nicorette Whitemint|tyggigúm|4|mg|30|stk|1|ţpakki||N07BA01|01.08.2010|30.06.2013|L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 092655|G03CA0310|Vagifem|sk-tfl|10|mcg|18|stk|1|pakki||G03CA03|01.03.2011||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2299|4193|lyfalmen|||1|18|0|7,2000|Vistor hf|Novo-Nordisk A/S|Estradíól||2299||2299|4193||1 092750|N05AH0203|Leponex (D.A.C.)|töflur|100|mg|100|stk|1|glas||N05AH02|01.05.2007||R|1|0|0|0|G|0|DAC|0|0|0|100|DKK|9369|13864|lyfalmen|V0277|13864|3|100|0|33,3333|D.A.C. ehf|D.A.C. ehf|Klózapín||9369||9369|13864||2 092879|M01AB0103|Indometacin Actavis|hylki|25|mg|28|stk|1|ţpakki||M01AB01|01.03.2010||R|1|0|0|0|G|0|AUK|0|0|1|100|GBP|428|1633|lyfalmen|||2|28|0|7,0000|Actavis Group hf|Actavis UK Ltd.|Indómetacín||428||428|1633||1 092891|M01AB0103|Indometacin Actavis|hylki|50|mg|28|stk|1|ţpakki||M01AB01|01.03.2010||R|1|0|0|0|G|0|AUK|0|0|1|100|GBP|557|1810|lyfalmen|||2|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Indómetacín||557||557|1810||1 092958|M05BA0408|Ostacid|töflur|70|mg|12|stk|1|ţpakki||M05BA04|01.05.2010||R|1|0|0|0|G|0|WIH|0|0|0|100|XEU|3395|3707|lyfalmen|V0203|3707|2|12|0|84,0000|Portfarma ehf|Williams & Halls|Alendrónsýra||1944||1944|3707||2 093016|N02AA0504|OxyNorm Dispersa|munndr.t|5|mg|28|stk|1|ţpakki||N02AA05|01.10.2011||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|1160|2635|lyfalmen|||1|28|0|1,8700|Icepharma hf|Norpharma|Oxýcódon||||1160|2635||2 093027|N02AA0504|OxyNorm Dispersa|munndr.t|10|mg|28|stk|1|ţpakki||N02AA05|01.10.2011||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|2663|4691|lyfalmen|||1|28|0|3,7300|Icepharma hf|Norpharma|Oxýcódon||||2663|4691||2 093038|N02AA0504|OxyNorm Dispersa|munndr.t|20|mg|28|stk|1|ţpakki||N02AA05|01.10.2011||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|5176|8128|lyfalmen|||1|28|0|7,4700|Icepharma hf|Norpharma|Oxýcódon||||5176|8128||2 093260|N02CC0101|Imigran|stl|12|mg/ml|0,5|ml|2|spr|+ penni|N02CC01|01.10.1992||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|6244|9589|lyfalmen|||1|1|0|2,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||6244||6244|9589||1 093284|G04BD1201|Betmiga|forđatfl|50|mg|30|stk|1|ţpakki||G04BD12|01.07.2013||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|6208|9540|lyfalmen|||1|30|0||Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||6208||6208|9540||1 093343|C09CA0301|Diovan|mixtúra|3|mg/ml|160|ml|1|fl|lausn|C09CA03|01.03.2012||R|0|0|0|0|G|0|NOH|0|0|0|100|DKK|1484|3078|lyfalmen|||1|160|0|6,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||1484||1484|3078||1 093617|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|100|stk||QG03DA02|01.10.1991||R|0|0|0|0|0|0|PAL|1|0|0|100|DKK|26745|46655|vetorma|||0|100|0||Icepharma hf|Pfizer Oy Animal Health|Medroxyprogesteronum||26745||26745|46655||2 093736|L02AE0305|Zoladex LA (D.A.C.)|vefjalyf|10,8|mg|1|stk|1|áf.spr||L02AE03|01.06.2010||R|0|0|0|1|G|0|DAC|0|0|0|100|SEK|61362|78345|lyfalmen|V0451|78345|3|1|0|83,7209|D.A.C. ehf|D.A.C. ehf|Góserelín||60256||60256|78345||2 093747|C09AA0503|Ramipril Actavis (DAC)|töflur|5|mg|100|stk|1|ţpakki||C09AA05|01.11.2011||R|1|0|0|0|G|0|DAC|0|0|0|100|XEU|1182|2665|lyfalmen|||3|100|0|200,0000|D.A.C. ehf|D.A.C. ehf|Ramipríl||1182||1182|2665|31.5.2013|2 093757|N02AA0501|Oxycontin|forđatfl|80|mg|28|stk|1|ţpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|16310|23192|lyfalmen|||1|28|0|29,8700|Icepharma hf|Norpharma |Oxýcódon||16310||16310|23192||2 093799|N02AA0501|Oxycontin|forđatfl|80|mg|98|stk|1|ţpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|32905|44019|lyfalmen|V0588|41015|1|98|0|104,5300|Icepharma hf|Norpharma |Oxýcódon||32905||32905|44019||2 093827|L04AC0501|Stelara|stl|45|mg/spr|0,5|ml|1|áf.spr||L04AC05|01.04.2011||R|0|1|0|1|0|1|JCI|0|1|0|100|SEK|573370|721462|lyfsjukr|||1|0,5|0|83,3300|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||573370||573370|721462||1 093838|L04AC0501|Stelara|stl|90|mg/spr|1|ml|1|áf.spr||L04AC05|01.05.2011||R|0|1|0|1|0|1|JCI|0|1|0|100|SEK|617490|776832|lyfsjukr|||1|1|0|166,6700|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||617490||617490|776832||1 094099|N02CC0501|Almogran|filmhtfl|12,5|mg|3|stk|1|ţpakki||N02CC05|01.06.2013||R|1|0|0|0|G|0|ALM|0|0|0|100|SEK|2617|4628|lyfalmen|V0236|3949|1|3|0|3,0000|Vistor hf|Almirall S.A.|Almótriptan||2617||2617|4628||1 094111|N02CC0501|Almogran|filmhtfl|12,5|mg|6|stk|1|ţpakki||N02CC05|01.07.2010||R|1|0|0|0|G|0|ALM|0|0|0|100|SEK|5327|8335|lyfalmen|V0236|7898|1|6|0|6,0000|Vistor hf|Almirall S.A.|Almótriptan||5327||5327|8335||1 094122|N02CC0501|Almogran|filmhtfl|12,5|mg|9|stk|1|ţpakki||N02CC05|01.07.2010||R|1|0|0|0|G|0|ALM|0|0|0|100|SEK|7894|11847|lyfalmen|V0236|11847|1|9|0|9,0000|Vistor hf|Almirall S.A.|Almótriptan||7894||7894|11847||1 094132|QM01AC0604|Metacam fyrir ketti|mixtúra|0,5|mg/ml|15|ml|1|fl||QM01AC06|01.01.2009||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|1802|3584|vetalmen|||0|15|0||Vistor hf|Boehringer Ingelheim|||1802||1802|3584||1 094287|L04AD0201|Advagraf|forđahlk|0,5|mg|50|stk|1|ţpakki||L04AD02|01.10.2007|30.04.2013|R|0|0|0|1|G|0|APE|0|0|0|100|XEU|13592|19781|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||13592||13592|19781||1 094441|J05AB0103|Aclovir|töflur|200|mg|25|stk|1|ţpakki||J05AB01|01.04.2013||R|1|0|0|0|G|0|RGM|0|0|1|100|XEU|2827|2648|lyfalmen|V0044|2648|2|25|0|1,2500|Medical ehf|ratiopharm GmbH|Acíklóvír||1170||1170|2648||2 094757|N04BC0406|Ropinirole Portfarma|forđatfl|8|mg|84|stk|1|glas||N04BC04|01.12.2012||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|31375|28123|lyfalmen|V0534|28123|2|84|0|112,0000|Portfarma ehf|Portfarma|Rópíníról||20239||20239|28123||2 094801|J05AR0401|Trizivir|filmhtfl|750|mg|60|stk|1|ţpakki|300+150+300 mg|J05AR04|01.08.2003||R|1|0|0|1|0|1|VII|0|0|0|100|GBP|79753|101973|lyfsjukr|||1|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Zídóvúdín, lamívúdín og abacavír||79753||79753|101973||1 094812|N01BX0403|Qutenza|plástur|179|mg|1|plástur|1|pakki||N01BX04|01.01.2011||R|0|1|0|0|0|0|APE|0|0|1|100|XEU|47944|62893|lyfalmen|||1|1|0||Vistor hf|Astellas Phama Europe B.V.|Capsaicin||||47944|62893||1 094834|QI09AB0801|Suiseng Vet|stl|||50|ml|1|hgl|dreifa|QI09AB08|01.05.2010||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|6541|11410|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Bakteríubólefni gegn Escherichia coli + Clostridium||6541||6541|11410||2 095208|G04BX0101|Emgesan|töflur|250|mg|100|stk|1|glas||G04BX01|01.03.2001||R|0|0|0|0|0|0|PCO|0|0|0|100|IKR|1577|3205|lyfalmen|||0|100|1|50,0000|Distica|Distica - óskráđ lyf|Magnesíum hýdroxíđ||1577||1577|3205||1 095418|G04BE0305|Vizarsin (Lyfis)|filmhtfl|50|mg|8|stk|1|pakki||G04BE03|01.02.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|5111|4933|lyfalmen|V0143|4933|3|8|0|8,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||2840||2840|4933||2 095588|N07BB0101|Antabus|freyđit|400|mg|50|stk|1|glas||N07BB01|01.12.1972||R|0|0|0|0|G|0|AGT|0|0|0|100|DKK|6163|9479|lyfalmen|||1|50|0|100,0000|Actavis Group hf|Actavis Group hf|Dísúlfíram||6163||6163|9479||1 095652|N05AX1301|Invega|forđatfl|3|mg|28|stk|1|ţpakki||N05AX13|01.02.2008||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|18620|26091|lyfalmen|||1|28|0|14,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||18620||18620|26091||1 095680|N05AX1301|Invega|forđatfl|6|mg|28|stk|1|ţpakki||N05AX13|01.02.2008||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|18620|26091|lyfalmen|||1|28|0|28,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||18620||18620|26091||1 095692|J01MA0204|Ciprofloxacin Portfarma|irl|2|mg/ml|100|ml|1|hgl||J01MA02|01.12.2010||R|0|0|0|0|0|1|POF|0|0|0|100|XEU|1941|2801|lyfsjukr|||2|100|0|0,4000|Portfarma ehf|Portfarma|Cíprófloxacín||1941||1941|2801||2 095704|J01MA0204|Ciprofloxacin Portfarma|irl|2|mg/ml|200|ml|1|hgl||J01MA02|01.12.2010||R|0|0|0|0|0|1|POF|0|0|0|100|XEU|3040|4387|lyfsjukr|||2|200|0|0,8000|Portfarma ehf|Portfarma|Cíprófloxacín||3040||3040|4387||2 095707|N05AX1301|Invega|forđatfl|9|mg|28|stk|1|ţpakki||N05AX13|01.02.2008||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|18620|26091|lyfalmen|||1|28|0|42,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||18620||18620|26091||1 095715|J02AC0103|Fluconazole Portfarma|irl|2|mg/ml|50|ml|1|hgl|lausn|J02AC01|01.10.2011||R|0|0|0|0|0|1|POF|0|0|0|100|XEU|2547|3676|lyfsjukr|||2|50|0|0,5000|Portfarma ehf|Portfarma|Flúkónazól||||2547|3676||2 095726|J02AC0103|Fluconazole Portfarma|irl|2|mg/ml|100|ml|1|hgl||J02AC01|01.09.2011||R|0|0|0|0|0|1|POF|0|0|0|100|XEU|3525|5087|lyfsjukr|||2|100|0|1,0000|Portfarma ehf|Portfarma|Flúkónazól||||3525|5087||2 095748|N02AX0212|Tramadol Actavis|hylki|50|mg|100|stk|1|glas||N02AX02|01.09.2011||R|1|0|1|0|G|0|AGP|0|0|1|100|XEU|1010|1579|lyfalmen|V0225|1579|2|100|0|16,6700|Actavis Group hf|Actavis Group PTC ehf|Tramadól||388||388|1579||1 095924|QM01AE9102|Canidryl|töflur|20|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|0|CHD|0|0|0|100|XEU|3683|7244|vetalmen|||0|100|0||Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||3683||3683|7244||2 095933|QM01AE9102|Canidryl|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|0|CHD|0|0|0|100|XEU|4860|9504|vetalmen|||0|100|0||Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||4860||4860|9504||2 095942|QM01AE9102|Canidryl|töflur|100|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|0|CHD|0|0|0|100|XEU|8851|17168|vetalmen|||0|100|0||Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||8851||8851|17168||2 096115|V03AF0101|Uromitexan|stl|100|mg/ml|4|ml|15|lykjur||V03AF01|01.10.1990||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|33894|44419|lyfsjukr|||1|60|0||Icepharma hf|Baxter Medical AB|Mesna||33894||33894|44419||2 096169|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|1|hgl||J06BA01|01.10.2008||R|0|0|0|0|0|1|OCT|0|1|0|100|DKK|12925|18103|lyfsjukr|||1|10|0||Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í ćđ||12925||12925|18103||1 096178|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|10|hgl||J06BA01|01.10.2008||R|0|0|0|0|0|1|OCT|0|1|0|100|DKK|101048|128698|lyfsjukr|||1|100|0||Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í ćđ||101048||101048|128698||1 096203|C09DA0107|Losartan HCT Bluefish|filmhtfl|62,5|mg|98|stk|1|ţpakki|50+12,5 mg|C09DA01|01.05.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|2423|3714|lyfalmen|V0088|2025|2|98|0|98,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Lósartan og ţvagrćsilyf||1949||1949|3714||2 096227|C09DA0107|Losartan HCT Bluefish|filmhtfl|125|mg|98|stk|1|ţpakki|100+25 mg|C09DA01|01.05.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|2522|3714|lyfalmen|V0089|1938|2|98|0|98,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Lósartan og ţvagrćsilyf||1949||1949|3714||2 096251|D06AX1301|Altargo|smyrsli|1|%|5|g|1|túpa||D06AX13|01.11.2007||R|0|0|0|0|0|0|GGL|0|0|1|100|GBP|2008|3795|lyfalmen|||1|5|0||GlaxoSmithKline ehf|Glaxo Group Limited|Retapamúlín||2008||2008|3795||1 096260|N06DA0301|Exelon|forđapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|0|0|0|0|G|0|NOE|0|0|0|100|DKK|15234|21842|lyfalmen|V0347|20543|1|30|0|14,5300|Vistor hf|Novartis Europharm Ltd|Rívastigmín||15234||15234|21842||1 096438|J01CA0413|Amoxin|mixt.kyr|100|mg/ml|60|ml|1|glas||J01CA04|01.05.2013||R|0|0|0|0|0|0|RGM|0|0|1|100|XEU|1717|3397|lyfalmen|||2|60|0|6,0000|Medical ehf|ratiopharm GmbH|Amoxicillín||1717||1717|3397||2 096488|L04AX0401|Revlimid|hylki|5|mg|21|stk|1|ţpakki|hart|L04AX04|01.03.2009||R|1|1|0|1|0|1|CEE|0|1|0|100|XEU|693757|872548|lyfsjukr|||1|21|0|10,5000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||693757||693757|872548||2 096497|L04AX0401|Revlimid|hylki|10|mg|21|stk|1|ţpakki|hart|L04AX04|01.03.2009||R|1|1|0|1|0|1|CEE|0|1|0|100|XEU|735419|924833|lyfsjukr|||1|21|0|21,0000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||735419||735419|924833||2 096506|L04AX0401|Revlimid|hylki|15|mg|21|stk|1|ţpakki|hart|L04AX04|01.03.2009||R|1|1|0|1|0|1|CEE|0|1|0|100|XEU|773481|972601|lyfsjukr|||1|21|0|31,5000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||773481||773481|972601||2 096515|L04AX0401|Revlimid|hylki|25|mg|21|stk|1|ţpakki|hart|L04AX04|01.03.2009||R|1|1|0|1|0|1|CEE|0|1|0|100|XEU|848868|1067212|lyfsjukr|||1|21|0|52,5000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||848868||848868|1067212||2 096679|N06DA0301|Exelon|forđapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|0|0|0|0|G|0|NOE|0|0|0|100|DKK|16252|23120|lyfalmen|V0349|21821|1|30|0|30,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||16252||16252|23120||1 096685|C03BA1102|Natrilix Retard|forđatfl|1,5|mg|30|stk|1|ţpakki||C03BA11|01.03.1999||R|1|0|0|0|G|0|SEV|0|0|0|100|DKK|1498|3097|lyfalmen|||1|30|0|18,0000|Icepharma hf|Servier|Indapamíđ||1498||1498|3097||2 096688|N06DA0301|Exelon|forđapl|9,5|mg/sólh|60|pokar|1|pakki||N06DA03|01.01.2008||R|0|0|0|0|G|0|NOE|0|0|0|100|DKK|32506|43518|lyfalmen|||1|60|0|60,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||32506||32506|43518||1 096768|L02AE0102|Suprecur|nefúđi|0,15|mg/sk|10|g|2|fl|lausn|L02AE01|01.01.2012||R|0|0|0|1|G|0|SNO|0|0|0|100|NOK|18922|26470|lyfalmen|||1|20|0|16,6700|Vistor hf|Sanofi-aventis Norge AS|Búserelín||18922||18922|26470||1 097033|B05AA0706|Tetraspan|irl|60|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05AA07|01.04.2010||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|27516|36415|lyfsjukr|||2|10000|0||Actavis Group hf|Braun|Hýdróxyetýl sterkja||27516||27516|36415||1 097061|QI09AB1301|Stellamune One|stl|||100|ml|10|glös|Fleyti|QI09AB13|01.10.2012||R|0|0|0|0|0|0|ELA|0|0|0|100|DKK|74109|129279|vetorma|||1|1000|0||Icepharma hf|Elanco Animal Health A/S|Óvirkar bakteríur í bóluefnum||74109||74109|129279||2 097080|R06AX2701|Aerius|filmhtfl|5|mg|30|stk|1|ţpakki||R06AX27|01.11.2012||R|1|0|0|0|G|0|MLD|0|0|1|100|DKK|1656|3313|lyfalmen|V0366|2558|1|30|0|30,0000|Vistor hf|Merck Sharp & Dohme Limited|Deslóratadín||1656||1656|3313||1 097092|QN02AF0102|Alvegesic vet.|stl|10|mg/ml|10|ml|1|hgl||QN02AF01|01.08.2010||R|0|0|0|0|0|0|AUW|1|0|0|100|XEU|8173|15866|vetalmen|||0|10|0||Icepharma hf|ALVETRA u. WERFFTt GmbH|Bútorfanóltartrat||||8173|15866||2 097269|J01FF0103|Dalacin (D.A.C.)|hylki|300|mg|20|stk|1|ţpakki||J01FF01|01.06.2007||R|1|0|0|0|0|0|DAC|0|0|1|100|DKK|2199|4056|lyfalmen|V0461|4056|3|20|0|5,0000|D.A.C. ehf|D.A.C. ehf|Klindamýcín||2199||2199|4056||2 097498|N06AX1602|Efexor Depot|forđahlk|37,5|mg|7|stk|1|ţpakki||N06AX16|01.12.2012||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|582|1844|lyfalmen|V0333|1669|1|7|0|2,6300|Icepharma hf|Pfizer ApS|Venlafaxín||582||582|1844||1 097531|N06AX1602|Efexor Depot|forđahlk|75|mg|98|stk|1|ţpakki||N06AX16|01.07.2012||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|11208|16380|lyfalmen|V0334|5971|1|98|0|73,5000|Icepharma hf|Pfizer ApS|Venlafaxín||11208||11208|16380||1 097577|N06AX1602|Efexor Depot|forđahlk|150|mg|98|stk|1|ţpakki||N06AX16|01.09.2011||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|21279|29428|lyfalmen|V0335|5527|1|98|0|147,0000|Icepharma hf|Pfizer ApS|Venlafaxín||||21279|29428||1 097599|N05BA0603|Temesta|töflur|1|mg|100|stk|1|ţpakki||N05BA06|01.02.2012||R|0|0|0|0|0|0|PCO|0|0|1|100|DKK|2448|4397|lyfalmen|||0|100|1|40,0000|Distica|Distica - óskráđ lyf|Lórazepam||2448||2448|4397||1 097881|A10BB1201|Amaryl|töflur|3|mg|90|stk|1|ţpakki||A10BB12|01.09.1997||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|3196|2646|lyfalmen|V0023|2471|1|90|0|135,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríđ||1168||1168|2646||1 097887|N02CC0104|Sumacta|húđuđtfl|50|mg|12|stk|1|ţpakki||N02CC01|01.11.2007||R|0|0|0|0|G|0|AGP|0|0|0|100|IKR|2738|2371|lyfalmen|V0233|2371|2|12|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Súmatriptan||967||967|2371|| 097896|N02CC0104|Sumacta|húđuđtfl|100|mg|6|stk|1|ţpakki||N02CC01|01.11.2007||R|0|0|0|0|G|0|AGP|0|0|0|100|IKR|1917|1677|lyfalmen|||2|6|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Súmatriptan||460||460|1677|30.6.2013|1 097905|N06AX1104|Miron Smelt|munndr.t|15|mg|30|stk|1|ţpakki||N06AX11|01.11.2007||R|0|0|0|0|0|0|AGP|0|0|0|100|XEU|1110|2546|lyfalmen|V0329|2546|2|30|0|15,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||1095||1095|2546||1 098059|C09CA0303|Valpress|filmhtfl|80|mg|98|stk|1|ţpakki||C09CA03|01.12.2007||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|4632|2427|lyfalmen|V0072|2427|2|98|0|98,0000|Actavis Group hf|Actavis hf|Valsartan||1008||1008|2427||1 098068|C09CA0303|Valpress|filmhtfl|160|mg|98|stk|1|ţpakki||C09CA03|01.12.2007||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|6115|1951|lyfalmen|||2|98|0|196,0000|Actavis Group hf|Actavis hf|Valsartan||660||660|1951|31.5.2013|1 098233|D07AC0401|Synalar|krem|0,25|mg/g|30|g|1|túpa||D07AC04|01.04.1998||R|0|0|0|0|G|0|BIG|0|0|1|100|SEK|711|2021|lyfalmen|||1|30|0||Icepharma hf|Bioglan AB|Flúócínólón||711||711|2021||2 098245|D07AC0401|Synalar|smyrsli|0,25|mg/g|30|g|1|túpa||D07AC04|01.08.2011||R|0|0|0|0|G|0|BIG|0|0|1|100|SEK|711|2021|lyfalmen|||1|30|0||Icepharma hf|Bioglan AB|Flúócínólón||711||711|2021||2 098290|D08AC0202|Hibitane|sk-krem|10|mg/ml|250|ml|1|glas||D08AC02|01.06.2011||L|0|0|0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa|||0|250|0||Icepharma hf|Bioglan AB|Klórhexidín|||||||2 098378|N03AX0904|Lamotrigin ratiopharm|dreifit.|25|mg|50|stk|1|ţpakki||N03AX09|01.05.2012||R|0|0|0|0|G|0|RGM|0|0|0|100|IKR|1063|1784|lyfalmen|V0243|1784|2|50|0|4,1600|Medical ehf|ratiopharm GmbH|Lamótrigín||538||538|1784||2 098387|N03AX0904|Lamotrigin ratiopharm|dreifit.|50|mg|50|stk|1|ţpakki||N03AX09|01.05.2012||R|0|0|0|0|G|0|RGM|0|0|0|100|IKR|1812|2126|lyfalmen|V0244|2030|2|50|0|8,3300|Medical ehf|ratiopharm GmbH|Lamótrigín||788||788|2126||2 098405|N03AX0904|Lamotrigin ratiopharm|dreifit.|100|mg|100|stk|1|ţpakki||N03AX09|01.05.2012||R|0|0|0|0|G|0|RGM|0|0|0|100|IKR|5116|3830|lyfalmen|V0245|3830|2|100|0|33,3300|Medical ehf|ratiopharm GmbH|Lamótrigín||2034||2034|3830||2 098423|N03AX0904|Lamotrigin ratiopharm|dreifit.|200|mg|100|stk|1|ţpakki||N03AX09|01.05.2012||R|0|0|0|0|G|0|RGM|0|0|0|100|IKR|9166|8332|lyfalmen|V0232|8332|2|100|0|66,6600|Medical ehf|ratiopharm GmbH|Lamótrigín||5325||5325|8332||2 098713|V03AB2502|Flumazenil B. Braun|stl|0,1|mg/ml|5|ml|5|lykjur||V03AB25|01.04.2011||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|18845|25533|lyfsjukr|||2|25|0||Actavis Group hf|Braun|Flúmazeníl||18845||18845|25533||1 098722|J07BM0101|Gardasil|stl|||0,5|ml|1|áf.spr|dreifa|J07BM01|01.08.2008||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|16739|23731|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Papillomavírus (manna gerđ 6, 11, 16, 18)||16739||16739|23731||2 099204|L02BA0301|Faslodex|stl|250|mg/spr|5|ml|2|spr||L02BA03|01.12.2010||R|0|0|0|1|0|1|ASZ|0|0|0|100|SEK|101833|129683|lyfsjukr|||1|10|0|60,2400|Vistor hf|AstraZeneca UK Ltd|Fulvestrant||101833||101833|129683||1 099476|N05AH0406|Quetiapin Mylan|filmhtfl|25|mg|100|stk|1|ţpakki||N05AH04|01.03.2008||R|1|0|0|0|G|0|MYL|0|0|0|100|IKR|3475|2644|lyfalmen|V0284|2642|2|100|0|6,2500|Icepharma hf|Mylan AB|Quetíapín||1167||1167|2644||2 099485|N05AH0406|Quetiapin Mylan|filmhtfl|100|mg|100|stk|1|ţpakki||N05AH04|01.03.2008||R|1|0|0|0|G|0|MYL|0|0|0|100|IKR|7244|7659|lyfalmen|V0285|7204|2|100|0|25,0000|Icepharma hf|Mylan AB|Quetíapín||4833||4833|7659||2 099494|N05AH0406|Quetiapin Mylan|filmhtfl|200|mg|100|stk|1|ţpakki||N05AH04|01.03.2008||R|1|0|0|0|G|0|MYL|0|0|0|100|IKR|11260|16451|lyfalmen|V0286|15653|2|100|0|50,0000|Icepharma hf|Mylan AB|Quetíapín||11260||11260|16451||2 099705|D08AG0201|Betadine|húđlausn|100|mg/ml|500|ml|1|brusar|vatnslausn|D08AG02|01.04.1985||L|0|0|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Norpharma a/s|Jođ/pólývídón|||||||2 099721|D08AG0201|Betadine|lyf.sápa|75|mg/ml|500|ml|1|brusar||D08AG02|01.04.1985||L|0|0|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Norpharma a/s|Jođ/pólývídón|||||||2 099835|N03AX1107|Topiramat Actavis|filmhtfl|25|mg|60|stk|1|plglas||N03AX11|01.08.2010||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|2965|4092|lyfalmen|V0247|4092|2|60|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||2225||2225|4092||1 099847|N03AX1107|Topiramat Actavis|filmhtfl|50|mg|60|stk|1|plglas||N03AX11|01.09.2010||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|4099|6193|lyfalmen|V0248|6193|2|60|0|10,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||3761||3761|6193||1 099858|N03AX1107|Topiramat Actavis|filmhtfl|100|mg|60|stk|1|plglas||N03AX11|01.08.2010||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|8327|10302|lyfalmen|V0249|10302|2|60|0|20,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||6765||6765|10302||1 099863|L01XE0401|Sutent|hylki|12,5|mg|28|stk|1|ţpakki||L01XE04|01.12.2012||R|1|0|0|1|0|1|IPI|0|1|0|100|DKK|186951|236506|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Limited|Sunitíníb||186951||186951|236506||1 099902|H02AB0605|Prednisolone Actavis|töflur|5|mg|98|stk|1|ţpakki||H02AB06|01.01.2011||R|1|0|0|0|G|0|AUK|0|0|1|100|GBP|695|1999|lyfalmen|V0414|1999|2|98|0|49,0000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||695||695|1999||1 100211|QN01AX9301|Tricaine Pharmaq|duft|1000|mg/g|25|g|1|askja|lausn handa fiskum|QN01AX93|01.07.2013||R|0|0|0|0|0|0|PHL|0|0|0|100|GBP|5882|9596|veteldis|||0|25|0||PHARMAQ Ltd.|PHARMAQ Ltd|Tricaine Methane Sulfónat||5882||5882|9596||1 100291|G04BE0801|Cialis|filmhtfl|2,5|mg|28|stk|1|ţpakki||G04BE08|01.11.2008||R|0|0|0|0|0|0|LIL|0|0|0|100|XEU|13271|19378|lyfalmen|||1|28|0|7,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||13271|19378||2 100300|G04BE0801|Cialis|filmhtfl|5|mg|28|stk|1|ţpakki||G04BE08|01.11.2008||R|0|0|0|0|0|0|LIL|0|0|0|100|XEU|11873|17290|lyfalmen|||1|28|0|14,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||11873|17290||2 100428|N06AX1103|Miron|filmhtfl|15|mg|100|stk|1|plglas||N06AX11|01.01.2012||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|2028|3817|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis hf|Mirtazapín||2024||2024|3817||1 101034|R06AX2704|Desloratadine ratiopharm|filmhtfl|5|mg|100|stk|1|ţpakki||R06AX27|01.10.2012||R|1|0|0|0|G|0|RGM|0|0|1|100|XEU|3551|5906|lyfalmen|V0458|4291|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Deslóratadín||3551||3551|5906||2 101106|N03AX1201|Neurontin|filmhtfl|600|mg|100|stk|1|ţpakki||N03AX12|01.03.2009||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|11564|13472|lyfalmen|||1|100|0|33,3300|Icepharma hf|Pfizer ApS|Gabapentín||9082||9082|13472||1 101115|N03AX1201|Neurontin|filmhtfl|800|mg|100|stk|1|ţpakki||N03AX12|01.03.2009||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|17497|24682|lyfalmen|||1|100|0|44,4400|Icepharma hf|Pfizer ApS|Gabapentín||17497||17497|24682||1 101691|C08CA0502|Adalat Oros|forđatfl|20|mg|28|stk|1|ţpakki||C08CA05|01.10.1999||R|1|0|0|0|G|0|BAP|0|0|0|100|DKK|2119|3947|lyfalmen|||1|28|0|18,6667|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||||2119|3947||2 101709|C08CA0502|Adalat Oros|forđatfl|20|mg|98|stk|1|ţpakki||C08CA05|01.10.1999||R|1|0|0|0|G|0|BAP|0|0|0|100|DKK|6838|10402|lyfalmen|||1|98|0|65,3333|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||||6838|10402||2 101742|N06AX1104|Miron Smelt|munndr.t|30|mg|30|stk|1|ţpakki||N06AX11|01.11.2007||R|0|0|0|0|0|0|AGP|0|0|0|100|XEU|1368|2919|lyfalmen|V0330|2919|2|30|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||1368||1368|2919||1 101751|N06AX1104|Miron Smelt|munndr.t|30|mg|96|stk|1|ţpakki||N06AX11|01.11.2007||R|0|0|0|0|G|0|AGP|0|0|0|100|XEU|2810|4892|lyfalmen|V0331|4892|2|96|0|96,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||2810||2810|4892||1 101756|C09DA0106|Lopress Comp|filmhtfl|62,5|mg|100|stk|1|glas|50+12,5 mg|C09DA01|01.11.2010||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|2981|2066|lyfalmen|V0088|2066|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Lósartan og ţvagrćsilyf||744||744|2066||1 101760|N06AX1104|Miron Smelt|munndr.t|45|mg|96|stk|1|ţpakki||N06AX11|01.12.2011||R|0|0|0|0|0|0|AGP|0|0|0|100|XEU|5573|8672|lyfalmen|V0332|8672|2|96|0|144,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||5573||5573|8672||1 101767|C09DA0106|Lopress Comp|filmhtfl|125|mg|100|stk|1|glas|100+25 mg|C09DA01|01.11.2010||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|4094|1978|lyfalmen|V0089|1978|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Lósartan og ţvagrćsilyf||680||680|1978||1 101769|N02AX0211|Nobligan Retard (D.A.C.)|forđatfl|150|mg|100|stk|1|ţpakki||N02AX02|01.09.2007||R|1|0|1|0|G|0|DAC|0|0|1|100|DKK|5180|8134|lyfalmen|V0227|7321|3|100|0|50,0000|D.A.C. ehf|D.A.C. ehf|Tramadól||5180||5180|8134||2 101823|QM01AC0602|Metacam fyrir hesta|mixtúra|15|mg/ml|250|ml|1|fl||QM01AC06|01.02.2009||R|0|0|0|0|0|0|BOI|0|0|0|100|SEK|17981|34699|vetalmen|||0|250|0||Vistor hf|Boehringer Ingelheim|||||17981|34699||1 101825|A09AA0206|Creon 10.000|sh-hylki|150|mg|100|stk|1|plglas||A09AA02|01.09.2011|30.06.2013|R|1|0|0|0|G|0|APR|0|0|0|100|DKK|3120|5316|lyfalmen|||1|100|0|16,6700|Vistor hf|Abbott Products GmbH|Hvatablöndur (lípasi, próteasi o.s.frv.)||||3120|5316||1 101893|G03DB0801|Visanne|töflur|2|mg|28|stk|1|ţpakki||G03DB08|01.05.2012||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|7162|10845|lyfalmen|||1|28|0|28,0000|Icepharma hf|Bayer AB|Díenógest||7162||7162|10845||2 101904|G03DB0801|Visanne|töflur|2|mg|84|stk|1|ţpakki||G03DB08|01.05.2012||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|21484|29686|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer AB|Díenógest||21484||21484|29686||2 102051|N05AF0103|Fluanxol Mite|filmhtfl|0,5|mg|100|stk|1|glas||N05AF01|01.03.2013||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|1081|2527|lyfalmen|||1|100|0|8,3333|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1081||1081|2527||1 102062|N05AF0103|Fluanxol Mite|filmhtfl|1|mg|100|stk|1|glas||N05AF01|01.03.2013||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|1683|3350|lyfalmen|||1|100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1683||1683|3350||1 102173|N02BE0107|Paratabs|filmhtfl|500|mg|100|stk|1|ţpakki||N02BE01|01.03.2013||R|1|0|0|0|0|0|APC|0|0|1|100|XEU|422|1625|lyfalmen|V0230|1625|2|100|0|16,6667|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól||422||422|1625||1 102743|L01XA0303|Oxaliplatin Actavis|irţ|5|mg/ml|40|ml|1|hgl||L01XA03|01.05.2013||R|0|0|0|1|0|1|AGP|0|0|0|100|XEU|10376|14904|lyfsjukr|||2|40|0||Actavis Group hf|Actavis Group PTC ehf|Oxalíplatín||10376||10376|14904||1 102871|C01DA1401|Imdur|forđatfl|60|mg|98|stk|1|ţpakki||C01DA14|01.07.1989||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|3880|6356|lyfalmen|V0041|5276|1|98|0|147,0000|Vistor hf|AstraZeneca A/S DK|Ísósorbíđ mónónítrat||3880||3880|6356||1 102905|N01AX1001|Diprivan|stl|10|mg/ml|50|ml|1|dćla|einnota dćla|N01AX10|01.01.1994||R|0|0|0|0|0|1|AZA|0|0|0|100|SEK|1944|2806|lyfsjukr|||1|50|0||Vistor hf|AstraZeneca AB|Própófól||1944||1944|2806||1 102939|N01AX1001|Diprivan|stl|20|mg/ml|50|ml|1|dćla|einnota dćla|N01AX10|01.01.1988||R|0|0|0|0|0|1|AZA|0|0|0|100|SEK|3161|4562|lyfsjukr|||1|50|0||Vistor hf|AstraZeneca AB|Própófól||3161||3161|4562||1 102952|G04BD0803|Solifenacin Portfarma|filmhtfl|10|mg|90|stk|1|ţpakki||G04BD08|01.06.2013||R|1|0|0|0|G|0|PEH|0|0|0|100|XEU|16117|22950|lyfalmen|V0441|22950|2|90|0|180,0000|Portfarma ehf|Portfarma ehf|Sólífenacín||16117||16117|22950||2 103610|L01DB0105|Doxorubicin Actavis|irţ|2|mg/ml|25|ml|1|hgl|lausn|L01DB01|01.03.2013||R|0|0|0|1|0|1|APC|0|0|0|100|XEU|9261|13366|lyfsjukr|||2|25|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Doxórúbicín||9261||9261|13366||1 103633|C09DA0105|Presmin Combo|filmhtfl|62,5|mg|98|stk|1|ţpakki|50+12,5 mg|C09DA01|01.02.2008||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|2997|3647|lyfalmen|V0088|2025|2|98|0|98,0000|Portfarma ehf|Portfarma|Lósartan og ţvagrćsilyf||1900||1900|3647||2 103642|C09DA0105|Presmin Combo|filmhtfl|125|mg|98|stk|1|ţpakki|100+25 mg|C09DA01|01.02.2008||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|4280|3715|lyfalmen|V0089|1938|2|98|0|98,0000|Portfarma ehf|Portfarma|Lósartan og ţvagrćsilyf||1950||1950|3715||2 103651|C09CA0104|Presmin|filmhtfl|50|mg|98|stk|1|ţpakki||C09CA01|01.02.2008||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|2992|3715|lyfalmen|V0069|1759|2|98|0|98,0000|Portfarma ehf|Portfarma|Lósartan||1950||1950|3715||2 103660|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|10|stk|1|ţpakki||J05AB11|01.02.2008||R|1|0|0|0|G|0|POF|0|0|1|100|GBP|2508|2122|lyfalmen|V0033|2122|2|10|0|1,6667|Portfarma ehf|Portfarma|Valacíklóvír||785||785|2122||2 103669|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|40|stk|1|ţpakki||J05AB11|01.02.2008||R|1|0|0|0|G|0|POF|0|0|1|100|GBP|7229|8366|lyfalmen|V0182|8316|2|40|0|6,6700|Portfarma ehf|Portfarma|Valacíklóvír||5350||5350|8366||2 103678|N06AX1604|Venlafaxin (Portfarma)|forđahlk|75|mg|100|stk|1|ţpakki||N06AX16|01.12.2007||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|4454|6093|lyfalmen|V0334|6093|2|100|0|75,0000|Portfarma ehf|Portfarma|Venlafaxín||3688||3688|6093||2 103687|N06AX1604|Venlafaxin (Portfarma)|forđahlk|150|mg|100|stk|1|ţpakki||N06AX16|01.12.2007||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|7148|5640|lyfalmen|V0335|5640|2|100|0|150,0000|Portfarma ehf|Portfarma|Venlafaxín||3357||3357|5640||2 103806|N02AB0305|Fentanyl ratiopharm|forđapl|12|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RGM|0|0|0|100|XEU|2112|3897|lyfalmen|V0222|3897|2|5|0|3,6000|Medical ehf|ratiopharm GmbH|Fentanýl||2083||2083|3897||2 103813|B02BC0001|TISSEEL|vefjalím|||4|ml|10|áf.spr|+ Duo sett|B02BC|01.01.2013||R|0|0|0|0|0|1|BAA|0|0|0|100|SEK|358090|451285|lyfsjukr|||1|40|0||Icepharma hf|Baxter AG|Lyf til ađ minnka stađbundna blćđingu||358090||358090|451285||2 103854|L01XE1701|INLYTA|filmhtfl|1|mg|56|stk|1|ţpakki||L01XE17|01.05.2013||R|1|0|0|1|0|1|PZE|0|0|0|100|SEK|130592|165775|lyfsjukr|||1|56|0||Icepharma hf|Pfizer Ltd.|Axitinib||130592||130592|165775||2 103906|QD08AC5201|Malaseb vet.|hársápa|2|%|250|ml|1|glas|w/v|QD08AC52|01.10.2012||R|0|0|0|0|0|0|DEC|0|0|0|100|DKK|4013|7878|vetalmen|||1|250|0||Vistor hf|Dechra Veterinary Products A/S|Bígvaníđ og amídín-Klórhexidín í blöndum||4013||4013|7878||1 103937|A06AG0201|Toilax|innhl|2|mg/ml|5|ml|5|túpa||A06AG02|01.12.1975||L|0|0|0|0|0|0|ERC|0|0|0|100|DKK|||lyfalmen|||0|25|0|5,0000|Vistor hf|Orion Pharma|Bisakódýl|||||1986||1 103952|A06AG0201|Toilax|innhl/tf|||1|stk|1|pakki|túpa+4 tfl|A06AG02|01.12.1972||L|1|0|0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa|||0|1|0|1,0000|Vistor hf|Orion Pharma|Bisakódýl|||||||1 104026|V08AB0901|Visipaque|stl|270|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|13856|19272|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Jódixanól||13856||13856|19272||2 104047|C09CA0304|Valsartan LYFIS|filmhtfl|160|mg|98|stk|1|ţpakki||C09CA03|01.06.2012||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|3083|5265|lyfalmen|||2|98|0|196,0000|LYFIS ehf|LYFIS ehf|Valsartan||3083||3083|5265||2 104471|H01BA0201|Minirin|nefdr|0,1|mg/ml|2,5|ml|1|glas|+2 slöngur|H01BA02|01.01.1988||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|3170|5384|lyfalmen|||1|2,5|0|10,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||3170||3170|5384||1 104498|N05CH0101|Circadin|forđatfl|2|mg|21|stk|1|ţpakki||N05CH01|01.11.2007||R|1|0|0|0|0|0|RAD|0|0|1|100|DKK|2071|3881|lyfalmen|V0574|3403|1|21|0|21,0000|Vistor hf|RAD Neurim Pharmaceuticals EEC Ltd.|Melatonin||2071||2071|3881||1 104760|A07EC0202|Pentasa|eţ-stíll|1|g|28|stk|1|pakki||A07EC02|01.07.1991||R|0|0|0|0|G|0|FER|0|0|0|100|DKK|8358|12481|lyfalmen|||1|28|0|18,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||8358||8358|12481||1 104836|A07EC0202|Pentasa|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.01.1990||R|0|0|0|0|G|0|FER|0|0|0|100|DKK|4694|7469|lyfalmen|V0017|7469|1|700|0|4,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||4694||4694|7469||1 104851|A07EC0202|Pentasa|forđatfl|500|mg|100|stk|1|ţpakki||A07EC02|01.04.1992||R|1|0|0|0|G|0|FER|0|0|0|100|DKK|5312|8314|lyfalmen|||1|100|0|33,3333|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||5312||5312|8314||1 104959|B03XA0201|Aranesp|stl|100|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|129799|164780|lyfsjukr|||1|2|0|88,8900|Vistor hf|Amgen|Darbepóetín alfa||||129799|164780||1 105315|G03AA0705|Microgynon (D.A.C.)|töflur|||63|stk|1|ţpakki||G03AA07|01.05.2009||R|0|0|0|0|0|0|DAC|0|0|0|100|DKK|1304|2800|lyfalmen|V0545|2800|3|63|0|84,0000|D.A.C. ehf|D.A.C. ehf|Levónorgestrel og ethinylestradíól||1281||1281|2800||2 105586|C09XA0201|Rasilez|filmhtfl|150|mg|28|stk|1|ţpakki||C09XA02|01.01.2008||R|0|0|0|0|0|0|NOE|0|0|0|100|DKK|3986|6501|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||3986||3986|6501||1 105597|C09XA0201|Rasilez|filmhtfl|150|mg|98|stk|1|ţpakki|2 x 49 töflur|C09XA02|01.01.2008||R|0|0|0|0|0|0|NOE|0|0|0|100|DKK|13857|20114|lyfalmen|||1|98|0|98,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||13857||13857|20114||1 105608|C09XA0201|Rasilez|filmhtfl|300|mg|28|stk|1|ţpakki||C09XA02|01.01.2008||R|0|0|0|0|0|0|NOE|0|0|0|100|DKK|4594|7332|lyfalmen|||1|28|0|56,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||4594||4594|7332||1 105620|C09XA0201|Rasilez|filmhtfl|300|mg|98|stk|1|ţpakki|2 x 49 töflur|C09XA02|01.01.2008||R|0|0|0|0|0|0|NOE|0|0|0|100|DKK|15982|22781|lyfalmen|||1|98|0|196,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||15982||15982|22781||1 105785|N01BB0301|Carbocain|stl|10|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2522|4498|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Mepívakaín||2522||2522|4498||1 105796|N01BB0301|Carbocain|stl|20|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2982|5127|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Mepívakaín||2982||2982|5127||1 106006|J05AH0201|Tamiflu|hylki|30|mg|10|stk|1|ţpakki||J05AH02|01.11.2011||R|1|0|0|0|0|0|RRL|0|0|0|100|DKK|1860|3592|lyfalmen|||1|10|0|2,0000|Icepharma hf|Roche Registration Limited|Oseltamivír||1860||1860|3592||2 106017|J05AH0201|Tamiflu|hylki|45|mg|10|stk|1|ţpakki||J05AH02|01.11.2011||R|1|0|0|0|0|0|RRL|0|0|0|100|DKK|3720|6137|lyfalmen|||1|10|0|3,0000|Icepharma hf|Roche Registration Limited|Oseltamivír||3720||3720|6137||2 106021|J01FA0901|Klacid|töflur|250|mg|14|stk|1|ţpakki||J01FA09|01.04.1992||R|1|0|0|0|0|0|ABS|0|0|1|100|DKK|2601|4606|lyfalmen|||1|14|0|7,0000|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||2601||2601|4606|30.6.2013|1 106182|G03AA1203|Yasminelle|filmhtfl|||63|stk|1|ţpakki|3+0,02 mg|G03AA12|01.04.2013||R|0|0|0|0|0|0|BYP|0|0|0|100|DKK|3558|5915|lyfalmen|V0593|5915|1|63|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og ethinylestradíól||3558||3558|5915||2 106567|J05AB0102|Zovir|irs|500|mg/hgl|5|hgl|1|pakki||J05AB01|01.01.1995||R|0|0|0|0|0|1|GSK|0|0|0|100|GBP|18432|25015|lyfsjukr|||1|5|0|0,6250|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||18432||18432|25015||1 106898|J05AB0102|Zovir|irs|250|mg/hgl|5|hgl|1|pakki||J05AB01|01.07.1989||R|0|0|0|0|0|1|GSK|0|0|0|100|GBP|10193|14675|lyfsjukr|||1|5|0|0,3125|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||10193||10193|14675||1 106932|A10BG0303|Pioglitazone Teva Pharma|töflur|15|mg|98|stk|1|ţpakki||A10BG03|01.11.2012||R|1|1|0|0|G|0|TEV|0|0|0|100|XEU|9372|8410|lyfalmen|V0572|8410|2|98|0|49,0000|Medical ehf|Teva Pharma B.V.|Píóglítazón||5382||5382|8410||2 107092|N05AH0311|Olanzapine Ranbaxy|töflur|2,5|mg|28|stk|1|ţpakki||N05AH03|01.12.2011||R|1|0|0|0|G|0|RAN|0|0|0|100|XEU|2048|1784|lyfalmen|V0278|1709|2|28|0|7,0000|Artasan ehf|Ranbaxy (UK) Ltd|Olanzapín||538||538|1784||1 107138|C07AG0203|Carvedilol Actavis|filmhtfl|6,25|mg|100|stk|1|ţpakki||C07AG02|01.05.2012||R|1|0|0|0|G|0|ADG|0|0|0|100|XEU|1577|3205|lyfalmen|||2|100|0|16,6600|Actavis Group hf|Actavis Deutchland GmbH & Co. KG|Carvedílól||1577||1577|3205||1 107203|R06AX2201|Kestine|filmhtfl|10|mg|30|stk|1|ţpakki||R06AX22|01.06.2012||L|1|0|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||||1 107219|A07EC0102|Salazopyrin EN|sh-tfl|500|mg|100|stk|1|glas||A07EC01|01.04.1987||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|1587|3219|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Súlfasalazín||1587||1587|3219||1 107464|G04BD0803|Solifenacin Portfarma|filmhtfl|5|mg|30|stk|1|ţpakki||G04BD08|01.06.2013||R|1|0|0|0|G|0|PEH|0|0|0|100|XEU|4655|7416|lyfalmen|V0438|7416|2|30|0|30,0000|Portfarma ehf|Portfarma ehf|Sólífenacín||4655||4655|7416||2 107594|QP54AA0104|Bimectin Horse Oral Paste|pasta|18,7|mg/g|6,42|g|1|áf.spr||QP54AA01|01.04.2008||R|0|0|0|0|0|0|CRO|0|0|0|100|XEU|1558|2718|vetorma|||0|6,42|0||Portfarma ehf|Cross Vetpharm Group Ltd.|Ivermectinum||1558||1558|2718||2 107607|A02BA0201|Asyran|töflur|150|mg|60|stk|1|ţpakki||A02BA02|01.07.1986||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|934|2326|lyfalmen|||2|60|0|30,0000|Actavis Group hf|Actavis hf|Ranitidín||934||934|2326||1 108126|G04BD0402|Oxybutynin Mylan|töflur|5|mg|100|stk|1|ţpakki||G04BD04|01.05.2013||R|0|0|0|0|G|0|MYL|0|0|0|100|XEU|2838|4930|lyfalmen|||2|100|0|33,3300|Icepharma hf|Mylan AB|Oxýbútýnín||2838||2838|4930||2 108308|C08CA0501|Adalat|töflur|10|mg|100|stk|1|ţpakki||C08CA05|01.01.1991||R|1|0|0|0|G|0|BAP|0|0|0|100|DKK|3022|5182|lyfalmen|V0082|5182|1|100|0|33,3333|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||||3022|5182||2 108540|A10BH0201|Galvus|töflur|50|mg|30|stk|1|ţpakki||A10BH02|01.09.2008||R|0|0|0|0|G|0|NOE|0|0|0|100|DKK|3328|5600|lyfalmen|||1|30|0|15,0000|Vistor hf|Novartis Europharm Ltd|Vildagliptín||3328||3328|5600||1 108562|A10BH0201|Galvus|töflur|50|mg|90|stk|1|ţpakki||A10BH02|01.09.2008||R|0|0|0|0|G|0|NOE|0|0|0|100|DKK|9878|14561|lyfalmen|||1|90|0|45,0000|Vistor hf|Novartis Europharm Ltd|Vildagliptín||9878||9878|14561||1 108697|A16AA0601|Cystadane|duft|1|g|180|g|1|glas||A16AA06|01.07.2013||R|0|0|0|1|0|0|OEU|0|0|0|100|XEU|87947|113097|lyfalmen|||1|180|0|30,0000|Orphan Europe S.a.r.l.|Orphan Europe S.a.r.l.|Betain anhydrous||87947||87947|113097||2 108845|R01AD0501|Rhinocort Aqua|nefúđi|32|mcg/sk|120|skammtar|1|fl||R01AD05|01.10.1988|31.05.2013|R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|1234|2736|lyfalmen|||1|120|0|19,2000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||1234||1234|2736||1 108852|R01AD0501|Rhinocort Aqua|nefúđi|64|mcg/sk|120|skammtar|1|fl||R01AD05|01.10.1988||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|1692|3362|lyfalmen|V0443|3361|1|120|0|38,4000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||1692||1692|3362||1 109357|A02BC0508|Esomeprazol Actavis|sţ-hylki|20|mg|28|stk|1|ţpakki|hart|A02BC05|01.03.2012||R|1|0|0|0|0|0|APC|0|0|0|100|IKR|2382|2135|lyfalmen|||2|28|0|18,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||795||795|2135|30.6.2013|1 109421|V01AA0303|Alutard SQ, derm.farinae|stl|||5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|24487|33455|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|rykmaurar||24487||24487|33455||1 109439|V01AA0303|Alutard SQ, derm.farinae|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|19604|27326|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|rykmaurar||19604||19604|27326||1 109569|N02AA0505|Oxycodone ratiopharm|forđatfl|20|mg|28|stk|1|ţpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RGM|0|0|0|100|XEU|3704|6115|lyfalmen|V0584|6115|2|28|0|7,4700|Medical ehf|ratiopharm GmbH|Oxýcódon||3704||3704|6115||2 109578|N02AA0505|Oxycodone ratiopharm|forđatfl|20|mg|98|stk|1|ţpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RGM|0|0|0|100|XEU|10911|13715|lyfalmen|V0585|13715|2|98|0|26,1300|Medical ehf|ratiopharm GmbH|Oxýcódon||9260||9260|13715||2 109588|N02AA0505|Oxycodone ratiopharm|forđatfl|40|mg|28|stk|1|ţpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RGM|0|0|0|100|XEU|7087|10743|lyfalmen|V0586|10743|2|28|0|14,9300|Medical ehf|ratiopharm GmbH|Oxýcódon||7087||7087|10743||2 109597|N02AA0505|Oxycodone ratiopharm|forđatfl|40|mg|98|stk|1|ţpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RGM|0|0|0|100|XEU|18920|24421|lyfalmen|V0587|24421|2|98|0|52,2700|Medical ehf|ratiopharm GmbH|Oxýcódon||17289||17289|24421||2 109615|N02AA0505|Oxycodone ratiopharm|forđatfl|80|mg|98|stk|1|ţpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RGM|0|0|0|100|XEU|36038|41015|lyfalmen|V0588|41015|2|98|0|104,5300|Medical ehf|ratiopharm GmbH|Oxýcódon||30511||30511|41015||2 109678|N02BE0107|Paratabs|töflur|500|mg|20|stk|1|ţpakki||N02BE01|01.12.1983||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Actavis Group hf|Actavis hf|Paracetamól|||||||1 109728|N02BE0107|Paratabs|töflur|500|mg|30|stk|1|ţpakki||N02BE01|01.07.1992||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|Actavis Group hf|Actavis hf|Paracetamól|||||||1 110033|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|30|stk|1|ţpakki||R06AE07|01.09.2012||L|1|0|0|0|0|0|RGM|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Medical ehf|ratiopharm GmbH|Cetirizín|||||||2 110080|S01ED0105|Optimol|augndr|5|mg/ml|5|ml|1|glas||S01ED01|01.01.1987||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|523|1763|lyfalmen|||1|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól||523||523|1763||2 110242|V03AN0101|Conoxia|lyfjagas|100|%|3|l|1|hylki|undir ţrýstingi/LIV|V03AN01|01.04.2008||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|3|0||Ísaga ehf|AGA AB|Súrefni|||||||5 110395|G03AA0902|Mercilon|töflur|||63|stk|1|ţpakki|150/20 mcg|G03AA09|01.07.1990||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|1553|3172|lyfalmen|V0065|2915|1|63|0|84,0000|Vistor hf|N.V. Organon|Desógestrel og ethinylestradíól||1553||1553|3172||1 110397|V03AN0101|Conoxia|lyfjagas|100|%|5|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|5|0||Ísaga ehf|AGA AB|Súrefni|||||||5 110635|C08DA0104|Veraloc Retard|forđatfl|200|mg|100|stk|1|glas||C08DA01|01.10.1988||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|3970|6479|lyfalmen|||1|100|0|83,3333|Vistor hf|Orion Corporation|Verapamíl||3970||3970|6479||1 110750|J05AX0801|Isentress|filmhtfl|400|mg|60|stk|1|glas||J05AX08|01.04.2012||R|1|0|0|1|0|1|MLD|0|0|0|100|DKK|113807|144710|lyfsjukr|||1|60|0|30,0000|Vistor hf|Merck Sharp & Dohme Limited|Raltegravír||113807||113807|144710||1 111479|S01ED5113|Dorzolamide/Timolol Portfarma|augndr|5|mg/ml|5|ml|3|glas|+ dorzólamid 20 mg/ml|S01ED51|01.11.2011||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|5323|7454|lyfalmen|V0373|7454|2|15|0|75,0000|Portfarma ehf|Portfarma|Tímólól í blöndum||4683||4683|7454||2 111955|N02BE0101|Panodil|töflur|1|g|100|stk|1|glas||N02BE01|01.05.2003||R|1|0|0|0|0|0|GSH|0|0|1|100|DKK|756|2082|lyfalmen|||1|100|0|33,3300|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól||756||756|2082||1 112022|G03AC0802|Implanon NXT|vefjalyf|68|mg|1|stk|1|pakki||G03AC08|01.02.2011||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|21941|30259|lyfalmen|||1|1|0|1000,0000|Vistor hf|N.V. Organon|Etónógestrel||21941||21941|30259||1 112056|R03BB0501|Eklira Genuair|innönddu|322|mcg|60|skammtar|3|innö.t||R03BB05|01.01.2013||R|0|0|0|0|G|0|ALM|0|0|0|100|XEU|16947|23992|lyfalmen|||1|180|0||Vistor hf|Almirall S.A.|Aclídínumbrómíđ||16947||16947|23992||1 112641|M05BA0407|Alendronat Ranbaxy|töflur|70|mg|12|stk|1|ţpakki||M05BA04|01.04.2009||R|1|0|0|0|G|0|RAN|0|0|0|100|IKR|2094|3912|lyfalmen|V0203|3707|2|12|0|84,0000|Artasan ehf|Ranbaxy (UK) Ltd|Alendrónsýra||2094||2094|3912||1 113058|N07BA0148|Nicovel Fruit|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.02.2013||L|0|0|0|0|0|0|ORI|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Icepharma hf|Orifarm Generics A/S|Nikótín|||||||2 113394|A10BD0801|Eucreas|filmhtfl|900|mg|60|stk|1|ţpakki|50mg/850mg|A10BD08|01.11.2008||R|0|0|0|0|G|0|NOE|0|0|0|100|DKK|8582|12788|lyfalmen|V0024|11579|1|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||8582||8582|12788||1 113403|A10BD0801|Eucreas|filmhtfl|900|mg|180|stk|1|ţpakki|50mg/850mg|A10BD08|01.11.2008||R|0|0|0|0|G|0|NOE|0|0|0|100|DKK|25510|34738|lyfalmen|V0024|34738|1|180|0|90,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||25510||25510|34738||1 113412|A10BD0801|Eucreas|filmhtfl|1050|mg|60|stk|1|ţpakki|50mg/1000mg|A10BD08|01.11.2008||R|0|0|0|0|G|0|NOE|0|0|0|100|DKK|8694|12941|lyfalmen|V0025|10159|1|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||8694||8694|12941||1 113414|B05AA0114|Albuman|irl|40|g/líter|100|ml|1|hgl|lausn|B05AA01|01.03.2013||R|0|0|0|0|0|1|SSB|0|0|0|100|XEU|2340|3377|lyfsjukr|||1|100|0||Williams & Halls efh|Stichting Sanquin Bloedvoorziening|Albúmín||2340||2340|3377||2 113415|B01AB0501|Klexane|stl|100|mg/ml|0,2|ml|10|áf.spr|einnota dćla|B01AB05|01.10.1995||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|3582|5948|lyfalmen|||1|2|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||3582||3582|5948||1 113421|A10BD0801|Eucreas|filmhtfl|1050|mg|180|stk|1|ţpakki|50mg/1000mg|A10BD08|01.11.2008||R|0|0|0|0|G|0|NOE|0|0|0|100|DKK|22114|30476|lyfalmen|V0025|30476|1|180|0|90,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||22114||22114|30476||1 113704|B01AB0501|Klexane|stl|100|mg/ml|0,4|ml|10|áf.spr|einnota dćla|B01AB05|01.10.1995||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|6151|9462|lyfalmen|||1|4|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||6151||6151|9462||1 113818|L01XE0801|Tasigna|hylki|200|mg|112|stk|1|ţpakki||L01XE08|01.06.2008||R|0|1|0|1|0|1|NOE|0|0|0|100|DKK|672225|845525|lyfsjukr|||1|112|0||Vistor hf|Novartis Europharm Ltd|Nilotiníb||672225||672225|845525||1 113894|J01CE0204|Kaavepenin|töflur|1|g|20|stk|1|ţpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|694|1997|lyfalmen|||1|20|0|10,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||694||694|1997||1 113902|J01CE0204|Kaavepenin|töflur|1|g|30|stk|1|ţpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|878|2249|lyfalmen|||1|30|0|15,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||878||878|2249||1 113910|J01CE0204|Kaavepenin|töflur|1|g|40|stk|1|ţpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|1446|3026|lyfalmen|||1|40|0|20,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1446||1446|3026||1 114033|R03AC0210|Ventolin Diskus|innönddu|200|mcg/sk|60|skammtar|1|stk|Diskus tćki|R03AC02|01.03.1999||R|0|0|0|0|G|0|GSK|0|0|1|100|IKR|949|2346|lyfalmen|||1|60|0|15,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||949||949|2346||1 114328|L01AX0303|Temomedac|hylki|100|mg|5|stk|1|glas||L01AX03|01.04.2011||R|0|0|0|1|0|1|WIL|0|1|0|100|XEU|53030|68435|lyfsjukr|||2|5|0||Williams & Halls efh|medac Gesellschaft|Temozolomid||53030||53030|68435||2 114440|M01AH0501|Arcoxia|filmhtfl|30|mg|28|stk|1|ţpakki||M01AH05|01.01.2010||R|1|0|0|0|G|0|MSD|0|0|1|100|DKK|4168|6750|lyfalmen|||1|28|0|14,0000|Vistor hf|M.S.D.|Etoríkoxíb||4168||4168|6750||1 114447|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamíđ 20 mg|S01ED51|01.03.1999||R|0|0|0|0|G|0|MSD|0|0|0|100|DKK|2378|4301|lyfalmen|V0373|2485|1|5|0|25,0000|Vistor hf|M.S.D.|Tímólól í blöndum||2378||2378|4301||1 114512|D06BB0401|Condyline|áburđur|5|mg/ml|3,5|ml|1|glas|til penslunar|D06BB04|01.11.2010||R|0|0|0|0|0|0|GAN|0|0|1|100|XEU|2235|4105|lyfalmen|||1|3,5|0||Icepharma hf|Galderma Nordic AB|Pódófýllótoxín||2235||2235|4105||2 114531|L01AA0201|Leukeran|filmhtfl|2|mg|25|stk|1|glas||L01AA02|01.04.2013||R|0|0|0|0|G|0|ATL|0|0|0|100|XEU|1587|3219|lyfalmen|V0594|3219|1|25|0||Aspen Pharma Trading Ltd.|Aspen Pharma Trading Ltd.|Chlorambucíl||1587||1587|3219||1 114675|D10AD5301|Epiduo|hlaup|||60|g|1|túpa|0,1% / 2,5%|D10AD53|01.12.2011||R|0|0|0|0|0|0|GAN|0|0|0|100|SEK|6464|9890|lyfalmen|||1|60|0||Icepharma hf|Galderma Nordic AB|Adapalen og benzóýl peroxíđ||6464||6464|9890||2 114941|N05AH0312|Zalasta|töflur|2,5|mg|28|stk|1|ţpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|2511|1732|lyfalmen|V0278|1709|2|28|0|7,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||500||500|1732||2 114952|N05AH0312|Zalasta|töflur|5|mg|28|stk|1|ţpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|3283|2051|lyfalmen|V0279|1969|2|28|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||733||733|2051||2 114963|N05AH0312|Zalasta|töflur|7,5|mg|56|stk|1|ţpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|11394|6341|lyfalmen|V0280|6341|2|56|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||3869||3869|6341||2 114985|N05AH0312|Zalasta|töflur|10|mg|56|stk|1|ţpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|11990|4471|lyfalmen|V0282|4052|2|56|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||2502||2502|4471||2 114996|N05AH0312|Zalasta|munndr.t|5|mg|28|stk|1|ţpakki||N05AH03|01.01.2013||R|0|0|0|0|G|0|KNM|0|0|0|100|XEU|7443|7915|lyfalmen|V0457|7915|2|28|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||5020||5020|7915||2 115007|N05AH0312|Zalasta|munndr.t|10|mg|28|stk|1|ţpakki||N05AH03|01.01.2013||R|0|0|0|0|G|0|KNM|0|0|0|100|XEU|14575|15913|lyfalmen|V0456|15904|2|28|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||10867||10867|15913||2 115018|N05AH0312|Zalasta|munndr.t|15|mg|28|stk|1|ţpakki||N05AH03|01.01.2013||R|0|0|0|0|G|0|KNM|0|0|0|100|XEU|23840|23505|lyfalmen|V0475|13537|2|28|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||16559||16559|23505||2 115029|N05AH0312|Zalasta|munndr.t|20|mg|28|stk|1|ţpakki||N05AH03|01.01.2013||R|0|0|0|0|G|0|KNM|0|0|0|100|XEU|36754|30736|lyfalmen|V0540|30736|2|28|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||22321||22321|30736||2 115163|B01AE0701|Pradaxa|hylki|75|mg|10|stk|1|ţpakki|hart|B01AE07|01.01.2009||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|1921|3676|lyfalmen|||1|10|0|3,4100|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||1921||1921|3676||1 115241|V03AB1504|Naloxon B. Braun|stl|0,4|mg/ml|1|ml|10|lykjur||V03AB15|01.09.2010||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|8946|12911|lyfsjukr|||2|10|0||Actavis Group hf|Braun|Naloxón||8946||8946|12911||1 115285|J01CA0411|Amoxicillin Mylan|töflur|750|mg|20|stk|1|ţpakki||J01CA04|01.10.1998||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|1629|2715|lyfalmen|V0158|2669|2|20|0|15,0000|Icepharma hf|Mylan AB|Amoxicillín||1219||1219|2715||2 115330|B01AE0701|Pradaxa|hylki|75|mg|60|stk|1|ţpakki|hart|B01AE07|01.01.2009||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|11524|16812|lyfalmen|||1|60|0|20,4600|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||11524||11524|16812||1 115341|B01AE0701|Pradaxa|hylki|110|mg|10|stk|1|ţpakki|hart|B01AE07|01.01.2009||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|1921|3676|lyfalmen|||1|10|0|5,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||1921||1921|3676||1 115364|B01AE0701|Pradaxa|hylki|110|mg|60|stk|1|ţpakki|hart|B01AE07|01.01.2009||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|11524|16812|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||11524||11524|16812||1 115554|B03AC0601|Monofer|irl|100|mg/ml|10|ml|1|hgl||B03AC06|01.07.2013||R|0|0|0|0|G|0|PAC|0|0|1|100|DKK|56399|73504|lyfalmen|||1|10|0|10,0000|Vistor hf|Pharmacosmos A/S|Ferrii oxidum- dextran komplex||56399||56399|73504||1 115642|S01EC0301|Trusopt|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.04.1996||R|0|0|0|0|G|0|MSD|0|0|0|100|DKK|1913|3665|lyfalmen|V0369|3068|1|5|0|16,6667|Vistor hf|M.S.D.|Dorzólamíđ||1913||1913|3665||1 115931|R03AC1202|Serevent Diskus|innönddu|50|mcg/sk|60|skammtar|1|pakki||R03AC12|01.01.1995||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|3661|6056|lyfalmen|||1|60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról||3661||3661|6056||1 115980|P03AX0301|Prioderm|húđlausn|5|mg/ml|55|ml|1|glas||P03AX03|01.12.1983||L|0|0|0|0|0|0|NOP|0|0|0|100|IKR|||lyflausa|||0|55|0||Icepharma hf|Norpharma |Malatíón|||||||2 116004|J01DC0202|Zinacef|sts|1,5|g|5|hgl|1|pakki||J01DC02|01.06.2005||R|0|0|0|0|0|1|GSK|0|0|0|100|GBP|3677|5307|lyfsjukr|||1|5|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||3677||3677|5307||1 116046|J01DC0202|Zinacef|sts|750|mg|1|stk|5|hgl||J01DC02|01.09.1983||R|0|0|0|0|0|1|GSK|0|0|0|100|GBP|1922|2774|lyfsjukr|||1|5|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||1922||1922|2774||1 116198|C08CA0105|Amlodipin Bluefish|töflur|5|mg|100|stk|1|ţpakki||C08CA01|01.03.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|1153|1702|lyfalmen|V0056|1702|2|100|0|100,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Amlódipín||478||478|1702||2 116220|C08CA0105|Amlodipin Bluefish|töflur|10|mg|100|stk|1|ţpakki||C08CA01|01.03.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|1826|1606|lyfalmen|V0057|1606|2|100|0|200,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Amlódipín||408||408|1606||2 116244|D11AF01|Verucid|áburđur|||10|ml|1|glas||D11AF|01.11.1981||L|0|0|0|0|0|0|GAN|0|0|0|100|IKR|||lyflausa|||0|10|0||Icepharma hf|Galderma Nordic AB|Lyf viđ vörtum og líkţornum|||||||2 116327|D07AC1301|Elocon|krem|0,1|%|100|g|1|túpa||D07AC13|01.04.2009||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|2563|4554|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||2563||2563|4554||1 116418|D07AC1301|Elocon|smyrsli|0,1|%|100|g|1|túpa||D07AC13|01.04.2009||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|3011|5167|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||3011||3011|5167||1 116449|N05AH0313|Olanzapin Sandoz|filmhtfl|5|mg|250|stk|1|glas||N05AH03|01.05.2013||R|2|0|0|0|G|0|SHS|0|0|0|100|DKK|19925|14123|lyfalmen|||2|250|0|125,0000|Artasan ehf|Sandoz A/S|Olanzapín||9558||9558|14123||1 116551|M01AE0102|Ibufen|töflur|200|mg|20|stk|1|ţpakki||M01AE01|01.12.2008||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Actavis Group hf|Actavis hf|Íbúprófen|||||||1 116573|M01AE0102|Ibufen|töflur|400|mg|30|stk|1|ţpakki||M01AE01|01.05.2008||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|30|0|10,0000|Actavis Group hf|Actavis hf|Íbúprófen|||||||1 116584|M01AE0102|Ibufen|töflur|400|mg|100|stk|1|ţpakki||M01AE01|01.08.2008||R|1|0|0|0|G|0|ACA|0|0|1|100|XEU|766|1815|lyfalmen|V0562|1815|2|100|0|33,3333|Actavis Group hf|Actavis hf|Íbúprófen||561||561|1815||1 116595|M01AE0102|Ibufen|töflur|600|mg|30|stk|1|ţpakki||M01AE01|01.07.2008||R|1|0|0|0|G|0|ACA|0|0|1|100|XEU|381|1553|lyfalmen|V0563|1551|2|30|0|15,0000|Actavis Group hf|Actavis hf|Íbúprófen||369||369|1553||1 116606|M01AE0102|Ibufen|töflur|600|mg|100|stk|1|ţpakki||M01AE01|01.05.2008||R|1|0|0|0|G|0|ACA|0|0|1|100|XEU|917|2038|lyfalmen|V0564|2038|2|100|0|50,0000|Actavis Group hf|Actavis hf|Íbúprófen||724||724|2038||1 116694|G04BD1101|Toviaz|forđatfl|4|mg|84|stk|1|ţpakki||G04BD11|01.11.2008||R|1|0|0|0|G|0|IPI|0|0|0|100|DKK|17863|25141|lyfalmen|||1|84|0|84,0000|Icepharma hf|Pfizer Limited|Fesóteródín||17863||17863|25141||1 116697|C09CA0602|Candpress|töflur|8|mg|100|stk|1|ţpakki||C09CA06|01.01.2012||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|7628|10957|lyfalmen|V0081|10957|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan||7244||7244|10957||1 116705|G04BD1101|Toviaz|forđatfl|4|mg|28|stk|1|ţpakki||G04BD11|01.11.2008||R|1|0|0|0|G|0|IPI|0|0|0|100|DKK|6087|9375|lyfalmen|||1|28|0|28,0000|Icepharma hf|Pfizer Limited|Fesóteródín||6087||6087|9375||1 116716|G04BD1101|Toviaz|forđatfl|8|mg|28|stk|1|ţpakki||G04BD11|01.11.2008||R|1|0|0|0|G|0|IPI|0|0|0|100|DKK|6537|9990|lyfalmen|||1|28|0|56,0000|Icepharma hf|Pfizer Limited|Fesóteródín||6537||6537|9990||1 116727|G04BD1101|Toviaz|forđatfl|8|mg|84|stk|1|ţpakki||G04BD11|01.11.2008||R|1|0|0|0|G|0|IPI|0|0|0|100|DKK|19298|26942|lyfalmen|||1|84|0|168,0000|Icepharma hf|Pfizer Limited|Fesóteródín||19298||19298|26942||1 116928|J07AL0202|Prevenar 13|stl|2,2|mcg|0,5|ml|1|áf.spr||J07AL02|01.04.2010||R|0|1|0|0|0|0|IPI|0|0|0|100|DKK|8326|12437|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer Limited|Hreinsuđ pneumococca poly­sakkaríđ mótefnavakar (cojugated)||8326||8326|12437||1 117408|QA12AX0001|Calcimag vet. Kela|irl|||500|ml|12|plastf||QA12AX|01.04.2004||R|0|0|0|0|0|0|KEL|1|0|0|100|NOK|10727|20770|vetalmen|||0|6000|0||Icepharma hf|Kela Laboratoria NV|Kalsíum í blöndum međ D-vítamíni/eđa öđrum efnum||10727||10727|20770||2 117515|M01AE0303|Orudis|forđahlk|200|mg|100|stk|1|glas||M01AE03|01.10.1995||R|1|0|0|0|G|0|SNO|0|0|1|100|NOK|3291|5550|lyfalmen|||1|100|0|133,3333|Vistor hf|Sanofi-aventis Norge AS|Ketóprófen||3291||3291|5550||1 117531|N04BA0201|Madopar|hylki|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.07.1974||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|4573|7304|lyfalmen|V0435|7198|1|100|0|33,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||4573||4573|7304||2 117550|N05AH0405|Seroquel Prolong|forđatfl|50|mg|100|stk|1|ţpakki||N05AH04|01.12.2008||R|1|0|0|0|0|0|ASZ|0|0|0|100|SEK|15371|22014|lyfalmen|V0275|18939|1|100|0|12,5000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||15371|22014||1 117561|N05AH0405|Seroquel Prolong|forđatfl|200|mg|100|stk|1|ţpakki||N05AH04|01.12.2008||R|1|0|0|0|0|0|ASZ|0|0|0|100|SEK|27167|36818|lyfalmen|||1|100|0|50,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||27167|36818||1 117564|N04BA0201|Madopar|hylki|62,5|mg|100|stk|1|glas|50+12.5 mg|N04BA02|01.06.1981||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|1621|3265|lyfalmen|||1|100|0|8,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||1621||1621|3265||2 117573|N05AH0405|Seroquel Prolong|forđatfl|300|mg|10|stk|1|ţpakki||N05AH04|01.12.2008||R|1|0|0|0|0|0|ASZ|0|0|0|100|SEK|4698|7475|lyfalmen|||1|10|0|7,5000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||4698|7475||1 117584|N05AH0405|Seroquel Prolong|forđatfl|300|mg|100|stk|1|ţpakki||N05AH04|01.12.2008||R|1|0|0|0|0|0|ASZ|0|0|0|100|SEK|43600|57441|lyfalmen|||1|100|0|75,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||43600|57441||1 117595|N05AH0405|Seroquel Prolong|forđatfl|400|mg|100|stk|1|ţpakki||N05AH04|01.12.2008||R|1|0|0|0|0|0|ASZ|0|0|0|100|SEK|54334|70913|lyfalmen|||1|100|0|100,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||54334|70913||1 117676|L01DB0103|Caelyx|irţ|2|mg/ml|10|ml|1|hgl||L01DB01|01.01.2011||R|0|0|0|1|0|1|JCI|0|1|0|100|SEK|69130|88641|lyfsjukr|||1|10|0||Vistor hf|Janssen-Cilag International N.V.|Doxórúbicín||69130||69130|88641||1 117770|QP51AJ0101|Baycox Vet.|mixtúra|50|mg/ml|250|ml|1|fl||QP51AJ01|01.12.2005||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|9806|17106|vetorma|||0|250|0||Icepharma hf|Bayer Animal Health GmbH|||9806||9806|17106||2 117788|C08CA0502|Adalat Oros|forđatfl|30|mg|28|stk|1|ţpakki||C08CA05|01.07.1994||R|1|0|0|0|G|0|BAP|0|0|0|100|DKK|2467|4423|lyfalmen|V0085|4423|1|28|0|28,0000|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||||2467|4423||2 117796|C08CA0502|Adalat Oros|forđatfl|30|mg|98|stk|1|ţpakki||C08CA05|01.07.1994||R|1|0|0|0|G|0|BAP|0|0|0|100|DKK|5815|9003|lyfalmen|V0087|9003|1|98|0|98,0000|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||||5815|9003||2 117820|C08CA0502|Adalat Oros|forđatfl|60|mg|98|stk|1|ţpakki||C08CA05|01.07.1994||R|1|0|0|0|G|0|BAP|0|0|0|100|DKK|8089|12113|lyfalmen|V0086|12113|1|98|0|196,0000|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||||8089|12113||2 117929|QA12AA0301|Calci-kel vet. Kela|irl|20,8|mg/ml|100|ml|12|fl||QA12AA03|01.04.2004||R|0|0|0|0|0|0|KEL|0|0|0|100|NOK|7493|14560|vetalmen|||0|1200|0||Icepharma hf|Kela Laboratoria NV|Kalsíum glúkónat||7493||7493|14560||2 117937|QA12AA0301|Calci-kel vet. Kela|irl|20,8|mg/ml|500|ml|12|plastf||QA12AA03|01.04.2004||R|0|0|0|0|0|0|KEL|0|0|0|100|NOK|13142|25407|vetalmen|||0|6000|0||Icepharma hf|Kela Laboratoria NV|Kalsíum glúkónat||13142||13142|25407||2 118020|N05AH0306|Olanzapin Actavis|filmhtfl|2,5|mg|28|stk|1|ţpakki||N05AH03|01.05.2008||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|1828|1746|lyfalmen|V0278|1709|2|28|0|7,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||510||510|1746||1 118043|N05AH0306|Olanzapin Actavis|filmhtfl|5|mg|28|stk|1|ţpakki||N05AH03|01.04.2008||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|2997|2051|lyfalmen|V0279|1969|2|28|0|14,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||733||733|2051||1 118076|N05AH0306|Olanzapin Actavis|filmhtfl|10|mg|56|stk|1|ţpakki||N05AH03|01.03.2008||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|10766|4471|lyfalmen|V0282|4052|2|56|0|56,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||2502||2502|4471||1 118087|N05AH0306|Olanzapin Actavis|filmhtfl|15|mg|28|stk|1|ţpakki||N05AH03|01.04.2008||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|1767|3465|lyfalmen|V0283|3268|2|28|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||1767||1767|3465||1 118158|J01DC0203|Zinnat|mixt.kyr|25|mg/ml|100|ml|1|glas||J01DC02|01.10.1990||R|0|0|0|0|0|0|GSK|0|0|1|100|GBP|2190|4044|lyfalmen|||1|100|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||2190||2190|4044||1 118231|N01AX1301|Niontix|lyfjagas|100|%|4|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|9512|13728|lyfsjukr|||1|4|0||Ísaga ehf|AGA AB|di-Nitrogen oxíđ||9512||9512|13728||5 118307|A02BA0201|Asyran|töflur|150|mg|30|stk|1|ţpakki||A02BA02|01.04.1994||L|1|0|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||0|30|0|15,0000|Actavis Group hf|Actavis hf|Ranitidín|||||||1 118484|N05AH0306|Olanzapin Actavis|filmhtfl|7,5|mg|56|stk|1|ţpakki||N05AH03|01.04.2008||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|17486|6624|lyfalmen|V0280|6341|2|56|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||4076||4076|6624||1 118612|A07EC0203|Pentasa Sachets|forđakyr|1|g|150|stk|1|pakki|3 x 50 stk|A07EC02|01.04.1998||R|0|0|0|0|G|0|FER|0|0|0|100|DKK|23329|32001|lyfalmen|||1|150|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||23329||23329|32001||1 118793|C01AA0504|Lanoxin mite|töflur|62,5|mcg|120|stk|1|ţpakki||C01AA05|01.12.2010||R|1|0|0|0|G|0|AEG|0|0|0|100|XEU|494|1724|lyfalmen|||1|120|0|30,0000|GlaxoSmithKline ehf|Aspen Europe GmbH|Digoxín||494||494|1724||1 119031|L01XC0801|Vectibix|irţ|20|mg/ml|5|ml|1|hgl|lausn|L01XC08|01.06.2008||R|0|1|0|1|0|1|AEU|0|0|0|100|DKK|78047|99831|lyfsjukr|||1|5|0||Vistor hf|Amgen Europe B.V.|Panitúmúmab||78047||78047|99831||1 119394|C07AG0101|Trandate|filmhtfl|100|mg|50|stk|1|glas||C07AG01|01.04.2013||R|1|0|0|0|G|0|ATL|0|0|0|100|GBP|1019|2442|lyfalmen|V0595|2442|1|50|0|8,3333|Aspen Pharma Trading Ltd.|Aspen Pharma Trading Ltd.|Labetalól||1019||1019|2442||1 119825|N05BA1206|Alprazolam Krka|forđatfl|1|mg|30|stk|1|ţpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|1|100|XEU|973|2130|lyfalmen|V0309|2130|2|30|0|30,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||791||791|2130||2 119962|M01AE0109|Ibuprofen Portfarma|filmhtfl|400|mg|30|stk|1|ţpakki||M01AE01|01.03.2008||L|1|0|0|0|0|0|POF|0|0|1|100|IKR|||lyflausa|||0|30|0|10,0000|Portfarma ehf|Portfarma|Íbúprófen|||||||2 119984|C02KX0201|Volibris|filmhtfl|5|mg|30|stk|1|ţpakki||C02KX02|01.12.2008||R|1|1|0|1|0|1|GGL|0|1|0|100|GBP|439142|553006|lyfsjukr|||1|30|0|20,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Ambrisentanum||439142||439142|553006||1 120007|C02KX0201|Volibris|filmhtfl|10|mg|30|stk|1|ţpakki||C02KX02|01.12.2008||R|1|1|0|1|0|1|GGL|0|1|0|100|GBP|439142|553006|lyfsjukr|||1|30|0|40,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Ambrisentanum||439142||439142|553006||1 120022|S01FA0401|Cyclogyl 1 %|augndr|10|mg/ml|10|ml|1|glas||S01FA04|01.10.2003||R|0|0|0|0|G|0|SAL|0|0|0|100|USD|981|2390|lyfalmen|||1|10|0||Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Cýklópentólat||981||981|2390||1 120062|L01BA0401|Alimta|irţ|100|mg/hgl|1|hgl|1|pakki||L01BA04|01.11.2008||R|0|0|0|1|0|1|LIL|0|1|0|100|XEU|48624|62906|lyfsjukr|||1|1|0||Icepharma hf|Lilly ICOS Limited|Pemetrexed||48624||48624|62906||2 120798|H01AC0111|Omnitrope|stl|6,7|mg/ml|1,5|ml|1|rörlyk|lausn|H01AC01|01.04.2012||R|0|0|0|1|0|1|SDG|0|1|0|100|DKK|32069|42129|lyfsjukr|||1|1,5|0|15,0000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||32069||32069|42129||1 121164|A02BC0501|Nexium|mixt.kyr|10|mg|28|sk-pokar|1|pakki|dreifa|A02BC05|01.04.2009||R|0|0|0|0|0|0|AZD|0|0|0|100|SEK|5847|9046|lyfalmen|||1|28|0|9,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||5847||5847|9046||1 121286|M03AC0901|Esmeron|stl|10|mg/ml|5|ml|10|hgl||M03AC09|01.04.2009||R|0|0|0|0|0|1|ORG|0|0|0|100|DKK|9568|13809|lyfsjukr|||1|50|0||Vistor hf|N.V. Organon|Rókúrón, brómíđ||9568||9568|13809||1 121302|N02BA5102|Treo|freyđit|||60|stk|1|glas||N02BA51|01.12.2012||L|0|0|0|0|0|0|MAB|0|0|1|100|IKR|||lyflausa|||0|60|0|10,0000|Vistor hf|Meda AB|Acetýlsalicýlsýra í blöndum, ţó ekki međ geđlyfjum (psychole|||||||1 121327|R03AC0204|Ventolin|innúđal|0,1|mg/sk|200|skammtar|1|stauk||R03AC02|01.12.1972||R|0|0|0|0|G|0|GSK|0|0|1|100|IKR|467|1687|lyfalmen|||1|200|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||467||467|1687||1 121550|A02BC0507|Esomeprazole Portfarma|sţ-tfl|20|mg|98|stk|1|ţpakki||A02BC05|01.11.2011||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|8128|5224|lyfalmen|V0011|5070|2|98|0|65,3300|Portfarma ehf|Portfarma|Esómeprazól||3053||3053|5224||2 121562|B03BB0104|Folic Acid|töflur|5|mg|28|stk|1|ţpakki||B03BB01|01.01.2008||R|1|0|0|0|G|0|AUK|0|0|1|100|GBP|402|1595|lyfalmen|V0391|1592|2|28|0|350,0000|Actavis Group hf|Actavis UK Ltd.|Fólínsýra||400||400|1595||1 121582|N06AA0401|Anafranil|töflur|25|mg|100|stk|1|ţpakki||N06AA04|01.03.1977||R|1|0|0|0|G|0|NOH|0|0|0|100|DKK|1778|3480|lyfalmen|V0314|3097|1|100|0|25,0000|Vistor hf|Novartis Healthcare A/S-|Klómípramín||1778||1778|3480||1 121691|H02AB0605|Prednisolone Actavis|töflur|1|mg|28|stk|1|ţpakki||H02AB06|01.01.2011||R|1|0|0|0|G|0|AUK|0|0|1|100|GBP|268|1415|lyfalmen|||2|28|0|2,8000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||268||268|1415||1 122411|QI09AA0701|Ingelvac CircoFLEX|stl|||50|ml|1|hgl|dreifa|QI09AA07|01.12.2010||R|0|0|0|0|0|0|BIV|0|0|0|100|IKR|9600|16747|vetorma|||0|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Porcine circovirus Type ORF-2 protein||9600||9600|16747||1 122577|A04AA0105|Ondansetron BMM Pharma|filmhtfl|4|mg|10|stk|1|ţpakki||A04AA01|01.09.2012||R|1|0|0|0|G|0|BMM|0|0|0|100|XEU|3152|4587|lyfalmen|V0381|4587|2|10|0|2,5000|LYFIS ehf|BMM Pharma AB|Ondansetrón||2587||2587|4587||2 122588|A04AA0105|Ondansetron BMM Pharma|filmhtfl|4|mg|50|stk|1|ţpakki||A04AA01|01.11.2012||R|1|0|0|0|G|0|BMM|0|0|0|100|XEU|15552|15513|lyfalmen|||2|50|0|12,5000|LYFIS ehf|BMM Pharma AB|Ondansetrón||10574||10574|15513||2 122610|A04AA0105|Ondansetron BMM Pharma|filmhtfl|8|mg|10|stk|1|ţpakki||A04AA01|01.09.2012||R|1|0|0|0|G|0|BMM|0|0|0|100|XEU|3600|3880|lyfalmen|V0384|3880|2|10|0|5,0000|LYFIS ehf|BMM Pharma AB|Ondansetrón||2070||2070|3880||2 122643|A04AA0105|Ondansetron BMM Pharma|filmhtfl|8|mg|50|stk|1|ţpakki||A04AA01|01.11.2012||R|1|0|0|0|G|0|BMM|0|0|0|100|XEU|15552|15513|lyfalmen|||2|50|0|25,0000|LYFIS ehf|BMM Pharma AB|Ondansetrón||10574||10574|15513||2 123216|N05BA0105|Stesolid|eţ-stíll|5|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|0|0|0|0|0|0|AGT|0|0|1|100|DKK|846|2205|lyfalmen|||2|10|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||846||846|2205||1 123224|N05BA0105|Stesolid|eţ-stíll|10|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|0|0|0|0|0|0|AGT|0|0|1|100|DKK|1142|2610|lyfalmen|||2|10|0|10,0000|Actavis Group hf|Actavis Group hf|Díazepam||1142||1142|2610||1 123256|QP52AA5104|Zantel|töflur|550|mg|100|stk|1|ţpakki|50+500 mg|QP52AA51|01.07.2011||R|0|0|0|0|0|0|ICE|0|0|0|100|USD|26927|46973|vetorma|||0|100|0||Icepharma hf|Icepharma hf|||26927||26927|46973||2 123806|C07AA0512|Pranolol|töflur|20|mg|100|stk|1|glas||C07AA05|01.09.2011||R|1|0|0|0|G|0|AGT|0|0|0|100|XEU|247|1386|lyfalmen|||2|100|0|12,5000|Actavis Group hf|Actavis Group hf|Própranólól||||247|1386||1 123954|N06AB0404|Citalopram Bluefish|filmhtfl|10|mg|100|stk|1|ţpakki||N06AB04|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|2324|2067|lyfalmen|V0317|2067|2|100|0|50,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Cítalópram||745||745|2067||2 123992|N07XX0201|Rilutek|töflur|50|mg|56|stk|1|ţpakki||N07XX02|01.05.1998||R|1|0|0|0|G|0|AVS|0|0|0|100|NOK|43716|57587|lyfalmen|V0579|54044|1|56|0|28,0000|Vistor hf|Aventis Pharma SA|Rílúzól||43716||43716|57587||1 124020|QM01AC0603|Rheumocam|mixtúra|1,5|mg/ml|42|ml|1|plastf||QM01AC06|01.08.2009||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|1840|3660|vetalmen|||0|42|0||Icepharma hf|Chanelle Pharmaceuticals|||||1840|3660||2 124119|B01AC0401|Plavix|töflur|300|mg|30|stk|1|ţpakki||B01AC04|01.09.2009||R|1|0|0|0|0|0|SBM|0|0|0|100|NOK|38824|51447|lyfalmen|||1|30|0|120,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||||38824|51447||1 124207|N02CC0105|Sumatriptan Bluefish|töflur|100|mg|6|stk|1|ţpakki||N02CC01|01.04.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|1929|3098|lyfalmen|V0234|2520|2|6|0|12,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Súmatriptan||1499||1499|3098||2 124251|N02CC0105|Sumatriptan Bluefish|töflur|50|mg|12|stk|1|ţpakki||N02CC01|01.04.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|2756|2417|lyfalmen|V0233|2371|2|12|0|12,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Súmatriptan||1001||1001|2417||2 124354|G02AB0101|Methergin|töflur|0,125|mg|30|stk|1|ţpakki||G02AB01|01.03.1980||R|1|0|0|0|G|0|NOH|0|0|0|100|DKK|1009|2428|lyfalmen|||1|30|0|18,7500|Vistor hf|Novartis Healthcare A/S-|Metýlergómetrín||1009||1009|2428||1 124727|C09AA0201|Daren|töflur|10|mg|30|stk|1|ţpakki||C09AA02|01.01.1994||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|516|1754|lyfalmen|||2|30|0|30,0000|Actavis Group hf|Actavis hf|Enalapríl||516||516|1754||1 124870|S01ED5110|Duotrav|augndr|||2,5|ml|3|glas|40 mcg/ml+5 mg/ml|S01ED51|01.10.2011||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|9598|14178|lyfalmen|V0464|14178|0|7,5|0|75,0000|Vistor hf|Alcon Laboratories Ltd.|Tímólól í blöndum||9598||9598|14178||1 125054|C09AA0201|Daren|töflur|10|mg|100|stk|1|ţpakki||C09AA02|01.01.1994||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|849|2011|lyfalmen|V0066|2011|2|100|0|100,0000|Actavis Group hf|Actavis hf|Enalapríl||704||704|2011||1 125125|L01AA0301|Alkeran|töflur|2|mg|25|stk|1|glas||L01AA03|01.06.2013||R|0|0|0|1|G|0|ATL|0|0|0|100|XEU|2133|3966|lyfalmen|V0076|3966|1|25|0||Aspen Pharma Trading Ltd.|Aspen Pharma Trading Ltd.|Melphalan||2133||2133|3966||1 125973|D01BA0205|Terbinafin BMM Pharma|töflur|250|mg|28|stk|1|ţpakki||D01BA02|01.08.2012||R|1|0|0|0|0|0|BMM|0|0|0|100|XEU|2505|3062|lyfalmen|V0123|3062|2|28|0|28,0000|LYFIS ehf|BMM Pharma AB|Terbínafín||1472||1472|3062||2 126326|A07DA0301|Imodium|töflur|2|mg|16|stk|1|ţpakki||A07DA03|01.10.1991||L|1|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|16|0|3,2000|Vistor hf|McNeil Sweden AB|Lóperamíđ|||||||1 126374|L01XX1702|Hycamtin|hylki|1|mg|10|stk|1|ţpakki|hart|L01XX17|01.11.2008||R|0|0|0|1|0|1|SKB|0|0|0|100|GBP|111805|142198|lyfsjukr|||1|10|0||GlaxoSmithKline ehf|SmithKline Beecham Ltd|Tópótecan||||111805|142198||1 126385|L01XX1702|Hycamtin|hylki|0,25|mg|10|stk|1|ţpakki|hart|L01XX17|01.11.2008||R|0|0|0|1|0|1|SKB|0|0|0|100|GBP|28693|37892|lyfsjukr|||1|10|0||GlaxoSmithKline ehf|SmithKline Beecham Ltd|Tópótecan||||28693|37892||1 126540|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|10X10 cm|J01GB03|01.10.1995||R|0|0|0|0|0|1|INN|0|0|0|100|XEU|25608|34021|lyfsjukr|||1|1|0|0,5417|Innocoll Pharmaceuticals Ltd.|Innocoll Pharmaceuticals Ltd.|Gentamícín||25608||25608|34021||2 126649|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|5X5 cm|J01GB03|01.10.1995||R|0|0|0|0|0|1|INN|0|0|0|100|XEU|8535|12318|lyfsjukr|||1|1|0|0,1354|Innocoll Pharmaceuticals Ltd.|Innocoll Pharmaceuticals Ltd.|Gentamícín||8535||8535|12318||2 126684|J06BA0208|Privigen|irl|100|mg/ml|50|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|48819|63150|lyfsjukr|||1|50|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í ćđ||48819||48819|63150||2 126695|J06BA0208|Privigen|irl|100|mg/ml|100|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|97663|124450|lyfsjukr|||1|100|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í ćđ||97663||97663|124450||2 126707|J06BA0208|Privigen|irl|100|mg/ml|200|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|195256|246929|lyfsjukr|||1|200|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í ćđ||195256||195256|246929||2 126926|B01AF0101|Xarelto|filmhtfl|15|mg|100|stk|1|ţpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|39749|52608|lyfalmen|||1|100|0|150,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||39749|52608||2 126953|A07DA0301|Imodium|töflur|2|mg|100|stk|1|ţpakki||A07DA03|01.10.1991||R|1|0|0|0|G|0|MCS|0|0|0|100|SEK|1073|2516|lyfalmen|V0447|2170|1|100|0|20,0000|Vistor hf|McNeil Sweden AB|Lóperamíđ||1073||1073|2516||1 127383|R02AA0302|Strepsils med honning og citron|sogtfl|||36|stk|1|ţpakki||R02AA03|01.01.2009||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|36|0|6,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 127881|N07BA0149|Nicovel Mint|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.02.2013||L|0|0|0|0|0|0|ORI|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Icepharma hf|Orifarm Generics A/S|Nikótín|||||||2 128058|N05AH0301|Zyprexa|húđuđtfl|5|mg|28|stk|1|ţpakki||N05AH03|01.03.1998||R|1|0|0|0|G|0|ELD|0|0|0|100|XEU|8802|6321|lyfalmen|V0279|1969|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||3855||3855|6321||2 128131|QG51AG0101|Sulfa-Streptocillin vet.|legstíl|||30|stk|1|ţpakki||QG51AG01|01.03.2009||R|0|0|0|0|0|0|BID|1|0|0|100|DKK|12400|23982|vetalmen|||0|30|0||Vistor hf|Boehringer Ingelheim Danmark|Súlfónamíđar í blöndu međ öđrum lyfjum||12400||12400|23982||1 128348|C03AB0102|Centyl mite med kaliumklorid|töflur|||100|stk|1|glas||C03AB01|01.05.1999||R|1|0|0|0|G|0|LEP|0|0|0|100|DKK|1243|2748|lyfalmen|||1|100|0|50,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíđ og kalíum||1243||1243|2748||1 128777|N02BA5102|Treo|freyđit|||60|stk|1|glas||N02BA51|01.07.1988||L|0|0|0|0|0|0|MAB|0|0|1|100|IKR|||lyflausa|||0|60|0|10,0000|Vistor hf|Meda AB|Acetýlsalicýlsýra í blöndum, ţó ekki međ geđlyfjum (psychole|||||||1 128934|V03AF0101|Uromitexan|stl|100|mg/ml|10|ml|10|lykjur||V03AF01|01.10.1990||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|4131|5962|lyfsjukr|||1|100|0||Icepharma hf|Baxter Medical AB|Mesna||4131||4131|5962||2 129098|N05AH0301|Zyprexa|húđuđtfl|7,5|mg|56|stk|1|ţpakki||N05AH03|01.03.1998||R|1|0|0|0|0|0|ELD|0|0|0|100|XEU|31734|30512|lyfalmen|V0280|6341|1|56|0|42,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||22142||22142|30512||2 129106|N05AH0301|Zyprexa|húđuđtfl|10|mg|56|stk|1|ţpakki||N05AH03|01.03.1998||R|1|0|0|0|G|0|ELD|0|0|0|100|XEU|34491|23561|lyfalmen|V0282|4052|1|56|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||16604||16604|23561||2 129158|H02AB0605|Prednisolone Actavis|töflur|5|mg|28|stk|1|ţpakki||H02AB06|01.02.2011||R|1|0|0|0|G|0|AUK|0|0|1|100|GBP|225|1356|lyfalmen|||2|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||225||225|1356||1 129668|A02AH0002|Natriumbikarbonat|töflur|1|g|100|stk|1|glas||A02AH|01.08.2005||L|1|0|0|0|0|0|REP|0|0|0|100|SEK|||lyfalmen|||0|100|0||Vistor hf|Recip AB|Natríumhýdrógenkarbonat|||||3364||1 129817|R03BB0101|Atrovent|innúđal|0,25|mg/ml|60|plastl|1|pakki|í vél|R03BB01|01.04.1989||R|0|0|0|0|G|0|BOI|0|0|0|100|DKK|3522|5866|lyfalmen|||1|60|0|100,0000|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíđ||3522||3522|5866||1 130013|N05AH0401|Seroquel|töflur|100|mg|100|stk|1|ţpakki||N05AH04|01.09.1998||R|1|0|0|0|0|0|AZA|0|0|0|100|SEK|19230|23782|lyfalmen|V0285|7204|1|100|0|25,0000|Vistor hf|AstraZeneca AB|Quetíapín||16780||16780|23782||1 130021|N05AH0401|Seroquel|töflur|200|mg|100|stk|1|ţpakki||N05AH04|01.09.1998||R|1|0|0|0|0|0|AZA|0|0|0|100|SEK|30439|36059|lyfalmen|V0286|15653|1|100|0|50,0000|Vistor hf|AstraZeneca AB|Quetíapín||26562||26562|36059||1 130286|C01CA2406|Adrenalin Mylan|stl|1|mg/ml|1|ml|10|gl-lyk||C01CA24|01.06.2009||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|2418|4356|lyfalmen|||2|10|0|20,0000|Icepharma hf|Mylan AB|Adrenalín tartrat||2418||2418|4356||2 130397|QH01CA9301|Suprelorin|vefjalyf|4,7|mg|2|stk|1|pakki|fyrir hunda|QH01CA93|01.05.2012||R|0|0|0|0|0|0|VIR|1|0|0|100|DKK|14101|27249|vetalmen|||0|2|0||Vistor hf|Virbac S.A|Deslorelín||14101||14101|27249||1 130575|C03CA0101|Furix|stl|10|mg/ml|25|ml|5|lykjur||C03CA01|01.03.2003||R|0|0|0|0|G|0|NYC|0|0|0|100|DKK|4032|6563|lyfalmen|||2|125|0|31,2500|Vistor hf|Nycomed Danmark A/S|Fúrósemíđ||4032||4032|6563||1 130591|A03BA0103|Atropin Mylan|stl|0,5|mg/ml|1|ml|10|gl-lyk||A03BA01|01.06.2009||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|1890|3633|lyfalmen|||2|10|0|3,3400|Icepharma hf|Mylan AB|Atrópínsúlfat||1890||1890|3633||2 130596|N07BA0301|Champix|filmhtfl|||53|stk|1|ţpakki|0,5 mg og 1 mg|N07BA03|01.02.2009||R|1|0|0|0|0|0|IPI|0|0|1|100|DKK|11473|16742|lyfalmen|||1|53|0|23,7500|Icepharma hf|Pfizer Limited|Vareniclin||||11473|16742||1 130772|QI10AB0201|Alpha Ject 3000|stl|||500|ml|1|plpoki||QI10AB02|01.05.2009||R|0|0|0|0|0|0|PHA|0|0|0|100|NOK|65671|107142|veteldis|||0|500|0||Vistor hf|PHARMAQ AS|Aeromónas+Vibrio||||65671|107142||1 131136|C01CA2601|Efedrin Mylan|stl|50|mg/ml|1|ml|10|gl-lyk||C01CA26|01.06.2009||R|0|0|0|0|0|0|MYL|0|0|0|100|SEK|3464|5787|lyfalmen|||2|10|0|10,0000|Icepharma hf|Mylan AB|Efedrínhýdróklóríđ||||3464|5787||2 131334|N03AB0205|Fenantoin Recip|töflur|100|mg|100|stk|1|glas||N03AB02|01.06.2004||R|1|0|0|0|G|0|REP|0|0|0|100|SEK|488|1715|lyfalmen|||2|100|0|33,3333|Vistor hf|Recip AB|Fenýtóín||488||488|1715||1 131383|N03AA0204|Fenemal Recip|töflur|15|mg|100|stk|1|glas||N03AA02|01.06.2004||R|1|0|0|0|G|0|REP|0|0|0|100|SEK|769|2100|lyfalmen|||2|100|0|15,0000|Vistor hf|Recip AB|Fenemal||769||769|2100||1 131417|N03AA0204|Fenemal Recip|töflur|50|mg|100|stk|1|glas||N03AA02|01.06.2004||R|1|0|0|0|G|0|REP|0|0|0|100|SEK|1026|2451|lyfalmen|||2|100|0|50,0000|Vistor hf|Recip AB|Fenemal||1026||1026|2451||1 131441|N03AA0204|Fenemal Recip|töflur|100|mg|100|stk|1|glas||N03AA02|01.06.2004||R|1|0|0|0|G|0|REP|0|0|0|100|SEK|1135|2601|lyfalmen|||2|100|0|100,0000|Vistor hf|Recip AB|Fenemal||1135||1135|2601||1 131450|B01AC0405|Clopidogrel Qualigen (Lyfjaver)|filmhtfl|75|mg|28|stk|1|ţpakki||B01AC04|01.07.2011||R|1|0|0|0|G|0|LVR|0|0|0|100|XEU|2636|3010|lyfalmen|V0009|1803|3|28|0|28,0000|Lyfjaver ehf|Lyfjaver ehf|Klópídógrel||1434||1434|3010||3 131565|G03CA0306|Evorel|forđapl|100|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|5850|9050|lyfalmen|V0132|9050|1|26|0|182,0000|Vistor hf|Janssen-Cilag AB|Estradíól||5850||5850|9050||1 131740|N07BA0132|Nicorette Microtab Lemon|tungur.t|2|mg|90|stk|1|ţpakki||N07BA01|01.10.2008||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|90|0|6,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 131817|B01AF0101|Xarelto|filmhtfl|10|mg|10|stk|1|ţpakki||B01AF01|01.05.2009||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|3964|6470|lyfalmen|||1|10|0|10,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||3964||3964|6470||2 131828|B01AF0101|Xarelto|filmhtfl|10|mg|30|stk|1|ţpakki||B01AF01|01.05.2009||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|11892|17316|lyfalmen|||1|30|0|30,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||11892||11892|17316||2 131840|B01AF0101|Xarelto|filmhtfl|10|mg|100|stk|1|ţpakki||B01AF01|01.05.2009||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|39485|52277|lyfalmen|||1|100|0|100,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||39485||39485|52277||2 132260|N06DA0404|Galantamine Portfarma|forđahlk|8|mg|28|stk|1|ţpakki||N06DA04|01.12.2011||R|1|0|0|0|G|0|POF|0|0|0|100|SEK|8269|12360|lyfalmen|||2|28|0|14,0000|Portfarma ehf|Portfarma|Galantamín||8269||8269|12360||2 132361|C09DA0309|Valpress Comp|filmhtfl|172,5|mg|98|stk|1|ţpakki||C09DA03|01.10.2008||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|7356|2943|lyfalmen|V0581|2867|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Valsartan og ţvagrćsilyf||1385||1385|2943||1 132372|C09DA0309|Valpress Comp|filmhtfl|92,5|mg|98|stk|1|ţpakki||C09DA03|01.10.2008||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|4231|2943|lyfalmen|V0580|2867|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Valsartan og ţvagrćsilyf||1385||1385|2943||1 132546|A06AX0401|Constella|hylki|290|mcg|28|stk|1|glas||A06AX04|01.05.2013||R|0|0|0|0|0|0|ALM|0|0|0|100|DKK|12234|18077|lyfalmen|||1|28|0||Vistor hf|Almirall S.A.|Linaclotídum||12234||12234|18077||1 132662|R05DA0403|Kodein Recip|töflur|25|mg|100|stk|1|glas||R05DA04|01.08.2005||R|1|0|1|0|G|0|REP|0|0|1|100|SEK|1535|3148|lyfalmen|||2|100|0|25,0000|Vistor hf|Recip AB|Kódein||1535||1535|3148||1 132663|N06BA0402|Concerta|forđatfl|27|mg|30|stk|1|glas||N06BA04|01.02.2009||R|1|0|1|0|0|0|JAS|0|0|0|100|SEK|7521|11336|lyfalmen|||1|30|0|27,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||7521||7521|11336||1 132717|QN05CM9204|Nerfasin vet.|stl|100|mg/ml|50|ml|1|hgl|fyrir nautgripi og hesta|QN05CM92|01.07.2013||R|0|0|0|0|0|0|BVL|1|0|0|100|XEU|10799|20908|vetalmen|||0|50|0||Dýraheilsa ehf|Le Vet B.V.|||10799||10799|20908||2 132761|D08AG0201|Betadine|húđlausn|100|mg/ml|8|ml|1|glas||D08AG02|01.01.1986||L|0|0|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||0|8|0||Icepharma hf|Norpharma a/s|Jođ/pólývídón|||||||2 132845|S01HA0401|Alcaine|augndr|5|mg/ml|15|ml|1|glas||S01HA04|01.09.2003||R|0|0|0|0|0|0|SAL|0|0|0|100|USD|1119|2579|lyfalmen|||1|15|0||Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Proxýmetakaín||1119||1119|2579||1 132852|A07BA0104|Kolsuspension|mixtúra|150|mg/ml|100|ml|1|fl|dreifa|A07BA01|01.08.2005||L|0|0|0|0|0|0|ABI|0|0|0|100|IKR|||lyflausa|||0|100|0|3,0000|Vistor hf|Abigo Medical AB|Lyfjakol|||||||1 132902|G03AB0402|Trinovum 28|töflur|||84|stk|1|ţpakki||G03AB04|01.01.1993||R|0|0|0|0|0|0|JAS|0|0|0|100|SEK|1430|3004|lyfalmen|||1|84|0|84,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og ethinylestradíól||1430||1430|3004||1 133097|M03AX0104|NeuroBloc|stl|5000|ein/ml|0,5|ml|1|hgl||M03AX01|01.02.2009||R|0|0|0|1|0|1|EIS|0|1|0|100|SEK|29228|38564|lyfsjukr|||1|0,5|0||Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||29228||29228|38564||1 133109|M03AX0104|NeuroBloc|stl|5000|ein/ml|1|ml|1|hgl||M03AX01|01.02.2009||R|0|0|0|1|0|1|EIS|0|1|0|100|SEK|38879|50676|lyfsjukr|||1|1|0||Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||38879||38879|50676||1 133120|M03AX0104|NeuroBloc|stl|5000|ein/ml|2|ml|1|hgl||M03AX01|01.02.2009||R|0|0|0|1|0|1|EIS|0|1|0|100|SEK|50801|65638|lyfsjukr|||1|2|0||Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||||50801|65638||1 133411|B06AC0101|Cinryze|sts|500|ae|2|hgl|1|pakki|+ leysir, lausn|B06AC01|01.03.2013||R|0|1|0|1|0|1|VIO|0|0|0|100|DKK|275933|348178|lyfsjukr|||1|2|0||Williams & Halls efh|ViroPharma SPRL|C1 hemill||275933||275933|348178||2 133508|A06AD6501|Moxalole|mixtduft|13,8|g|8|pokar|1|pakki||A06AD65|01.05.2011||L|0|0|0|0|0|0|MEB|0|0|0|100|IKR|||lyflausa|||0|8|0||Vistor hf|Meda AB (V)|Makrógól 3350|||||||1 133530|A06AD6501|Moxalole|mixtduft|13,8|g|20|pokar|1|pakki||A06AD65|01.05.2011||L|0|0|0|0|0|0|MEB|0|0|0|100|IKR|||lyflausa|||0|20|0|10,0000|Vistor hf|Meda AB (V)|Makrógól 3350|||||||1 133551|J05AG0101|Viramune|töflur|200|mg|14|stk|1|ţpakki||J05AG01|01.03.2013||R|1|0|0|1|0|1|BII|0|0|0|100|DKK|8680|12527|lyfsjukr|||1|14|0|7,0000|Vistor hf|Boehringer Ingelheim International|Nevírapín||8680||8680|12527||1 133552|A06AD6501|Moxalole|mixtduft|13,8|g|50|pokar|1|pakki||A06AD65|01.05.2011||L|0|0|0|0|0|0|MEB|0|0|0|100|SEK|||lyfalmen|V0592|6964|0|50|0|25,0000|Vistor hf|Meda AB (V)|Makrógól 3350|||||6964||1 134338|J01FA0901|Klacid|mixt.kyr|50|mg/ml|50|ml|1|glas|pl.fl. m/sk.sprautu|J01FA09|01.07.1998||R|0|0|0|0|0|0|ABS|0|0|1|100|DKK|1526|3135|lyfalmen|||1|50|0|5,0000|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||1526||1526|3135||1 134352|S01EE0501|Taflotan|augndr|15|mcg/ml|0,3|ml|30|sk-hyl||S01EE05|01.03.2010||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|4034|6566|lyfalmen|V0378|5966|1|9|0|30,0000|Icepharma hf|Santen Oy|Taflúprost||4034||4034|6566||2 134374|S01EE0501|Taflotan|augndr|15|mcg/ml|0,3|ml|90|sk-hyl||S01EE05|01.06.2010||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|12092|17899|lyfalmen|V0378|17899|1|27|0|90,0000|Icepharma hf|Santen Oy|Taflúprost||12092||12092|17899||2 134520|L01DB0302 |Epirubicin Actavis|stl|2|mg/ml|25|ml|1|hgl||L01DB03|01.04.2009||R|0|0|0|1|0|1|AGT|0|0|0|100|XEU|4764|6876|lyfsjukr|||2|25|0||Actavis Group hf|Actavis Group hf|Epírúbicín||4764||4764|6876||1 134642|J05AE0801|Reyataz|hylki|300|mg|30|stk|1|plglas||J05AE08|01.01.2010||R|1|0|0|1|0|1|BRS|0|0|0|100|DKK|70776|90706|lyfsjukr|||1|30|0|30,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||70776||70776|90706||1 134862|J05AR0601|Atripla|filmhtfl|||30|stk|1|glas|600+200+245 mg|J05AR06|01.07.2008||R|0|0|0|1|0|1|GSI|0|0|0|100|DKK|131137|166459|lyfsjukr|||1|30|0|30,0000|Lyfjaver ehf|Gilead Science International (L)|Emtrícítabín, tenófóvír dísóproxíl og efavírenz||131137||131137|166459||3 135111|H01AC0101|Genotropin|sts|12|mg|1|rörlyk|1|pakki|tvíhólfa|H01AC01|01.04.1992||R|0|0|0|1|0|1|PER|0|1|0|100|DKK|53307|68783|lyfsjukr|||1|1|0|18,0000|Icepharma hf|Pfizer ApS|Sómatrópín||53307||53307|68783||1 135289|C07AG0203|Carvedilol Actavis|filmhtfl|12,5|mg|100|stk|1|ţpakki||C07AG02|01.07.2011||R|1|0|0|0|G|0|ADG|0|0|0|100|XEU|2659|4685|lyfalmen|||2|100|0|33,3333|Actavis Group hf|Actavis Deutchland GmbH & Co. KG|Carvedílól||2659||2659|4685||1 135319|C08DA0108|Verapamil Mylan|töflur|80|mg|100|stk|1|glas||C08DA01|01.01.1990||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1045|2477|lyfalmen|||2|100|0|33,3333|Icepharma hf|Mylan AB|Verapamíl||1045||1045|2477||2 135434|R03BA0502|Flixotide Diskus|innönddu|100|mcg/sk|60|skammtar|1|pakki|í diskus-t|R03BA05|01.07.1995||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|1337|2877|lyfalmen|||1|60|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||1337||1337|2877||1 135559|L01CD0202|Docetaxel Actavis|irţ|20|mg/ml|4|ml|1|hgl|lausn|L01CD02|01.04.2013||R|0|0|0|1|0|1|AVB|0|0|0|100|XEU|5401|7795|lyfsjukr|||2|4|0||Actavis Group PTC ehf|Actavis BV|Docetaxel||5401||5401|7795||1 136168|G03AB0401|Trinovum|töflur|||63|stk|1|ţpakki||G03AB04|01.10.1988||R|0|0|0|0|0|0|JAS|0|0|0|100|SEK|1721|3402|lyfalmen|||1|63|0|84,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og ethinylestradíól||1721||1721|3402||1 136181|L04AA1001|Rapamune|mixtúra|1|mg/ml|60|ml|1|fl||L04AA10|01.01.2013||R|0|0|0|1|G|0|IPI|0|0|0|100|DKK|34202|45647|lyfalmen|V0582|45647|1|60|0|20,0000|Icepharma hf|Pfizer Limited|Sirolimus||34202||34202|45647||2 136200|J04AC0102|Tibinide|töflur|300|mg|100|stk|1|glas||J04AC01|01.07.2005||R|1|0|0|0|0|0|REP|0|0|0|100|SEK|7170|10856|lyfalmen|||1|100|0|100,0000|Vistor hf|Recip AB|Ísóníazíđ||7170||7170|10856||1 136281|L04AB0101|Enbrel|sts|25|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.03.2012||R|0|0|0|1|0|1|IPI|0|1|0|100|DKK|74451|95319|lyfsjukr|||1|4|0|14,2900|Icepharma hf|Pfizer Limited|Etanercept||74451||74451|95319||1 136658|N05BA1206|Alprazolam Krka|forđatfl|0,5|mg|30|stk|1|ţpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|1|100|XEU|462|1550|lyfalmen|V0307|1550|2|30|0|15,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||367||367|1550||2 136964|L01CD0103|Paclitaxel Hospira|irţ|6|mg/ml|5|ml|1|hgl||L01CD01|01.10.2005||R|0|0|0|1|0|1|HUK|0|0|0|100|XEU|2363|3410|lyfsjukr|||2|5|0||Icepharma hf|Hospira UK Ltd|Paklítaxel||2363||2363|3410||2 136975|L01CD0103|Paclitaxel Hospira|irţ|6|mg/ml|16,7|ml|1|hgl|lausn|L01CD01|01.10.2005||R|0|0|0|1|0|1|HUK|0|0|0|100|XEU|7399|10679|lyfsjukr|||2|16,7|0||Icepharma hf|Hospira UK Ltd|Paklítaxel||7399||7399|10679||2 136987|L01CD0103|Paclitaxel Hospira|irţ|6|mg/ml|25|ml|1|hgl|lausn|L01CD01|01.10.2005||R|0|0|0|1|0|1|HUK|0|0|0|100|XEU|5453|7870|lyfsjukr|||2|25|0||Icepharma hf|Hospira UK Ltd|Paklítaxel||5453||5453|7870||2 136998|L01CD0103|Paclitaxel Hospira|irţ|6|mg/ml|50|ml|1|hgl|lausn|L01CD01|01.10.2005||R|0|0|0|1|0|1|HUK|0|0|0|100|XEU|8500|12268|lyfsjukr|||2|50|0||Icepharma hf|Hospira UK Ltd|Paklítaxel||8500||8500|12268||2 137110|L01XA0302|Oxaliplatin Hospira|irţ|5|mg/ml|20|ml|1|hgl||L01XA03|01.06.2011||R|0|0|0|1|0|1|HUK|0|0|0|100|XEU|5976|8625|lyfsjukr|||2|20|0||Icepharma hf|Hospira UK Ltd|Oxalíplatín||5976||5976|8625||2 137218|G03AC0902|Gestrina|filmhtfl|75|mcg|168|stk|1|ţpakki|6x28 stk|G03AC09|01.01.2013||R|0|0|0|0|0|0|APC|0|0|0|100|XEU|3376|5666|lyfalmen|||2|168|0|168,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Desógestrel||3376||3376|5666||1 137513|S01XA2011|Oculac|augndr|||10|ml|1|glas|međ rotvörn|S01XA20|01.10.1999||L|0|0|0|0|G|0|ACK|0|0|0|100|DKK|||lyfalmen|||0|10|0||Vistor hf|Alcon Denmark A/S|Gervitár og ađrar óvirkar samsetningar|||||1750||1 137521|S01XA2011|Oculac|augndr|||0,4|ml|20|sk-hyl|án rotvarnar|S01XA20|01.10.1999||L|0|0|0|0|G|0|ACK|0|0|0|100|DKK|||lyfalmen|||0|8|0||Vistor hf|Alcon Denmark A/S|Gervitár og ađrar óvirkar samsetningar|||||2131||1 137809|M05BA0302|Pamidronatdinatrium Hospira|irţ|3|mg/ml|5|ml|5|hgl|lausn|M05BA03|01.05.2005||R|0|0|0|0|0|1|MAY|0|1|0|100|XEU|21746|29174|lyfsjukr|||2|25|0|1,2500|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||21746||21746|29174||2 137820|M05BA0302|Pamidronatdinatrium Hospira|irţ|3|mg/ml|10|ml|1|hgl|lausn |M05BA03|01.05.2005||R|0|0|0|0|0|1|MAY|0|1|0|100|XEU|6322|9124|lyfsjukr|||2|10|0|0,5000|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||6322||6322|9124||2 137831|M05BA0302|Pamidronatdinatrium Hospira|irţ|6|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|0|0|0|0|0|1|MAY|0|1|0|100|XEU|10613|15202|lyfsjukr|||2|10|0|1,0000|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||10613||10613|15202||2 137842|M05BA0302|Pamidronatdinatrium Hospira|irţ|9|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|0|0|0|0|0|1|MAY|0|1|0|100|XEU|6241|9007|lyfsjukr|||2|10|0|1,5000|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||6241||6241|9007||2 137992|J01XA0106|Vancomycin Hospira|irs|500|mg/hgl|1|hgl|1|pakki||J01XA01|01.04.1997||R|0|0|0|0|0|1|HOS|0|0|0|100|XEU|749|1081|lyfsjukr|||2|1|0|0,2500|Icepharma hf|Hospira Enterprises B.V. (I)|Vankómýcín||749||749|1081||2 138073|J01XA0106|Vancomycin Hospira|irs|1|g/hgl|1|hgl|1|pakki||J01XA01|01.04.1997||R|0|0|0|0|0|1|HOS|0|0|0|100|XEU|1520|2194|lyfsjukr|||2|1|0|0,5000|Icepharma hf|Hospira Enterprises B.V. (I)|Vankómýcín||1520||1520|2194||2 138318|L01BA0109|Metoject|stl|50|mg/ml|0,35|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|3360|5644|lyfalmen|||1|0,35|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||3360||3360|5644||2 138594|S01ED0105|Optimol|augndr|5|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED01|01.01.1995||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|1706|3382|lyfalmen|||1|15|0|60,0000|Icepharma hf|Santen Oy|Tímólól||1706||1706|3382||2 138603|N07BB0001|Selincro|filmhtfl|18|mg|28|stk|1|ţpakki||N07BB|01.06.2013||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|17282|24412|lyfalmen|V0078|24412|1|28|0||Lundbeck Export A/S|H. Lundbeck A/S|Nalmefenum||17282||17282|24412||1 139050|S01ED5115|Arzotilol|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíđ 20 mg|S01ED51|01.01.2012||R|0|0|0|0|G|0|APC|0|0|0|100|XEU|4750|7454|lyfalmen|V0373|7454|2|15|0|75,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Tímólól í blöndum||4683||4683|7454||1 139840|R06AA0401|Tavegyl|töflur|1|mg|100|stk|1|ţpakki||R06AA04|01.08.1981||L|1|0|0|0|0|0|NEH|0|0|1|100|IKR|||lyflausa|||0|100|0|50,0000|Artasan ehf|Novartis Healthcare A/S|Klemastín|||||||1 140130|V03AB3501|Bridion|stl|100|mg/ml|2|ml|10|hgl||V03AB35|01.04.2009||R|0|0|0|1|0|1|ORG|0|0|0|100|DKK|137682|174673|lyfsjukr|||1|20|0||Vistor hf|N.V. Organon|Sugammadex||137682||137682|174673||1 140141|V03AB3501|Bridion|stl|100|mg/ml|5|ml|10|hgl||V03AB35|01.04.2009||R|0|0|0|1|0|1|ORG|0|0|0|100|DKK|344094|433720|lyfsjukr|||1|50|0||Vistor hf|N.V. Organon|Sugammadex||344094||344094|433720||1 140327|N04BC0502|Sifrol|töflur|0,088|mg|30|stk|1|ţpakki||N04BC05|01.05.2005||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|1458|3042|lyfalmen|V0266|1372|1|30|0|1,0600|Vistor hf|Boehringer Ingelheim International |Pramipexól||1458||1458|3042||1 140442|N05AF0503|Cisordinol-Acutard|stl|50|mg/ml|1|ml|10|lykjur||N05AF05|01.01.1991||R|0|0|0|0|0|1|LBK|0|0|0|100|DKK|11795|16685|lyfsjukr|||1|10|0|16,6700|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||11795||11795|16685||1 140566|H01BB0201|Syntocinon|stl|10|ae/ml|1|ml|5|lykjur||H01BB02|01.12.1972||R|0|0|0|0|0|1|DES|0|0|0|100|DKK|639|922|lyfsjukr|||1|5|0|3,3333|Swedish Orphan Biovitrum A/S|Defiante Farmaceutica S.A.|Oxýtócín||639||639|922||3 140729|QN01AX0001|Finquel, vet|duft|100|%|1000|g|1|fl|bađlausn handa fiskum|QN01AX|01.01.2012||R|0|0|0|0|0|0|SRR|1|0|0|100|NOK|95132|182840|vetalmen|||0|1000|0||Scan Aqua AS|Scan Aqua AS|Tricaine mesylate||95132||95132|182840||1 140954|N07BA0103|Nicorette|nefúđi|10|mg/ml|10|ml|1|glas||N07BA01|01.04.1994||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|10|0|3,3300|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 141044|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|áfspr||H02AB04|01.04.1994||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|1246|2752|lyfalmen|V0413|2469|1|2|0|4,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||1246||1246|2752||1 141153|R01AB0601|Otrivin Comp|nefúđi|1,1|mg/ml|10|ml|1|glas|0,5+0,6 mg/ml|R01AB06|01.05.2013||L|0|0|0|0|0|0|NAA|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S|Xýlómetazóín og Ípratrópíum|||||||1 141197|N02BE0112|Perfalgan (D.A.C.)|irl|10|mg/ml|100|ml|12|hgl||N02BE01|01.05.2008||R|0|0|0|0|0|1|DAC|0|0|0|100|DKK|4441|6236|lyfsjukr|||3|1200|0|4,0000|D.A.C. ehf|D.A.C. ehf|Paracetamól||4321||4321|6236||2 141388|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BB01|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3867|5581|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||3867||3867|5581||2 141432|N04BC0502|Sifrol|töflur|0,18|mg|30|stk|1|ţpakki||N04BC05|01.05.2005||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|2756|4818|lyfalmen|||1|30|0|2,1600|Vistor hf|Boehringer Ingelheim International |Pramipexól||2756||2756|4818||1 141438|G03GA0502|Gonal-f|stl|300|ae/penna|0,5|ml|1|penni|(22 mcg) áfylltur penni|G03GA05|01.01.2012||R|0|0|0|1|G|0|MSE|0|0|0|100|SEK|19581|27298|lyfalmen|||1|0,5|0|4,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||19581||19581|27298||2 141569|H02AB0908|Plenadren|töflur|5|mg|50|stk|1|glas|međ breyttan losunarhrađa|H02AB09|01.01.2013||R|1|0|0|0|G|0|VIO|0|0|1|100|DKK|52683|68841|lyfalmen|||1|50|0|8,3300|Williams & Halls efh|ViroPharma SPRL|Hýdrókortisón||52683||52683|68841||2 141684|G03AA1205|Yaz|filmhtfl|||84|stk|1|ţpakki|0,02mg/3mg|G03AA12|01.02.2009||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|4200|6793|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer AB|Dróspírenón og ethinylestradíól||||4200|6793||2 141872|R03DC0304|Montelukast Teva|tuggutfl|4|mg|98|stk|1|ţpakki||R03DC03|01.02.2013||R|1|0|0|0|G|0|TEV|0|0|0|100|XEU|13479|12515|lyfalmen|V0492|12515|2|98|0|39,2000|Medical ehf|Teva Pharma B.V.|Montelúkast||8383||8383|12515||2 141945|N04BC0502|Sifrol|töflur|0,18|mg|100|stk|1|ţpakki||N04BC05|01.05.2005||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|8638|12864|lyfalmen|V0267|2465|1|100|0|7,2000|Vistor hf|Boehringer Ingelheim International|Pramipexól||8638||8638|12864||1 142034|M01AE0218|Naproxen Mylan|töflur|500|mg|100|stk|1|glas||M01AE02|01.07.2012||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|2038|3730|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Naproxen||1961||1961|3730||2 142203|QS02QA0301|Otimectin vet.|eyrnahl|1|mg/g|10|g|1|túpa|fyrir ketti|QS02QA03|01.10.2012||L|0|0|0|0|0|0|LEV|1|0|0|100|XEU|1668|2910|vetorma|||0|10|0||Le Vet B.V.|Le Vet B.V.|Ivermectinum||||1668|2910||2 142299|C01BD0101|Cordarone|stl|50|mg/ml|3|ml|10|lykjur||C01BD01|01.04.1987||R|0|0|0|0|0|1|SNO|0|0|0|100|NOK|3333|4810|lyfsjukr|||1|30|0|7,5000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||3333||3333|4810||1 142307|C01BD0101|Cordarone|töflur|200|mg|30|stk|1|ţpakki||C01BD01|01.04.1987||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|1005|2423|lyfalmen|||1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||1005||1005|2423||1 142323|J01XX0501|Haiprex|töflur|1|g|100|stk|1|glas||J01XX05|01.10.1995||R|1|0|0|0|0|0|MEB|0|0|1|100|SEK|2977|5120|lyfalmen|||1|100|0|50,0000|Vistor hf|Meda AB (V)|Metenamín||2977||2977|5120||1 143139|V07AB0013|Sterilt vatten/vann/vand Fresenius Kabi|leysir|||100|ml|50|hgl|fyrir stungulyf|V07AB|01.11.2012||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|5000|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||2 143339|H02AB0403|Solu-Medrol|sts|125|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.07.1974||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|1449|3030|lyfalmen|||1|1|0|6,2500|Icepharma hf|Pfizer ApS|Metýlprednisólón||1449||1449|3030||1 143347|H02AB0403|Solu-Medrol|sts|500|mg|1|stk|1|hgl|+ leysir|H02AB04|01.07.1974||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|2276|3285|lyfsjukr|||1|1|0|25,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||2276||2276|3285||1 143511|J07BC2002|Twinrix Paediatric|bóluefni|||0,5|ml|1|dćla|einnota dćla|J07BC20|01.01.1999||R|0|0|0|0|0|0|GLB|0|0|0|100|GBP|3757|6187|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Lifrarbólgubóluefni (hepatitis)-Blöndur||3757||3757|6187||1 143526|C07AB0309|Atenolol Actavis|filmhtfl|50|mg|100|stk|1|ţpakki||C07AB03|01.10.2012||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|589|1700|lyfalmen|V0542|1699|2|100|0|66,6700|Actavis Group hf|Actavis Group PTC ehf|Atenólól||477||477|1700||1 143586|S01FA0601|Mydriacyl 1 %|augndr|10|mg/ml|15|ml|1|glas||S01FA06|01.09.2003||R|0|0|0|0|0|0|SAL|0|0|0|100|USD|924|2312|lyfalmen|||1|15|0||Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Trópíkamíđ||924||924|2312||1 143602|J01FA1001|Zitromax|töflur|500|mg|2|stk|1|ţpakki||J01FA10|01.11.1998||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|1479|3071|lyfalmen|V0173|2560|1|2|0|3,3333|Icepharma hf|Pfizer ApS|Azitrómýcín||1479||1479|3071||1 143609|A10BD0701|Janumet|filmhtfl|900|mg|56|stk|1|ţpakki|50/850 mg|A10BD07|01.03.2013||R|1|0|0|0|G|0|MLD|0|0|0|100|DKK|6632|10120|lyfalmen|V0387|9034|1|56|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Metforminum og sitagliptinum||6632||6632|10120||1 143610|N02CX0201|Catapresan|töflur|25|mcg|100|stk|1|ţpakki||N02CX02|01.04.1974||R|1|0|0|0|G|0|BOI|0|0|0|100|DKK|1333|2871|lyfalmen|||1|100|0|25,0000|Vistor hf|Boehringer Ingelheim|Klónidín||1333||1333|2871||1 143631|A10BD0701|Janumet|filmhtfl|1050|mg|56|stk|1|ţpakki|50/1000mg|A10BD07|01.03.2009||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|8457|12617|lyfalmen|V0386|9156|1|56|0|28,0000|Vistor hf|M.S.D.|Metforminum og sitagliptinum||8457||8457|12617||1 143727|D07AB0201|Locoid|smyrsli|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|608|1880|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||608||608|1880||1 143800|N05AN0101|Litarex|forđatfl|6|mmól|100|stk|1|glas||N05AN01|01.04.1974||R|1|0|0|0|G|0|AGT|0|0|0|100|DKK|1208|2700|lyfalmen|||2|100|0|25,0000|Actavis Group hf|Actavis Group hf|Litíum||1208||1208|2700||1 143891|J01FA1001|Zitromax|töflur|500|mg|3|stk|1|ţpakki||J01FA10|01.11.1998||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|1732|3417|lyfalmen|V0174|3063|1|3|0|5,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1732||1732|3417||1 144030|N04BA0207|Sinemet depot mite|forđatfl|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.04.1992||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|2096|3915|lyfalmen|||1|100|0|16,6667|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||2096||2096|3915||1 144035|N05AH0501|Sycrest|tungur.t|10|mg|60|stk|1|ţpakki||N05AH05|01.10.2011||R|0|0|0|0|0|0|ORR|0|0|0|100|DKK|23046|31646|lyfalmen|||1|60|0|30,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||23046||23046|31646||1 144139|H01AC0106|Norditropin Simplexx|stl|10|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|0|0|0|1|0|1|NAS|0|1|0|100|DKK|80935|103456|lyfsjukr|||1|1,5|0|22,5000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||80935||80935|103456||1 144436|H01AC0106|Norditropin Simplexx|stl|6,7|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|0|0|0|1|0|1|NAS|0|1|0|100|DKK|60491|77799|lyfsjukr|||1|1,5|0|15,0000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||60491||60491|77799||1 144725|H01AC0106|Norditropin Simplexx|stl|3,3|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|0|0|0|1|0|1|NAS|0|1|0|100|DKK|37586|49053|lyfsjukr|||1|1,5|0|7,5000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||37586||37586|49053||1 144808|D07AB0201|Locoid|lausn|1|mg/ml|30|ml|1|glas||D07AB02|01.10.1986||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|657|1947|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||657||657|1947||1 145077|L04AB0201|Remicade|irs|100|mg|1|hgl|1|pakki||L04AB02|01.06.2011||R|0|1|0|1|0|1|CEO|0|1|0|100|DKK|85587|109294|lyfsjukr|||1|1|0|26,6700|Vistor hf|Centocor B.V.|Infliximab||85587||85587|109294||1 145508|D07AC0104|Diproderm|krem|0,5|mg/g|100|g|1|túpa||D07AC01|01.03.1977||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|2227|4094|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||2227||2227|4094||1 145607|P02CX0101|Vanquin|töflur|50|mg|8|stk|1|ţpakki||P02CX01|01.12.1972||L|1|0|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||0|8|0|1,1400|Vistor hf|Recip AB|Pýrvín|||||||1 145698|N05AH0301|Zyprexa|húđuđtfl|10|mg|28|stk|1|ţpakki||N05AH03|01.03.1998||R|1|0|0|0|0|0|ELD|0|0|0|100|XEU|20646|20282|lyfalmen|||1|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||13991||13991|20282||2 146082|L04AA2601|Benlysta|irs|120|mg/hgl|1|hgl|1|pakki|lausn|L04AA26|01.12.2011||R|0|0|0|1|0|1|GGL|0|1|0|100|GBP|30263|39863|lyfsjukr|||1|1|0|4,8000|GlaxoSmithKline ehf|Glaxo Group Limited|Belimumab||30263||30263|39863||1 146207|L01XX1903|Irinotecan Hospira|irţ|20|mg/ml|2|ml|1|hgl|lausn|L01XX19|01.03.2009||R|0|0|0|1|0|1|HUK|0|0|0|100|XEU|3053|4406|lyfsjukr|||2|2|0||Icepharma hf|Hospira UK Ltd|Írinótekan||3053||3053|4406||2 146218|L01XX1903|Irinotecan Hospira|irţ|20|mg/ml|5|ml|1|hgl|lausn|L01XX19|01.03.2009||R|0|0|0|1|0|1|HUK|0|0|0|100|XEU|6201|8950|lyfsjukr|||2|5|0||Icepharma hf|Hospira UK Ltd|Írinótekan||6201||6201|8950||2 146473|N06BA0901|Strattera|hylki|80|mg|28|stk|1|ţpakki|hart|N06BA09|01.01.2010||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|18072|25404|lyfalmen|||1|28|0|28,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||18072||18072|25404||2 146530|P01AB0102|Flagyl|töflur|400|mg|10|stk|1|ţpakki||P01AB01|01.10.1995||R|1|0|0|0|0|0|SNO|0|0|1|100|NOK|889|2264|lyfalmen|||1|10|0|2,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||889||889|2264||1 147241|L01BC0102|Arabine|stl/irl|100|mg/ml|1|ml|5|hgl||L01BC01|01.03.2009||R|0|0|0|1|0|1|HOP|0|0|0|100|XEU|2531|3653|lyfsjukr|||2|5|0||Icepharma hf|Hospira Nordic AB|Cýtarabín||2531||2531|3653||2 147252|L01BC0102|Arabine|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.03.2009||R|0|0|0|1|0|1|HOP|0|0|0|100|XEU|1568|2263|lyfsjukr|||2|10|0||Icepharma hf|Hospira Nordic AB|Cýtarabín||1568||1568|2263||2 148213|R05CB1301|Pulmozyme|innúđal|1|mg/ml|2,5|ml|30|lykjur||R05CB13|01.01.1997||R|0|0|0|0|0|0|ROA|0|0|1|100|DKK|113455|145109|lyfalmen|||1|75|0|30,0000|Icepharma hf|Roche A.S.|Dornase alfa||113455||113455|145109||2 148263|J01CA0802|Penomax|filmhtfl|200|mg|20|stk|1|ţpakki||J01CA08|01.09.2012||R|0|0|0|0|0|0|OPF|0|0|1|100|DKK|1213|2382|lyfalmen|V0577|2382|2|20|0|6,6667|Portfarma ehf|Orion Corporation|Pívmecillínam||975||975|2382||2 148274|J01CA0802|Penomax|filmhtfl|200|mg|30|stk|1|ţpakki||J01CA08|01.09.2012||R|0|0|0|0|0|0|OPF|0|0|1|100|DKK|1805|3517|lyfalmen|||2|30|0|10,0000|Portfarma ehf|Orion Corporation|Pívmecillínam||1805||1805|3517||2 148285|J01CA0802|Penomax|filmhtfl|200|mg|100|stk|1|glas||J01CA08|01.09.2012||R|0|0|0|0|0|0|OPF|0|0|1|100|DKK|6469|9128|lyfalmen|||2|100|0|33,3300|Portfarma ehf|Orion Corporation|Pívmecillínam||5907||5907|9128||2 148363|D11AH0401|Toctino|hylki|10|mg|30|stk|1|ţpakki|mjúk|D11AH04|01.03.2012||R|0|1|0|1|0|0|SLI|0|0|0|100|DKK|83732|107807|lyfalmen|||1|30|0|15,0000|GlaxoSmithKline ehf|Stiefel Laboratories (Ireland) Ltd.|Alítretínóín||83732||83732|107807||1 148374|D11AH0401|Toctino|hylki|30|mg|30|stk|1|ţpakki|mjúk|D11AH04|01.03.2012||R|0|1|0|1|0|0|SLI|0|0|0|100|DKK|83732|107807|lyfalmen|||1|30|0|45,0000|GlaxoSmithKline ehf|Stiefel Laboratories (Ireland) Ltd.|Alítretínóín||83732||83732|107807||1 148452|N04AA0201|Akineton|töflur|2|mg|100|stk|1|ţpakki||N04AA02|01.11.2005||R|1|0|0|0|G|0|LFS|0|0|0|100|DKK|857|2220|lyfalmen|||1|100|0|20,0000|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|Bíperíden||857||857|2220||1 148642|N01AX6301|Livopan|lyfjagas|||5|l|1|hylki|50% + 50%|N01AX63|01.05.2012||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|62097|79814|lyfsjukr|||1|5|0||Ísaga ehf|AGA AB|Tvínituroxíđ og súrefni||62097||62097|79814||5 148741|L01CA0207|Vincristine Hospira|stl|1|mg/ml|1|ml|5|hgl||L01CA02|01.01.1991||R|0|0|0|1|0|1|HOP|0|0|0|100|XEU|6586|9505|lyfsjukr|||2|5|0||Icepharma hf|Hospira Nordic AB|Vínkristín||6586||6586|9505||2 148752|L01CA0207|Vincristine Hospira|stl|1|mg/ml|2|ml|5|hgl||L01CA02|01.07.2004||R|0|0|0|1|0|1|HOP|0|0|0|100|XEU|13806|19209|lyfsjukr|||2|10|0||Icepharma hf|Hospira Nordic AB|Vínkristín||13806||13806|19209||2 148917|L01BA0301|Tomudex|irs|2|mg/hgl|1|hgl|1|pakki||L01BA03|01.03.1998||R|0|0|0|1|0|1|HOS|0|0|0|100|XEU|29535|38949|lyfsjukr|||1|1|0||Icepharma hf|Hospira Enterprises B.V. (I)|Raltítrexed||29535||29535|38949||2 148999|QN05CM9201|Rompun, vet.|stl|20|mg/ml|25|ml|1|hgl||QN05CM92|01.12.1972||R|0|0|0|0|0|0|BAN|1|0|0|100|DKK|3654|7189|vetalmen|||0|25|0||Icepharma hf|Bayer Animal Health GmbH|||3654||3654|7189||2 149146|N05AG0201|Orap|töflur|1|mg|75|stk|1|ţpakki||N05AG02|01.03.2004||R|0|0|0|0|0|0|PCO|0|0|0|100|SEK|2182|4033|lyfalmen|||0|75|1|18,7500|Distica|Distica - óskráđ lyf|Pímózíđ||2182||2182|4033||1 149375|S01EE0103|Latanoprost Portfarma|augndr|50|mcg/ml|2,5|ml|1|glas||S01EE01|01.03.2010||R|0|0|0|0|G|0|POF|0|0|0|100|DKK|1049|2483|lyfalmen|V0376|1727|2|2,5|0|25,0000|Portfarma ehf|Portfarma|Latanóprost||1049||1049|2483||2 150162|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|60|sk-hyl||S01GX08|01.01.2013||R|0|0|0|0|G|0|LTH|0|0|0|100|SEK|5455|8510|lyfalmen|||1|24|0||Vistor hf|Laboratoires THEA|Ketotifen||5455||5455|8510||1 150521|B03XA0201|Aranesp|stl|40|mcg/spr|0,4|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|52737|68067|lyfsjukr|||1|1,6|0|35,5600|Vistor hf|Amgen|Darbepóetín alfa||||52737|68067||1 150996|J07AH0401|Mencevax ACWY|stl|50|mcg|0,5|ml|1|hgl||J07AH04|01.11.2008||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|3588|5956|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Hreinsađir fjórgildir meningókokka polysakkaríđ mótefnavakar||||3588|5956||1 151191|N05AF0102|Fluanxol Depot|stl|20|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1977||R|0|0|0|0|G|0|LBK|0|0|0|100|DKK|6605|10083|lyfalmen|||1|10|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||6605||6605|10083||1 151217|G01AF0102|Flagyl|sk-stíll|500|mg|10|stk|1|pakki|+ hanskar|G01AF01|01.10.1995||R|0|0|0|0|G|0|SNO|0|0|0|100|NOK|1199|2688|lyfalmen|||1|10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1199||1199|2688||1 151518|N06DX0101|Ebixa|filmhtfl|20|mg|28|stk|1|ţpakki||N06DX01|01.11.2008||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|16040|22854|lyfalmen|V0606|18107|1|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||16040|22854||1 151529|N06DX0101|Ebixa|filmhtfl|20|mg|98|stk|1|ţpakki||N06DX01|01.11.2008||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|49526|61918|lyfalmen|V0607|50080|1|98|0|98,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||47167||47167|61918||1 151627|G03GA0801|Ovitrelle|stl|250|mcg/spr|0,5|ml|1|pakki|lausn,áf.lyfjap.+ spr.nál|G03GA08|01.04.2012||R|0|0|0|1|G|0|MSE|0|0|0|100|SEK|5228|8200|lyfalmen|||1|0,5|0|1,0000|Icepharma hf|Merck Serono Europe Ltd|Chóríógónadótrópín alfa||5228||5228|8200||2 151640|G04CA0204|Tamsulogen|hylki|0,4|mg|90|stk|1|ţpakki|međ br. losunarhrađa|G04CA02|01.05.2006||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|5556|3974|lyfalmen|V0148|2282|2|90|0|90,0000|Icepharma hf|Mylan AB|Tamsúlósín||2139||2139|3974||2 151928|N06AA1201|Sinquan|hylki|25|mg|100|stk|1|ţpakki||N06AA12|01.12.1972||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|1584|3215|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Doxepín||1584||1584|3215||1 151975|A02BC0110|Omeprazol ratiopharm|sţ-hylki|20|mg|100|stk|1|glas|hart|A02BC01|01.02.2012||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|4359|3711|lyfalmen|V0006|3711|2|100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól||1947||1947|3711||2 152223|M03BX0103|Lioresal|stl|50|mcg/ml|1|ml|5|lykjur|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|0|1|0|1|NOH|0|0|0|100|DKK|2020|2915|lyfsjukr|||1|5|0|0,4500|Vistor hf|Novartis Healthcare A/S-|Baklófen||2020||2020|2915||1 152318|D01BA0204|Terbinafine (D.A.C.)|töflur|250|mg|28|stk|1|ţpakki||D01BA02|01.12.2010||R|1|0|0|0|0|0|DAC|0|0|0|100|XEU|2606|3088|lyfalmen|V0123|3062|3|28|0|28,0000|D.A.C. ehf|D.A.C. ehf|Terbínafín||1491||1491|3088||2 152348|M02AA0701|Felden gel|hlaup|5|mg/g|25|g|1|túpa||M02AA07|01.04.1996||L|0|0|0|0|0|0|PER|0|0|1|100|IKR|||lyflausa|||0|25|0||Icepharma hf|Pfizer ApS|Píroxíkam|||||||1 152397|R03BA0202|Pulmicort Turbuhaler|innönddu|100|mcg/sk|200|skammtar|1|stauk||R03BA02|01.04.1991||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|3369|5657|lyfalmen|||1|200|0|25,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||3369||3369|5657||1 152413|R03BA0202|Pulmicort Turbuhaler|innönddu|200|mcg/sk|200|skammtar|1|stauk||R03BA02|01.10.1989||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|5598|8706|lyfalmen|||1|200|0|50,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||5598||5598|8706||1 152421|R03BA0202|Pulmicort Turbuhaler|innönddu|400|mcg/sk|200|skammtar|1|stauk||R03BA02|01.10.1989||R|0|0|0|0|G|0|ASZ|0|0|0|100|SEK|10205|15008|lyfalmen|||1|200|0|100,0000|Vistor hf|AstraZeneca UK Ltd|Búdesóníđ||10205||10205|15008||1 152635|B01AC0601|Hjartamagnyl|sţ-tfl|75|mg|100|stk|1|glas||B01AC06|01.06.2012||L|1|0|0|0|0|0|AGP|0|0|0|100|IKR|||lyflausa|||0|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Asetýlsalicýlsýra|||||||1 152663|N04BC0504|Oprymea (Lyfis)|töflur|0,7|mg|100|stk|1|ţpakki||N04BC05|01.07.2010||R|0|0|0|0|G|0|LYF|0|0|0|100|XEU|18971|18997|lyfalmen|V0269|18997|3|100|0|28,0000|LYFIS ehf|LYFIS ehf|Pramipexól||12967||12967|18997||2 152991|J02AC0201|Sporanox|hylki|100|mg|4|stk|1|ţpakki|hart|J02AC02|01.01.1995||R|1|0|0|0|0|0|JAS|0|0|1|100|SEK|1294|2818|lyfalmen|||1|4|0|2,0000|Vistor hf|Janssen-Cilag AB|Ítracónazól||1294||1294|2818||1 153080|R06AE0704|Histasin|töflur|10|mg|10|stk|1|ţpakki||R06AE07|01.01.1998||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Actavis Group hf|Actavis hf|Cetirizín|||||||1 153122|N01BB5203|Xylocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|(10mg+5míkróg)/ml|N01BB52|01.10.1995||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|1854|3584|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín í blöndum||1854||1854|3584||1 153197|R06AE0704|Histasin|töflur|10|mg|30|stk|1|ţpakki||R06AE07|01.01.1998||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Actavis Group hf|Actavis hf|Cetirizín|||||||1 153222|B03XA0201|Aranesp|stl|30|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|40052|52148|lyfsjukr|||1|1,2|0|26,6700|Vistor hf|Amgen|Darbepóetín alfa||||40052|52148||1 153254|N01BB0203|Xylocain|stl|20|mg/ml|20|ml|5|hgl|međ rotvörn|N01BB02|01.03.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2341|4250|lyfalmen|V0561|3844|1|100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||2341||2341|4250||1 153270|N01BB0203|Xylocain|stl|10|mg/ml|20|ml|5|hgl|međ rotvörn|N01BB02|01.03.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|1638|3289|lyfalmen|V0560|3003|1|100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||1638||1638|3289||1 153288|R06AE0704|Histasin|töflur|10|mg|100|stk|1|ţpakki||R06AE07|01.01.1998||R|1|0|0|0|G|0|ACA|0|0|1|100|XEU|2308|3888|lyfalmen|V0575|3804|2|100|0|100,0000|Actavis Group hf|Actavis hf|Cetirizín||2076||2076|3888||1 153379|J02AA0104|AmBisome|irs|50|mg/hgl|10|hgl|1|pakki||J02AA01|01.07.2001||R|0|0|0|0|0|1|GIS|0|0|0|100|DKK|230469|291121|lyfsjukr|||1|10|0|14,2857|Gilead Sience Sweden AB|Gilead Science International ltd.|Amfóterícín||230469||230469|291121||3 153417|C07AA0512|Pranolol|töflur|40|mg|100|stk|1|glas||C07AA05|01.10.2011||R|1|0|0|0|G|0|AGT|0|0|0|100|XEU|550|1800|lyfalmen|||2|100|0|25,0000|Actavis Group hf|Actavis Group hf|Própranólól||||550|1800||1 153507|L02BG0602|Exemestan Actavis|filmhtfl|25|mg|100|stk|1|ţpakki||L02BG06|01.08.2011||R|0|0|0|0|G|0|APC|0|0|0|100|XEU|32746|43820|lyfalmen|V0452|43820|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Exemestan||32746||32746|43820||1 153536|J02AC0201|Sporanox|hylki|100|mg|15|stk|1|ţpakki|hart|J02AC02|01.04.1995||R|1|0|0|0|0|0|JAS|0|0|1|100|SEK|4470|7163|lyfalmen|||1|15|0|7,5000|Vistor hf|Janssen-Cilag AB|Ítracónazól||4470||4470|7163||1 153553|N05BA0205|Risolid|filmhtfl|10|mg|24|stk|1|glas||N05BA02|01.07.2012||R|1|0|0|0|0|0|AGT|0|0|1|100|XEU|323|1490|lyfalmen|||2|24|0|8,0000|Actavis Group hf|Actavis Group hf|Klórdíazepoxíđ||323||323|1490||1 153564|N05BA0205|Risolid|filmhtfl|25|mg|24|stk|1|glas||N05BA02|01.07.2012||R|1|0|0|0|0|0|AGT|0|0|1|100|XEU|536|1781|lyfalmen|||2|24|0|20,0000|Actavis Group hf|Actavis Group hf|Klórdíazepoxíđ||536||536|1781||1 154480|R06AX2201|Kestine|filmhtfl|20|mg|100|stk|1|ţpakki||R06AX22|01.06.2012||R|1|0|0|0|G|0|APS|0|0|1|100|DKK|9489|14028|lyfalmen|||1|100|0|200,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||9489||9489|14028||1 154558|N03AX2201|Fycompa|filmhtfl|12|mg|28|stk|1|ţpakki||N03AX22|01.07.2013||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|25764|35057|lyfalmen|||1|28|0||Vistor hf|Eisai Europe Ltd.|Perampanel||25764||25764|35057||1 154591|M01AB5501|Arthrotec|töflur|50,2|mg|20|stk|1|pakki|ţp (0,2+50 mg)|M01AB55|01.04.1993||R|1|0|0|0|G|0|PER|0|0|1|100|DKK|1064|2503|lyfalmen|||1|20|0|10,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||1064||1064|2503||1 154618|B05BA1021|SmofKabiven|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|29371|38743|lyfsjukr|||1|3944|0||Icepharma hf|Fresenius Kabi|Blöndur||29371||29371|38743||2 154629|B05BA1021|SmofKabiven|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|38480|50175|lyfsjukr|||1|5908|0||Icepharma hf|Fresenius Kabi|Blöndur||38480||38480|50175||2 154640|B05BA1021|SmofKabiven|irl|2200|kcal|1970|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|42279|54943|lyfsjukr|||1|7880|0||Icepharma hf|Fresenius Kabi|Blöndur||42279||42279|54943||2 154662|B05BA1022|SmofKabiven Elektrolytfri|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|31292|41154|lyfsjukr|||1|3944|0||Icepharma hf|Fresenius Kabi|Blöndur||31292||31292|41154||2 154673|B05BA1022|SmofKabiven Elektrolytfri|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|38493|50191|lyfsjukr|||1|5908|0||Icepharma hf|Fresenius Kabi|Blöndur||38493||38493|50191||2 154706|B05BA1023|SmofKabiven Perifer|irl|800|kcal|1206|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|27576|36490|lyfsjukr|||1|4824|0||Icepharma hf|Fresenius Kabi|Blöndur||27576||27576|36490||2 154708|M01AB5501|Arthrotec|töflur|50,2|mg|100|stk|1|pakki|ţp (0,2+50 mg)|M01AB55|01.04.1993||R|1|0|0|0|G|0|PER|0|0|1|100|DKK|3320|5590|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||3320||3320|5590||1 154717|B05BA1023|SmofKabiven Perifer|irl|1300|kcal|1904|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|35957|47009|lyfsjukr|||1|7616|0||Icepharma hf|Fresenius Kabi|Blöndur||35957||35957|47009||2 154728|N06AX1608|Venlafaxin Actavis|forđahlk|75|mg|28|stk|1|ţpakki|hart|N06AX16|01.08.2009||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|1537|3150|lyfalmen|||2|28|0|21,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1537||1537|3150||1 154739|N06AX1608|Venlafaxin Actavis|forđahlk|75|mg|98|stk|1|ţpakki|hart|N06AX16|01.08.2009||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|4707|6067|lyfalmen|||2|98|0|73,5000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||3290||3669|6067|30.6.2013|1 154761|N06AX1608|Venlafaxin Actavis|forđahlk|150|mg|98|stk|1|ţpakki|hart|N06AX16|01.08.2009||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|7012|5706|lyfalmen|V0335|5527|2|98|0|147,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||3405||3405|5706||1 154952|L04AX0501|Esbriet|hylki|267|mg|252|stk|1|ţpakki|hart|L04AX05|01.07.2012||R|1|1|0|1|0|0|INT|0|0|0|100|DKK|453286|571597|lyfalmen|||1|252|0|28,0300|Vistor hf|InterMune Europe Ltd.|Pírfenidon||453286||453286|571597||1 155085|L01AA0201|Leukeran|töflur|2|mg|25|stk|1|glas||L01AA02|01.06.2001||R|0|0|0|0|G|0|ATL|0|0|0|100|XEU|1587|3219|lyfalmen|V0594|3219|1|25|0||Aspen Pharma Trading Ltd.|Aspen Pharma Trading Ltd.|Chlorambucíl||1587||1587|3219||1 155219|N03AX1106|Topiramate Portfarma|filmhtfl|25|mg|60|stk|1|ţpakki||N03AX11|01.04.2010||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|2233|4092|lyfalmen|V0247|4092|2|60|0|5,0000|Portfarma ehf|Portfarma|Tópíramat||2225||2225|4092||2 155230|N03AX1106|Topiramate Portfarma|filmhtfl|50|mg|60|stk|1|ţpakki||N03AX11|01.04.2010||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|3764|6193|lyfalmen|V0248|6193|2|60|0|10,0000|Portfarma ehf|Portfarma|Tópíramat||3761||3761|6193||2 155241|N03AX1106|Topiramate Portfarma|filmhtfl|100|mg|60|stk|1|ţpakki||N03AX11|01.04.2010||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|6767|10302|lyfalmen|V0249|10302|2|60|0|20,0000|Portfarma ehf|Portfarma|Tópíramat||6765||6765|10302||2 155390|N05AF0301|Truxal|töflur|50|mg|100|stk|1|glas||N05AF03|01.12.1972||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|1533|3145|lyfalmen|||1|100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||1533||1533|3145||1 155432|N05AF0301|Truxal|töflur|15|mg|100|stk|1|glas||N05AF03|01.12.1972||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|656|1945|lyfalmen|||1|100|0|5,0000|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||656||656|1945||1 155478|G03AC0902|Gestrina|filmhtfl|75|mcg|84|stk|1|ţpakki|3x28 stk|G03AC09|01.01.2013||R|0|0|0|0|0|0|APC|0|0|0|100|XEU|1689|3358|lyfalmen|V0590|3358|2|84|0|84,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Desógestrel||1689||1689|3358||1 155648|J02AC0201|Sporanox|hylki|100|mg|28|stk|1|ţpakki|hart|J02AC02|01.04.1995||R|1|0|0|0|0|0|JAS|0|0|1|100|SEK|6979|10595|lyfalmen|||1|28|0|14,0000|Vistor hf|Janssen-Cilag AB|Ítracónazól||6979||6979|10595||1 156506|A10AB0405|Humalog KwikPen|stl|100|ae/ml|3|ml|5|rörlyk||A10AB04|01.05.2011||R|0|0|0|0|G|0|ELD|0|0|0|100|XEU|5708|8856|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||5708||5708|8856||2 156517|A10AD0403|Humalog Mix25 KwikPen|stl|100|ae/ml|3|ml|5|rörlyk||A10AD04|01.05.2011||R|0|0|0|0|G|0|ELD|0|0|0|100|XEU|5963|9205|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insulín lispro||5963||5963|9205||2 156528|J01XE0101|Furadantin|töflur|50|mg|15|stk|1|ţpakki||J01XE01|01.08.2010||R|1|0|0|0|0|0|REP|0|0|1|100|SEK|449|1662|lyfalmen|||2|15|0|3,7500|Vistor hf|Recip AB|Nítrófúrantóín||449||449|1662||1 156563|L01XA0210|Carboplatin Hospira|irţ|10|mg/ml|15|ml|1|hgl||L01XA02|01.04.1992||R|0|0|0|1|0|1|HOP|0|0|0|100|XEU|2372|3423|lyfsjukr|||2|15|0||Icepharma hf|Hospira Nordic AB|Karbóplatín||2372||2372|3423||2 156574|L01XA0210|Carboplatin Hospira|irţ|10|mg/ml|5|ml|1|hgl||L01XA02|01.04.1992||R|0|0|0|1|0|1|HOP|0|0|0|100|XEU|1391|2008|lyfsjukr|||2|5|0||Icepharma hf|Hospira Nordic AB|Karbóplatín||1391||1391|2008||2 156585|L01XA0210|Carboplatin Hospira|irţ|10|mg/ml|45|ml|1|hgl||L01XA02|01.04.1992||R|0|0|0|1|0|1|HOP|0|0|0|100|XEU|6498|9378|lyfsjukr|||2|45|0||Icepharma hf|Hospira Nordic AB|Karbóplatín||6498||6498|9378||2 156596|A08AB0101|Xenical|hylki|120|mg|84|stk|1|ţpakki||A08AB01|01.07.1999||R|1|0|0|0|0|0|ROC|0|0|0|100|DKK|9536|14093|lyfalmen|||1|84|0|28,0000|Icepharma hf|Roche|Orlístat||9536||9536|14093||2 156597|L01XA0210|Carboplatin Hospira|irţ|10|mg/ml|60|ml|1|hgl||L01XA02|01.04.2007||R|0|0|0|1|0|1|HOP|0|0|0|100|XEU|8704|12562|lyfsjukr|||2|60|0||Icepharma hf|Hospira Nordic AB|Karbóplatín||8704||8704|12562||2 156661|P02CA0101|Vermox|töflur|100|mg|6|stk|1|ţpakki||P02CA01|01.12.1982||R|1|0|0|0|0|0|JAS|0|0|0|100|SEK|902|2282|lyfalmen|||1|6|0|3,0000|Vistor hf|Janssen-Cilag AB|Mebendazól||902||902|2282||1 156723|QN01AX0303|Ketador vet.|stl|100|mg/ml|50|ml|1|hgl|lausn|QN01AX03|01.04.2013||R|0|0|1|0|0|0|RPG|1|0|0|100|XEU|11862|22949|vetalmen|||0|50|0||Icepharma hf|Richter Pharma AG|||11862||11862|22949||2 156861|QJ01MA9002|Enrotron Flavour|töflur|50|mg|10|stk|1|ţpakki|handa hundum|QJ01MA90|01.09.2012||R|0|0|0|0|0|0|ANI|0|0|0|100|IKR|1898|3775|vetalmen|||0|10|0||Dýraheilsa ehf|aniMedica GmbH|Enrofloxacinum||1898||1898|3775||2 157047|N07BA0146|Nicotinell Tropical Fruit|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.11.2011||L|0|0|0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S|Nikótín|||||||1 157741|N05AH0311|Olanzapine Ranbaxy|töflur|5|mg|28|stk|1|ţpakki||N05AH03|01.12.2011||R|1|0|0|0|G|0|RAN|0|0|0|100|XEU|2740|2144|lyfalmen|V0279|1969|2|28|0|14,0000|Artasan ehf|Ranbaxy (UK) Ltd|Olanzapín||801||801|2144||1 157863|N03AF0104|Tegretol|töflur|200|mg|100|stk|1|ţpakki||N03AF01|01.01.2010||R|1|0|0|0|G|0|NOH|0|0|0|100|DKK|1536|3149|lyfalmen|V0239|3149|1|100|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1536||1536|3149||1 157869|D11AX1601|Vaniqa|krem|11,5|%|30|g|1|túpa||D11AX16|01.01.2013||R|0|0|0|0|0|0|ALM|0|0|0|100|DKK|7109|10773|lyfalmen|||1|30|0||Vistor hf|Almirall S.A.|Eflórníthin||7109||7109|10773||1 158163|N05AH0405|Seroquel Prolong|forđatfl|50|mg|10|stk|1|ţpakki||N05AH04|01.10.2011||R|1|0|0|0|0|0|ASA|0|0|0|100|SEK|1634|3283|lyfalmen|||1|10|0|1,2500|Vistor hf|Astra Zeneca A/S|Quetíapín||||1634|3283||1 158185|N05AH0405|Seroquel Prolong|forđatfl|150|mg|100|stk|1|ţpakki||N05AH04|01.10.2011||R|1|0|0|0|0|0|ASA|0|0|0|100|SEK|30113|40515|lyfalmen|||1|100|0|37,5000|Vistor hf|Astra Zeneca A/S|Quetíapín||||30113|40515||1 158287|N03AF0104|Tegretol|töflur|200|mg|50|stk|1|ţpakki||N03AF01|01.12.1972||R|1|0|0|0|G|0|NOH|0|0|0|100|DKK|958|2358|lyfalmen|V0239|1575|1|50|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||958||958|2358||1 158431|B02BD0801|NovoSeven|sts|1|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|0|1|0|1|0|1|NAS|0|0|0|100|DKK|104233|132695|lyfsjukr|||1|1|0|0,0200|Vistor hf|Novo-Nordisk A/S|Eptacog alfa (virkjađ)||||104233|132695||1 158442|B02BD0801|NovoSeven|sts|2|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|0|1|0|1|0|1|NAS|0|0|0|100|DKK|208467|263509|lyfsjukr|||1|1|0|0,0400|Vistor hf|Novo-Nordisk A/S|Eptacog alfa (virkjađ)||||208467|263509||1 158453|B02BD0801|NovoSeven|sts|5|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|0|1|0|1|0|1|NAS|0|0|0|100|DKK|591102|743716|lyfsjukr|||1|1|0|0,1000|Vistor hf|Novo-Nordisk A/S|Eptacog alfa (virkjađ)||||591102|743716||1 158608|J02AX0501|Mycamine|irs|50|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|0|1|0|1|0|1|APG|0|0|0|100|XEU|53334|68817|lyfsjukr|||1|1|0|0,5000|Vistor hf|Astellas Pharma GmbH|Micafungin||||53334|68817||1 158619|J02AX0501|Mycamine|irs|100|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|0|1|0|1|0|1|APG|0|0|0|100|XEU|76083|97367|lyfsjukr|||1|1|0|1,0000|Vistor hf|Astellas Pharma GmbH|Micafungin||76083||76083|97367||1 158683|H01BB0201|Syntocinon|nefúđi|6,7|mcg/sk|5|ml|1|stauk||H01BB02|01.07.1988||R|0|0|0|0|G|0|DES|0|0|0|100|DKK|826|2178|lyfalmen|||1|5|0|13,3333|Swedish Orphan Biovitrum A/S|Defiante Farmaceutica S.A.|Oxýtócín||826||826|2178||3 158725|M01AB0516|Diklofenak Mylan|sţ-tfl|50|mg|100|stk|1|ţpakki||M01AB05|01.12.2008||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|1068|2041|lyfalmen|V0469|2014|2|100|0|50,0000|Icepharma hf|Mylan AB|Díklófenak||726||726|2041||2 159107|N02AB0303|Fentanyl Actavis|forđapl|25|mcg/klst|5|stk|1|ţpakki||N02AB03|01.12.2008||R|0|0|1|0|G|0|AGP|0|0|0|100|XEU|2128|3506|lyfalmen|V0219|3505|2|5|0|7,5000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||1797||1797|3506||1 159118|N02AB0303|Fentanyl Actavis|forđapl|50|mcg/klst|5|stk|1|ţpakki||N02AB03|01.12.2008||R|0|0|1|0|G|0|AGP|0|0|0|100|XEU|3649|5979|lyfalmen|V0220|5978|2|5|0|15,0000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||3605||3605|5979||1 159130|N02AB0303|Fentanyl Actavis|forđapl|75|mcg/klst|5|stk|1|ţpakki||N02AB03|01.12.2008||R|0|0|1|0|G|0|AGP|0|0|0|100|XEU|5238|7715|lyfalmen|V0221|7714|2|5|0|22,5000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||4874||4874|7715||1 159141|N02AB0303|Fentanyl Actavis|forđapl|100|mcg/klst|5|stk|1|ţpakki||N02AB03|01.12.2008||R|0|0|1|0|G|0|AGP|0|0|0|100|XEU|5855|8388|lyfalmen|V0223|8387|2|5|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||5366||5366|8388||1 159295|C09DA0310|Valsartan/Hydrochlorothiazide ratiopharm|filmhtfl|172,5|mg|98|stk|1|ţpakki|160/12,5 mg|C09DA03|01.11.2012||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|3218|2867|lyfalmen|V0581|2867|2|98|0|98,0000|Medical ehf|ratiopharm GmbH|Valsartan og ţvagrćsilyf||1330||1330|2867||2 159517|N06AB0401|Cipramil|töflur|20|mg|56|stk|1|ţpakki||N06AB04|01.04.1993||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|5226|4769|lyfalmen|V0318|1234|1|56|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||2720||2720|4769||1 159541|N06AB0401|Cipramil|töflur|40|mg|56|stk|1|ţpakki||N06AB04|01.04.1993||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|13402|12509|lyfalmen|V0320|2345|1|56|0|112,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||8378||8378|12509||1 159558|N06AB0401|Cipramil|töflur|10|mg|28|stk|1|ţpakki||N06AB04|01.04.1993||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|1895|2728|lyfalmen|V0062|1234|1|28|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||1228||1228|2728||1 159632|N06AB0401|Cipramil|töflur|20|mg|28|stk|1|ţpakki||N06AB04|01.04.1993||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|3281|3791|lyfalmen|V0067|1234|1|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||2005||2005|3791||1 159640|N06AB0401|Cipramil|töflur|40|mg|28|stk|1|ţpakki||N06AB04|01.04.1993||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|6760|5016|lyfalmen|V0071|2233|1|28|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||2901||2901|5016||1 159672|R05CB0105|Acetylcystein Mylan|freyđit|200|mg|25|stk|1|pakki||R05CB01|01.03.2010||R|0|0|0|0|G|0|MYL|0|0|1|100|SEK|547|1796|lyfalmen|||2|25|0|10,0000|Icepharma hf|Mylan AB|Acetýlcýstein||547||547|1796||2 159683|R05CB0105|Acetylcystein Mylan|freyđit|200|mg|100|stk|1|pakki||R05CB01|01.03.2010||R|0|0|0|0|G|0|MYL|0|0|1|100|SEK|1660|3319|lyfalmen|||2|100|0|40,0000|Icepharma hf|Mylan AB|Acetýlcýstein||1660||1660|3319||2 159772|B01AD0701|Rapilysin|sts|10|ae/hgl|2|hgl|1|pakki|+ leysir|B01AD07|01.02.2002||R|0|0|0|0|0|1|APC|0|0|0|100|DKK|101604|129396|lyfsjukr|||1|2|0|1,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Reteplasi||101604||101604|129396||1 159973|QM01AG9002|Flunixin|stl|50|mg/ml|50|ml|1|hgl|nautg,hesta og svín|QM01AG90|01.11.2011||R|0|0|0|0|0|0|NOB|1|0|0|100|XEU|4244|8322|vetalmen|||0|50|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|||4244||4244|8322||2 160279|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|56|stk|1|ţpakki||A02BC04|01.05.2011||R|1|0|0|0|G|0|APC|0|0|0|100|IKR|2078|3008|lyfalmen|V0010|2977|2|56|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||1433||1433|3008||1 160325|N05BA0105|Stesolid|stl|5|mg/ml|2|ml|25|lykjur||N05BA01|01.04.1974||R|0|0|0|0|0|1|AGT|0|0|0|100|DKK|2291|3306|lyfsjukr|||2|50|0|25,0000|Actavis Group hf|Actavis Group hf|Díazepam||2291||2291|3306||1 160408|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|36983|48296|lyfsjukr|||1|100|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||36983||36983|48296||2 160457|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|53849|69463|lyfsjukr|||1|150|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||53849||53849|69463||2 160523|N05AB0401|Stemetil|töflur|5|mg|100|stk|1|ţpakki||N05AB04|01.06.1981||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|1015|2436|lyfalmen|||1|100|0|5,0000|Vistor hf|Sanofi-aventis Norge AS|Próklórperazín||1015||1015|2436||1 160531|C10AC0101|Questran|skammtar|4|g|50|skammtar|1|pakki||C10AC01|01.04.1988||R|0|0|0|0|0|0|BRS|0|0|0|100|DKK|2386|4312|lyfalmen|||1|50|0|14,2857|Vistor hf|Bristol-Myers Squibb|Kólestýramín||2386||2386|4312||1 160622|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|71838|92039|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||71838||71838|92039||2 160852|R01AX0301|Atrovent|nefúđi|21|mcg/sk|15|ml|1|glas|180 sk, lausn|R01AX03|01.09.2009||R|0|0|0|0|G|0|BOI|0|0|1|100|DKK|1213|2707|lyfalmen|||1|15|0|15,7500|Vistor hf|Boehringer Ingelheim|Ípratrópínbrómíđ||1213||1213|2707||1 161075|H02AB0403|Solu-Medrol|sts|40|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.08.1980||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|599|1867|lyfalmen|||1|1|0|2,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||599||599|1867||1 161091|H02AB0901|Solu-Cortef|sts|250|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|930|1342|lyfsjukr|||1|1|0|8,3333|Icepharma hf|Pfizer ApS|Hýdrókortisón||930||930|1342||1 161117|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|5|hgl|Act-O-Vial |H02AB09|01.08.1998||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|844|1218|lyfsjukr|||1|5|0|16,6667|Icepharma hf|Pfizer ApS|Hýdrókortisón||844||844|1218||1 161125|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|612|1885|lyfalmen|||1|1|0|3,3333|Icepharma hf|Pfizer ApS|Hýdrókortisón||612||612|1885||1 161133|G03CA0306|Evorel|forđapl|75|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|5198|8159|lyfalmen|V0131|8159|1|26|0|136,5000|Vistor hf|Janssen-Cilag AB|Estradíól||5198||5198|8159||1 161547|L02BG0601|Aromasin|töflur|25|mg|100|stk|1|ţpakki||L02BG06|01.06.2001||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|60847|79086|lyfalmen|V0452|43820|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Exemestan||60847||60847|79086||1 161870|N07BC5101|Suboxone|tungur.t|10|mg|28|stk|1|ţpakki|8+2 mg|N07BC51|01.08.2011||R|0|0|1|1|0|1|RBP|0|0|0|100|DKK|14339|19766|lyfsjukr|||1|28|0|28,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín í blöndum||14250||14250|19766||1 162080|H01AC0111|Omnitrope|stl|6,7|mg/ml|1,5|ml|5|rörlyk|lausn|H01AC01|01.04.2012||R|0|0|0|1|0|1|SDG|0|1|0|100|DKK|160347|203118|lyfsjukr|||1|7,5|0|75,0000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||160347||160347|203118||1 162115|N06AA0906|Saroten|töflur|25|mg|100|stk|1|glas||N06AA09|01.12.2011||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|786|2123|lyfalmen|V0512|2055|1|100|0|33,3300|Lundbeck Export A/S|H. Lundbeck A/S|Amitriptýlín||786||786|2123||1 162149|N06AA0906|Saroten|töflur|10|mg|100|stk|1|glas||N06AA09|01.12.2011||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|437|1646|lyfalmen|V0510|1620|1|100|0|13,3300|Lundbeck Export A/S|H. Lundbeck A/S|Amitriptýlín||437||437|1646||1 162261|H01CB0501|Signifor|stl|0,6|mg|1|ml|60|lykjur||H01CB05|01.11.2012||R|0|0|0|0|0|0|NOE|0|0|0|100|DKK|550788|693962|lyfalmen|||1|60|0||Vistor hf|Novartis Europharm Ltd|PAsireótiđ disapartate||550788||550788|693962||1 162354|A07EC0101|Salazopyrin|töflur|500|mg|100|stk|1|glas||A07EC01|01.12.1972||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|1937|3698|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Súlfasalazín||1937||1937|3698||1 162778|QN05CM9002|Detonervin, vet.|stl|10|mg/ml|5|ml|1|hgl|f.hesta og nautgr.|QN05CM90|01.12.2011||R|0|0|0|0|0|0|LEV|1|0|0|100|XEU|5495|10724|vetalmen|||0|5|0||Le Vet B.V.|Le Vet B.V.|||||5495|10724||2 162841|A10BA0203|Metformin Bluefish|filmhtfl|500|mg|100|stk|1|ţpakki||A10BA02|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|446|1576|lyfalmen|V0500|1576|2|100|0|25,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Metformín||386||386|1576||2 162852|A10BA0203|Metformin Bluefish|filmhtfl|850|mg|100|stk|1|ţpakki||A10BA02|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|723|2037|lyfalmen|||2|100|0|42,5000|LYFIS ehf|Bluefish Pharmaceuticals AB|Metformín||723||723|2037||2 162863|A10BA0203|Metformin Bluefish|filmhtfl|1000|mg|60|stk|1|ţpakki||A10BA02|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|891|2267|lyfalmen|V0502|2267|2|60|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Metformín||891||891|2267||2 162874|C10AA0106|Simvastatin Bluefish|filmhtfl|10|mg|100|stk|1|ţpakki||C10AA01|01.08.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|743|1528|lyfalmen|V0108|1528|2|100|0|33,3400|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||351||351|1528||2 162885|C10AA0106|Simvastatin Bluefish|filmhtfl|20|mg|100|stk|1|ţpakki||C10AA01|01.08.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|836|1662|lyfalmen|V0109|1662|2|100|0|66,6700|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||449||449|1662||2 162896|C10AA0106|Simvastatin Bluefish|filmhtfl|40|mg|100|stk|1|ţpakki||C10AA01|01.08.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|1347|2011|lyfalmen|V0110|2011|2|100|0|133,3333|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||704||704|2011||2 162903|S01ED5115|Arzotilol|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamíđ 20 mg|S01ED51|01.01.2012||R|0|0|0|0|G|0|APC|0|0|0|100|XEU|1657|3245|lyfalmen|V0373|2485|2|5|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Tímólól í blöndum||1606||1606|3245||1 162929|G04CA0205|Ranomax|forđahlk|0,4|mg|100|stk|1|ţpakki||G04CA02|01.04.2009||R|1|0|0|0|G|0|RAN|0|0|0|100|XEU|4802|2535|lyfalmen|V0148|2535|2|100|0|100,0000|Artasan ehf|Ranbaxy (UK) Ltd|Tamsúlósín||1087||1087|2535||1 162933|R03BA0501|Flixotide|innúđal|50|mcg/sk|120|skammtar|1|stauk||R03BA05|01.07.1994||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|1458|3042|lyfalmen|||1|120|0|20,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||1458||1458|3042||1 163089|N06BA0401|Ritalin|töflur|10|mg|30|stk|1|ţpakki||N06BA04|01.12.1972||R|1|0|1|0|0|0|NOH|0|0|0|100|DKK|1156|2629|lyfalmen|||1|30|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||1156||1156|2629||1 163246|P01AB0102|Flagyl|töflur|400|mg|30|stk|1|ţpakki||P01AB01|01.10.1995||R|1|0|0|0|0|0|SNO|0|0|1|100|NOK|1710|3387|lyfalmen|||1|30|0|6,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1710||1710|3387||1 163274|C03AA0304|Dehydratin Neo|töflur|25|mg|20|stk|1|pakki||C03AA03|01.02.2009||R|1|0|0|0|G|0|AEA|0|0|0|100|XEU|205|1328|lyfalmen|||2|20|0|20,0000|Actavis hf|Actavis EAD|hýdróklórtíazíđ||||205|1328||1 163493|R03BA0501|Flixotide|innúđal|125|mcg/sk|120|skammtar|1|stauk||R03BA05|01.07.1994||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|2544|4528|lyfalmen|||1|120|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2544||2544|4528||1 163494|L01XE0501|Nexavar|filmhtfl|200|mg|112|stk|1|ţpakki||L01XE05|01.06.2013||R|0|0|0|1|0|1|BGB|0|1|0|100|DKK|607104|763798|lyfsjukr|||1|112|0||Icepharma hf|Bayer Pharma AG|Sorafeníb||607104||607104|763798||2 163667|M01AE0113|Ibuxin|filmhtfl|800|mg|30|stk|1|ţpakki||M01AE01|01.03.2013||R|1|0|0|0|G|0|ROY|0|0|1|100|XEU|707|1888|lyfalmen|||2|30|0|20,0000|Medical ehf|ratiopharm Oy|Íbúprófen||614||614|1888||2 163675|M01AE0113|Ibuxin|filmhtfl|800|mg|100|stk|1|ţpakki||M01AE01|01.03.2013||R|1|0|0|0|G|0|ROY|0|0|1|100|XEU|1696|3045|lyfalmen|||2|100|0|66,6700|Medical ehf|ratiopharm Oy|Íbúprófen||1460||1460|3045||2 163709|V03AE0101|Resonium|duft|||454|g|1|stauk||V03AE01|01.01.2000||R|0|0|0|0|0|0|PCO|0|0|0|100|IKR|8140|12183|lyfalmen|||0|454|1|10,0800|Distica|Distica - óskráđ lyf|Pólýstýren súlfónat||8140||8140|12183||1 164119|J05AE1101|Incivo|filmhtfl|375|mg|42|stk|1|glas||J05AE11|01.02.2012||R|0|1|0|1|0|1|JCI|0|1|0|100|SEK|360959|454886|lyfsjukr|||1|42|0|7,0000|Vistor hf|Janssen-Cilag International N.V.|Telaprevír||360959||360959|454886||1 164251|L01BB0201|Puri-nethol|töflur|50|mg|25|stk|1|glas||L01BB02|01.06.2001||R|0|0|0|0|G|0|ATL|0|0|0|100|XEU|3495|5829|lyfalmen|||1|25|0||Aspen Pharma Trading Ltd.|Aspen Pharma Trading Ltd.|Merkaptópúrín||3495||3495|5829||1 164256|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3921|5659|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||3921||3921|5659||2 164807|N04BD0105|Selegilin Mylan|töflur|5|mg|100|stk|1|glas||N04BD01|01.10.1995||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|3115|5309|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Selegilín||||3115|5309||2 164818|N04BD0105|Selegilin Mylan|töflur|10|mg|100|stk|1|glas||N04BD01|01.05.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|10271|15098|lyfalmen|||2|100|0|200,0000|Icepharma hf|Mylan AB|Selegilín||10271||10271|15098||2 164829|N06AA0406|Klomipramin Mylan|töflur|10|mg|100|stk|1|glas||N06AA04|01.10.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1267|2781|lyfalmen|||2|100|0|10,0000|Icepharma hf|Mylan AB|Klómípramín||1267||1267|2781||2 164840|N06AA0406|Klomipramin Mylan|töflur|25|mg|100|stk|1|glas||N06AA04|01.10.1992||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1498|3097|lyfalmen|V0314|3097|2|100|0|25,0000|Icepharma hf|Mylan AB|Klómípramín||1498||1498|3097||2 164871|A07EC0204|Asacol|eţ-stíll|500|mg|60|stk|1|pakki||A07EC02|01.01.2000||R|0|0|0|0|G|0|TIL|0|0|0|100|SEK|7610|11458|lyfalmen|V0014|11340|1|60|0|20,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||||7610|11458||2 165001|C05AA0102|Proctosedyl|eţ-stíll|||12|stk|1|pakki||C05AA01|01.12.1972||L|0|0|0|0|0|0|SNO|0|0|0|100|IKR|||lyflausa|||0|12|0||Vistor hf|Sanofi-aventis Norge AS|Hýdrókortisón|||||||1 165019|C05AA0102|Proctosedyl|eţ-smyr|||30|g|1|túpa||C05AA01|01.03.1981||L|0|0|0|0|0|0|SNO|0|0|0|100|IKR|||lyflausa|||0|30|0||Vistor hf|Sanofi-aventis Norge AS|Hýdrókortisón|||||||1 165175|N05BA0205|Risolid|filmhtfl|10|mg|100|stk|1|glas||N05BA02|01.03.2012||R|1|0|0|0|0|0|AGT|0|0|1|100|XEU|846|2205|lyfalmen|||2|100|0|33,3300|Actavis Group hf|Actavis Group hf|Klórdíazepoxíđ||846||846|2205||1 165179|N03AX2201|Fycompa|filmhtfl|10|mg|28|stk|1|ţpakki||N03AX22|01.07.2013||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|25764|35057|lyfalmen|||1|28|0||Vistor hf|Eisai Europe Ltd.|Perampanel||25764||25764|35057||1 165306|QN05CM9101|Dorbene vet.|stl|1|mg/ml|10|mg|1|hgl||QN05CM91|01.05.2009||R|0|0|0|0|0|0|LAS|1|0|0|100|XEU|6991|13596|vetalmen|||0|10|0||Dýraheilsa ehf|Laboratorios SYVA S.A.|Metetomidinum||6991||6991|13596||2 165449|C08CA0202|Plendil|forđatfl|10|mg|98|stk|1|ţpakki||C08CA02|01.10.1995||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|5272|8260|lyfalmen|V0059|5961|1|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Felódipín||5272||5272|8260||1 165507|L01XX1904|Irinotecan Actavis|irţ|20|mg/ml|25|ml|1|hgl|lausn|L01XX19|01.04.2013||R|0|0|0|1|0|1|AGT|0|0|0|100|XEU|24203|32257|lyfsjukr|||2|25|0||Actavis Group hf|Actavis Group hf|Írinótekan||24203||24203|32257||1 165548|C08CA0202|Plendil|forđatfl|5|mg|98|stk|1|ţpakki||C08CA02|01.10.1995||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|3403|5703|lyfalmen|V0058|4948|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Felódipín||3403||3403|5703||1 165603|H01AC0104|Saizen|sts|8|mg/ml|1,5|ml|5|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|EMA|0|1|0|100|SEK|277041|349569|lyfsjukr|||1|7,5|0|90,0000|Icepharma hf|E. Merck AB|Sómatrópín||277041||277041|349569||2 165662|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|36983|48296|lyfsjukr|||1|100|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||36983||36983|48296||2 165670|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|53849|69463|lyfsjukr|||1|150|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||53849||53849|69463||2 165761|R06AE0501|Postafen|töflur|25|mg|100|stk|1|ţpakki||R06AE05|01.12.1972||R|1|0|0|0|G|0|UCN|0|0|1|100|SEK|729|2045|lyfalmen|||1|100|0|50,0000|Vistor hf|UCB Nordic A/S|Meklózín||729||729|2045||1 165779|R06AE0501|Postafen|töflur|25|mg|25|stk|1|ţpakki||R06AE05|01.12.1972||R|1|0|0|0|G|0|UCN|0|0|1|100|SEK|211|1337|lyfalmen|||1|25|0|12,5000|Vistor hf|UCB Nordic A/S|Meklózín||211||211|1337||1 165787|R06AE0501|Postafen|töflur|25|mg|10|stk|1|ţpakki||R06AE05|01.12.1972||L|1|0|0|0|0|0|UCN|0|0|1|100|IKR|||lyflausa|||0|10|0|5,0000|Vistor hf|UCB Nordic A/S|Meklózín|||||||1 165791|N06DA0206|Donepezil Medical|filmhtfl|5|mg|98|stk|1|ţpakki||N06DA02|01.04.2012||R|1|0|0|0|G|0|MED|0|0|0|100|XEU|24619|11351|lyfalmen|V0341|9401|2|98|0|65,3300|Medical ehf|Medical ehf|Dónepezíl||7532||7532|11351||2 165859|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|4143|5979|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||4143||4143|5979||2 165878|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|71838|92039|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||71838||71838|92039||2 165894|V08CA0301|Omniscan|stl|0,5|mmol/ml|50|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|243520|307500|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||243520||243520|307500||2 166008|QJ51RC2202|Nafpenzal vet.|spenalyf|||3|g|20|spr||QJ51RC22|01.02.2010||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|4729|9253|vetalmen|||0|60|0||Vistor hf|Intervet International BV|||||4729|9253||1 166120|A16AX0701|Kuvan|lausnart|100|mg|120|stk|1|glas||A16AX07|01.04.2013||R|0|0|0|1|0|0|MSE|0|0|0|100|SEK|497201|626711|lyfalmen|||1|120|0||Icepharma hf|Merck Serono Europe Ltd|Saprópterín||497201||497201|626711||2 166157|P01BA0201|Plaquenil|töflur|200|mg|100|stk|1|ţpakki||P01BA02|01.12.1972||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|1886|3628|lyfalmen|||1|100|0|38,7597|Vistor hf|Sanofi-aventis Norge AS|Hydroxýklórókín||1886||1886|3628||1 166165|H01CA0201|Synarela|nefúđi|200|mcg/sk|8|ml|1|stauk|60 sk|H01CA02|01.04.1992||R|0|0|0|1|G|0|PER|0|0|0|100|DKK|15355|21994|lyfalmen|||1|8|0|30,0000|Icepharma hf|Pfizer ApS|Nafarelín||15355||15355|21994||1 166351|M01AE0217|Naproxen-E Mylan|sh-tfl|250|mg|100|stk|1|glas||M01AE02|01.07.1993||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|2309|4207|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Naproxen||2309||2309|4207||2 166362|M01AE0217|Naproxen-E Mylan|sh-tfl|500|mg|100|stk|1|glas||M01AE02|01.07.1993||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|4370|7026|lyfalmen|V0428|7026|2|100|0|100,0000|Icepharma hf|Mylan AB|Naproxen||4370||4370|7026||2 166496|J01CA0413|Amoxin|mixt.kyr|100|mg/ml|40|ml|1|glas||J01CA04|01.06.2013||R|0|0|0|0|0|0|RGM|0|0|1|100|XEU|1404|2969|lyfalmen|||2|40|0|4,0000|Medical ehf|ratiopharm GmbH|Amoxicillín||1404||1404|2969||2 166709|G04CA0103|Alfuzosin Ranbaxy|forđatfl|10|mg|90|stk|1|ţpakki||G04CA01|01.07.2009||R|1|0|0|0|G|0|RAN|0|0|0|100|XEU|4939|5635|lyfalmen|V0550|5635|2|90|0|120,0000|Artasan ehf|Ranbaxy (UK) Ltd|Alfúzósín||3353||3353|5635||1 166858|M09AB0201|Xiapex|sts|0,9|mg/hgl|1|hgl|1|stk|+ leysir|M09AB02|01.09.2011||R|0|1|0|1|G|0|KUA|0|0|0|100|DKK|132126|168541|lyfalmen|||1|1|0|1,0000|Auxilium UK Limited|Auxilium UK Limited|Clostridíum||132126||132126|168541||1 166869|N02BA0110|Aspirin Actavis|töflur|300|mg|100|stk|1|glas||N02BA01|01.11.2010||L|1|0|0|0|0|0|AUK|0|0|1|100|IKR|||lyflausa|||0|100|0|10,0000|Actavis Group hf|Actavis UK Ltd.|Acetýlsalicýlsýra|||||||1 167319|N06AX1608|Venlafaxin Actavis|forđahlk|37,5|mg|7|stk|1|ţpakki|hart|N06AX16|01.08.2009||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|454|1669|lyfalmen|V0333|1669|2|7|0|2,6300|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||454||454|1669||1 168275|M04AA0104|Allopurinol|töflur|100|mg|100|stk|1|ţpakki||M04AA01|01.06.2009||R|1|0|0|0|G|0|AUK|0|0|0|100|GBP|525|1766|lyfalmen|||2|100|0|25,0000|Actavis Group hf|Actavis UK Ltd.|Allópúrinol||||525|1766||1 168309|A02BC0306|Lanser|sţ-hylki|30|mg|98|stk|1|ţpakki||A02BC03|01.08.2009||R|1|0|0|0|G|0|AGP|0|0|0|100|IKR|4452|5213|lyfalmen|||2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Lansóprazól||3045||3045|5213||1 168618|L01BA0109|Metoject|stl|50|mg/ml|0,15|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|2572|4566|lyfalmen|||1|0,15|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2572||2572|4566||2 168629|L01BA0109|Metoject|stl|50|mg/ml|0,2|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|2755|4817|lyfalmen|||1|0,2|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2755||2755|4817||2 168640|L01BA0109|Metoject|stl|50|mg/ml|0,3|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|3026|5187|lyfalmen|||1|0,3|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||3026||3026|5187||2 168651|L01BA0109|Metoject|stl|50|mg/ml|0,4|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|3421|5728|lyfalmen|||1|0,4|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||3421||3421|5728||2 168662|L01BA0109|Metoject|stl|50|mg/ml|0,5|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|3603|5977|lyfalmen|||1|0,5|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||3603||3603|5977||2 168740|N03AF0105|Tegretol Retard|forđatfl|200|mg|200|stk|1|ţpakki||N03AF01|01.07.1988||R|1|0|0|0|G|0|NOH|0|0|0|100|DKK|3085|5268|lyfalmen|V0240|5267|1|200|0|40,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||3085||3085|5268||1 168971|N03AF0105|Tegretol Retard|forđatfl|400|mg|200|stk|1|ţpakki||N03AF01|01.07.1988||R|1|0|0|0|G|0|NOH|0|0|0|100|DKK|5693|8836|lyfalmen|V0433|8834|1|200|0|80,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||5693||5693|8836||1 168997|L01CA0401|Navelbine|irţ|10|mg/ml|1|ml|10|hgl||L01CA04|01.03.1998||R|0|0|0|1|0|1|PFP|0|0|0|100|SEK|56127|72322|lyfsjukr|||1|10|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||56127||56127|72322||1 169433|L01CA0401|Navelbine|irţ|10|mg/ml|5|ml|10|hgl||L01CA04|01.03.1998||R|0|0|0|1|0|1|PFP|0|0|0|100|SEK|244029|308139|lyfsjukr|||1|50|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||244029||244029|308139||1 169557|J05AB0601|Cymevene|irs|500|mg|5|hgl|1|pakki|+innr.sía|J05AB06|01.10.1995||R|0|0|0|0|0|1|ROA|0|0|0|100|DKK|21929|29403|lyfsjukr|||1|5|0|5,0000|Icepharma hf|Roche A.S.|Gancíklóvír||21929||21929|29403||2 169664|J07BK0101|Varilrix|bóluefni|||0,5|ml|1|hgl|ţurrefni + 0.5 ml leysir|J07BK01|01.10.1995||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|5273|8261|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Hlaupabóla, veikluđ veira||5273||5273|8261||1 169729|D10BA0105|Isotretinoin Portfarma|hylki|10|mg|30|stk|1|ţpakki||D10BA01|01.10.2009||R|0|1|0|1|G|0|POF|0|0|0|30|IKR|1407|2896|lyfalmen|||2|30|0|10,0000|Portfarma ehf|Portfarma|Ísótretínóín||1351||1351|2896|31.5.2013|2 169740|D10BA0105|Isotretinoin Portfarma|hylki|20|mg|30|stk|1|ţpakki||D10BA01|01.10.2009||R|0|1|0|1|G|0|POF|0|0|0|30|IKR|2450|4265|lyfalmen|||2|30|0|20,0000|Portfarma ehf|Portfarma|Ísótretínóín||2352||2352|4265|31.5.2013|2 169751|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|500|mg|20|stk|1|ţpakki||J01MA02|01.06.2009||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|1168|2646|lyfalmen|V0411|2646|2|20|0|10,0000|Portfarma ehf|Portfarma|Cíprófloxacín||1168||1168|2646||2 169762|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|500|mg|10|stk|1|ţpakki||J01MA02|01.06.2009||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|647|1933|lyfalmen|V0177|1933|2|10|0|5,0000|Portfarma ehf|Portfarma|Cíprófloxacín||647||647|1933||2 169773|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|250|mg|20|stk|1|ţpakki||J01MA02|01.06.2009||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|638|1921|lyfalmen|V0418|1921|2|20|0|5,0000|Portfarma ehf|Portfarma|Cíprófloxacín||638||638|1921||2 169784|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|250|mg|10|stk|1|ţpakki||J01MA02|01.06.2009||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|393|1586|lyfalmen|V0176|1586|2|10|0|2,5000|Portfarma ehf|Portfarma|Cíprófloxacín||393||393|1586||2 169912|N01BB0102|Marcain|stl|2,5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|3071|5249|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||3071||3071|5249||1 169920|N01BB0102|Marcain|stl|5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|3305|5569|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||3305||3305|5569||1 170062|L04AC0701|RoActemra|irţ|20|mg/ml|4|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|24549|32691|lyfsjukr|||1|4|0|4,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||||24549|32691||2 170085|L04AC0701|RoActemra|irţ|20|mg/ml|10|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|60928|78347|lyfsjukr|||1|10|0|10,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||||60928|78347||2 170092|J07BC2001|Twinrix Adult|bóluefni|||1|ml|1|dćla|einnota dćla|J07BC20|01.01.1999||R|0|0|0|0|0|0|GLB|0|0|0|100|GBP|5669|8803|lyfalmen|||1|1|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Lifrarbólgubóluefni (hepatitis)-Blöndur||5669||5669|8803||1 170107|L04AC0701|RoActemra|irţ|20|mg/ml|20|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|115168|146418|lyfsjukr|||1|20|0|20,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||115168||115168|146418||2 170505|J04AB0201|Rimactan|hylki|300|mg|100|stk|1|ţpakki||J04AB02|01.07.2012||R|1|0|0|0|G|0|SAD|0|0|0|100|DKK|16215|23073|lyfalmen|V0571|23073|1|100|0|50,0000|Icepharma hf|Sandoz GmbH|Rífampicín||16215||16215|23073||2 170514|C01BC0301|Rytmonorm|töflur|150|mg|100|stk|1|ţpakki||C01BC03|01.04.1996||R|1|0|0|1|G|0|ABS|0|0|0|100|DKK|3942|6440|lyfalmen|||1|100|0|50,0000|Vistor hf|Abbott Scandinavia AB|Própafenón||3942||3942|6440||1 170548|C01BC0301|Rytmonorm|töflur|300|mg|100|stk|1|ţpakki||C01BC03|01.04.1996||R|1|0|0|1|G|0|ABS|0|0|0|100|DKK|6899|10485|lyfalmen|||1|100|0|100,0000|Vistor hf|Abbott Scandinavia AB|Própafenón||6899||6899|10485||1 170555|N01BB5301|Carbocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|10 mg+5 míkróg/ml|N01BB53|01.12.1982||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2512|4484|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Mepívakaín í blöndum||2512||2512|4484||1 170628|J01GB0304|Gentamicin B. Braun|irl|1|mg/ml|80|ml|20|fl||J01GB03|01.04.2011||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|11562|16393|lyfsjukr|||2|1600|0|6,6700|Actavis Group hf|Braun|Gentamícín||11562||11562|16393||1 170640|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|80|ml|20|fl||J01GB03|01.04.2011||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|27813|36788|lyfsjukr|||2|1600|0|20,0000|Actavis Group hf|Braun|Gentamícín||27813||27813|36788||1 170651|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|120|ml|20|fl||J01GB03|01.04.2011||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|41720|54241|lyfsjukr|||2|2400|0|30,0000|Actavis Group hf|Braun|Gentamícín||41720||41720|54241||1 170697|M05BA0406|Alendronat Actavis|töflur|70|mg|12|stk|1|ţpakki||M05BA04|01.06.2009||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|3395|3707|lyfalmen|V0203|3707|2|12|0|84,0000|Actavis Group hf|Actavis Group PTC ehf|Alendrónsýra||1944||1944|3707||1 170763|M05BA0706|Risedronate sodium Portfarma|filmhtfl|35|mg|12|stk|1|ţpakki||M05BA07|01.03.2011||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|12363|2409|lyfalmen|V0207|1664|2|12|0|84,0000|Portfarma ehf|Portfarma|Rísedrónsýru||995||995|2409||2 170997|L01BC0701|Vidaza|irţ|25|mg/ml|4|ml|1|hgl||L01BC07|01.09.2009||R|0|0|0|1|0|1|CEE|0|1|0|100|XEU|58232|74964|lyfsjukr|||1|4|0||Celgene Europe ltd|Celgene Europe ltd|Azasitidín||58232||58232|74964||2 171404|QS02CA0102|Canaural|eyrnadr|||25|ml|1|glas|handa hundum|QS02CA01|01.01.2012||R|0|0|0|0|0|0|DEC|1|0|0|100|DKK|2768|5488|vetalmen|||0|25|0||Vistor hf|Dechra Veterinary Products A/S|||2768||2768|5488||1 171603|N01BB5101|Marcain adrenalin|stl|2,5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|3807|6256|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín í blöndum||3807||3807|6256||1 171611|N01BB5101|Marcain adrenalin|stl|5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|3843|6305|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín í blöndum||3843||3843|6305||1 171777|H03BB0101|Neo-Mercazole|töflur|5|mg|100|stk|1|glas||H03BB01|01.08.2005||R|0|0|0|0|0|0|LDR|0|0|0|100|NOK|1587|3219|lyfalmen|||0|100|1|33,3333|Parlogis hf|Parlogis - óskráđ lyf|Karbímazól||1587||1587|3219||2 171793|N03AX1101|Topimax|töflur|25|mg|60|stk|1|ţpakki||N03AX11|01.01.2003||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|4647|7405|lyfalmen|V0247|4092|1|60|0|5,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||4647||4647|7405||1 171876|N03AX1101|Topimax|töflur|50|mg|60|stk|1|ţpakki||N03AX11|01.01.2003||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|7649|11511|lyfalmen|V0248|6193|1|60|0|10,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||7649||7649|11511||1 171991|V08CA0101|Magnevist|stl|469|mg/ml|15|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|0|0|0|0|0|1|BGB|0|0|0|100|DKK|45269|58695|lyfsjukr|||1|75|0||Icepharma hf|Bayer Pharma AG|Gadópentetat||45269||45269|58695||2 172049|V08CA0101|Magnevist|stl|469|mg/ml|10|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|0|0|0|0|0|1|BGB|0|0|0|100|DKK|30180|39758|lyfsjukr|||1|50|0||Icepharma hf|Bayer Pharma AG|Gadópentetat||30180||30180|39758||2 172249|QJ01MA9002|Enrotron Flavour|töflur|150|mg|10|stk|1|ţpakki|handa hundum|QJ01MA90|01.09.2012||R|0|0|0|0|0|0|ANI|0|0|0|100|IKR|3289|6488|vetalmen|||0|10|0||Dýraheilsa ehf|aniMedica GmbH|Enrofloxacinum||3289||3289|6488||2 172353|N03AX1101|Topimax|töflur|100|mg|60|stk|1|ţpakki||N03AX11|01.01.2003||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|13813|20059|lyfalmen|V0249|10302|1|60|0|20,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||13813||13813|20059||1 172395|N03AX1101|Topimax|töflur|200|mg|60|stk|1|ţpakki||N03AX11|01.01.2003||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|25924|35258|lyfalmen|||1|60|0|40,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||25924||25924|35258||1 172411|V08CA0101|Magnevist|stl|469|mg/ml|20|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|0|0|0|0|0|1|BGB|0|0|0|100|DKK|69413|88996|lyfsjukr|||1|100|0||Icepharma hf|Bayer Pharma AG|Gadópentetat||69413||69413|88996||2 172482|N06DA0303|Nimvastid (Lyfis)|hylki|6|mg|112|stk|1|ţpakki||N06DA03|01.04.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|XEU|30322|32953|lyfalmen|V0346|32953|3|112|0|74,6700|LYFIS ehf|LYFIS ehf|Rívastigmín||24087||24087|32953||2 172619|L01AB0101|Myleran|filmhtfl|2|mg|100|stk|1|glas||L01AB01|01.06.2001||R|0|0|0|1|G|0|ATL|0|0|0|100|XEU|3531|5878|lyfalmen|V0068|5878|1|100|0||Aspen Pharma Trading Ltd.|Aspen Pharma Trading Ltd.|Búsúlfan||3531||3531|5878||1 172627|C07FB0202|Logimax forte|forđatfl|105|mg|98|stk|1|pakki|ţp 10 + 95 mg|C07FB02|01.07.1999||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|12094|17901|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Metóprólól og önnur blóđţrýstingslćkkandi lyf||12094||12094|17901||1 172684|N02AA0303|Palladon|forđahlk|4|mg|56|stk|1|ţpakki||N02AA03|01.09.2000||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|6430|9844|lyfalmen|||1|56|0|11,2000|Icepharma hf|Norpharma |Hýdrómorphón||6430||6430|9844||2 172692|N02AA0303|Palladon|forđahlk|8|mg|56|stk|1|ţpakki||N02AA03|01.09.2000||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|11946|17389|lyfalmen|||1|56|0|22,4000|Icepharma hf|Norpharma |Hýdrómorphón||11946||11946|17389||2 172723|N05AH0410|Quetiapin Actavis|filmhtfl|25|mg|100|stk|1|ţpakki||N05AH04|01.07.2013||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|3080|5261|lyfalmen|V0284|2642|2|100|0|6,2500|Actavis Group hf|Actavis Group PTC ehf|Quetíapín||3080||3080|5261||1 172759|N02AA0303|Palladon|forđahlk|16|mg|56|stk|1|ţpakki||N02AA03|01.09.2000||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|20725|28733|lyfalmen|||1|56|0|44,8000|Icepharma hf|Norpharma |Hýdrómorphón||20725||20725|28733||2 172794|M05BA0707|Risedronato Semanal Qualigen (Lyfjaver)|filmhtfl|35|mg|4|stk|1|ţpakki||M05BA07|01.05.2011||R|1|0|0|0|0|0|LVR|0|0|0|100|IKR|830|2183|lyfalmen|V0207|555|3|4|0|28,0000|Lyfjaver ehf|Lyfjaver ehf|Rísedrónsýru||830||830|2183||3 172895|H01CB0501|Signifor|stl|0,9|mg|1|ml|60|lykjur||H01CB05|01.11.2012||R|0|0|0|0|0|0|NOE|0|0|0|100|DKK|618686|779174|lyfalmen|||1|60|0||Vistor hf|Novartis Europharm Ltd|PAsireótiđ disapartate||618686||618686|779174||1 172916|N02AA0303|Palladon|forđahlk|24|mg|56|stk|1|ţpakki||N02AA03|01.09.2000||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|27027|36642|lyfalmen|||1|56|0|67,2000|Icepharma hf|Norpharma |Hýdrómorphón||27027||27027|36642||2 173088|N05CD0202|Mogadon|töflur|5|mg|50|stk|1|ţpakki||N05CD02|01.12.1972||R|1|0|0|0|0|0|MAB|0|0|1|100|DKK|433|1640|lyfalmen|||1|50|0|50,0000|Vistor hf|Meda AB|Nítrazepam||433||433|1640||1 173284|C10AA0702|Rosuvastatin Actavis|filmhtfl|20|mg|98|stk|1|ţpakki||C10AA07|01.12.2012||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|10763|15771|lyfalmen|V0118|15771|2|98|0|196,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rósuvastatín||10763||10763|15771||1 173310|N05BE0108|Buspiron Mylan|töflur|5|mg|100|stk|1|ţpakki||N05BE01|01.04.1995||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|3616|5994|lyfalmen|||2|100|0|16,6667|Icepharma hf|Mylan AB|Búspírón hýdróklóríđ||3616||3616|5994||2 173344|A06AG1101|Microlax|innhl|||5|ml|12|túpa||A06AG11|01.12.1972||L|0|0|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||0|60|0|12,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, ţ.m.t. í blöndum|||||3670||1 173518|N05BE0108|Buspiron Mylan|töflur|10|mg|100|stk|1|ţpakki||N05BE01|01.04.1995||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|6398|9800|lyfalmen|||2|100|0|33,3333|Icepharma hf|Mylan AB|Búspírón hýdróklóríđ||6398||6398|9800||2 173750|B03XA0201|Aranesp|stl|10|mcg/spr|0,4|ml|4|spr|áfylltar spr.međ nálarvörn|B03XA02|01.08.2011||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|16793|22828|lyfsjukr|||1|1,6|0|8,8900|Vistor hf|Amgen|Darbepóetín alfa||16690||16690|22828||1 173942|H01AC0111|Omnitrope|stl|3,3|mg/ml|1,5|ml|1|rörlyk|lausn|H01AC01|01.04.2012||R|0|0|0|1|0|1|SDG|0|1|0|100|DKK|16036|22008|lyfsjukr|||1|1,5|0|7,5000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||16036||16036|22008||1 173955|N05BA0106|Stesolid Novum|stl|5|mg/ml|2|ml|10|lykjur||N05BA01|01.07.1985||R|0|0|0|0|0|1|AGT|0|0|0|100|DKK|1530|2208|lyfsjukr|||2|20|0|10,0000|Actavis Group hf|Actavis Group hf|Díazepam||1530||1530|2208||1 174300|J01CE0204|Kaavepenin|töflur|800|mg|14|stk|1|ţpakki||J01CE02|01.01.1989||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|702|2008|lyfalmen|||1|14|0|5,6000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||702||702|2008||1 174354|J01CA0414|Amoxicilline Actavis Disper|töflur|500|mg|20|stk|1|ţpakki|hrćra vel í vatni og drekka|J01CA04|01.03.2013||R|0|0|0|0|0|0|AVB|0|0|1|100|XEU|1388|2947|lyfalmen|||2|20|0|10,0000|Actavis Group PTC ehf|Actavis BV|Amoxicillín||1388||1388|2947||1 174359|J01CE0204|Kaavepenin|töflur|1|g|14|stk|1|ţpakki||J01CE02|01.01.1989||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|717|2029|lyfalmen|||1|14|0|7,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||717||717|2029||1 174433|S01EA0501|Alphagan|augndr|2|mg/ml|5|ml|1|glas||S01EA05|01.04.2009||R|0|0|0|0|G|0|ALL|0|0|0|100|SEK|1853|3583|lyfalmen|V0368|2828|1|5|0|25,0000|Vistor hf|Allergan|Brímónidín||1853||1853|3583||1 174664|S01EA0501|Alphagan|augndr|2|mg/ml|5|ml|3|glös||S01EA05|01.04.2009||R|0|0|0|0|G|0|ALL|0|0|0|100|SEK|5435|8483|lyfalmen|V0368|8483|1|15|0|75,0000|Vistor hf|Allergan|Brímónidín||5435||5435|8483||1 175612|J05AB1101|Valtrex|töflur|500|mg|10|stk|1|ţpakki||J05AB11|01.10.1996||R|1|0|0|0|G|0|GSK|0|0|1|100|GBP|2507|2272|lyfalmen|V0033|2122|1|10|0|1,6667|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||895||895|2272||1 175868|V03AN0101|Conoxia|lyfjagas|100|%|37|l|1|gashyl|kćlt|V03AN01|01.10.2012||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|37|0||Ísaga ehf|AGA AB|Súrefni|||||||5 176214|N05AH0301|Zyprexa|húđuđtfl|2,5|mg|28|stk|1|ţpakki||N05AH03|01.01.1999||R|1|0|0|0|0|0|ELD|0|0|0|100|XEU|6706|5075|lyfalmen|V0278|1709|1|28|0|7,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||2944||2944|5075||2 176520|M01AH0105|Cloxabix|hylki|100|mg|100|stk|1|ţpakki||M01AH01|01.03.2013||R|1|0|0|0|G|0|WIH|0|0|1|100|XEU|5972|9217|lyfalmen|V0429|9217|2|100|0|50,0000|Portfarma ehf|Williams & Halls|Celekoxíb||5972||5972|9217||2 176616|N05CH0101|Circadin|forđatfl|2|mg|30|stk|1|ţpakki||N05CH01|01.10.2012||R|1|0|0|0|0|0|RAD|0|0|1|100|DKK|2788|4862|lyfalmen|V0574|4862|2|30|0|30,0000|Vistor hf|RAD Neurim Pharmaceuticals EEC Ltd.|Melatonin||2788||2788|4862||1 176681|L03AB1001|PegIntron|sts|50|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.04.2013||R|0|0|0|1|0|1|DSM|0|0|0|100|DKK|55268|71244|lyfsjukr|||1|4|0|26,6700|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||55268||55268|71244||1 177176|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|100|ml|50|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|9434|13616|lyfsjukr|||1|5000|0||Icepharma hf|Baxter Medical AB|Kolvetni||9434||9434|13616||2 177454|N02BE0107|Paratabs|filmhtfl|500|mg|300|stk|1|glas||N02BE01|01.05.2013||R|1|0|0|0|0|0|ACA|0|0|1|100|XEU|1161|2636|lyfalmen|||2|300|0|50,0000|Actavis Group hf|Actavis hf|Paracetamól||1161||1161|2636||1 177627|QH02AB0201|Dexaject|stl|2|mg/ml|100|ml|1|hgl||QH02AB02|01.06.2013||R|0|0|0|0|0|0|DOR|1|0|0|100|XEU|4639|9080|vetalmen|||0|100|0||Icepharma hf|Dopharma Reserch B.V|Dexamethasón||4639||4639|9080||2 178004|H02AB0801|Kenalog|stl|40|mg/ml|1|ml|1|hgl||H02AB08|01.02.2002||R|0|0|0|0|0|0|PCO|0|0|1|100|IKR|723|2037|lyfalmen|||0|1|1|5,3330|Distica|Distica - óskráđ lyf|Tríamcínólón||723||723|2037||1 178722|N06AB0404|Citalopram Bluefish|filmhtfl|40|mg|100|stk|1|ţpakki||N06AB04|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|5438|4187|lyfalmen|V0320|4187|2|100|0|200,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Cítalópram||2295||2295|4187||2 179157|L04AB0601|Simponi|stl|50|mg|1|spr|1|spr|áfyllt sprauta|L04AB06|01.06.2011||R|0|1|0|1|0|1|CEO|0|1|0|100|DKK|168701|213602|lyfsjukr|||1|1|0|30,1200|Vistor hf|Centocor B.V.|Golimumab||168701||168701|213602||1 179364|N03AX1406|Zelta|filmhtfl|500|mg|100|stk|1|ţpakki||N03AX14|01.04.2012||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|10671|5436|lyfalmen|V0253|5436|2|100|0|33,3300|LYFIS ehf|LYFIS ehf|Levetíracetam||3208||3208|5436||2 179552|B01AF0101|Xarelto|filmhtfl|15|mg|28|stk|1|ţpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|11172|16331|lyfalmen|||1|28|0|42,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||11172|16331||2 180130|L01AX0303|Temomedac|hylki|250|mg|5|stk|1|glas||L01AX03|01.04.2011||R|0|0|0|1|0|1|WIL|0|1|0|100|XEU|131638|167088|lyfsjukr|||2|5|0||Williams & Halls efh|medac Gesellschaft|Temozolomid||131638||131638|167088||2 180166|A07EC0301|Dipentum|hylki|250|mg|100|stk|1|glas||A07EC03|01.01.1990||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|5664|8796|lyfalmen|||1|100|0|25,0000|Vistor hf|U.C.B|Olsalazín||5664||5664|8796||1 180500|G04CA0207|Tamsulosin Medical|hylki|0,4|mg|100|stk|1|ţpakki|međ br. losunarhrađa|G04CA02|01.12.2012||R|1|0|0|0|G|0|MED|0|0|0|100|XEU|2632|3413|lyfalmen|V0148|2535|2|100|0|100,0000|Medical ehf|Medical ehf|Tamsúlósín||1729||1729|3413||2 180539|R01AA0705|Otrivin Menthol ukonserveret|nefúđi|1|mg/ml|10|ml|1|glas|sk-úđari|R01AA07|01.05.2001||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||||1 180729|S03CA0401|Hydrocortison m.Terram.|aug.eydr|||5|ml|1|túpa|+ Polymyxin B|S03CA04|01.11.1981||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|806|2150|lyfalmen|||1|5|0||Icepharma hf|Pfizer ApS|Hýdrókortisón og sýkingalyf||806||806|2150||1 181219|J04AB0201|Rimactan|hylki|300|mg|60|stk|1|ţpakki||J04AB02|01.02.2013||R|1|0|0|0|G|0|SAD|0|0|0|100|DKK|9729|14357|lyfalmen|V0571|13844|1|60|0|30,0000|Icepharma hf|Sandoz GmbH|Rífampicín||9729||9729|14357||2 181255|G01AF0201|Canesten|sk-krem|10|mg/g|50|g|1|sett|+stjaka|G01AF02|01.12.1982||L|0|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|50|0|5,0000|Icepharma hf|Bayer AB|Klótrímazól|||||||2 181552|QJ51DD1201|Pathozone vet.|spenalyf|250|mg/dćlu|10|ml|10|dćlur|dćla + rýja|QJ51DD12|01.10.1995||R|0|0|0|0|0|0|PFV|0|0|0|100|DKK|8134|15791|vetalmen|||0|100|0||Icepharma hf|Pfizer vet.|Cefoperazone||8134||8134|15791||2 181750|L01BA0108|Methotrexate Pfizer|irţ|100|mg/ml|10|ml|1|hgl||L01BA01|01.04.1991||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|9888|14271|lyfsjukr|||1|10|0||Icepharma hf|Pfizer ApS|Metótrexat||9888||9888|14271||1 181980|C10BA0201|Inegy|töflur|30|mg|28|stk|1|ţpakki|10 mg + 20 mg|C10BA02|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|6189|9514|lyfalmen|V0617|9514|1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb og simvastatín||6189||6189|9514||1 182170|QM01AG9001|Finadyne, vet.|kyrni|25|mg/g|10|g|10|skammt||QM01AG90|01.01.1991||R|0|0|0|0|0|0|IBV|0|0|0|100|SEK|6108|11901|vetalmen|||0|100|0||Vistor hf|Intervet International BV|||6108||6108|11901||1 182307|L04AD0201|Advagraf|forđahlk|0,5|mg|50|stk|1|ţpakki||L04AD02|01.11.2012||R|0|0|0|1|G|0|APE|0|0|0|100|XEU|13082|19141|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||13082||13082|19141||1 182502|C01CA0302|Noradrenalin Abcur|irţ|1|mg/ml|5|ml|10|lykjur||C01CA03|01.05.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|18682|25328|lyfsjukr|||2|50|0|8,3300|Icepharma hf|Abcur AB|Noradrenalín||18682||18682|25328||2 183327|QM01AG9001|Finadyne, vet.|stl|50|mg/ml|50|ml|1|hgl||QM01AG90|01.07.1992||R|0|0|0|0|0|0|IBV|1|0|0|100|DKK|5453|10643|vetalmen|||0|50|0||Vistor hf|Intervet International BV|||5453||5453|10643||1 183516|N02CC0105|Sumatriptan Bluefish|töflur|100|mg|6|stk|1|ţpakki||N02CC01|01.03.2013||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|1929|3098|lyfalmen|V0234|2520|2|6|0|12,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Súmatriptan||1499||1499|3098||2 183660|C01CA2407|Jext|stl|300|mcg|1|stk|1|pakki|áfylltur penni|C01CA24|01.10.2011||R|0|0|0|0|G|0|ALK|0|0|1|100|DKK|5854|9056|lyfalmen|||1|1|0|0,6000|Vistor hf|ALK-Abello A/S|Adrenalín tartrat||||5854|9056||1 183735|J05AE1101|Incivo|filmhtfl|375|mg|168|stk|1|pakki||J05AE11|01.03.2012||R|0|1|0|1|0|1|JCI|0|1|0|100|SEK|1443826|1813884|lyfsjukr|||1|168|0|28,0000|Vistor hf|Janssen-Cilag International N.V.|Telaprevír||1443826||1443826|1813884||1 183871|H02AA0201|Florinef|töflur|0,1|mg|100|stk|1|glas||H02AA02|01.12.1972||R|0|0|0|0|G|0|BRS|0|0|0|100|DKK|1202|2692|lyfalmen|||1|100|0|100,0000|Vistor hf|Bristol-Myers Squibb|Flúdrókortisón||1202||1202|2692||1 184176|J01CR0201|Amoksiklav|mixtúrud|31,25|mg/ml|100|ml|1|glas|25+6.25 mg/ml|J01CR02|01.01.1996||R|0|0|0|0|0|0|LPM|0|0|1|100|XEU|495|1725|lyfalmen|||2|100|0|2,5000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||495||495|1725||1 184192|J01CR0201|Amoksiklav|mixtúrud|62,5|mg/ml|100|ml|1|glas|50+12.5 mg/ml|J01CR02|01.01.1996||R|0|0|0|0|0|0|LPM|0|0|1|100|IKR|1603|2190|lyfalmen|||2|100|0|5,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||835||835|2190||1 184234|A07EC0204|Asacol|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.02.2000||R|0|0|0|0|G|0|TIL|0|0|0|100|SEK|5122|8055|lyfalmen|V0017|7469|1|700|0|4,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||||5122|8055||2 184259|L02BG0401|Femar|töflur|2,5|mg|30|stk|1|ţpakki||L02BG04|01.03.1998||R|0|0|0|0|G|0|NOH|0|0|0|100|DKK|21976|30303|lyfalmen|V0170|10179|1|30|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Letrózól||21976||21976|30303||1 184275|L02BG0401|Femar|töflur|2,5|mg|100|stk|1|ţpakki||L02BG04|01.03.1998||R|0|0|0|0|G|0|NOH|0|0|0|100|DKK|55851|72816|lyfalmen|V0185|20258|1|100|0|100,0000|Vistor hf|Novartis Healthcare A/S-|Letrózól||55851||55851|72816||1 184341|J01CR0201|Amoksiklav|töflur|625|mg|16|stk|1|glas|500+125 mg|J01CR02|01.01.1996||R|0|0|0|0|0|0|LPM|0|0|1|100|XEU|1194|2681|lyfalmen|||2|16|0|8,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1194||1194|2681||1 184432|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|6|stk|1|ţpakki||N02CC03|01.05.2001||R|0|0|0|0|G|0|AZA|0|0|0|100|SEK|5540|8626|lyfalmen|V0235|6903|1|6|0|6,0000|Vistor hf|AstraZeneca AB|Zolmítriptan||5540||5540|8626||1 187057|N07BB0001|Selincro|filmhtfl|18|mg|7|stk|1|ţpakki||N07BB|01.06.2013||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|4320|6957|lyfalmen|V0078|6103|1|7|0||Lundbeck Export A/S|H. Lundbeck A/S|Nalmefenum||4320||4320|6957||1 187595|D11AH0201|Elidel|krem|1|%|30|g|1|túpa||D11AH02|01.09.2012||R|0|0|0|0|G|0|MAB|0|0|1|100|DKK|4761|7561|lyfalmen|||1|30|0||Vistor hf|Meda AB|Pímekrólímus||4761||4761|7561||1 188364|J01AA1201|Tygacil|irs|50|mg|10|hgl|1|pakki||J01AA12|01.08.2012||R|0|0|0|0|0|1|WTE|0|0|0|100|DKK|78055|99842|lyfsjukr|||1|10|0|5,0000|Icepharma hf|Wyeth Europe|Tigecýklín||78055||78055|99842||2 188631|N03AG0102|Orfiril|mixtúra|60|mg/ml|250|ml|1|glas||N03AG01|01.10.1995||R|0|0|0|0|G|0|DEA|0|0|0|100|XEU|2966|5105|lyfalmen|||1|250|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||2966||2966|5105||1 188987|S01EC0101|Diamox|töflur|250|mg|100|stk|1|glas||S01EC01|01.12.1972||R|1|0|0|0|G|0|MPH|0|0|0|100|USD|2010|3798|lyfalmen|||1|100|0|33,3333|Icepharma hf|Mercury Pharmaceuticals Ltd.|Acetazólamíđ||2010||2010|3798||2 189052|M05BA0604|Iasibon|irţ|1|mg/ml|2|ml|1|lykja||M05BA06|01.10.2012||R|0|0|0|0|0|1|PSA|0|1|0|100|DKK|9762|14089|lyfsjukr|||2|2|0|0,3400|Portfarma ehf|Pharmathen S.A.|Íbandrónsýra||9762||9762|14089||2 189148|J05AG0501|EDURANT|filmhtfl|25|mg|30|stk|1|glas||J05AG05|01.04.2013||R|0|0|0|1|0|1|JCI|0|0|0|100|SEK|50215|64902|lyfsjukr|||1|30|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Rilpívírin||50215||50215|64902||1 189175|V03AC0101|Desferal|irs|500|mg|10|hgl|1|pakki|lausn|V03AC01|01.04.2007||R|0|0|0|0|0|1|NOH|0|0|0|100|DKK|7241|10451|lyfsjukr|||1|10|0||Vistor hf|Novartis Healthcare A/S-|Deferoxamín||7241||7241|10451||1 189506|H02AB0401|Depo-Medrol|stl|40|mg/ml|5|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|2522|4498|lyfalmen|||1|5|0|10,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||2522||2522|4498||1 189514|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|1039|2469|lyfalmen|V0413|2469|1|2|0|4,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||1039||1039|2469||1 189522|H02AB0401|Depo-Medrol|stl|40|mg/ml|1|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|503|1736|lyfalmen|||1|1|0|2,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||503||503|1736||1 189627|L01BA0108|Methotrexate Pfizer|stl/irl|25|mg/ml|1|ml|1|hgl||L01BA01|01.11.2011||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|466|673|lyfsjukr|||1|1|0||Icepharma hf|Pfizer ApS|Metótrexat||466||466|673||1 190425|C08CA0502|Adalat Oros|forđatfl|60|mg|98|stk|1|ţpakki||C08CA05|01.03.2013||R|1|0|0|0|G|0|BGB|0|0|0|100|DKK|8089|12113|lyfalmen|V0086|12113|1|98|0|196,0000|Icepharma hf|Bayer Pharma AG|Nífedipín||||8089|12113||2 190702|M01AB0101|Confortid|eţ-stíll|100|mg|10|stk|1|pakki||M01AB01|01.01.2012||R|0|0|0|0|G|0|AGT|0|0|1|100|DKK|1009|2428|lyfalmen|||2|10|0|10,0000|Actavis Group hf|Actavis Group hf|Indómetacín||1009||1009|2428||1 190728|M01AB0101|Confortid|eţ-stíll|50|mg|10|stk|1|ţpakki||M01AB01|01.08.2012||R|0|0|0|0|G|0|AGT|0|0|1|100|DKK|891|2267|lyfalmen|||2|10|0|5,0000|Actavis Group hf|Actavis Group hf|Indómetacín||891||891|2267||1 191064|B05XC03|Vitalipid Infant|irţ|||10|ml|10|lykjur||B05XC|01.10.1985||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3906|5637|lyfsjukr|||1|100|0||Icepharma hf|Fresenius Kabi|Vítamín||3906||3906|5637||2 191079|C10AA0702|Rosuvastatin Actavis|filmhtfl|10|mg|98|stk|1|ţpakki||C10AA07|01.12.2012||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|7085|10740|lyfalmen|V0117|10740|2|98|0|98,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rósuvastatín||7085||7085|10740||1 191247|B05XC02|Vitalipid Adult|irţ|||10|ml|10|lykjur||B05XC|01.10.1985||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3721|5370|lyfsjukr|||1|100|0||Icepharma hf|Fresenius Kabi|Vítamín||3721||3721|5370||2 191254|B05XC01|Soluvit|irs|||10|ml|10|hgl||B05XC|01.10.1985||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3839|5541|lyfsjukr|||1|100|0||Icepharma hf|Fresenius Kabi|Vítamín||3839||3839|5541||2 191403|R01AA0503|Nezeril|nefúđi|0,25|mg/ml|7,5|ml|1|glas|sk-úđari|R01AA05|01.10.1994||L|0|0|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||0|7,5|0|4,6875|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||||1 191742|C08CA0202|Plendil|forđatfl|2,5|mg|98|stk|1|ţpakki||C08CA02|01.08.2012||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|4667|7432|lyfalmen|||1|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Felódipín||4667||4667|7432||1 192456|N06AX1104|Miron Smelt|munndr.t|15|mg|96|stk|1|ţpakki||N06AX11|01.12.2011||R|0|0|0|0|G|0|AGP|0|0|0|100|XEU|3876|6350|lyfalmen|||2|96|0|48,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||3876||3876|6350||1 192617|C03AB0101|Centyl med kaliumklorid|sh-tfl|||100|stk|1|glas||C03AB01|01.12.1972||R|1|0|0|0|G|0|LEP|0|0|0|100|DKK|1625|3271|lyfalmen|||1|100|0|100,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíđ og kalíum||1625||1625|3271||1 192699|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|100|ml|50|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|9422|13598|lyfsjukr|||1|5000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||9422||9422|13598||2 192867|S01BA0103|Ozurdex|vefjalyf|700|mcg|1|stk|1|pakki|til ísetningar, vefjalyf|S01BA01|01.10.2012||R|0|1|0|1|0|1|API|0|0|0|100|SEK|194099|245477|lyfsjukr|||2|1|0||Vistor hf|Allergan Pharmaceuticals Ireland|Dexametasón||194099||194099|245477||1 193583|L01XE1801|Jakavi|töflur|5|mg|60|stk|1|glas||L01XE18|01.11.2012||R|1|0|0|1|0|1|NOE|0|0|0|100|DKK|329069|414864|lyfsjukr|||1|60|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||329069||329069|414864||1 193821|A12AA0601|Calcium-Sandoz|freyđit|500|mg|20|stk|1|glas||A12AA06|01.12.1972||L|0|0|0|0|0|0|SAN|0|0|0|100|IKR|||lyfalmen|||0|20|0|7,5500|Vistor hf|Sandoz A/S|Kalsíumlaktóglúkónat|||||2302||1 193999|QN01AX9301|Tricaine Pharmaq|duft|1000|mg/g|250|g|1|askja|lausn handa fiskum|QN01AX93|01.07.2013||R|0|0|0|0|0|0|PHL|0|0|0|100|GBP|42904|69998|veteldis|||0|250|0||PHARMAQ Ltd.|PHARMAQ Ltd|Tricaine Methane Sulfónat||42904||42904|69998||1 195040|C07AB0311|Atenolol Mylan|töflur|25|mg|250|stk|1|glas||C07AB03|01.07.2009||R|2|0|0|0|G|0|MYL|0|0|0|100|SEK|1907|3657|lyfalmen|||2|250|0|83,3300|Icepharma hf|Mylan AB|Atenólól||1907||1907|3657||2 195149|B03BA0201|Betolvex|stl|1|mg/ml|1|ml|5|lykjur||B03BA02|01.11.1981||R|0|0|0|0|G|0|AGT|0|0|1|100|DKK|2414|4350|lyfalmen|||2|5|0|250,0000|Actavis Group hf|Actavis Group hf|Cýanókóbalamíntannín-komplex||2414||2414|4350|30.6.2013|1 195156|B03BA0201|Betolvex|stl|1|mg/ml|1|ml|1|lykja||B03BA02|01.05.2013||R|0|0|0|0|G|0|AGT|0|0|1|100|DKK|794|2134|lyfalmen|||2|1|0|50,0000|Actavis Group hf|Actavis Group hf|Cýanókóbalamíntannín-komplex||794||794|2134||1 195445|N05AE0403|Ziprasidon Actavis|hylki|40|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.06.2013||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|14480|20896|lyfalmen|V0609|20896|2|56|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Ziprasidon||14480||14480|20896||1 195455|V07AB0002|Sterilt Vand "Baxter" Viaflo|leysir|||100|ml|50|pokar|leysir f.stungulyf|V07AB|01.07.2013||L|0|0|0|0|0|0|BAM|0|0|0|100|IKR|||lyflausa|||0|5000|0||Icepharma hf|Baxter Medical AB|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||2 195472|A02BC0507|Esomeprazole Portfarma|sţ-tfl|40|mg|98|stk|1|ţpakki||A02BC05|01.11.2011||R|1|0|0|0|0|0|POF|0|0|0|100|IKR|9142|7989|lyfalmen|V0012|5070|2|98|0|130,6700|Portfarma ehf|Portfarma|Esómeprazól||5074||5074|7989||2 195583|H01AC0104|Saizen|sts|8|mg/ml|2,5|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|EMA|0|1|0|100|SEK|92347|117778|lyfsjukr|||1|2,5|0|30,0000|Icepharma hf|E. Merck AB|Sómatrópín||92347||92347|117778||2 195587|L04AB0601|Simponi|stl|50|mg|1|áf-penni|1|penni|áfylltur penni|L04AB06|01.06.2011||R|0|1|0|1|0|1|CEO|0|1|0|100|DKK|168701|213602|lyfsjukr|||1|1|0|30,1200|Vistor hf|Centocor B.V.|Golimumab||168701||168701|213602||1 195669|D01AC2002|Pevisone|krem|||15|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|0|JAS|0|0|1|100|SEK|786|2123|lyfalmen|||1|15|0||Vistor hf|Janssen-Cilag AB|Blöndur||786||786|2123||1 195768|R01BA0101|Rinexin|forđatfl|50|mg|30|stk|1|ţpakki||R01BA01|01.03.1981||R|1|0|0|0|G|0|REP|0|0|1|100|SEK|403|1599|lyfalmen|||1|30|0|15,0000|Vistor hf|Recip AB|Fenýlprópanólamín||403||403|1599||1 195776|R01BA0101|Rinexin|forđatfl|50|mg|100|stk|1|glas||R01BA01|01.03.1981||R|1|0|0|0|G|0|REP|0|0|1|100|SEK|853|2215|lyfalmen|||1|100|0|50,0000|Vistor hf|Recip AB|Fenýlprópanólamín||853||853|2215||1 196022|C07AB0311|Atenolol Mylan|töflur|50|mg|250|stk|1|glas||C07AB03|01.07.2009||R|2|0|0|0|G|0|MYL|0|0|0|100|SEK|2437|4382|lyfalmen|||2|250|0|166,6700|Icepharma hf|Mylan AB|Atenólól||2437||2437|4382||2 196121|G03AB0302|Triquilar|töflur|80|mcg|63|stk|1|pakki|ţp, 50+30 míkróg etc.|G03AB03|01.01.1985||R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|1555|3175|lyfalmen|||1|63|0|84,0000|Icepharma hf|Bayer Pharma AG|Levónorgestrel og ethinylestradíól||1555||1555|3175||2 196327|N07BA0145|Nicorette Freshdrops|munnstfl|2|mg|24|stk|1|ţpakki||N07BA01|01.12.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 196551|N02BE0114|Pinex|mixtúra|24|mg/ml|100|ml|1|fl||N02BE01|01.07.2012||L|0|0|0|0|0|0|APC|0|0|1|100|IKR|||lyflausa|||0|100|0|0,8000|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||||1 196851|C07AG0101|Trandate|stl|5|mg/ml|20|ml|5|lykjur||C07AG01|01.05.2012||R|0|0|0|0|G|0|ATL|0|0|0|100|GBP|5811|8997|lyfalmen|||1|100|0|0,8333|Aspen Pharma Trading Ltd.|Aspen Pharma Trading Ltd.|Labetalól||5811||5811|8997||1 196913|B03XA0201|Aranesp|stl|20|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|26871|35606|lyfsjukr|||1|2|0|17,7800|Vistor hf|Amgen|Darbepóetín alfa||||26871|35606||1 197103|QH01CA9001|Receptal, vet.|stl|4|mcg/ml|10|ml|1|hgl||QH01CA90|01.07.1998||R|0|0|0|0|0|0|IBV|1|0|0|100|DKK|2585|5136|vetalmen|||0|10|0||Vistor hf|Intervet International BV|||2585||2585|5136||1 197554|N07BA0147|Nicorette QuickMist|munnhúđi|1|mg/sk|150|skammtar|1|fl|1 x 150 úđaskammtar|N07BA01|01.01.2013||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|150|0|0,4400|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 197657|N05BA1203|Tafil|töflur|1|mg|20|stk|1|ţpakki||N05BA12|01.10.1990||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|861|2226|lyfalmen|||1|20|0|20,0000|Icepharma hf|Pfizer ApS|Alprazólam||861||861|2226||1 197673|N05BA1203|Tafil|töflur|1|mg|100|stk|1|ţpakki||N05BA12|01.10.1990||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|2818|4903|lyfalmen|||1|100|0|100,0000|Icepharma hf|Pfizer ApS|Alprazólam||2818||2818|4903||1 197848|N01BB0203|Xylocain|hlaup|20|mg/ml|10|g|10|plspr||N01BB02|01.10.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2214|4077|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||2214||2214|4077||1 198580|L01AA0301|Alkeran|töflur|2|mg|25|stk|1|glas||L01AA03|01.06.2001||R|0|0|0|1|G|0|ATL|0|0|0|100|XEU|2133|3966|lyfalmen|V0076|3966|1|25|0||Aspen Pharma Trading Ltd.|Aspen Pharma Trading Ltd.|Melphalan||2133||2133|3966||1 198648|L01BC0203|Flurablastin|stl|50|mg/ml|20|ml|10|hgl||L01BC02|01.04.1991||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|7212|10409|lyfsjukr|||1|200|0||Icepharma hf|Pfizer ApS|Flúóróúracíl||7212||7212|10409||1 199091|L01XX1101|Estracyt|hylki|140|mg|100|stk|1|glas||L01XX11|01.12.1978||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|36242|48207|lyfalmen|||1|100|0||Icepharma hf|Pfizer ApS|Estramústín||36242||36242|48207||1 199272|N03AX1404|Levetiracetam Actavis|filmhtfl|250|mg|100|stk|1|ţpakki||N03AX14|01.12.2011||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|8572|3837|lyfalmen|V0515|3525|2|100|0|16,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||2039||2039|3837||1 199539|N05CD0503|Halcion|töflur|0,25|mg|30|stk|1|ţpakki||N05CD05|01.11.1981||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|636|1918|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Tríazólam||636||636|1918||1 199584|A02BC0508|Esomeprazol Actavis|sţ-hylki|20|mg|98|stk|1|glas|hart|A02BC05|01.03.2012||R|1|0|0|0|G|0|APC|0|0|0|100|IKR|7641|5070|lyfalmen|V0011|5070|2|98|0|65,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||2940||2940|5070||1 199692|B03XA0201|Aranesp|stl|300|mcg/spr|0,6|ml|1|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|94645|120662|lyfsjukr|||1|0,6|0|66,6700|Vistor hf|Amgen|Darbepóetín alfa||||94645|120662||1 199737|G02CB0301|Dostinex|töflur|0,5|mg|8|stk|1|glas||G02CB03|01.07.1993||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|4692|7466|lyfalmen|V0126|7466|1|8|0|8,0000|Icepharma hf|Pfizer ApS|Kabególín||4692||4692|7466||1 199836|B01AC1301|ReoPro|stl|2|mg/ml|5|ml|1|hgl||B01AC13|01.09.1997||R|0|0|0|0|0|1|JAB|0|0|0|100|XEU|56617|72937|lyfsjukr|||1|5|0|0,4000|Janssen Biologics B.V.|Janssen Biologics B.V.|Abciximab||56617||56617|72937||0 199940|L01XC1101|Yervoy|stţ|5|mg/ml|40|ml|1|hgl|lausn|L01XC11|01.05.2012||R|0|1|0|1|0|1|BMS|0|1|0|100|DKK|2749495|3452492|lyfsjukr|||1|40|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Ipilimumab||2749490||2749490|3452492||1 300373|A05AA0201|Destolit|töflur|150|mg|60|stk|1|ţpakki||A05AA02|01.01.1998||R|0|0|0|0|0|0|PCO|0|0|0|100|GBP|5290|8113|lyfalmen|||0|60|1|12,0000|Distica|Distica - óskráđ lyf|Úrsódeoxýkól sýra||5165||5165|8113||1 370007|B02BA0102|Konakion Novum|stl|10|mg/ml|0,2|ml|5|lykjur||B02BA01|01.10.1995||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|678|979|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Roche|Fýtómenadíón||678||678|979||2 370173|QH01CA9301|Suprelorin|vefjalyf|9,4|mg|2|stk|1|pakki|fyrir hunda|QH01CA93|01.05.2012||R|0|0|0|0|0|0|VIR|1|0|0|100|DKK|31145|59976|vetalmen|||0|2|0||Vistor hf|Virbac S.A|Deslorelín||31145||31145|59976||1 370395|J01CA0413|Amoxin|filmhtfl|375|mg|20|stk|1|ţpakki||J01CA04|01.03.2013||R|0|0|0|0|0|0|RGM|0|0|1|100|IKR|1425|2705|lyfalmen|||2|20|0|7,5000|Medical ehf|ratiopharm GmbH|Amoxicillín||1211||1211|2705||2 370434|A02BC0508|Esomeprazol Actavis|sţ-hylki|40|mg|98|stk|1|glas|hart|A02BC05|01.03.2012||R|1|0|0|0|G|0|APC|0|0|0|100|IKR|11531|5070|lyfalmen|V0012|5070|2|98|0|130,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||2940||2940|5070||1 370940|J01DB0401|Kefzol|sts|1|g|1|stk|1|hgl||J01DB04|01.07.1995||R|0|0|0|0|0|1|NOM|0|0|0|100|DKK|590|852|lyfsjukr|||1|1|0|0,3333|Icepharma hf|NordMedica ApS|Cefazólín||590||590|852||2 371284|D11AH0201|Elidel|krem|1|%|60|g|1|túpa||D11AH02|01.09.2012||R|0|0|0|0|G|0|MAB|0|0|1|100|DKK|10339|15191|lyfalmen|||1|60|0||Vistor hf|Meda AB|Pímekrólímus||10339||10339|15191||1 371583|A06AG1001|Klyx|innhl|||240|ml|1|fl||A06AG10|01.12.1978||L|0|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||0|240|0|1,0000|Vistor hf|Ferring Lćgemidler A/S|Dókúsatnatríum, ţ.m.t. í blöndum|||||||1 371609|A06AG1001|Klyx|innhl|||120|ml|1|fl||A06AG10|01.12.1978||L|0|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||0|120|0|1,0000|Vistor hf|Ferring Lćgemidler A/S|Dókúsatnatríum, ţ.m.t. í blöndum|||||||1 371617|A06AG1001|Klyx|innhl|||120|ml|10|fl||A06AG10|01.12.1978||L|0|0|0|0|0|0|FEL|0|0|0|100|SEK|||lyfalmen|||0|1200|0|10,0000|Vistor hf|Ferring Lćgemidler A/S|Dókúsatnatríum, ţ.m.t. í blöndum|||||10362||1 371658|A02BA0201|Asyran|töflur|150|mg|10|stk|1|ţpakki||A02BA02|01.10.1995||L|1|0|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||0|10|0|5,0000|Actavis Group hf|Actavis hf|Ranitidín|||||||1 372045|N05AL0501|Solian|töflur|50|mg|90|stk|1|ţpakki||N05AL05|01.01.2005||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|4788|7598|lyfalmen|||1|90|0|11,2500|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríđ||4788||4788|7598||1 372151|N04BA0209|Madopar Quick "125"|lausnart|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.11.2000||R|0|0|0|0|G|0|ROC|0|0|0|100|DKK|3676|6077|lyfalmen|||1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3676||3676|6077||2 372177|N07BA0103|Nicorette|innsogsl|10|mg|42|rör|1|pakki|ţp+munnstk|N07BA01|01.09.1977||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|42|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 372185|N07BA0103|Nicorette|innsogsl|10|mg|18|rör|1|pakki|ţp+munnstk|N07BA01|01.09.1977||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|18|0|3,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 372283|N06AB1006|Escitalopram Portfarma|filmhtfl|10|mg|100|stk|1|ţpakki||N06AB10|01.11.2012||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|4922|4468|lyfalmen|V0325|3015|2|100|0|100,0000|Portfarma ehf|Portfarma|Escítalópram||2500||2500|4468||2 373001|G03AB0501|Gracial|töflur|||66|stk|1|pakki|ţp 3 x (15+7 stk)|G03AB05|01.07.1998||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|2521|4497|lyfalmen|||1|66|0|66,0000|Vistor hf|N.V. Organon|Desógestrel og ethinylestradíól||2521||2521|4497||1 373241|N05AL0501|Solian|töflur|200|mg|90|stk|1|ţpakki||N05AL05|01.01.2005||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|16050|22866|lyfalmen|||1|90|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríđ||16050||16050|22866||1 373324|R03AK0602|Seretide Diskus|innönddu|150|mcg/sk|60|skammtar|1|pakki|50+100 mcg, discus|R03AK06|01.05.2000||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|4052|6591|lyfalmen|||1|60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||4052||4052|6591||1 373340|R03AK0602|Seretide Diskus|innönddu|300|mcg/sk|60|skammtar|1|pakki|50+250 mcg, discus|R03AK06|01.05.2000||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|6647|10141|lyfalmen|||1|60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||6647||6647|10141||1 373365|R03AK0602|Seretide Diskus|innönddu|550|mcg/sk|60|skammtar|1|pakki|50+500 mcg, discus|R03AK06|01.05.2000||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|8715|12970|lyfalmen|V0437|12970|1|60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||8715||8715|12970||1 373853|L02BB0307|Bicalutamid Medical|filmhtfl|50|mg|30|stk|1|ţpakki||L02BB03|01.06.2012||R|0|0|0|0|G|0|MED|0|0|0|100|XEU|7486|5591|lyfalmen|V0420|5436|2|30|0|30,0000|Medical ehf|Medical ehf|Bíkalútamíđ||3321||3321|5591||2 373857|C07AB0309|Atenolol Actavis|töflur|25|mg|100|stk|1|ţpakki||C07AB03|01.10.2012||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|469|1654|lyfalmen|V0541|1654|2|100|0|33,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Atenólól||443||443|1654||1 373951|G02CB0301|Dostinex|töflur|0,5|mg|2|stk|1|glas||G02CB03|01.04.1998||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|1588|3220|lyfalmen|V0126|1867|1|2|0|2,0000|Icepharma hf|Pfizer ApS|Kabególín||1588||1588|3220||1 374143|L01XE1201|Caprelsa|filmhtfl|100|mg|30|stk|1|ţpakki||L01XE12|01.07.2012||R|1|1|0|1|0|1|AZA|0|0|0|100|SEK|404056|508973|lyfsjukr|||1|30|0||Vistor hf|AstraZeneca AB|Vandetaníb||404056||404056|508973||1 374231|A10BA0201|Glucophage|töflur|500|mg|100|stk|1|ţpakki||A10BA02|01.01.1987||R|1|0|0|0|G|0|MCK|0|0|0|100|SEK|587|1851|lyfalmen|V0500|1576|1|100|0|25,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||587||587|1851||2 374251|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|30|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|5763|8317|lyfsjukr|||2|7500|0||Icepharma hf|Fresenius Kabi|Kolvetni||5763||5763|8317||2 374348|G04CA0201|Omnic|forđahlk|0,4|mg|30|stk|1|ţpakki||G04CA02|01.08.1998||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|4629|7380|lyfalmen|||1|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||4629||4629|7380||1 374397|J05AB1101|Valtrex|töflur|250|mg|60|stk|1|ţpakki||J05AB11|01.01.2003||R|1|0|0|0|G|0|GSK|0|0|1|100|GBP|11304|16511|lyfalmen|||1|60|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||11304||11304|16511||1 374504|G01AF0502|Pevaryl Depot|krem/sti|||15|g|1|sett|kr.+1sk-stíll m.forđaverkun|G01AF05|01.01.1997||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|15|0|1,5000|Vistor hf|McNeil Sweden AB|Ekónazól|||||||1 374587|B01AB0501|Klexane|stl|100|mg/ml|0,6|ml|10|áf.spr|einnota dćla|B01AB05|01.01.1993||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|8622|12842|lyfalmen|||1|6|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||8622||8622|12842||1 374595|B01AB0501|Klexane|stl|100|mg/ml|0,8|ml|10|áf.spr|einnota dćla|B01AB05|01.01.1993||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|10176|14968|lyfalmen|||1|8|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||10176||10176|14968||1 374603|B01AB0501|Klexane|stl|100|mg/ml|1|ml|10|lykjur|einnota dćla|B01AB05|01.01.1993||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|11917|17350|lyfalmen|||1|10|0|50,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||11917||11917|17350||1 376246|B01AC2401|Brilique|filmhtfl|90|mg|168|stk|1|ţpakki||B01AC24|01.06.2011||R|1|0|0|0|G|0|AZA|0|0|0|100|SEK|32221|43161|lyfalmen|V0459|43161|1|168|0|84,0000|Vistor hf|AstraZeneca AB|Ticagrelor||32221||32221|43161||1 376509|L04AD0202|Prograf|hylki|1|mg|50|stk|1|ţpakki||L04AD02|01.06.2010||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|19940|27748|lyfalmen|||1|50|0|10,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||19940||19940|27748||1 376533|L04AD0202|Prograf|hylki|5|mg|50|stk|1|ţpakki||L04AD02|01.06.2010||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|93735|120361|lyfalmen|||1|50|0|50,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||93735||93735|120361||1 377242|J01FA0901|Klacid|töflur|500|mg|14|stk|1|ţpakki||J01FA09|01.04.1992||R|1|0|0|0|0|0|ABS|0|0|1|100|DKK|4310|6944|lyfalmen|||1|14|0|14,0000|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||4310||4310|6944||1 377333|J05AB1101|Valtrex|töflur|500|mg|42|stk|1|ţpakki||J05AB11|01.10.1996||R|1|0|0|0|G|0|GSK|0|0|1|100|GBP|10948|8874|lyfalmen|V0182|8732|1|42|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||5721||5721|8874||1 378686|D11AX1801|Solaraze|hlaup|3|%|100|g|1|túpa||D11AX18|01.08.2012||R|0|0|0|0|0|0|ALM|0|0|0|100|XEU|16475|23399|lyfalmen|||1|100|0||Vistor hf|Almirall S.A.|Önnur húđlyf-Diclofenacum||16475||16475|23399||1 379570|L04AB0101|Enbrel|stl|50|mg|4|pennar|1|pakki|lausn|L04AB01|01.03.2012||R|0|0|0|1|0|1|IPI|0|1|0|100|DKK|148882|188729|lyfsjukr|||1|4|0|28,5800|Icepharma hf|Pfizer Limited|Etanercept||148882||148882|188729||1 379669|H01CB0202|Sandostatin Lar|sts|10|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|1|0|1|NOH|0|0|0|100|DKK|115598|146958|lyfsjukr|||1|2|0|14,2900|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||115598||115598|146958||1 379677|H01CB0202|Sandostatin Lar|sts|20|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|1|0|1|NOH|0|0|0|100|DKK|162871|206286|lyfsjukr|||1|2|0|28,5700|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||162871||162871|206286||1 379685|H01CB0202|Sandostatin Lar|sts|30|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|1|0|1|NOH|0|0|0|100|DKK|206213|260680|lyfsjukr|||1|2|0|42,8600|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||206213||206213|260680||1 379796|N04BC0406|Ropinirole Portfarma|forđatfl|2|mg|84|stk|1|glas||N04BC04|01.12.2012||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|9239|8561|lyfalmen|V0532|8561|2|84|0|28,0000|Portfarma ehf|Portfarma|Rópíníról||5492||5492|8561||2 379875|N05BA0105|Stesolid|innhl|5|mg/2.5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|0|0|0|0|0|0|AGT|0|0|1|100|DKK|1518|3124|lyfalmen|||2|12,5|0|2,5000|Actavis Group hf|Actavis Group hf|Díazepam||1518||1518|3124||1 379883|N05BA0105|Stesolid|innhl|10|mg/2.5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|0|0|0|0|0|0|AGT|0|0|1|100|DKK|1876|3614|lyfalmen|||2|12,5|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||1876||1876|3614||1 380276|N03AX1406|Zelta|filmhtfl|250|mg|100|stk|1|ţpakki||N03AX14|01.04.2012||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|8431|3525|lyfalmen|V0515|3525|2|100|0|16,6700|LYFIS ehf|LYFIS ehf|Levetíracetam||1811||1811|3525||2 381005|N07BA0146|Nicotinell Tropical Fruit|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.11.2011||L|0|0|0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S|Nikótín|||||||1 381194|A10AD0401|Humalog Mix25 100 E/ml Pen|stl|100|ae/ml|3|ml|5|pennar||A10AD04|01.09.1999||R|0|0|0|0|G|0|ELD|0|0|0|100|XEU|5634|8755|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insulín lispro||5634||5634|8755||2 381505|G04BE0305|Vizarsin (Lyfis)|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|7667|7527|lyfalmen|V0143|7400|3|12|0|12,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||4736||4736|7527||2 382162|N04BC0406|Ropinirole Portfarma|forđatfl|4|mg|84|stk|1|glas||N04BC04|01.12.2012||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|16328|14820|lyfalmen|V0533|14820|2|84|0|56,0000|Portfarma ehf|Portfarma|Rópíníról||10068||10068|14820||2 382383|V03AN0101|Conoxia|lyfjagas|100|%|10|l|1|hylki|kćlt|V03AN01|01.10.2012||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|10|0||Ísaga ehf|AGA AB|Súrefni|||||||5 383000|R03CC1201|Bambec|töflur|10|mg|100|stk|1|glas||R03CC12|01.10.1991||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|7254|10971|lyfalmen|||1|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Bambúteról||7254||7254|10971||1 383117|QP52AA5103|Drontal Vet.|töflur|250|mg|2|stk|1|ţpakki|230+20 mg|QP52AA51|01.06.2000||L|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1293|2256|vetorma|||0|2|0||Icepharma hf|Bayer Animal Health GmbH|||||1293|2256||2 383133|QP52AA5103|Drontal Vet.|töflur|250|mg|20|stk|1|ţpakki|230+20 mg|QP52AA51|01.06.2000||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|7790|13589|vetorma|||0|20|0||Icepharma hf|Bayer Animal Health GmbH|||7790||7790|13589||2 383257|D01AC0802|Dermatin|sápa|20|mg/ml|60|ml|1|glas||D01AC08|01.07.1998||L|0|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|60|0||Actavis Group hf|Actavis hf|Ketókónazól|||||||1 383265|D01AC0802|Dermatin|sápa|20|mg/ml|120|ml|1|glas||D01AC08|01.07.1998||L|0|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|120|0||Actavis Group hf|Actavis hf|Ketókónazól|||||||1 383445|J05AG0101|Viramune|forđatfl|400|mg|30|stk|1|ţpakki||J05AG01|01.03.2013||R|1|0|0|1|0|1|BII|0|0|0|100|DKK|42834|55639|lyfsjukr|||1|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Nevírapín||42834||42834|55639||1 383933|L01XE1801|Jakavi|töflur|15|mg|60|stk|1|glas||L01XE18|01.11.2012||R|1|0|0|1|0|1|NOE|0|0|0|100|DKK|658126|827831|lyfsjukr|||1|60|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||658126||658126|827831||1 385238|C10BA0201|Inegy|töflur|50|mg|28|stk|1|ţpakki|10 mg + 40 mg|C10BA02|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|8491|12663|lyfalmen|V0616|12663|1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb og simvastatín||8491||8491|12663||1 386278|G04BE0305|Vizarsin (Lyfis)|filmhtfl|100|mg|8|stk|1|pakki||G04BE03|01.02.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|6200|6097|lyfalmen|V0144|6097|3|8|0|16,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||3691||3691|6097||2 386953|L02BG0301|Arimidex|filmhtfl|1|mg|98|stk|1|ţpakki||L02BG03|01.03.1998||R|0|0|0|0|G|0|AZA|0|0|0|100|SEK|59899|77897|lyfalmen|V0184|11981|1|98|0|98,0000|Vistor hf|AstraZeneca AB|Anastrózól||59899||59899|77897||1 387579|N05BA1206|Alprazolam Krka|forđatfl|0,5|mg|60|stk|1|ţpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|0|100|XEU|934|2063|lyfalmen|V0308|2063|2|60|0|30,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||742||742|2063||2 387662|QA12CC0202|Magnesiumsulfat Icepharma vet.|stl|200|mg/ml|100|ml|1|plhgl||QA12CC02|01.07.1996||R|0|0|0|0|0|0|ICE|0|0|0|100|XEU|737|1466|vetalmen|||0|100|0||Icepharma hf|Icepharma hf|||737||737|1466||2 387746|J02AA0101|Abelcet|irţ|5|mg/ml|20|ml|10|hgl|+ síunálar|J02AA01|01.04.1996||R|0|0|0|0|0|1|TBV|0|0|0|100|DKK|202133|255559|lyfsjukr|||1|200|0|28,5714|Vistor hf|Teva Pharma B.V.|Amfóterícín||202133||202133|255559||1 387759|L03AB1001|PegIntron|sts|120|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.04.2013||R|0|0|0|1|0|1|DSM|0|0|0|100|DKK|130307|165418|lyfsjukr|||1|4|0|64,0000|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||130307||130307|165418||1 387991|R03DC0304|Montelukast Teva|tuggutfl|5|mg|98|stk|1|ţpakki||R03DC03|01.01.2013||R|1|0|0|0|G|0|TEV|0|0|0|100|XEU|13479|11100|lyfalmen|V0491|11100|2|98|0|49,0000|Medical ehf|Teva Pharma B.V.|Montelúkast||7348||7348|11100||2 388198|L01XE0901|Torisel|irţ|30|mg|1|hgl|1|pakki||L01XE09|01.09.2012||R|0|0|0|1|0|1|IPI|0|0|0|100|DKK|164173|207920|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Limited|Temsirolímus||164173||164173|207920||1 388256|N01BB2001|Emla|krem|||5|g|5|túpa|+12 umbúđ.|N01BB20|01.01.1987||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|3449|5766|lyfalmen|||1|25|0||Vistor hf|AstraZeneca A/S DK|Blöndur||3449||3449|5766||1 388264|N01BB2001|Emla|krem|||30|g|1|túpa||N01BB20|01.01.1987||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|4347|6994|lyfalmen|||1|30|0||Vistor hf|AstraZeneca A/S DK|Blöndur||4347||4347|6994||1 388272|N01BB2001|Emla|plástur|||2|stk|1|pakki||N01BB20|01.04.1994||L|0|0|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||0|2|0||Vistor hf|AstraZeneca A/S DK|Blöndur|||||||1 388278|N01AH0601|Remifentanil Actavis|sts/irs|5|mg|5|hgl|1|pakki|ţykkni,lausn|N01AH06|01.04.2013||R|0|0|1|0|0|1|AGP|0|0|0|100|XEU|13462|18777|lyfsjukr|||2|5|0||Actavis Group hf|Actavis Group PTC ehf|Remífentaníl||13462||13462|18777||1 388280|N01BB2001|Emla|plástur|||20|stk|1|pakki||N01BB20|01.04.1994||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|8435|12587|lyfalmen|||1|20|0||Vistor hf|AstraZeneca A/S DK|Blöndur||8435||8435|12587||1 388482|A02BC0402|Rabeprazol Actavis|sh-tfl|10|mg|28|stk|1|ţpakki||A02BC04|01.06.2011||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|808|1646|lyfalmen|V0466|1646|2|28|0|14,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||437||437|1646||1 389106|G03FA0103|Femanor|töflur|||84|stk|1|pakki|ţp 2+1 mg |G03FA01|01.08.1998||R|0|0|0|0|G|0|BIP|0|0|0|100|SEK|2922|5045|lyfalmen|V0410|5045|1|84|0|84,0000|Vistor hf|BioPhausia AB|Noretísterón og östrógen||2922||2922|5045||1 389122|G03FB0503|Femasekvens|töflur|||84|stk|1|pakki|ţp samsett pk. |G03FB05|01.08.1998||R|0|0|0|0|G|0|BIP|0|0|0|100|DKK|2187|4040|lyfalmen|||1|84|0|84,0000|Vistor hf|BioPhausia AB|Noretísterón og östrógen||2187||2187|4040||1 389155|G03CA0312|Femanest|töflur|2|mg|84|stk|1|ţpakki||G03CA03|01.05.1997||R|0|0|0|0|G|0|BIP|0|0|0|100|SEK|862|2227|lyfalmen|V0128|2227|1|84|0|84,0000|Vistor hf|BioPhausia AB|Estradíól||862||862|2227||1 389171|G03CA0312|Femanest|töflur|1|mg|84|stk|1|ţpakki||G03CA03|01.05.1997||R|0|0|0|0|G|0|BIP|0|0|0|100|DKK|642|1926|lyfalmen|||1|84|0|42,0000|Vistor hf|BioPhausia AB|Estradíól||642||642|1926||1 389395|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|10|sk-hyl|einnota hylki|S01BC03|01.04.1996||R|0|0|0|0|G|0|NOL|0|0|1|100|SEK|975|2382|lyfalmen|V0367|1795|1|3|0||Vistor hf|Novartis Healthcare A/S|Díklófenak||975||975|2382||1 389414|G04BE0305|Vizarsin (Lyfis)|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|2712|3648|lyfalmen|V0143|2467|3|4|0|4,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||1901||1901|3648||2 389443|N04BC0504|Oprymea (Lyfis)|töflur|0,18|mg|100|stk|1|ţpakki||N04BC05|01.07.2010||R|0|0|0|0|G|0|LYF|0|0|0|100|XEU|3917|2465|lyfalmen|V0267|2465|3|100|0|7,2000|LYFIS ehf|LYFIS ehf|Pramipexól||1036||1036|2465||2 389637|G03GA0502|Gonal-f|stl|900|ae/penna|1,5|ml|1|penni|áfylltur penni (66 mcg)|G03GA05|01.01.2012||R|0|0|0|1|G|0|MSE|0|0|0|100|SEK|56605|73763|lyfalmen|||1|1,5|0|12,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||56605||56605|73763||2 389939|N05CF0106|Zopiclone Actavis|filmhtfl|7,5|mg|30|stk|1|ţpakki||N05CF01|01.05.2013||R|1|0|0|0|0|0|AGT|0|0|0|100|SEK|399|1594|lyfalmen|||2|30|0|30,0000|Actavis Group hf|Actavis Group hf|Zópíklón||261||399|1594|31.5.2013|1 389944|L04AD0201|Advagraf|forđahlk|1|mg|50|stk|1|ţpakki||L04AD02|01.03.2012||R|0|0|0|1|G|0|APE|0|0|0|100|XEU|18646|26124|lyfalmen|||1|50|0|10,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||18646||18646|26124||1 390699|N05CM1801|Dexdor|irţ|100|mcg/ml|2|ml|25|lykjur|lausn|N05CM18|01.03.2012||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|82796|105791|lyfsjukr|||1|50|0|5,0000|Vistor hf|Orion Corporation|Dexmedetómid||82796||82796|105791||1 390757|A07AA0201|Mycostatin|mixtúra|100000|ae/ml|100|ml|1|glas||A07AA02|01.04.1974||R|0|0|0|0|G|0|BRS|0|0|1|100|DKK|2948|5081|lyfalmen|||1|100|0|6,6667|Vistor hf|Bristol-Myers Squibb|Nýstatín||2948||2948|5081||1 390784|A10BG0303|Pioglitazone Teva Pharma|töflur|15|mg|28|stk|1|ţpakki||A10BG03|01.11.2012||R|1|1|0|0|G|0|TEV|0|0|0|100|XEU|3068|5245|lyfalmen|||2|28|0|14,0000|Medical ehf|Teva Pharma B.V.|Píóglítazón||3068||3068|5245||2 390971|M01AH0101|Celebra|hylki|100|mg|100|stk|1|ţpakki||M01AH01|01.07.2002||R|1|0|0|0|G|0|PER|0|0|1|100|DKK|7065|10712|lyfalmen|V0429|9217|1|100|0|50,0000|Icepharma hf|Pfizer ApS|Celekoxíb||7065||7065|10712||1 390997|M01AH0101|Celebra|hylki|200|mg|20|stk|1|ţpakki||M01AH01|01.07.2002||R|1|0|0|0|G|0|PER|0|0|1|100|DKK|2790|4865|lyfalmen|V0037|4274|1|20|0|20,0000|Icepharma hf|Pfizer ApS|Celekoxíb||2790||2790|4865||1 391010|G03GA0502|Gonal-f|stl|450|ae/penna|0,75|ml|1|penni|áfylltur penni (33 mcg)|G03GA05|01.01.2012||R|0|0|0|1|G|0|MSE|0|0|0|100|SEK|29345|39551|lyfalmen|||1|0,75|0|6,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||29345||29345|39551||2 391268|M01AH0101|Celebra|hylki|200|mg|100|stk|1|ţpakki||M01AH01|01.07.2002||R|1|0|0|0|G|0|PER|0|0|1|100|DKK|13615|19810|lyfalmen|V0196|16790|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Celekoxíb||13615||13615|19810||1 391730|N01BB0203|Xylocain|úđalyf|100|mg/ml|50|ml|1|glas|+ sk-úđari|N01BB02|01.10.1990||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2777|4847|lyfalmen|||1|50|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||2777||2777|4847||1 392225|V08CA0301|Omniscan|stl|0,5|mmol/ml|50|ml|10|plastf|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|243520|307500|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||243520||243520|307500||2 392402|N05AH0306|Olanzapin Actavis|filmhtfl|5|mg|100|stk|1|glas||N05AH03|01.11.2012||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|4606|6629|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||4080||4080|6629||1 392563|A04AA0101|Zofran|mixtúra|0,8|mg/ml|50|ml|1|glas||A04AA01|01.03.2013||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|9973|14690|lyfalmen|||1|50|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||9973||9973|14690||1 393192|N05AH0409|Quetiapin Orion|filmhtfl|200|mg|100|stk|1|ţpakki||N05AH04|01.10.2012||R|1|0|0|0|G|0|OPF|0|0|0|100|IKR|20927|15671|lyfalmen|V0286|15653|2|100|0|50,0000|Portfarma ehf|Orion Corporation|Quetíapín||10690||10690|15671||2 393735|H02AB0908|Plenadren|töflur|20|mg|50|stk|1|glas|međ breyttan losunarhrađa|H02AB09|01.01.2013||R|1|0|0|0|G|0|VIO|0|0|1|100|DKK|86656|111477|lyfalmen|||1|50|0|33,3300|Williams & Halls efh|ViroPharma SPRL|Hýdrókortisón||86656||86656|111477||2 393918|QJ51CF0204|Orbenin vet.|spenalyf|500|mg/dćlu|1|stk|24|spr||QJ51CF02|01.09.1983||R|0|0|0|0|0|0|PAL|0|0|0|100|DKK|5674|11067|vetalmen|||0|24|0||Icepharma hf|Pfizer Oy Animal Health|||5674||5674|11067||2 393934|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.06.1998||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 393942|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.06.1998||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 393959|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.06.1998||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 394010|N06AB1005|Escitalopram LYFIS|filmhtfl|20|mg|100|stk|1|ţpakki||N06AB10|01.02.2012||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|4775|2949|lyfalmen|V0327|2949|2|100|0|200,0000|LYFIS ehf|LYFIS ehf|Escítalópram||1390||1390|2949||2 394262|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.06.1998||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 395372|L01XA0303|Oxaliplatin Actavis|irţ|5|mg/ml|20|ml|1|hgl||L01XA03|01.05.2013||R|0|0|0|1|0|1|AGP|0|0|0|100|XEU|26945|35698|lyfsjukr|||2|20|0||Actavis Group hf|Actavis Group PTC ehf|Oxalíplatín||26945||26945|35698||1 395522|B03XA0201|Aranesp|stl|500|mcg/spr|1|ml|1|spr|áfyllt spr.međ nálarvörn|B03XA02|01.08.2011||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|150102|189087|lyfsjukr|||1|1|0|111,1100|Vistor hf|Amgen|Darbepóetín alfa||149167||149167|189087||1 395886|R03AK0704|Symbicort Turbuhaler (Lyfjaver)|innönddu|164,5|mcg/sk|360|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2011||R|0|0|0|0|G|0|LVR|0|0|0|100|SEK|27246|36917|lyfalmen|V0356|36917|3|360|0|90,0000|Lyfjaver ehf|Lyfjaver ehf|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||27246||27246|36917|| 395954|V08CA0101|Magnevist|stl|469|mg/ml|30|ml|10|hgl|röntgenskuggaefni|V08CA01|01.04.2007||R|0|0|0|0|0|1|BGB|0|0|0|100|DKK|181077|229134|lyfsjukr|||1|300|0||Icepharma hf|Bayer Pharma AG|Gadópentetat||181077||181077|229134||2 396318|R06AX2201|Kestine|filmhtfl|10|mg|100|stk|1|ţpakki||R06AX22|01.06.2012||R|1|0|0|0|G|0|APS|0|0|1|100|DKK|4089|6641|lyfalmen|||1|100|0|100,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||4089||4089|6641||1 397161|J01CA0414|Amoxicilline Actavis Disper|töflur|375|mg|20|stk|1|ţpakki|hrćra vel í vatni og drekka|J01CA04|01.03.2013||R|0|0|0|0|0|0|AVB|0|0|1|100|XEU|1277|2795|lyfalmen|||2|20|0|7,5000|Actavis Group PTC ehf|Actavis BV|Amoxicillín||1277||1277|2795||1 397494|L01XC0601|Erbitux|irl|5|mg/ml|20|ml|1|hgl|lausn|L01XC06|01.12.2011||R|0|0|0|1|0|1|MKA|0|1|0|100|SEK|37723|49225|lyfsjukr|||1|20|0||Icepharma hf|Merck KgaA|Cetúxímab||37723||37723|49225||2 397567|N07BC0101|Subutex|tungur.t|2|mg|7|stk|1|ţpakki||N07BC01|01.01.2013||R|0|0|1|0|0|1|RBP|0|0|0|100|DKK|1285|1855|lyfsjukr|||1|7|0|1,7500|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín||1285||1285|1855||1 397745|L01BC0601|Xeloda|töflur|150|mg|60|stk|1|ţpakki||L01BC06|01.01.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|9994|14424|lyfsjukr|||1|60|0||Icepharma hf|Roche|Capecitabín||9994||9994|14424||2 397752|L01BC0601|Xeloda|töflur|500|mg|120|stk|1|ţpakki||L01BC06|01.01.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|57301|73795|lyfsjukr|||1|120|0||Icepharma hf|Roche|Capecitabín||57301||57301|73795||2 397796|A06AB5801|Picoprep|mixtduft|||2|pokar|1|pakki|lausn|A06AB58|01.10.2011||L|0|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||0|2|0||Vistor hf|Ferring Lćgemidler A/S|Natríumpicosúlfat|||||||1 398821|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|40|mg|56|stk|1|ţpakki||A02BC05|01.08.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|IKR|7175|3356|lyfalmen|V0012|2897|3|56|0|74,6700|LYFIS ehf|LYFIS ehf|Esómeprazól||1687||1687|3356||2 399241|B01AC0404|Clopidogrel Krka (Lyfis)|filmhtfl|75|mg|28|stk|1|ţpakki||B01AC04|01.07.2010||R|1|0|0|0|G|0|LYF|0|0|0|100|XEU|3558|3830|lyfalmen|V0009|1803|3|28|0|28,0000|LYFIS ehf|LYFIS ehf|Klópídógrel||2034||2034|3830||2 399510|N02AX0204|Tradolan|filmhtfl|50|mg|100|stk|1|ţpakki||N02AX02|01.05.2012||R|1|0|1|0|G|0|GLP|0|0|1|100|SEK|410|1609|lyfalmen|V0225|1579|1|100|0|16,6700|Vistor hf|G.L.Pharma GmbH|Tramadól||410||410|1609||1 399519|N03AX0901|Lamictal|dreifit.|50|mg|56|stk|1|ţpakki||N03AX09|01.03.1999||R|1|0|0|0|G|0|GSK|0|0|0|100|IKR|2049|2274|lyfalmen|V0244|2274|1|56|0|9,3333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||896||896|2274||1 399733|B01AB0401|Fragmin|stl|25000|ae/ml|0,3|ml|10|áf.spr|7500 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.1993||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|9109|13509|lyfalmen|||1|3|0|30,0000|Icepharma hf|Pfizer ApS|Dalteparín||9109||9109|13509||1 399782|D06BB0601|Vectavir|krem|10|mg/g|2|g|1|túpa||D06BB06|01.04.1997||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|2|0||Artasan ehf|Novartis Healthcare A/S-A|Pencíklóvír|||||||1 399856|L03AB1101|Pegasys|stl|180|mcg/pen|0,5|ml|4|lyfjap|áfylltur lyfjapenni|L03AB11|01.05.2012||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|115145|146389|lyfsjukr|||1|2|0|27,6900|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||115145||115145|146389||2 400044|S03CA0102|Sofradex|aug.eydr|||8|ml|1|glas||S03CA01|01.03.1980||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|1523|3131|lyfalmen|||1|8|0||Vistor hf|Sanofi-aventis Norge AS|Dexametasón og sýkingalyf||1523||1523|3131||1 400101|R05DB2002|Pektolin|mixtúra|||150|ml|1|glas||R05DB20|01.06.1981||L|0|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|150|0||Actavis Group hf|Actavis hf|Blöndur|||||||1 400143|C10AB0401|Lopid|hylki|300|mg|100|stk|1|ţpakki||C10AB04|01.04.1988||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|5202|8164|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Gemfíbrózíl||5202||5202|8164||1 400267|N05BA0402|Sobril|töflur|25|mg|25|stk|1|ţpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|226|1357|lyfalmen|||1|25|0|12,5000|Icepharma hf|Pfizer ApS|Oxazepam||226||226|1357||1 400424|N05BA0402|Sobril|töflur|15|mg|100|stk|1|ţpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|409|1607|lyfalmen|||1|100|0|30,0000|Icepharma hf|Pfizer ApS|Oxazepam||409||409|1607||1 400432|N05BA0402|Sobril|töflur|15|mg|25|stk|1|ţpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|195|1315|lyfalmen|||1|25|0|7,5000|Icepharma hf|Pfizer ApS|Oxazepam||195||195|1315||1 400573|C10AX0901|Ezetrol|töflur|10|mg|28|stk|1|ţpakki||C10AX09|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|5443|8494|lyfalmen|V0612|8494|1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb||5443||5443|8494||1 401084|M01AH0105|Cloxabix|hylki|200|mg|20|stk|1|ţpakki||M01AH01|01.03.2013||R|1|0|0|0|G|0|WIH|0|0|1|100|XEU|2358|4274|lyfalmen|V0037|4274|2|20|0|20,0000|Portfarma ehf|Williams & Halls|Celekoxíb||2358||2358|4274||2 401801|B01AC2401|Brilique|filmhtfl|90|mg|56|stk|1|ţpakki||B01AC24|01.06.2011||R|1|0|0|0|G|0|AZA|0|0|0|100|SEK|11132|16276|lyfalmen|V0459|14387|1|56|0|28,0000|Vistor hf|AstraZeneca AB|Ticagrelor||11132||11132|16276||1 401828|N06AA1001|Noritren|töflur|10|mg|100|stk|1|glas||N06AA10|01.01.1985||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|766|2096|lyfalmen|||1|100|0|13,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||766||766|2096||1 401851|N06AA1001|Noritren|töflur|25|mg|100|stk|1|glas||N06AA10|01.01.1985||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|1225|2724|lyfalmen|||1|100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||1225||1225|2724||1 401877|C09AA0103|Katopril|töflur|25|mg|100|stk|1|pakki||C09AA01|01.10.1995||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|1164|2640|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis hf|Kaptópríl||1164||1164|2640|30.6.2013|1 401901|C09AA0103|Katopril|töflur|50|mg|100|stk|1|pakki||C09AA01|01.10.1995||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|1902|3650|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis hf|Kaptópríl||1902||1902|3650|31.5.2013|1 402395|N06DX0103|Nemdatine|filmhtfl|20|mg|98|stk|1|ţpakki||N06DX01|01.07.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|40301|53301|lyfalmen|V0607|50080|2|98|0|98,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Memantín||40301||40301|53301||1 402651|J07BB0205|Influvac|bóluefni|||0,5|ml|1|áfspr||J07BB02|01.12.1998||R|0|0|0|0|0|0|AHP|0|0|0|100|XEU|659|1949|lyfalmen|||1|0,5|0||Vistor hf|Abbott Healthcare Products B.V.|Inflúensa, hreinsađir mótefnavakar||659||659|1949||1 402743|QJ01RA0102|Streptocillin, vet.|stl|||100|ml|1|hgl||QJ01RA01|01.11.1979||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|1687|3356|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Danmark|||1687||1687|3356||1 402873|N06DA0302|Exelon (Lyfjaver)|forđapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.10.2012||R|0|0|0|0|G|0|LVR|0|0|0|100|DKK|15240|21821|lyfalmen|V0349|21821|3|30|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||15217||15217|21821||3 403226|L04AA0605|Myfenax (Lyfis)|hylki|250|mg|100|stk|1|ţpakki||L04AA06|01.03.2011||R|1|0|0|1|G|0|LYF|0|0|0|100|XEU|20823|25681|lyfalmen|V0470|25681|3|100|0|12,5000|LYFIS ehf|LYFIS ehf|Mýcófenólsýra||18293||18293|25681||2 403444|QG02AD9001|Estrumat, vet.|stl|0,25|mg/ml|20|ml|1|hgl||QG02AD90|01.01.1991||R|0|0|0|0|0|0|IBV|1|0|0|100|DKK|5188|10134|vetalmen|||0|20|0||Vistor hf|Intervet International BV|||5188||5188|10134||1 403550|C08CA0302|Lomir Retard|forđahlk|2,5|mg|100|stk|1|ţpakki||C08CA03|01.10.1992||R|1|0|0|0|G|0|NOH|0|0|0|100|DKK|5925|9153|lyfalmen|||1|100|0|50,0000|Vistor hf|Novartis Healthcare A/S-|Ísradipín||5925||5925|9153||1 403856|L01BA0108|Methotrexate Pfizer|irţ|100|mg/ml|50|ml|1|hgl||L01BA01|01.10.2011||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|37326|48727|lyfsjukr|||1|50|0||Icepharma hf|Pfizer ApS|Metótrexat||||37326|48727||1 403915|S01GX0101|Lomudal|augndr|20|mg/ml|13,5|ml|1|glas||S01GX01|01.07.1992||R|0|0|0|0|G|0|SNO|0|0|0|100|NOK|1453|3036|lyfalmen|||1|13,5|0||Vistor hf|Sanofi-aventis Norge AS|Krómóglíkatsýra||1453||1453|3036||1 404426|S01XA2019|Oftagel|augngel|2,5|mg/g|10|g|1|túpa||S01XA20|01.04.2004||L|0|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|10|0||Icepharma hf|Santen Oy|Gervitár og ađrar óvirkar samsetningar|||||1934||2 404533|B01AD0201|Actilyse|sts/irs|50|mg|1|stk|1|hgl|+ leysir|B01AD02|01.07.1989||R|0|0|0|0|0|1|BOI|0|0|0|100|DKK|65744|84391|lyfsjukr|||1|1|0|0,5000|Vistor hf|Boehringer Ingelheim|Alteplasi||65744||65744|84391||1 404818|C03AA0305|Hydromed|töflur|25|mg|100|stk|1|ţpakki||C03AA03|01.06.2013||R|1|0|0|0|G|0|MEV|0|0|0|100|DKK|1204|2695|lyfalmen|||2|100|0|100,0000|Vistor hf|MediLink A/S|hýdróklórtíazíđ||1204||1204|2695||1 404939|B02BA0102|Konakion Novum|stl|10|mg/ml|1|ml|5|lykjur||B02BA01|01.04.1991||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|691|997|lyfsjukr|||1|5|0|2,5000|Icepharma hf|Roche|Fýtómenadíón||691||691|997||2 405076|C03EA0114|Diuramin mite|töflur|27,5|mg|100|stk|1|ţpakki|2,5+25 mg|C03EA01|01.05.2013||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|1076|2520|lyfalmen|V0559|2520|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Hýdróklórtíazíđ og kalíumsparandi lyf||1076||1076|2520||2 405466|QM01AX9001|Cartrophen vet.|stl|100|mg/ml|10|ml|1|hgl|lausn f.hunda|QM01AX90|01.08.2011||R|0|0|0|0|0|0|AEL|1|0|0|100|XEU|8211|15939|vetalmen|||0|10|0||Icepharma hf|Arthropharm Europe Limited|Pentosan Polysulfate Sodium||8211||8211|15939||2 405589|J07BD5203|Priorix|bóluefni|||0,5|ml|1|hgl|+ einnota dćla|J07BD52|01.03.1999||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|1760|3456|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|mislingar í blöndum međ hettusótt og rauđum hundum (veiklađa||1760||1760|3456||1 405597|J07BD5203|Priorix|bóluefni|||0,5|ml|10|hgl||J07BD52|01.11.2001||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|18759|26266|lyfalmen|||1|5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|mislingar í blöndum međ hettusótt og rauđum hundum (veiklađa||18759||18759|26266||1 405677|J01DD0401|Rocephalin|irţ|2|g|1|hgl|1|pakki|lausn|J01DD04|01.03.2013||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|4264|6154|lyfsjukr|||1|1|0|1,0000|Icepharma hf|Roche|Ceftríaxón||4264||4264|6154||2 405985|N05AE0301|Serdolect|filmhtfl|12|mg|28|stk|1|ţpakki||N05AE03|01.01.2006||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|18297|25686|lyfalmen|||1|28|0|21,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||18297||18297|25686||1 406025|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.12.1983||R|0|0|0|0|0|1|GEH|0|0|0|100|IKR|20662|27813|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jóhexól||20662||20662|27813||2 406033|N05AE0301|Serdolect|filmhtfl|16|mg|28|stk|1|ţpakki||N05AE03|01.01.2006||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|20875|28921|lyfalmen|||1|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||20875||20875|28921||1 406165|N05AE0301|Serdolect|filmhtfl|20|mg|28|stk|1|ţpakki||N05AE03|01.01.2006||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|22880|31438|lyfalmen|||1|28|0|35,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||22880||22880|31438||1 406322|N05AE0301|Serdolect|filmhtfl|4|mg|100|stk|1|glas||N05AE03|01.10.2006||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|20639|28625|lyfalmen|||1|100|0|25,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||20639||20639|28625||1 406355|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.12.1983||R|0|0|0|0|0|1|GEH|0|0|0|100|IKR|23122|30901|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jóhexól||23122||23122|30901||2 406371|N05AE0301|Serdolect|filmhtfl|12|mg|100|stk|1|glas||N05AE03|01.10.2006||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|62229|80821|lyfalmen|||1|100|0|75,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||62229||62229|80821||1 406389|N05AE0301|Serdolect|filmhtfl|16|mg|100|stk|1|glas||N05AE03|01.10.2006||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|73051|94402|lyfalmen|||1|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||73051||73051|94402||1 406397|N05AE0301|Serdolect|filmhtfl|20|mg|100|stk|1|glas||N05AE03|01.10.2006||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|82824|106667|lyfalmen|||1|100|0|125,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||82824||82824|106667||1 406462|N05AE0301|Serdolect|filmhtfl|4|mg|30|stk|1|ţpakki||N05AE03|01.01.2006||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|6316|9688|lyfalmen|||1|30|0|7,5000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||6316||6316|9688||1 406894|H01AC0111|Omnitrope|stl|3,3|mg/ml|1,5|ml|5|rörlyk|lausn|H01AC01|01.04.2012||R|0|0|0|1|0|1|SDG|0|1|0|100|DKK|80176|102503|lyfsjukr|||1|7,5|0|37,5000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||80176||80176|102503||1 407142|C09CA0304|Valsartan LYFIS|filmhtfl|80|mg|98|stk|1|ţpakki||C09CA03|01.06.2012||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|3372|5661|lyfalmen|V0072|2427|2|98|0|98,0000|LYFIS ehf|LYFIS ehf|Valsartan||3372||3372|5661||2 407395|N02CA7201|Anervan|töflur|160,5|mg|100|stk|1|pakki|ţp (0,5+10+50+100 mg)|N02CA72|01.10.1995|30.06.2013|R|1|0|0|0|G|0|REP|0|0|0|100|SEK|2210|4071|lyfalmen|||1|100|0|12,5000|Vistor hf|Recip AB|Ergotamínlyf í blöndum međ geđlyfjum (psycoleptica)||2210||2210|4071||1 407981|N05BA0402|Sobril|töflur|10|mg|25|stk|1|ţpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|169|1279|lyfalmen|||1|25|0|5,0000|Icepharma hf|Pfizer ApS|Oxazepam||169||169|1279||1 407999|N05BA0402|Sobril|töflur|10|mg|100|stk|1|ţpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|368|1551|lyfalmen|||1|100|0|20,0000|Icepharma hf|Pfizer ApS|Oxazepam||368||368|1551||1 408266|N05BA1206|Alprazolam Krka|forđatfl|1|mg|60|stk|1|ţpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|0|100|XEU|1975|3021|lyfalmen|V0310|3021|2|60|0|60,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||1442||1442|3021||2 408453|L03AB1001|PegIntron|sts|100|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.04.2013||R|0|0|0|1|0|1|DSM|0|0|0|100|DKK|110538|140608|lyfsjukr|||1|4|0|53,3300|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||110538||110538|140608||1 408740|D07AC0104|Diproderm|smyrsli|0,5|mg/g|100|g|1|túpa||D07AC01|01.03.1977||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|2899|5014|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||2899||2899|5014||1 408773|D07AC0104|Diproderm|áburđur|0,5|mg/ml|100|ml|1|glas||D07AC01|01.03.1977||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|2273|4157|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||2273||2273|4157||1 409078|J02AC0101|Diflucan|mixtúrud|10|mg/ml|35|ml|1|glas||J02AC01|01.07.1992||R|0|0|0|0|0|0|PER|0|0|1|100|DKK|4312|6947|lyfalmen|||1|35|0|1,7500|Icepharma hf|Pfizer ApS|Flúkónazól||4312||4312|6947||1 409417|C09CA0701|Micardis|töflur|80|mg|28|stk|1|ţpakki||C09CA07|01.02.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|3751|6179|lyfalmen|||1|28|0|56,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||3751||3751|6179||1 409425|R01AD0502|Rhinocort Turbuhaler|nefúđad|100|mcg/sk|200|skammtar|1|stauk||R01AD05|01.01.1992||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|4403|7071|lyfalmen|||1|200|0|100,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||4403||4403|7071||1 409474|C09CA0701|Micardis|töflur|80|mg|98|stk|1|ţpakki||C09CA07|01.02.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|12559|18485|lyfalmen|||1|98|0|196,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||12559||12559|18485||1 409516|C09CA0701|Micardis|töflur|40|mg|28|stk|1|ţpakki||C09CA07|01.02.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|2995|5145|lyfalmen|||1|28|0|28,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||2995||2995|5145||1 409745|N05AX1302|Xeplion|stl|100|mg|1|stk|1|áf.spr|forđadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|80903|104257|lyfalmen|||1|1|0|40,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||80903||80903|104257||1 409763|C09CA0701|Micardis|töflur|40|mg|98|stk|1|ţpakki||C09CA07|01.02.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|10177|14970|lyfalmen|||1|98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||10177||10177|14970||1 409927|G04BD1201|Betmiga|forđatfl|50|mg|90|stk|1|ţpakki||G04BD12|01.07.2013||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|17494|24678|lyfalmen|||1|90|0||Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||17494||17494|24678||1 409975|M01AH0105|Cloxabix|hylki|200|mg|100|stk|1|ţpakki||M01AH01|01.03.2013||R|1|0|0|0|G|0|WIH|0|0|1|100|XEU|11508|16790|lyfalmen|V0196|16790|2|100|0|100,0000|Portfarma ehf|Williams & Halls|Celekoxíb||11508||11508|16790||2 410639|P01BA0102|Klorokinfosfat Recip|filmhtfl|250|mg|20|stk|1|ţpakki||P01BA01|01.08.2005||R|1|0|0|0|0|0|REP|0|0|0|100|SEK|1181|2663|lyfalmen|||1|20|0|6,2000|Vistor hf|Recip AB|Klórókín||1181||1181|2663||1 410712|D10AD0102|Aberela|krem|0,05|%|30|g|1|túpa||D10AD01|01.10.2007||R|0|0|0|0|0|0|JAS|0|0|0|100|SEK|807|2152|lyfalmen|||1|30|0||Vistor hf|Janssen-Cilag AB|Tretínóín||807||807|2152||1 411033|M03BX0105|Baklofen Mylan|töflur|10|mg|50|stk|1|ţpakki||M03BX01|01.01.1990||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|706|2014|lyfalmen|||2|50|0|10,0000|Icepharma hf|Mylan AB|Baklófen||706||706|2014||2 411389|N05CD0801|Dormicum|stl|5|mg/ml|10|ml|5|lykjur||N05CD08|01.10.1990||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|4920|7101|lyfsjukr|||1|50|0|16,6667|Icepharma hf|Roche|Mídazólam||4920||4920|7101||2 411827|J05AF0501|Epivir|töflur|150|mg|60|stk|1|glas||J05AF05|01.03.1999||R|1|0|0|1|0|1|VII|0|0|0|100|GBP|24934|33175|lyfsjukr|||1|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Lamívúdín||24934||24934|33175||1 411918|N02CC0101|Imigran|nefúđi|20|mg/sk|6|skammtar|1|pakki||N02CC01|01.07.2000||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|7294|11026|lyfalmen|||1|6|0|6,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||7294||7294|11026||1 412049|L02AE0301|Zoladex|vefjalyf|3,6|mg|1|áf.spr|1|pakki||L02AE03|01.01.1990||R|0|0|0|1|G|0|AZA|0|0|0|100|SEK|22723|31241|lyfalmen|||1|1|0|27,9070|Vistor hf|AstraZeneca AB|Góserelín||22723||22723|31241||1 412361|B01AB0501|Klexane|stl|100|mg/ml|3|ml|1|hgl|međ rotv.|B01AB05|01.02.1999||R|0|0|0|0|0|1|SNO|0|0|0|100|NOK|3819|5512|lyfsjukr|||1|3|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||3819||3819|5512||1 412395|QM01AE0301|Romefen, vet.|stl|100|mg/ml|100|ml|1|hgl||QM01AE03|01.10.1995||R|0|0|0|0|0|0|MER|1|0|0|100|DKK|8602|16690|vetalmen|||0|100|0||Vistor hf|Merial|||8602||8602|16690||1 412547|L03AB0701|Avonex|stl|30|mcg/pen|0,5|ml|4|spr|lausn,áfylltur lyfjapenni|L03AB07|01.11.2011||R|0|0|0|1|0|1|BIB|0|1|0|100|XEU|129223|164057|lyfsjukr|||1|2|0|27,9100|Icepharma hf|Biogen Idec Ltd|Interferón beta-1a||129223||129223|164057||2 412581|N05AX1302|Xeplion|stl|75|mg|1|stk|1|áf.spr|forđadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|62922|81690|lyfalmen|||1|1|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||62922||62922|81690||1 412825|L02BA0107|Tamoxifen Mylan|töflur|10|mg|100|stk|1|glas||L02BA01|01.01.1990||R|0|0|0|0|G|0|MYL|0|0|0|100|SEK|3547|5900|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Tamoxífen||3547||3547|5900||2 412924|L02BA0107|Tamoxifen Mylan|töflur|20|mg|100|stk|1|glas||L02BA01|01.01.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|3659|6053|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Tamoxífen||3659||3659|6053||2 413988|N02BE0107|Paratabs|filmhtfl|500|mg|20|stk|1|ţpakki||N02BE01|01.03.2013||L|1|0|0|0|0|0|APC|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||||1 414006|N06AB0404|Citalopram Bluefish|filmhtfl|10|mg|30|stk|1|ţpakki||N06AB04|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|890|1322|lyfalmen|V0062|1322|2|30|0|15,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Cítalópram||200||200|1322||2 414167|N06DA0205|Donesyn|filmhtfl|10|mg|98|stk|1|ţpakki||N06DA02|01.05.2011||R|1|0|0|0|G|0|WIH|0|0|0|100|XEU|18960|9401|lyfalmen|V0342|9401|2|98|0|130,6700|Portfarma ehf|Williams & Halls|Dónepezíl||6106||6106|9401||2 414680|C03BA1102|Natrilix Retard|forđatfl|1,5|mg|90|stk|1|ţpakki||C03BA11|01.03.1999||R|1|0|0|0|G|0|SEV|0|0|0|100|DKK|4342|6988|lyfalmen|||1|90|0|54,0000|Icepharma hf|Servier|Indapamíđ||4342||4342|6988||2 414789|N03AF0104|Tegretol|mixtúra|20|mg/ml|300|ml|1|glas||N03AF01|01.09.2007||R|0|0|0|0|G|0|NOH|0|0|0|100|DKK|1334|2873|lyfalmen|||1|300|0|6,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1334||1334|2873||1 415338|N05AA0201|Nozinan|filmhtfl|25|mg|100|stk|1|ţpakki||N05AA02|01.11.2012||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|2099|3919|lyfalmen|||1|100|0|8,3333|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||2099||2099|3919||1 415556|B03AC0204|Venofer (D.A.C.)|stl|20|mg/ml|5|ml|5|hgl||B03AC02|01.03.2011||R|0|0|0|0|G|0|DAC|0|0|1|100|CHF|14756|18924|lyfalmen|V0034|18874|3|25|0|5,0000|D.A.C. ehf|D.A.C. ehf|Járnoxíđ (sykurflétta)||12909||12909|18924||2 415679|G03CA0310|Vagifem|sk-tfl|25|mcg|15|stk|1|pakki||G03CA03|01.01.1995||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|1916|3669|lyfalmen|||1|15|0|15,0000|Vistor hf|Novo-Nordisk A/S|Estradíól||1916||1916|3669||1 415946|N03AX1405|Matever|filmhtfl|500|mg|100|stk|1|ţpakki||N03AX14|01.02.2012||R|1|0|0|0|0|0|PSA|0|0|0|100|XEU|10671|5918|lyfalmen|V0253|5436|2|100|0|33,3300|Portfarma ehf|Pharmathen S.A.|Levetíracetam||3560||3560|5918||2 416446|C09DA0101|Cozaar Comp|filmhtfl|62,5|mg|98|stk|1|ţpakki|50+12,5 mg|C09DA01|01.09.1997||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|9583|9691|lyfalmen|V0088|2025|1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og ţvagrćsilyf||6318||6318|9691||1 416494|A02BC0507|Esomeprazole Portfarma|sţ-tfl|40|mg|28|stk|1|ţpakki||A02BC05|01.11.2011||R|1|0|0|0|0|0|POF|0|0|0|100|IKR|4213|2535|lyfalmen|V0005|2183|2|28|0|37,3300|Portfarma ehf|Portfarma|Esómeprazól||1087||1087|2535||2 416818|A02BA0205|Zantac|mixtúra|15|mg/ml|300|ml|1|glas||A02BA02|01.03.2013||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|4557|7282|lyfalmen|||1|300|0|15,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ranitidín||4557||4557|7282||1 416859|A01AA0101|Duraphat|tannlakk|22,6|mg/ml|10|ml|1|túpa||A01AA01|01.10.1995||R|0|0|0|0|G|0|GOG|0|0|1|100|XEU|2921|5044|lyfalmen|||1|10|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríđ||2921||2921|5044||2 416867|A01AA0101|Duraphat|tannlakk|22,6|mg/ml|30|ml|5|túpa||A01AA01|01.10.1988||R|0|0|0|0|G|0|GOG|0|0|1|100|DKK|26232|35645|lyfalmen|||1|150|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríđ||26232||26232|35645||2 416883|D10AX0301|Skinoren|krem|200|mg/g|30|g|1|túpa||D10AX03|01.07.1991||R|0|0|0|0|0|0|IGB|0|0|0|100|DKK|1310|2840|lyfalmen|||1|30|0||Icepharma hf|Intendis GmbH Berlin|Azelainsýra||1310||1310|2840||2 417266|N05AH0409|Quetiapin Orion|filmhtfl|100|mg|100|stk|1|ţpakki||N05AH04|01.10.2012||R|1|0|0|0|G|0|OPF|0|0|0|100|IKR|10510|7204|lyfalmen|V0285|7204|2|100|0|25,0000|Portfarma ehf|Orion Corporation|Quetíapín||4500||4500|7204||2 417832|J05AF0601|Ziagen|filmhtfl|300|mg|60|stk|1|ţpakki||J05AF06|01.07.2005||R|1|0|0|1|0|1|VII|0|0|0|100|GBP|40810|53099|lyfsjukr|||1|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Abacavír||40810||40810|53099||1 417880|B02BD0901|BeneFIX|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD09|01.07.2012||R|0|0|0|1|0|1|IPI|0|1|0|100|DKK|100311|127773|lyfsjukr|||1|1|0|2,2200|Icepharma hf|Pfizer Limited|Storkuţáttur IX||100311||100311|127773||1 418043|B01AE0701|Pradaxa|hylki|150|mg|180|stk|1|ţpakki|hart|B01AE07|01.10.2011||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|34572|46111|lyfalmen|V0460|46111|1|180|0|122,7200|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||||34572|46111||1 418483|A07EC0201|Mesasal|sh-tfl|250|mg|100|stk|1|ţpakki||A07EC02|01.10.1991||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|4940|7806|lyfalmen|||1|100|0|16,6667|Vistor hf|Sanofi-aventis Norge AS|Mesalazín (5-amínósalicýlsýra)||4940||4940|7806||1 418592|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|28|áf.spr||L04AC03|01.06.2012||R|0|0|0|1|0|1|BIO|0|0|0|100|DKK|135933|172478|lyfsjukr|||1|18,76|0|28,0000|Swedish Orphan Biovitrum AB|Swedish Orphan Biovitrum AB|Anakinra||135933||135933|172478||1 418665|D07XC0101|Diprosalic|smyrsli|||50|g|1|túpa||D07XC01|01.11.1979||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1616|3259|lyfalmen|||1|50|0||Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||1616||1616|3259||1 418731|A07EC0201|Mesasal|eţ-stíll|500|mg|60|stk|1|pakki||A07EC02|01.10.1991||R|0|0|0|0|G|0|SNO|0|0|0|100|NOK|7524|11340|lyfalmen|V0014|11340|1|60|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Mesalazín (5-amínósalicýlsýra)||7524||7524|11340||1 418981|R06AX2703|Desloratadine Actavis|filmhtfl|5|mg|100|stk|1|ţpakki||R06AX27|01.05.2012||R|1|0|0|0|G|0|APC|0|0|1|100|XEU|2371|4291|lyfalmen|V0458|4291|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Deslóratadín||2371||2371|4291||1 418988|QA07AA0101|Colinovina, vet.|mixtúra|200|mg/ml|200|ml|1|glas||QA07AA01|01.03.1981||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|2065|4108|vetalmen|||0|200|0||Vistor hf|Boehringer Ingelheim Danmark|||2065||2065|4108||1 418996|QA07AA0101|Colinovina, vet.|mixtúra|200|mg/ml|200|ml|1|sett|+ dćla|QA07AA01|01.03.1981||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|2680|5319|vetalmen|||0|200|0||Vistor hf|Boehringer Ingelheim Danmark|||2680||2680|5319||1 419242|A11CC0301|Etalpha|hylki|0,25|mcg|100|stk|1|ţpakki||A11CC03|01.11.1979||R|1|0|0|0|G|0|LEP|0|0|0|100|DKK|2786|4859|lyfalmen|||1|100|0|25,0000|Vistor hf|LEO Pharma A/S|Alfakalsídól||2786||2786|4859||1 419309|A11CC0301|Etalpha|hylki|1|mcg|100|stk|1|ţpakki||A11CC03|01.11.1979||R|1|0|0|0|G|0|LEP|0|0|0|100|DKK|7180|10870|lyfalmen|||1|100|0|100,0000|Vistor hf|LEO Pharma A/S|Alfakalsídól||7180||7180|10870||1 419820|J05AE0201|Crixivan|hylki|400|mg|180|stk|1|glas||J05AE02|01.04.1997||R|1|0|0|1|0|1|MSD|0|0|0|100|DKK|52720|68046|lyfsjukr|||1|180|0|30,0000|Vistor hf|M.S.D.|Indínavír||52720||52720|68046||1 419838|A16AA0401|Cystagon|hylki|150|mg|100|stk|1|glas||A16AA04|01.02.2008||R|1|0|0|1|0|1|ORP|0|0|0|100|DKK|40005|52089|lyfsjukr|||1|100|0|7,5000|Swedish Orphan International AB|Orphan Europe (S)|Mecaptamín||40005||40005|52089||3 419945|D07AD0101|Dermovat|húđlausn|0,5|mg/ml|25|ml|1|glas|í hársvörđ|D07AD01|01.09.1982||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|824|2175|lyfalmen|||1|25|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||824||824|2175||1 420117|B01AB0401|Fragmin|stl|10000|ae/ml|1|ml|10|lykjur||B01AB04|01.04.1993||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|12172|17999|lyfalmen|||1|10|0|40,0000|Icepharma hf|Pfizer ApS|Dalteparín||12172||12172|17999||1 420678|N07BC0101|Subutex|tungur.t|8|mg|7|stk|1|ţpakki||N07BC01|01.01.2013||R|0|0|1|1|0|1|RBP|0|0|0|100|DKK|4948|7141|lyfsjukr|||1|7|0|7,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín||4948||4948|7141||1 421180|C01BD0101|Cordarone|töflur|100|mg|30|stk|1|ţpakki||C01BD01|01.07.1989||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|1227|2726|lyfalmen|V0036|2725|1|30|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||1227||1227|2726||1 422121|C07AB0205|Seloken|töflur|50|mg|100|stk|1|ţpakki||C07AB02|01.05.2009||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|1573|3200|lyfalmen|V0051|3041|1|100|0|33,3300|Vistor hf|AstraZeneca A/S DK|Metóprólól||1573||1573|3200||1 422246|C07AB0206|Seloken ZOC|forđatfl|95|mg|98|stk|1|ţpakki||C07AB02|01.07.1988||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|3532|5880|lyfalmen|V0049|4278|1|98|0|62,0700|Vistor hf|AstraZeneca A/S DK|Metóprólól||3532||3532|5880||1 422337|C07AB0206|Seloken ZOC|forđatfl|190|mg|98|stk|1|ţpakki||C07AB02|01.07.1988||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|5808|8993|lyfalmen|V0054|7737|1|98|0|124,1300|Vistor hf|AstraZeneca A/S DK|Metóprólól||5808||5808|8993||1 422474|B02BB0101|Riastap|sts/irs|1|g|1|hgl|1|pakki|lausn|B02BB01|01.12.2011||R|0|0|0|1|0|1|CSB|0|0|0|100|SEK|76230|97551|lyfsjukr|||1|1|0|0,2000|Icepharma hf|CSL Behring GmbH|Manna Fíbrínógen||76230||76230|97551||2 423527|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|20|mg|56|stk|1|ţpakki||A02BC05|01.08.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|IKR|4596|3599|lyfalmen|V0011|2897|3|56|0|37,3300|LYFIS ehf|LYFIS ehf|Esómeprazól||1865||1865|3599||2 423737|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|120|ml|10|fl||J01GB03|01.07.2012||R|0|0|0|0|0|1|BRU|0|0|0|100|XEU|22100|29618|lyfsjukr|||2|1200|0|15,0000|Actavis Group hf|B.Braun Melsungen AG|Gentamícín||22100||22100|29618||1 424960|QP52AC1302|Panacur, vet.|pasta|187,5|mg/g|24|g|1|sk-dćl||QP52AC13|01.05.1999||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|1637|2856|vetorma|||0|24|0||Vistor hf|Intervet International BV|||1637||1637|2856||1 425181|N05CD0306|Flunitrazepam Mylan|töflur|1|mg|100|stk|1|glas||N05CD03|01.10.1992||R|1|0|1|0|0|0|MYL|0|0|0|100|SEK|1119|2579|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Flúnítrazepam||1119||1119|2579||2 425608|N07BC5101|Suboxone|tungur.t|2,5|mg|28|stk|1|ţpakki|2+0,5 mg|N07BC51|01.08.2011||R|0|0|1|1|0|1|RBP|0|0|0|100|DKK|4818|6907|lyfsjukr|||1|28|0|7,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín í blöndum||4786||4786|6907||1 425939|C09CA0102|Lopress|töflur|12,5|mg|100|stk|1|glas||C09CA01|01.06.2012||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|2248|3953|lyfalmen|||2|100|0|25,0000|Actavis Group hf|Actavis hf|Lósartan||2124||2124|3953||1 426122|R01AA0503|Nezeril|nefdr|0,1|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|0|0|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||0|2|0|0,5000|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||||1 426593|J01CE0204|Kaavepenin|töflur|500|mg|20|stk|1|ţpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|702|2008|lyfalmen|||1|20|0|5,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||702||702|2008||1 426601|J01CE0204|Kaavepenin|töflur|500|mg|30|stk|1|ţpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|916|2301|lyfalmen|||1|30|0|7,5000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||916||916|2301||1 427186|C10BA0201|Inegy|töflur|90|mg|28|stk|1|ţpakki|10 mg + 80 mg|C10BA02|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|9054|13433|lyfalmen|V0614|13433|1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb og simvastatín||9054||9054|13433||1 427765|A06AB0801|Laxoberal|dropar|7,5|mg/ml|30|ml|1|plglas||A06AB08|01.09.2008||L|0|0|0|0|0|0|BII|0|0|0|100|IKR|||lyfalmen|||0|30|0|45,0000|Vistor hf|Boehringer Ingelheim International |Natríum pícósúlfat|||||2807||1 428018|R06AX2201|Kestine|filmhtfl|10|mg|10|stk|1|ţpakki||R06AX22|01.06.2012||L|1|0|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||||1 428441|D07AC1301|Elocon|krem|0,1|%|30|g|1|túpa||D07AC13|01.08.2008||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|868|2235|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||868||868|2235||1 428524|D07AC1301|Elocon|smyrsli|0,1|%|30|g|1|túpa||D07AC13|01.08.2008||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1019|2442|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||1019||1019|2442||1 428822|C10AA0504|Atorvastatin Portfarma|filmhtfl|20|mg|100|stk|1|ţpakki||C10AA05|01.06.2006||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|6185|1896|lyfalmen|V0113|1746|2|100|0|100,0000|Portfarma ehf|Portfarma|Atorvastatín||620||620|1896||2 428828|N06DA0303|Nimvastid (Lyfis)|hylki|3|mg|112|stk|1|ţpakki||N06DA03|01.04.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|XEU|27914|30874|lyfalmen|V0344|30874|3|112|0|37,3300|LYFIS ehf|LYFIS ehf|Rívastigmín||22431||22431|30874||2 429098|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|500|ml|20|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|4106|5926|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||4106||4106|5926||2 429167|J07CA0602|Pentavac|bóluefni|||0,5|ml|1|hgl|+ dreifa í dćlu|J07CA06|01.10.1999||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|4267|6885|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|barnaveiki, haemophilus influenza B, kíghósti, mćnusótt, stí||4267||4267|6885||2 429225|J07CA0602|Pentavac|bóluefni|||0,5|ml|10|hgl||J07CA06|01.12.1999||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|41987|55417|lyfalmen|||1|5|0||Icepharma hf|Sanofi Pasteur MSD|barnaveiki, haemophilus influenza B, kíghósti, mćnusótt, stí||41987||41987|55417||2 429503|J02AC0401|Noxafil|mixtúra|40|mg/ml|105|ml|1|fl||J02AC04|01.07.2012||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|101890|129754|lyfsjukr|||1|105|0|5,2500|Vistor hf|Merck Sharp & Dohme Limited|Posacónazól||101890||101890|129754||1 429837|C03DA0101|Aldactone|töflur|100|mg|100|stk|1|ţpakki||C03DA01|01.11.1981||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|4124|6689|lyfalmen|||1|100|0|133,3333|Icepharma hf|Pfizer ApS|Spírónólaktón||4124||4124|6689||1 430009|N01AH0102|Leptanal|stl|50|mcg/ml|10|ml|5|lykjur||N01AH01|01.10.1989||R|0|0|1|0|0|1|JAS|0|0|0|100|SEK|1769|2553|lyfsjukr|||1|50|0||Vistor hf|Janssen-Cilag AB|Fentanýl||1769||1769|2553||1 430074|N05CD0801|Dormicum|stl|1|mg/ml|5|ml|10|lykjur||N05CD08|01.07.1990||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|1456|2101|lyfsjukr|||1|50|0|3,3333|Icepharma hf|Roche|Mídazólam||1456||1456|2101||2 430157|QJ01EW1001|Tribrissen, vet.|stl|480|mg/ml|100|ml|1|hgl|80+400 mg/ml|QJ01EW10|01.10.1990||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|4516|8844|vetalmen|||0|100|0||Vistor hf|Intervet International BV|||4516||4516|8844||1 430281|L02BG0303|Astrozol|filmhtfl|1|mg|98|stk|1|ţpakki||L02BG03|01.08.2011||R|0|0|0|0|G|0|WIH|0|0|0|100|XEU|29589|11981|lyfalmen|V0184|11981|2|98|0|98,0000|Portfarma ehf|Williams & Halls|Anastrózól||7992||7992|11981||2 430417|N03AX2101|Trobalt|filmhtfl|400|mg|84|stk|1|ţpakki||N03AX21|01.12.2011|30.06.2013|R|1|1|0|0|G|0|GGL|0|0|0|100|GBP|32309|43271|lyfalmen|||1|84|0|37,3300|GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||32309||32309|43271||1 430521|G04BE0305|Vizarsin (Lyfis)|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|2994|3741|lyfalmen|V0144|3049|3|4|0|8,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||1969||1969|3741||2 430710|J07AP0301|Typhim Vi|stl|25|mcg/spr|0,5|ml|1|áfspr||J07AP03|01.07.1994||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|2476|4435|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Taugaveiki, hreinsađir mótefnavakar||2476||2476|4435||2 430862|J01FA1005|Azithromycin Actavis|filmhtfl|500|mg|2|stk|1|ţpakki||J01FA10|01.05.2013||R|1|0|0|0|0|0|AHF|0|0|1|100|XEU|1105|2560|lyfalmen|V0173|2560|2|2|0|3,3300|Actavis Group PTC ehf|Actavis Group hf|Azitrómýcín||1105||1105|2560||1 431023|D06AX0101|Fucidin|smyrsli|20|mg/g|15|g|1|túpa||D06AX01|01.04.1989||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|768|2099|lyfalmen|||1|15|0||Vistor hf|LEO Pharma A/S|Fúsidínsýra||768||768|2099||1 431049|C01DA0801|Sorbangil|töflur|10|mg|100|stk|1|ţpakki||C01DA08|01.07.1989||R|1|0|0|0|G|0|REP|0|0|0|100|SEK|1210|2703|lyfalmen|||1|100|0|16,6667|Vistor hf|Recip AB|Ísósorbíđ dínítrat||1210||1210|2703||1 431495|L01CD0201|Taxotere|irţ|160|mg|8|ml|1|hgl|lausn|L01CD02|01.04.2011||R|0|0|0|1|0|1|AVS|0|0|0|100|NOK|238633|301367|lyfsjukr|||1|8|0||Vistor hf|Aventis Pharma SA|Docetaxel||238633||238633|301367||1 431759|M01AB5503|Arthrotec Forte|töflur|75,2|mg|20|stk|1|ţpakki|75+0,2 mg|M01AB55|01.09.2009||R|1|0|0|0|G|0|PER|0|0|1|100|DKK|1427|3000|lyfalmen|||1|20|0|15,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||||1427|3000||1 431783|M01AB5503|Arthrotec Forte|töflur|75,2|mg|100|stk|1|ţpakki|75+0,2 mg|M01AB55|01.09.2009||R|1|0|0|0|G|0|PER|0|0|1|100|DKK|4426|7102|lyfalmen|||1|100|0|75,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||4426||4426|7102||1 432665|M09AX0101|Artzal|stl|10|mg/ml|2,5|ml|5|dćlur|einnota dćlur plast|M09AX01|01.10.2011||R|0|0|0|0|G|0|NDR|0|0|0|100|SEK|34583|46125|lyfalmen|||1|12,5|0|34,7222|Vistor hf|Nordic Drugs AB|Natríumhýalúrónat||||34583|46125||1 432972|QJ01CR0201|Combisyn|töflur|50|mg|100|stk|1|töflur||QJ01CR02|01.02.2012||R|0|0|0|0|0|0|NOB|1|0|0|100|XEU|3746|7365|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og Clavulansýra||3746||3746|7365||2 433194|N05AD0301|Buronil|húđuđtfl|25|mg|100|stk|1|glas||N05AD03|01.01.2013||R|1|0|0|0|G|0|MEV|0|0|0|100|DKK|1787|3492|lyfalmen|||1|100|0|8,3333|Vistor hf|MediLink A/S|Melperón||1787||1787|3492||1 433250|N04BX0201|Comtess|töflur|200|mg|100|stk|1|glas||N04BX02|01.07.1999||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|11162|16317|lyfalmen|||1|100|0|20,0000|Vistor hf|Orion Corporation|Entakapón||11162||11162|16317||1 433292|N02AA0106|Contalgin Uno|forđahlk|30|mg|28|stk|1|ţpakki||N02AA01|01.05.1998||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|2611|4620|lyfalmen|||1|28|0|8,4000|Icepharma hf|Pfizer ApS|Morfín||2611||2611|4620||1 433318|N02AA0106|Contalgin Uno|forđahlk|90|mg|28|stk|1|ţpakki||N02AA01|01.05.1998||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|5715|8866|lyfalmen|||1|28|0|25,2000|Icepharma hf|Pfizer ApS|Morfín||5715||5715|8866||1 433512|A02BC0507|Esomeprazole Portfarma|sţ-tfl|20|mg|7|stk|1|ţpakki||A02BC05|01.11.2011||R|1|0|0|0|0|0|POF|0|0|0|100|IKR|581|1843|lyfalmen|V0004|534|2|7|0|4,6700|Portfarma ehf|Portfarma|Esómeprazól||581||581|1843||2 434088|V08CA0901|Gadovist|stl|1|mmol/ml|15|ml|10|hgl|lausn|V08CA09|01.03.2013||R|0|0|0|0|0|1|BYP|0|0|0|100|DKK|199787|252615|lyfsjukr|||1|150|0||Icepharma hf|Bayer Pharma AG|Gadóbútról||199787||199787|252615||2 434091|N06DX0102|Memantine Merz|filmhtfl|10|mg|100|stk|1|ţpakki||N06DX01|01.07.2013||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|18571|26030|lyfalmen|V0605|26030|2|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||18571||18571|26030||1 434169|R03DC0304|Montelukast Teva|filmhtfl|10|mg|98|stk|1|ţpakki||R03DC03|01.01.2013||R|1|0|0|0|G|0|TEV|0|0|0|100|XEU|7050|5579|lyfalmen|V0490|5579|2|98|0|98,0000|Medical ehf|Teva Pharma B.V.|Montelúkast||3312||3312|5579||2 434261|QN01AX9301|Tricaine Pharmaq|duft|1000|mg/g|1000|g|1|askja|lausn handa fiskum|QN01AX93|01.07.2013||R|0|0|0|0|0|0|PHL|0|0|0|100|GBP|97224|158621|veteldis|||0|1000|0||PHARMAQ Ltd.|PHARMAQ Ltd|Tricaine Methane Sulfónat||97224||97224|158621||1 434639|QP52AC1302|Panacur, vet.|töflur|250|mg|10|stk|1|ţpakki||QP52AC13|01.04.1992||L|0|0|0|0|0|0|IBV|0|0|0|100|DKK|1147|2001|vetorma|||0|10|0||Vistor hf|Intervet International BV|||||1147|2001||1 434670|D01AC2001|Daktacort|krem|||50|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|0|MCS|0|0|1|100|SEK|932|2323|lyfalmen|||1|50|0||Vistor hf|McNeil Sweden AB|Blöndur||932||932|2323||1 434829|C01CA2404|EpiPen|stl|0,3|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|0|0|0|0|G|0|MEB|0|0|1|100|DKK|5855|9057|lyfalmen|||1|1|0|0,6000|Vistor hf|Meda AB (V)|Adrenalín tartrat||5855||5855|9057||1 434837|C01CA2405|EpiPen Junior|stl|0,15|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|0|0|0|0|G|0|MEB|0|0|1|100|DKK|5855|9057|lyfalmen|||1|1|0|0,3000|Vistor hf|Meda AB (V)|Adrenalín tartrat||5855||5855|9057||1 434852|N06AB0302|Fontex|dreifit.|20|mg|100|stk|1|pakki|ţp (10x10 stk)|N06AB03|01.06.1998||R|1|0|0|0|0|0|ELI|0|0|0|100|XEU|10382|15250|lyfalmen|V0315|5938|1|100|0|100,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||10382||10382|15250||2 435537|N02CC0301|Zomig|töflur|5|mg|6|stk|1|ţpakki||N02CC03|01.06.1999||R|1|0|0|0|G|0|ASZ|0|0|0|100|SEK|6979|10595|lyfalmen|||1|6|0|12,0000|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||6979||6979|10595||1 435594|N02CC0301|Zomig|töflur|2,5|mg|6|stk|1|ţpakki||N02CC03|01.11.1998||R|1|0|0|0|G|0|ASZ|0|0|0|100|SEK|4432|7111|lyfalmen|||1|6|0|6,0000|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||4432||4432|7111||1 435651|N05AH0401|Seroquel|töflur|25|mg|100|stk|1|ţpakki||N05AH04|01.09.1998||R|1|0|0|0|0|0|AZA|0|0|0|100|SEK|8612|11323|lyfalmen|V0284|2642|1|100|0|6,2500|Vistor hf|AstraZeneca AB|Quetíapín||7511||7511|11323||1 435817|N05AH0407|Quetiapina Qualigen (Lyfjaver)|töflur|25|mg|60|stk|1|ţpakki||N05AH04|01.06.2011||R|1|0|0|0|G|0|LVR|0|0|0|100|IKR|929|2142|lyfalmen|V0284|1585|3|60|0|3,7500|Lyfjaver ehf|Lyfjaver ehf|Quetíapín||800||800|2142||3 435974|C01DA0801|Sorbangil|töflur|10|mg|250|stk|1|plglas||C01DA08|01.04.2004||R|1|0|0|0|G|0|REP|0|0|0|100|SEK|2913|5033|lyfalmen|||1|250|0|41,6700|Vistor hf|Recip AB|Ísósorbíđ dínítrat||2913||2913|5033||1 436010|L01AA0901|Levact|irţ|2,5|mg/ml|100|mg|5|hgl|lausn|L01AA09|01.11.2011||R|0|0|0|1|0|1|AST|0|1|0|100|DKK|238318|300972|lyfsjukr|||1|500|0||Icepharma hf|Astellas Pharma GmbH|Bentamustine||238318||238318|300972||2 436022|C09DA0308|Diovan Comp 80 mg/12,5 mg|töflur|92,5|mg|28|stk|1|pakki||C09DA03|01.10.1999||R|1|0|0|0|0|0|NOH|0|0|0|100|DKK|3570|5932|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og ţvagrćsilyf||3570||3570|5932||1 436147|M01AE0217|Naproxen-E Mylan|sh-tfl|250|mg|20|stk|1|ţpakki||M01AE02|01.07.1993||L|1|0|0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa|||0|20|0|10,0000|Icepharma hf|Mylan AB|Naproxen|||||||2 436394|H01BA0202|Octostim|nefúđi|0,15|mg/sk|2,5|ml|1|úđagl||H01BA02|01.01.2013||R|0|0|0|1|0|1|FEL|0|0|0|100|DKK|43538|56523|lyfsjukr|||1|2,5|0|150,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||43538||43538|56523||1 436410|D06AX0101|Fucidin|krem|20|mg/g|15|g|1|túpa||D06AX01|01.01.1989||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|748|2071|lyfalmen|||1|15|0||Vistor hf|LEO Pharma A/S|Fúsidínsýra||748||748|2071||1 436877|L01AA0901|Levact|irţ|2,5|mg/ml|25|mg|20|hgl|lausn|L01AA09|01.11.2011||R|0|0|0|1|0|1|AST|0|1|0|100|DKK|244403|308608|lyfsjukr|||1|500|0||Icepharma hf|Astellas Pharma GmbH|Bentamustine||244403||244403|308608||2 436915|N05AD0101|Haldol|töflur|1|mg|100|stk|1|ţpakki||N05AD01|01.12.1972||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|995|2409|lyfalmen|||1|100|0|12,5000|Vistor hf|Janssen-Cilag AB|Halóperídól||995||995|2409||1 436931|N05AD0101|Haldol|töflur|4|mg|100|stk|1|ţpakki||N05AD01|01.12.1972||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|3640|6027|lyfalmen|||1|100|0|50,0000|Vistor hf|Janssen-Cilag AB|Halóperídól||3640||3640|6027||1 437013|B01AC0404|Clopidogrel Krka (Lyfis)|filmhtfl|75|mg|100|stk|1|ţpakki||B01AC04|01.07.2010||R|1|0|0|0|G|0|LYF|0|0|0|100|XEU|8442|7030|lyfalmen|V0029|7030|3|100|0|100,0000|LYFIS ehf|LYFIS ehf|Klópídógrel||4373||4373|7030||2 437774|N06DX0103|Nemdatine|filmhtfl|10|mg|98|stk|1|ţpakki||N06DX01|01.07.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|18845|26374|lyfalmen|V0605|25509|2|98|0|49,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Memantín||18845||18845|26374||1 437935|L01AA0901|Levact|irţ|2,5|mg/ml|25|mg|5|hgl|lausn|L01AA09|01.11.2011||R|0|0|0|1|0|1|AST|0|1|0|100|DKK|68503|87854|lyfsjukr|||1|125|0||Icepharma hf|Astellas Pharma GmbH|Bentamustine||68503||68503|87854||2 438225|N07XX0701|Fampyra|forđatfl|10|mg|28|stk|1|glas||N07XX07|01.12.2011||R|0|0|0|1|0|0|BIB|0|0|0|100|XEU|32977|44109|lyfalmen|V0016|44109|1|28|0|14,0000|Icepharma hf|Biogen Idec Ltd|Fampridine||32977||32977|44109||2 438416|S02CA0301|Ciproxin-Hydrocortison|eyrnadr|||10|ml|1|túpa|2 mg + 10 mg/ml|S02CA03|01.09.2002||R|0|0|0|0|G|0|SAL|0|0|1|100|USD|1236|2739|lyfalmen|||1|10|0||Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Hýdrókortisón og sýkingalyf||1236||1236|2739||1 438432|N06AX1602|Efexor Depot|forđahlk|75|mg|98|stk|1|ţpakki||N06AX16|01.10.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|11208|16380|lyfalmen|V0334|5971|1|98|0|73,5000|Icepharma hf|Pfizer ApS|Venlafaxín||11208||11208|16380||1 438759|L01XE1501|Zelboraf|filmhtfl|240|mg|56|stk|1|ţpakki||L01XE15|01.08.2012||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|349859|440956|lyfsjukr|||1|56|0||Icepharma hf|Roche Registration Limited|Vemurafeníb||349859||349859|440956||2 438762|R06AX1301|Clarityn|töflur|10|mg|10|stk|1|ţpakki||R06AX13|01.07.1989||L|1|0|0|0|0|0|MBV|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Vistor hf|Merck Sharp & Dohme B.V.|Lóratadín|||||||1 438770|R06AX1301|Clarityn|töflur|10|mg|30|stk|1|ţpakki||R06AX13|01.07.1989||L|1|0|0|0|0|0|MBV|0|0|1|100|IKR|||lyflausa|||1|30|0|30,0000|Vistor hf|Merck Sharp & Dohme B.V.|Lóratadín|||||||1 438788|R06AX1301|Clarityn|töflur|10|mg|100|stk|1|ţpakki||R06AX13|01.07.1989||L|1|0|0|0|G|0|MBV|0|0|1|100|DKK|||lyfalmen|V0362|2090|1|100|0|100,0000|Vistor hf|Merck Sharp & Dohme B.V.|Lóratadín|||||9226||1 438806|B03XA0201|Aranesp|stl|130|mcg/spr|0,65|ml|4|áf.spr|nálavörn|B03XA02|01.12.2010||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|166096|210333|lyfsjukr|||1|2,6|0|115,5600|Vistor hf|Amgen|Darbepóetín alfa||166096||166096|210333||1 439208|J01DC0203|Zinnat|töflur|250|mg|14|stk|1|ţpakki||J01DC02|01.10.1990||R|0|0|0|0|0|0|GSK|0|0|1|100|GBP|2591|4592|lyfalmen|||1|14|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||2591||2591|4592||1 439489|C07FB0201|Logimax|forđatfl|55|mg|98|stk|1|pakki|ţp 5+50 mg|C07FB02|01.04.1997||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|8898|13220|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Metóprólól og önnur blóđţrýstingslćkkandi lyf||8898||8898|13220||1 439594|C10BA0201|Inegy|töflur|50|mg|98|stk|1|ţpakki|10 mg + 40 mg|C10BA02|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|22303|30714|lyfalmen|V0615|30714|1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb og simvastatín||22303||22303|30714||1 439794|R01AA0704|Otrivin ukonserveret|nefúđi|1|mg/ml|10|ml|1|glas|sk-úđari|R01AA07|01.05.2001||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||||1 440099|J01CR0202|Augmentin|mixtduft|91,4|mg/ml|70|ml|1|glas|80+11,4 mg/ml|J01CR02|01.08.1998||R|0|0|0|0|0|0|GSK|0|0|1|100|IKR|1066|2278|lyfalmen|V0163|2130|1|70|0|5,6000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||899||899|2278||1 440677|J01CE0106|Penicillin Actavis|sts|600|mg/hgl|10|hgl|1|pakki|1 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|0|1|AGT|0|0|0|100|DKK|1494|2156|lyfsjukr|||2|10|0|1,6700|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||1494||1494|2156||1 440693|J01CE0106|Penicillin Actavis|sts|1,2|g/hgl|10|hgl|1|pakki|2 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|0|1|AGT|0|0|0|100|DKK|2359|3405|lyfsjukr|||2|10|0|3,3300|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||2359||2359|3405||1 441006|C03DA0101|Aldactone|töflur|25|mg|100|stk|1|ţpakki||C03DA01|01.12.1972||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|934|2326|lyfalmen|V0046|2326|1|100|0|33,3333|Icepharma hf|Pfizer ApS|Spírónólaktón||934||934|2326||1 441279|D01AC2002|Pevisone|krem|||30|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|0|JAS|0|0|1|100|SEK|1273|2789|lyfalmen|||1|30|0||Vistor hf|Janssen-Cilag AB|Blöndur||1273||1273|2789||1 441619|J05AR0801|Eviplera|filmhtfl|470|mg|30|stk|1|glas|200+25+245 mg|J05AR08|01.05.2012||R|0|0|0|1|0|1|GIL|0|0|0|100|DKK|126497|160636|lyfsjukr|||1|30|0||Gilead Sience Sweden AB|Gilead Science International Limited|Emtrícítabín, rilpívírin og tenófóvír||126497||126497|160636||3 441634|P03AC0401|Nix|hársápa|10|mg/ml|59|ml|1|pakki||P03AC04|01.01.1996||L|0|0|0|0|0|0|ACH|0|0|0|100|IKR|||lyflausa|||0|59|0||Aco Hud Nordic AB|ACO Hud AB|Permetrín|||||||1 441949|G03DC0202|Primolut N|töflur|5|mg|30|stk|1|ţpakki||G03DC02|01.12.1972||R|0|0|0|0|G|0|BAP|0|0|0|100|DKK|1062|2501|lyfalmen|||1|30|0|30,0000|Icepharma hf|Bayer Schering Pharma AG|Noretísterón||1062||1062|2501||2 442407|N05AH0312|Zalasta|töflur|15|mg|28|stk|1|ţpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|14592|6629|lyfalmen|V0283|3268|2|28|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||4080||4080|6629||2 442705|B01AE0701|Pradaxa|hylki|150|mg|60|stk|1|ţpakki|hart|B01AE07|01.10.2011||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|11524|16812|lyfalmen|V0460|15370|1|60|0|40,9000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||||11524|16812||1 443135|H04AA0102|GlucaGen Hypokit|sts|1|mg|1|stk|1|hgl|dćla|H04AA01|01.01.1989||R|0|0|0|0|G|0|NAS|0|0|1|100|DKK|3480|5808|lyfalmen|||1|1|0|1,0000|Vistor hf|Novo-Nordisk A/S|Glúkagon||3480||3480|5808||1 443358|N02AA0101|Contalgin|forđatfl|200|mg|90|stk|1|ţpakki||N02AA01|01.04.1993||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|26532|36021|lyfalmen|||1|90|0|180,0000|Icepharma hf|Pfizer ApS|Morfín||26532||26532|36021||1 443500|L01XA0211|Carboplatin Actavis|irţ|10|mg/ml|45|ml|1|hgl||L01XA02|01.05.2013||R|0|0|0|1|0|1|APC|0|0|0|100|XEU|4678|6752|lyfsjukr|||2|45|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Karbóplatín||4678||4678|6752||1 444041|N05AH0501|Sycrest|tungur.t|10|mg|20|stk|1|ţpakki||N05AH05|01.10.2011||R|0|0|0|0|0|0|ORR|0|0|0|100|DKK|7682|11557|lyfalmen|||1|20|0|10,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||7682||7682|11557||1 444102|A06AB0603|Senokot (Icepharma)|töflur|7,5|mg|60|stk|1|ţpakki||A06AB06|01.10.2012||R|1|0|0|0|0|0|ICE|0|0|0|100|GBP|982|2391|lyfalmen|||3|60|0||Icepharma hf|Icepharma hf|Senna||982||982|2391||2 444315|N06AB0302|Fontex|dreifit.|20|mg|30|stk|1|pakki|ţp (2 x 15 stk)|N06AB03|01.06.1998||R|1|0|0|0|0|0|ELI|0|0|0|100|DKK|3154|5362|lyfalmen|V0061|3416|1|30|0|30,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||3154||3154|5362||2 444362|N01AF0302|Pentocur|sts|1|g|10|hgl|1|pakki||N01AF03|01.07.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|26494|35132|lyfsjukr|||2|10|0||Icepharma hf|Abcur AB|Tíópentalnatríum||26494||26494|35132||2 444430|N04BA0208|Madopar Quick "62,5"|lausnart|62,5|mg|100|stk|1|glas|50+12,5 mg|N04BA02|01.11.2000||R|0|0|0|0|G|0|ROC|0|0|0|100|DKK|2296|4189|lyfalmen|||1|100|0|8,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2296||2296|4189||2 445155|D07CA0102|Fucidin-Hydrocortison|krem|30|mg/g|30|g|1|túpa|20 + 10 mg|D07CA01|01.02.1998||R|0|0|0|0|G|0|LEO|0|0|1|100|DKK|1602|3239|lyfalmen|||1|30|0||Vistor hf|LEO A/S|Hýdrókortisón og sýklalyf||1602||1602|3239||1 445479|N04BC0407|Ropinirol Actavis|forđatfl|2|mg|84|stk|1|ţpakki||N04BC04|01.12.2012||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|8705|8561|lyfalmen|V0532|8561|2|84|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rópíníról||5492||5492|8561||1 446187|QA12CX9001|Tonophosphan, vet.|stl|200|mg/ml|50|ml|1|hgl||QA12CX90|01.12.1972||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|1459|2902|vetalmen|||0|50|0||Vistor hf|Intervet International BV|||1459||1459|2902||1 446268|C08CA0502|Adalat Oros|forđatfl|20|mg|98|stk|1|ţpakki||C08CA05|01.03.2013||R|1|0|0|0|G|0|BGB|0|0|0|100|DKK|6724|10246|lyfalmen|||1|98|0|65,3333|Icepharma hf|Bayer Pharma AG|Nífedipín||||6724|10246|31.5.2013|2 446618|N03AF0301|Inovelon|mixtúra|40|mg/ml|460|ml|1|fl||N03AF03|01.09.2012||R|0|0|0|1|G|0|EIS|0|0|0|100|SEK|20251|28138|lyfalmen|||1|460|0|13,1400|Vistor hf|Eisai Ltd|Rúfínamíđ||20251||20251|28138||1 447052|B01AB0401|Fragmin|stl|25000|ae/ml|0,72|ml|5|áf.spr|18000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|10684|15663|lyfalmen|||1|3,6|0|36,0000|Icepharma hf|Pfizer ApS|Dalteparín||10684||10684|15663||1 447110|B01AB0401|Fragmin|stl|25000|ae/ml|0,4|ml|5|áf.spr|10000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|6089|9377|lyfalmen|||1|2|0|20,0000|Icepharma hf|Pfizer ApS|Dalteparín||6089||6089|9377||1 447136|B01AB0401|Fragmin|stl|25000|ae/ml|0,5|ml|5|áf.spr|12500 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|7537|11358|lyfalmen|||1|2,5|0|25,0000|Icepharma hf|Pfizer ApS|Dalteparín||7537||7537|11358||1 447151|B01AB0401|Fragmin|stl|25000|ae/ml|0,6|ml|5|áf.spr|15000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|8969|13317|lyfalmen|||1|3|0|30,0000|Icepharma hf|Pfizer ApS|Dalteparín||8969||8969|13317||1 448125|C08CA0501|Adalat|töflur|10|mg|100|stk|1|ţpakki||C08CA05|01.03.2013||R|1|0|0|0|G|0|BGB|0|0|0|100|DKK|3022|5182|lyfalmen|V0082|5182|1|100|0|33,3333|Icepharma hf|Bayer Pharma AG|Nífedipín||||3022|5182||2 448217|C05AA0801|Doloproct|eţ-stíll|||10|stk|1|pakki||C05AA08|01.01.1991||R|0|0|0|0|0|0|IGB|0|0|0|100|DKK|672|1967|lyfalmen|||1|10|0||Icepharma hf|Intendis GmbH Berlin|Flúókortólón||672||672|1967||2 448233|C05AA0801|Doloproct|eţ-krem|||30|g|1|túpa||C05AA08|01.01.1991||R|0|0|0|0|0|0|IGB|0|0|0|100|DKK|1314|2845|lyfalmen|||1|30|0||Icepharma hf|Intendis GmbH Berlin|Flúókortólón||1314||1314|2845||2 448688|M03BX0103|Lioresal|töflur|25|mg|50|stk|1|ţpakki||M03BX01|01.12.1972||R|1|0|0|0|G|0|NOH|0|0|1|100|DKK|2136|3970|lyfalmen|V0202|3739|1|50|0|25,0000|Vistor hf|Novartis Healthcare A/S-|Baklófen||2136||2136|3970||1 449470|B05BB0120|Natriumhydrogenkarbonat B.Braun|irl|500|mmól/l|0,25|l|1|fl|lausn|B05BB01|01.02.2012||R|0|0|0|0|0|1|BRU|0|0|0|100|XEU|1158|1671|lyfsjukr|||2|0,25|0||Actavis Group hf|B.Braun Melsungen AG|Elektrólýtar||1158||1158|1671||1 449611|C07AB0311|Atenolol Mylan|töflur|100|mg|98|stk|1|ţpakki||C07AB03|01.01.1991||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1450|3031|lyfalmen|||2|98|0|130,6667|Icepharma hf|Mylan AB|Atenólól||1450||1450|3031||2 449819|J01CE0106|Penicillin Actavis|sts|3|g/hgl|10|hgl|1|pakki|5 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|0|1|AGT|0|0|0|100|DKK|5595|8075|lyfsjukr|||2|10|0|8,3300|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||5595||5595|8075||1 449911|A10AC0110|Humulin NPH KwikPen|stl|100|ae/ml|3|ml|5|pennar|áfylltur penni|A10AC01|01.01.2012||R|0|0|0|0|G|0|ELI|0|0|0|100|XEU|5439|8488|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Danmark A/S|Insúlín (manna)||5439||5439|8488||2 450009|QN51AA0101|Euthasol vet.|stl|400|mg/ml|100|ml|1|fl||QN51AA01|01.07.2012||R|0|0|1|0|0|0|LEV|1|0|0|100|XEU|4716|9228|vetalmen|||0|100|0||Le Vet B.V.|Le Vet B.V.|Pentobarbital||4716||4716|9228||2 450155|J01CR0202|Augmentin|töflur|1|g|12|stk|1|pakki|ţp 875+125 mg|J01CR02|01.01.1997||R|0|0|0|0|0|0|GSK|0|0|1|100|IKR|1115|2415|lyfalmen|V0169|1857|1|12|0|10,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||999||999|2415||1 450775|N05CF0201|Stilnoct|töflur|10|mg|100|stk|1|ţpakki||N05CF02|01.10.1992||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|3108|4224|lyfalmen|||1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||2322||2322|4224||1 450979|QP54AA0107|Noromectin Drench|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA01|01.11.2011||R|0|0|0|0|0|0|NOB|1|0|0|100|XEU|7526|13129|vetorma|||0|2,5|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||7526||7526|13129||2 451153|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|56010|72175|lyfsjukr|||1|100|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||56010||56010|72175||2 451419|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|84016|107323|lyfsjukr|||1|150|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||84016||84016|107323||2 451476|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|112019|142466|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||112019||112019|142466||2 451761|L01AB0101|Myleran|filmhtfl|2|mg|100|stk|1|glas||L01AB01|01.06.2013||R|0|0|0|1|G|0|ATL|0|0|0|100|XEU|3531|5878|lyfalmen|V0068|5878|1|100|0||Aspen Pharma Trading Ltd.|Aspen Pharma Trading Ltd.|Búsúlfan||3531||3531|5878||1 451989|N06AB0401|Cipramil|töflur|30|mg|28|stk|1|ţpakki||N06AB04|01.11.1999||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|5777|8161|lyfalmen|||1|28|0|42,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||5200||5200|8161||1 451997|N06AB0401|Cipramil|töflur|30|mg|100|stk|1|glas||N06AB04|01.11.1999||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|15256|21870|lyfalmen|||1|100|0|150,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||15256||15256|21870||1 452022|D01AC0801|Fungoral|sápa|20|mg/ml|120|ml|1|fl||D01AC08|01.01.2012||L|0|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|120|0||Vistor hf|McNeil Sweden AB|Ketókónazól|||||||1 452284|M01AB1501|Toradol|stl|30|mg/ml|1|ml|5|lykjur||M01AB15|01.04.1992||R|0|0|0|0|G|0|ROA|0|0|1|100|DKK|1172|2651|lyfalmen|||1|5|0|5,0000|Icepharma hf|Roche A.S.|Ketórólak||1172||1172|2651||2 452467|QI09AB0401|Rhiniseng|stl|||50|ml|1|hgl|dreifa|QI09AB04|01.03.2011||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|11276|19670|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||11276||11276|19670||2 452482|V07AB0009|Sterilt Vann B. Braun|leysir|||100|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|2000|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||1 452862|D06BB1001|Aldara|krem|50|mg/g|250|mg|12|stk|einnota pokar|D06BB10|01.03.2000||R|0|0|0|0|0|0|LAB|0|0|1|100|SEK|12376|18255|lyfalmen|||1|3000|0||Vistor hf|Laboratories 3M Santé|Imikvímóđ||12376||12376|18255||1 452866|B05AA0114|Albuman|irl|200|g/líter|100|ml|1|hgl|lausn|B05AA01|01.03.2013||R|0|0|0|0|0|1|SSB|0|0|0|100|XEU|8714|12576|lyfsjukr|||1|100|0||Williams & Halls efh|Stichting Sanquin Bloedvoorziening|Albúmín||8714||8714|12576||2 452896|A06AD1701|Phosphoral|mixtúra|||45|ml|2|fl||A06AD17|01.03.1999||R|0|0|0|0|0|0|LCC|0|0|0|100|DKK|2366|4284|lyfalmen|||1|90|0||Clean Chemical Sweden AB|Laboratorios Casen-Fleet S.L.U.|Natríumfosföt||2366||2366|4284||1 452904|N02AA0501|Oxycontin|forđatfl|10|mg|28|stk|1|ţpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|2398|4328|lyfalmen|V0597|3669|1|28|0|3,7300|Icepharma hf|Norpharma |Oxýcódon||2398||2398|4328||2 452920|N02AA0501|Oxycontin|forđatfl|10|mg|98|stk|1|ţpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|5313|8316|lyfalmen|V0598|7165|1|98|0|13,0700|Icepharma hf|Norpharma |Oxýcódon||5313||5313|8316||2 452995|N02AA0501|Oxycontin|forđatfl|20|mg|28|stk|1|ţpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|4630|7382|lyfalmen|V0584|6115|1|28|0|7,4700|Icepharma hf|Norpharma |Oxýcódon||4630||4630|7382||2 453126|QP54AA0101|Eqvalan, vet.|pasta|18,7|mg/g|6,4|g|1|sk-dćl||QP54AA01|01.01.1991||R|0|0|0|0|0|0|MEF|0|0|0|100|XEU|1490|2599|vetorma|||0|6,4|0||Vistor hf|Merial (MSD)|Ivermectinum||1490||1490|2599||1 453175|N02AA0501|Oxycontin|forđatfl|20|mg|98|stk|1|ţpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|10409|15287|lyfalmen|V0585|13715|1|98|0|26,1300|Icepharma hf|Norpharma |Oxýcódon||10409||10409|15287||2 453498|N02AA0501|Oxycontin|forđatfl|40|mg|28|stk|1|ţpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|8861|13169|lyfalmen|V0586|10743|1|28|0|14,9300|Icepharma hf|Norpharma |Oxýcódon||8861||8861|13169||2 453571|N02AA0501|Oxycontin|forđatfl|40|mg|98|stk|1|ţpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|19747|27506|lyfalmen|V0587|24421|1|98|0|52,2700|Icepharma hf|Norpharma|Oxýcódon||19747||19747|27506||2 453753|N05AE0401|Zeldox|sts|20|mg/hgl|1|hgl|1|pakki|+leysir|N05AE04|01.03.2002||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|2779|4011|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Pfizer ApS|Ziprasidon||2779||2779|4011||1 453795|J07AL0102|Pneumo 23|bóluefni|||0,5|ml|1|dćla||J07AL01|01.09.2003||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|2323|4226|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Hreinsuđ pneumococca poly­sakkaríđ mótefnavakar||2323||2323|4226||2 454036|A09AA0206|Creon 10.000|sh-hylki|150|mg|100|stk|1|plglas||A09AA02|01.07.2013||R|1|0|0|0|G|0|APR|0|0|0|100|DKK|3228|5464|lyfalmen|||1|100|0|16,6700|Vistor hf|Abbott Products GmbH|Hvatablöndur (lípasi, próteasi o.s.frv.)||3228||3228|5464||1 454439|N06DA0201|Aricept|töflur|5|mg|28|stk|1|ţpakki||N06DA02|01.09.1998||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|15484|22156|lyfalmen|||1|28|0|18,6667|Icepharma hf|Pfizer ApS|Dónepezíl||15484||15484|22156||1 454454|N06DA0201|Aricept|töflur|5|mg|98|stk|1|ţpakki||N06DA02|01.09.1998||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|43930|39501|lyfalmen|V0341|9401|1|98|0|65,3333|Icepharma hf|Pfizer ApS|Dónepezíl||29305||29305|39501||1 454491|A02BC0507|Esomeprazole Portfarma|sţ-tfl|20|mg|28|stk|1|ţpakki||A02BC05|01.11.2011||R|1|0|0|0|0|0|POF|0|0|0|100|IKR|2138|2174|lyfalmen|V0004|2135|2|28|0|18,6700|Portfarma ehf|Portfarma|Esómeprazól||823||823|2174||2 454678|N06DA0201|Aricept|töflur|10|mg|28|stk|1|ţpakki||N06DA02|01.09.1998||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|17382|24538|lyfalmen|||1|28|0|37,3333|Icepharma hf|Pfizer ApS|Dónepezíl||17382||17382|24538||1 454686|N06DA0201|Aricept|töflur|10|mg|98|stk|1|ţpakki||N06DA02|01.09.1998||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|48400|44002|lyfalmen|V0342|9401|1|98|0|130,6667|Icepharma hf|Pfizer ApS|Dónepezíl||32891||32891|44002||1 454819|N02BE0115|Paracet|eţ-stíll|60|mg|10|stk|1|pakki||N02BE01|01.07.2011||L|0|0|0|0|0|0|AGP|0|0|1|100|IKR|||lyflausa|||0|10|0|0,2000|Actavis Group hf|Actavis Group PTC ehf|Paracetamól|||||||1 454850|L01XX1701|Hycamtin|irs|4|mg/hgl|1|hgl|1|pakki||L01XX17|01.02.1999||R|0|0|0|1|0|1|SKB|0|0|0|100|GBP|52584|67875|lyfsjukr|||1|1|0||GlaxoSmithKline ehf|SmithKline Beecham Ltd|Tópótecan||52584||52584|67875||1 454918|QJ01CE0902|Penovet, vet.|stl|300000|ae/ml|100|ml|1|hgl||QJ01CE09|01.10.1997||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|1159|2305|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Danmark|||1159||1159|2305||1 454955|J01CA0414|Amoxicilline Actavis Disper|töflur|750|mg|20|stk|1|ţpakki|hrćra vel í vatni og drekka|J01CA04|01.03.2013||R|0|0|0|0|0|0|AVB|0|0|1|100|XEU|1743|3432|lyfalmen|||2|20|0|15,0000|Actavis Group PTC ehf|Actavis BV|Amoxicillín||1743||1743|3432||1 455329|A10BF0101|Glucobay|töflur|50|mg|30|stk|1|ţpakki||A10BF01|01.12.1997||R|1|0|0|0|G|0|BGB|0|0|0|100|DKK|1084|2531|lyfalmen|||1|30|0|5,0000|Icepharma hf|Bayer Pharma AG|Acarbósa||1084||1084|2531||2 455337|A10BF0101|Glucobay|töflur|50|mg|120|stk|1|ţpakki||A10BF01|01.12.1997|30.06.2013|R|1|0|0|0|G|0|BYP|0|0|0|100|DKK|3763|6196|lyfalmen|||1|120|0|20,0000|Icepharma hf|Bayer Pharma AG|Acarbósa||3763||3763|6196||2 455584|J05AB0901|Famvir|töflur|500|mg|21|stk|1|ţpakki||J05AB09|01.10.1995||R|1|0|0|0|G|0|NOH|0|0|1|100|DKK|22138|30507|lyfalmen|||1|21|0|14,0000|Vistor hf|Novartis Healthcare A/S-|Famcíclóvír||22138||22138|30507||1 455949|J01AA0207|Doxylin|töflur|100|mg|10|stk|1|ţpakki||J01AA02|01.10.2008||R|1|0|0|0|0|0|AGT|0|0|1|100|XEU|556|1809|lyfalmen|||2|10|0|10,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||556||556|1809||1 455956|J01AA0207|Doxylin|töflur|100|mg|15|stk|1|ţpakki||J01AA02|01.01.2009||R|1|0|0|0|0|0|AGT|0|0|1|100|XEU|1030|2457|lyfalmen|||2|15|0|15,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||1030||1030|2457||1 455972|J01AA0207|Doxylin|töflur|100|mg|30|stk|1|ţpakki||J01AA02|01.10.2008||R|1|0|0|0|0|0|AGT|0|0|1|100|XEU|2018|3808|lyfalmen|||2|30|0|30,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||2018||2018|3808||1 457508|J07AH0801|Nimenrix|sts|5|mcg|0,5|ml|1|hgl|+áfyllt sprauta|J07AH08|01.07.2013||R|0|0|0|0|0|0|GSB|0|0|0|100|GBP|7430|11212|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals|Hreinsađir fjórgildi A,C,Y,W-135 og fl.||7430||7430|11212||1 457615|N06AB1006|Escitalopram Portfarma|filmhtfl|20|mg|100|stk|1|ţpakki||N06AB10|01.11.2012||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|4787|3784|lyfalmen|V0327|2949|2|100|0|200,0000|Portfarma ehf|Portfarma|Escítalópram||2000||2000|3784||2 457692|L01BA0109|Metoject|stl|50|mg/ml|0,45|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|3660|6055|lyfalmen|||1|0,45|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||3660||3660|6055||2 457726|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|28|stk|1|ţpakki||A02BC04|01.05.2011||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|808|1646|lyfalmen|V0003|1646|2|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||437||437|1646||1 458067|N05CM0201|Heminevrin|hylki|300|mg|25|stk|1|glas||N05CM02|01.12.1998||R|1|0|0|0|0|0|CHE|0|0|1|100|SEK|1211|2705|lyfalmen|||1|25|0|5,0000|Vistor hf|CHEPLAPHARM Arzneimittel GmbH|Clómetíazól||1211||1211|2705||1 458349|J01CA0801|Selexid|töflur|200|mg|20|stk|1|ţpakki||J01CA08|01.12.1980||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|1456|3040|lyfalmen|V0577|2382|1|20|0|6,6667|Vistor hf|LEO Pharma A/S|Pívmecillínam||1456||1456|3040||1 458865|A07AA0906|Vancomycin Xellia|hylki|250|mg|28|stk|1|ţpakki|hart hylki|A07AA09|01.01.2011||R|1|0|0|0|G|0|XEL|0|0|1|100|DKK|24449|33407|lyfalmen|||2|28|0|3,5000|Actavis Group hf|Xellia Pharmaceuticals ApS|Vankómýcín||24449||24449|33407||1 459354|J01FF0101|Dalacin|stl|150|mg/ml|2|ml|1|lykja||J01FF01|01.11.1979||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|865|1248|lyfsjukr|||1|2|0|0,1667|Icepharma hf|Pfizer ApS|Klindamýcín||865||865|1248||1 459420|J01FF0101|Dalacin|stl|150|mg/ml|4|ml|1|lykja||J01FF01|01.11.1979||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|1584|2286|lyfsjukr|||1|4|0|0,3333|Icepharma hf|Pfizer ApS|Klindamýcín||1584||1584|2286||1 459766|N05AH0501|Sycrest|tungur.t|5|mg|20|stk|1|ţpakki||N05AH05|01.10.2011||R|0|0|0|0|0|0|ORR|0|0|0|100|DKK|7682|11557|lyfalmen|||1|20|0|5,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||7682||7682|11557||1 459828|N07BA0145|Nicorette Freshdrops|munnstfl|2|mg|96|stk|1|ţpakki||N07BA01|01.12.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 459859|B02AA0201|Cyklokapron|töflur|500|mg|30|stk|1|ţpakki||B02AA02|01.04.1989||R|1|0|0|0|G|0|MAS|0|0|1|100|SEK|2280|4167|lyfalmen|||1|30|0|7,5000|Vistor hf|Meda AS|Tranexamsýra||2280||2280|4167||1 459867|B02AA0201|Cyklokapron|töflur|500|mg|60|stk|1|ţpakki||B02AA02|01.04.1989||R|1|0|0|0|G|0|MAS|0|0|1|100|SEK|2800|4878|lyfalmen|||1|60|0|15,0000|Vistor hf|Meda AS|Tranexamsýra||2800||2800|4878|30.6.2013|1 460170|J07BC0202|Avaxim|bóluefni|||0,5|ml|1|dćla|einnota dćla|J07BC02|01.04.1998||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|4063|6606|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Lifrarbólga-A, dauđ veira (inactiv­ated whole virus)||4063||4063|6606||2 460293|J04AB0201|Rimactan|hylki|150|mg|100|stk|1|ţpakki||J04AB02|01.09.2012||R|1|0|0|0|G|0|SAD|0|0|0|100|DKK|8311|12417|lyfalmen|||1|100|0|25,0000|Icepharma hf|Sandoz GmbH|Rífampicín||8311||8311|12417||2 460826|QJ01CR0201|Combisyn|töflur|250|mg|100|stk|1|töflur||QJ01CR02|01.11.2011||R|0|0|0|0|0|0|NOB|1|0|0|100|XEU|7199|13996|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og Clavulansýra||7199||7199|13996||2 460972|J07BB0205|Influvac|bóluefni|||0,5|ml|10|áf.spr||J07BB02|01.12.1998||R|0|0|0|0|0|0|AHP|0|0|0|100|XEU|5658|8788|lyfalmen|||1|5|0||Vistor hf|Abbott Healthcare Products B.V.|Inflúensa, hreinsađir mótefnavakar||5658||5658|8788||1 461731|N02BE5102|Parkodin|töflur|510|mg|10|stk|1|pakki|ţp 10+500 mg|N02BE51|01.01.1989||R|1|0|0|0|0|0|ACA|0|0|1|100|XEU|208|1332|lyfalmen|||2|10|0|1,6667|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema međ geđlyfjum (psycholeptica)||208||208|1332||1 462028|D07AD0101|Dermovat|krem|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|517|1755|lyfalmen|||1|25|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||517||517|1755||1 462044|D07AD0101|Dermovat|smyrsli|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|570|1828|lyfalmen|||1|25|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||570||570|1828||1 462049|C08CA0501|Adalat|töflur|20|mg|100|stk|1|ţpakki||C08CA05|01.03.2013||R|1|0|0|0|G|0|BGB|0|0|0|100|DKK|3796|6241|lyfalmen|V0083|6241|1|100|0|66,6667|Icepharma hf|Bayer Pharma AG|Nífedipín||||3796|6241||2 462358|A07EA0601|Entocort|endaţ.dr|20|mcg/ml|7|stk|1|ţpakki|samsett pk|A07EA06|01.04.1993||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|7187|10879|lyfalmen|||1|7|0|7,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||7187||7187|10879||1 462813|A07AA0906|Vancomycin Xellia|hylki|125|mg|28|stk|1|ţpakki|hart hylki|A07AA09|01.01.2011||R|1|0|0|0|G|0|XEL|0|0|1|100|DKK|12208|18044|lyfalmen|||2|28|0|1,7500|Actavis Group hf|Xellia Pharmaceuticals ApS|Vankómýcín||12208||12208|18044||1 462986|QM01AE9101|Rimadyl vet.|stl|50|mg/ml|20|ml|1|hgl||QM01AE91|01.06.2000||R|0|0|0|0|0|0|PAL|1|0|0|100|DKK|6769|13170|vetalmen|||0|20|0||Icepharma hf|Pfizer Oy Animal Health|||||6769|13170||2 463490|N03AX2101|Trobalt|filmhtfl|100|mg|84|stk|1|ţpakki||N03AX21|01.12.2011|30.06.2013|R|1|1|0|0|G|0|GGL|0|0|0|100|GBP|8631|12855|lyfalmen|||1|84|0|9,3300|GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||8631||8631|12855||1 463612|QM01AE9101|Rimadyl vet.|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.06.2000||R|0|0|0|0|0|0|PAL|0|0|0|100|DKK|5400|10541|vetalmen|||0|100|0||Icepharma hf|Pfizer Oy Animal Health|||5400||5400|10541||2 463642|J01XA0107|Vancomycin Xellia|irs|1|g/hgl|1|hgl|1|pakki||J01XA01|01.04.2013||R|0|0|0|0|0|1|XEL|0|0|0|100|XEU|809|1168|lyfsjukr|||2|1|0|0,5000|Actavis Group hf|Xellia Pharmaceuticals ApS|Vankómýcín||809||809|1168||1 463941|M01AX0501|Glucomed|töflur|625|mg|60|stk|1|ţpakki||M01AX05|01.11.2012||L|1|0|0|0|0|0|LEX|0|0|1|100|IKR|||lyflausa|||0|60|0|52,8000|Icepharma hf|Laboratories Expansvience|Glúkósamín|||||||2 464164|N02BE0101|Panodil|töflur|500|mg|30|stk|1|ţpakki||N02BE01|01.04.1992||L|1|0|0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1 465065|S01EE0104|Latanoprost Actavis|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.10.2011||R|0|0|0|0|G|0|APC|0|0|0|100|DKK|3021|5181|lyfalmen|V0376|5181|2|7,5|0|75,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Latanóprost||3021||3021|5181||1 465203|QJ01RA0103|Depomycine, vet.|stl|||100|ml|1|hgl||QJ01RA01|01.12.1982||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|1199|2385|vetalmen|||0|100|0||Vistor hf|Intervet International BV|||1199||1199|2385||1 465237|QJ01CR5001|Duplocillin L.A., vet.|stl|||100|ml|1|hgl||QJ01CR50|01.05.1983||R|0|0|0|0|0|0|IBV|1|0|0|100|DKK|1133|2254|vetalmen|||0|100|0||Vistor hf|Intervet International BV|||1133||1133|2254||1 465260|QJ01AA0603|Engemycin, vet.|stl|100|mg/ml|100|ml|1|hgl||QJ01AA06|01.12.1982||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|1214|2415|vetalmen|||0|100|0||Vistor hf|Intervet International BV|||1214||1214|2415||1 465278|QJ51RC2301|Nafpenzal DC, vet.|spenalyf|||3|g|4|spr||QJ51RC23|01.04.1985||R|0|0|0|0|0|0|IBV|0|0|0|100|XEU|640|1273|vetalmen|||0|12|0||Vistor hf|Intervet International BV|Prókaínpenicillín í blöndum međ öđrum sýklalyfjum||640||640|1273||1 465333|L01BA0109|Metoject|stl|50|mg/ml|0,6|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|4015|6540|lyfalmen|||1|0,6|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||4015||4015|6540||2 465472|M05BA0803|Zoledronic acid Actavis|irţ|4|mg/hgl|5|ml|1|hgl|lausn|M05BA08|01.06.2013||R|0|0|0|1|0|1|APC|0|0|0|100|XEU|33798|44299|lyfsjukr|||2|5|0|1,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Zoledronsýra||33798||33798|44299||1 465932|L04AA1303|Leflunomide ratiopharm|filmhtfl|20|mg|100|stk|1|glas||L04AA13|01.05.2013||R|0|1|0|1|G|0|RGM|0|0|0|100|XEU|27895|32297|lyfalmen|V0454|29725|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Leflúnómíđ||23565||23565|32297||2 466003|N06AB0310|Seromex|hylki|20|mg|30|stk|1|ţpakki||N06AB03|01.02.2013||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|1601|1867|lyfalmen|V0038|1867|2|30|0|30,0000|Medical ehf|ratiopharm GmbH|Flúoxetín||599||599|1867||2 466029|N06AB0310|Seromex|hylki|20|mg|100|stk|1|ţpakki||N06AB03|01.02.2013||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|4767|3098|lyfalmen|V0039|3098|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Flúoxetín||1499||1499|3098||2 466086|N02AA0101|Contalgin|forđatfl|10|mg|25|stk|1|ţpakki||N02AA01|01.07.1992||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|674|1970|lyfalmen|||1|25|0|2,5000|Icepharma hf|Pfizer ApS|Morfín||674||674|1970||1 466094|N02AA0101|Contalgin|forđatfl|10|mg|100|stk|1|ţpakki||N02AA01|01.08.1984||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|2475|4434|lyfalmen|||1|100|0|10,0000|Icepharma hf|Pfizer ApS|Morfín||2475||2475|4434||1 466169|N02AA0101|Contalgin|forđatfl|30|mg|25|stk|1|ţpakki||N02AA01|01.07.1992||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|1492|3089|lyfalmen|||1|25|0|7,5000|Icepharma hf|Pfizer ApS|Morfín||1492||1492|3089||1 466219|N02AA0101|Contalgin|forđatfl|30|mg|100|stk|1|ţpakki||N02AA01|01.08.1984||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|5172|8123|lyfalmen|||1|100|0|30,0000|Icepharma hf|Pfizer ApS|Morfín||5172||5172|8123||1 466466|N02AA0101|Contalgin|forđatfl|60|mg|25|stk|1|ţpakki||N02AA01|01.10.1995||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|2775|4844|lyfalmen|||1|25|0|15,0000|Icepharma hf|Pfizer ApS|Morfín||2775||2775|4844||1 466482|L04AD0102|Sandimmun Neoral|hylki|25|mg|50|stk|1|ţpakki||L04AD01|01.07.1994||R|0|0|0|0|G|0|NOH|0|0|0|100|DKK|7993|11982|lyfalmen|||1|50|0|5,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||7993||7993|11982||1 466680|N02AA0101|Contalgin|forđatfl|100|mg|25|stk|1|ţpakki||N02AA01|01.07.1992||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|4565|7293|lyfalmen|||1|25|0|25,0000|Icepharma hf|Pfizer ApS|Morfín||4565||4565|7293||1 466813|N06AG0201|Aurorix|töflur|150|mg|100|stk|1|ţpakki||N06AG02|01.10.1990||R|1|0|0|0|G|0|MAS|0|0|0|100|SEK|4330|6971|lyfalmen|V0063|6449|1|100|0|50,0000|Vistor hf|Meda AS|Móklóbemíđ||4330||4330|6971||1 467191|L03AA0201|Neupogen|stl|0,6|mg/ml|0,5|ml|1|spr|áfyllt sprauta, lausn|L03AA02|01.02.2004||R|0|0|0|1|0|1|AEU|0|0|0|100|DKK|15418|21232|lyfsjukr|||1|0,5|0|0,8600|Vistor hf|Amgen Europe B.V.|Fílgrastím||15418||15418|21232||1 467258|L03AA0201|Neupogen|stl|0,96|mg/ml|0,5|ml|1|spr|áfyllt sprauta, lausn|L03AA02|01.02.2004||R|0|0|0|1|0|1|AEU|0|0|0|100|DKK|23628|31536|lyfsjukr|||1|0,5|0|1,3700|Vistor hf|Amgen Europe B.V.|Fílgrastím||23628||23628|31536||1 467459|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|50|ml|50|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|7475|10788|lyfsjukr|||1|2500|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||7475||7475|10788||2 467480|L03AB0502|IntronA|stl|18|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|0|0|0|1|0|1|SCP|0|0|0|100|DKK|18662|24530|lyfsjukr|||1|1,2|0|9,0000|Vistor hf|Schering-Plough|Interferón alfa-2b||18046||18046|24530||1 467514|L04AA1001|Rapamune|mixtúra|1|mg/ml|60|ml|1|fl||L04AA10|01.04.2004||R|0|0|0|1|G|0|WTE|0|0|0|100|DKK|34202|45647|lyfalmen|V0582|45647|1|60|0|20,0000|Icepharma hf|Wyeth Europe|Sirolimus||34202||34202|45647||2 467563|L04AD0102|Sandimmun Neoral|hylki|50|mg|50|stk|1|ţpakki||L04AD01|01.07.1994||R|0|0|0|0|G|0|NOH|0|0|0|100|DKK|15593|22293|lyfalmen|||1|50|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||15593||15593|22293||1 467621|L03AB0502|IntronA|stl|60|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|0|0|0|1|0|1|SCP|0|0|0|100|DKK|55982|69812|lyfsjukr|||1|1,2|0|30,0000|Vistor hf|Schering-Plough|Interferón alfa-2b||54127||54127|69812||1 467699|G03FA1701|Angemin|töflur|||84|stk|1|ţpakki|2+1 mg|G03FA17|01.10.2012||R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|7570|11403|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og östrogen||7570||7570|11403||2 467720|L04AD0102|Sandimmun Neoral|hylki|100|mg|50|stk|1|ţpakki||L04AD01|01.07.1994||R|0|0|0|0|G|0|NOH|0|0|0|100|DKK|29690|39984|lyfalmen|||1|50|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||29690||29690|39984||1 467810|J01DI0201|Zinforo|irţ|600|mg|10|hgl|1|pakki|lausn|J01DI02|01.04.2013||R|0|0|0|0|0|1|AZA|0|0|0|100|SEK|97907|124756|lyfsjukr|||1|10|0||Vistor hf|AstraZeneca AB|Ceftarólin||97907||97907|124756||1 467993|N05AD0101|Haldol|stl|5|mg/ml|1|ml|5|lykjur||N05AD01|01.08.2000||R|0|0|0|0|0|1|JAS|0|0|0|100|SEK|526|759|lyfsjukr|||1|5|0|3,1250|Vistor hf|Janssen-Cilag AB|Halóperídól||526||526|759||1 468082|N06AB0401|Cipramil|töflur|10|mg|100|stk|1|plglas||N06AB04|01.04.1993||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|6471|6782|lyfalmen|V0317|2067|1|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||4192||4192|6782||1 468116|N01AH0102|Leptanal|stl|50|mcg/ml|2|ml|5|lykjur||N01AH01|01.11.2001||R|0|0|1|0|0|1|JAS|0|0|0|100|SEK|400|577|lyfsjukr|||1|10|0||Vistor hf|Janssen-Cilag AB|Fentanýl||400||400|577||1 468124|N06AB0401|Cipramil|töflur|20|mg|100|stk|1|glas||N06AB04|01.04.1993||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|9422|6465|lyfalmen|V0318|2204|1|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||3960||3960|6465||1 468165|N06AB0401|Cipramil|töflur|40|mg|100|stk|1|glas||N06AB04|01.04.1993||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|23806|12959|lyfalmen|V0320|4187|1|100|0|200,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||8707||8707|12959||1 468568|J01XA0107|Vancomycin Xellia|irs|500|mg/hgl|1|hgl|1|pakki||J01XA01|01.04.2013||R|0|0|0|0|0|1|XEL|0|0|0|100|XEU|405|585|lyfsjukr|||2|1|0|0,2500|Actavis Group hf|Xellia Pharmaceuticals ApS|Vankómýcín||405||405|585||1 468803|M05BA0705|Risedronat Actavis|filmhtfl|35|mg|12|stk|1|ţpakki||M05BA07|01.03.2011||R|1|0|0|0|G|0|APC|0|0|0|100|IKR|4530|1664|lyfalmen|V0207|1664|2|12|0|84,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rísedrónsýru||450||450|1664||1 468996|A02BC0402|Rabeprazol Actavis|sţ-tfl|10|mg|100|stk|1|glas||A02BC04|01.01.2012||R|1|0|0|0|G|0|APC|0|0|0|100|IKR|4172|5146|lyfalmen|V0467|5146|2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||2996||2996|5146||1 469346|C10AB0401|Lopid|töflur|600|mg|98|stk|1|ţpakki||C10AB04|01.07.1991||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|5689|8830|lyfalmen|||1|98|0|49,0000|Icepharma hf|Pfizer ApS|Gemfíbrózíl||5689||5689|8830||1 469375|N03AX1404|Levetiracetam Actavis|filmhtfl|500|mg|100|stk|1|glas||N03AX14|01.11.2012||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|12221|5918|lyfalmen|V0253|5436|2|100|0|33,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||3560||3560|5918||1 469480|B05BA0311|Glucos Fresenius Kabi|irl|500|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|7660|11055|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||7660||7660|11055||2 469817|N02AX0206|Nobligan Retard|forđatfl|200|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|1|0|1|0|G|0|GRU|0|0|1|100|DKK|6371|9763|lyfalmen|V0228|9060|1|100|0|66,6667|Icepharma hf|Grunenthal|Tramadól||6371||6371|9763||2 469874|N02AX0206|Nobligan Retard|forđatfl|150|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|1|0|1|0|G|0|GRU|0|0|1|100|DKK|5180|8134|lyfalmen|V0227|7321|1|100|0|50,0000|Icepharma hf|Grunenthal|Tramadól||5180||5180|8134||2 469932|N02AX0206|Nobligan Retard|forđatfl|100|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|1|0|1|0|G|0|GRU|0|0|1|100|DKK|3382|5674|lyfalmen|V0226|4997|1|100|0|33,3333|Icepharma hf|Grunenthal|Tramadól||3382||3382|5674||2 470385|R03BA0501|Flixotide|innúđal|250|mcg/sk|120|skammtar|1|stauk||R03BA05|01.04.1995||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|4633|7386|lyfalmen|||1|120|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||4633||4633|7386||1 470397|N05CM1801|Dexdor|irţ|100|mcg/ml|4|ml|4|hgl|lausn|N05CM18|01.03.2012||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|31209|41050|lyfsjukr|||1|16|0|1,6000|Vistor hf|Orion Corporation|Dexmedetómid||31209||31209|41050||1 470989|V08AB0201|Omnipaque|stl|180|mg J/ml|15|ml|10|plastf||V08AB02|01.01.2005||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|7299|10534|lyfsjukr|||1|150|0||Icepharma hf|GE Healthcare AS|Jóhexól||7299||7299|10534||2 471144|V08AB0201|Omnipaque|stl|240|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|9743|14062|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Jóhexól||9743||9743|14062||2 471151|V08AB0201|Omnipaque|stl|300|mg J/ml|10|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|IKR|4414|6371|lyfsjukr|||1|100|0||Icepharma hf|GE Healthcare AS|Jóhexól||4414||4414|6371||2 471169|V08AB0201|Omnipaque|stl|300|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|9734|14049|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Jóhexól||9734||9734|14049||2 471177|V08AB0201|Omnipaque|stl|350|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|13979|19426|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Jóhexól||13979||13979|19426||2 471425|A10BB0701|Mindiab|töflur|5|mg|100|stk|1|ţpakki||A10BB07|01.07.1990||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|1230|2731|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Glípízíđ||1230||1230|2731||1 471821|QP52AC1302|Panacur, vet.|töflur|250|mg|20|stk|1|ţpakki||QP52AC13|01.04.1992||L|0|0|0|0|0|0|IBV|0|0|0|100|DKK|2146|3744|vetorma|||0|20|0||Vistor hf|Intervet International BV|||||2146|3744||1 471938|L01AA0101|Sendoxan|töflur|50|mg|100|stk|1|ţpakki||L01AA01|01.01.1988||R|0|0|0|0|G|0|BAM|0|0|0|100|SEK|3463|5785|lyfalmen|||1|100|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíđ||3463||3463|5785||2 471953|QV03AB9001|Antisedan, vet.|stl|5|mg/ml|10|ml|1|hgl||QV03AB90|01.08.2006||R|0|0|0|0|0|0|ORC|1|0|0|100|DKK|4807|9403|vetalmen|||0|10|0||Vistor hf|Orion Corporation|Atipamesól||4807||4807|9403||1 472092|C07AB0206|Seloken ZOC|forđatfl|47,5|mg|98|stk|1|ţpakki||C07AB02|01.07.1989||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|2176|4025|lyfalmen|V0048|2848|1|98|0|31,0300|Vistor hf|AstraZeneca A/S DK|Metóprólól||2176||2176|4025||1 472099|R02AA0307|Strepsils Warm|sogtfl|||24|stk|1|ţpakki||R02AA03|01.08.2011||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 472332|J07BC0201|Havrix|bóluefni|1440|ein/ml|0,5|ml|1|dćla|einnota dćla|J07BC02|01.10.1995||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|3094|5280|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-A, dauđ veira (inactiv­ated whole virus)||3094||3094|5280||1 472338|S01AA2701|APROKAM|sts|50|mg|10|hgl|1|pakki|lausn|S01AA27|01.04.2013||R|0|0|0|1|0|1|THA|0|0|0|100|SEK|16082|22065|lyfsjukr|||1|10|0||Vistor hf|Laboratories THEA|Cefuroxím||16082||16082|22065||1 472599|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|40|mg|98|stk|1|glas||A02BC05|01.08.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|9141|5179|lyfalmen|V0012|5070|3|98|0|130,6700|LYFIS ehf|LYFIS ehf|Esómeprazól||3020||3020|5179||2 472759|R06AX2701|Aerius|filmhtfl|5|mg|100|stk|1|ţpakki||R06AX27|01.11.2012||R|1|0|0|0|G|0|MLD|0|0|1|100|DKK|4638|7392|lyfalmen|V0458|4291|1|100|0|100,0000|Vistor hf|Merck Sharp & Dohme Limited|Deslóratadín||4638||4638|7392||1 474007|B05AA0507|Promiten|stl|150|mg/ml|20|ml|20|lykjur|plastlykjur|B05AA05|01.03.1999||R|0|0|0|0|0|1|MAB|0|0|0|100|SEK|16117|22109|lyfsjukr|||1|400|0||Vistor hf|Meda AB|Dextran||16117||16117|22109||1 474043|N01AH0601|Remifentanil Actavis|sts/irs|2|mg|5|hgl|1|pakki|ţykkni,lausn|N01AH06|01.06.2012||R|0|0|1|0|0|1|AGP|0|0|0|100|XEU|5331|7694|lyfsjukr|||2|5|0||Actavis Group hf|Actavis Group PTC ehf|Remífentaníl||5331||5331|7694||1 474106|M02AA1301|Deep Relief|hlaup|5|%|50|g|1|túpa||M02AA13|01.06.2000||L|0|0|0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa|||0|50|0||Icepharma hf|Mentholatum Company Ltd.|Íbúprófen|||||||2 474114|N02CA7201|Anervan|töflur|160,5|mg|30|stk|1|pakki|ţp (0,5+10+50+100 mg)|N02CA72|01.10.1995|30.06.2013|R|1|0|0|0|G|0|REP|0|0|0|100|SEK|1033|2461|lyfalmen|||1|30|0|3,7500|Vistor hf|Recip AB|Ergotamínlyf í blöndum međ geđlyfjum (psycoleptica)||1033||1033|2461||1 474197|M02AA1301|Deep Relief|hlaup|5|%|15|g|1|túpa||M02AA13|01.06.2000||L|0|0|0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa|||0|15|0||Icepharma hf|Mentholatum Company Ltd.|Íbúprófen|||||||2 474395|J05AG0101|Viramune|töflur|200|mg|60|stk|1|ţpakki||J05AG01|01.03.2007||R|1|0|0|1|0|1|BII|0|0|0|100|DKK|36885|48173|lyfsjukr|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Nevírapín||36885||36885|48173||1 474551|R01AD0901|Nasonex|nefúđi|50|mcg/sk|140|skammtar|1|úđagl|18 g í pakkn.|R01AD09|01.05.1998||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1781|3484|lyfalmen|||1|140|0|35,0000|Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||1781||1781|3484||1 474608|QB03AC9001|Uniferon|stl|200|mg/ml|100|ml|12|hgl|lausn|QB03AC90|01.08.2011||R|0|0|0|0|0|0|PHM|0|0|0|100|DKK|27906|53756|vetalmen|||0|1200|0||Icepharma hf|Pharmacosmos A/S|Járn hýdróxíđ||||27906|53756||2 474628|N05AH0313|Olanzapin Sandoz|filmhtfl|10|mg|250|stk|1|glas||N05AH03|01.05.2013||R|2|0|0|0|G|0|SHS|0|0|0|100|DKK|32466|15654|lyfalmen|||2|250|0|250,0000|Artasan ehf|Sandoz A/S|Olanzapín||10677||10677|15654||1 474657|N04BC0504|Oprymea (Lyfis)|töflur|0,088|mg|30|stk|1|ţpakki||N04BC05|01.07.2010||R|0|0|0|0|G|0|LYF|0|0|0|100|XEU|808|1372|lyfalmen|V0266|1372|3|30|0|1,0600|LYFIS ehf|LYFIS ehf|Pramipexól||237||237|1372||2 475434|B01AA0301|Kovar|töflur|2|mg|100|stk|1|glas||B01AA03|01.10.1995||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1100|2553|lyfalmen|||2|100|0|26,6667|Actavis Group hf|Actavis hf|Warfarín||1100||1100|2553||1 475467|G03CA0306|Evorel|forđapl|50|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|3193|5416|lyfalmen|V0130|5416|1|26|0|91,0000|Vistor hf|Janssen-Cilag AB|Estradíól||3193||3193|5416||1 475491|N02AA5902|Parkodin forte|töflur|530|mg|20|stk|1|pakki|ţp 30+500 mg|N02AA59|01.04.1992||R|1|0|0|0|0|0|ACA|0|0|1|100|NOK|552|1803|lyfalmen|||2|20|0|6,6667|Actavis Group hf|Actavis hf|Kódein í blöndum nema međ geđlyfjum||552||552|1803||1 475533|N02AA5902|Parkodin forte|töflur|530|mg|30|stk|1|pakki|ţp 30+500 mg|N02AA59|01.04.1992||R|1|0|0|0|0|0|ACA|0|0|1|100|NOK|697|2001|lyfalmen|||2|30|0|10,0000|Actavis Group hf|Actavis hf|Kódein í blöndum nema međ geđlyfjum||697||697|2001||1 475715|N02AA5902|Parkodin forte|töflur|530|mg|100|stk|1|pakki|ţp 30+500 mg|N02AA59|01.04.1992||R|1|0|1|0|0|0|ACA|0|0|1|100|NOK|1652|3308|lyfalmen|||2|100|0|33,3333|Actavis Group hf|Actavis hf|Kódein í blöndum nema međ geđlyfjum||1652||1652|3308||1 475798|R03AC1302|Oxis Turbuhaler|innönddu|4,5|mcg/sk|60|skammtar|1|stauk||R03AC13|01.10.1997||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|3178|5395|lyfalmen|||1|60|0|11,2500|Vistor hf|AstraZeneca A/S DK|Formóteról||3178||3178|5395||1 475822|R03AC1302|Oxis Turbuhaler|innönddu|9|mcg/sk|60|skammtar|1|stauk||R03AC13|01.10.1997||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|4145|6718|lyfalmen|||1|60|0|22,5000|Vistor hf|AstraZeneca A/S DK|Formóteról||4145||4145|6718||1 475921|A10AB0404|Humalog Pen|stl|100|ae/ml|3|ml|5|pennar|einnota pennar|A10AB04|01.11.1999||R|0|0|0|0|G|0|ELD|0|0|0|100|XEU|5636|8758|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||5636||5636|8758||2 476093|A10AC0106|Humulin NPH Pen|stl|100|ae/ml|3|ml|5|pennar|Einnota pennar|A10AC01|01.06.1999||R|0|0|0|0|G|0|ELI|0|0|0|100|XEU|6090|9379|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Danmark A/S|Insúlín (manna)||6090||6090|9379||2 476434|B03XA0201|Aranesp|stl|60|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|78220|100049|lyfsjukr|||1|1,2|0|53,3300|Vistor hf|Amgen|Darbepóetín alfa||||78220|100049||1 476580|R03AC0206|Ventoline|lausn|2|mg/ml|20|lykjur|1|pakki|f. vél|R03AC02|01.04.1992||R|0|0|0|0|G|0|GSK|0|0|1|100|IKR|1146|2616|lyfalmen|||1|20|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||1146||1146|2616||1 476736|N05AH0311|Olanzapine Ranbaxy|töflur|10|mg|56|stk|1|ţpakki||N05AH03|01.12.2011||R|1|0|0|0|G|0|RAN|0|0|0|100|XEU|10766|5237|lyfalmen|V0282|4052|2|56|0|56,0000|Artasan ehf|Ranbaxy (UK) Ltd|Olanzapín||3062||3062|5237||1 477017|C10AX0901|Ezetrol|töflur|10|mg|98|stk|1|ţpakki||C10AX09|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|18532|25981|lyfalmen|V0613|25981|1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb||18532||18532|25981||1 477059|P01BB5101|Malarone|filmhtfl|350|mg|12|stk|1|glas|250 + 100 mg|P01BB51|01.02.2006||R|1|0|0|0|0|0|GSK|0|0|0|100|GBP|5095|8018|lyfalmen|||1|12|0|3,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Prógúaníl í blöndum||5095||5095|8018||1 477547|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|||20|ml|10|hgl|fyrir stungulyf|V07AB|01.02.2007||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|200|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||2 477554|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|||50|ml|10|hgl|fyrir stungulyf|V07AB|01.02.2007||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||2 477752|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|200|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||2 477760|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|50|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||2 477786|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|100|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|1000|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||2 477941|L01XX4401|Zaltrap|irţ|25|mg/ml|4|ml|1|hgl|lausn|L01XX44|01.06.2013||R|0|0|0|1|0|1|SGA|0|0|0|100|NOK|58118|74821|lyfsjukr|||1|4|0||Vistor hf|Sanofi-aventis groupe|Afliberceptum||58118||58118|74821||1 478119|A10BA0202|Metformin Actavis|filmhtfl|500|mg|100|stk|1|glas||A10BA02|01.12.2011||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|483|1577|lyfalmen|V0500|1576|2|100|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Metformín||387||387|1577||1 479407|L04AA1302|Leflunomide medac|filmhtfl|20|mg|100|stk|1|glas||L04AA13|01.07.2011||R|0|1|0|1|G|0|WIL|0|0|0|100|XEU|21515|29725|lyfalmen|V0454|29725|2|100|0|100,0000|Williams & Halls efh|medac Gesellschaft|Leflúnómíđ||21515||21515|29725||2 480867|N06DA0205|Donesyn|filmhtfl|5|mg|98|stk|1|ţpakki||N06DA02|01.05.2011||R|1|0|0|0|G|0|WIH|0|0|0|100|XEU|16516|9401|lyfalmen|V0341|9401|2|98|0|65,3333|Portfarma ehf|Williams & Halls|Dónepezíl||6106||6106|9401||2 480897|G03XC0101|Evista|töflur|60|mg|84|stk|1|ţpakki||G03XC01|01.02.1999||R|0|0|0|0|G|0|DSG|0|0|0|100|SEK|13177|19260|lyfalmen|||1|84|0|84,0000|Icepharma hf|Daiichi Sankyo Europe GmbH|Raloxífen||13177||13177|19260||1 481176|N06AX1201|Zyban|forđatfl|150|mg|100|stk|1|ţpakki||N06AX12|01.09.2000||R|1|0|0|0|0|0|GSK|0|0|0|100|GBP|13736|19962|lyfalmen|||1|100|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Bupropionum||13736||13736|19962||1 481208|D07AC1302|Ovixan|krem|0,1|%|30|g|1|túpa||D07AC13|01.06.2013||R|0|0|0|0|G|0|GAB|0|0|1|100|SEK|861|2226|lyfalmen|||2|30|0||Vistor hf|Gallencia AB|Mómetasón||861||861|2226||1 481534|N02AX0204|Tradolan|filmhtfl|50|mg|20|stk|1|ţpakki||N02AX02|01.05.2012||R|1|0|1|0|G|0|GLP|0|0|1|100|SEK|346|1521|lyfalmen|V0055|1339|1|20|0|3,3300|Vistor hf|G.L.Pharma GmbH|Tramadól||346||346|1521||1 482457|N02BA5102|Treo|freyđit|||20|stk|1|glas||N02BA51|01.12.2012||L|0|0|0|0|0|0|MAB|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Vistor hf|Meda AB|Acetýlsalicýlsýra í blöndum, ţó ekki međ geđlyfjum (psychole|||||||1 483104|L01XC0801|Vectibix|irţ|20|mg/ml|5|ml|1|hgl|lausn|L01XC08|01.03.2013||R|0|1|0|1|0|1|AEU|0|0|0|100|DKK|78047|99831|lyfsjukr|||1|5|0||Vistor hf|Amgen Europe B.V.|Panitúmúmab||78047||78047|99831||1 483217|B01AF0101|Xarelto|filmhtfl|20|mg|98|stk|1|ţpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|38955|51612|lyfalmen|||1|98|0|196,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||38955|51612||2 483371|B05AA0114|Albuman|irl|40|g/líter|400|ml|1|hgl|lausn|B05AA01|01.03.2013||R|0|0|0|0|0|1|SSB|0|0|0|100|XEU|6972|10062|lyfsjukr|||1|400|0||Williams & Halls efh|Stichting Sanquin Bloedvoorziening|Albúmín||6972||6972|10062||2 483602|J02AC0101|Diflucan|irl|2|mg/ml|50|ml|1|fl||J02AC01|01.04.1990||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|2799|4040|lyfsjukr|||1|50|0|0,5000|Icepharma hf|Pfizer ApS|Flúkónazól||2799||2799|4040||1 483663|B03BA0302|Vibeden|stl|1|mg/ml|1|ml|3|lykja||B03BA03|01.07.2012||R|0|0|0|0|G|0|SHS|0|0|1|100|DKK|3567|5927|lyfalmen|||1|3|0|150,0000|Artasan ehf|Sandoz A/S|Hýdroxókóbalamín||3567||3567|5927||1 483685|J02AC0101|Diflucan|irl|2|mg/ml|100|ml|1|hgl||J02AC01|01.03.2001||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|4831|6972|lyfsjukr|||1|100|0|1,0000|Icepharma hf|Pfizer ApS|Flúkónazól||4831||4831|6972||1 483711|S01ED5114|Latanoprost/Timolol Portfarma|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml|S01ED51|01.01.2012||R|0|0|0|0|G|0|POF|0|0|0|100|DKK|2447|4395|lyfalmen|V0374|4395|2|2,5|0|25,0000|Portfarma ehf|Portfarma|Tímólól í blöndum||2447||2447|4395||2 483968|C03AA0305|Hydromed|töflur|12,5|mg|100|stk|1|ţpakki||C03AA03|01.06.2013||R|0|0|0|0|G|0|MEV|0|0|0|100|DKK|967|2371|lyfalmen|||2|100|0|50,0000|Vistor hf|MediLink A/S|hýdróklórtíazíđ||967||967|2371||1 483996|N02AX0212|Tramadol Actavis|hylki|50|mg|20|stk|1|ţpakki||N02AX02|01.09.2011||R|1|0|1|0|G|0|AGP|0|0|1|100|XEU|294|1339|lyfalmen|V0055|1339|2|20|0|3,3300|Actavis Group hf|Actavis Group PTC ehf|Tramadól||213||213|1339||1 484022|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|3|spr|+ leysir|L02AE04|01.01.1995||R|0|0|0|1|0|1|FER|0|0|0|100|DKK|57733|74337|lyfsjukr|||1|3|0|112,5000|Vistor hf|Ferring|Triptórelín||57733||57733|74337||1 484238|D11AX1001|Propecia|töflur|1|mg|28|stk|1|ţpakki||D11AX10|01.08.1999||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|5999|9254|lyfalmen|||1|28|0|28,0000|Vistor hf|M.S.D.|Fínasteríđ||5999||5999|9254||1 484327|L03AA1301|Neulasta|stl|6|mg/spr|0,6|ml|1|spr|nálavörn|L03AA13|01.11.2010||R|0|0|0|1|0|1|AEU|0|0|0|100|DKK|154520|195805|lyfsjukr|||1|0,6|0|20,0000|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||154520||154520|195805||1 484618|A01AD0201|Andolex|lausn|1,5|mg/ml|300|ml|1|glas|lausn til munnskolunar|A01AD02|01.01.1996||R|0|0|0|0|G|0|MEB|0|0|1|100|SEK|1432|3007|lyfalmen|||1|300|0||Vistor hf|Meda AB (V)|Benzýdamín||1432||1432|3007||1 484721|L04AD0201|Advagraf|forđahlk|3|mg|50|stk|1|ţpakki||L04AD02|01.03.2012||R|0|0|0|1|G|0|APE|0|0|0|100|XEU|55339|72174|lyfalmen|||1|50|0|30,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||55339||55339|72174||1 485006|S01BA0401|Ultracortenol|augnsm|5|mg/g|5|g|1|túpa||S01BA04|01.01.2012||R|0|0|0|0|G|0|ANS|0|0|1|100|XEU|1255|2765|lyfalmen|||1|5|0||Anstalt zur gewerblichen Produktion|Anstalt zur gewerblichen Produktion|Prednisólón||1255||1255|2765||1 485252|L01CD0202|Docetaxel Actavis|irţ|20|mg/ml|7|ml|1|hgl|lausn|L01CD02|01.04.2013||R|0|0|0|1|0|1|AVB|0|0|0|100|XEU|9003|12994|lyfsjukr|||2|7|0||Actavis Group PTC ehf|Actavis BV|Docetaxel||9003||9003|12994||1 486779|M01AE0218|Naproxen Mylan|töflur|250|mg|20|stk|1|ţpakki||M01AE02|01.04.1995||L|1|0|0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa|||0|20|0|10,0000|Icepharma hf|Mylan AB|Naproxen|||||||2 486860|S01BA0101|Maxidex|augndr|1|mg/ml|5|ml|1|glas||S01BA01|01.01.1977||R|0|0|0|0|G|0|SAL|0|0|1|100|USD|472|1694|lyfalmen|||1|5|0||Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Dexametasón||472||472|1694||1 486886|S01CA0101|Maxitrol|augndr|||5|ml|1|glas||S01CA01|01.07.1990||R|0|0|0|0|G|0|SAL|0|0|1|100|USD|674|1970|lyfalmen|||1|5|0||Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Dexametasón||674||674|1970||1 487341|A10BG0302|Pioglitazone Actavis|töflur|30|mg|98|stk|1|ţpakki||A10BG03|01.09.2012||R|1|1|0|0|G|0|APC|0|0|0|100|XEU|19874|24168|lyfalmen|V0573|24168|2|98|0|98,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Píóglítazón||17087||17087|24168||1 487682|N06AB1005|Escitalopram LYFIS|filmhtfl|15|mg|100|stk|1|ţpakki||N06AB10|01.02.2012||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|4775|3875|lyfalmen|V0326|3875|2|100|0|150,0000|LYFIS ehf|LYFIS ehf|Escítalópram||2067||2067|3875||2 487692|L04AB0101|Enbrel|sts|10|mg|4|hgl|1|pakki|+ leysir, lausn|L04AB01|01.12.2012||R|0|0|0|1|0|1|IPI|0|1|0|100|DKK|35864|46892|lyfsjukr|||1|4|0|5,7200|Icepharma hf|Pfizer Limited|Etanercept||35864||35864|46892||1 487725|L03AB0502|IntronA|stl|60|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.10.2012||R|0|0|0|1|0|1|SCP|0|0|0|100|DKK|55982|72140|lyfsjukr|||1|1,2|0|30,0000|Vistor hf|Schering-Plough|Interferón alfa-2b||55982||55982|72140||1 487796|L04AA1302|Leflunomide medac|töflur|10|mg|100|stk|1|glas||L04AA13|01.07.2011||R|0|1|0|1|G|0|WIL|0|0|0|100|XEU|33128|44299|lyfalmen|V0453|44299|2|100|0|50,0000|Williams & Halls efh|medac Gesellschaft|Leflúnómíđ||33128||33128|44299||2 487827|M01AB0517|Diclomex|sţ-tfl|50|mg|100|stk|1|ţpakki||M01AB05|01.04.2013||R|1|0|0|0|G|0|RGM|0|0|1|100|IKR|1033|2014|lyfalmen|V0469|2014|2|100|0|50,0000|Medical ehf|ratiopharm GmbH|Díklófenak||706||706|2014||2 488049|M01AX0101|Relifex|töflur|500|mg|20|stk|1|ţpakki||M01AX01|01.04.1995||R|1|0|0|0|G|0|MAB|0|0|1|100|SEK|990|2402|lyfalmen|||1|20|0|10,0000|Vistor hf|Meda AB|Nabúmeton||990||990|2402||1 488056|M01AX0101|Relifex|töflur|500|mg|60|stk|1|plglas||M01AX01|01.07.1998||R|1|0|0|0|G|0|MAB|0|0|1|100|SEK|2753|4814|lyfalmen|V0198|3125|1|60|0|30,0000|Vistor hf|Meda AB|Nabúmeton||2753||2753|4814||1 488767|D05BB0201|Neotigason|hylki|10|mg|50|stk|1|ţpakki||D05BB02|01.04.1992||R|1|0|0|1|G|0|APC|0|0|0|100|DKK|5960|9201|lyfalmen|||1|50|0|14,2857|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||5960||5960|9201||1 488791|D05BB0201|Neotigason|hylki|25|mg|50|stk|1|ţpakki||D05BB02|01.04.1992||R|1|0|0|1|G|0|APC|0|0|0|100|DKK|11406|16651|lyfalmen|||1|50|0|35,7143|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||11406||11406|16651||1 489259|B03XA0201|Aranesp|stl|80|mcg/spr|0,4|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|104265|132735|lyfsjukr|||1|1,6|0|71,1100|Vistor hf|Amgen|Darbepóetín alfa||||104265|132735||1 489591|M01AB0506|Voltaren Rapid|töflur|50|mg|10|stk|1|ţpakki||M01AB05|01.01.1996||R|1|0|0|0|0|0|NOH|0|0|1|100|IKR|338|1311|lyfalmen|V0188|520|1|10|0|5,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||192||192|1311||1 489609|M01AB0506|Voltaren Rapid|töflur|50|mg|30|stk|1|ţpakki||M01AB05|01.01.1996||R|1|0|0|0|G|0|NOH|0|0|1|100|IKR|882|1687|lyfalmen|V0188|1560|1|30|0|15,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||467||467|1687||1 490417|G03FB0504|Evorel Sequi|forđapl|||8|stk|1|pakki||G03FB05|01.08.1999||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|2477|4436|lyfalmen|||1|8|0|28,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||2477||2477|4436||1 490425|G03FA0104|Evorel Conti|forđapl|||8|stk|1|pakki||G03FA01|01.08.1999||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|2460|4413|lyfalmen|||1|8|0|28,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||2460||2460|4413||1 490797|C10AA0501|Zarator|töflur|10|mg|30|stk|1|ţpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|3993|6510|lyfalmen|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Atorvastatín||3993||3993|6510||1 490805|C10AA0501|Zarator|töflur|10|mg|100|stk|1|ţpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|10930|10741|lyfalmen|V0112|2636|1|100|0|50,0000|Icepharma hf|Pfizer ApS|Atorvastatín||7086||7086|10741||1 490813|C10AA0501|Zarator|töflur|20|mg|30|stk|1|ţpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|5309|8310|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Atorvastatín||5309||5309|8310||1 490821|C10AA0501|Zarator|töflur|20|mg|100|stk|1|ţpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|14425|14543|lyfalmen|V0113|1746|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Atorvastatín||9865||9865|14543||1 490854|C10AA0501|Zarator|töflur|40|mg|100|stk|1|ţpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|16474|18344|lyfalmen|V0114|3196|1|100|0|200,0000|Icepharma hf|Pfizer ApS|Atorvastatín||12447||12447|18344||1 491213|N03AX2201|Fycompa|filmhtfl|6|mg|28|stk|1|ţpakki||N03AX22|01.07.2013||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|25764|35057|lyfalmen|||1|28|0||Vistor hf|Eisai Europe Ltd.|Perampanel||25764||25764|35057||1 491313|L03AA0202|Zarzio|stl/irl|30|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.12.2012||R|0|0|0|1|0|1|SAR|0|0|0|100|DKK|42424|55125|lyfsjukr|||1|2,5|0|4,2900|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||42424||42424|55125||1 491860|L03AX0301|Oncotice|duft|500|millj ae|3|hgl|1|pakki|Fyrir ídreypivökva.|L03AX03|01.03.1999||R|0|0|0|1|0|1|ORG|0|0|0|100|DKK|49842|64434|lyfsjukr|||1|3|0|20,8300|Vistor hf|N.V. Organon|BCG bóluefni||49842||49842|64434||1 492405|N04BA0202|Madopar Depot|forđahlk|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.01.1991||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|3314|5581|lyfalmen|||1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3314||3314|5581||2 492512|A02BC0102|Losec|sh-tfl|10|mg|14|stk|1|ţpakki||A02BC01|01.09.2009||L|1|0|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||0|14|0|7,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||||1 492520|A02BC0102|Losec|sh-tfl|10|mg|100|stk|1|glas||A02BC01|01.01.1999||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|13089|19150|lyfalmen|V0002|5316|1|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól||13089||13089|19150||1 492546|A02BC0102|Losec|sh-tfl|20|mg|14|stk|1|ţpakki||A02BC01|01.05.2009||L|1|0|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||0|14|0|14,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||||1 493113|R02AA0306|Strepsils Jordbćr Sukkerfri|sogtfl|||24|stk|1|ţpakki||R02AA03|01.09.2011||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 493218|B03AC0601|Monofer|irl|100|mg/ml|5|ml|1|hgl||B03AC06|01.07.2013||R|0|0|0|0|G|0|PAC|0|0|1|100|DKK|28199|38113|lyfalmen|||1|5|0|5,0000|Vistor hf|Pharmacosmos A/S|Ferrii oxidum- dextran komplex||28199||28199|38113||1 493313|G04BD0704|Tolterodin Actavis|forđahlk|2|mg|100|stk|1|ţpakki||G04BD07|01.01.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|18383|25794|lyfalmen|||2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Tólteródín||18383||18383|25794||1 493689|N03AX1404|Levetiracetam Actavis|filmhtfl|1000|mg|100|stk|1|ţpakki||N03AX14|01.12.2011||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|19123|12282|lyfalmen|V0516|11666|2|100|0|66,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||8212||8212|12282||1 494013|N06AA0601|Surmontil|töflur|25|mg|100|stk|1|glas||N06AA06|01.10.1995||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|1389|2948|lyfalmen|||1|100|0|16,6667|Vistor hf|Sanofi-aventis Norge AS|Trímípramín||1389||1389|2948||1 494138|N02CX0101|Sandomigrin|töflur|0,5|mg|100|stk|1|ţpakki||N02CX01|01.04.1974||R|1|0|0|0|G|0|NOH|0|0|0|100|DKK|2491|4455|lyfalmen|||1|100|0|33,3333|Vistor hf|Novartis Healthcare A/S-|Pízótífen||2491||2491|4455||1 494237|L01XC0201|MabThera|irţ|100|mg|10|ml|2|hgl|lausn|L01XC02|01.11.2003||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|81597|104287|lyfsjukr|||1|20|0||Icepharma hf|Roche Registration Limited|Rítúxímab||81597||81597|104287||2 494286|L01XC0201|MabThera|irţ|500|mg|50|ml|1|hgl|lausn|L01XC02|01.11.2003||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|203992|257892|lyfsjukr|||1|50|0||Icepharma hf|Roche Registration Limited|Rítúxímab||203992||203992|257892||2 494559|D10AF0101|Dalacin|fleyti|10|mg/ml|60|ml|1|glas|Áburđur, fleyti|D10AF01|01.10.1995||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|2033|3829|lyfalmen|||1|60|0||Icepharma hf|Pfizer ApS|Klindamýcín||2033||2033|3829||1 494682|G03CA0320|Estrofem 2 mg|töflur|2|mg|84|stk|1|skífup||G03CA03|01.12.1980||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2280|4167|lyfalmen|V0128|2227|1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Estradíól||2280||2280|4167||1 494724|G03FA0102|Kliogest|töflur|||84|stk|1|skífup||G03FA01|01.10.1986||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|3314|5581|lyfalmen|V0410|5045|1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||3314||3314|5581||1 494831|B01AC0702|Persantin retard|forđahlk|200|mg|60|stk|1|glas|hart hylki|B01AC07|01.04.2006||R|1|0|0|0|G|0|BII|0|0|0|100|DKK|1843|3569|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Dípýrídamól||1843||1843|3569||1 495283|A04AA0101|Zofran|töflur|8|mg|15|stk|1|ţpakki||A04AA01|01.01.1991||R|1|0|0|0|G|0|GSK|0|0|0|100|GBP|18312|6293|lyfalmen|V0384|5820|1|15|0|7,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||3834||3834|6293||1 495382|A04AA0101|Zofran|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.01.1991||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|7122|6399|lyfalmen|V0382|6399|1|10|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||3912||3912|6399||1 495820|J05AH0101|Relenza|innúđadu|5|mg/úđask|20|skammtar|1|stauk|+diskhaler|J05AH01|01.02.2000||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|2794|4870|lyfalmen|||1|20|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Zanamivír||2794||2794|4870||1 496040|N06DA0303|Nimvastid (Lyfis)|hylki|4,5|mg|112|stk|1|ţpakki||N06DA03|01.04.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|XEU|30322|32953|lyfalmen|V0345|32953|3|112|0|56,0000|LYFIS ehf|LYFIS ehf|Rívastigmín||24087||24087|32953||2 496174|QJ01MA9001|Baytril vet.|töflur|150|mg|10|stk|1|ţpakki||QJ01MA90|01.03.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|4620|9044|vetalmen|||0|10|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||4620||4620|9044||2 496468|A10BG0302|Pioglitazone Actavis|töflur|15|mg|98|stk|1|ţpakki||A10BG03|01.09.2012||R|1|1|0|0|G|0|APC|0|0|0|100|XEU|12849|8859|lyfalmen|V0572|8410|2|98|0|49,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Píóglítazón||5710||5710|8859||1 496547|C07AG0101|Trandate|stl|5|mg/ml|20|ml|5|lykjur||C07AG01|01.01.1985||R|0|0|0|0|G|0|ATL|0|0|0|100|GBP|5811|8997|lyfalmen|||1|100|0|0,8333|Aspen Pharma Trading Ltd.|Aspen Pharma Trading Ltd.|Labetalól||5811||5811|8997||1 496554|C07AG0101|Trandate|filmhtfl|100|mg|50|stk|1|glas||C07AG01|01.02.1982||R|1|0|0|0|G|0|ATL|0|0|0|100|GBP|1019|2442|lyfalmen|V0595|2442|1|50|0|8,3333|Aspen Pharma Trading Ltd.|Aspen Pharma Trading Ltd.|Labetalól||1019||1019|2442||1 496644|L03AB0103|Multiferon|stl|3|millj ae|0,5|ml|6|áf.spr|lausn|L03AB01|01.12.2011||R|0|0|0|1|0|1|SOI|0|1|0|100|DKK|86770|110779|lyfsjukr|||1|3|0|9,0000|Swedish Orphan International AB|Swedish Orphan International AB|Interferón-alfa natural||86770||86770|110779||3 496752|C07AG0101|Trandate|filmhtfl|200|mg|100|stk|1|glas||C07AG01|01.01.1986||R|1|0|0|0|G|0|ATL|0|0|0|100|GBP|3198|5423|lyfalmen|V0600|5423|1|100|0|33,3333|Aspen Pharma Trading Ltd.|Aspen Pharma Trading Ltd.|Labetalól||3198||3198|5423||1 496935|N02AG0201|Ketogan|eţ-stíll|||10|stk|1|pakki||N02AG02|01.07.1994||R|0|0|1|0|G|0|PER|0|0|0|100|DKK|473|1695|lyfalmen|||1|10|0|4,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||473||473|1695||1 496950|N02AG0201|Ketogan|töflur|||20|stk|1|ţpakki|5 + 25 mg|N02AG02|01.07.1994||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|854|2216|lyfalmen|||1|20|0|4,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||854||854|2216||1 497012|A07AA1201|Dificlir|filmhtfl|200|mg|20|stk|1|ţpakki||A07AA12|01.08.2012||R|1|0|0|0|0|1|APE|0|0|0|100|XEU|250166|315841|lyfsjukr|||1|20|0|10,0000|Vistor hf|Astellas Phama Europe B.V.|Fidaxomicin||250166||250166|315841||1 497099|N02AG0201|Ketogan|töflur|||100|stk|1|ţpakki|5 + 25 mg|N02AG02|01.07.1994||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|3258|5505|lyfalmen|||1|100|0|20,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||3258||3258|5505||1 497289|C09AA0201|Daren|töflur|5|mg|30|stk|1|ţpakki||C09AA02|01.07.1990||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|343|1517|lyfalmen|||2|30|0|15,0000|Actavis Group hf|Actavis hf|Enalapríl||343||343|1517||1 497297|C09AA0201|Daren|töflur|5|mg|100|stk|1|ţpakki||C09AA02|01.07.1990||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|509|1609|lyfalmen|V0448|1609|2|100|0|50,0000|Actavis Group hf|Actavis hf|Enalapríl||410||410|1609||1 497313|C09AA0201|Daren|töflur|20|mg|100|stk|1|ţpakki||C09AA02|01.07.1990||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|1058|2256|lyfalmen|V0449|2256|2|100|0|200,0000|Actavis Group hf|Actavis hf|Enalapríl||883||883|2256||1 497983|N04BC0407|Ropinirol Actavis|forđatfl|4|mg|84|stk|1|ţpakki||N04BC04|01.12.2012||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|15212|14820|lyfalmen|V0533|14820|2|84|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rópíníról||10068||10068|14820||1 497995|S01EC0303|Dorzolamide Portfarma|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.10.2011||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|1520|3068|lyfalmen|V0369|3068|2|5|0|16,6667|Portfarma ehf|Portfarma|Dorzólamíđ||1477||1477|3068||2 498048|H02AB0103|Diprospan|stl|7|mg/ml|2|ml|1|hgl|5 + 2 mg/ml|H02AB01|01.09.2004||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1373|2926|lyfalmen|||1|2|0|9,3300|Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||1373||1373|2926||1 498964|N05AE0401|Zeldox|hylki|20|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.03.2002||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|17116|24204|lyfalmen|V0608|17095|1|56|0|14,0000|Icepharma hf|Pfizer ApS|Ziprasidon||17116||17116|24204||1 498980|N05AE0401|Zeldox|hylki|40|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.03.2002||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|18258|25637|lyfalmen|V0609|20896|1|56|0|28,0000|Icepharma hf|Pfizer ApS|Ziprasidon||18258||18258|25637||1 499004|N05AE0401|Zeldox|hylki|60|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.03.2002||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|22743|31266|lyfalmen|V0610|20679|1|56|0|42,0000|Icepharma hf|Pfizer ApS|Ziprasidon||22743||22743|31266||1 499020|N05AE0401|Zeldox|hylki|80|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.03.2002||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|27476|37206|lyfalmen|V0611|27333|1|56|0|56,0000|Icepharma hf|Pfizer ApS|Ziprasidon||27476||27476|37206||1 499070|R01AD0501|Rhinocort Aqua|nefúđi|32|mcg/sk|120|skammtar|1|fl||R01AD05|01.03.2013||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|1220|2717|lyfalmen|||1|120|0|19,2000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||1220||1220|2717||1 499109|N05AH0410|Quetiapin Actavis|forđatfl|50|mg|100|stk|1|ţpakki||N05AH04|01.07.2013||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|12921|18939|lyfalmen|V0275|18939|2|100|0|12,5000|Actavis Group PTC ehf|Actavis Group PTC ehf|Quetíapín||12921||12921|18939||1 499189|N03AX2201|Fycompa|filmhtfl|4|mg|28|stk|1|ţpakki||N03AX22|01.07.2013||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|25764|35057|lyfalmen|||1|28|0||Vistor hf|Eisai Europe Ltd.|Perampanel||25764||25764|35057||1 499273|B01AF0101|Xarelto|filmhtfl|20|mg|28|stk|1|ţpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|11172|16331|lyfalmen|||1|28|0|56,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||11172|16331||2 501225|C09DA0310|Valsartan/Hydrochlorothiazide ratiopharm|filmhtfl|185|mg|98|stk|1|ţpakki|160/25 mg|C09DA03|01.11.2012||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|4880|3815|lyfalmen|||2|98|0|98,0000|Medical ehf|ratiopharm GmbH|Valsartan og ţvagrćsilyf||2023||2023|3815||2 501278|G04BD1201|Betmiga|forđatfl|25|mg|30|stk|1|ţpakki||G04BD12|01.07.2013||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|6208|9540|lyfalmen|||1|30|0||Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||6208||6208|9540||1 502047|N04BA0201|Madopar|hylki|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.12.1983||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|3089|5274|lyfalmen|V0434|4547|1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3089||3089|5274||2 502633|N06AA2101|Ludiomil|töflur|25|mg|100|stk|1|ţpakki||N06AA21|01.06.1977||R|1|0|0|0|G|0|AML|0|0|0|100|DKK|3012|5168|lyfalmen|||1|100|0|25,0000|Vistor hf|Amdipharm Limited|Maprótilín||3012||3012|5168||1 503151|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|1|spr|+ leysir|L02AE04|01.01.1995||R|0|0|0|1|0|1|FER|0|0|0|100|DKK|26130|34676|lyfsjukr|||1|1|0|37,5000|Vistor hf|Ferring|Triptórelín||26130||26130|34676||1 503491|N06DA0303|Nimvastid (Lyfis)|hylki|1,5|mg|28|stk|1|ţpakki||N06DA03|01.04.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|XEU|6693|8127|lyfalmen|V0354|8127|3|28|0|4,6700|LYFIS ehf|LYFIS ehf|Rívastigmín||5175||5175|8127||2 503795|M01AB0512|Voltaren Dolo|húđuđtfl|25|mg|20|stk|1|ţpakki||M01AB05|01.10.2011||L|1|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|20|0|5,0000|Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||||1 504014|N04BC0407|Ropinirol Actavis|forđatfl|8|mg|84|stk|1|ţpakki||N04BC04|01.12.2012||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|29796|28123|lyfalmen|V0534|28123|2|84|0|112,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rópíníról||20239||20239|28123||1 504020|B05AA0114|Albuman|irl|40|g/líter|250|ml|1|hgl|lausn|B05AA01|01.04.2013||R|0|0|0|0|0|1|SSB|0|0|0|100|XEU|4344|6269|lyfsjukr|||1|250|0||Williams & Halls efh|Stichting Sanquin Bloedvoorziening|Albúmín||4344||4344|6269||2 504119|A10BB1202|Glimeryl|töflur|4|mg|90|stk|1|ţpakki||A10BB12|01.11.2011||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|1671|2927|lyfalmen|V0494|2926|2|90|0|180,0000|Actavis Group hf|Actavis Group PTC ehf|Glímepíríđ||1374||1374|2927||1 504191|N02BA5102|Treo|freyđit|||20|stk|1|glas||N02BA51|01.07.1988||L|0|0|0|0|0|0|MAB|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Vistor hf|Meda AB|Acetýlsalicýlsýra í blöndum, ţó ekki međ geđlyfjum (psychole|||||||1 504266|G03CA0401|Ovestin|töflur|1|mg|90|stk|1|ţpakki||G03CA04|01.01.1988||R|0|0|0|0|G|0|ORG|0|0|0|100|DKK|2061|3867|lyfalmen|||1|90|0|45,0000|Vistor hf|N.V. Organon|Estríól||2061||2061|3867||1 504878|N05BA0801|Lexotan|töflur|3|mg|100|stk|1|ţpakki||N05BA08|01.01.1987||R|1|0|0|0|0|0|ROC|0|0|1|100|DKK|1171|2650|lyfalmen|||1|100|0|30,0000|Icepharma hf|Roche|Brómazepam||1171||1171|2650||2 505647|N07BA0147|Nicorette QuickMist|munnhúđi|1|mg/sk|300|skammtar|1|fl|2 x 150 úđaskammtar|N07BA01|01.11.2012||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|300|0|0,8800|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 505743|N06AA2101|Ludiomil|töflur|75|mg|100|stk|1|ţpakki||N06AA21|01.05.1978||R|1|0|0|0|G|0|AML|0|0|0|100|DKK|8287|12384|lyfalmen|||1|100|0|75,0000|Vistor hf|Amdipharm Limited|Maprótilín||8287||8287|12384||1 505834|L01DB0101|Adriamycin|stl|2|mg/ml|5|ml|1|plhgl||L01DB01|01.05.2008||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|1821|2628|lyfsjukr|||1|5|0||Icepharma hf|Pfizer ApS|Doxórúbicín||1821||1821|2628||1 505875|L01DB0101|Adriamycin|stl|2|mg/ml|10|ml|1|plhgl||L01DB01|01.05.2008||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|3638|5251|lyfsjukr|||1|10|0||Icepharma hf|Pfizer ApS|Doxórúbicín||3638||3638|5251||1 505883|L01DB0101|Adriamycin|stl|2|mg/ml|25|ml|1|plhgl||L01DB01|01.05.2008||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|8301|11980|lyfsjukr|||1|25|0||Icepharma hf|Pfizer ApS|Doxórúbicín||8301||8301|11980||1 506972|N06AA1201|Sinquan|hylki|50|mg|100|stk|1|ţpakki||N06AA12|01.12.1972||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|2487|4450|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Doxepín||2487||2487|4450||1 506998|A06AB0202|Toilax|sh-tfl|5|mg|25|stk|1|ţpakki||A06AB02|01.12.1975||L|1|0|0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa|||0|25|0|12,5000|Vistor hf|Orion Pharma|Bisakódýl|||||||1 507004|A06AB0202|Toilax|sh-tfl|5|mg|100|stk|1|ţpakki||A06AB02|01.12.1975||R|1|0|0|0|0|0|ERC|0|0|0|100|DKK|404|1601|lyfalmen|||1|100|0|50,0000|Vistor hf|Orion Pharma|Bisakódýl||404||404|1601||1 507103|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|24|g|1|spr||QP52AF02|01.07.1995||L|0|0|0|0|0|0|PAL|0|0|0|100|DKK|665|1160|vetorma|||0|24|0||Icepharma hf|Pfizer Oy Animal Health|||||665|1160||2 507343|QP52AC1302|Panacur, vet.|mixtúra|100|mg/ml|1000|ml|1|fl||QP52AC13|01.12.1978||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|16230|28312|vetorma|||0|1000|0||Vistor hf|Intervet International BV|||16230||16230|28312||1 508622|C08DA0103|Isoptin retard|forđatfl|240|mg|98|stk|1|ţpakki||C08DA01|01.10.1993||R|1|0|0|0|G|0|ABS|0|0|0|100|DKK|2581|4579|lyfalmen|||1|98|0|98,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||2581||2581|4579||1 508671|QJ01MA9001|Baytril vet.|mixtúra|25|mg/ml|100|ml|1|plastf||QJ01MA90|01.03.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|5157|10075|vetalmen|||0|100|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||||5157|10075||2 508689|QJ01MA9001|Baytril vet.|stl|50|mg/ml|50|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|4646|9094|vetalmen|||0|50|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||4646||4646|9094||2 508705|QJ01MA9001|Baytril vet.|stl|100|mg/ml|100|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|13766|26605|vetalmen|||0|100|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||13766||13766|26605||2 508921|L01CD0401|Jevtana|irţ|60|mg|15|ml|1|hgl|+ leysir|L01CD04|01.08.2011||R|0|0|0|1|0|1|SOF|0|1|0|100|NOK|733461|922376|lyfsjukr|||1|15|0||Vistor hf|SANOFI|Cabazitaxel||733461||733461|922376||1 509042|N05AF0502|Cisordinol Depot|stl|200|mg/ml|1|ml|10|lykjur||N05AF05|01.03.1984||R|0|0|0|0|G|0|LBK|0|0|0|100|DKK|9179|13604|lyfalmen|||1|10|0|133,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||9179||9179|13604||1 509273|G03CA0401|Ovestin|sk-krem|1|mg/g|15|g|1|túpa|+stjaka|G03CA04|01.01.1988||L|0|0|0|0|G|0|ORG|0|0|0|100|DKK|||lyfalmen|||0|15|0|75,0000|Vistor hf|N.V. Organon|Estríól|||||2906||1 509577|G03HB0102|Diane mite|töflur|||63|stk|1|ţpakki||G03HB01|01.06.2013||R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|2221|4086|lyfalmen|V0134|3554|1|63|0|84,0000|Icepharma hf|Bayer Pharma AG|Cýpróterón og östrógen||2221||2221|4086||2 509653|J05AR0101|Combivir|filmhtfl|450|mg|60|stk|1|ţpakki|150+300 mg|J05AR01|01.05.2004||R|1|0|0|1|0|1|VII|0|0|0|100|GBP|47362|61322|lyfsjukr|||1|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Zídóvúdín og lamívúdín||47362||47362|61322||1 510255|B03XA0103|NeoRecormon|stl|2000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|16794|22959|lyfsjukr|||1|1,8|0|12,0000|Icepharma hf|Roche|Epóetín||16794||16794|22959||2 510263|B03XA0103|NeoRecormon|stl|3000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|25139|33432|lyfsjukr|||1|1,8|0|18,0000|Icepharma hf|Roche|Epóetín||25139||25139|33432||2 510271|B03XA0103|NeoRecormon|stl|5000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|41235|53632|lyfsjukr|||1|1,8|0|30,0000|Icepharma hf|Roche|Epóetín||41235||41235|53632||2 510305|B03XA0103|NeoRecormon|stl|10000|ae/spr|0,6|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|81546|104223|lyfsjukr|||1|3,6|0|60,0000|Icepharma hf|Roche|Epóetín||81546||81546|104223||2 510608|L01XX4401|Zaltrap|irţ|25|mg/ml|8|ml|1|hgl|lausn|L01XX44|01.06.2013||R|0|0|0|1|0|1|SGA|0|0|0|100|NOK|116236|147759|lyfsjukr|||1|8|0||Vistor hf|Sanofi-aventis groupe|Afliberceptum||116236||116236|147759||1 510810|B03XA0201|Aranesp|stl|150|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|189339|239503|lyfsjukr|||1|1,2|0|133,3300|Vistor hf|Amgen|Darbepóetín alfa||||189339|239503||1 510974|G04CB0102|Finol|töflur|5|mg|98|stk|1|glas||G04CB01|01.01.1998||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|4210|3469|lyfalmen|V0445|3033|2|98|0|98,0000|Actavis Group hf|Actavis hf|Fínasteríđ||1770||1770|3469||1 511071|C09CA0701|Micardis|töflur|20|mg|28|stk|1|ţpakki||C09CA07|01.03.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|2735|4789|lyfalmen|||1|28|0|14,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||2735||2735|4789||1 511303|G03FB0501|Trisekvens|töflur|||84|stk|1|skífup||G03FB05|01.12.1980||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2717|4765|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2717||2717|4765||1 511493|B05AA0509|Rheomacrodex med NaCl|irl|100|mg/ml|500|ml|12|pokar||B05AA05|01.07.1991||R|0|0|0|0|0|1|MAB|0|0|0|100|SEK|24245|32310|lyfsjukr|||1|6000|0||Vistor hf|Meda AB|Dextran||24245||24245|32310||1 511501|B05AA0502|Macrodex 60 mg/ml med NaCl|irl|||500|ml|12|pokar||B05AA05|01.07.1991||R|0|0|0|0|0|1|MAB|0|0|0|100|SEK|15167|20917|lyfsjukr|||1|6000|0||Vistor hf|Meda AB|Dextran||15167||15167|20917||1 512192|N06AB1005|Escitalopram LYFIS|filmhtfl|10|mg|100|stk|1|ţpakki||N06AB10|01.02.2012||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|4775|3015|lyfalmen|V0325|3015|2|100|0|100,0000|LYFIS ehf|LYFIS ehf|Escítalópram||1438||1438|3015||2 512608|B05XA3101|Peditrace|irţ|||10|ml|10|hgl||B05XA31|01.07.1993||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|5303|7654|lyfsjukr|||1|100|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ öđrum efnum||5303||5303|7654||2 513309|D04AB0101|Xylocain|smyrsli|5|%|35|g|1|pakki||D04AB01|01.09.2003||L|0|0|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||0|35|0||Vistor hf|AstraZeneca A/S DK|Lídókaín|||||||1 513474|N05AH0501|Sycrest|tungur.t|5|mg|60|stk|1|ţpakki||N05AH05|01.10.2011||R|0|0|0|0|0|0|ORR|0|0|0|100|DKK|23046|31646|lyfalmen|||1|60|0|15,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||23046||23046|31646||1 513758|QJ01CR0201|Combisyn|stl|175|mg/ml|100|ml|1|hgl|140+35 mg/ml|QJ01CR02|01.11.2011||R|0|0|0|0|0|0|NOB|1|0|0|100|XEU|2141|4259|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og Clavulansýra||2141||2141|4259||2 514265|R03AC0302|Bricanyl Turbuhaler|innönddu|0,25|mg/sk|200|skammtar|1|stauk||R03AC03|01.07.1993||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|1903|3651|lyfalmen|||1|200|0|25,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||1903||1903|3651||1 514427|C07AG0203|Carvedilol Actavis|filmhtfl|25|mg|100|stk|1|ţpakki||C07AG02|01.07.2011||R|1|0|0|0|G|0|ADG|0|0|0|100|XEU|3921|6412|lyfalmen|||2|100|0|66,6667|Actavis Group hf|Actavis Deutchland GmbH & Co. KG|Carvedílól||3921||3921|6412||1 514840|N06BA0901|Strattera|hylki|100|mg|28|stk|1|ţpakki|hart|N06BA09|01.07.2013||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|20691|28691|lyfalmen|||1|28|0|35,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||20691||20691|28691||2 515049|N06AX1801|Edronax|töflur|4|mg|60|stk|1|ţpakki||N06AX18|01.06.2000||R|1|0|0|0|G|0|PER|0|0|0|100|IKR|4026|4291|lyfalmen|||1|60|0|30,0000|Icepharma hf|Pfizer ApS|Reboxetin||2371||2371|4291||1 515239|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|100|stk|1|glas||C01DA02|01.05.2011||L|0|0|0|0|G|0|NYC|0|0|0|100|DKK|||lyfalmen|||0|100|0|10,0000|Vistor hf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||2653||1 515247|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|100|stk|1|glas||C01DA02|01.05.2011||L|0|0|0|0|G|0|NYC|0|0|0|100|DKK|||lyfalmen|||0|100|0|20,0000|Vistor hf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||2665||1 516219|J01FA1006|Azithromycin Eberth|irs|500|mg|10|ml|1|hgl||J01FA10|01.12.2012||R|0|0|0|0|0|1|FRI|0|0|0|100|DKK|5423|6737|lyfsjukr|||1|10|0|1,0000|Portfarma ehf|Dr. Friedrich Eberth Arzneimittel GmbH|Azitrómýcín||4668||4668|6737||2 517073|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|120|stk|1|ţpakki||A02BC04|01.06.2011||R|1|0|0|0|G|0|APC|0|0|0|100|IKR|5112|6362|lyfalmen|||2|120|0|120,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||3885||3885|6362|30.4.2013|1 517714|A10BX0201|Novonorm|töflur|0,5|mg|90|stk|1|ţpakki||A10BX02|01.10.2000||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2981|5126|lyfalmen|V0462|2808|1|90|0|11,2500|Vistor hf|Novo-Nordisk A/S|Repaglíníđ||2981||2981|5126||1 517755|A10BX0201|Novonorm|töflur|1|mg|90|stk|1|ţpakki||A10BX02|01.10.2000||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|3246|5488|lyfalmen|V0471|2951|1|90|0|22,5000|Vistor hf|Novo-Nordisk A/S|Repaglíníđ||3246||3246|5488||1 517813|A10BX0201|Novonorm|töflur|2|mg|90|stk|1|ţpakki||A10BX02|01.10.2000||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|3491|5823|lyfalmen|V0472|3075|1|90|0|45,0000|Vistor hf|Novo-Nordisk A/S|Repaglíníđ||3491||3491|5823||1 517824|C01CA0302|Noradrenalin Abcur|irţ|1|mg/ml|10|ml|10|lykjur||C01CA03|01.05.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|37364|48774|lyfsjukr|||2|100|0|16,6600|Icepharma hf|Abcur AB|Noradrenalín||37364||37364|48774||2 517990|R06AX2201|Kestine|filmhtfl|20|mg|10|stk|1|ţpakki||R06AX22|01.06.2012||L|1|0|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||0|10|0|20,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||||1 518241|M01AB0509|Modifenac|forđahlk|75|mg|20|stk|1|ţpakki||M01AB05|01.11.2000||R|1|0|0|0|G|0|AGT|0|0|1|100|DKK|926|2315|lyfalmen|||1|20|0|15,0000|Actavis Group hf|Actavis Group hf|Díklófenak||926||926|2315||1 518258|M01AB0509|Modifenac|forđahlk|75|mg|100|stk|1|ţpakki|međ breyttan losunarhrađa|M01AB05|01.11.2000||R|1|0|0|0|G|0|AGT|0|0|1|100|DKK|3487|5818|lyfalmen|||1|100|0|75,0000|Actavis Group hf|Actavis Group hf|Díklófenak||3487||3487|5818||1 518332|G03AC0901|Cerazette|töflur|75|mcg|84|stk|1|ţpakki|3x28 stk|G03AC09|01.01.2001||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|2104|3926|lyfalmen|V0590|3358|1|84|0|84,0000|Vistor hf|N.V. Organon|Desógestrel||2104||2104|3926||1 518337|N05AH0407|Quetiapina Qualigen (Lyfjaver)|töflur|200|mg|60|stk|1|ţpakki||N05AH04|01.06.2011||R|1|0|0|0|G|0|LVR|0|0|0|100|IKR|12499|10350|lyfalmen|V0286|9392|3|60|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Quetíapín||6800||6800|10350||3 518660|L03AB1001|PegIntron|sts|80|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.04.2013||R|0|0|0|1|0|1|DSM|0|0|0|100|DKK|88086|112430|lyfsjukr|||1|4|0|42,6700|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||88086||88086|112430||1 518897|A10BH0501|Trajenta|filmhtfl|5|mg|90|stk|1|ţpakki||A10BH05|01.12.2012||R|1|0|0|0|G|0|BII|0|0|0|100|DKK|19436|27116|lyfalmen|||1|90|0|90,0000|Vistor hf|Boehringer Ingelheim International|Línaglíptín||19436||19436|27116||1 518944|J01CE0205|Kaavepenin Frukt|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|1148|2618|lyfalmen|||1|125|0|3,1250|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1148||1148|2618||1 519463|J01EE0108|Eusaprim|mixtúra|48|mg/ml|100|ml|1|glas|8+40 mg/ml|J01EE01|01.07.2011||R|0|0|0|0|0|0|AUG|0|0|1|100|SEK|1720|3401|lyfalmen|||1|100|0|2,5000|Aspen Europe GmbH|Aspen Europe GmbH|Súlfametoxazól og trímetóprím||1720||1720|3401||1 519819|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|1|spr|einnota sprauta|M09AX01|01.01.2001||R|0|0|0|0|G|0|NYC|0|0|0|100|DKK|7327|11071|lyfalmen|V0431|9583|2|2|0|5,7222|Vistor hf|Nycomed Danmark A/S|Natríumhýalúrónat||7327||7327|11071||1 520239|G04BE0301|Viagra|filmhtfl|25|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|4858|7693|lyfalmen|V0142|7559|1|4|0|2,0000|Icepharma hf|Pfizer ApS|Síldenafíl||4858||4858|7693||1 520288|G04BE0301|Viagra|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|5486|8552|lyfalmen|V0143|2467|1|4|0|4,0000|Icepharma hf|Pfizer ApS|Síldenafíl||5486||5486|8552||1 520338|G04BE0301|Viagra|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|15457|22122|lyfalmen|V0143|7400|1|12|0|12,0000|Icepharma hf|Pfizer ApS|Síldenafíl||15457||15457|22122||1 520346|G04BE0301|Viagra|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|5883|9096|lyfalmen|V0144|3049|1|4|0|8,0000|Icepharma hf|Pfizer ApS|Síldenafíl||5883||5883|9096||1 520379|G04BE0301|Viagra|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|16279|23153|lyfalmen|V0144|9146|1|12|0|24,0000|Icepharma hf|Pfizer ApS|Síldenafíl||16279||16279|23153||1 520502|C08CA0102|Amlo|töflur|5|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1355|1718|lyfalmen|V0056|1702|2|100|0|100,0000|Actavis Group hf|Actavis hf|Amlódipín||490||490|1718||1 520577|C08CA0102|Amlo|töflur|10|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|2163|1609|lyfalmen|V0057|1606|2|100|0|200,0000|Actavis Group hf|Actavis hf|Amlódipín||410||410|1609||1 520759|M03BC5101|Norgesic|töflur|||30|stk|1|ţpakki||M03BC51|01.03.1981||R|1|0|0|0|G|0|MEB|0|0|1|100|SEK|370|1554|lyfalmen|||1|30|0|7,5000|Vistor hf|Meda AB (V)|Orfenadrín í blöndum||370||370|1554||1 520874|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|25|stk|1|glas||C01DA02|01.05.2011||L|0|0|0|0|G|0|NYC|0|0|0|100|DKK|||lyfalmen|||0|25|0|2,5000|Vistor hf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||1789||1 520882|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|25|stk|1|glas||C01DA02|01.05.2011||L|0|0|0|0|G|0|NYC|0|0|0|100|DKK|||lyfalmen|||0|25|0|5,0000|Vistor hf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||1800||1 521203|N04BC0502|Sifrol|töflur|0,7|mg|100|stk|1|ţpakki||N04BC05|01.05.2005||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|32357|43331|lyfalmen|V0269|18997|1|100|0|28,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||32357||32357|43331||1 521954|N03AX2101|Trobalt|filmhtfl|200|mg|84|stk|1|ţpakki||N03AX21|01.12.2011|30.06.2013|R|1|1|0|0|G|0|GGL|0|0|0|100|GBP|16856|23878|lyfalmen|||1|84|0|18,6700|GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||16856||16856|23878||1 521966|A10BX0202|Repaglinid Krka (LYFIS)|töflur|1|mg|90|stk|1|ţpakki||A10BX02|01.11.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|2606|2951|lyfalmen|V0471|2951|3|90|0|22,5000|LYFIS ehf|LYFIS ehf|Repaglíníđ||1391||1391|2951||2 522003|QJ51RC2302|Streptocillin, vet.|spenalyf|||8|g|40|spr||QJ51RC23|01.12.1982||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|8466|16429|vetalmen|||0|320|0||Vistor hf|Boehringer Ingelheim Danmark|||8466||8466|16429||1 522399|N05AE0403|Ziprasidon Actavis|hylki|20|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.06.2013||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|11731|17095|lyfalmen|V0608|17095|2|56|0|14,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Ziprasidon||11731||11731|17095||1 522599|J07CA0202|Tetravac|bóluefni|||0,5|ml|1|spr|einnota dćla|J07CA02|01.10.1999||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|2308|4205|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|barnaveiki, kíghósti, mćnusótt, stífkrampi||2308||2308|4205||2 522706|L04AC0201|Simulect|sts|20|mg|1|hgl|1|pakki|+leysir|L04AC02|01.06.2004||R|0|0|0|1|0|1|NOE|0|0|0|100|DKK|187682|237423|lyfsjukr|||1|1|0|0,5000|Vistor hf|Novartis Europharm Ltd|Basiliximab||187682||187682|237423||1 522730|N02AX0204|Tradolan|filmhtfl|50|mg|20|stk|1|ţpakki||N02AX02|01.08.1998||R|1|0|1|0|G|0|GLP|0|0|1|100|SEK|346|1521|lyfalmen|V0055|1339|1|20|0|3,3300|Vistor hf|G.L.Pharma GmbH|Tramadól||346||346|1521||1 522771|N02AX0204|Tradolan|filmhtfl|50|mg|100|stk|1|ţpakki||N02AX02|01.08.1998||R|1|0|1|0|G|0|GLP|0|0|1|100|SEK|410|1609|lyfalmen|V0225|1579|1|100|0|16,6700|Vistor hf|G.L.Pharma GmbH|Tramadól||410||410|1609||1 522797|N02AX0204|Tradolan|filmhtfl|50|mg|250|stk|1|ţpakki||N02AX02|01.08.1998||R|1|0|1|0|G|0|GLP|0|0|1|100|DKK|2794|4870|lyfalmen|||1|250|0|41,6700|Vistor hf|G.L.Pharma GmbH|Tramadól||2794||2794|4870||1 522813|N02AX0204|Tradolan|stl|50|mg/ml|2|ml|5|lykjur||N02AX02|01.08.1998||R|0|0|1|0|G|0|GLP|0|0|1|100|DKK|398|1592|lyfalmen|||1|10|0|1,6667|Vistor hf|G.L.Pharma GmbH|Tramadól||398||398|1592||1 523043|N02AA5902|Parkodin forte|töflur|530|mg|40|stk|1|pakki|ţp 30+500 mg|N02AA59|01.11.1998||R|1|0|0|0|0|0|ACA|0|0|1|100|NOK|1091|2540|lyfalmen|||2|40|0|13,3333|Actavis Group hf|Actavis hf|Kódein í blöndum nema međ geđlyfjum||1091||1091|2540||1 523274|S01XA2008|Artelac|augndr|||10|ml|1|glas|plastglas|S01XA20|01.05.1998||L|0|0|0|0|G|0|GEM|0|0|0|100|IKR|||lyfalmen|||0|10|0||Actavis Group hf|Gerhard Mann|Gervitár og ađrar óvirkar samsetningar|||||1464||1 523758|L01XE0801|Tasigna|hylki|150|mg|112|stk|1|ţpakki||L01XE08|01.03.2013||R|0|1|0|1|0|1|NOE|0|0|0|100|DKK|396124|499018|lyfsjukr|||1|112|0||Vistor hf|Novartis Europharm Ltd|Nilotiníb||396124||396124|499018||1 523779|R06AD0201|Phenergan|töflur|25|mg|100|stk|1|ţpakki||R06AD02|01.10.1995||R|1|0|0|0|G|0|SNO|0|0|1|100|NOK|1286|2807|lyfalmen|||1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Prómetazín||1286||1286|2807||1 524215|C01DA1401|Imdur|forđatfl|30|mg|28|stk|1|ţpakki||C01DA14|01.07.1993||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|463|1681|lyfalmen|||1|28|0|21,0000|Vistor hf|AstraZeneca A/S DK|Ísósorbíđ mónónítrat||463||463|1681||1 524223|C01DA1401|Imdur|forđatfl|30|mg|98|stk|1|ţpakki||C01DA14|01.07.1993||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|2664|4692|lyfalmen|||1|98|0|73,5000|Vistor hf|AstraZeneca A/S DK|Ísósorbíđ mónónítrat||2664||2664|4692||1 524276|A02BC0401|Pariet|sh-tfl|20|mg|98|stk|1|ţpakki||A02BC04|01.06.2011||R|1|0|0|0|0|0|EIS|0|0|0|100|IKR|8619|6020|lyfalmen|V0010|5210|1|98|0|98,0000|Vistor hf|Eisai Ltd|Rabeprazól||3635||3635|6020||1 524934|QM01AE9001|Quadrisol|hlaup|100|mg/ml|1|spr|1|pakki|f. hesta|QM01AE90|01.07.2010||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|1917|3813|vetalmen|||0|1|0||Icepharma hf|Zoetis Belgium S.A.|Vedaprófen||1917||1917|3813||2 525014|M03BC5101|Norgesic|töflur|||100|stk|1|ţpakki||M03BC51|01.06.1981||R|1|0|0|0|G|0|MEB|0|0|1|100|SEK|764|2093|lyfalmen|||1|100|0|25,0000|Vistor hf|Meda AB (V)|Orfenadrín í blöndum||764||764|2093||1 525030|M01AB0505|Voltaren|stl|25|mg/ml|3|ml|5|lykjur|lausn|M01AB05|01.05.2007||R|0|0|0|0|0|0|NOH|0|0|0|100|DKK|780|2115|lyfalmen|||1|15|0|3,7500|Vistor hf|Novartis Healthcare A/S-|Díklófenak||780||780|2115||1 525147|M01AB0504|Klofen-L|forđahlk|100|mg|30|stk|1|glas||M01AB05|01.01.1993||R|1|0|0|0|G|0|ACA|0|0|1|100|XEU|1507|3109|lyfalmen|||2|30|0|30,0000|Actavis Group hf|Actavis hf|Díklófenak||1507||1507|3109||1 525170|M01AB0504|Klofen-L|forđahlk|100|mg|100|stk|1|glas||M01AB05|01.01.1993||R|1|0|0|0|G|0|ACA|0|0|1|100|XEU|5021|7916|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis hf|Díklófenak||5021||5021|7916||1 525188|N06BA0701|Modiodal|töflur|100|mg|30|stk|1|ţpakki||N06BA07|01.03.2002||R|1|0|0|0|0|0|TBV|0|0|0|100|DKK|8671|12909|lyfalmen|||1|30|0|10,0000|Vistor hf|Teva Pharma B.V.|Modafinil||8671||8671|12909||1 525720|B01AF0101|Xarelto|filmhtfl|20|mg|100|stk|1|ţpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|39749|52608|lyfalmen|||1|100|0|200,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||39749|52608||2 525857|B05XA0103|Kaliumklorid B.Braun|irţ|1|mmol/ml|50|ml|20|hgl||B05XA01|01.09.2010||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|5476|7903|lyfsjukr|||2|1000|0||Actavis Group hf|Braun|Kalíumklóríđ||5476||5476|7903||1 525865|B05XA0303|Natriumklorid B.Braun|irţ|1|mmol/ml|50|ml|20|hgl||B05XA03|01.09.2010||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|4986|7196|lyfsjukr|||2|1000|0||Actavis Group hf|Braun|Natríumklóríđ||4986||4986|7196||1 525998|V07AB0004|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|1000|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||1 526004|V07AB0009|Sterilt Vann B. Braun|leysir|||50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|1000|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||1 526368|N04BA0201|Madopar|töflur|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.11.1981||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|4496|7198|lyfalmen|V0435|7198|1|100|0|33,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||4496||4496|7198||2 526376|N03AG0103|Orfiril Retard|forđatfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|1|0|0|0|G|0|DEA|0|0|0|100|XEU|4192|6782|lyfalmen|||1|100|0|20,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||4192||4192|6782||1 526798|N03AG0102|Orfiril|sh-tfl|600|mg|100|stk|1|glas||N03AG01|01.10.1995||R|1|0|0|0|G|0|DEA|0|0|0|100|XEU|3586|5953|lyfalmen|||1|100|0|40,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||3586||3586|5953||1 527112|N02BE0116|Pinex Smelt|munndr.t|250|mg|20|stk|1|ţpakki||N02BE01|01.09.2011||L|0|0|0|0|0|0|APC|0|0|1|100|IKR|||lyflausa|||0|20|0|1,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||||1 527143|J01XD0102|Flagyl|irl|5|g/1000ml|100|ml|20|pokar||J01XD01|01.12.1983||R|0|0|0|0|0|1|SNO|0|0|0|100|NOK|15547|21394|lyfsjukr|||1|2000|0|6,6667|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||15547||15547|21394||1 527523|S01GX0601|Emadine|augndr|0,5|mg/ml|5|ml|1|glas||S01GX06|01.05.2003||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|1248|2755|lyfalmen|||0|5|0||Vistor hf|Alcon Laboratories Ltd.|Emedastín||1248||1248|2755||1 528374|G03BA0307|Nebido|stl|250|mg/ml|4|ml|1|lykja||G03BA03|01.07.2012||R|0|0|0|0|G|0|BGB|0|0|0|100|DKK|17096|24179|lyfalmen|||1|4|0|55,5600|Icepharma hf|Bayer Pharma AG|Testósterón||17096||17096|24179||2 528418|D07AC1302|Ovixan|krem|0,1|%|100|g|1|túpa||D07AC13|01.06.2013||R|0|0|0|0|G|0|GAB|0|0|1|100|SEK|2473|4431|lyfalmen|||2|100|0||Vistor hf|Gallencia AB|Mómetasón||2473||2473|4431||1 528472|R03AK0704|Symbicort Turbuhaler (Lyfjaver)|innönddu|164,5|mcg/sk|120|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2011||R|0|0|0|0|G|0|LVR|0|0|0|100|SEK|9081|13470|lyfalmen|V0356|12306|3|120|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||9081||9081|13470||3 528584|A07EC0202|Pentasa|forđatfl|1|g|60|stk|1|ţpakki|6 x 10 stk|A07EC02|01.06.2012||R|1|0|0|0|G|0|FEL|0|0|0|100|DKK|6933|10532|lyfalmen|||1|60|0|40,0000|Vistor hf|Ferring Lćgemidler A/S|Mesalazín (5-amínósalicýlsýra)||6933||6933|10532||1 529289|R02AA0301|Strepsils|sogtfl|||24|stk|1|ţpakki||R02AA03|01.09.1982||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 529438|QJ51RC2002|Ampiclox vet.|spenalyf|||3|g|24|spr|spenadćlur|QJ51RC20|01.06.1998||R|0|0|0|0|0|0|PAL|0|0|0|100|DKK|4531|8873|vetalmen|||0|72|0||Icepharma hf|Pfizer Oy Animal Health|||4531||4531|8873||2 529446|QJ01CA0401|Clamoxyl, vet.|töflur|40|mg|100|stk|1|ţpakki||QJ01CA04|01.10.1987||R|0|0|0|0|0|0|PAL|0|0|0|100|DKK|4817|9422|vetalmen|||0|100|0||Icepharma hf|Pfizer Oy Animal Health|||4817||4817|9422||2 529735|N03AB0501|Pro-Epanutin|irţ|50|mg/ml|10|ml|10|hgl||N03AB05|01.12.2001||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|69159|88677|lyfsjukr|||1|100|0|11,1000|Icepharma hf|Pfizer ApS|Fosfenýtóín||69159||69159|88677||1 529852|L02BG0304|Anastrozole Bluefish|filmhtfl|1|mg|98|stk|1|ţpakki||L02BG03|01.03.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|17433|12414|lyfalmen|V0184|11981|2|98|0|98,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Anastrózól||8309||8309|12414||2 530188|A06AD6502|Movicol|mixtduft|13,8|g|50|pokar|1|pakki||A06AD65|01.09.2011||L|0|0|0|0|0|0|NOI|0|0|0|100|XEU|||lyfalmen|V0592|6964|0|50|0|25,0000|Artasan ehf|Norgine A/S|Makrógól 3350|||||6973||1 530379|L02BG0304|Anastrozole Bluefish|filmhtfl|1|mg|28|stk|1|ţpakki||L02BG03|01.03.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|11860|7572|lyfalmen|V0186|7572|2|28|0|28,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Anastrózól||4769||4769|7572||2 530701|QN05CM9204|Nerfasin vet.|stl|20|mg/ml|25|ml|1|hgl|nautg. hestar,hundar og kettir|QN05CM92|01.07.2013||R|0|0|0|0|0|0|BVL|1|0|0|100|XEU|1646|3274|vetalmen|||0|25|0||Dýraheilsa ehf|Le Vet B.V.|||1646||1646|3274||2 530741|G03FA0105|Activelle|töflur|||84|stk|1|pakki|ţp 1+0,5 mg|G03FA01|01.03.2000||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|3037|5202|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||3037||3037|5202||1 530828|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|6012|8677|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||6012||6012|8677||2 531459|R03CC0303|Bricanyl Retard|forđatfl|7,5|mg|100|stk|1|glas||R03CC03|01.01.1985||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|3087|5271|lyfalmen|||1|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||3087||3087|5271||1 531913|J05AG0101|Viramune|mixtúra|10|mg/ml|240|ml|1|fl||J05AG01|01.03.2007||R|0|0|0|1|0|1|BII|0|0|0|100|DKK|8267|11931|lyfsjukr|||1|240|0|6,0000|Vistor hf|Boehringer Ingelheim International |Nevírapín||8267||8267|11931||1 532048|L04AA0605|Myfenax (Lyfis)|hylki|500|mg|50|stk|1|ţpakki||L04AA06|01.03.2011||R|1|0|0|1|G|0|LYF|0|0|0|100|XEU|20421|4587|lyfalmen|V0187|4587|3|50|0|12,5000|LYFIS ehf|LYFIS ehf|Mýcófenólsýra||2587||2587|4587||2 532374|P02CA0101|Vermox|mixtúra|20|mg/ml|30|ml|1|glas||P02CA01|01.12.1982||R|0|0|0|0|0|0|JAS|0|0|0|100|SEK|683|1982|lyfalmen|||1|30|0|3,0000|Vistor hf|Janssen-Cilag AB|Mebendazól||683||683|1982||1 532504|R06AX2704|Desloratadine ratiopharm|filmhtfl|5|mg|30|stk|1|ţpakki||R06AX27|01.09.2012||R|1|0|0|0|G|0|RGM|0|0|1|100|XEU|1228|2728|lyfalmen|V0366|2558|2|30|0|30,0000|Medical ehf|ratiopharm GmbH|Deslóratadín||1228||1228|2728||2 532671|J01EA0107|Trimetoprim Meda|töflur|100|mg|30|stk|1|glas||J01EA01|01.03.2010||R|1|0|0|0|0|0|MEB|0|0|1|100|SEK|361|1542|lyfalmen|||1|30|0|7,5000|Vistor hf|Meda AB (V)|Trímetóprím||361||361|1542||1 532697|J01EA0107|Trimetoprim Meda|töflur|100|mg|100|stk|1|glas||J01EA01|01.03.2010||R|1|0|0|0|0|0|MEB|0|0|1|100|SEK|1048|2482|lyfalmen|||1|100|0|25,0000|Vistor hf|Meda AB (V)|Trímetóprím||1048||1048|2482||1 532705|J01EA0107|Trimetoprim Meda|töflur|160|mg|14|stk|1|glas||J01EA01|01.03.2010||R|1|0|0|0|0|0|MEB|0|0|1|100|SEK|290|1445|lyfalmen|||1|14|0|5,6000|Vistor hf|Meda AB (V)|Trímetóprím||290||290|1445||1 532721|J01EA0107|Trimetoprim Meda|töflur|160|mg|100|stk|1|glas||J01EA01|01.03.2010||R|1|0|0|0|0|0|MEB|0|0|1|100|SEK|1846|3573|lyfalmen|||1|100|0|40,0000|Vistor hf|Meda AB (V)|Trímetóprím||1846||1846|3573||1 532983|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|1000|ml|10|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|2392|3452|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||2392||2392|3452||2 533737|R03CC0303|Bricanyl Retard|forđatfl|5|mg|100|stk|1|glas||R03CC03|01.04.1986||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|2093|3911|lyfalmen|||1|100|0|33,3333|Vistor hf|AstraZeneca A/S DK|Terbútalín||2093||2093|3911||1 533779|A02BC0111|Omeprazol Pensa|sţ-hylki|20|mg|28|stk|1|ţpakki||A02BC01|01.12.2012||L|1|0|0|0|0|0|PEN|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|Lyfjaver ehf|Pensa Pharma AB|Ómeprazól|||||||3 534183|N05AH0308|Lazapix|filmhtfl|20|mg|28|stk|1|ţpakki||N05AH03|01.02.2013||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|15330|21963|lyfalmen|V0281|21963|2|28|0|56,0000|Portfarma ehf|Portfarma|Olanzapín||15330||15330|21963||2 534471|L04AA1001|Rapamune|filmhtfl|1|mg|100|stk|1|ţpakki||L04AA10|01.06.2012||R|0|0|0|1|G|0|IPI|0|0|0|100|DKK|59196|77014|lyfalmen|||1|100|0|33,3300|Icepharma hf|Pfizer Limited|Sirolimus||59196||59196|77014||1 534885|L01AA0601|Holoxan|sts/irs|1000|mg|1|stk|1|hgl||L01AA06|01.07.2013||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|6414|9257|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíđ||6414||6414|9257||2 535773|P03AA5401|Tenutex|áburđur|245|mg/g|100|g|1|túpa|(20 mg + 225 mg)/g|P03AA54|01.12.1997||L|0|0|0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|Bioglan AB|Dísúlfíram í blöndum|||||||2 536037|S01EB0105|Isopto Carpine|augndr|20|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|0|0|0|0|G|0|SAL|0|0|0|100|USD|440|1650|lyfalmen|||1|10|0|25,0000|Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Pílókarpín||440||440|1650||1 536052|S01EB0105|Isopto Carpine|augndr|40|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|0|0|0|0|G|0|SAL|0|0|0|100|USD|561|1815|lyfalmen|||1|10|0|25,0000|Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Pílókarpín||561||561|1815||1 536115|C10AA0504|Atorvastatin Portfarma|filmhtfl|80|mg|100|stk|1|ţpakki||C10AA05|01.11.2011||R|1|0|0|0|0|0|POF|0|0|0|100|IKR|9376|5425|lyfalmen|||2|100|0|400,0000|Portfarma ehf|Portfarma|Atorvastatín||3200||3200|5425|31.5.2013|2 536133|A10BA0202|Metformin Actavis|filmhtfl|1000|mg|30|stk|1|ţpakki||A10BA02|01.11.2012||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|409|1607|lyfalmen|V0502|1133|2|30|0|15,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Metformín||409||409|1607||1 536289|L03AB0502|IntronA|stl|30|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.10.2012||R|0|0|0|1|0|1|SCP|0|0|0|100|DKK|30101|39659|lyfsjukr|||1|1,2|0|15,0000|Vistor hf|Schering-Plough|Interferón alfa-2b||30101||30101|39659||1 536460|N05AX1302|Xeplion|stl|150|mg|1|stk|1|áf.spr|forđadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|112191|143523|lyfalmen|||1|1|0|60,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||112191||112191|143523||1 536745|L01AA0601|Holoxan|sts/irs|500|mg|1|stk|1|hgl||L01AA06|01.07.2013||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|3207|4629|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíđ||3207||3207|4629||2 536840|N07XX0701|Fampyra|forđatfl|10|mg|56|stk|1|glas||N07XX07|01.12.2011||R|0|0|0|1|0|0|BIB|0|0|0|100|XEU|65953|85494|lyfalmen|V0019|85494|1|56|0|28,0000|Icepharma hf|Biogen Idec Ltd|Fampridine||65953||65953|85494||2 537465|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|30|pokar|Freeflex umbúđir|B05BB01|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|6368|9191|lyfsjukr|||2|7500|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||6368||6368|9191||2 537811|G03CA0401|Ovestin|sk-stíll|0,5|mg|15|stk|1|pakki||G03CA04|01.01.1988||L|0|0|0|0|G|0|ORG|0|0|0|100|DKK|||lyfalmen|||0|15|0|37,5000|Vistor hf|N.V. Organon|Estríól|||||2491||1 538181|A02AD0106|Rennie|sog/tugg|||24|stk|1|ţpakki||A02AD01|01.10.1995||L|0|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|24|0|2,4000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||||2 538199|A02AD0106|Rennie|sog/tugg|||48|stk|1|ţpakki||A02AD01|01.10.1995||L|0|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|48|0|4,8000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||||2 538207|A02AD0106|Rennie|sog/tugg|||96|stk|1|ţpakki||A02AD01|01.10.1995||L|0|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|96|0|9,6000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||||2 538496|L03AB0702|Rebif|stl|22|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.05.1999||R|0|0|0|1|0|1|MSE|0|1|0|100|SEK|140171|177797|lyfsjukr|||1|6|0|61,3953|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||140171||140171|177797||2 539031|N03AG0401|Sabrilex|töflur|500|mg|100|stk|1|ţpakki||N03AG04|01.10.1992||R|1|0|0|1|G|0|SNO|0|0|0|100|NOK|8884|13201|lyfalmen|||1|100|0|25,0000|Vistor hf|Sanofi-aventis Norge AS|Vígabatrín||8884||8884|13201||1 539152|N05AH0407|Quetiapina Qualigen (Lyfjaver)|töflur|100|mg|60|stk|1|ţpakki||N05AH04|01.06.2011||R|1|0|0|0|G|0|LVR|0|0|0|100|IKR|5863|5015|lyfalmen|V0285|4322|3|60|0|15,0000|Lyfjaver ehf|Lyfjaver ehf|Quetíapín||2900||2900|5015||3 539551|N05BA0105|Stesolid|töflur|2|mg|25|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|222|1352|lyfalmen|||2|25|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||222||222|1352||1 539577|N05BA0105|Stesolid|töflur|2|mg|100|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|0|AGT|0|0|0|100|DKK|646|1932|lyfalmen|||2|100|0|20,0000|Actavis Group hf|Actavis Group hf|Díazepam||646||646|1932||1 539783|D01AC2001|Daktacort|krem|||15|g|1|túpa||D01AC20|01.04.1986||L|0|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|15|0||Vistor hf|McNeil Sweden AB|Blöndur|||||||1 539973|G01AA1001|Dalacin|sk-krem|20|mg/g|40|g|1|sett|+7 stjökur|G01AA10|01.10.1994||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|1811|3525|lyfalmen|||1|40|0|8,0000|Icepharma hf|Pfizer ApS|Klindamýcín||1811||1811|3525||1 540070|D06BA0101|Flamazine|krem|10|mg/g|250|g|1|dos||D06BA01|01.10.1988||R|0|0|0|0|0|0|SON|0|0|1|100|DKK|2812|4895|lyfalmen|||1|250|0||Icepharma hf|Smith & Nephew|Silfursúlfadíazín||2812||2812|4895||2 540970|QP54AB5207|Equest Pramox vet|hlaup|||11,8|g|1|sk-dćl|19,5mg/g+121,7mg/g|QP54AB52|01.12.2012||R|0|0|0|0|0|0|PAS|0|0|0|100|XEU|2604|4543|vetorma|||0|11,8|0||Vistor hf|Pfizer Oy Animal Health|||2604||2604|4543||1 540989|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíđ 20 mg|S01ED51|01.07.2000||R|0|0|0|0|G|0|MSD|0|0|0|100|DKK|5933|9164|lyfalmen|V0373|7454|1|15|0|75,0000|Vistor hf|M.S.D.|Tímólól í blöndum||5933||5933|9164||1 541128|M01CC0101|Atamir|hylki|150|mg|200|stk|1|glas||M01CC01|01.09.1983||R|1|0|0|0|G|0|SGM|0|0|0|100|DKK|9592|14169|lyfalmen|V0199|14169|1|200|0|60,0000|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||9592||9592|14169||3 541136|M01CC0101|Atamir|hylki|250|mg|200|stk|1|plglas||M01CC01|12.10.2004||R|1|0|0|0|G|0|SGM|0|0|0|100|DKK|15537|22222|lyfalmen|V0200|22222|1|200|0|100,0000|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||15537||15537|22222||3 541169|R02AA0302|Strepsils med honning og citron|sogtfl|||24|stk|1|ţpakki||R02AA03|01.09.1982||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 541834|N06DA0207|Donepezil Bluefish|filmhtfl|5|mg|98|stk|1|ţpakki||N06DA02|01.04.2013||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|13192|9848|lyfalmen|V0341|9401|2|98|0|65,3300|LYFIS ehf|Bluefish Pharmaceuticals AB|Dónepezíl||6433||6433|9848||2 542216|J01GB0304|Gentamicin B. Braun|irl|1|mg/ml|80|ml|10|fl||J01GB03|01.08.2011||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|5931|8560|lyfsjukr|||2|800|0|3,3300|Actavis Group hf|Braun|Gentamícín||5931||5931|8560||1 542937|N05AE0403|Ziprasidon Actavis|hylki|60|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.06.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|14307|20679|lyfalmen|V0610|20679|2|56|0|42,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Ziprasidon||14307||14307|20679||1 542977|J04BA0201|Dapson|töflur|50|mg|100|stk|1|glas||J04BA02|01.05.1998|31.05.2013|R|0|0|0|1|0|0|LDR|0|0|0|100|IKR|4756|7554|lyfalmen|||0|100|1|100,0000|Parlogis hf|Parlogis - óskráđ lyf|Dapsón||4756||4756|7554||2 543236|N05AA0201|Nozinan|töflur|5|mg|100|stk|1|ţpakki||N05AA02|01.10.2012||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|717|2029|lyfalmen|||1|100|0|1,6667|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||717||717|2029||1 543330|C07AA0302|Visken|töflur|10|mg|98|stk|1|ţpakki||C07AA03|01.12.1983||R|1|0|0|0|G|0|NOH|0|0|0|100|DKK|2932|5059|lyfalmen|||1|98|0|65,3333|Vistor hf|Novartis Healthcare A/S-|Pindólól||2932||2932|5059||1 543374|S01ED5113|Dorzolamide/Timolol Portfarma|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamid 20mg/ml|S01ED51|01.11.2011||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|2236|3245|lyfalmen|V0373|2485|2|5|0|25,0000|Portfarma ehf|Portfarma|Tímólól í blöndum||1606||1606|3245||2 543710|A06AC0101|Vi-Siblin|kyrni|610|mg/g|250|g|1|stauk||A06AC01|01.06.1999||L|0|0|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||0|250|0|21,7857|Vistor hf|Recip AB|Semen psyllii (ispaghula)|||||||1 543744|R01AA0503|Nezeril|nefúđi|0,5|mg/ml|7,5|ml|1|glas|sk-úđari|R01AA05|01.10.1994||L|0|0|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||0|7,5|0|9,3750|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||||1 543972|J05AE1201|Victrelis|hylki|200|mg|336|stk|1|ţpakki|hörđ|J05AE12|01.01.2012||R|0|1|0|1|0|1|MLD|0|1|0|100|DKK|518113|652114|lyfsjukr|||1|336|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Boceprevír||518113||518113|652114||1 544429|L04AD0202|Prograf|hylki|0,5|mg|50|stk|1|ţpakki||L04AD02|01.06.2010||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|13128|19199|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||13128||13128|19199||1 545176|G03HB0103|Cypretyl|töflur|||63|stk|1|ţpakki||G03HB01|01.10.2012||R|0|0|0|0|0|0|RGM|0|0|0|100|XEU|1949|3554|lyfalmen|V0134|3554|2|63|0|84,0000|Medical ehf|ratiopharm GmbH|Cýpróterón og östrógen||1832||1832|3554||2 545681|D06AX0901|Bactroban|smyrsli|20|mg/g|15|g|1|túpa||D06AX09|01.07.1994||R|0|0|0|0|0|0|GSK|0|0|1|100|GBP|964|2367|lyfalmen|||1|15|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Múpírócín||964||964|2367||1 545814|N05AF0501|Cisordinol|töflur|2|mg|100|stk|1|glas||N05AF05|01.06.1984||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|913|2297|lyfalmen|||1|100|0|6,6667|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||913||913|2297||1 545848|N05AF0501|Cisordinol|töflur|10|mg|100|stk|1|glas||N05AF05|01.06.1984||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|2252|4129|lyfalmen|||1|100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||2252||2252|4129||1 545996|V01AA0507|Alutard SQ, birkifrjo|stl|||5|ml|4|hgl|byrjunarsett|V01AA05|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|30488|40986|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|trjáfrjó||30488||30488|40986||1 546002|V01AA0507|Alutard SQ, birkifrjo|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA05|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|24581|33573|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|trjáfrjó||24581||24581|33573||1 546044|V01AA0210|Alutard SQ, vallarfoxgras|stl|||5|ml|4|hgl|byrjunarsett|V01AA02|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|30668|41212|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|grasfrjó||30668||30668|41212||1 546051|V01AA0210|Alutard SQ, vallarfoxgras|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA02|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|26054|35421|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|grasfrjó||26054||26054|35421||1 546143|N02BE0108|Paratabs Retard|forđatfl|500|mg|30|stk|1|ţpakki||N02BE01|01.10.1993||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|Actavis Group hf|Actavis hf|Paracetamól|||||||1 546168|N02BE0108|Paratabs Retard|forđatfl|500|mg|100|stk|1|glas||N02BE01|01.10.1993||R|1|0|0|0|0|0|ACA|0|0|1|100|XEU|1387|2945|lyfalmen|||2|100|0|16,6667|Actavis Group hf|Actavis hf|Paracetamól||1387||1387|2945||1 546722|C09DA0310|Valsartan/Hydrochlorothiazide ratiopharm|filmhtfl|92,5|mg|98|stk|1|ţpakki|80/12,5 mg|C09DA03|01.11.2012||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|3218|2867|lyfalmen|V0580|2867|2|98|0|98,0000|Medical ehf|ratiopharm GmbH|Valsartan og ţvagrćsilyf||1330||1330|2867||2 546844|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|100|stk|1|glas||A02BC04|01.10.2012||R|1|0|0|0|G|0|APC|0|0|0|100|IKR|3141|5316|lyfalmen|V0010|5316|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||3120||3120|5316||1 547612|A02BX0202|Antepsin|töflur|1|g|60|stk|1|ţpakki||A02BX02|01.01.1986||L|1|0|0|0|0|0|ORC|0|0|0|100|IKR|||lyfalmen|||0|60|0|15,0000|Vistor hf|Orion Corporation|Súkralfat|||||4860||1 547659|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|20|mg|28|stk|1|ţpakki||A02BC05|01.08.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|IKR|2267|2135|lyfalmen|V0004|2135|3|28|0|18,6700|LYFIS ehf|LYFIS ehf|Esómeprazól||795||795|2135||2 547687|B01AC1601|Integrilin|irl|0,75|mg/ml|100|ml|1|fl||B01AC16|01.07.2000||R|0|0|0|1|0|1|GGL|0|0|0|100|GBP|10114|14576|lyfsjukr|||1|100|0|0,3800|GlaxoSmithKline ehf|Glaxo Group Limited|Eptifibatíđ||10114||10114|14576||1 547695|B01AC1601|Integrilin|stl|2|mg/ml|10|ml|1|hgl||B01AC16|01.07.2000||R|0|0|0|1|0|1|GGL|0|0|0|100|GBP|3333|4810|lyfsjukr|||1|10|0|0,1000|GlaxoSmithKline ehf|Glaxo Group Limited|Eptifibatíđ||3333||3333|4810||1 547729|G03GA0601|Puregon|stl|100|ae/hgl|0,5|ml|1|hgl||G03GA06|01.01.2000||R|0|0|0|1|G|0|ORG|0|0|0|100|DKK|7867|11810|lyfalmen|||1|0,5|0|1,3333|Vistor hf|N.V. Organon|Follitrópín beta||7867||7867|11810||1 548120|C07AB0312|Atenolol LYFIS|filmhtfl|50|mg|100|stk|1|ţpakki||C07AB03|01.05.2012||R|1|0|0|0|G|0|LYF|0|0|0|100|XEU|578|1699|lyfalmen|V0542|1699|2|100|0|66,6600|LYFIS ehf|LYFIS ehf|Atenólól||476||476|1699||2 548121|L03AB0801|Betaferon|sts|250|mcg/ml|15|spr|1|pakki|+leysir|L03AB08|01.07.2013||R|0|0|0|1|0|1|SAG|0|1|0|100|DKK|132107|167677|lyfsjukr|||1|15|0|30,0000|Icepharma hf|Schering AG|Interferón beta-1b||132107||132107|167677||2 548326|M01AE0112|ibuxin rapid|filmhtfl|400|mg|10|stk|1|ţpakki||M01AE01|01.09.2012||L|0|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||0|10|0|3,3300|LYFIS ehf|ratiopharm GmbH|Íbúprófen|||||||2 548894|B02BC0001|TISSEEL|vefjalím|||2|ml|10|áf.spr|+ Duo sett|B02BC|01.01.2013||R|0|0|0|0|0|1|BAA|0|0|0|100|SEK|183785|232533|lyfsjukr|||1|20|0||Icepharma hf|Baxter AG|Lyf til ađ minnka stađbundna blćđingu||183785||183785|232533||2 549113|J06BB1601|Synagis|sts|50|mg/hgl|1|hgl|1|pakki||J06BB16|01.01.2004||R|0|0|0|0|0|1|ABV|0|0|0|100|DKK|95371|121573|lyfsjukr|||1|1|0||Vistor hf|AbbVie Ltd.|Palivisumab||95371||95371|121573||1 549139|N05AD0102|Haldol Depot|stl|100|mg/ml|1|ml|5|lykjur||N05AD01|01.01.1987||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|9861|14537|lyfalmen|||1|5|0|151,5152|Vistor hf|Janssen-Cilag AB|Halóperídól||9861||9861|14537||1 549170|J06BB1601|Synagis|sts|100|mg/hgl|1|hgl|1|pakki||J06BB16|01.01.2004||R|0|0|0|0|0|1|ABV|0|0|0|100|DKK|141226|179121|lyfsjukr|||1|1|0||Vistor hf|AbbVie Ltd.|Palivisumab||141226||141226|179121||1 549255|N06DX0102|Memantine Merz|filmhtfl|20|mg|28|stk|1|ţpakki||N06DX01|01.07.2013||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|12832|18828|lyfalmen|V0606|18107|2|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||12832||12832|18828||1 549674|B01AF0101|Xarelto|filmhtfl|15|mg|98|stk|1|ţpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|38955|51612|lyfalmen|||1|98|0|147,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||38955|51612||2 550061|N02BE0102|Panodil Brus|freyđit|500|mg|24|stk|1|ţpakki||N02BE01|01.04.1992||L|0|0|0|0|0|0|GSH|0|0|1|100|IKR|||lyfalmen|||0|24|0|4,0000|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||1661||1 550624|N02BE0103|Panodil Junior|mixtúra|24|mg/ml|60|ml|1|glas||N02BE01|01.11.1981||L|0|0|0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa|||0|60|0|0,4800|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1 550731|N02BE0103|Panodil Junior|eţ-stíll|125|mg|10|stk|1|pakki||N02BE01|01.11.1981||L|0|0|0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa|||0|10|0|0,4167|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1 551328|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|20|sk-hyl||S01GX08|01.06.2013||L|0|0|0|0|0|0|LTH|0|0|0|100|IKR|||lyflausa|||0|8|0||Vistor hf|Laboratoires THEA|Ketotifen|||||||1 551388|B05BC0101|Mannitol Baxter Viaflo|irl|150|mg/ml|500|ml|20|plpok|lausn|B05BC01|01.08.2012||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|9412|13584|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Mannitól||9412||9412|13584||2 551408|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|12|stk|1|ţpakki||N02CC03|01.05.2001||R|0|0|0|0|G|0|AZA|0|0|0|100|SEK|9327|13807|lyfalmen|V0235|13807|1|12|0|12,0000|Vistor hf|AstraZeneca AB|Zolmítriptan||9327||9327|13807||1 551572|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|1|hgl|dreifa|H02AB08|01.11.2003||R|0|0|0|0|G|0|MAB|0|0|1|100|SEK|1900|3647|lyfalmen|||1|1|0|2,6667|Vistor hf|Meda AB|Tríamcínólón||1900||1900|3647||1 551606|M01AX0101|Relifex|töflur|500|mg|100|stk|1|ţpakki||M01AX01|01.04.1995||R|1|0|0|0|G|0|MAB|0|0|1|100|SEK|3042|5209|lyfalmen|V0198|5209|1|100|0|50,0000|Vistor hf|Meda AB|Nabúmeton||3042||3042|5209||1 551739|N02AA0102|Morfin|töflur|10|mg|20|stk|1|pakki||N02AA01|01.04.1999||R|0|0|1|0|0|0|LDR|0|0|0|100|IKR|738|2057|lyfalmen|||0|20|1|2,0000|Parlogis hf|Parlogis - óskráđ lyf|Morfín||738||738|2057||2 551846|A02BC0401|Pariet|sh-tfl|10|mg|28|stk|1|ţpakki||A02BC04|01.05.2001||R|1|0|0|0|0|0|EIS|0|0|0|100|IKR|2157|1821|lyfalmen|V0466|1646|1|28|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||565||565|1821||1 551853|A02BC0401|Pariet|sh-tfl|10|mg|56|stk|1|ţpakki||A02BC04|01.05.2001||R|1|0|0|0|0|0|EIS|0|0|0|100|IKR|3931|3501|lyfalmen|V0467|2882|1|56|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||1793||1793|3501||1 551879|A02BC0401|Pariet|sh-tfl|20|mg|14|stk|1|ţpakki||A02BC04|01.11.2001||R|1|0|0|0|0|0|EIS|0|0|0|100|IKR|1510|1077|lyfalmen|V0003|823|1|14|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||21||21|1077||1 551929|A02BC0401|Pariet|sh-tfl|20|mg|28|stk|1|ţpakki||A02BC04|01.05.2001||R|1|0|0|0|0|0|EIS|0|0|0|100|IKR|3631|1821|lyfalmen|V0003|1646|1|28|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||565||565|1821||1 551937|A02BC0401|Pariet|sh-tfl|20|mg|56|stk|1|ţpakki||A02BC04|01.05.2001||R|1|0|0|0|0|0|EIS|0|0|0|100|IKR|7648|3501|lyfalmen|V0010|2977|1|56|0|56,0000|Vistor hf|Eisai Ltd|Rabeprazól||1793||1793|3501||1 551989|N03AX1406|Zelta|filmhtfl|1000|mg|100|stk|1|ţpakki||N03AX14|01.04.2012||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|19123|11666|lyfalmen|V0516|11666|2|100|0|66,6700|LYFIS ehf|LYFIS ehf|Levetíracetam||7762||7762|11666||2 552224|C08CA0501|Adalat|töflur|20|mg|100|stk|1|ţpakki||C08CA05|01.04.1985||R|1|0|0|0|G|0|BAP|0|0|0|100|DKK|3796|6241|lyfalmen|V0083|6241|1|100|0|66,6667|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||||3796|6241||2 552328|B05BB0119|Ringer-Acetat Baxter Viaflo|irl|||1000|ml|10|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|1882|2716|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||1882||1882|2716||2 552377|M01AE0102|Ibufen|filmhtfl|400|mg|50|stk|1|glas||M01AE01|01.11.2012||L|1|0|0|0|0|0|AGP|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6600|Actavis Group hf|Actavis Group PTC ehf|Íbúprófen|||||||1 552764|QN01AX9301|Tricaine Pharmaq|duft|1000|mg/g|100|g|1|askja|lausn handa fiskum|QN01AX93|01.07.2013||R|0|0|0|0|0|0|PHL|0|0|0|100|GBP|17300|28225|veteldis|||0|100|0||PHARMAQ Ltd.|PHARMAQ Ltd|Tricaine Methane Sulfónat||17300||17300|28225||1 552877|N05CF0105|Zopiklon Mylan|filmhtfl|7,5|mg|500|stk|1|plglas||N05CF01|01.07.2007||R|2|0|0|0|0|0|MYL|0|0|0|100|SEK|5230|8202|lyfalmen|V0316|8202|2|500|0|500,0000|Icepharma hf|Mylan AB|Zópíklón||5230||5230|8202||2 552901|N03AF0201|Trileptal|filmhtfl|150|mg|100|stk|1|ţpakki||N03AF02|01.10.2000||R|1|0|0|0|G|0|NOH|0|0|0|100|DKK|3319|5588|lyfalmen|||1|100|0|15,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||3319||3319|5588||1 553206|N02CC0601|Relpax|filmhtfl|40|mg|18|stk|1|ţpakki||N02CC06|01.08.2009||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|12107|17918|lyfalmen|V0237|17918|1|18|0|18,0000|Icepharma hf|Pfizer ApS|Eletriptan||||12107|17918||1 553339|N02CC0601|Relpax|filmhtfl|40|mg|6|stk|1|ţpakki||N02CC06|01.10.2001||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|4141|6713|lyfalmen|V0237|5973|1|6|0|6,0000|Icepharma hf|Pfizer ApS|Eletriptan||4141||4141|6713||1 554154|QA12CE9902|Selevitan, vet.|stl|||100|ml|5|hgl||QA12CE99|01.05.1983||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|7674|14908|vetalmen|||0|500|0||Vistor hf|Boehringer Ingelheim Danmark|||7674||7674|14908||1 555235|N05AB0303|Peratsin|húđuđtfl|4|mg|100|stk|1|glas||N05AB03|01.02.2013||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|2292|4183|lyfalmen|||2|100|0|13,3300|Vistor hf|Orion Corporation|Perfenazín||2292||2292|4183||1 555268|N05AB0303|Peratsin|húđuđtfl|8|mg|100|stk|1|glas||N05AB03|01.02.2013||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|2612|4621|lyfalmen|V0027|3512|2|100|0|26,6700|Vistor hf|Orion Corporation|Perfenazín||2612||2612|4621||1 555292|N05AB0303|Peratsin|húđuđtfl|2|mg|100|stk|1|glas||N05AB03|01.02.2013||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|1971|3744|lyfalmen|||2|100|0|6,6700|Vistor hf|Orion Corporation|Perfenazín||1971||1971|3744||1 556921|H01AC0104|Saizen|sts|5,83|mg/ml|1,03|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|EMA|0|1|0|100|SEK|27727|36680|lyfsjukr|||1|1,03|0|9,0000|Icepharma hf|E. Merck AB|Sómatrópín||27727||27727|36680||2 556936|N03AF0201|Trileptal|filmhtfl|300|mg|100|stk|1|ţpakki||N03AF02|01.02.2000||R|1|0|0|0|G|0|NOH|0|0|0|100|DKK|4918|7776|lyfalmen|||1|100|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||4918||4918|7776||1 556944|N03AF0201|Trileptal|filmhtfl|600|mg|50|stk|1|glas||N03AF02|01.02.2000||R|1|0|0|0|G|0|NOH|0|0|0|100|DKK|6688|10197|lyfalmen|V0242|7082|1|50|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||6688||6688|10197||1 556951|N03AF0201|Trileptal|filmhtfl|600|mg|100|stk|1|ţpakki||N03AF02|01.02.2000||R|1|0|0|0|G|0|NOH|0|0|0|100|DKK|9588|14164|lyfalmen|V0242|14164|1|100|0|60,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||9588||9588|14164||1 557546|D10AF0202|Zineryt|áburđur|||30|ml|1|glas|+ leysir|D10AF02|01.07.1985||R|0|0|0|0|0|0|ASP|0|0|0|100|XEU|1612|3253|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Erýtrómýcín||1612||1612|3253||1 557980|M01AH0105|Cloxabix|hylki|100|mg|20|stk|1|ţpakki||M01AH01|01.03.2013||R|1|0|0|0|G|0|WIH|0|0|1|100|XEU|2898|5012|lyfalmen|||2|20|0|10,0000|Portfarma ehf|Williams & Halls|Celekoxíb||2898||2898|5012||2 558770|L04AA2701|Gilenya|hylki|0,5|mg|28|stk|1|ţpakki||L04AA27|01.09.2011||R|0|1|0|1|0|1|NOE|0|1|0|100|DKK|283088|357158|lyfsjukr|||1|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Fingolimod||||283088|357158||1 559013|C08DA0103|Isoptin retard|forđatfl|120|mg|28|stk|1|ţpakki||C08DA01|01.01.1995||R|1|0|0|0|G|0|ABS|0|0|0|100|DKK|854|2216|lyfalmen|||1|28|0|14,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||854||854|2216||1 559021|C08DA0103|Isoptin retard|forđatfl|120|mg|98|stk|1|ţpakki||C08DA01|01.01.1995||R|1|0|0|0|G|0|ABS|0|0|0|100|DKK|1960|3729|lyfalmen|||1|98|0|49,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||1960||1960|3729||1 559286|C05BA0101|Hirudoid|krem|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|0|0|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|STADA Arzneimittel AG|Heparínóíđ|||||||2 559401|S01ED5104|Fotil|augndr|25|mg/ml|5|ml|1|glas|5+20 mg/ml|S01ED51|01.10.1995||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|1577|3205|lyfalmen|||1|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||1577||1577|3205||2 559476|C05BA0101|Hirudoid|hlaup|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|0|0|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|STADA Arzneimittel AG|Heparínóíđ|||||||2 559948|G03CA0303|Estring|sk-hring|7,5|mcg/sólh|1|stk|1|pakki||G03CA03|01.07.1994||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|5774|8946|lyfalmen|||1|1|0|90,0000|Icepharma hf|Pfizer ApS|Estradíól||5774||5774|8946||1 559971|C01DA0201|Discotrine|forđapl|10|mg/sólh|30|stk|1|ţpakki||C01DA02|01.01.1994||R|0|0|0|0|G|0|MEB|0|0|0|100|SEK|3631|6015|lyfalmen|||1|30|0|60,0000|Vistor hf|Meda AB (V)|Glýcerýltrínítrat||3631||3631|6015||1 559989|N01AB0701|Suprane|innönd.l|||240|ml|1|fl||N01AB07|01.01.1995||R|0|0|0|0|0|1|BAX|0|0|0|100|SEK|14193|19695|lyfsjukr|||1|240|0||Icepharma hf|Baxter|Desflúran||14193||14193|19695||2 560060|S01XA2004|Vidisic|augngel|2|mg/g|10|g|1|túpa||S01XA20|01.04.1993||L|0|0|0|0|G|0|GEM|0|0|0|100|XEU|||lyfalmen|||0|10|0||Actavis Group hf|Gerhard Mann|Gervitár og ađrar óvirkar samsetningar|||||1495||1 560244|N06AB0404|Citalopram Bluefish|filmhtfl|20|mg|30|stk|1|ţpakki||N06AB04|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|791|1322|lyfalmen|V0067|1322|2|30|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Cítalópram||200||200|1322||2 560326|J05AB0102|Zovir|töflur|200|mg|25|stk|1|ţpakki||J05AB01|01.07.1989||R|1|0|0|0|G|0|GSK|0|0|1|100|GBP|1362|2911|lyfalmen|V0044|2648|1|25|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||1362||1362|2911||1 560367|D06BB0303|Zovir|krem|50|mg/g|2|g|1|túpa||D06BB03|01.07.1994||L|0|0|0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa|||0|2|0||GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Acíklóvír|||||||1 560375|S01AD0301|Zovir|augnsm|30|mg/g|4,5|g|1|túpa||S01AD03|01.01.1988||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|1500|3100|lyfalmen|||1|4,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||1500||1500|3100||1 560383|J05AB0102|Zovir|mixtúra|40|mg/ml|125|ml|1|glas||J05AB01|01.01.1995||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|5743|8904|lyfalmen|||1|125|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||5743||5743|8904||1 560391|J05AB0102|Zovir|mixtúra|80|mg/ml|100|ml|1|glas||J05AB01|01.01.1995||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|6227|9566|lyfalmen|||1|100|0|2,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||6227||6227|9566||1 560490|C01CX0801|Simdax|irţ|2,5|mg/ml|5|ml|1|lykja||C01CX08|01.09.2001||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|101098|128760|lyfsjukr|||1|5|0|1,1400|Vistor hf|Orion Corporation|Levosimendan||101098||101098|128760||1 560557|C01CX0801|Simdax|irţ|2,5|mg/ml|5|ml|4|lykjur||C01CX08|01.09.2001||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|467547|588654|lyfsjukr|||1|20|0|4,5500|Vistor hf|Orion Corporation|Levosimendan||467547||467547|588654||1 560761|C10AA0505|Atorvastatin Bluefish|filmhtfl|80|mg|100|stk|1|ţpakki||C10AA05|01.10.2012||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|9323|13359|lyfalmen|V0115|13359|2|100|0|400,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Atorvastatín||9000||9000|13359||2 561145|N03AX2101|Trobalt|filmhtfl|||63|stk|1|ţpakki|21x50mg+42x100mg|N03AX21|01.12.2011|30.06.2013|R|1|1|0|0|G|0|GGL|0|0|0|100|GBP|5425|8469|lyfalmen|||1|63|0|5,8400|GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||5425||5425|8469||1 561159|S01ED5105|Fotil forte|augndr|45|mg/ml|5|ml|1|glas|5+40 mg/ml|S01ED51|01.10.1995||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|1732|3417|lyfalmen|||1|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||1732||1732|3417||2 562014|C09BA0201|Daraziđ|töflur|32,5|mg|100|stk|1|glas|20+12,5 mg|C09BA02|01.06.2011||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|1988|3767|lyfalmen|||2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Enalapríl og ţvagrćsilyf||1988||1988|3767||1 562176|B02BD0901|BeneFIX|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD09|01.02.2013||R|0|0|0|1|0|1|IPI|0|0|0|100|DKK|50228|64919|lyfsjukr|||1|1|0|1,1100|Icepharma hf|Pfizer Limited|Storkuţáttur IX||50228||50228|64919||2 562254|S01EE0105|Monoprost|augndr|50|mcg/ml|0,2|ml|90|sk-hyl|90 (18x5)|S01EE01|01.03.2013||R|0|0|0|0|G|0|THA|0|0|0|100|SEK|5160|8107|lyfalmen|||1|18|0|90,0000|Vistor hf|Laboratories THEA|Latanóprost||5160||5160|8107||1 562577|J06BA0207|Kiovig|irl|100|mg/ml|300|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|0|0|100|SEK|254966|321865|lyfsjukr|||1|300|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||254966||254966|321865||2 562668|L04AA2601|Benlysta|irs|400|mg/hgl|1|hgl|1|pakki|lausn|L04AA26|01.12.2011||R|0|0|0|1|0|1|GGL|0|1|0|100|GBP|100876|128482|lyfsjukr|||1|1|0|16,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Belimumab||100876||100876|128482||1 563111|L04AX0501|Esbriet|hylki|267|mg|63|stk|1|ţpakki|hart|L04AX05|01.07.2012||R|1|1|0|1|0|0|INT|0|0|0|100|DKK|115767|148011|lyfalmen|||1|63|0|7,0000|Vistor hf|InterMune Europe Ltd.|Pírfenidon||115767||115767|148011||1 563346|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|3|spr|einnota sprauta|M09AX01|01.01.2001||R|0|0|0|0|G|0|NYC|0|0|0|100|DKK|21344|29510|lyfalmen|V0431|28750|2|6|0|17,1667|Vistor hf|Nycomed Danmark A/S|Natríumhýalúrónat||21344||21344|29510||1 563361|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|5|spr|einnota sprauta|M09AX01|01.01.2001||R|0|0|0|0|G|0|NYC|0|0|0|100|DKK|36011|47917|lyfalmen|V0431|47917|2|10|0|28,6111|Vistor hf|Nycomed Danmark A/S|Natríumhýalúrónat||36011||36011|47917||1 563379|D07AC1701|Cutivat|krem|0,5|mg/g|30|g|1|túpa||D07AC17|01.07.1995||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|693|1996|lyfalmen|||1|30|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||693||693|1996||1 563395|D07AC1701|Cutivat|smyrsli|50|mcg/g|30|g|1|túpa||D07AC17|01.07.1995||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|670|1964|lyfalmen|||1|30|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||670||670|1964||1 563502|N02AA0101|Contalgin|forđatfl|5|mg|100|stk|1|ţpakki||N02AA01|01.10.1993||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|1393|2953|lyfalmen|||1|100|0|5,0000|Icepharma hf|Pfizer ApS|Morfín||1393||1393|2953||1 563528|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|30|spr|einnota sprauta|M09AX01|01.01.2001||R|0|0|0|0|G|0|NYC|0|0|0|100|DKK|207620|263286|lyfalmen|||2|60|0|171,6667|Vistor hf|Nycomed Danmark A/S|Natríumhýalúrónat||207620||207620|263286||1 563577|S01ED5104|Fotil|augndr|25|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|3615|5993|lyfalmen|||1|15|0|60,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||3615||3615|5993||2 563593|S01ED5105|Fotil forte|augndr|45|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|3747|6174|lyfalmen|||1|15|0|60,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||3747||3747|6174||2 563756|H01CB0501|Signifor|stl|0,3|mg|1|ml|60|lykjur||H01CB05|01.11.2012||R|0|0|0|0|0|0|NOE|0|0|0|100|DKK|468170|590277|lyfalmen|||1|60|0||Vistor hf|Novartis Europharm Ltd|PAsireótiđ disapartate||468170||468170|590277||1 563779|M05BA0708|Risedronate Bluefish|filmhtfl|35|mg|12|stk|1|ţpakki||M05BA07|01.07.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|2323|1664|lyfalmen|V0207|1664|2|12|0|84,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Rísedrónsýru||450||450|1664||2 563899|QP54AA0105|Noromectin|áhella|0,5|w/v|1000|ml|1|fl|lausn|QP54AA01|01.11.2011||R|0|0|0|0|0|0|NOB|1|0|0|100|XEU|11473|20014|vetorma|||0|1000|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||11473||11473|20014||2 563918|N02AA0505|Oxycodone ratiopharm|forđatfl|5|mg|28|stk|1|ţpakki||N02AA05|01.04.2013||R|1|0|1|0|G|0|RGM|0|0|0|100|XEU|1845|3572|lyfalmen|V0596|3572|2|28|0|1,8600|Medical ehf|ratiopharm GmbH|Oxýcódon||1845||1845|3572||2 564088|J05AB0401|Rebetol|hylki|200|mg|168|stk|1|ţpakki|hart|J05AB04|01.02.2002||R|1|0|0|1|0|1|SCP|0|0|0|100|DKK|82583|105524|lyfsjukr|||1|168|0|33,6000|Vistor hf|Schering-Plough|Ribavirin||82583||82583|105524||1 564441|R06AX2701|Aerius|mixtúra|0,5|mg/ml|120|ml|1|glas||R06AX27|01.11.2012||R|1|0|0|0|G|0|MLD|0|0|1|100|DKK|1113|2570|lyfalmen|||1|120|0|12,0000|Vistor hf|Merck Sharp & Dohme Limited|Deslóratadín||1113||1113|2570||1 565306|A02BX1302|Galieve Cool Mint|mixtúra|||300|ml|1|glerfl|dreifa|A02BX13|01.12.2010||L|0|0|0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||0|300|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||||1 565457|A07EC0301|Dipentum|töflur|500|mg|100|stk|1|glas||A07EC03|01.10.1994||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|11650|16985|lyfalmen|||1|100|0|50,0000|Vistor hf|U.C.B|Olsalazín||11650||11650|16985||1 565982|H01BA0401|Glypressin|stl|0,1|mg/ml|8,5|ml|5|lykjur|lausn|H01BA04|01.08.2012||R|0|0|0|0|0|1|FEL|0|0|0|100|DKK|36610|47828|lyfsjukr|||1|42,5|0|0,3600|Vistor hf|Ferring Lćgemidler A/S|Terlípressín||36610||36610|47828||1 566182|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|1|glas||S01EC04|01.01.2001||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|1393|2953|lyfalmen|V0444|2224|0|5|0|25,0000|Vistor hf|Alcon Laboratories Ltd.|Brinzólamíđ||1393||1393|2953||1 566373|N05AA0201|Nozinan|filmhtfl|100|mg|100|stk|1|ţpakki||N05AA02|01.11.2012||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|5330|8339|lyfalmen|||1|100|0|33,3333|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||5330||5330|8339||1 567028|L01XE0701|Tyverb|filmhtfl|250|mg|84|stk|1|glas||L01XE07|01.02.2012||R|1|0|0|1|0|1|GGL|0|0|0|100|GBP|203584|257380|lyfsjukr|||1|84|0||GlaxoSmithKline ehf|Glaxo Group Limited|Labatinibum||203584||203584|257380||1 567460|C01CA2407|Jext|stl|150|mcg|1|stk|1|pakki|áfylltur penni|C01CA24|01.10.2011||R|0|0|0|0|G|0|ALK|0|0|1|100|DKK|5854|9056|lyfalmen|||1|1|0|0,3000|Vistor hf|ALK-Abello A/S|Adrenalín tartrat||||5854|9056||1 567503|N05AX0801|Risperdal|töflur|1|mg|60|stk|1|ţpakki||N05AX08|01.01.1995||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|3487|5818|lyfalmen|V0291|3442|1|60|0|12,0000|Vistor hf|Janssen-Cilag AB|Risperídón||3487||3487|5818||1 567510|C07AG0101|Trandate|filmhtfl|200|mg|100|stk|1|glas||C07AG01|01.06.2013||R|1|0|0|0|G|0|ATL|0|0|0|100|GBP|3198|5423|lyfalmen|V0600|5423|1|100|0|33,3333|Aspen Pharma Trading Ltd.|Aspen Pharma Trading Ltd.|Labetalól||3198||3198|5423||1 567511|N05AX0801|Risperdal|töflur|2|mg|60|stk|1|ţpakki||N05AX08|01.01.1995||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|7058|10703|lyfalmen|V0292|5635|1|60|0|24,0000|Vistor hf|Janssen-Cilag AB|Risperídón||7058||7058|10703||1 567529|N05AX0801|Risperdal|töflur|3|mg|60|stk|1|ţpakki||N05AX08|01.01.1995||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|10317|15161|lyfalmen|V0293|8247|1|60|0|36,0000|Vistor hf|Janssen-Cilag AB|Risperídón||10317||10317|15161||1 567537|N05AX0801|Risperdal|töflur|4|mg|60|stk|1|ţpakki||N05AX08|01.01.1995||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|13548|19726|lyfalmen|V0294|10536|1|60|0|48,0000|Vistor hf|Janssen-Cilag AB|Risperídón||13548||13548|19726||1 567545|R01AC0201|Livostin|nefúđi|0,5|mg/úđask|15|ml|1|glas||R01AC02|01.06.1998||L|0|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|15|0|12,5000|Vistor hf|McNeil Sweden AB|Levókabastín|||||||1 567946|A02BX1302|Galieve Cool Mint|mixtúra|||10|ml|24|skammt|dreifa|A02BX13|01.12.2010||L|0|0|0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||0|240|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||||1 568709|R01AX0601|Bactroban Nasal|nefsm|20|mg/g|3|g|1|túpa||R01AX06|01.07.1994||R|0|0|0|0|0|0|GSK|0|0|1|100|GBP|1077|2521|lyfalmen|||1|3|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Mupirocin||1077||1077|2521||1 568840|C08CA0201|Feldil|forđatfl|5|mg|100|stk|1|glas||C08CA02|01.04.2003||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|2930|5049|lyfalmen|V0058|5049|2|100|0|100,0000|Actavis Group hf|Actavis hf|Felódipín||2925||2925|5049||1 568865|C08CA0201|Feldil|forđatfl|10|mg|100|stk|1|glas||C08CA02|01.04.2003||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|3687|6083|lyfalmen|V0059|6083|2|100|0|200,0000|Actavis Group hf|Actavis hf|Felódipín||3681||3681|6083||1 569378|L01AA0601|Holoxan|sts/irs|2000|mg|1|stk|1|hgl||L01AA06|01.07.2013||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|12868|18032|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíđ||12868||12868|18032||2 569467|M03BX0103|Lioresal|stl|2|mg/ml|5|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|0|1|0|1|NOH|0|0|0|100|DKK|17337|23640|lyfsjukr|||1|5|0|18,1800|Vistor hf|Novartis Healthcare A/S-|Baklófen||17337||17337|23640||1 569483|M03BX0103|Lioresal|stl|0,5|mg/ml|20|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|0|1|0|1|NOH|0|0|0|100|DKK|19935|26901|lyfsjukr|||1|20|0|18,1800|Vistor hf|Novartis Healthcare A/S-|Baklófen||19935||19935|26901||1 571524|A02BX1303|Galieve Peppermint|tuggutfl|||24|stk|1|ţpakki|dreifa|A02BX13|01.12.2010||L|0|0|0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||0|24|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||||1 572422|L04AD0201|Advagraf|forđahlk|5|mg|50|stk|1|ţpakki||L04AD02|01.03.2012||R|0|0|0|1|G|0|APE|0|0|0|100|XEU|84843|109201|lyfalmen|||1|50|0|50,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||84843||84843|109201||1 572612|N03AX1404|Levetiracetam Actavis|filmhtfl|500|mg|100|stk|1|ţpakki||N03AX14|01.12.2011||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|10671|5918|lyfalmen|V0253|5436|2|100|0|33,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||3560||3560|5918||1 572798|A02BX1303|Galieve Peppermint|tuggutfl|||48|stk|1|ţpakki|dreifa|A02BX13|01.12.2010||L|0|0|0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||0|48|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||||1 573065|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|20|mg|98|stk|1|glas||A02BC05|01.08.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|8127|5070|lyfalmen|V0011|5070|3|98|0|65,3300|LYFIS ehf|LYFIS ehf|Esómeprazól||2940||2940|5070||2 573120|N03AX0903|Lamotrin|dreifit.|100|mg|98|stk|1|ţpakki||N03AX09|01.12.2010||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|5300|3844|lyfalmen|V0245|3753|2|98|0|32,6700|Actavis Group hf|Actavis hf|Lamótrigín||2044||2044|3844||1 573177|S01ED5110|Duotrav|augndr|||2,5|ml|1|glas|40 mcg/ml+5 mg/ml|S01ED51|01.10.2011||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|3575|5938|lyfalmen|V0464|4726|0|2,5|0|25,0000|Vistor hf|Alcon Laboratories Ltd.|Tímólól í blöndum||3575||3575|5938||1 573287|G03CA0306|Evorel|forđapl|25|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|3364|5650|lyfalmen|V0129|5650|1|26|0|45,5000|Vistor hf|Janssen-Cilag AB|Estradíól||3364||3364|5650||1 573436|N06DX0102|Memantine Merz|filmhtfl|20|mg|98|stk|1|ţpakki||N06DX01|01.07.2013||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|37734|50080|lyfalmen|V0607|50080|2|98|0|98,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||37734||37734|50080||1 573477|L01XC0301|Herceptin|sts|150|mg/hgl|1|hgl|1|pakki||L01XC03|01.01.2002||R|0|0|0|1|0|1|ROC|0|1|0|100|DKK|97463|124199|lyfsjukr|||1|1|0||Icepharma hf|Roche|Trastuzumab||97463||97463|124199||2 573634|J01DH0201|Meronem|sts/irs|500|mg/hgl|500|mg|10|hgl||J01DH02|01.10.1995||R|0|0|0|0|0|1|AZA|0|0|0|100|SEK|24864|33087|lyfsjukr|||1|5000|0|2,5000|Vistor hf|AstraZeneca AB|Meropenem||24864||24864|33087||1 573642|J01DH0201|Meronem|sts/irs|1|g/hgl|1|g|10|hgl||J01DH02|01.10.1995||R|0|0|0|0|0|1|AZA|0|0|0|100|SEK|42099|54717|lyfsjukr|||1|10|0|5,0000|Vistor hf|AstraZeneca AB|Meropenem||42099||42099|54717||1 573790|M01AB0506|Voltaren Rapid|töflur|50|mg|100|stk|1|ţpakki||M01AB05|01.01.1996||R|1|0|0|0|G|0|NOH|0|0|1|100|IKR|2477|2728|lyfalmen|V0189|2391|1|100|0|50,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||1228||1228|2728||1 574423|L01XC1301|Perjeta|irţ|420|mg|14|ml|1|hgl||L01XC13|01.06.2013||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|456418|574687|lyfsjukr|||1|14|0||Icepharma hf|Roche Registration Limited|Pertuzumab||456418||456418|574687||2 575324|N06AB0601|Zoloft|töflur|50|mg|28|stk|1|ţpakki||N06AB06|01.10.1995||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|2495|2183|lyfalmen|V0151|1545|1|28|0|28,0000|Icepharma hf|Pfizer ApS|Sertralín||830||830|2183||1 575340|N06AB0601|Zoloft|töflur|50|mg|98|stk|1|ţpakki||N06AB06|01.10.1995||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|7773|7056|lyfalmen|V0322|2717|1|98|0|98,0000|Icepharma hf|Pfizer ApS|Sertralín||4392||4392|7056||1 575357|N06AB0601|Zoloft|töflur|100|mg|28|stk|1|ţpakki||N06AB06|01.03.2001||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|4602|2183|lyfalmen|V0152|2041|1|28|0|56,0000|Icepharma hf|Pfizer ApS|Sertralín||830||830|2183||1 575365|N06AB0601|Zoloft|töflur|100|mg|98|stk|1|ţpakki||N06AB06|01.03.2001||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|14009|7056|lyfalmen|V0323|4154|1|98|0|196,0000|Icepharma hf|Pfizer ApS|Sertralín||4392||4392|7056||1 575472|P03AX0301|Prioderm|hársápa|10|mg/ml|40|g|1|túpa||P03AX03|01.04.1994||L|0|0|0|0|0|0|NOP|0|0|0|100|IKR|||lyflausa|||0|40|0||Icepharma hf|Norpharma |Malatíón|||||||2 575555|J01CA0413|Amoxin|mixt.kyr|50|mg/ml|60|ml|1|glas||J01CA04|01.06.2013||R|0|0|0|0|0|0|RGM|0|0|1|100|XEU|1211|2705|lyfalmen|||2|60|0|3,0000|Medical ehf|ratiopharm GmbH|Amoxicillín||1211||1211|2705||2 575563|J01CA0413|Amoxin|mixt.kyr|50|mg/ml|100|ml|1|glas||J01CA04|01.05.2013||R|0|0|0|0|0|0|RGM|0|0|1|100|XEU|1531|3142|lyfalmen|||2|100|0|5,0000|Medical ehf|ratiopharm GmbH|Amoxicillín||1531||1531|3142||2 575571|J01CA0413|Amoxin|filmhtfl|500|mg|20|stk|1|ţpakki||J01CA04|01.03.2013||R|0|0|0|0|0|0|RGM|0|0|1|100|IKR|1541|2215|lyfalmen|V0159|2215|2|20|0|10,0000|Medical ehf|ratiopharm GmbH|Amoxicillín||853||853|2215||2 575589|J01CA0413|Amoxin|filmhtfl|500|mg|30|stk|1|ţpakki||J01CA04|01.03.2013||R|0|0|0|0|0|0|RGM|0|0|1|100|IKR|1648|2766|lyfalmen|V0160|2766|2|30|0|15,0000|Medical ehf|ratiopharm GmbH|Amoxicillín||1256||1256|2766||2 575621|J01CA0413|Amoxin|filmhtfl|750|mg|20|stk|1|ţpakki||J01CA04|01.03.2013||R|0|0|0|0|0|0|RGM|0|0|1|100|IKR|1556|2669|lyfalmen|V0158|2669|2|20|0|15,0000|Medical ehf|ratiopharm GmbH|Amoxicillín||1185||1185|2669||2 576032|N03AX0903|Lamotrin|dreifit.|25|mg|42|stk|1|ţpakki||N03AX09|01.12.2010||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1150|1622|lyfalmen|V0243|1499|2|42|0|3,5000|Actavis Group hf|Actavis hf|Lamótrigín||420||420|1622||1 576122|L01XE1801|Jakavi|töflur|20|mg|60|stk|1|glas||L01XE18|01.11.2012||R|1|0|0|1|0|1|NOE|0|0|0|100|DKK|658126|827831|lyfsjukr|||1|60|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||658126||658126|827831||1 576714|L01BB0201|Puri-nethol|töflur|50|mg|25|stk|1|glas||L01BB02|01.12.2012||R|0|0|0|0|G|0|ATL|0|0|0|100|XEU|3495|5829|lyfalmen|||1|25|0||Aspen Pharma Trading Ltd.|Aspen Pharma Trading Ltd.|Merkaptópúrín||3495||3495|5829||1 578259|A04AA0106|Ondansetron Mylan|filmhtfl|8|mg|10|stk|1|ţpakki||A04AA01|01.05.2012||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|3841|3964|lyfalmen|V0384|3880|2|10|0|5,0000|Icepharma hf|Mylan AB|Ondansetrón||2132||2132|3964||2 578654|QP52AA5104|Zantel|töflur|550|mg|20|stk|1|ţpakki|50+500 mg|QP52AA51|01.07.2011||R|0|0|0|0|0|0|ICE|0|0|0|100|USD|5729|9994|vetorma|||0|20|0||Icepharma hf|Icepharma hf|||5729||5729|9994||2 579110|R03CC0301|Bricanyl|stl|0,5|mg/ml|1|ml|10|lykjur||R03CC03|01.12.1972||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|1340|2881|lyfalmen|||1|10|0|0,3300|Vistor hf|AstraZeneca A/S DK|Terbútalín||1340||1340|2881||1 579421|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|40|mg|28|stk|1|ţpakki||A02BC05|01.08.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|IKR|4212|2183|lyfalmen|V0005|2183|3|28|0|37,3300|LYFIS ehf|LYFIS ehf|Esómeprazól||830||830|2183||2 579854|L04AX0305|Methotrexate Pfizer|töflur|2,5|mg|30|stk|1|glas||L04AX03|01.01.1994||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|369|1553|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Metótrexat||369||369|1553||1 580104|N07BB0001|Selincro|filmhtfl|18|mg|14|stk|1|ţpakki||N07BB|01.06.2013||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|8641|12868|lyfalmen|V0078|12206|1|14|0||Lundbeck Export A/S|H. Lundbeck A/S|Nalmefenum||8641||8641|12868||1 580190|N06AB1005|Escitalopram LYFIS|filmhtfl|5|mg|100|stk|1|ţpakki||N06AB10|01.02.2012||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|2800|2884|lyfalmen|V0324|2884|2|100|0|50,0000|LYFIS ehf|LYFIS ehf|Escítalópram||1342||1342|2884||2 580227|A10BX0202|Repaglinid Krka (LYFIS)|töflur|0,5|mg|90|stk|1|ţpakki||A10BX02|01.11.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|2394|2808|lyfalmen|V0462|2808|3|90|0|11,2500|LYFIS ehf|LYFIS ehf|Repaglíníđ||1287||1287|2808||2 580960|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|1000|ml|10|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|2210|3190|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||2210||2210|3190||2 581328|C10AA0505|Atorvastatin Bluefish|filmhtfl|20|mg|100|stk|1|ţpakki||C10AA05|01.10.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|2837|1746|lyfalmen|V0113|1746|2|100|0|100,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Atorvastatín||510||510|1746||2 581806|A10BX0202|Repaglinid Krka (LYFIS)|töflur|2|mg|90|stk|1|ţpakki||A10BX02|01.11.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|2801|3075|lyfalmen|V0472|3075|3|90|0|45,0000|LYFIS ehf|LYFIS ehf|Repaglíníđ||1482||1482|3075||2 581890|QN02AF0103|Torphasol vet.|stl|10|mg/ml|20|ml|1|hgl||QN02AF01|01.02.2011||R|0|0|0|0|0|0|ANI|1|0|0|100|XEU|14529|28070|vetalmen|||0|20|0||Dýraheilsa ehf|aniMedica GmbH|Bútorfanóltartrat||14529||14529|28070||2 581969|S01EE0401|Travatan|augndr|40|mcg/ml|2,5|ml|1|glas||S01EE04|01.07.2011||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|2326|4230|lyfalmen|||0|2,5|0|25,0000|Vistor hf|Alcon Laboratories Ltd.|Cýklópentólat||2326||2326|4230||1 582080|H01AC0107|Humatrope 6 mg|sts|6|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|0|0|0|1|0|1|ELI|0|1|0|100|XEU|28387|37508|lyfsjukr|||1|1|0|9,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||28387||28387|37508||2 582114|H01AC0108|Humatrope 12 mg|sts|12|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|0|0|0|1|0|1|ELI|0|1|0|100|XEU|54782|70634|lyfsjukr|||1|1|0|18,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||54782||54782|70634||2 582130|H01AC0109|Humatrope 24 mg|sts|24|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|0|0|0|1|0|1|ELI|0|1|0|100|XEU|109563|139384|lyfsjukr|||1|1|0|36,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||109563||109563|139384||2 582213|R01AA0503|Nezeril|nefúđi|0,1|mg/ml|7,5|ml|1|glas|sk-úđari|R01AA05|01.10.1994||L|0|0|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||0|7,5|0|1,8750|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||||1 582221|V08AB0201|Omnipaque|stl|140|mg J/ml|200|ml|10|plastf||V08AB02|01.04.2011||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|67191|86207|lyfsjukr|||1|2000|0||Icepharma hf|GE Healthcare AS|Jóhexól||67191||67191|86207||2 582247|QP54AA0301|Dectomax vet.|stl|10|mg/ml|50|ml|1|hgl||QP54AA03|01.02.1999||R|0|0|0|0|0|0|PAL|1|0|0|100|DKK|5010|8740|vetorma|||0|50|0||Icepharma hf|Pfizer Oy Animal Health|Doramectinum||5010||5010|8740||2 582262|QP54AA0301|Dectomax vet.|stl|10|mg/ml|200|ml|1|hgl||QP54AA03|01.02.1999||R|0|0|0|0|0|0|PAL|1|0|0|100|DKK|18877|32930|vetorma|||0|200|0||Icepharma hf|Pfizer Oy Animal Health|Doramectinum||18877||18877|32930||2 582451|A02BC0507|Esomeprazole Portfarma|sţ-tfl|20|mg|56|stk|1|ţpakki||A02BC05|01.11.2011||R|1|0|0|0|0|0|POF|0|0|0|100|IKR|4597|3810|lyfalmen|V0011|2897|2|56|0|37,3300|Portfarma ehf|Portfarma|Esómeprazól||2019||2019|3810||2 582452|V08AB0201|Omnipaque|stl|300|mg J/ml|100|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|45180|58583|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Jóhexól||45180||45180|58583||2 582635|V08AB0201|Omnipaque|stl|300|mg J/ml|500|ml|6|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|102788|130881|lyfsjukr|||1|3000|0||Icepharma hf|GE Healthcare AS|Jóhexól||102788||102788|130881||2 582882|V08AB0901|Visipaque|stl|270|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|49805|64388|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Jódixanól||49805||49805|64388||2 582990|H01AC0104|Saizen|sts|8|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|EMA|0|1|0|100|SEK|55408|71420|lyfsjukr|||1|1,5|0|18,0000|Icepharma hf|E. Merck AB|Sómatrópín||55408||55408|71420||2 583401|V08AB0901|Visipaque|stl|270|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|99044|126183|lyfsjukr|||1|2000|0||Icepharma hf|GE Healthcare AS|Jódixanól||99044||99044|126183||2 583443|C07AA0705|Sotalol Mylan|töflur|80|mg|100|stk|1|ţpakki||C07AA07|01.01.1994||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1142|2610|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Sótalól||1142||1142|2610||2 583450|V08AB0901|Visipaque|stl|270|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|118217|150245|lyfsjukr|||1|3000|0||Icepharma hf|GE Healthcare AS|Jódixanól||118217||118217|150245||2 583518|V08AB0901|Visipaque|stl|320|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|53980|69627|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Jódixanól||53980||53980|69627||2 583609|V08AB0901|Visipaque|stl|320|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|111197|141435|lyfsjukr|||1|2000|0||Icepharma hf|GE Healthcare AS|Jódixanól||111197||111197|141435||2 583708|V08AB0901|Visipaque|stl|320|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|121552|154430|lyfsjukr|||1|3000|0||Icepharma hf|GE Healthcare AS|Jódixanól||121552||121552|154430||2 583849|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|20|plpok|Excel umbúđir|B05BB01|01.11.2002||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3835|5535|lyfsjukr|||2|5000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||3835||3835|5535||2 584029|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|9|plpok|Excel umbúđir|B05BA03|01.11.2002||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2323|3353|lyfsjukr|||2|9000|0||Icepharma hf|Fresenius Kabi|Kolvetni||2323||2323|3353||2 584133|L03AB0502|IntronA|stl|18|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.10.2012||R|0|0|0|1|0|1|SCP|0|0|0|100|DKK|18662|25303|lyfsjukr|||1|1,2|0|9,0000|Vistor hf|Schering-Plough|Interferón alfa-2b||18662||18662|25303||1 584292|N06AG0201|Aurorix|töflur|300|mg|30|stk|1|ţpakki||N06AG02|01.07.1995||R|1|0|0|0|G|0|MAS|0|0|0|100|SEK|1921|3676|lyfalmen|V0064|3182|1|30|0|30,0000|Vistor hf|Meda AS|Móklóbemíđ||1921||1921|3676||1 585679|B01AB0101|Heparin Leo|stl|5000|ae/ml|5|ml|5|hgl||B01AB01|01.12.1972||R|0|0|0|0|0|1|LEP|0|0|0|100|DKK|4611|6655|lyfsjukr|||1|25|0|12,5000|Vistor hf|LEO Pharma A/S|Heparín||4611||4611|6655||1 585869|J07BC0201|Havrix|bóluefni|1440|ein/ml|1|ml|1|dćla|einnota dćla|J07BC02|01.07.1994||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|4366|7020|lyfalmen|||1|1|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-A, dauđ veira (inactiv­ated whole virus)||4366||4366|7020||1 585975|C07AB0312|Atenolol LYFIS|filmhtfl|25|mg|100|stk|1|ţpakki||C07AB03|01.05.2012||R|1|0|0|0|G|0|LYF|0|0|0|100|XEU|472|1694|lyfalmen|V0541|1654|2|100|0|33,3300|LYFIS ehf|LYFIS ehf|Atenólól||472||472|1694||2 586107|L04AD0102|Sandimmun Neoral|mixtúra|100|mg/ml|50|ml|1|glas||L04AD01|01.07.1994||R|0|0|0|0|G|0|NOH|0|0|0|100|DKK|32769|43848|lyfalmen|||1|50|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||32769||32769|43848||1 586206|D07AB0201|Locoid|smyrsli|1|mg/g|100|g|1|túpa||D07AB02|01.03.1977||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|1749|3440|lyfalmen|||1|100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1749||1749|3440||1 586223|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|80|ml|10|fl||J01GB03|01.08.2011||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|14268|19789|lyfsjukr|||2|800|0|10,0000|Actavis Group hf|Braun|Gentamícín||14268||14268|19789||1 586241|J01GB0101|Tobi Podhaler|innönddu|28|mg|224|stk|1|ţpakki|hart hylki+innönd.tćki|J01GB01|01.04.2012||R|0|0|0|1|0|1|NOE|0|1|0|100|DKK|381028|480073|lyfsjukr|||1|224|0|56,0000|Vistor hf|Novartis Europharm Ltd|Tobramýcín||381028||381028|480073||1 586694|N06DX0103|Nemdatine|filmhtfl|20|mg|28|stk|1|ţpakki||N06DX01|01.07.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|12258|18107|lyfalmen|V0606|18107|2|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Memantín||12258||12258|18107||1 587141|N05AE0403|Ziprasidon Actavis|hylki|80|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.06.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|19613|27338|lyfalmen|V0611|27333|2|56|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Ziprasidon||19613||19613|27338||1 587437|N06DX0103|Nemdatine|filmhtfl|10|mg|28|stk|1|ţpakki||N06DX01|01.07.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|5357|8376|lyfalmen|V0604|8376|2|28|0|14,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Memantín||5357||5357|8376||1 587641|C09DA0602|Candpress Comp|töflur|28,5|mg|100|stk|1|ţpakki|16 + 12,5 mg|C09DA06|01.01.2012||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|10184|14276|lyfalmen|V0095|14276|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan og ţvagrćsilyf||9670||9670|14276||1 588395|N03AX2101|Trobalt|filmhtfl|50|mg|84|stk|1|ţpakki||N03AX21|01.12.2011|30.06.2013|R|1|1|0|0|G|0|GGL|0|0|0|100|GBP|4429|7107|lyfalmen|||1|84|0|4,6700|GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||4429||4429|7107||1 588574|J01FF0101|Dalacin|hylki|300|mg|20|stk|1|ţpakki||J01FF01|01.10.1995||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|2201|4059|lyfalmen|V0461|4056|1|20|0|5,0000|Icepharma hf|Pfizer ApS|Klindamýcín||2201||2201|4059||1 588608|B01AC0501|Ticlid|töflur|250|mg|100|stk|1|ţpakki||B01AC05|01.04.1995||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|9748|14383|lyfalmen|||1|100|0|50,0000|Vistor hf|Sanofi-aventis Norge AS|Tíklópídín||9748||9748|14383||1 588911|N05AH0306|Olanzapin Actavis|filmhtfl|10|mg|100|stk|1|glas||N05AH03|01.11.2012||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|9438|7395|lyfalmen|V0282|7236|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||4640||4640|7395||1 589358|QP54AA0501|Stronghold vet.|bl.lausn|120|mg|1|ml|3|túpa||QP54AA05|01.04.2004||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|6127|10688|vetorma|||0|3|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||6127||6127|10688||2 589366|QP54AA0501|Stronghold vet.|bl.lausn|15|mg|0,25|ml|3|túpa||QP54AA05|01.04.2004||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|2374|4141|vetorma|||0|0,75|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||2374||2374|4141||2 589374|QP54AA0501|Stronghold vet.|bl.lausn|240|mg|2|ml|3|túpa||QP54AA05|01.04.2004||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|5911|10311|vetorma|||0|6|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||5911||5911|10311||2 589382|QP54AA0501|Stronghold vet.|bl.lausn|30|mg|0,25|ml|3|túpa||QP54AA05|01.04.2004||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|3193|5570|vetorma|||0|0,75|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||3193||3193|5570||2 589390|QP54AA0501|Stronghold vet.|bl.lausn|60|mg|0,5|ml|3|túpa||QP54AA05|01.04.2004||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|3316|5785|vetorma|||0|1,5|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||3316||3316|5785||2 589408|QP54AA0501|Stronghold vet.|bl.lausn|45|mg|0,75|ml|3|túpa||QP54AA05|01.04.2004||R|0|0|0|0|0|0|ZBE|1|0|0|100|DKK|3194|5572|vetorma|||0|2,25|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||3194||3194|5572||2 589888|N01AF0302|Pentocur|sts|0,5|g|10|hgl|1|pakki||N01AF03|01.07.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|13576|18920|lyfsjukr|||2|10|0||Icepharma hf|Abcur AB|Tíópentalnatríum||13576||13576|18920||2 590092|L04AB0401|Humira|stl|40|mg/penna|0,8|ml|2|pennar|áfylltur penni|L04AB04|01.07.2013||R|0|1|0|1|0|1|ABV|0|1|0|100|DKK|152022|192670|lyfsjukr|||1|1,6|0|27,5900|Vistor hf|AbbVie Ltd.|Adalimumab||152022||152022|192670||1 590497|D01AC0101|Canesten|krem|10|mg/g|20|g|1|túpa||D01AC01|01.12.1982||L|0|0|0|0|0|0|BAE|0|0|1|100|IKR|||lyflausa|||0|20|0||Icepharma hf|Bayer AB|Klótrímazól|||||||2 590562|C01DA1403|Ismo|forđatfl|60|mg|98|stk|1|glas||C01DA14|01.10.1999||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|3091|5276|lyfalmen|V0041|5276|2|98|0|147,0000|Actavis Group hf|Actavis hf|Ísósorbíđ mónónítrat||3091||3091|5276||1 590752|N05AF0102|Fluanxol Depot|stl|100|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1979||R|0|0|0|0|G|0|LBK|0|0|0|100|DKK|23056|31659|lyfalmen|||1|10|0|250,0000|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||23056||23056|31659||1 590919|B01AD1101|Metalyse|sts/irs|10000|ein|1|stk|1|hgl|+ leysir áfyllt sprauta|B01AD11|01.07.2001||R|0|0|0|0|0|1|BOI|0|0|0|100|DKK|181062|229115|lyfsjukr|||1|1|0|0,7500|Vistor hf|Boehringer Ingelheim|Tenekteplasi||181062||181062|229115||1 591260|N06DA0302|Exelon (Lyfjaver)|forđapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.10.2012||R|0|0|0|0|G|0|LVR|0|0|0|100|DKK|15233|20543|lyfalmen|V0347|20543|3|30|0|14,5300|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||14199||14199|20543||3 592378|D08AC0201|Hibiscrub|lyf.sápa|40|mg/ml|500|ml|1|glas||D08AC02|01.10.1976||L|0|0|0|0|0|0|REM|0|0|0|100|IKR|||lyflausa|||0|500|0||Vistor hf|Regent Medical Overseas Limited|Klórhexidín||||||30.6.2013|1 592977|L01XE1201|Caprelsa|filmhtfl|300|mg|30|stk|1|ţpakki||L01XE12|01.07.2012||R|1|1|0|1|0|1|AZA|0|0|0|100|SEK|824453|1036571|lyfsjukr|||1|30|0||Vistor hf|AstraZeneca AB|Vandetaníb||824453||824453|1036571||1 593384|N03AE0101|Rivotril|töflur|0,5|mg|50|stk|1|glas||N03AE01|01.01.1978||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|520|1759|lyfalmen|V0238|769|1|50|0|3,1250|Icepharma hf|Roche|Klónazepam||520||520|1759||2 593392|N03AE0101|Rivotril|töflur|0,5|mg|150|stk|1|glas||N03AE01|01.01.1978||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|921|2308|lyfalmen|V0238|2308|1|150|0|9,3750|Icepharma hf|Roche|Klónazepam||921||921|2308||2 593434|N03AE0101|Rivotril|töflur|2|mg|100|stk|1|glas||N03AE01|01.01.1978||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|1359|2907|lyfalmen|||1|100|0|25,0000|Icepharma hf|Roche|Klónazepam||1359||1359|2907||2 593654|N07BA0146|Nicotinell Tropical Fruit|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.11.2011||L|0|0|0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S|Nikótín|||||||1 594325|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|12|hgl|dreifa|H02AB08|01.12.2003||R|0|0|0|0|G|0|MAB|0|0|1|100|SEK|21430|29618|lyfalmen|||1|12|0|32,0000|Vistor hf|Meda AB|Tríamcínólón||21430||21430|29618||1 594408|C10AA0504|Atorvastatin Portfarma|filmhtfl|40|mg|100|stk|1|ţpakki||C10AA05|01.06.2006||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|7867|3346|lyfalmen|V0114|3196|2|100|0|200,0000|Portfarma ehf|Portfarma|Atorvastatín||1680||1680|3346||2 594713|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|10|g|1|spr||QP52AF02|01.07.1995||L|0|0|0|0|0|0|PAL|0|0|0|100|DKK|340|593|vetorma|||0|10|0||Icepharma hf|Pfizer Oy Animal Health|||||340|593||2 595066|H05BA0102|Miacalcic|stl|100|ae/ml|1|ml|5|lykjur||H05BA01|01.03.1979||R|0|0|0|0|0|1|NOH|0|0|0|100|DKK|6001|8661|lyfsjukr|||1|5|0|5,0000|Vistor hf|Novartis Healthcare A/S-|Samtengt laxakalsítónín||6001||6001|8661||1 595198|G04BD1201|Betmiga|forđatfl|25|mg|90|stk|1|ţpakki||G04BD12|01.07.2013||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|17494|24678|lyfalmen|||1|90|0||Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||17494||17494|24678||1 595991|J07BB0201|Fluarix|bóluefni|||0,5|ml|1|áfspr||J07BB02|01.10.1994||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|609|1881|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Inflúensa, hreinsađir mótefnavakar||609||609|1881||1 596023|D08AC0201|Hibiscrub|lyf.sápa|40|mg/ml|250|ml|1|glas||D08AC02|01.06.1982||L|0|0|0|0|0|0|REM|0|0|0|100|IKR|||lyflausa|||0|250|0||Vistor hf|Regent Medical Overseas Limited|Klórhexidín|||||||1 596085|B03XA0201|Aranesp|stl|50|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|65274|83801|lyfsjukr|||1|2|0|44,4400|Vistor hf|Amgen|Darbepóetín alfa||||65274|83801||1 596881|N05CM1801|Dexdor|irţ|100|mcg/ml|2|ml|5|lykjur|lausn|N05CM18|01.03.2012||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|19506|26363|lyfsjukr|||1|10|0|1,0000|Vistor hf|Orion Corporation|Dexmedetómid||19506||19506|26363||1 597401|J01FF0101|Dalacin|hylki|150|mg|24|stk|1|ţpakki||J01FF01|01.06.1979||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|2351|4264|lyfalmen|||1|24|0|3,0000|Icepharma hf|Pfizer ApS|Klindamýcín||2351||2351|4264||1 597433|L01XC1101|Yervoy|stţ|5|mg/ml|10|ml|1|hgl|lausn|L01XC11|01.05.2012||R|0|1|0|1|0|1|BMS|0|1|0|100|DKK|687379|864543|lyfsjukr|||1|10|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Ipilimumab||687379||687379|864543||1 597567|D01AC0301|Pevaryl|krem|10|mg/g|30|g|1|túpa||D01AC03|01.05.1978||L|0|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|30|0||Vistor hf|McNeil Sweden AB|Ekónazól|||||||1 598094|R06AD0101|Vallergan|mixtúra|5|mg/ml|150|ml|1|glas||R06AD01|01.03.2004||R|0|0|0|0|0|0|SNO|0|0|1|100|NOK|461|1679|lyfalmen|||1|150|0|25,0000|Vistor hf|Sanofi-aventis Norge AS|Alímemazín||461||461|1679||1 598499|M01AE0112|ibuxin rapid|filmhtfl|400|mg|30|stk|1|ţpakki||M01AE01|01.09.2012||L|0|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||0|30|0|10,0000|LYFIS ehf|ratiopharm GmbH|Íbúprófen|||||||2 598925|M01AE0114|Nurofen Apelsin|mixtúra|40|mg/ml|100|ml|1|glas||M01AE01|01.04.2013||L|0|0|0|0|0|0|REC|0|0|1|100|DKK|||lyfalmen|||0|100|0|3,3333|Vistor hf|Reckitt Benckiser Healthcare Ltd|Íbúprófen|||||1815||1 599010|L01XE1701|INLYTA|filmhtfl|5|mg|56|stk|1|ţpakki||L01XE17|01.05.2013||R|1|0|0|1|0|1|PZE|0|0|0|100|SEK|652961|821349|lyfsjukr|||1|56|0||Icepharma hf|Pfizer Ltd.|Axitinib||652961||652961|821349||2 599320|QV03AB9002|Narcostop|stl|5|mg/ml|10|ml|1|hgl|fyrir hunda og ketti|QV03AB90|01.07.2013||R|0|0|0|0|0|0|BVL|1|0|0|100|XEU|4561|8930|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet B.V.|Atipamesól||4561||4561|8930||2 692098|N06BA0104|Amfetamin Glostrup|töflur|5|mg|100|stk|1|glas||N06BA01|01.07.2011||R|0|0|1|0|0|0|PCO|0|0|0|100|DKK|4140|6711|lyfalmen|||0|100|1|33,3300|Distica|Distica - óskráđ lyf|Amfetamín||||4140|6711||1 916827|A03FA0301|Motilium|töflur|10|mg|100|stk|1|ţpakki||A03FA03|01.05.1998||R|0|0|0|0|0|0|PCO|0|0|1|100|SEK|2869|4973|lyfalmen|||0|100|1|33,3333|Distica|Distica - óskráđ lyf|Dómíperídón||2869||2869|4973||1 923351|S01XA2006|Lacri - Lube|augnsm|||3,5|g|1|túpa||S01XA20|01.01.1998||R|0|0|0|0|0|0|PCO|0|0|0|100|IKR|480|1705|lyfalmen|||0|3,5|1||Distica|Distica - óskráđ lyf|Gervitár og ađrar óvirkar samsetningar||480||480|1705||1 938483|M04AC0101|Colchicine|töflur|0,5|mg|100|stk|1|glas||M04AC01|01.01.1998||R|0|0|0|0|0|0|LDR|0|0|0|100|GBP|6076|9360|lyfalmen|||0|100|1|50,0000|Parlogis hf|Parlogis - óskráđ lyf|Kolkisín||6076||6076|9360||2 938780|C09AA0104|Captopril|hylki|1|mg|100|stk|1|glas||C09AA01|01.01.2000||R|0|0|0|0|0|0|LDR|0|0|0|100|GBP|17454|24628|lyfalmen|||0|100|1|2,0000|Parlogis hf|Parlogis - óskráđ lyf|Kaptópríl||17454||17454|24628||2 940313|G03BA0302|Testosteron|vefjatfl|100|mg|1|stk|1|pakki||G03BA03|01.04.1998||R|0|0|0|0|0|0|PCO|0|0|0|100|GBP|2848|4944|lyfalmen|||0|1|1|33,3300|Distica|Distica - óskráđ lyf|Testósterón||2848||2848|4944||1 944505|H02AB1005|Cortisonacetat|töflur|5|mg|100|stk|1|glas||H02AB10|01.12.2002||R|0|0|0|0|0|0|PCO|0|0|1|100|DKK|5440|8490|lyfalmen|||0|100|1|13,3300|Distica|Distica - óskráđ lyf|Kortisón||5440||5440|8490||1 944852|A06AX0102|Glycerol infant|eţ-stíll|||12|stk|1|pakki||A06AX01|01.10.1998||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|342|1516|lyfalmen|||0|12|1||Parlogis hf|Parlogis - óskráđ lyf|Glýceról||342||342|1516||2 944985|A06AX0103|Glycerol adult|eţ-stíll|||12|stk|1|pakki||A06AX01|01.10.1998||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|664|1956|lyfalmen|||0|12|1||Parlogis hf|Parlogis - óskráđ lyf|Glýceról||664||664|1956||2 945850|R06AD0202|Atosil|stl|25|mg/ml|2|ml|5|lykjur||R06AD02|01.03.2001||R|0|0|0|0|0|0|PCO|0|0|1|100|IKR|2293|4185|lyfalmen|||0|10|1|10,0000|Distica|Distica - óskráđ lyf|Prómetazín||2293||2293|4185||1 947715|H02AB1004|Cortisone Acetat|töflur|25|mg|100|stk|1|glas||H02AB10|01.01.1998||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|5033|7933|lyfalmen|||0|100|1|66,6667|Parlogis hf|Parlogis - óskráđ lyf|Kortisón||5033||5033|7933||2 948242|H02AB0203|Dexamethason|töflur|0,5|mg|100|stk|1|pakki||H02AB02|01.04.2005||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|1990|3770|lyfalmen|||0|100|1|33,3300|Parlogis hf|Parlogis - óskráđ lyf|Dexametasón||1990||1990|3770||2 951592|H02AB0907|Hydrocortison|töflur|1|mg|100|stk|1|glas||H02AB09|01.08.2009||R|0|0|0|0|0|0|PCO|0|0|1|100|DKK|5440|8490|lyfalmen|||0|100|1|3,3300|Distica|Distica - óskráđ lyf|Hýdrókortisón||5440||5440|8490||1 954421|C03CA0109|Furosemid|mixtúra|10|mg/ml|60|ml|1|glas||C03CA01|01.08.2009||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|1870|3606|lyfalmen|||0|60|1||Parlogis hf|Parlogis - óskráđ lyf|Fúrósemíđ||||1870|3606||2 954504|C07AA0510|Syprol|mixtúra|2|mg/ml|150|ml|1|fl||C07AA05|01.08.2009||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|5690|8832|lyfalmen|||0|150|1||Parlogis hf|Parlogis - óskráđ lyf|Própranólól||||5690|8832||2 961393|A04AD0501|Vogalene|hylki|15|mg|20|stk|1|ţpakki||A04AD05|01.01.1998||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|1960|3729|lyfalmen|||0|20|1|20,0000|Parlogis hf|Parlogis - óskráđ lyf|Metópímazín||1960||1960|3729||2 961591|H02AB0906|Hydrocortisone|töflur|10|mg|20|stk|1|ţpakki||H02AB09|01.08.2009||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|1850|3579|lyfalmen|||0|20|1|6,6700|Parlogis hf|Parlogis - óskráđ lyf|Hýdrókortisón||1850||1850|3579||2 961658|H02AB0905|Hydrocortisone|töflur|20|mg|25|stk|1|glas||H02AB09|01.01.2009||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|6231|9572|lyfalmen|||0|25|1|16,7000|Parlogis hf|Parlogis - óskráđ lyf|Hýdrókortisón||6231||6231|9572||2 962466|H02AB0203|Dexamethason|töflur|4|mg|100|stk|1|glas||H02AB02|01.08.2009||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|3451|5769|lyfalmen|||0|100|1|266,6600|Parlogis hf|Parlogis - óskráđ lyf|Dexametasón||||3451|5769||2 962945|R06AB0201|Polaramin|töflur|2|mg|30|stk|1|ţpakki||R06AB02|01.11.2009||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|2360|4276|lyfalmen|||0|30|1|10,0000|Parlogis hf|Parlogis - óskráđ lyf|Dexklórfeníramín||2360||2360|4276||2 965767|A03AA0703|Dicykloverin Syrup|mixtúra|2|mg/ml|120|ml|1|glas||A03AA07|01.08.2011||R|0|0|0|1|0|0|LDR|0|0|0|100|IKR|8480|12648|lyfalmen|||0|120|1|3,0000|Parlogis hf|Parlogis - óskráđ lyf|Dícýklóverín||8480||8480|12648||2 967333|N05AH0408|Quetiapin Bluefish|filmhtfl|25|mg|60|stk|1|ţpakki||N05AH04|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|1200|2142|lyfalmen|V0284|1585|2|60|0|3,7500|LYFIS ehf|Bluefish Pharmaceuticals AB|Quetíapín||800||800|2142||2 967341|N05AH0408|Quetiapin Bluefish|filmhtfl|100|mg|60|stk|1|ţpakki||N05AH04|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|6800|4468|lyfalmen|V0285|4322|2|60|0|15,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Quetíapín||2500||2500|4468||2 967359|N05AH0408|Quetiapin Bluefish|filmhtfl|200|mg|60|stk|1|ţpakki||N05AH04|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|12500|9392|lyfalmen|V0286|9392|2|60|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Quetíapín||6100||6100|9392||2 967367|N05AH0408|Quetiapin Bluefish|filmhtfl|300|mg|60|stk|1|ţpakki||N05AH04|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|25000|26945|lyfalmen|V0287|26945|2|60|0|45,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Quetíapín||19300||19300|26945||2